<?xml version="1.0" encoding="UTF-8"?>
<rdf:RDF
   xmlns:ao="http://www.w3.org/ns/oa#"
   xmlns:dailymed="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/"
   xmlns:dct="http://purl.org/dc/terms/"
   xmlns:dikbD2R="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/"
   xmlns:domeo="http://www.w3.org/ns/domeo#"
   xmlns:foafx="http://xmlns.com/foaf/0.1/"
   xmlns:pav="http://purl.org/pav/"
   xmlns:permissions="http://vocab.deri.ie/cpo#"
   xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
   xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#"
   xmlns:sio="http://semanticscience.org/resource/"
>
  <rdf:Description rdf:about="urn:domeoclient:uuid:3AEAAD22-7B34-43F4-9287-7A481EDB120D">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-07 19:46:29 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5ABD9862-F044-4404-AD04-73DA04ADDA8B</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotationset:1DED06A6-8562-4CCF-A58C-CA25748FBD31</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:5150A4B8-C71B-4315-88E2-A0ACAEA33BCB"/>
    <pav:lastSavedOn>2014-07-07 19:50:36 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:4543C59F-15AE-426D-B65C-5A3B7D36FB5C">
    <pav:createdOn>2014-07-07 09:38:38 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A5E637EF-5CA5-4AAC-BD8B-C136A86E17B7</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:35C5E273-FFFA-4DC2-98FD-912FDF2383BB"/>
    <pav:lastSavedOn>2014-07-07 09:44:18 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotationset:F37BE993-E972-47AE-896D-FF4D33157ECF</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:12EBC24C-8600-4D85-A9A7-1C62410457FF">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/CCEE52EA-EDD1-4655-8203-DF4101ABDED4"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/A0A76A9B-9342-4FF7-9356-72AEACE106D4"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:56F5125F-1AA7-472B-A219-462D80281246">
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotation:0727E2BC-3033-4256-A0CA-905EA9439BEF</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-07-08 15:34:18 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:2831B1E5-422A-4596-84B5-3924AA0D86E8"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2014-07-08 15:33:35 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:0F235438-66A4-4847-A5E7-8A71C3802072</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:6A61BF30-0A71-478D-A329-0FB7BB575023">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-120.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:6A61BF30-0A71-478D-A329-0FB7BB575023"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>6A61BF30-0A71-478D-A329-0FB7BB575023</domeo:uuid>
    <pav:createdOn>2014-07-07 20:47:03 -0400</pav:createdOn>
    <ao:prefix>and other oral coumarin anticoagulants, resulting in a prolongation of prothrombin time. This possible drug interaction should be considered when </ao:prefix>
    <ao:exact>FLAGYL </ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>(metronidazole) is prescribed for patients on this type of anticoagulant therapy.</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:4C547F49-FC88-4CBB-B168-644256663CB3">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/2A91DFDD-1E15-471E-90AC-E705C49E07AF"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/1948CE05-84FB-406D-BD86-37071A76770B"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:1779DC20-9623-4186-A08A-76653EBE000C">
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:23515E27-98AC-4DC9-A4B7-EBFE2991219F</domeo:belongsToSet>
    <pav:createdOn>2014-07-08 08:43:41 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:33292E01-9C31-4824-B80E-DC8033F8CFC9"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2014-07-08 08:46:38 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotationset:57174A7C-3100-4C8F-9C4A-2991CEE124D5</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:51450C97-6C41-4FBD-8342-15BE45A2DDE8">
    <pav:createdOn>2014-07-08 16:16:30 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:D5FE9F58-EB3F-4295-9090-E3B773EBD671</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:lineageUri>urn:domeoserver:annotation:9E32C426-D9F1-4C43-94F7-E5D26B9164C2</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-07-08 16:17:10 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:A7CD6119-C16D-4C28-A98A-7728036DFE6F"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <ao:body rdf:nodeID="N096a4f82f94e4bc18a85cdcad17de92e"/>
    <rdfs:label>expertstudy Annotation</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B6AAAF28-5676-44E1-8BFD-81077C83CD8C">
    <domeo:belongsToSet>urn:domeoclient:uuid:06661B74-00AE-4DF7-A9CC-742273A11E94</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotation:40D80906-943B-4425-B2E4-DCCF54D3460F</pav:lineageUri>
    <pav:lastSavedOn>2014-07-07 20:30:15 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:630EFBF6-01E4-4465-8FD1-6D3CAD06A978"/>
    <pav:createdOn>2014-07-07 20:29:20 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B8588523-C329-4303-ADDC-E0587156E5F6">
    <domeo:belongsToSet>urn:domeoserver:annotationset:7E49EB7A-DE0E-4720-82D1-8460BA0C770D</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:4BBB711C-7040-45DF-872C-62117B1760E0"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <ao:body rdf:nodeID="Nd836162d55be400e83a22ec91b2bbcb3"/>
    <pav:lineageUri>urn:domeoserver:annotation:2716758F-9424-4F22-ACAD-E253BAA4FB5E</pav:lineageUri>
    <pav:createdOn>2014-07-08 14:05:01 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:lastSavedOn>2014-07-08 14:10:48 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:FE1A477B-EB1A-420B-AD02-C547D6535DE1">
    <pav:createdOn>2014-07-08 15:38:45 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotation:C3C6AA52-3368-4828-B75F-21457ABA0F61</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:body rdf:nodeID="N3952d26c2dab4d359bc4be576bf66204"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A7033EE8-62A2-4AAF-AD21-7D4F7611919F</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-07-08 15:41:14 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:5C353245-0082-48BE-BC73-23D94862A8F2"/>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C9102084-C282-4E15-B574-E2F9B43D3401">
    <pav:lineageUri>urn:domeoserver:annotation:A57A8B5C-7CD7-4695-91AA-D6309DEA80BC</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoclient:uuid:F8266BC9-0FBE-4F89-99BF-28181281C00F</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-07-07 19:59:48 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:CCA45320-FC3E-4533-A916-4F4B67DB1F3C"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2014-07-07 20:00:02 -0400</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:37A38B64-B8DE-4261-A02E-126661A1A141">
    <ao:suffix> equivalent to that of a 20 mg oral dose.</ao:suffix>
    <pav:createdOn>2014-07-07 09:49:48 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:37A38B64-B8DE-4261-A02E-126661A1A141"/>
    <domeo:uuid>37A38B64-B8DE-4261-A02E-126661A1A141</domeo:uuid>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>metabolite </ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/BCF87F07-1002-4D09-9C67-0FC1C19D5FB6">
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/85762</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>ritonavir</rdfs:label>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E4F73D48-6A10-4A06-BFBC-DEBAA86412DF">
    <ao:prefix>xsd:String</ao:prefix>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:E4F73D48-6A10-4A06-BFBC-DEBAA86412DF"/>
    <ao:exact>co-administration of known enzyme inducers (e.g., carbamazepine, phenytoin, rifampin, and phenobarbital) with risperidone may cause a decrease in the combined plasma concentrations of risperidone and 9-hydroxyrisperidone</ao:exact>
    <domeo:uuid>E4F73D48-6A10-4A06-BFBC-DEBAA86412DF</domeo:uuid>
    <pav:createdOn>2014-07-07 19:53:04 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:befcd494-a98b-4f55-ab9f-59ef8bb5e4de">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-84.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid></domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:befcd494-a98b-4f55-ab9f-59ef8bb5e4de"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>tacrine</ao:exact>
    <ao:prefix>ncreased the Cmax and AUC of </ao:prefix>
    <pav:createdOn>2014-07-07 08:06:58 -0400</pav:createdOn>
    <ao:suffix> by approximately 54% and 64%,</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoserver:annotationset:063A7209-93BB-42E1-A05D-D45CEF402ED2">
    <ao:item rdf:resource="urn:domeoclient:uuid:E8841241-0057-420C-85E3-2C0EC4B7CC39"/>
    <rdfs:label>NER Sets</rdfs:label>
    <permissions:permissions rdf:nodeID="Na46495a1a31840e0ac5ff1904bca3fa0"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:E43E2315-081D-4703-B4E6-7A9270E74E0C"/>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:FB923729-1203-488D-9A56-696B720C1DD3"/>
    <domeo:deleted>false</domeo:deleted>
    <pav:lastSavedOn>2014-07-08 15:30:37 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">3</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotationset:7bc2bb03-2737-42c9-8874-80f8ab9161ef</pav:lineageUri>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-198.txt.html</ao:annotatesResource>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812e52b20002"/>
    <pav:previousVersion>urn:domeoclient:uuid:24a71afc-cb92-4091-829a-4573f0f6f976</pav:previousVersion>
    <ao:item rdf:resource="file:///home/yin2/python-SPL-connector/0b953413-5ff5-40c0-8b69-e7687ef3bd6f"/>
    <pav:createdOn>2014-07-07 08:07:06 -0400</pav:createdOn>
    <dct:description>The NER set is created automatically by NER annotation loading program.</dct:description>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:item rdf:resource="urn:domeoclient:uuid:DA5D5837-3580-49DF-8E5E-F517AB8DF46C"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/5E9503EF-2AD5-454F-AEED-6D410C618627">
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>risperidone</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/35636</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:2EBD1022-9ACE-4AD0-8A64-807BD0BEDD5F">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <ao:suffix>, respectively, compared to those seen in healthy younger volunteers (18–45 years). Due to age-differences in plasma protein binding, the corresponding increase in the AUC of free (unbound)</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:2EBD1022-9ACE-4AD0-8A64-807BD0BEDD5F"/>
    <pav:createdOn>2014-07-07 09:57:54 -0400</pav:createdOn>
    <domeo:uuid>2EBD1022-9ACE-4AD0-8A64-807BD0BEDD5F</domeo:uuid>
    <ao:exact>N-desmethyl metabolite</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:541EE0BD-455D-4A7A-854B-562676BFC39B">
    <pav:lineageUri>urn:domeoserver:annotationset:57174A7C-3100-4C8F-9C4A-2991CEE124D5</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:23515E27-98AC-4DC9-A4B7-EBFE2991219F</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:previousVersion>urn:domeoclient:uuid:5BCE2FDB-C586-44CD-88F7-6EE2BDB6B929</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:createdOn>2014-07-08 08:50:50 -0400</pav:createdOn>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:lastSavedOn>2014-07-08 08:51:47 -0400</pav:lastSavedOn>
    <ao:body rdf:nodeID="N41fe3d7adfbf4fe685d30669685be554"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:71D6BAC6-DC3A-4C58-B200-6867338DA2E2"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F2F67FFA-C8CC-4C69-BA89-71EE02913503">
    <pav:createdOn>2014-07-07 10:00:00 -0400</pav:createdOn>
    <ao:suffix>Cmax</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:F2F67FFA-C8CC-4C69-BA89-71EE02913503"/>
    <ao:prefix> </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>sildenafil </ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <domeo:uuid>F2F67FFA-C8CC-4C69-BA89-71EE02913503</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/A3AA3D34-8E43-4492-8637-CCA7838E6BCB">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>propranolol</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/8787</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoserver:annotationset:CF899881-76E1-4005-BE12-FE1112B9CEF9">
    <pav:lineageUri>urn:domeoserver:annotationset:9dfd7548-433e-473e-a57e-dbf0a5e8ce4a</pav:lineageUri>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-30.txt.html</ao:annotatesResource>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-07 08:06:48 -0400</pav:createdOn>
    <permissions:permissions rdf:nodeID="Na46a479b0868494f9b860e5c8d4dabb1"/>
    <domeo:deleted>false</domeo:deleted>
    <dct:description>The NER set is created automatically by NER annotation loading program.</dct:description>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">3</pav:versionNumber>
    <pav:previousVersion>urn:domeoclient:uuid:70f21ecb-416a-4adb-82a4-3db09cc292f6</pav:previousVersion>
    <ao:item rdf:resource="urn:domeoclient:uuid:15A2900B-9AAF-45A2-A032-E281FA828CB4"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812e52b20002"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <ao:item rdf:resource="file:///home/yin2/python-SPL-connector/ec50bbd0-119c-4595-8b2e-59f79b86e7f0"/>
    <pav:lastSavedOn>2014-07-08 19:52:52 -0400</pav:lastSavedOn>
    <rdfs:label>NER Sets</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:94A767A9-A61D-461C-B793-8808E2041006">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">3</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:previousVersion>urn:domeoclient:uuid:21a2d27a-13b1-4797-ba7a-c0517e32bb06</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:32944008-A6C6-4D66-8C43-EE4CF2256965</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotationset:cf593dca-fe93-451b-8f37-2a96e065da13</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:72F9AAF8-555C-4C03-9E68-B916924DFF3C"/>
    <pav:createdOn>2014-07-21 10:01:38 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-07-21 10:02:11 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/B1C80378-05AF-4F54-B108-29F0FCF2815B">
    <rdfs:label>fluconazole</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/4450</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C6A24744-4135-4C9F-A637-7703EFEA0D59">
    <pav:createdOn>2014-07-08 19:40:15 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2014-07-08 19:40:31 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotation:241EB034-D373-43CB-A58B-8792BCFF5891</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:5DA41851-B1C4-4333-976C-F8C3B63A82E8"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:AFA31957-0959-46DF-B640-AD0687F186D6</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/31809C64-5016-4FAC-B2FF-A4F084885AB4">
    <rdfs:label>propranolol</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/8787</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:1042BEE0-D02D-4D4B-90A7-BDFF93CE2721">
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:createdOn>2014-07-07 20:38:03 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoclient:uuid:8D643EAC-88DF-4484-A479-D1E798544DF5</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:CBA9257A-6BFA-4C8D-A8DA-49FF788B2ABB"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotation:B0B846BA-A21E-4F55-94FC-D459C8453080</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2014-07-07 20:38:37 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:FB775B66-BA10-4024-BDD0-5CE62758B779">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:FB775B66-BA10-4024-BDD0-5CE62758B779"/>
    <ao:exact> 9-hydroxyrisperidone</ao:exact>
    <domeo:uuid>FB775B66-BA10-4024-BDD0-5CE62758B779</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>at 10 ng/mL and</ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <ao:suffix> at 50 ng/mL, changes of unknown clinical significance.</ao:suffix>
    <pav:createdOn>2014-07-07 19:47:09 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:900260F9-4D67-46D8-94CE-466B51D8EFDA">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/4DA8DAF4-7FC4-40C0-B72B-9E5949E0AAF9"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/419612D9-028A-4427-B768-B6BAB067A5B0"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B5821CB1-C20E-47EB-95E6-9E2CFB1CEF28">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7E49EB7A-DE0E-4720-82D1-8460BA0C770D</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:body rdf:nodeID="Ncb2bba057abc426993f6978923e1deef"/>
    <pav:lastSavedOn>2014-07-08 14:10:48 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotation:E7D1E94B-8DBC-4C2C-A201-2860B444486E</pav:lineageUri>
    <pav:createdOn>2014-07-08 14:02:32 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:88DF9883-0917-4393-BB07-BC836EA33919"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:8F1F77E8-8F5C-4350-8372-B2695D0D5BBD">
    <ao:suffix>xsd:String</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-194.txt.html</ao:hasSource>
    <ao:exact>Small doses of quinidine completely inhibit the CYP2D6 hydroxylation metabolic pathway, making all patients, in effect, slow metabolizers [see Clinical Pharmacology (12)]. Concomitant administration of quinidine (50 mg three times daily) with 150 mg immediate-release propafenone three times daily decreased the clearance of propafenone by 60% in EM, making them PM. Steady-state plasma concentrations increased by more that 2-fold for propafenone, and decreased 50% for 5OH-propafenone. A 100 mg dose of quinidine increased steady state concentrations of propafenone 3-fold. Avoid concomitant use of propafenone and quinidine.</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:8F1F77E8-8F5C-4350-8372-B2695D0D5BBD"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>xsd:String</ao:prefix>
    <pav:createdOn>2014-07-08 14:03:24 -0400</pav:createdOn>
    <domeo:uuid>8F1F77E8-8F5C-4350-8372-B2695D0D5BBD</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:444669EA-407A-4639-A8CA-72F7B927C60B">
    <domeo:uuid>444669EA-407A-4639-A8CA-72F7B927C60B</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:444669EA-407A-4639-A8CA-72F7B927C60B"/>
    <ao:suffix>in monotherapy.</ao:suffix>
    <ao:prefix>in combination with other hypoglycemic agents were generally similar to those seen with </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-08 08:40:10 -0400</pav:createdOn>
    <ao:exact>AVANDIA </ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:CB4806A3-01B7-46D7-A04A-F22C0AA913DE">
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <domeo:deleted>false</domeo:deleted>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotationset:9225D5DB-6859-4086-9FD4-D0BDF3ADB4EF</pav:lineageUri>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812e52b20002"/>
    <rdfs:label>Default Set</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:lastSavedOn>2014-07-07 20:28:50 -0400</pav:lastSavedOn>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <ao:item rdf:resource="urn:domeoclient:uuid:C21EA743-EDED-4661-B40D-5CD15D2EE955"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-53.txt.html</ao:annotatesResource>
    <ao:item rdf:resource="urn:domeoclient:uuid:9DA84262-6A4D-43C9-8EBF-32649516E683"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:83E35C31-8662-4D63-8D75-4E5962696051"/>
    <pav:createdOn>2014-07-07 20:27:44 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <permissions:permissions rdf:nodeID="Na637fbd890c44dc69385c0af620e7597"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/8D351DCF-757B-4036-9D77-B788A5C7F1B1">
    <rdfs:label>citalopram</rdfs:label>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/2556</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:EF9B7607-379E-4AC7-8BD6-F80D41D0C2F8">
    <ao:context rdf:resource="urn:domeoclient:uuid:509296DF-B123-4BF0-83A9-60329DB03E04"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotationset:1DED06A6-8562-4CCF-A58C-CA25748FBD31</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2014-07-07 19:50:36 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-07 19:46:50 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5ABD9862-F044-4404-AD04-73DA04ADDA8B</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:AEFB34F5-676C-4384-9B02-311075C59D2B">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:E91EABBF-C02A-4D53-B504-850B9783818A"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:lastSavedOn>2014-07-07 20:16:04 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotation:C700A185-8428-48D8-A241-B914F62FAE1E</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-07-07 20:14:57 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoclient:uuid:B44CD6F1-18F6-4252-9E79-5D5107E7044D</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:8B2D8833-1AE4-41FA-B72A-180709AECC86">
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <domeo:belongsToSet>urn:domeoclient:uuid:C56FAF33-D751-43EF-B31E-95E23B8E733A</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:A4222577-0D92-4A9B-A1B6-C0DE1209FC51"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:body rdf:nodeID="N745d8187e32e4f258999e722ea19bbfc"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:createdOn>2014-07-07 20:36:11 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotation:EAD0868A-65CE-435E-82E3-0AAF3581BCB3</pav:lineageUri>
    <pav:lastSavedOn>2014-07-07 20:36:25 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:EDCDCFE8-C8C9-46C5-9B41-E5151A46DE38">
    <pav:lineageUri>urn:domeoserver:annotation:414D0D47-E171-4525-8D07-28599D63B69E</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:FE9AADB1-C722-4760-8125-5860CC27B488"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoclient:uuid:06661B74-00AE-4DF7-A9CC-742273A11E94</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-07 20:30:15 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:createdOn>2014-07-07 20:29:17 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:9C63E074-D1D1-4494-ABF3-C28488FB57E2">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:23515E27-98AC-4DC9-A4B7-EBFE2991219F</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:60BB8E86-2F9F-497F-BB60-44B1ED83874E"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-07-08 08:40:03 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-07-08 08:46:38 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotationset:57174A7C-3100-4C8F-9C4A-2991CEE124D5</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:D51EDA8E-DA34-47CD-B996-4CFA6AFC27BF">
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:E07E4FF7-42C6-4591-ABCD-0B1AACC8916F"/>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:6ADA22D4-36CE-4212-8A7D-8F44DE2131D9">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-07-08 15:39:24 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:4E7EA884-B898-4032-8586-82F4A062BB59"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-07-08 15:41:14 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotation:7D54CDF4-46F3-44B5-9040-6F024285A169</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <ao:body rdf:nodeID="N1df69f6e16594e488f576cdbc14ac4c0"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A7033EE8-62A2-4AAF-AD21-7D4F7611919F</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:9725C2C6-828E-4C82-A910-9732D8C41EF1">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-08 13:59:04 -0400</pav:createdOn>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:9725C2C6-828E-4C82-A910-9732D8C41EF1"/>
    <domeo:uuid>9725C2C6-828E-4C82-A910-9732D8C41EF1</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-194.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>Drugs that inhibit CYP2D6 (such as desipramine, paroxetine, ritonavir, sertraline) and CYP3A4 (such as ketoconazole, ritonavir, saquinavir, erythromycin, and grapefruit juice) can be expected to cause increased plasma levels of propafenone. The combination of CYP3A4 inhibition and either CYP2D6 deficiency or CYP2D6 inhibition with administration of propafenone may increase the risk of adverse reactions, including proarrhythmia. Therefore, simultaneous use of RYTHMOL SR with both a CYP2D6 inhibitor and a CYP3A4 inhibitor should be avoided</ao:exact>
    <ao:suffix>xsd:String</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:1C22DD7A-B548-4CEF-8D7A-5FDFB7B5EFA8">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>1C22DD7A-B548-4CEF-8D7A-5FDFB7B5EFA8</domeo:uuid>
    <ao:exact>Concomitant administration of rifampin and propafenone in extensive metabolizers decreased the plasma concentrations of propafenone by 67% with a corresponding decrease of 5OH-propafenone by 65%. The concentrations of norpropafenone increased by 30%. In poor metabolizers, there was a 50% decrease in propafenone plasma concentrations and increased the AUC and Cmax of norpropafenone by 74 and 20%, respectively. Urinary excretion of propafenone and its metabolites decreased significantly. Similar results were noted in elderly patients: Both the AUC and Cmax propafenone decreased by 84%, with a corresponding decrease in AUC and Cmax of 5OH-propafenone by 69 and 57%.</ao:exact>
    <ao:prefix>xsd:String</ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:1C22DD7A-B548-4CEF-8D7A-5FDFB7B5EFA8"/>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-194.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-08 14:04:38 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:738231FC-4090-4D56-90FB-4FBFF166BD23">
    <pav:createdOn>2014-07-07 20:08:05 -0400</pav:createdOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:7AF9EBF8-2117-41ED-AFF0-409C2C82DEF0"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:6C63DD1E-3B4D-4549-95F4-FEBCF87CFCEA"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <ao:item rdf:resource="urn:domeoclient:uuid:0C4287F4-02E3-419A-8EAB-4582BAABB3A2"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:33D490C1-2CDC-486B-B4B1-DF68A1F97CC7"/>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812e52b20002"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:93F4CA25-B4EB-4AA8-8B3E-263A35D74809"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:item rdf:resource="urn:domeoclient:uuid:4EB69CDA-6FBD-4895-B0C2-F2637FC7DC16"/>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <ao:item rdf:resource="urn:domeoclient:uuid:6A23345D-2B18-41F9-B907-989DBB2E341E"/>
    <pav:lineageUri>urn:domeoserver:annotationset:616206B4-FA20-4095-A18F-19181AEE9A83</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Default Set</rdfs:label>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:D31028B6-43FD-43E4-9CA5-59C6B2336813"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:8C7C035E-1863-43C3-9F69-DDB013B30715"/>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-23.txt.html</ao:annotatesResource>
    <permissions:permissions rdf:nodeID="N03f8776ca8b942808d07e122df4760a8"/>
    <domeo:deleted>false</domeo:deleted>
    <pav:lastSavedOn>2014-07-07 20:09:59 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N2663075b8c914761ad6725c342c16376">
    <domeo:sets rdf:resource="urn:pddi:uuid:4431CDD6-C079-428D-91F6-514F2FF5B77B"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nf6976a7f6a9541ffbb405484931bcd9e">
    <permissions:accessType>urn:person:uuid:080e143046812afe0146812e52b20002</permissions:accessType>
    <permissions:isLocked>false</permissions:isLocked>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:5F40D6FC-BF07-4E5A-BB51-EB521FF63890">
    <ao:item rdf:resource="urn:domeoclient:uuid:81151024-3DB0-42AD-B773-62D7D6CEF0C4"/>
    <rdfs:label>Default Set</rdfs:label>
    <permissions:permissions rdf:nodeID="N5879bba1c08647faa31197657b25cf1a"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:734AC941-3742-4348-B334-A442FCED1802"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:04501B56-E22B-4072-B48A-DD7DDF7B25F9"/>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-50.txt.html</ao:annotatesResource>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:item rdf:resource="urn:domeoclient:uuid:0134AD2A-C253-4CDE-AF90-97772789E401"/>
    <pav:createdOn>2014-07-07 20:23:14 -0400</pav:createdOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:D8B7217A-0E2A-4A58-9940-24D039448A5A"/>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812e52b20002"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotationset:76F5A319-89A6-476A-941D-176AEE2DC101</pav:lineageUri>
    <pav:lastSavedOn>2014-07-07 20:25:19 -0400</pav:lastSavedOn>
    <domeo:deleted>false</domeo:deleted>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:22D2C3BF-DF88-45CF-9F0D-D56E76DC4DD3">
    <pav:lineageUri>urn:domeoserver:annotation:F5B6C3F6-C7AC-45E2-B75B-5B1BCE7FFC01</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:4AE53870-0F9C-4B76-81EF-43A19DE4BE7C"/>
    <pav:createdOn>2014-07-07 19:58:32 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2014-07-07 19:59:12 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5ABD9862-F044-4404-AD04-73DA04ADDA8B</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:91239536-9595-4DEC-9FCC-6F4DE09C1950">
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotation:E6A7057D-2233-4BB6-AA41-C3DE448595A0</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:E808FC5F-C42C-4A63-8F24-AF42F13FD845"/>
    <ao:body rdf:nodeID="Ncaacf543c27a4a41b5c3394a74abba6b"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:lastSavedOn>2014-07-08 15:56:00 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5B2167F6-4E63-4A7B-85C1-ACA56DDE7073</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:createdOn>2014-07-08 15:56:00 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:90F34130-1F08-4A3C-940C-1142C6D51481">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-08 14:38:27 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-190.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:90F34130-1F08-4A3C-940C-1142C6D51481"/>
    <ao:exact> M–2</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix> metabolism, although CYP2D6 also contributes to the formation of</ao:prefix>
    <domeo:uuid>90F34130-1F08-4A3C-940C-1142C6D51481</domeo:uuid>
    <ao:suffix>.</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:0546FBBA-CDB2-46D1-830E-2F04F36E980E">
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:0DB2814A-76A7-4557-B7FB-171C5A845E17"/>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/86490AFC-CD00-42BB-8142-F90AFDBD9AD3">
    <rdfs:label>zidovudine</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/11413</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:472196F7-4FC8-4182-A979-F3EA2A6B03E6">
    <ao:context rdf:resource="urn:domeoclient:uuid:DFAB1A9B-478A-4576-BB50-288C0F93B87F"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotation:E27F6BE7-F726-4EBB-A0B8-6015CBC501E6</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoclient:uuid:921CCEB9-21F5-4162-854B-F60FC028BC15</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-08 12:02:05 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-07-08 12:02:05 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A7CC0DB6-A806-46A4-95AB-91A6F2531533">
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdOn>2014-07-07 19:48:58 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotationset:1DED06A6-8562-4CCF-A58C-CA25748FBD31</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:82E011D1-3D6C-4BEA-8CAD-519E0D372E99"/>
    <pav:lastSavedOn>2014-07-07 19:50:36 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5ABD9862-F044-4404-AD04-73DA04ADDA8B</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:9CCAF920-9EFC-4521-9D3F-42FDD3027A7B">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-197.txt.html</ao:hasSource>
    <domeo:uuid>9CCAF920-9EFC-4521-9D3F-42FDD3027A7B</domeo:uuid>
    <ao:prefix> and </ao:prefix>
    <ao:exact>GZDV</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:9CCAF920-9EFC-4521-9D3F-42FDD3027A7B"/>
    <ao:suffix> accounts for 14% and 74%, respectively, of the dose following oral administration. A second metabolite, 3'-amino-3'-deoxythymidine (AMT), has been identified in the plasma following single-dose intravenous (IV) administration of </ao:suffix>
    <pav:createdOn>2014-07-08 14:20:03 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A927CF27-CC1C-4BE1-9435-0875A6356C3E">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <ao:item rdf:resource="urn:domeoclient:uuid:980D8375-2A34-47AE-9648-D44F8E1E5609"/>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-126.txt.html</ao:annotatesResource>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812e52b20002"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <pav:lineageUri>urn:domeoserver:annotationset:2284D213-C18C-49EF-9A63-58BE09CF8066</pav:lineageUri>
    <domeo:deleted>false</domeo:deleted>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Default Set</rdfs:label>
    <ao:item rdf:resource="urn:domeoclient:uuid:F0107AFB-72DB-4880-85F1-BC51F3724590"/>
    <pav:lastSavedOn>2014-07-08 08:58:29 -0400</pav:lastSavedOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:BDE1F912-643A-43B6-9AF4-9B44C866F37D"/>
    <pav:createdOn>2014-07-08 08:58:10 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <permissions:permissions rdf:nodeID="Ne8fd0c5d20af43d99bce2cf3936dbce7"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C21EA743-EDED-4661-B40D-5CD15D2EE955">
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-07-07 20:27:44 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:142CCD33-941A-42D7-92F5-348698C3FDEC"/>
    <pav:lineageUri>urn:domeoserver:annotation:15EFA505-A9EC-45F8-9420-B43309427D26</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-07-07 20:28:50 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoclient:uuid:CB4806A3-01B7-46D7-A04A-F22C0AA913DE</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:8DD896DF-7FBD-4E79-9415-D948A381C673">
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <ao:body rdf:nodeID="Na22d2403452f4ffe9928c9d5800d7b44"/>
    <pav:lineageUri>urn:domeoserver:annotation:A41E8F9C-8257-433D-B606-F59E60BE9CA8</pav:lineageUri>
    <pav:lastSavedOn>2014-07-07 20:21:40 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoclient:uuid:CE45A5D4-BD84-4E02-AC7B-C9E12233EC3A</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:4DCCDDAE-E949-4935-AF25-54EFF6FEE358"/>
    <pav:createdOn>2014-07-07 20:21:05 -0400</pav:createdOn>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:77992245-2A09-487C-9288-2429C3D41073">
    <domeo:uuid>77992245-2A09-487C-9288-2429C3D41073</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:77992245-2A09-487C-9288-2429C3D41073"/>
    <pav:createdOn>2014-07-07 20:05:50 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-22.txt.html</ao:hasSource>
    <ao:exact>fluconazole </ao:exact>
    <ao:prefix>Oral contraceptives were administered as a single dose both before and after the oral administration of </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix>50 mg once daily for 10 days in 10 healthy women. There was no significant difference in ethinyl estradiol or levonorgestrel AUC after the administration of 50 mg of fluconazole. The mean increase in ethinyl estradiol AUC was 6% (range: -47 to 108%) and </ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoserver:annotationset:5ABD9862-F044-4404-AD04-73DA04ADDA8B">
    <ao:item rdf:resource="urn:domeoclient:uuid:337FE4E5-D823-4551-923A-D6EF2ACC0F76"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:759582FD-ED8F-49B1-93B0-E61DA9EE4C4D"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:920DFA54-D4BC-4BAF-985B-F826DE90874B"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:DCDE5E75-6026-4866-87C6-43FEF0091162"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:137ED6B6-D58E-4B3D-919B-4BF77268CD53"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:67735738-FC3C-42FD-BFD7-D8C8D19F702E"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:4F68FF3B-A357-479D-A040-E265F4DED0D7"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:3A3C3AB7-425B-41ED-BC9B-F0435A0297DB"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:5ECE4644-6492-4EB6-9B47-5798A8F8F45D"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:7D1C2D83-F022-46FF-BB88-033A263EDC15"/>
    <pav:createdOn>2014-07-07 19:42:28 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:item rdf:resource="urn:domeoclient:uuid:6165FCEB-2550-42FF-A2B1-9784A3303E79"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:130562BB-40D3-499C-B72D-0AE05B41F0FF"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:99EE304F-3479-4C41-9EA2-2ACE78EA72CB"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:73E9EFE7-3251-4EBB-A0D6-127592063D5B"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:54022FB0-AA7C-455C-A000-B3052D915530"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:9A1171A2-A76D-4CA2-B04D-A83316D5759E"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:37635111-1873-4732-862A-B5807BF1EF10"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:DE9A23B8-8079-4596-9CC4-6E5E11BBFB8C"/>
    <rdfs:label>Default Set</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotationset:1DED06A6-8562-4CCF-A58C-CA25748FBD31</pav:lineageUri>
    <ao:item rdf:resource="urn:domeoclient:uuid:C27C38CA-1604-4FDC-B80E-A5F7086C56BB"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:5B0BA3D0-BE5E-4C18-9751-42A24A039F70"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:55DE2655-F516-43B2-9BD9-788B44D396AC"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:67751AC3-CAE1-46D3-8A18-DFA03CCD1681"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:B682A853-E31E-4B00-ADD5-E614528CF156"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:CCFE1C13-B2A8-4E11-91F5-9E9AC9A08608"/>
    <pav:lastSavedOn>2014-07-07 19:59:12 -0400</pav:lastSavedOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:48DCEB49-16E5-4D13-AA11-E59D34114D77"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:2B7A79EA-546C-4BB9-9E76-51AA78FB3451"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:7077B078-BE1D-4254-B06C-784D3164483E"/>
    <permissions:permissions rdf:nodeID="Na211c39f95804379ab6f944d89a1359e"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <ao:item rdf:resource="urn:domeoclient:uuid:8AA734F5-542D-41CD-9EDE-DACB98D2EA8C"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:8CE927FA-57EC-46D6-B20D-48D87B95196E"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:D82AA03C-CE3D-4F97-93AE-E2F464DED5F8"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:816AFB9C-4A0A-4DE1-87DB-B5EF38823F10"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:3B812E4A-068C-4297-829E-92BE73C93CF2"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:FE03C3B3-B16C-4BEF-86C5-45AB7FF59385"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:B46C4987-02D9-4559-B8A5-B281F9E9250B"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:4E98B74F-8A06-446F-9BA0-3BF75766A076"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:FBC49810-612F-4640-9BAA-70A6E612220E"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:19759B42-A673-4877-B3AF-CDBC44302F63"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:56A26E88-85CF-488F-BED1-587BCD4DEC7C"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:CB98CB58-0E88-47D6-BE17-C8B7765876D3"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:3AEAAD22-7B34-43F4-9287-7A481EDB120D"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:EA070005-07F9-4514-9D25-BBAB543B971D"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:53444DA6-EFD4-42C1-9FCB-6AD24BB84832"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:08A3DC90-84E8-4276-877E-061AC357DDA3"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:C36FACB4-80E8-4D03-B3E7-2142613CAB4A"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:887DF478-2114-4B46-8877-EB346E75B396"/>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:annotatesResource>
    <ao:item rdf:resource="urn:domeoclient:uuid:E055844E-921A-44DC-B47A-D5FDBB96AEA9"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:4F012F36-22C1-4326-8AFD-9DBB3F0F3993"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:CF904069-6E2E-4CB6-A610-70066165AC89"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:F44B6567-1288-433F-AF8E-39F4AC950E60"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:E61B013F-126F-4D29-868B-25BA354A7E0F"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:EF9B7607-379E-4AC7-8BD6-F80D41D0C2F8"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:2A40295A-06C7-4D99-9873-CD21866FED44"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:CF082F25-5A3B-47A4-B556-A95EB5E8F6ED"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:3E78683D-D035-4F7E-9A8A-14A3381527CA"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:117052E4-6784-41A4-B815-9E3518A1CCFB"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:E1D6ADF1-AE00-4E26-BA74-3E927A4DE5EA"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:7F5224B1-C1D6-41EE-8832-301040B84271"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:22D2C3BF-DF88-45CF-9F0D-D56E76DC4DD3"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:F9F0536F-1818-4273-B244-A651525D47DD"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:FCE1BB80-1EF1-4DF7-92C7-EBCD8FE195D9"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:EF6F1C63-9235-49B6-82C9-7715B4FD68D7"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:B0EE7D24-D38E-447F-BDE5-EB9118B102E2"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:AFA8D73D-B788-4C3E-856C-C22E347F5EBC"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:59B5D954-E73B-4EFF-B597-82FE1AFA9882"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:B6DBFC52-0B8E-43ED-8D86-68D172CF514C"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:A7CC0DB6-A806-46A4-95AB-91A6F2531533"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:F4054B29-6745-4EE5-B992-FD07D7BE3230"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:9BF00F9A-B1AE-4C45-BC7F-84B9C55BD6DB"/>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:40520150-B72F-4AAE-822F-F3A56B8EC9EB"/>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <ao:item rdf:resource="urn:domeoclient:uuid:A2775810-A766-4B23-A5D0-7AC52C206807"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:7831E286-91D4-4126-919B-883E1EA69CBA"/>
    <pav:previousVersion>urn:domeoclient:uuid:99E6884F-42C7-412D-864F-F65AE5123E46</pav:previousVersion>
    <ao:item rdf:resource="urn:domeoclient:uuid:4D6663BD-2805-46B5-BCAF-8863DFD12AEB"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:F9AC1D61-58E8-40AA-B5A7-651E0D5145BA"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:B0779619-A8C5-45DB-812D-D0CCFD025563"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:598F70E5-78CC-40CD-B003-2ECF5F1F07CB"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:773D6F85-78D5-455C-8B18-BCB2E1E1B6F8"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:B93C6BA7-9F30-4002-A557-1C9C46C308F7"/>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812e52b20002"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:59265737-F0DD-4FFD-B986-FCAEB3962E0B"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:AB39CE70-06A3-4B7C-9F42-04D29726E1D3"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <ao:item rdf:resource="urn:domeoclient:uuid:A113E100-0D7F-48FA-9485-DF4B79B6D3C4"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:8A6C73C6-3A1F-461F-9817-855065C77FE9"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:B070D36A-6F20-4184-BF24-12B662F31AE0"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:0C3B04D1-EA76-42E1-9C85-0D52A0AA9F4D"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:380CAFAB-F13E-4844-9A26-B9BADAEE53FF"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:4C98BC55-C073-4B2D-A1EF-169277F2920F"/>
    <domeo:deleted>false</domeo:deleted>
    <ao:item rdf:resource="urn:domeoclient:uuid:5C41F5FD-EFAB-4A38-9898-1CE8DD82FA04"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:9B2D885E-A860-4489-B5DF-D35BB6908AE7"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:330E3EDD-7BBE-4A51-8E64-7A9BB36833A3"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:BB14D7C1-A7C7-4F32-9504-B26D88BB695B"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:13AAE387-F0FD-453B-9D2B-F637D8300274"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:C87E7139-F2E2-41D8-8701-A510A685DAA1"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:BFBA5C57-7297-4D17-B1ED-B12C0FFB6D77"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/F7CA2B97-C5F9-46D6-BFFF-90E12B0B93D1">
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/35636</dailymed:activeMoietyRxCUI>
    <rdfs:label>risperidone</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:FBDBB1ED-7C40-442B-94E8-A15DD3E5AF6B">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-161.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:FBDBB1ED-7C40-442B-94E8-A15DD3E5AF6B"/>
    <ao:suffix>xsd:String</ao:suffix>
    <pav:createdOn>2014-07-08 12:05:19 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>xsd:String</ao:prefix>
    <domeo:uuid>FBDBB1ED-7C40-442B-94E8-A15DD3E5AF6B</domeo:uuid>
    <ao:exact>Coadministration of nelfinavir at steady-state with a single oral dose of azithromycin resulted in increased azithromycin serum concentrations. Although a dose adjustment of azithromycin is not recommended when administered in combination with nelfinavir, close monitoring for known side effects of azithromycin, such as liver enzyme abnormalities and hearing impairment, is warranted (see ADVERSE REACTIONS).</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:2170C968-DE55-497F-9E90-B298C10C35F0">
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <domeo:belongsToSet>urn:domeoclient:uuid:C673D49F-D791-4325-A924-0B57680A3527</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:34463BBE-C9DF-48F9-96A7-330B41DE0E75</pav:lineageUri>
    <pav:lastSavedOn>2014-07-08 08:57:14 -0400</pav:lastSavedOn>
    <ao:body rdf:nodeID="N289f90950b36473cbd19dfd95a06aa50"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:EEB964D6-E299-4CC6-9980-96352ECB3A5E"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-08 08:57:13 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:71C7B108-B407-474E-8BAE-25D3DB6CC2D4">
    <domeo:uuid>71C7B108-B407-474E-8BAE-25D3DB6CC2D4</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-27.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:71C7B108-B407-474E-8BAE-25D3DB6CC2D4"/>
    <pav:createdOn>2014-07-07 20:16:42 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>zidovudine </ao:exact>
    <ao:suffix>AUC following the administration of fluconazole. The mean ± SD increase in AUC was 20% ± 32% (range: -27 to 104%). The metabolite, GZDV, to parent drug ratio significantly decreased after the administration of fluconazole, from 7.6 ± 3.6 to 5.7 ± 2.2.</ao:suffix>
    <ao:prefix>dose for at least two weeks. There was a significant increase in </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:68ECE5EE-A978-45A8-9A38-A4EACE88CBDA">
    <domeo:belongsToSet>urn:domeoserver:annotationset:A5E637EF-5CA5-4AAC-BD8B-C136A86E17B7</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotation:25F45A65-B85C-427C-B68E-8D4CC83A856A</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:54D7DE5A-82B5-4F76-8E10-019EEF4B1766"/>
    <pav:createdOn>2014-07-07 11:06:43 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-07-07 11:12:49 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:body rdf:nodeID="N87f517a3446042478ba5c2a312374b04"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:DA5D5837-3580-49DF-8E5E-F517AB8DF46C">
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:lineageUri>urn:domeoserver:annotation:B059ECF5-8CAC-44BB-B2AB-43B2C38B53F5</pav:lineageUri>
    <pav:createdOn>2014-07-08 15:30:06 -0400</pav:createdOn>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <ao:body rdf:nodeID="Nc127679f3fa14839921c6a9e996cbcc0"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-08 15:30:37 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:063A7209-93BB-42E1-A05D-D45CEF402ED2</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:DA095187-0CC5-4431-AB91-5E7585F11CFC"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:08DA4EC5-B08E-44C6-BB0B-CA31B1E6FE78">
    <domeo:belongsToSet>urn:domeoserver:annotationset:A5E637EF-5CA5-4AAC-BD8B-C136A86E17B7</domeo:belongsToSet>
    <pav:previousVersion>urn:domeoclient:uuid:53FAA6D0-9A40-44F9-8FE0-3166137CEF10</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-07 09:58:12 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:F2709D47-1FC8-4669-BC79-3CEEAA38A81E"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:lastSavedOn>2014-07-07 10:03:14 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotationset:F37BE993-E972-47AE-896D-FF4D33157ECF</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/CB34AE0A-F55D-4FD1-8DCA-AFD5309C11F7">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/4450</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>fluconazole</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:0E96FF17-2659-44E0-B125-6B2E95C6E2D6">
    <ao:exact>co-administration of known enzyme inducers (e.g., carbamazepine, phenytoin, rifampin, and phenobarbital) with risperidone may cause a decrease in the combined plasma concentrations of risperidone and 9-hydroxyrisperidone</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>xsd:String</ao:prefix>
    <domeo:uuid>0E96FF17-2659-44E0-B125-6B2E95C6E2D6</domeo:uuid>
    <pav:createdOn>2014-07-07 19:53:25 -0400</pav:createdOn>
    <ao:suffix>xsd:String</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:0E96FF17-2659-44E0-B125-6B2E95C6E2D6"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:0170DEB4-EB91-4979-B149-660548D6A165">
    <pav:createdOn>2014-07-07 10:01:38 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotationset:F37BE993-E972-47AE-896D-FF4D33157ECF</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:4E744ADB-7FE2-4D27-81C7-5803DDC55C0E"/>
    <pav:previousVersion>urn:domeoclient:uuid:53FAA6D0-9A40-44F9-8FE0-3166137CEF10</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A5E637EF-5CA5-4AAC-BD8B-C136A86E17B7</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <pav:lastSavedOn>2014-07-07 10:03:14 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:24B6A4F5-D719-417E-8D2F-4A1DD6141F71">
    <pav:createdOn>2014-07-08 08:52:51 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:23515E27-98AC-4DC9-A4B7-EBFE2991219F</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-08 08:54:46 -0400</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:CF0C75CF-03DD-494F-B816-5CEBCCB4109E"/>
    <pav:lineageUri>urn:domeoserver:annotation:C688B6AB-5D39-40A7-A6B9-816F329BE4EE</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:9D31038F-F548-4C1C-941D-543901DA01FE">
    <domeo:uuid>9D31038F-F548-4C1C-941D-543901DA01FE</domeo:uuid>
    <ao:prefix>. There was a mean ± SD increase in </ao:prefix>
    <pav:createdOn>2014-07-07 20:22:07 -0400</pav:createdOn>
    <ao:suffix>AUC of 26% ± 9% (range: 12 to 39%). Tolbutamide Cmax increased 11% ± 9% (range: -6 to 27%). (See PRECAUTIONS.)</ao:suffix>
    <ao:exact>tolbutamide </ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:9D31038F-F548-4C1C-941D-543901DA01FE"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-29.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:14D38197-2B20-4741-9E64-FB69D139B82C">
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:lastSavedOn>2014-07-08 08:51:47 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdOn>2014-07-08 08:49:03 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotationset:57174A7C-3100-4C8F-9C4A-2991CEE124D5</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:735DC3EF-FC0F-4358-8149-5513CF9C8EF3"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:23515E27-98AC-4DC9-A4B7-EBFE2991219F</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>urn:domeoclient:uuid:5BCE2FDB-C586-44CD-88F7-6EE2BDB6B929</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:450E7451-5300-4833-9BED-8738A8D83B21">
    <domeo:uuid>450E7451-5300-4833-9BED-8738A8D83B21</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:450E7451-5300-4833-9BED-8738A8D83B21"/>
    <pav:createdOn>2014-07-08 09:20:18 -0400</pav:createdOn>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:exact> Propranolol did not have an effect on the pharmacokinetics of fluvastatin.</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-132.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>xsd:String</ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D300FAFB-DA5E-4FB9-B03D-5907F592F1F8">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix>is rapidly distributed. The volume of distribution is 1 to 2 L/kg. In plasma, risperidone is bound to albumin and α1-acid glycoprotein. The plasma protein binding of risperidone is 90%, and that of its major metabolite, 9-hydroxyrisperidone, is 77%. Neit</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:D300FAFB-DA5E-4FB9-B03D-5907F592F1F8"/>
    <ao:prefix>Distribution: </ao:prefix>
    <domeo:uuid>D300FAFB-DA5E-4FB9-B03D-5907F592F1F8</domeo:uuid>
    <ao:exact>Risperidone </ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-07 19:46:35 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:63759ED3-5523-4017-96A7-C1AF471A4463">
    <ao:suffix> tablets should be taken with water [see Clinical Pharmacology (12.3) and Dosage and Administration (2.1)].</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:63759ED3-5523-4017-96A7-C1AF471A4463"/>
    <ao:prefix>, it is recommended that </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>fexofenadine hydrochloride</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-139.txt.html</ao:hasSource>
    <domeo:uuid>63759ED3-5523-4017-96A7-C1AF471A4463</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-08 09:33:10 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/73454139-0B0D-48FA-9133-D060ACC18FC1">
    <rdfs:label>nifedipine</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/7417</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B957C19D-4651-4FB6-B157-0A13B8DE6324">
    <ao:suffix>may be needed when gemfibrozil is introduced [see Drug Interactions (7.1)].</ao:suffix>
    <ao:exact>rosiglitazone </ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:B957C19D-4651-4FB6-B157-0A13B8DE6324"/>
    <domeo:uuid>B957C19D-4651-4FB6-B157-0A13B8DE6324</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>, a decrease in the dose of </ao:prefix>
    <pav:createdOn>2014-07-08 08:45:59 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C25F055F-A9AA-4B20-A17C-3208554B27FE">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:C25F055F-A9AA-4B20-A17C-3208554B27FE"/>
    <ao:prefix>bserved following administration of oral solution from 90 to 240 mg/m2 every 6 hours. Oral bioavailability, terminal half-life, and oral clearance were comparable to adult values. As in adult patients, the major route of elimination was by metabolism to </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-197.txt.html</ao:hasSource>
    <ao:suffix>. After intravenous dosing, about 29% of the dose was excreted in the urine unchanged, and about 45% of the dose was excreted as GZDV [see Dosage and Administration (2.1)].</ao:suffix>
    <domeo:uuid>C25F055F-A9AA-4B20-A17C-3208554B27FE</domeo:uuid>
    <pav:createdOn>2014-07-08 14:21:05 -0400</pav:createdOn>
    <ao:exact>GZDV</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N4e7ac1a61b7147279c293bd846a6a49c">
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
    <permissions:isLocked>false</permissions:isLocked>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/85c05bcb-ac0b-4d0c-829e-b702d09c26db">
    <pav:lastSavedOn>2014-07-07 08:06:51 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7E49EB7A-DE0E-4720-82D1-8460BA0C770D</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:8eee6a59-46ed-4041-8ebd-ab9bd943229b"/>
    <pav:createdOn>2014-07-07 08:06:51 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotationset:def720a3-9364-4d0d-a156-423274fb2386</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:13AAE387-F0FD-453B-9D2B-F637D8300274">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:createdOn>2014-07-07 19:50:34 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-07-07 19:50:36 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:body rdf:nodeID="N0ab0e7c43977446cbd449d045f25a4c1"/>
    <pav:lineageUri>urn:domeoserver:annotationset:1DED06A6-8562-4CCF-A58C-CA25748FBD31</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5ABD9862-F044-4404-AD04-73DA04ADDA8B</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:AD6A21FA-30D4-43BC-8D81-37E51F220FBA"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:CB1371E2-FBD9-4D1D-B003-5C391C17C73A">
    <ao:suffix>was about 2 hours longer in patients with liver disease, compared to healthy subjects.</ao:suffix>
    <domeo:uuid>CB1371E2-FBD9-4D1D-B003-5C391C17C73A</domeo:uuid>
    <pav:createdOn>2014-07-08 08:43:11 -0400</pav:createdOn>
    <ao:prefix>was significantly lower in patients with moderate to severe liver disease (Child-Pugh Class B/C) compared to healthy subjects. As a result, unbound Cmax and AUC0-inf were increased 2- and 3-fold, respectively. Elimination half-life for </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:CB1371E2-FBD9-4D1D-B003-5C391C17C73A"/>
    <ao:exact>rosiglitazone </ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:1E02046D-5245-46AE-9208-717405D7DF80">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-08 12:06:15 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:1E02046D-5245-46AE-9208-717405D7DF80"/>
    <ao:prefix>Plasma concentrations of </ao:prefix>
    <ao:suffix>and its metabolite, normeperidine, may be increased by acyclovir, thus caution should be used with concomitant administration.</ao:suffix>
    <domeo:uuid>1E02046D-5245-46AE-9208-717405D7DF80</domeo:uuid>
    <ao:exact>meperidine </ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-163.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:0505C3FD-D949-47BA-8DA3-BF23A9FEA75A">
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-07-08 09:13:23 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-08 09:13:22 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoclient:uuid:698327F3-D853-41CB-ADF0-60C4BFEB24F4</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:6D392C36-EFE2-4294-A383-4E8079828BE8"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <ao:body rdf:nodeID="N548a437ae06f444ea92d85e08a3f0745"/>
    <pav:lineageUri>urn:domeoserver:annotation:0644AD3D-6800-47D0-B0C3-98B1BBA5702D</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:55C7526C-ABE2-46C9-BC0C-7650CC2A391E">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/AC839FA9-6493-45F4-A616-B24C258ADE3D"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/B8F23E92-2827-483E-8296-5E8BE85291A6"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoserver:annotationset:32944008-A6C6-4D66-8C43-EE4CF2256965">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:item rdf:resource="urn:domeoclient:uuid:3CA5C2AE-41CD-4AFA-B575-63B5E8796CBC"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:344A5D2F-014C-4385-9EFC-D45AA24FD6AB"/>
    <domeo:deleted>false</domeo:deleted>
    <dct:description>The NER set is created automatically by NER annotation loading program.</dct:description>
    <ao:item rdf:resource="urn:domeoclient:uuid:56A35079-EF48-414A-B9BF-0DB91C8DFB1C"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:F598ED30-6E74-4DA9-BC16-082FF843DCBA"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:1506CBBE-CBA9-4F6A-BC58-57285B451EC3"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:203F5C51-D82C-4FC1-B87D-AD8FF7372848"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <ao:item rdf:resource="urn:domeoclient:uuid:22717717-F84A-439E-81E0-413A56482DD1"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:6168D465-62D5-4B6C-BE48-0B71373BA594"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:D5E8779C-83A0-4F43-8C63-95B2C4B0BE18"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:8296C0C0-1C3C-44C8-9B26-378BE7A2167B"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:9333FDEF-9C18-4199-AF10-FFE42674F5FB"/>
    <pav:lineageUri>urn:domeoserver:annotationset:cf593dca-fe93-451b-8f37-2a96e065da13</pav:lineageUri>
    <ao:item rdf:resource="file:///home/yin2/python-SPL-connector/3aae0f3a-9f40-4ba8-a000-4aec379d9be4"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:BACA32E9-C346-4CFC-84F0-69F0173195F5"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:A44FCBB3-9EDC-4EFA-A3BD-7C8E0304D317"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:C2002171-DEDA-4096-AF22-F840F116027E"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:E161FE99-2F94-4F2C-971C-29FC6EB3FDA5"/>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-6.txt.html</ao:annotatesResource>
    <pav:lastSavedOn>2014-07-21 10:02:25 -0400</pav:lastSavedOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:85BB898D-F66E-44D4-B7CB-0ED0EB4D70A8"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">4</pav:versionNumber>
    <ao:item rdf:resource="urn:domeoclient:uuid:7BC202B1-7906-4CD6-8994-24D54A06B863"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:94A767A9-A61D-461C-B793-8808E2041006"/>
    <pav:previousVersion>urn:domeoserver:annotationset:F152ADB6-9B17-4343-B66C-7C85AE7BBDD0</pav:previousVersion>
    <ao:item rdf:resource="urn:domeoclient:uuid:263C56AC-501C-4B49-BDAE-9B423F305365"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:65BFE6BA-907E-4480-A3BF-B6EA54E48B65"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:78252549-FC1F-492A-A5A4-76ED9AB6F2CC"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:483F76E5-1D7F-4A20-81C1-51BE0194127E"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812e52b20002"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:4E2557F1-AB97-476F-A2D3-386033B0FBDD"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:3E3130FC-0907-4E19-8842-732E612964EE"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:7C4BF249-DC7E-484D-B5CB-8DE807B5C07D"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:D9EED41A-E6F7-4E30-82A2-EFCE4D840C64"/>
    <rdfs:label>NER Sets</rdfs:label>
    <ao:item rdf:resource="urn:domeoclient:uuid:69655336-349D-4D66-93ED-E23E6CCB9AAB"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:D4E0E92E-4021-4F3E-AF8B-C653EECCD3B4"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:DF9B45EC-5F40-464E-914F-DDB0582BF93D"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:C13E7833-8C5F-4F29-A3E0-9297D779D6C1"/>
    <permissions:permissions rdf:nodeID="Nbed970982c9d49de9796d3319d6b1dbd"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:BED6541B-23EB-4390-89E7-171E1D6FA12C"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:EDFA8C04-287E-4E02-A34E-9FAF2A0DB09D"/>
    <pav:createdOn>2014-07-07 08:06:47 -0400</pav:createdOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:A8BEE8F3-D849-420F-B702-9E0D9766DAEB"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:419480B6-68DE-4067-BC3C-11AEAAC9FE41"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:0BDF881C-B03D-4ACA-80BA-F2714EA0074F">
    <pav:lineageUri>urn:domeoserver:annotation:B22FC58D-505F-43E4-8B72-9ABD6815BF4F</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:AD5B6A0D-35F7-45B4-AEC9-1F259D4615D1</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:7A1C9B36-806F-4044-8F68-5A318498BC6C"/>
    <pav:lastSavedOn>2014-07-08 19:47:49 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-08 19:47:25 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:59F64E10-91D1-4EB7-8B16-23D4CBDFA6A4">
    <domeo:uuid>59F64E10-91D1-4EB7-8B16-23D4CBDFA6A4</domeo:uuid>
    <ao:suffix>can inhibit the metabolism of diazepam, resulting in increased concentrations of diazepam and its metabolites. Diazepam does not alter the pharmacokinetics of propranolol.</ao:suffix>
    <pav:createdOn>2014-07-08 09:07:58 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-128.txt.html</ao:hasSource>
    <ao:exact>Propranolol </ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:59F64E10-91D1-4EB7-8B16-23D4CBDFA6A4"/>
    <ao:prefix>xsd:String</ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:0CF6D389-9007-4813-A39A-F02AC2F194BF">
    <ao:suffix>were variable and were generally not statistically different from placebo or glyburide controls.</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:0CF6D389-9007-4813-A39A-F02AC2F194BF"/>
    <domeo:uuid>0CF6D389-9007-4813-A39A-F02AC2F194BF</domeo:uuid>
    <ao:exact>AVANDIA </ao:exact>
    <ao:prefix>The changes in triglycerides during therapy with </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-08 08:40:13 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:180F9EC8-2179-4455-B418-8AAF372AA675">
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:55C7526C-ABE2-46C9-BC0C-7650CC2A391E"/>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:65faa5b1-21d0-4ddb-b606-3a4b995a94ef">
    <ao:suffix> is metabolized by CYP3A4. Coa</ao:suffix>
    <ao:exact>Nifedipine</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:65faa5b1-21d0-4ddb-b606-3a4b995a94ef"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid></domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-115.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-07 08:06:43 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>Phenytoin: </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:AF463AE0-BCFA-44C8-B6DD-9CB1162FFB57">
    <pav:createdOn>2014-07-21 10:05:03 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:AF463AE0-BCFA-44C8-B6DD-9CB1162FFB57"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-10.txt.html</ao:hasSource>
    <domeo:uuid>AF463AE0-BCFA-44C8-B6DD-9CB1162FFB57</domeo:uuid>
    <ao:suffix>, formed by oxidative deamination, accounted for about 10%. </ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>fluvoxethanol</ao:exact>
    <ao:prefix> which, together with its N-acetylated analog, accounted for about 60% of the urinary excretion products. A third metabolite, </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/5a2288fb-5e17-44e5-898b-20dede7cb21b">
    <pav:lineageUri>urn:domeoserver:annotationset:252ecf83-cda9-4022-8d2e-563cf1fb984b</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:FC706AFD-18B6-480C-8EAA-2B16C3212C10</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:43057692-88dd-423b-a1d4-0b7bb3aeba77"/>
    <pav:createdOn>2014-07-07 08:06:39 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-07-07 08:06:39 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:BA4FC9A4-D363-4102-A981-9BB361F8EC8C">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:createdOn>2014-07-08 14:56:44 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-07-08 14:57:00 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotation:57621D21-2F17-42E3-A799-5DBA354913EB</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:2CD1333E-DD8C-41F8-8B2C-A24926A13D02"/>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:41C13D3C-1D2B-4D38-9EB5-BC4A471BE99A</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:body rdf:nodeID="Nbf54f9e93d694653b290cb1d1a195d4a"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/5AB20F80-BC18-4891-A9B4-168721105167">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/drug-product"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/261455</dailymed:activeMoietyRxCUI>
    <rdfs:label>avandia</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B5848078-B8B2-4608-8ADE-6713D8FF58D8">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>tacrine</ao:exact>
    <ao:prefix>s of </ao:prefix>
    <pav:createdOn>2014-07-08 15:15:00 -0400</pav:createdOn>
    <domeo:uuid>B5848078-B8B2-4608-8ADE-6713D8FF58D8</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-86.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:B5848078-B8B2-4608-8ADE-6713D8FF58D8"/>
    <ao:suffix>, although the estimated mean treatment effect was different in each analysis</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C2BA26F9-AC03-431C-BDFF-02DC0B51B78C">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>Quinupristin/Dalfopristin:In vitro drug interaction studies have demonstrated that quinupristin/dalfopristin significantly inhibits the CYP3A metabolism of nifedipine. Concomitant administration of quinupristin/dalfopristin and nifedipine (repeated oral dose) in healthy volunteers increased AUC and Cmax for nifedipine by factors of 1.44 and 1.18, respectively, compared to nifedipine monotherapy. Upon coadministration of quinupristin/dalfopristin with nifedipine, blood pressure should be monitored and a reduction of the dose of nifedipine considered</ao:exact>
    <ao:suffix>xsd:String</ao:suffix>
    <pav:createdOn>2014-07-08 14:52:01 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>C2BA26F9-AC03-431C-BDFF-02DC0B51B78C</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-114.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:C2BA26F9-AC03-431C-BDFF-02DC0B51B78C"/>
    <ao:prefix>xsd:String</ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:54F09193-5CC7-4ED3-9261-88C7428E0572">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <pav:createdOn>2014-07-08 09:14:48 -0400</pav:createdOn>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-131.txt.html</ao:annotatesResource>
    <pav:lineageUri>urn:domeoserver:annotationset:8EDA9BCC-F9A8-4561-8575-047E931B1A78</pav:lineageUri>
    <ao:item rdf:resource="urn:domeoclient:uuid:1209694E-3FDB-4A08-A579-76605D36B1D7"/>
    <domeo:deleted>false</domeo:deleted>
    <rdfs:label>Default Set</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:item rdf:resource="urn:domeoclient:uuid:EB7F039A-9B7C-4CAD-8970-E914E6233F44"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:E0EC1D06-E110-4856-97AB-6EE6B8AB317F"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:EC38A969-37CF-4F97-8F26-1782C1E8F202"/>
    <pav:lastSavedOn>2014-07-08 09:15:28 -0400</pav:lastSavedOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:7F34F894-7585-47C8-9ADF-AD1FB473036B"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <permissions:permissions rdf:nodeID="N05bd096ab162492c94b5d0a16acd3a7d"/>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812e52b20002"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:34DDD2AA-0C18-4F6D-BFC5-FECA040CBB7C"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:BC03E40F-69A1-453D-80CF-43BD3146314C">
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:23515E27-98AC-4DC9-A4B7-EBFE2991219F</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-08 08:51:47 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotationset:57174A7C-3100-4C8F-9C4A-2991CEE124D5</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:8F2E3E6E-B3EE-4173-A296-DA4AFECA8AF5"/>
    <pav:createdOn>2014-07-08 08:46:45 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:previousVersion>urn:domeoclient:uuid:5BCE2FDB-C586-44CD-88F7-6EE2BDB6B929</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/5A39A9EB-5E3D-48B3-BB2E-313515FFB236">
    <rdfs:label>fexofenadine hydrochloride</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/236474</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:619E6482-4318-4FF7-942F-03EED065FA23">
    <ao:exact>rosiglitazone </ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <ao:suffix>AUC by 66%, compared to the administration of rosiglitazone (8 mg) alone [see Drug Interactions (7.1)].4</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:619E6482-4318-4FF7-942F-03EED065FA23"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>619E6482-4318-4FF7-942F-03EED065FA23</domeo:uuid>
    <ao:prefix>administration (600 mg once a day), an inducer of CYP2C8, for 6 days is reported to decrease </ao:prefix>
    <pav:createdOn>2014-07-08 08:46:47 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:15E77545-0C06-4098-80D9-E494850EF1FB">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-07-08 08:54:09 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:23515E27-98AC-4DC9-A4B7-EBFE2991219F</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:C8DEE5C6-55D9-4BBC-85C2-A0B2C46A265E</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:ACD33836-557A-490B-8596-AAF387EB5EBB"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2014-07-08 08:54:46 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoserver:annotationset:B584DAF4-7AB3-43F0-AA6F-6463A34A4831">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <domeo:deleted>false</domeo:deleted>
    <dct:description>The NER set is created automatically by NER annotation loading program.</dct:description>
    <ao:item rdf:resource="urn:domeoclient:uuid:92066FE5-1405-41B1-85CA-8A8C29A94EB7"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">3</pav:versionNumber>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-192.txt.html</ao:annotatesResource>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:createdOn>2014-07-07 08:07:05 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-07-08 14:47:41 -0400</pav:lastSavedOn>
    <pav:previousVersion>urn:domeoclient:uuid:4b851b5d-9534-4ce0-a17e-7087d56f31e6</pav:previousVersion>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812e52b20002"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <pav:lineageUri>urn:domeoserver:annotationset:a7dfba5e-79ae-4a48-ab23-f16a539121db</pav:lineageUri>
    <permissions:permissions rdf:nodeID="N6b69cbe6c2804e27b4e4746d7a6582fa"/>
    <ao:item rdf:resource="file:///home/yin2/python-SPL-connector/7ae3a17c-18f8-436e-b816-ba09f3ff1dcd"/>
    <rdfs:label>NER Sets</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/a00b6a0b-5870-4218-bd0e-1a999185f12b">
    <pav:createdOn>2014-07-07 08:06:29 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:cd87917e-4b7b-4df1-8946-26a2b89c3123"/>
    <pav:lineageUri>urn:domeoserver:annotationset:ecd845f9-401b-446c-8abd-920f97670010</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:C9868B04-3F07-42FC-8F5C-D0B3D0DA54B1</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:lastSavedOn>2014-07-07 08:06:29 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:2E1A3A60-E806-4B27-8C91-3F81F0B2226B">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:2E1A3A60-E806-4B27-8C91-3F81F0B2226B"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <ao:prefix>and its major circulating</ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-07 09:57:20 -0400</pav:createdOn>
    <ao:exact> N-desmethyl metabolite</ao:exact>
    <ao:suffix> are both approximately 96% bound to plasma proteins. Protein binding is independent of total drug concentrations</ao:suffix>
    <domeo:uuid>2E1A3A60-E806-4B27-8C91-3F81F0B2226B</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/E9386BA8-0C34-4C3D-A902-605E9575CD22">
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>methadone</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/6813</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E1F292D3-D7D0-4351-BFCC-3AFCF3B73226">
    <pav:createdOn>2014-07-08 09:24:13 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:E1F292D3-D7D0-4351-BFCC-3AFCF3B73226"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>, </ao:prefix>
    <ao:suffix> and glucuronic acid, and sulfate conjugates of 4-hydroxy propranolol.</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-135.txt.html</ao:hasSource>
    <ao:exact>naphthyloxylactic acid</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>E1F292D3-D7D0-4351-BFCC-3AFCF3B73226</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:8D7BF51F-72A9-4D44-BDC4-91B1CBD96D9B">
    <pav:createdOn>2014-07-08 15:44:53 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>xsd:String</ao:prefix>
    <domeo:uuid>8D7BF51F-72A9-4D44-BDC4-91B1CBD96D9B</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:8D7BF51F-72A9-4D44-BDC4-91B1CBD96D9B"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-7.txt.html</ao:hasSource>
    <ao:exact>cimetidine did not affect the AUC of risperidone and 9-hydroxyrisperidone combined</ao:exact>
    <ao:suffix>xsd:String</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:16071B8A-0D01-4246-AF6D-001BAAD999EC">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix> and </ao:prefix>
    <domeo:uuid>16071B8A-0D01-4246-AF6D-001BAAD999EC</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:16071B8A-0D01-4246-AF6D-001BAAD999EC"/>
    <ao:suffix>increased by 24% (95% C.I. range 18 to 31%) and 13% (95% C.I. range 8 to 18%), respectively relative to placebo. Fluconazole treatment did not cause a decrease in the ethinyl estradiol AUC of any individual subject in this study compared to placebo dosin</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-21.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-07 20:00:56 -0400</pav:createdOn>
    <ao:exact>norethindrone </ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:61F2A059-CABA-457B-A6FE-EE88ACCD9985">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotationset:F37BE993-E972-47AE-896D-FF4D33157ECF</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2014-07-07 09:44:18 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A5E637EF-5CA5-4AAC-BD8B-C136A86E17B7</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2014-07-07 09:43:54 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:5AE76B76-C14D-4ADE-8F12-C92F7868F83E"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/EA48A47B-C2BF-4775-966C-E7FD9981D298">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>trazodone</rdfs:label>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/10737</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:10B70FF9-9A5E-489B-9AB0-BC7BE3191369">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>and </ao:prefix>
    <ao:suffix>were coadministered.</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:10B70FF9-9A5E-489B-9AB0-BC7BE3191369"/>
    <ao:exact>trazodone </ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-136.txt.html</ao:hasSource>
    <domeo:uuid>10B70FF9-9A5E-489B-9AB0-BC7BE3191369</domeo:uuid>
    <pav:createdOn>2014-07-08 09:25:36 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:91E17503-6125-4400-96AB-ADC20AA1778D">
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:539A2287-0EAA-4035-9DF6-020FD4CB0F55"/>
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoserver:annotationset:23515E27-98AC-4DC9-A4B7-EBFE2991219F">
    <ao:item rdf:resource="urn:domeoclient:uuid:08D9C061-174E-46EF-AF78-C90119DC56DF"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:8410EFB2-8516-402D-8897-8A16FB9EF532"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:A3AF9C3D-E78E-4973-B274-664C01EDAC39"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:DD30FC84-F408-46CB-B1A2-6D566D12E8B7"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:61C3F83D-35C4-4073-8027-13127C4B0AAA"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:399FF35C-A05B-43A2-B4E2-580847186BC6"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:41960471-ACCF-442F-9B2E-192108B22043"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:BB822DA9-9165-43B8-87AA-B14F889A5494"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:AA4CD511-5DB6-4C87-B4A7-2867E9097700"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">3</pav:versionNumber>
    <ao:item rdf:resource="urn:domeoclient:uuid:8AD1102B-2F90-459C-AD9E-FB512EDA7542"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:7784C5C8-C087-4E77-9A96-3470246F49C0"/>
    <pav:lineageUri>urn:domeoserver:annotationset:57174A7C-3100-4C8F-9C4A-2991CEE124D5</pav:lineageUri>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:annotatesResource>
    <ao:item rdf:resource="urn:domeoclient:uuid:5D38711D-E2B6-455C-9915-755FA8BE4B5E"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:68A2783E-4A88-456C-AE77-4C384F154759"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:7AA77C36-4C02-464C-B6F2-DF542FF996A9"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:51AF0CA9-6F4C-40EF-8602-AAFBEF302739"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:7CBA491A-1C36-4A48-8CB0-A8C61E2A139E"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:D00E402A-6BAB-4252-8071-8444AEF24E9B"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <ao:item rdf:resource="urn:domeoclient:uuid:4F73F61E-E52A-4179-B2CF-7673C04CE37D"/>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:0B3B5126-B681-4D78-BC07-6E2D7ED0A3DF"/>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812e52b20002"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:B752AAB8-6B04-4816-88CD-EB70ADF809A9"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:BBB93B97-8AD4-4D2E-8D37-22B3781AEF71"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:9C63E074-D1D1-4494-ABF3-C28488FB57E2"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:122513B4-2721-41E9-AC85-6EB95C153974"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:EBC8A919-3FB5-4437-80FF-7964A1A87A2E"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:BCF0BF4F-A014-4C3F-B48D-43FE6F97E692"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:7B1B6A74-1A7B-48D3-AC89-A5842AFC360D"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:BFB71C54-4802-4C93-ABB0-37D1A60425FB"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:1779DC20-9623-4186-A08A-76653EBE000C"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:83E50C5D-510D-47CE-AA37-898B57D1C9B1"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:C93B2C33-8805-49A5-85A4-1E72F0142400"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:71E8A105-B07C-4899-AF5A-BD798C3C484A"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:541EE0BD-455D-4A7A-854B-562676BFC39B"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:FC101F04-BB16-40BC-8350-A803BEF007F2"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:6C352172-64DF-4EE5-8AE0-B0F86B8E4F0B"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:80BE5846-6376-42D1-BDBD-2FD62537AEF9"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:F85D7215-5E2B-4614-AEB9-BCFF1B459F34"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:FCE26E10-B287-4815-9A1E-2DDCDFC0F852"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:D74138EC-1E07-40A5-B6E5-F8130C30C935"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:BC03E40F-69A1-453D-80CF-43BD3146314C"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:D42A01CC-DBD2-4020-ABB3-06C1A1DED759"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:30D239C1-7EB5-4678-A47E-A0171774A349"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:24B6A4F5-D719-417E-8D2F-4A1DD6141F71"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:8089D978-0806-4028-BD81-F0F8C4FFD1CB"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:4D2891B5-4DB4-4FF6-9EA1-7A40EAA266F6"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:CB32CAD9-A4A5-47F2-8568-BBCE46210DCA"/>
    <rdfs:label>Default Set</rdfs:label>
    <ao:item rdf:resource="urn:domeoclient:uuid:06EDFED5-3057-4E24-8162-4B0F2B8C6F1C"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:EB75C25A-6C63-4297-9772-CF11D5C04339"/>
    <pav:createdOn>2014-07-08 08:38:22 -0400</pav:createdOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:C273DCAA-0AA8-4910-A572-AA71F5F193CB"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:A928CC89-1353-4933-B9B7-D9F19B446555"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:897CCE4F-BAA0-4285-A7DC-C44CECD44CAF"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:6A85F321-84DD-45D0-A71C-412271B1A04E"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:75B65B95-22F0-4F1E-AC57-6DC0251ACD56"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:497D456F-A9F4-418D-A6E6-8C644760649B"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:B0EBA812-42AB-4B7F-8E39-3E01885ABE39"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:64405421-2608-4CFF-B9B7-24BEF8D08CD1"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:61AA5AEA-7ED1-4831-8A8A-1150577A32F2"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:19FCD5A4-DAD1-4385-92A4-C97DA109A39A"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:73FD549E-291A-4B42-8D79-D565B6BC56D6"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:A702B53A-0DB9-41E0-A53E-EB4ECB7132EB"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:36325AE6-3B95-478B-91AB-8657B22E41A4"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:7D7AFE72-079D-47EC-9089-BE3A5CC4DDDF"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:03AC039F-E307-488D-9444-D362A5683585"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:D3826C1D-60FD-4571-B1BE-8626E7C83AEA"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:9D895D4C-742C-45D3-A2A4-1F667FAC5019"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:48D61CA1-37E6-4FCA-AE42-448CBEA41CD4"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:8D53677A-2702-40DF-AC2F-37B38591C6F1"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:6719DB2A-15BD-434A-9E47-DC8CC9574E56"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:item rdf:resource="urn:domeoclient:uuid:607C6F6D-1F88-482B-89CC-3B1CE45A2E73"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:ADF27897-075B-4F06-9D4C-568727330F07"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:4B88BC04-B0EB-4FB6-9530-3AB96B6E4E46"/>
    <permissions:permissions rdf:nodeID="Ncb8170a89a934e38a1ecadc24118b2f0"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:50BEF9AF-E12A-4A36-BB4A-285EF838E096"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:4337DB52-8336-44F2-B382-46DDFA2386A0"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:26B99496-2759-493D-88DA-2CE5CD5A6F58"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:A3086698-5AE9-4E68-B263-4535D1D30820"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:A2EB0E75-194D-44CC-A447-85CB6FC8E94B"/>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <ao:item rdf:resource="urn:domeoclient:uuid:982DE6D2-1536-4AF3-8090-72E0C7BD0D53"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:411AED3B-F654-4C24-B918-A9E737A89AD0"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:CA19C0B4-A6AA-4D2A-961B-91E4F3C1E4CB"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:21DE8793-4F0E-4DE8-AB49-FB83D02C8C3A"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:7022DAEA-7889-4B04-9A51-29FE6F0BE4B2"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:7EEEF385-0BE2-41E2-A72E-4F6918F72180"/>
    <domeo:deleted>false</domeo:deleted>
    <ao:item rdf:resource="urn:domeoclient:uuid:26E74365-668E-4061-AD6C-DA15F81B9DED"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:61CF88E4-7AB3-427C-B456-38D30D24900C"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:5562FCAA-167D-4389-8046-E0C3CD11A57D"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:E432223F-A867-4C08-9D45-C972B81B9B91"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:34750E55-254E-4B35-BA70-AE39B36453B5"/>
    <pav:previousVersion>urn:domeoserver:annotationset:11F3FAF9-F874-4254-B6A8-110524082186</pav:previousVersion>
    <ao:item rdf:resource="urn:domeoclient:uuid:EC52E3BA-595C-4898-AB8A-72864AC3BB2A"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:9DDE1701-45F4-4E13-B434-DCE97580922B"/>
    <pav:lastSavedOn>2014-07-08 08:54:46 -0400</pav:lastSavedOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:4D60C3ED-A808-4189-A99A-5A90B43F2521"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:854BFBC4-B40D-4A6D-BBB1-81136F88D29A"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:5CEE5BD7-E5C5-478E-B803-2CBD5D4A8DE5"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:14D38197-2B20-4741-9E64-FB69D139B82C"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:A0DA7C50-5C43-428E-8C26-0DEDA41D3FBC"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:EE7C9EAC-785B-4B0C-84E2-41BCACF3E353"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:A34C5CD3-6C19-4D77-B8BE-838A8FE67CB5"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:669CA41E-0BFF-4BE0-9F75-CCEB7B793D71"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:C49BA751-1E41-4789-8530-81D4EAEC1D57"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:15E77545-0C06-4098-80D9-E494850EF1FB"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:DA6752A8-C0A9-43A0-B592-1639618860DA"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:2FA201F3-9541-4F59-9B85-2A444A0D4F87"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:9A6BA5E0-3F05-4309-BE07-2C1C74223C40"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:EF2016C0-0435-461F-B46F-5F2F183C369E"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:100A0CCD-71E9-4396-9B64-DD8E5ACB7174"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:46A53F25-C7A3-4D90-8A60-29F0AF4E0BB9"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:12B10864-82D4-4C50-973A-65EA156311BB"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:599F96F6-5F17-4537-A258-6339B57FADDE"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:57505AB0-C496-4EE9-96B3-7C5E98ADC57F"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:47DC8C8E-41CE-4A4E-9F24-883332884266"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:3FDD79AE-B4FE-4A32-B94F-86B9FA134E73"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:00294AD3-D060-4A30-81CC-B07BEDF6204C"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:54D7DE5A-82B5-4F76-8E10-019EEF4B1766">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:54D7DE5A-82B5-4F76-8E10-019EEF4B1766"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:exact>In study in healthy volunteers, co-administration with ritonavir, a potent CYP3A inhibitor, at steady state (500 mg BID) with sildenafil (100 mg single dose) resulted in a 300% (4-fold) increase in sildenafil Cmax and a 1000% (11-fold) increase in sildenafil plasma AUC. At 24 hours, the plasma levels of sildenafil were still approximately 200 ng/mL, compared to approximately 5 ng/mL when sildenafil was dosed alone. This is consistent with ritonavir's marked effects on a broad range of P450 substrates. Although the interaction between other protease inhibitors (except saquinavir) and REVATIO has not been studied, their concomitant use is expected to increase sildenafil levels.</ao:exact>
    <domeo:uuid>54D7DE5A-82B5-4F76-8E10-019EEF4B1766</domeo:uuid>
    <pav:createdOn>2014-07-07 11:06:43 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:395C134E-55A6-4E4F-B3C2-5F4EAD380C5E">
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotationset:F37BE993-E972-47AE-896D-FF4D33157ECF</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-07 09:44:18 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:A73CA70C-594C-4651-8C54-617A39333BF3"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A5E637EF-5CA5-4AAC-BD8B-C136A86E17B7</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2014-07-07 09:35:34 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:40487319-2D7C-4141-BDF6-2DD339521BBE">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:40487319-2D7C-4141-BDF6-2DD339521BBE"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-56.txt.html</ao:hasSource>
    <domeo:uuid>40487319-2D7C-4141-BDF6-2DD339521BBE</domeo:uuid>
    <pav:createdOn>2014-07-07 20:32:08 -0400</pav:createdOn>
    <ao:exact>Zonisamide </ao:exact>
    <ao:suffix>had no appreciable effect on the steady-state plasma concentrations of phenytoin, carbamazepine, or valproate during clinical trials. Zonisamide did not inhibit mixed-function liver oxidase enzymes (cytochrome P450), as measured in human liver microsomal</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7B19BF0D-C186-4BCB-B3DB-C6682B64E203">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:201C251D-D3C3-4CB8-A932-55045D0F92E2"/>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:lastSavedOn>2014-07-08 14:10:48 -0400</pav:lastSavedOn>
    <ao:body rdf:nodeID="N49cf6f3468854b8290985bfb8d20a582"/>
    <pav:createdOn>2014-07-08 14:01:51 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotation:D157398D-E740-4BF2-93D4-266A5926608D</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7E49EB7A-DE0E-4720-82D1-8460BA0C770D</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:12BD4746-33B5-4A1A-BBB2-DAED545318FA">
    <pav:createdOn>2014-07-07 20:50:01 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:29AAB777-4FBF-49C4-ACFD-F2FC169A463D</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:5CBA1F4C-8006-43EA-B7B4-1B100AB0538E</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:51546F2E-82E2-467D-9134-5220E7AAC16A"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-07-07 20:51:02 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:70A87BF4-C82E-4FBC-AE3B-7D16BFF92FB7">
    <ao:suffix>reduced plasma concentrations of trazodone (as well as mCPP) by 76 and 60%, respectively, compared to pre-carbamazepine values.</ao:suffix>
    <pav:createdOn>2014-07-08 09:28:17 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-137.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:70A87BF4-C82E-4FBC-AE3B-7D16BFF92FB7"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>70A87BF4-C82E-4FBC-AE3B-7D16BFF92FB7</domeo:uuid>
    <ao:exact>carbamazepine </ao:exact>
    <ao:prefix>400 mg/day with trazodone 100 mg to 300 mg daily, </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:47A49213-4781-4A5D-998D-28DB4593DAE8">
    <ao:prefix>. In all 26-week controlled trials, across the recommended dose range, </ao:prefix>
    <domeo:uuid>47A49213-4781-4A5D-998D-28DB4593DAE8</domeo:uuid>
    <ao:suffix>as monotherapy was associated with increases in total cholesterol, LDL, and HDL and decreases in free fatty acids. These changes were statistically significantly different from placebo or glyburide controls (Table 7).</ao:suffix>
    <ao:exact>AVANDIA </ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-08 08:39:31 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:47A49213-4781-4A5D-998D-28DB4593DAE8"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:1224BD42-425D-416C-86A8-AAEA31EEA238">
    <ao:context rdf:resource="urn:domeoclient:uuid:9EFE3B77-625E-4E43-9E5A-F8C4EC580340"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2014-07-08 12:02:05 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotation:50692B19-D017-494A-8219-D6E1E1F881AB</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoclient:uuid:921CCEB9-21F5-4162-854B-F60FC028BC15</domeo:belongsToSet>
    <pav:createdOn>2014-07-08 12:01:52 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:5CDFDD7B-38DF-4408-B5D4-B77F373BA882">
    <pav:lineageUri>urn:domeoserver:annotation:F66AC69A-D805-4A9A-AC11-1403AA5EC910</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoclient:uuid:86E1DCE1-FFC6-4513-AEF9-EF158A019E6B</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:createdOn>2014-07-08 08:59:09 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2014-07-08 09:00:25 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:6A11AA7C-97E0-419E-91D1-4C7C6426A05D"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:6206BC85-FA3F-4FA8-A69F-5BA06BCB888E">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A5E637EF-5CA5-4AAC-BD8B-C136A86E17B7</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <rdfs:label>Highlight</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:77F1E69B-901A-41F9-8FB0-4F3BD1660D3B"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:createdOn>2014-07-07 09:37:55 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotationset:F37BE993-E972-47AE-896D-FF4D33157ECF</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-07-07 09:44:18 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:40DF0243-E4B1-4FCF-9A78-C1F8BC78BF21">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-195.txt.html</ao:hasSource>
    <domeo:uuid>40DF0243-E4B1-4FCF-9A78-C1F8BC78BF21</domeo:uuid>
    <ao:exact>N-depropylpropafenone</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:40DF0243-E4B1-4FCF-9A78-C1F8BC78BF21"/>
    <ao:suffix> has weaker sodium channel activity but equivalent affinity for beta-receptors).</ao:suffix>
    <pav:createdOn>2014-07-08 13:52:56 -0400</pav:createdOn>
    <ao:prefix>, has similar sodium and calcium channel activity, but about 10 times less beta-blocking activity (</ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/4C5F8827-9FFD-4247-B213-97551D74CE55">
    <rdfs:label>fluvastatin</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/41127</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoserver:annotationset:A3F3FCF5-5359-4741-877D-D2B185DE2072">
    <pav:lineageUri>urn:domeoserver:annotationset:36d69682-41d6-46f9-9364-1554c834acdb</pav:lineageUri>
    <domeo:deleted>false</domeo:deleted>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812e52b20002"/>
    <permissions:permissions rdf:nodeID="N57e218f459e8455b922477980e35d728"/>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-86.txt.html</ao:annotatesResource>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:previousVersion>urn:domeoclient:uuid:28a596ad-9b4c-4253-830a-6d1728b938c4</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">3</pav:versionNumber>
    <dct:description>The NER set is created automatically by NER annotation loading program.</dct:description>
    <ao:item rdf:resource="urn:domeoclient:uuid:74382DD9-DC18-4CB3-BC5D-36E8D1786DF0"/>
    <pav:lastSavedOn>2014-07-08 15:15:12 -0400</pav:lastSavedOn>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <rdfs:label>NER Sets</rdfs:label>
    <pav:createdOn>2014-07-07 08:07:06 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F11BAEB6-7B0E-40A9-95E0-887BA08E9F97">
    <ao:suffix>xsd:String</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-08 19:46:32 -0400</pav:createdOn>
    <ao:exact>The effect of fluconazole on the pharmacokinetics and pharmacodynamics of midazolam was examined in a randomized, cross-over study in 12 volunteers. In the study, subjects ingested placebo or 400 mg fluconazole on Day 1 followed by 200 mg daily from Day 2 to Day 6. In addition, a 7.5 mg dose of midazolam was orally ingested on the first day, 0.05 mg/kg was administered intravenously on the fourth day, and 7.5 mg orally on the sixth day. Fluconazole reduced the clearance of IV midazolam by 51%. On the first day of dosing, fluconazole increased the midazolam AUC and Cmax by 259% and 150%, respectively. On the sixth day of dosing, fluconazole increased the midazolam AUC and Cmax by 259% and 74%, respectively. The psychomotor effects of midazolam were significantly increased after oral administration of midazolam but not significantly affected following intravenous midazolam.</ao:exact>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:F11BAEB6-7B0E-40A9-95E0-887BA08E9F97"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-32.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>F11BAEB6-7B0E-40A9-95E0-887BA08E9F97</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoserver:annotationset:A5E637EF-5CA5-4AAC-BD8B-C136A86E17B7">
    <ao:item rdf:resource="urn:domeoclient:uuid:F13B25C3-3520-42DE-85EF-21881CB9A279"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:B886CBC4-6B52-4262-B1B8-616044D4371E"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:59BCB49F-3C4C-4535-8F02-274F903E1D23"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:315E84B1-D1AA-45C2-B6CA-88D16B9BF064"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:1AD45413-AE14-4440-8748-CB2433A309DC"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:5F57F497-8A0D-4979-90F5-BA7BFF86F211"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:756C08BB-1427-4C5A-A11E-DCE1339428E0"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:1C306C1B-1C06-45C3-9856-1CA3A21437C6"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:6DF383E4-F15A-49B5-8192-02F522393878"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:0BB459C5-5005-45E8-A601-3A8BE0582675"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:560A42E5-FE10-4D20-A7E1-B57AD34849F4"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:item rdf:resource="urn:domeoclient:uuid:3740D7B2-9B0B-4C7D-98C9-28B70BD55415"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:D705184F-D0E2-4344-B3D4-EB88BD052E18"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:69BAF58F-968A-4C0A-A53D-74650194B697"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:D738283F-367A-4514-A1FA-3C792F0DB088"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:52DF4CCD-81DA-45EC-A5AB-3F14F0A82EE1"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:BDBB4C34-2A25-4D80-977D-F5AD5B96B02C"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:9E691305-649C-45E1-80A7-3CD32A5FD422"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:88A5D137-DCC2-49D2-B766-3D4F86BA4A28"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:2DBAC4D6-E498-4781-B492-2552C42FD677"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <ao:item rdf:resource="urn:domeoclient:uuid:8A08C851-9953-4E36-9386-3031662BF511"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:CD4292A0-45D4-4667-BB35-1F3A52D4DE87"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:743B29FF-A999-476C-951A-9B2D5CC1C8D9"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:4FFCA2F9-0603-44F9-B812-904155A17612"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:A48848C7-4C13-47C4-9C63-54788AD8ED68"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:ABDF5E6F-63DD-422A-A52B-E7786B66AB1A"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:7C818BF8-AA65-4B86-AB2F-52969B6B4B4F"/>
    <permissions:permissions rdf:nodeID="Ne07b3259b9ca4a47932799da685f3c83"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:3D2DB395-0FF8-444E-A19D-E69F5D5AAAB1"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:8A9CC7E7-29F6-4AF0-A986-C8CBE97A4964"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:61F7D186-E350-44AC-A3F2-F9FBDA3C1764"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:AC56289B-E372-495E-88D3-3D4C45D79ACF"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:61F2A059-CABA-457B-A6FE-EE88ACCD9985"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:20F33871-7B08-46E0-A1BF-CC8A7EB28474"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:B62C9921-205A-437D-AB79-A525799C2D90"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:F3CA35E9-AEA1-406C-BAD1-E54E69EB5BC5"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:C7FBB110-7C8D-4BAE-9B98-22638C9B3686"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:10096701-5979-4E64-8E76-15CB321AC27A"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:7C133996-DAAF-4D29-88DA-98631B0B3BB8"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:B0351284-4078-469B-9852-85337F49883D"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:BBE5812F-4BD5-46A9-983B-F7350B4B8065"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:BB588D9C-5799-46AB-97CC-B0462C5184CA"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:B03D187E-821B-460F-B68E-A349CCC50FE7"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:0AED07DB-D873-46A2-A8AB-26F80E17A2CC"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:1A7D29FE-D656-444E-AF88-46433E658EBB"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:25F5D9E1-9601-4792-859E-BF2A3F33C9AF"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:6206BC85-FA3F-4FA8-A69F-5BA06BCB888E"/>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:annotatesResource>
    <ao:item rdf:resource="urn:domeoclient:uuid:053BD548-1DBD-4227-A349-1605741A1114"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:8F513DD1-EAE9-468A-ACE8-EA70D5117880"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:11D3A139-FD05-43C0-8AA3-D07CA93EB14C"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:0151A8DE-1840-4184-A1AD-7C1D14FC1ADF"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:74B40B0D-80D4-4D6C-A228-565389F7354A"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:FB06B874-B4FF-4D62-8B98-AF71219A34FD"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:AED0860A-0698-4A2A-8C7F-C0C3750004A3"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:5771D074-1193-4EB7-997B-31710E663873"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:19D66CB7-02F7-43A0-919A-2B5BE0033495"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:F69143F7-43EE-4FDF-9D56-2651B98E6002"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:1E1426F8-CEA1-4F14-A350-042797326C36"/>
    <pav:lineageUri>urn:domeoserver:annotationset:F37BE993-E972-47AE-896D-FF4D33157ECF</pav:lineageUri>
    <ao:item rdf:resource="urn:domeoclient:uuid:C8E7398B-A687-4370-874E-68C2EFFD0F5C"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:4AF8E204-1E57-411D-9013-3CA029E06DB7"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:5F1E24AE-5F51-41CD-9C93-2A6088CE7FE9"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:1C971DC5-F04F-473E-9509-6E1B9DE2F91E"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:B51EB7EF-7461-4184-98B0-3424937CD1FA"/>
    <pav:previousVersion>urn:domeoserver:annotationset:CD8CF855-5351-4137-B84B-ECB9707C608F</pav:previousVersion>
    <ao:item rdf:resource="urn:domeoclient:uuid:0170DEB4-EB91-4979-B149-660548D6A165"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:9F8F3833-59D2-418E-848E-66B8A9611402"/>
    <pav:lastSavedOn>2014-07-07 11:12:49 -0400</pav:lastSavedOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:CA969ACC-523C-4D38-BD0F-F71CD3AEB48F"/>
    <domeo:deleted>false</domeo:deleted>
    <ao:item rdf:resource="urn:domeoclient:uuid:9E114CCF-88D8-4F9D-8613-FF14BCC4D2DD"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:FC2068AC-90C4-4F49-892E-8BBE8145A240"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:9BCF217D-125A-4CCD-8BB9-E8D797EB4954"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:C1A463F7-64C8-4DC4-83EA-60E4A57F63F3"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:0C897DE4-8371-4AB8-8304-233D75C3D5C4"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:50D4EE64-0052-490F-9CA0-76253C39A1FD"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:B2A822AE-953B-494E-B6C8-999D70A6CF0A"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:8DD7480D-E4F1-4530-9B61-A05EAB8A0A7B"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:3FD41C4D-A301-4EA2-A72F-08EE8358A099"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:4388EE9C-D8AA-4371-A246-D92D12E328A6"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:4F891964-9FB2-4065-86DE-0D7A029BB5BB"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:71D6757B-3E92-499D-BFB9-13AEB04F23BA"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:B1510031-6C56-42CA-8590-3A1B5ADD6A7D"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:C9ACBCB7-738B-47D3-9E81-7BC584E142D6"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:08DA4EC5-B08E-44C6-BB0B-CA31B1E6FE78"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:94BC5217-C389-4C2C-ABA6-22B93B6F70E8"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:F521837B-E550-4F34-A5BD-8C6E842281EC"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:FDBFD92B-DC7C-44FB-8F3D-3C3A11A0F0DD"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:78766AFA-FB26-436F-9FBE-744E65FC2DA1"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:101BF336-26FE-483C-89AB-6013CA4CD0BF"/>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <ao:item rdf:resource="urn:domeoclient:uuid:4543C59F-15AE-426D-B65C-5A3B7D36FB5C"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:F9FFF331-4555-417B-A31B-B9FD56920E60"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:799D80AA-0C08-46BD-B79B-45AEEB971F79"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:DC912587-7435-4123-A04D-00971BD8B7A9"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:EB1D6CB2-B734-4DE7-B630-05FF0D70D1DF"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:6924A8BB-D094-4B99-8CC6-4C1C52D1971C"/>
    <pav:createdOn>2014-07-07 09:33:57 -0400</pav:createdOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:CE9CDAC4-3C9D-4E89-95A8-A53185AACF8B"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">4</pav:versionNumber>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <rdfs:label>Default Set</rdfs:label>
    <ao:item rdf:resource="urn:domeoclient:uuid:65A4FA6D-7065-4765-87CF-AB16D8E5A9D4"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:407FBD24-344A-40CA-B18B-841C2F55C44D"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:D57CA9DE-D321-4D8D-8ABA-4B63CB3D44B7"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:6E7D7526-1740-4ADC-9F18-70FC154C7D9D"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:54400419-BC05-429A-AC24-786E53EBBC07"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:A985AB9E-D0F3-4E9A-A4A5-D4C311D56DBC"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:A3FEA294-9E0E-452E-9F32-77BD7358CCB4"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:C2CA98EF-6FC7-4DAD-A0A2-66784F962B31"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:5A07D976-5651-4E28-A92F-4FCF50FD08E6"/>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812e52b20002"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:395C134E-55A6-4E4F-B3C2-5F4EAD380C5E"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:4BC34D35-17F6-49DA-A8BA-DBBFD0BD7819"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:68ECE5EE-A978-45A8-9A38-A4EACE88CBDA"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:BA224B85-9213-4D9B-ABE6-F8C7AAD2D473"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:A98A2D6C-5168-4E16-8726-BB2F3BF90FDC"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:1A4D607F-E80D-4B26-A5F5-3912A297D942"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:E96D33F6-142B-4A53-83BD-A17107D024E4"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:50A07CC8-B02F-4746-8B09-F09F638E2254"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:D3377A5F-678E-4E2C-B503-9C0CC3C16A04"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:CCFB939C-0A41-4B05-B1AF-F1FAF1080E01"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:D0E5A738-3AF8-4916-9A58-DD4E82CA9E9F"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:419C7F38-E49C-4AA8-98BE-BD8D59B65810">
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <ao:body rdf:nodeID="Ndb65d5051b424394a5571b0f8031cd36"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">3</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5B2167F6-4E63-4A7B-85C1-ACA56DDE7073</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:previousVersion>urn:domeoclient:uuid:42a83e8e-3067-409a-8471-bf6887759cee</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:3EDAD445-40E3-4EB0-BF26-CA562642BAB0"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotationset:061a21f6-0ef7-497f-bd03-574c24bc0d7c</pav:lineageUri>
    <pav:lastSavedOn>2014-07-08 15:43:16 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-08 15:43:16 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:FB77F85C-78C3-42B3-BBE8-77FA8FC73110">
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:88277212-693D-4F60-BB36-52271F5C953B"/>
    <ao:body rdf:nodeID="N3d572e04019f442d8697cc830d7fad5a"/>
    <pav:createdOn>2014-07-08 15:22:43 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotation:BDD33A26-0E4C-474A-A1C6-6324317669E0</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:11406278-E817-40C1-94F2-0DAE4C5FB656</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-07-08 15:22:42 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:995C6B02-7021-4FE7-BA75-B9C34AB69C09">
    <pav:createdOn>2014-07-08 19:47:48 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:995C6B02-7021-4FE7-BA75-B9C34AB69C09"/>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-31.txt.html</ao:hasSource>
    <ao:suffix>(See PRECAUTIONS.</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>The AUC and Cmax of glyburide (5 mg single dose) were significantly increased following the administration of fluconazole in 20 normal male volunteers. There was a mean ± SD increase in AUC of 44% ± 29% (range: -13 to 115%) and Cmax increased 19% ± 19% (range: -23 to 62%). Five subjects required oral glucose following the ingestion of glyburide after 7 days of fluconazole administration. </ao:exact>
    <domeo:uuid>995C6B02-7021-4FE7-BA75-B9C34AB69C09</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:1209694E-3FDB-4A08-A579-76605D36B1D7">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:lineageUri>urn:domeoserver:annotation:83F3D963-26E2-4231-A26E-64E56BD753D5</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:AB07B422-A2C8-4EFF-AB73-7F294EB50835"/>
    <pav:lastSavedOn>2014-07-08 09:15:28 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <ao:body rdf:nodeID="N5ebb25ec997a4a8a8e6afbf25750e9c8"/>
    <pav:createdOn>2014-07-08 09:15:27 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoclient:uuid:54F09193-5CC7-4ED3-9261-88C7428E0572</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:8A9CC7E7-29F6-4AF0-A986-C8CBE97A4964">
    <ao:context rdf:resource="urn:domeoclient:uuid:4DDB7604-39B2-403D-962F-0AAD8F6547AD"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A5E637EF-5CA5-4AAC-BD8B-C136A86E17B7</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:lastSavedOn>2014-07-07 09:44:18 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-07 09:42:03 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotationset:F37BE993-E972-47AE-896D-FF4D33157ECF</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:5372C985-BD8B-48DC-919B-78E26F288022">
    <domeo:belongsToSet>urn:domeoclient:uuid:6B178133-9B11-445F-A5BB-EF967EA53386</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:createdOn>2014-07-08 12:29:01 -0400</pav:createdOn>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:lastSavedOn>2014-07-08 12:29:01 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:D64630DF-4F6D-414D-AEED-E6781F4A963F"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotation:DF21DD60-3686-4A8D-8555-81A279A6E9E2</pav:lineageUri>
    <ao:body rdf:nodeID="N1ec64a49af9d48faad35552c5b81cd88"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:423352B3-8ABA-48B7-98CF-B191A7BFC955">
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-139.txt.html</ao:annotatesResource>
    <ao:item rdf:resource="urn:domeoclient:uuid:8FC38083-ECBA-4875-8517-ADB6E4075689"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:D0C372FF-08E3-4674-8762-7CAB3CFC5C0D"/>
    <rdfs:label>Default Set</rdfs:label>
    <ao:item rdf:resource="urn:domeoclient:uuid:E512F39B-79C1-4DCF-B972-C4F710C1BCBA"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:item rdf:resource="urn:domeoclient:uuid:D0AADEA6-8768-46C2-B68F-6213C82579AB"/>
    <pav:lineageUri>urn:domeoserver:annotationset:CC00A2B5-AA6D-4BDC-9500-D87E292ED21D</pav:lineageUri>
    <ao:item rdf:resource="urn:domeoclient:uuid:F646572E-B969-438E-A7F9-F78708BEB651"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:8B9E1BD5-B077-42D2-81BD-F76692A03855"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:AB6F5B33-04B6-4BFF-84B2-C8333F34524C"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:FAE98F89-D4F8-4983-B42C-00D341030245"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:C5825E02-3090-4552-BDE0-3C3A833DF951"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:D5F1D8D1-230B-4686-8A52-6BE91F89A5CB"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:C710E7F2-14E9-4D9F-AF4D-BB3BB31DDDE1"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:CEFBAE30-68A1-447B-B8EB-87DCBC0E389B"/>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812e52b20002"/>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:5F8045C8-5AD4-45EF-AD66-B283A265353D"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:C12DCA82-CE24-40D6-952A-A3F5395F8D27"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:AC961730-8EF7-4E27-A1B2-BA2D4CA6B161"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:73C13A6E-1AA6-404D-ACA7-3543294F7C0E"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:lastSavedOn>2014-07-08 09:35:29 -0400</pav:lastSavedOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:93915E60-0340-4F12-8A8A-F95F8DA176F5"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:item rdf:resource="urn:domeoclient:uuid:79EA7C97-DC71-4F18-8530-A375BD6B0934"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:EE9A106F-D61D-431B-9AF5-24759392428B"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:7CFFCD0A-CB23-4373-B8B3-2B3A4C4B8588"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:A9132970-66F0-427D-8062-6BF37F06BF1C"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:F2DC0496-DA9C-41B6-8A47-26244C1FD0ED"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:06F5C90C-030E-4FE1-8B9D-CE973BCF5CB1"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:EEA8974C-14B9-4871-9A82-DA731C3D9E38"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:76CF4898-7375-498D-B5C6-754888833FC6"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:B4B54D7C-0FC0-4205-97CB-C18FFA0599D7"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:DA42D122-3010-429C-B980-DB548D699AE1"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:9F30A64D-EE5B-4F2B-8A69-7ECE39EA536B"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:9AFEC25A-7770-4D4D-97CA-8F2103A062E7"/>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <ao:item rdf:resource="urn:domeoclient:uuid:81905BDC-D3EE-4998-8837-50782592281E"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:24A8B748-5958-4D4A-998D-BA9C4302D6A0"/>
    <permissions:permissions rdf:nodeID="N1558d9582ab6405480a5633c303119bb"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:6DA8A644-B7CA-454E-9039-433003CE8C04"/>
    <domeo:deleted>false</domeo:deleted>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:item rdf:resource="urn:domeoclient:uuid:4DDBA8A7-CDB3-40B9-800E-825DAC51D276"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:A29E5506-73C2-4E2C-ACEF-1D382A41B4BB"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:F31B7B89-739C-4B70-9004-4813A7C9F4E9"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:5FF7629F-F304-4A86-BE42-01786FB50EDA"/>
    <pav:createdOn>2014-07-08 09:30:30 -0400</pav:createdOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:F0697D9D-646C-47A1-8922-F74AE2E2F93A"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:0D5DA780-13BE-454F-8F2A-50EEBFA54789"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:684009B0-C0FC-4BBB-823A-4D648E4262EA"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:91C6CD27-CC1A-4F81-B1DB-C1F416895390"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:7FBC21DB-8AB8-4EC2-936B-EB29896B9254"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:312F878C-8DBF-4403-8209-A5AC17F01EB8">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/E30EFB78-74C0-4737-AE5F-F2213012EDF0"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/CECB4775-D4B7-429E-8E14-0456EA8E8052"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:19D66CB7-02F7-43A0-919A-2B5BE0033495">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotationset:F37BE993-E972-47AE-896D-FF4D33157ECF</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2014-07-07 09:44:18 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A5E637EF-5CA5-4AAC-BD8B-C136A86E17B7</domeo:belongsToSet>
    <pav:createdOn>2014-07-07 09:38:08 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:3E5B6F57-ECEC-478D-9EBF-025B19048464"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/56B0DEA3-D4B8-4D76-863C-D2C262C4AF2E">
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/679314</dailymed:activeMoietyRxCUI>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>9-hydroxyrisperidone</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:641CBD79-D57F-4A7A-B321-274C4D24C748">
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:AC8C9B28-6185-4FA3-A82C-194F809A60A8"/>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:920DFA54-D4BC-4BAF-985B-F826DE90874B">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-07 19:43:35 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5ABD9862-F044-4404-AD04-73DA04ADDA8B</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:55E3FF4C-A1A8-4D4F-AD9B-91B6BD60C2ED"/>
    <pav:lineageUri>urn:domeoserver:annotationset:1DED06A6-8562-4CCF-A58C-CA25748FBD31</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-07-07 19:50:36 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D43FCBC1-59D3-4B63-8504-A7883192F3A3">
    <ao:prefix>treatment did not cause a decrease in the</ao:prefix>
    <domeo:uuid>D43FCBC1-59D3-4B63-8504-A7883192F3A3</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:D43FCBC1-59D3-4B63-8504-A7883192F3A3"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-21.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-07 20:01:02 -0400</pav:createdOn>
    <ao:exact> ethinyl estradiol</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix> AUC of any individual subject in this study compared to placebo dosing. The individual AUC values of norethindrone decreased very slightly (&lt;5%) in 3 of the 21 subjects after fluconazole treatment.</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/D7A28440-08F4-43AC-9202-1443C29DAA3E">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>valproate</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/40254</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C44331BB-773C-4338-8049-4956F3685832">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotation:1D1C38E3-A63D-4E68-9D68-0D307655D2D1</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:createdOn>2014-07-08 15:03:21 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:2E252AB2-20BD-4522-8B0C-3376444BB437</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-08 15:03:24 -0400</pav:lastSavedOn>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:12A75B96-2A4B-477D-9FA3-394A35EC16A3"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:body rdf:nodeID="N668ac451d16b4fed8559a9ee025c96ea"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:FF4D892F-0BD2-4FD8-9160-6124946DB29D">
    <domeo:deleted>false</domeo:deleted>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:39BBA246-6636-4708-986A-236B349DBC5A"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:AEF4A18D-0D98-4600-85BC-F76580C44FF6"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:A751B0FE-9015-43D2-AA1E-AF456C1C9527"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812e52b20002"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:item rdf:resource="urn:domeoclient:uuid:771F6C88-6D8B-47F6-B6F2-55064E77133B"/>
    <rdfs:label>Default Set</rdfs:label>
    <ao:item rdf:resource="urn:domeoclient:uuid:81EB6128-9B59-429F-93DC-F824E1C1731E"/>
    <pav:createdOn>2014-07-08 09:23:56 -0400</pav:createdOn>
    <permissions:permissions rdf:nodeID="N4297ae45353f4051a15762a953c5670f"/>
    <pav:lastSavedOn>2014-07-08 09:24:20 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotationset:6C6F013D-FC6E-4ED5-B8DF-40252FBB912A</pav:lineageUri>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-135.txt.html</ao:annotatesResource>
    <ao:item rdf:resource="urn:domeoclient:uuid:EC4DCAFE-CA86-476E-8005-98C657C55AFD"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7D7AFE72-079D-47EC-9089-BE3A5CC4DDDF">
    <ao:context rdf:resource="urn:domeoclient:uuid:7001DCC7-6265-46EB-A6C2-9C6B3E296409"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:23515E27-98AC-4DC9-A4B7-EBFE2991219F</domeo:belongsToSet>
    <pav:createdOn>2014-07-08 08:43:14 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2014-07-08 08:46:38 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotationset:57174A7C-3100-4C8F-9C4A-2991CEE124D5</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/FF2BF6A3-274B-4A01-9381-03CE2B964685">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>methadone</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/6813</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:509F6E6E-9A2D-47D4-9790-C21E0B41EEC3">
    <pav:createdOn>2014-07-08 08:42:33 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <ao:exact>rosiglitazone</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:509F6E6E-9A2D-47D4-9790-C21E0B41EEC3"/>
    <ao:suffix>.</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>Results of the population pharmacokinetic analysis (n = 716 &lt;65 years; n = 331 ≥65 years) showed that age does not significantly affect the pharmacokinetics of </ao:prefix>
    <domeo:uuid>509F6E6E-9A2D-47D4-9790-C21E0B41EEC3</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:0CE9A1DF-8DE2-490C-BDED-1F28F4629E27">
    <pav:lineageUri>urn:domeoserver:annotation:026EF790-76F3-4B94-A247-E1BBD91A0BB3</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5B2167F6-4E63-4A7B-85C1-ACA56DDE7073</domeo:belongsToSet>
    <pav:createdOn>2014-07-08 15:48:09 -0400</pav:createdOn>
    <ao:body rdf:nodeID="Ne9ec5a3511834ae8be64e5b76ef2201b"/>
    <pav:lastSavedOn>2014-07-08 15:56:00 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:8C6194A4-8368-4656-9E3C-7E4284F1F9AA"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:0282A432-FB98-473A-82A0-99D09B3D531B">
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoclient:uuid:3857B7A8-EDF2-4956-9CF4-A1B13773E162</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:A99F9870-64B2-4CCB-8D5F-CDF8313D2C06</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdOn>2014-07-07 20:16:42 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-07-07 20:18:07 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:71C7B108-B407-474E-8BAE-25D3DB6CC2D4"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A5666665-429A-40E8-930C-06F3AC6B57C1">
    <pav:lineageUri>urn:domeoserver:annotation:9D77ECAD-AD14-481F-BFE8-6414E6691956</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:1DE6D6F6-8001-4C18-B383-AF52EA3FC9FE"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:createdOn>2014-07-07 20:50:02 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2014-07-07 20:51:02 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:29AAB777-4FBF-49C4-ACFD-F2FC169A463D</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:45496314-6BF2-4A53-98BB-B5A1361F6D61">
    <ao:suffix>xsd:String</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:45496314-6BF2-4A53-98BB-B5A1361F6D61"/>
    <ao:exact>Combined administration of citalopram (40 mg) and ketoconazole (200 mg) decreased the Cmax and AUC of ketoconazole by 21% and 10%, respectively, and did not significantly affect the pharmacokinetics of citalopram.</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-80.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-08 15:05:01 -0400</pav:createdOn>
    <domeo:uuid>45496314-6BF2-4A53-98BB-B5A1361F6D61</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:BCD6D501-58BB-4255-B1E4-8D43F901ADE6">
    <domeo:uuid>BCD6D501-58BB-4255-B1E4-8D43F901ADE6</domeo:uuid>
    <ao:exact>N-desmethy</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:BCD6D501-58BB-4255-B1E4-8D43F901ADE6"/>
    <ao:suffix>l metabolite are both approximately 96% bound to plasma proteins. Protein binding is independent of total drug concentrations.</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>and its major circulating </ao:prefix>
    <pav:createdOn>2014-07-07 09:37:00 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:009F8C96-1AEA-4B59-B278-1C6873AA45B5">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:item rdf:resource="urn:domeoclient:uuid:9BACEF41-5562-4C68-9907-012342332FB8"/>
    <pav:lineageUri>urn:domeoserver:annotationset:DF9E26B3-27D6-4752-9EA5-0BE02B287516</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <permissions:permissions rdf:nodeID="N08dfa93142b64b39954e01cd5e5be37f"/>
    <pav:createdOn>2014-07-07 20:49:24 -0400</pav:createdOn>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812e52b20002"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Default Set</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <domeo:deleted>false</domeo:deleted>
    <pav:lastSavedOn>2014-07-07 20:49:30 -0400</pav:lastSavedOn>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-121.txt.html</ao:annotatesResource>
    <ao:item rdf:resource="urn:domeoclient:uuid:57025C5D-977A-46F5-ADF5-8441A9FC0693"/>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:2F2B075B-7F85-4E5F-A15D-EBBCF050E6D6">
    <ao:exact>ODV</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-6.txt.html</ao:hasSource>
    <ao:suffix> were unaltered by age or gender differences. Dosage adjustment based on the age or gender of a patient is generally not necessary [see Dosage and Administration (2)].</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:2F2B075B-7F85-4E5F-A15D-EBBCF050E6D6"/>
    <ao:prefix> or </ao:prefix>
    <pav:createdOn>2014-07-21 10:01:23 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>2F2B075B-7F85-4E5F-A15D-EBBCF050E6D6</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:3857B7A8-EDF2-4956-9CF4-A1B13773E162">
    <ao:item rdf:resource="urn:domeoclient:uuid:C85411D9-2A99-483A-972C-7598B110F9E0"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:9F611555-5361-4C0E-A4A4-F71A543874F2"/>
    <pav:createdOn>2014-07-07 20:16:35 -0400</pav:createdOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:736E8702-7E07-4AA1-B52A-E135ED1049B3"/>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812e52b20002"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <permissions:permissions rdf:nodeID="N16e1603e5e8c48688af2d465bf6ab686"/>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-27.txt.html</ao:annotatesResource>
    <ao:item rdf:resource="urn:domeoclient:uuid:08FAE140-9EFB-466F-87F2-3C4FB308BC6F"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:deleted>false</domeo:deleted>
    <pav:lastSavedOn>2014-07-07 20:18:07 -0400</pav:lastSavedOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:ECE13C32-CF6F-45B3-88CA-0A913EAE55D3"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <rdfs:label>Default Set</rdfs:label>
    <ao:item rdf:resource="urn:domeoclient:uuid:48A10FCC-D3EB-470D-8C14-4E88B338BE93"/>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <ao:item rdf:resource="urn:domeoclient:uuid:9DCC526E-8763-49C5-98FB-B1613386AA3D"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:3407A3F0-5CF5-40EC-AD36-0C1F5658770B"/>
    <pav:lineageUri>urn:domeoserver:annotationset:8E8A6762-7EA3-460A-97DD-FB05CFF15DBA</pav:lineageUri>
    <ao:item rdf:resource="urn:domeoclient:uuid:0282A432-FB98-473A-82A0-99D09B3D531B"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:92E6B82B-0CB3-4359-ADB2-A9EE3DB5A351">
    <ao:suffix>In clinical trials using</ao:suffix>
    <domeo:uuid>92E6B82B-0CB3-4359-ADB2-A9EE3DB5A351</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-194.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:92E6B82B-0CB3-4359-ADB2-A9EE3DB5A351"/>
    <ao:exact>The pharmacokinetics of propafenone was not affected by the coadministration of either propranolol or metoprolol. </ao:exact>
    <ao:prefix> </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-08 14:09:11 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:949C5F18-81B3-41C6-BE8B-1AFA953A5286">
    <domeo:uuid>949C5F18-81B3-41C6-BE8B-1AFA953A5286</domeo:uuid>
    <ao:suffix>could be subject to two kinds of drug-drug interactions. First, inhibitors of CYP 2D6 interfere with conversion of risperidone to 9-hydroxyrisperidone [see 7 DRUG INTERACTIONS]. This occurs with quinidine, giving essentially all recipients a risperidone </ao:suffix>
    <ao:exact>Risperidone </ao:exact>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:949C5F18-81B3-41C6-BE8B-1AFA953A5286"/>
    <pav:createdOn>2014-07-07 19:48:52 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:06479317-E885-46F1-8D20-E48995D73AC4">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>xsd:String</ao:prefix>
    <pav:createdOn>2014-07-08 08:52:48 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:06479317-E885-46F1-8D20-E48995D73AC4"/>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <ao:exact>Digoxin</ao:exact>
    <domeo:uuid>06479317-E885-46F1-8D20-E48995D73AC4</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:34DF20A0-C194-4F9B-AD0F-A6A5666F60E6">
    <ao:exact>norethindrone</ao:exact>
    <ao:suffix>), which are predominantly metabolized by CYP3A4.</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:34DF20A0-C194-4F9B-AD0F-A6A5666F60E6"/>
    <pav:createdOn>2014-07-08 08:44:31 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <ao:prefix>and </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>34DF20A0-C194-4F9B-AD0F-A6A5666F60E6</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:b1a4941a-3331-422c-9873-68f122f30adc">
    <ao:suffix> levels.</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-191.txt.html</ao:hasSource>
    <domeo:uuid></domeo:uuid>
    <ao:exact>fluvastatin</ao:exact>
    <ao:prefix>ffect plasma itraconazole or </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:b1a4941a-3331-422c-9873-68f122f30adc"/>
    <pav:createdOn>2014-07-07 08:06:45 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:07BF8C39-D9C6-446D-9F23-C06F132088A4">
    <pav:createdOn>2014-07-08 14:38:04 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotation:2BB3D412-1E8C-4E7B-B850-E8B9D6CB29A1</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:20C3E750-EA09-4B64-8810-7C43F42F8F50"/>
    <pav:lastSavedOn>2014-07-08 14:40:40 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:C2CFDC7A-D407-48FD-81AA-DFCEA656C0BE</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7BB5C7CC-5AEF-4D00-829C-6C8F0E50D486">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-12.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:suffix>There was a 23% increase in T </ao:suffix>
    <pav:createdOn>2014-07-21 10:09:15 -0400</pav:createdOn>
    <ao:exact>In a study comparing the disposition of intravenously administered diazepam before and after 21 days of dosing with either sertraline (50 to 200 mg/day escalating dose) or placebo, there was a 32% decrease relative to baseline in diazepam clearance for the sertraline group compared to a 19% decrease relative to baseline for the placebo group (p &lt; 0.03). </ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:7BB5C7CC-5AEF-4D00-829C-6C8F0E50D486"/>
    <domeo:uuid>7BB5C7CC-5AEF-4D00-829C-6C8F0E50D486</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:9169FF55-28DB-4701-B68A-358850EDFD95">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotation:76686C8D-9A81-401B-83AA-8A93878DDBBF</pav:lineageUri>
    <ao:body rdf:nodeID="N0dc06b8b944b478dbea28a617a7c8fb4"/>
    <pav:lastSavedOn>2014-07-08 19:46:35 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:C524950D-FEC8-4563-9BFB-C816C764385C</domeo:belongsToSet>
    <pav:createdOn>2014-07-08 19:46:32 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:F11BAEB6-7B0E-40A9-95E0-887BA08E9F97"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:85080FBE-9D21-4608-A18C-5BB6574C4AAE">
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:AFFE5BB1-A40C-4E7F-8B02-439CA1FD04C1"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:BD24CFC4-ABB3-434E-9897-CD48A4D2ADA5">
    <domeo:uuid>BD24CFC4-ABB3-434E-9897-CD48A4D2ADA5</domeo:uuid>
    <ao:exact>Plasma zidovudine concentrations were determined on two occasions (before and following fluconazole 200 mg daily for 15 days) in 13 volunteers with AIDS or ARC who were on a stable zidovudine dose for at least two weeks. There was a significant increase in zidovudine AUC following the administration of fluconazole. The mean ± SD increase in AUC was 20% ± 32% (range: -27 to 104%). The metabolite, GZDV, to parent drug ratio significantly decreased after the administration of fluconazole, from 7.6 ± 3.6 to 5.7 ± 2.2.</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:BD24CFC4-ABB3-434E-9897-CD48A4D2ADA5"/>
    <pav:createdOn>2014-07-07 20:17:32 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-27.txt.html</ao:hasSource>
    <ao:prefix>xsd:String</ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>xsd:String</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:67EA985C-B122-4F30-AFC2-CCB43D5D83A8">
    <pav:createdOn>2014-07-08 09:28:14 -0400</pav:createdOn>
    <domeo:uuid>67EA985C-B122-4F30-AFC2-CCB43D5D83A8</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:exact>Carbamazepine </ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:67EA985C-B122-4F30-AFC2-CCB43D5D83A8"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-137.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>induces CYP3A4. Following coadministration of carbamazepine 400 mg/day with trazodone 100 mg to 300 mg daily, carbamazepine reduced plasma concentrations of trazodone (as well as mCPP) by 76 and 60%, respectively, compared to pre-carbamazepine values.</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:6E7D7526-1740-4ADC-9F18-70FC154C7D9D">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">3</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A5E637EF-5CA5-4AAC-BD8B-C136A86E17B7</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:57F0F7FA-4574-4993-9F3B-9298794A1D9C"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2014-07-07 10:54:10 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotationset:F37BE993-E972-47AE-896D-FF4D33157ECF</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-07 10:03:24 -0400</pav:createdOn>
    <pav:previousVersion>urn:domeoserver:annotationset:E0912BFE-3C9A-4C5D-81F4-9D862F25D230</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:9333FDEF-9C18-4199-AF10-FFE42674F5FB">
    <domeo:belongsToSet>urn:domeoserver:annotationset:32944008-A6C6-4D66-8C43-EE4CF2256965</domeo:belongsToSet>
    <pav:previousVersion>urn:domeoclient:uuid:21a2d27a-13b1-4797-ba7a-c0517e32bb06</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:291F5C9B-106B-46C8-9617-F191BBB2F751"/>
    <pav:lineageUri>urn:domeoserver:annotationset:cf593dca-fe93-451b-8f37-2a96e065da13</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">3</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2014-07-21 10:02:02 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-07-21 10:02:11 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:9D030CDB-566E-4D88-8D74-12A6DF8F84AB">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:9D030CDB-566E-4D88-8D74-12A6DF8F84AB"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-7.txt.html</ao:hasSource>
    <domeo:uuid>9D030CDB-566E-4D88-8D74-12A6DF8F84AB</domeo:uuid>
    <ao:exact>cimetidine did not affect the AUC of risperidone and 9-hydroxyrisperidone combined</ao:exact>
    <ao:suffix>, whereas</ao:suffix>
    <pav:createdOn>2014-07-08 15:44:35 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>xsd:String</ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C7AEA97A-9C05-4DC4-993A-3692CD72DBF6">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2014-07-07 20:10:27 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-07-07 20:12:43 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotation:F72815EA-DE71-4AD1-A6AC-A9C727B0046B</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:1E7CE8F9-62B5-44A0-AABC-50E8FF7C4D9E"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoclient:uuid:21FE87BA-B7AA-4926-95E7-7E20EA2E4643</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:21FE87BA-B7AA-4926-95E7-7E20EA2E4643">
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <pav:createdOn>2014-07-07 20:10:18 -0400</pav:createdOn>
    <permissions:permissions rdf:nodeID="Ndea8479551704062ac8a93c2e92d827c"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:1762A543-B637-49B5-A4ED-4B9311ED36D1"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:item rdf:resource="urn:domeoclient:uuid:5D918B1F-3225-4686-A401-07868FC465A5"/>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <ao:item rdf:resource="urn:domeoclient:uuid:64EB2603-4A87-4E9E-AB5D-A9C2CBF4406A"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:68210666-C6C1-4B81-A69F-1AD82FD19CA0"/>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812e52b20002"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:item rdf:resource="urn:domeoclient:uuid:C7AEA97A-9C05-4DC4-993A-3692CD72DBF6"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:4C9C4BAA-DD71-4F08-86F7-7FE9A2EF8CF0"/>
    <domeo:deleted>false</domeo:deleted>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-24.txt.html</ao:annotatesResource>
    <rdfs:label>Default Set</rdfs:label>
    <ao:item rdf:resource="urn:domeoclient:uuid:B8F5CDC4-B4BB-4203-A5A9-BB01E739D22D"/>
    <pav:lineageUri>urn:domeoserver:annotationset:63A463A3-6A14-440E-8ED7-007BE2AA5478</pav:lineageUri>
    <pav:lastSavedOn>2014-07-07 20:12:43 -0400</pav:lastSavedOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:2194D376-E23D-4032-9E14-B41C862D51B2"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/06C43F74-BFE4-4D12-A90C-CC09F2C57EC0">
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>zonisamide</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/39998</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:891C5D04-C5C8-47AF-8B66-E66C5F25FF01">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>891C5D04-C5C8-47AF-8B66-E66C5F25FF01</domeo:uuid>
    <ao:exact>Fluconazole </ao:exact>
    <pav:createdOn>2014-07-07 20:10:29 -0400</pav:createdOn>
    <ao:suffix>half-life decreased from 33.4 ± 4.4 hours to 26.8 ± 3.9 hours. (See PRECAUTIONS.)</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:891C5D04-C5C8-47AF-8B66-E66C5F25FF01"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>increased 32% ± 17% (range: 16 to 72%). </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-24.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E134A5C2-40CD-489F-AE84-B0040F8D0941">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>Amitriptyline did not affect the pharmacokinetics of risperidone or risperidone and 9-hydroxyrisperidone combined</ao:exact>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:E134A5C2-40CD-489F-AE84-B0040F8D0941"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-7.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-08 15:42:52 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix>xsd:String</ao:suffix>
    <domeo:uuid>E134A5C2-40CD-489F-AE84-B0040F8D0941</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:8CE927FA-57EC-46D6-B20D-48D87B95196E">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:486F1875-BE96-445A-B94C-56B972E73163"/>
    <pav:createdOn>2014-07-07 19:48:36 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotationset:1DED06A6-8562-4CCF-A58C-CA25748FBD31</pav:lineageUri>
    <pav:lastSavedOn>2014-07-07 19:50:36 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5ABD9862-F044-4404-AD04-73DA04ADDA8B</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoserver:annotationset:7E49EB7A-DE0E-4720-82D1-8460BA0C770D">
    <permissions:permissions rdf:nodeID="Nf6976a7f6a9541ffbb405484931bcd9e"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812e52b20002"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:item rdf:resource="urn:domeoclient:uuid:1D0A9A36-1469-43DB-927C-3422E01D71EA"/>
    <domeo:deleted>false</domeo:deleted>
    <rdfs:label>NER Sets</rdfs:label>
    <ao:item rdf:resource="urn:domeoclient:uuid:2EB5E47F-B66E-44F8-9384-DC066F6C5771"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:EA11E66F-660C-46D5-B222-C541A09953D4"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">4</pav:versionNumber>
    <ao:item rdf:resource="urn:domeoclient:uuid:40D7C070-F1A5-4DA0-A500-0A309BCF13C4"/>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <pav:previousVersion>urn:domeoserver:annotationset:27438ECD-5CA6-4882-BE94-B038F102173B</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotationset:def720a3-9364-4d0d-a156-423274fb2386</pav:lineageUri>
    <ao:item rdf:resource="urn:domeoclient:uuid:B115457B-6573-489E-97A1-794F562EF7E2"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:B8588523-C329-4303-ADDC-E0587156E5F6"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:AFC6F324-041F-49E5-95F8-8106928974F3"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:0FC9A1FC-0D72-4871-82DC-81A8C658E5A8"/>
    <dct:description>The NER set is created automatically by NER annotation loading program.</dct:description>
    <ao:item rdf:resource="urn:domeoclient:uuid:B5821CB1-C20E-47EB-95E6-9E2CFB1CEF28"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:8FF24A6F-2178-43B1-A0E1-109514E57181"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:3916A1F8-D023-4A40-8707-E00BD0D82213"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:7B19BF0D-C186-4BCB-B3DB-C6682B64E203"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:0313DB5F-EB99-4442-991D-8B993A0F2EE3"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:FCB599A7-C7CF-4E31-AAD2-7226E2C20D8B"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:CB6F6828-0358-4241-8207-69A8687C9B37"/>
    <pav:createdOn>2014-07-07 08:06:51 -0400</pav:createdOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:AA70235E-0C4F-49BA-8DCD-EBA299F33730"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:960DF358-FF78-4C37-91FE-21CF19E22817"/>
    <pav:lastSavedOn>2014-07-08 14:10:47 -0400</pav:lastSavedOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:56F78626-4EE9-4038-ADA8-61D7D5DDE571"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:825E94D7-A56C-4804-AACC-D6EB9189DE40"/>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-194.txt.html</ao:annotatesResource>
    <ao:item rdf:resource="urn:domeoclient:uuid:839D16FA-BCC2-4042-B5A5-DD0504556C7B"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:4CBC8554-5F6F-4DB5-82A4-30C03AA012CD"/>
    <ao:item rdf:resource="file:///home/yin2/python-SPL-connector/85c05bcb-ac0b-4d0c-829e-b702d09c26db"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:7E0CFC7F-65D4-4237-A8ED-2B7239AB9784"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:AA3A993C-272A-4746-BB5C-A4D6A8B03411"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:60E6EF68-9B3F-4F29-A307-34BF23344F95"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A2775810-A766-4B23-A5D0-7AC52C206807">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:84DFA5A2-ACDE-4ECD-8DEB-0CF25A36BACD"/>
    <pav:createdOn>2014-07-07 19:47:02 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-07-07 19:50:36 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotationset:1DED06A6-8562-4CCF-A58C-CA25748FBD31</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5ABD9862-F044-4404-AD04-73DA04ADDA8B</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F62BD12C-2E69-42FB-A04C-B6D7C7FBB29C">
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812e52b20002"/>
    <pav:createdOn>2014-07-08 08:55:49 -0400</pav:createdOn>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-124.txt.html</ao:annotatesResource>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotationset:AD5AEDDD-73F5-4D63-8A6B-604150C10A0A</pav:lineageUri>
    <permissions:permissions rdf:nodeID="N7aa7bc8023cd4d8daca2a4b95fef0693"/>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <ao:item rdf:resource="urn:domeoclient:uuid:E0BA825A-F88D-47F9-857E-632807039170"/>
    <rdfs:label>Default Set</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:item rdf:resource="urn:domeoclient:uuid:C152A582-9934-4BB0-B266-57744AF622AB"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:854A5EDE-6356-45B0-BCB9-BE45DA770390"/>
    <domeo:deleted>false</domeo:deleted>
    <pav:lastSavedOn>2014-07-08 08:56:07 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D0AADEA6-8768-46C2-B68F-6213C82579AB">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:ACC0015D-29FE-4F25-AA89-36F5F42E1F68"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotation:F328A7DE-6C64-4B84-AF5F-FCAE161FF6B1</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoclient:uuid:423352B3-8ABA-48B7-98CF-B191A7BFC955</domeo:belongsToSet>
    <pav:createdOn>2014-07-08 09:30:46 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2014-07-08 09:35:29 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C693AD83-B232-413C-A0F6-A65E4A1455AA">
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <domeo:belongsToSet>urn:domeoclient:uuid:7821C64B-A0CD-480C-9DC8-F790FC33069A</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-07-08 12:21:43 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-07-08 12:21:50 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotation:CC11A98E-F1BA-4A5F-9A1E-A36D0AE62BF7</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:5C803E1E-D69A-40B2-9B06-AC9770FF4DFF"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:69181454-C97E-4504-8427-9DD543BDF751">
    <ao:context rdf:resource="urn:domeoclient:uuid:224CE40F-FA7D-412A-991C-46B58835C734"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-07-07 20:37:16 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:createdOn>2014-07-07 20:37:07 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoclient:uuid:7E6B38CA-10F3-41E5-9A31-80E5F9447237</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:3C83DC02-02B0-4E5A-936F-DB89A42FAA36</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F9609A5E-97AD-401C-B5AD-3228508C73BD">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>xsd:String</ao:prefix>
    <pav:createdOn>2014-07-08 15:41:15 -0400</pav:createdOn>
    <domeo:uuid>F9609A5E-97AD-401C-B5AD-3228508C73BD</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-177.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:F9609A5E-97AD-401C-B5AD-3228508C73BD"/>
    <ao:exact>There is a potentially relevant interaction between diazepam and compounds which inhibit certain hepatic enzymes (particularly cytochrome P450 3A and 2C19). Data indicate that these compounds influence the pharmacokinetics of diazepam and may lead to increased and prolonged sedation. At present, this reaction is known to occur with cimetidine, ketoconazole, fluvoxamine, fluoxetine, and omeprazole</ao:exact>
    <ao:suffix>xsd:String</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:DC1D393E-F328-497D-A3FA-0BC8D9F870A1">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:DC1D393E-F328-497D-A3FA-0BC8D9F870A1"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-128.txt.html</ao:hasSource>
    <domeo:uuid>DC1D393E-F328-497D-A3FA-0BC8D9F870A1</domeo:uuid>
    <ao:prefix>and its metabolites. </ao:prefix>
    <ao:suffix>does not alter the pharmacokinetics of propranolol.</ao:suffix>
    <pav:createdOn>2014-07-08 09:08:02 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>Diazepam </ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D9F8F6A3-1C3D-4E25-9870-A403388D2394">
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <ao:item rdf:resource="urn:domeoclient:uuid:FD63354B-6615-453C-8145-6C8E2C0841EF"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:90167837-91E4-4A5F-84B4-A76DEAFA81F6"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <permissions:permissions rdf:nodeID="Nefc5b5ed38e14f519711388dae9a587b"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:4CE342AF-CFF4-436C-8AE9-F334ED3D9C32"/>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812e52b20002"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:0E94D58B-540F-4528-9F95-4F7176AA19B4"/>
    <pav:createdOn>2014-07-08 12:24:34 -0400</pav:createdOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:6D6548E2-7D2B-452A-82BD-490EFFDD8FDF"/>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-166.txt.html</ao:annotatesResource>
    <pav:lineageUri>urn:domeoserver:annotationset:9D4C5A43-BB8B-4A26-8D2E-B84C6029C267</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:item rdf:resource="urn:domeoclient:uuid:8D2365AB-E6ED-4F38-8690-7EB2E8B7E934"/>
    <rdfs:label>Default Set</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:B46DBE05-F202-4111-97A3-83A697D3FA62"/>
    <domeo:deleted>false</domeo:deleted>
    <pav:lastSavedOn>2014-07-08 12:25:29 -0400</pav:lastSavedOn>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:ACC0015D-29FE-4F25-AA89-36F5F42E1F68">
    <domeo:uuid>ACC0015D-29FE-4F25-AA89-36F5F42E1F68</domeo:uuid>
    <ao:suffix>AUC by 41% and Cmax by 43%.</ao:suffix>
    <ao:exact>fexofenadine </ao:exact>
    <ao:prefix>containing antacid (Maalox®1) decreased </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-139.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:ACC0015D-29FE-4F25-AA89-36F5F42E1F68"/>
    <pav:createdOn>2014-07-08 09:30:46 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:8DE85D27-2DC8-4B45-A385-EC2E0FAC1635">
    <rdfs:label>Highlight</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:9B7CF463-6EFD-4D7B-AE5F-CFFFC40C6107"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-08 14:20:01 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotationset:0f67c012-7596-4b02-a927-63c0ccbc3afa</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">3</pav:versionNumber>
    <pav:previousVersion>urn:domeoclient:uuid:e75c9d7b-f906-4c66-8a84-e6eef34d0954</pav:previousVersion>
    <pav:lastSavedOn>2014-07-08 14:24:44 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:42258B16-6749-4B39-B28D-88C8B63F7A43</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:014825DB-33FE-4C88-8EBE-8618F90BB82F">
    <domeo:belongsToSet>urn:domeoclient:uuid:8D643EAC-88DF-4484-A479-D1E798544DF5</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotation:FD1DFA97-9BBF-46A0-8502-862E95DE398A</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:88371A6C-1368-436F-988B-CC0B30903A9A"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:lastSavedOn>2014-07-07 20:38:37 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-07 20:38:00 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:DD30FC84-F408-46CB-B1A2-6D566D12E8B7">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-07-08 08:42:48 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotationset:57174A7C-3100-4C8F-9C4A-2991CEE124D5</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:A7D225EF-5C27-4DC2-8F2F-673A67EBA563"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:23515E27-98AC-4DC9-A4B7-EBFE2991219F</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2014-07-08 08:46:38 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoserver:annotationset:7C1C282A-E938-4B71-A30D-A7B67DB129EE">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812e52b20002"/>
    <pav:lastSavedOn>2014-07-08 14:53:28 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:createdOn>2014-07-07 08:07:06 -0400</pav:createdOn>
    <rdfs:label>NER Sets</rdfs:label>
    <ao:item rdf:resource="file:///home/yin2/python-SPL-connector/f2056576-10b4-4525-b819-b988fc2931c4"/>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <dct:description>The NER set is created automatically by NER annotation loading program.</dct:description>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-88.txt.html</ao:annotatesResource>
    <ao:item rdf:resource="urn:domeoclient:uuid:36330B96-6498-4A69-94F9-98F5F003CC11"/>
    <domeo:deleted>false</domeo:deleted>
    <pav:lineageUri>urn:domeoserver:annotationset:a9cc5584-e837-4dad-beba-c452ba45f3c1</pav:lineageUri>
    <pav:previousVersion>urn:domeoclient:uuid:70335747-398e-4d3b-aec7-12f94ee97fb4</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">3</pav:versionNumber>
    <permissions:permissions rdf:nodeID="N2e9abfea72284e44b683e499606d2826"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:56A26E88-85CF-488F-BED1-587BCD4DEC7C">
    <pav:createdOn>2014-07-07 19:47:04 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5ABD9862-F044-4404-AD04-73DA04ADDA8B</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-07 19:50:36 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:21BB89F3-A6EB-41F3-A8A0-3EDF64C57EBE"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotationset:1DED06A6-8562-4CCF-A58C-CA25748FBD31</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:796DD621-ABBA-4C43-A828-7B3F14FF2E3E">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>(1g q12h iv) could be substituted for the specified comparator if the causative pathogen was suspected or confirmed methicillin-resistant staphylococcus or if the patient was allergic to </ao:prefix>
    <ao:suffix>, cephalosporins or carbapenems. Study JRV 304 enrolled 450 patients (n = 229 Synercid; n= 221 Comparator) and Study JRV 305 enrolled 443 patients (n = 221 Synercid; n = 222 Comparator). </ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:796DD621-ABBA-4C43-A828-7B3F14FF2E3E"/>
    <ao:exact>penicillins</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-119.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-07 20:46:08 -0400</pav:createdOn>
    <domeo:uuid>796DD621-ABBA-4C43-A828-7B3F14FF2E3E</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D12FB5C2-47E0-4EB5-B892-3B9DC9806833">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:D12FB5C2-47E0-4EB5-B892-3B9DC9806833"/>
    <ao:suffix>is introduced [see Drug Interactions (7.1)].</ao:suffix>
    <ao:exact>gemfibrozil </ao:exact>
    <ao:prefix>may be needed when </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-08 08:46:00 -0400</pav:createdOn>
    <domeo:uuid>D12FB5C2-47E0-4EB5-B892-3B9DC9806833</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:B736374E-F0F6-4B93-8883-B0EB4CCF0B24">
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:68E15F64-3CE8-4FAB-A79C-2379BBEB9C23"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A972F880-764D-466A-8723-37A51E7F0A19">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>xsd:String</ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-08 13:59:24 -0400</pav:createdOn>
    <ao:exact>Drugs that inhibit CYP2D6 (such as desipramine, paroxetine, ritonavir, sertraline) and CYP3A4 (such as ketoconazole, ritonavir, saquinavir, erythromycin, and grapefruit juice) can be expected to cause increased plasma levels of propafenone. The combination of CYP3A4 inhibition and either CYP2D6 deficiency or CYP2D6 inhibition with administration of propafenone may increase the risk of adverse reactions, including proarrhythmia. Therefore, simultaneous use of RYTHMOL SR with both a CYP2D6 inhibitor and a CYP3A4 inhibitor should be avoided</ao:exact>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-194.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:A972F880-764D-466A-8723-37A51E7F0A19"/>
    <domeo:uuid>A972F880-764D-466A-8723-37A51E7F0A19</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E1C1DEA3-B3B4-40C4-948B-B14CF3F67706">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotation:89A18F43-0329-49AA-9B9F-53EFE0361C45</pav:lineageUri>
    <pav:lastSavedOn>2014-07-07 20:14:34 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoclient:uuid:B41CE612-345D-4E17-94DB-98BD2C6B5559</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:E9596FFF-1508-486F-B332-A0A16717BF8E"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdOn>2014-07-07 20:13:34 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:A39CC67D-1901-459D-B0B8-39681A921204">
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:87745CB9-8FA7-464F-8951-65523296C788"/>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:4F891964-9FB2-4065-86DE-0D7A029BB5BB">
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:lastSavedOn>2014-07-07 11:12:49 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2014-07-07 11:11:50 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotation:7C1B71E2-1A50-406C-A4DF-542CAD1D37B8</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:CC7CA38D-AE4E-485A-90AF-2EBDAA671ED6"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A5E637EF-5CA5-4AAC-BD8B-C136A86E17B7</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A899C9F5-4260-4BFA-B02D-21CC29BE7E52">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:254EBF3B-2982-4364-95A9-D0B679894EC5"/>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:lastSavedOn>2014-07-08 15:56:00 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-08 15:50:51 -0400</pav:createdOn>
    <ao:body rdf:nodeID="N6e4675d5fed74a5c9abf89a208f11015"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5B2167F6-4E63-4A7B-85C1-ACA56DDE7073</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:6E7BB482-4146-4F6C-9682-DF28F19FFF74</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:4E98B74F-8A06-446F-9BA0-3BF75766A076">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdOn>2014-07-07 19:43:26 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:43E72BA4-F3E6-4C32-90A5-E919E16BD340"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotationset:1DED06A6-8562-4CCF-A58C-CA25748FBD31</pav:lineageUri>
    <pav:lastSavedOn>2014-07-07 19:50:36 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5ABD9862-F044-4404-AD04-73DA04ADDA8B</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoserver:annotationset:F8B6985A-9E31-47A9-A3BD-27C4204B5532">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">3</pav:versionNumber>
    <dct:description>The NER set is created automatically by NER annotation loading program.</dct:description>
    <ao:item rdf:resource="file:///home/yin2/python-SPL-connector/bbedd82f-ca32-40a5-879c-88175b047f72"/>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812e52b20002"/>
    <pav:lineageUri>urn:domeoserver:annotationset:bdca43f8-d464-44b4-963c-ef9b9ef75392</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <permissions:permissions rdf:nodeID="Nc1755b3b0c6c4ca4a74d233019132e17"/>
    <rdfs:label>NER Sets</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:createdOn>2014-07-07 08:07:02 -0400</pav:createdOn>
    <pav:previousVersion>urn:domeoclient:uuid:9ac9eb06-243e-429f-916b-894a0ec865fd</pav:previousVersion>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-85.txt.html</ao:annotatesResource>
    <ao:item rdf:resource="urn:domeoclient:uuid:BF5B9586-8B87-4545-B4AB-36CD8A6842A6"/>
    <domeo:deleted>false</domeo:deleted>
    <pav:lastSavedOn>2014-07-08 15:27:47 -0400</pav:lastSavedOn>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoserver:annotationset:C524950D-FEC8-4563-9BFB-C816C764385C">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>NER Sets</rdfs:label>
    <domeo:deleted>false</domeo:deleted>
    <pav:lineageUri>urn:domeoserver:annotationset:fdad2024-fe2f-47d6-b26b-7fda5c8669d1</pav:lineageUri>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812e52b20002"/>
    <dct:description>The NER set is created automatically by NER annotation loading program.</dct:description>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">3</pav:versionNumber>
    <pav:previousVersion>urn:domeoclient:uuid:eee60b3b-99e2-4771-97de-f25b37a230b4</pav:previousVersion>
    <ao:item rdf:resource="file:///home/yin2/python-SPL-connector/2c5e4473-045b-4993-8f47-357c8a48a1ae"/>
    <permissions:permissions rdf:nodeID="N8de17b4fc9c14bfb99b4abd91fc1b88c"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-32.txt.html</ao:annotatesResource>
    <pav:lastSavedOn>2014-07-08 19:46:34 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:9169FF55-28DB-4701-B68A-358850EDFD95"/>
    <pav:createdOn>2014-07-07 08:07:00 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:43E72BA4-F3E6-4C32-90A5-E919E16BD340">
    <ao:exact>Risperidone </ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>is well absorbed. The absolute oral bioavailability of risperidone is 70% (CV=25%). The relative oral bioavailability of risperidone from a tablet is 94% (CV=10%) when compared to a solution.</ao:suffix>
    <domeo:uuid>43E72BA4-F3E6-4C32-90A5-E919E16BD340</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:43E72BA4-F3E6-4C32-90A5-E919E16BD340"/>
    <pav:createdOn>2014-07-07 19:43:26 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <ao:prefix>Absorption: </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/2A15FE31-8FA9-40F5-A760-5DD109DE3566">
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/679314</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>9-hydroxyrisperidone</rdfs:label>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:19E2719A-8D07-4CBD-A8D8-E312B8066467">
    <pav:lastSavedOn>2014-07-07 20:14:34 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoclient:uuid:B41CE612-345D-4E17-94DB-98BD2C6B5559</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdOn>2014-07-07 20:13:30 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:8CF1380F-B77E-41E4-A47C-425B72CC1166"/>
    <pav:lineageUri>urn:domeoserver:annotation:9811C122-E192-421B-A38D-DE472BB3A8B9</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:21797E6A-7A79-4039-B057-F569BB109D0A">
    <domeo:uuid>21797E6A-7A79-4039-B057-F569BB109D0A</domeo:uuid>
    <ao:exact> sildenafil AUC</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:21797E6A-7A79-4039-B057-F569BB109D0A"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <ao:suffix> and a 55% decrease in sildenafil Cmax. Co-administration resulted in a 50% increase in AUC of bosentan. The combination of both drugs did not lead to clinically significant changes in blood pressure (supine or standing). Concomitant administration of po</ao:suffix>
    <ao:prefix>(a moderate inducer of CYP3A, CYP2C9 and possibly of cytochrome P450 2C19) at steady state (125 mg BID) resulted in a 63% decrease of</ao:prefix>
    <pav:createdOn>2014-07-07 09:42:46 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/05F43156-9499-468D-886D-43E1E6B18F9F">
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>cimetidine</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/2541</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B0EBA812-42AB-4B7F-8E39-3E01885ABE39">
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:AACB148D-E63A-4610-A835-D766ED240017"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdOn>2014-07-08 08:42:46 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:23515E27-98AC-4DC9-A4B7-EBFE2991219F</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotationset:57174A7C-3100-4C8F-9C4A-2991CEE124D5</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2014-07-08 08:46:38 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:6819E238-7679-4EEF-827E-2E642C80664C">
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoclient:uuid:921213C5-987C-46D2-9095-A8DDC2B714AB</domeo:belongsToSet>
    <pav:createdOn>2014-07-07 20:00:49 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-07-07 20:04:45 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:4212DEFB-18BD-45B7-9672-279543486F2E"/>
    <pav:lineageUri>urn:domeoserver:annotation:C1DAD6EB-F7CE-4AA3-B427-A1C8A792A1B9</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/AB0A1481-FD34-441F-844A-402263A4D0F6">
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/2541</dailymed:activeMoietyRxCUI>
    <rdfs:label>cimetidine</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B5CD836A-F310-4CCA-A338-1A237A923AFA">
    <ao:suffix> [See Clinical Pharmacology (12.4).]</ao:suffix>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-122.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>An inhibitor of CYP2C8 (e.g., gemfibrozil) may increase the AUC of rosiglitazone and an inducer of CYP2C8 (e.g., rifampin) may decrease the AUC of rosiglitazone. Therefore, if an inhibitor or an inducer of CYP2C8 is started or stopped during treatment with rosiglitazone, changes in diabetes treatment may be needed based upon clinical response.</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:B5CD836A-F310-4CCA-A338-1A237A923AFA"/>
    <pav:createdOn>2014-07-07 20:50:29 -0400</pav:createdOn>
    <domeo:uuid>B5CD836A-F310-4CCA-A338-1A237A923AFA</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/8CC81AC0-CEFB-4A96-947B-166920995536">
    <rdfs:label>rifampin</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/9384</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:DE6BBBA2-E835-420D-88DD-35B02A3B87C1">
    <ao:exact>co-administration of known enzyme inducers (e.g., carbamazepine, phenytoin, rifampin, and phenobarbital) with risperidone may cause a decrease in the combined plasma concentrations of risperidone and 9-hydroxyrisperidone</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:DE6BBBA2-E835-420D-88DD-35B02A3B87C1"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>xsd:String</ao:prefix>
    <domeo:uuid>DE6BBBA2-E835-420D-88DD-35B02A3B87C1</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-07 19:51:49 -0400</pav:createdOn>
    <ao:suffix>xsd:String</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:1272AB51-6930-40DA-BFA9-64BBAF19E4F8">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-07-08 14:25:21 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:5F2EAB8E-988F-446A-A2CD-BACEBB26F805"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:42258B16-6749-4B39-B28D-88C8B63F7A43</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-08 14:26:16 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotation:3A453B02-044D-4FB1-A7E2-7C58591D9E88</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:4DCCDDAE-E949-4935-AF25-54EFF6FEE358">
    <ao:exact>The pharmacokinetics of theophylline were determined from a single intravenous dose of aminophylline (6 mg/kg) before and after the oral administration of fluconazole 200 mg daily for 14 days in 16 normal male volunteers. There were significant increases in theophylline AUC, Cmax, and half-life with a corresponding decrease in clearance. The mean ± SD theophylline AUC increased 21% ± 16% (range: -5 to 48%). The Cmax increased 13% ± 17% (range: -13 to 40%). Theophylline clearance decreased 16% ± 11 % (range: -32 to 5%). The half-life of theophylline increased from 6.6 ± 1.7 hours to 7.9 ± 1.5 hours. </ao:exact>
    <pav:createdOn>2014-07-07 20:21:05 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:4DCCDDAE-E949-4935-AF25-54EFF6FEE358"/>
    <ao:suffix>(See PRECAUTIONS.</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-28.txt.html</ao:hasSource>
    <domeo:uuid>4DCCDDAE-E949-4935-AF25-54EFF6FEE358</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:22E2B3A5-0F25-44F0-9BD1-962C23CAF0E8">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>The clinical effect from </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:22E2B3A5-0F25-44F0-9BD1-962C23CAF0E8"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix>results from the combined concentrations of risperidone and its major metabolite, 9-hydroxyrisperidone [see 12 CLINICAL PHARMACOLOGY]. Antagonism at receptors other than D2 and 5HT2 [see 12 CLINICAL PHARMACOLOGY] may explain some of the other effects of </ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <domeo:uuid>22E2B3A5-0F25-44F0-9BD1-962C23CAF0E8</domeo:uuid>
    <pav:createdOn>2014-07-07 19:42:57 -0400</pav:createdOn>
    <ao:exact>risperidone </ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7FF4AC6B-3611-40E7-8A46-6935871B9CA4">
    <pav:createdOn>2014-07-08 12:01:58 -0400</pav:createdOn>
    <ao:prefix>therapy with or without other drugs or diseases that are known to produce pulmonary toxicity. A causal relationship to </ao:prefix>
    <ao:exact>mexiletine </ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:7FF4AC6B-3611-40E7-8A46-6935871B9CA4"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix>therapy has not been established. In addition, there have been isolated reports of drowsiness, nystagmus, ataxia, dyspepsia, hypersensitivity reaction, and exacerbation of congestive heart failure in patients with pre-existing compromised ventricular fun</ao:suffix>
    <domeo:uuid>7FF4AC6B-3611-40E7-8A46-6935871B9CA4</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-160.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:2A108741-132A-48F3-8621-A6262F30D450">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/6BB530E4-371C-4611-9227-183E9C959EC6"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/F80C79CE-7884-4960-BFF4-EECCB3DF9C3D"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B17DEDF7-5117-4719-B40F-88EDC0752913">
    <ao:context rdf:resource="urn:domeoclient:uuid:D83571AE-9C61-456B-896B-1D4E29645B31"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotationset:061a21f6-0ef7-497f-bd03-574c24bc0d7c</pav:lineageUri>
    <pav:createdOn>2014-07-08 15:45:42 -0400</pav:createdOn>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:lastSavedOn>2014-07-08 15:45:42 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">4</pav:versionNumber>
    <pav:previousVersion>urn:domeoserver:annotationset:6C113438-07CB-4840-A14B-360CDF3BD22A</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5B2167F6-4E63-4A7B-85C1-ACA56DDE7073</domeo:belongsToSet>
    <ao:body rdf:nodeID="N923c917ab20e469e85a56d71e9734601"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/A4581FDC-1E74-44A2-8B80-9192C98CBA5D">
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/metabolite"/>
    <rdfs:label>normeperidine</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/0</dailymed:activeMoietyRxCUI>
    <dct:description>Referred to the drug in the interaction.</dct:description>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C710E7F2-14E9-4D9F-AF4D-BB3BB31DDDE1">
    <domeo:belongsToSet>urn:domeoclient:uuid:423352B3-8ABA-48B7-98CF-B191A7BFC955</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotation:C1E90903-58BF-44FD-AE43-82471B113365</pav:lineageUri>
    <pav:lastSavedOn>2014-07-08 09:35:29 -0400</pav:lastSavedOn>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <ao:body rdf:nodeID="Ncc6d28d4009048af8aec31c48af2e81e"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:B1A54878-F086-483F-BB56-18237215082B"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:createdOn>2014-07-08 09:31:42 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:71E8A105-B07C-4899-AF5A-BD798C3C484A">
    <domeo:belongsToSet>urn:domeoserver:annotationset:23515E27-98AC-4DC9-A4B7-EBFE2991219F</domeo:belongsToSet>
    <ao:body rdf:nodeID="N69359b24f9094664acd5cca01641d85b"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:createdOn>2014-07-08 08:53:58 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotation:94BBE632-D6A3-48A5-A252-B2125C1F2B8A</pav:lineageUri>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-08 08:54:46 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:AD5C1981-E550-4092-A3D8-AA534BCAEC42"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E8EC66C6-270E-4A0B-8EFF-F6E14DB619E4">
    <pav:createdOn>2014-07-07 19:48:41 -0400</pav:createdOn>
    <ao:exact>risperidone </ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:E8EC66C6-270E-4A0B-8EFF-F6E14DB619E4"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>E8EC66C6-270E-4A0B-8EFF-F6E14DB619E4</domeo:uuid>
    <ao:suffix>and higher 9-hydroxyrisperidone concentrations than poor metabolizers, the pharmacokinetics of risperidone and 9-hydroxyrisperidone combined, after single and multiple doses, are similar in extensive and poor metabolizers.</ao:suffix>
    <ao:prefix>, whereas poor CYP 2D6 metabolizers convert it much more slowly. Although extensive metabolizers have lower </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:236D4F49-BAB0-4E0E-8A40-4AF081E16AE0">
    <ao:prefix>xsd:String</ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-07 09:40:02 -0400</pav:createdOn>
    <ao:exact>Ritonavir </ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:236D4F49-BAB0-4E0E-8A40-4AF081E16AE0"/>
    <domeo:uuid>236D4F49-BAB0-4E0E-8A40-4AF081E16AE0</domeo:uuid>
    <ao:suffix>and other CYP3A Inhibitors</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:110DB62E-8987-43E3-8C7D-E1BEF7CB0ACF">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix> and </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:110DB62E-8987-43E3-8C7D-E1BEF7CB0ACF"/>
    <ao:suffix> metabolites have electrophysiologic properties similar to </ao:suffix>
    <domeo:uuid>110DB62E-8987-43E3-8C7D-E1BEF7CB0ACF</domeo:uuid>
    <pav:createdOn>2014-07-08 13:54:59 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-195.txt.html</ao:hasSource>
    <ao:exact>norpropafenone</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:9CE4CEB9-85C0-4430-A721-05FF371838AA">
    <ao:suffix>AUC of 13% ± 11% (range: -3.4 to -31%) and Cmax decreased 19% ± 14% (range: -5 to -40%). However, the administration of cimetidine 600 mg to 900 mg intravenously over a four-hour period (from one hour before to 3 hours after a single oral dose of flucona</ao:suffix>
    <ao:exact>fluconazole </ao:exact>
    <pav:createdOn>2014-07-07 20:08:12 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:9CE4CEB9-85C0-4430-A721-05FF371838AA"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>AUC and Cmax. There was a mean ± SD decrease in </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-23.txt.html</ao:hasSource>
    <domeo:uuid>9CE4CEB9-85C0-4430-A721-05FF371838AA</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:263C56AC-501C-4B49-BDAE-9B423F305365">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">3</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2014-07-21 10:01:16 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:6D58C87F-6507-4CBE-A71C-249E52E6A189"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <pav:previousVersion>urn:domeoclient:uuid:21a2d27a-13b1-4797-ba7a-c0517e32bb06</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:32944008-A6C6-4D66-8C43-EE4CF2256965</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotationset:cf593dca-fe93-451b-8f37-2a96e065da13</pav:lineageUri>
    <pav:lastSavedOn>2014-07-21 10:02:11 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:761B10E4-4950-40A7-9DFE-73826A9C6CFF">
    <ao:exact>sildenafi</ao:exact>
    <domeo:uuid>761B10E4-4950-40A7-9DFE-73826A9C6CFF</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-07 10:02:43 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:761B10E4-4950-40A7-9DFE-73826A9C6CFF"/>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N480229c169e14edf9197d4832a9c01ec">
    <permissions:accessType>urn:person:uuid:080e143046812afe0146812e52b20002</permissions:accessType>
    <permissions:isLocked>false</permissions:isLocked>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:015F557A-02A3-4D42-B273-E16B5158D869">
    <pav:createdOn>2014-07-07 09:41:44 -0400</pav:createdOn>
    <ao:exact>itraconazole</ao:exact>
    <ao:prefix>, </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:015F557A-02A3-4D42-B273-E16B5158D869"/>
    <ao:suffix>, and ritonavir).</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>015F557A-02A3-4D42-B273-E16B5158D869</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7FBC21DB-8AB8-4EC2-936B-EB29896B9254">
    <ao:context rdf:resource="urn:domeoclient:uuid:577B7F0B-0576-4755-9243-C37BEFE35128"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoclient:uuid:423352B3-8ABA-48B7-98CF-B191A7BFC955</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:0F38060F-1C79-4EAF-AF85-B39BFB16D5DE</pav:lineageUri>
    <pav:lastSavedOn>2014-07-08 09:35:29 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-08 09:31:57 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:42E149BE-DCF1-4C4A-A6DE-2843E6EFC9E2">
    <ao:suffix>xsd:String</ao:suffix>
    <domeo:uuid>42E149BE-DCF1-4C4A-A6DE-2843E6EFC9E2</domeo:uuid>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:42E149BE-DCF1-4C4A-A6DE-2843E6EFC9E2"/>
    <ao:exact>Co-administration of chlorpromazine with propranolol resulted in a 70% increase in propranolol plasma level.</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-08 09:22:59 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-134.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:8FF24A6F-2178-43B1-A0E1-109514E57181">
    <pav:lastSavedOn>2014-07-08 13:59:58 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7E49EB7A-DE0E-4720-82D1-8460BA0C770D</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">3</pav:versionNumber>
    <pav:previousVersion>urn:domeoclient:uuid:203110ef-d319-4c8c-8da1-19d68e91f895</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <ao:body rdf:nodeID="N95dd15ea8e664c77ae1b4b9d1698a0f7"/>
    <pav:lineageUri>urn:domeoserver:annotationset:def720a3-9364-4d0d-a156-423274fb2386</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:9725C2C6-828E-4C82-A910-9732D8C41EF1"/>
    <pav:createdOn>2014-07-08 13:59:04 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoserver:annotationset:BA8F9408-39CC-4619-AA2D-75BA5518E56A">
    <rdfs:label>Default Set</rdfs:label>
    <permissions:permissions rdf:nodeID="N795282a01bb64101bfccb18a12b33eda"/>
    <pav:lineageUri>urn:domeoserver:annotationset:701D90A9-2BA7-4D65-A3A7-505A77C8FE71</pav:lineageUri>
    <pav:createdOn>2014-07-08 12:10:17 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-07-08 12:10:57 -0400</pav:lastSavedOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:18F45C11-AE96-46E1-B6CE-AB9E2F4A137C"/>
    <pav:previousVersion>urn:domeoclient:uuid:A5FB54B8-3827-40E1-AF2B-7E3B92AE72A3</pav:previousVersion>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-164.txt.html</ao:annotatesResource>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812e52b20002"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <ao:item rdf:resource="urn:domeoclient:uuid:48942F18-B958-4486-930C-C2AC5474075F"/>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <ao:item rdf:resource="urn:domeoclient:uuid:9E783620-42AF-4752-A325-B509AFDFFB28"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:9D43D92D-A158-4401-9166-0FF62DFFDC47"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:29FCBA5D-B9E2-4B61-A0D1-201E0003999F"/>
    <domeo:deleted>false</domeo:deleted>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <ao:item rdf:resource="urn:domeoclient:uuid:583AC4E3-86F9-4998-A7D6-2C8269DE79CF"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A4222577-0D92-4A9B-A1B6-C0DE1209FC51">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>A4222577-0D92-4A9B-A1B6-C0DE1209FC51</domeo:uuid>
    <ao:prefix>xsd:String</ao:prefix>
    <pav:createdOn>2014-07-07 20:36:11 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:A4222577-0D92-4A9B-A1B6-C0DE1209FC51"/>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-57.txt.html</ao:hasSource>
    <ao:exact>Zonisamide single dose pharmacokinetic parameters were not affected by cimetidine (300 mg four times a day for 12 days).</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:5ECE4644-6492-4EB6-9B47-5798A8F8F45D">
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdOn>2014-07-07 19:58:35 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-07-07 19:59:12 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:5093F3FF-29BF-42B4-9DC6-DEA357DA4394"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotation:F96D2D24-32BD-4263-82C1-5EC735559A06</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5ABD9862-F044-4404-AD04-73DA04ADDA8B</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:0B895EAD-D7C4-4E9B-B382-DEBD787CE8B8">
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:3E86AA83-E2A8-46C4-BD9A-365D504AF7F8"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B342A310-4F6C-4D9A-97A7-A6E4A8716120">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>did not have a significant effect on </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:B342A310-4F6C-4D9A-97A7-A6E4A8716120"/>
    <pav:createdOn>2014-07-08 09:12:47 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-130.txt.html</ao:hasSource>
    <domeo:uuid>B342A310-4F6C-4D9A-97A7-A6E4A8716120</domeo:uuid>
    <ao:suffix>pharmacokinetics.</ao:suffix>
    <ao:exact>propranolol’s </ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:06B0EE80-4CF0-4C8C-9834-50D1BE1F6B19">
    <ao:prefix>xsd:String</ao:prefix>
    <ao:exact>bosentan</ao:exact>
    <ao:suffix>xsd:String</ao:suffix>
    <pav:createdOn>2014-07-07 09:43:50 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:06B0EE80-4CF0-4C8C-9834-50D1BE1F6B19"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <domeo:uuid>06B0EE80-4CF0-4C8C-9834-50D1BE1F6B19</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:897CCE4F-BAA0-4285-A7DC-C44CECD44CAF">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:createdOn>2014-07-08 08:47:38 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <pav:previousVersion>urn:domeoclient:uuid:5BCE2FDB-C586-44CD-88F7-6EE2BDB6B929</pav:previousVersion>
    <pav:lastSavedOn>2014-07-08 08:51:47 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:CB9CB80C-C629-4453-B307-7061BD797F36"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:23515E27-98AC-4DC9-A4B7-EBFE2991219F</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotationset:57174A7C-3100-4C8F-9C4A-2991CEE124D5</pav:lineageUri>
    <ao:body rdf:nodeID="N4d50196103054e1591b4d5f27b38ee07"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:268F088F-6652-4DC8-BE01-1C667AE682BC">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:41C13D3C-1D2B-4D38-9EB5-BC4A471BE99A</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:4885B27C-1141-4B6B-B543-012F813E6D37</pav:lineageUri>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <ao:body rdf:nodeID="N174116b6ae1a4e1a939b5831b2b1c1db"/>
    <pav:lastSavedOn>2014-07-08 14:57:00 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-08 14:57:00 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:5C66B984-0CCA-4D6A-A33E-79218FAC8139"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/EDB20E1F-6517-47D2-99B9-047ED9C2AEF5">
    <rdfs:label>digoxin</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/3407</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:977F575F-4B3E-4EAC-BFEA-5E0193ADAED2">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-24.txt.html</ao:hasSource>
    <ao:prefix>AUC and a significant increase in apparent oral clearance of </ao:prefix>
    <domeo:uuid>977F575F-4B3E-4EAC-BFEA-5E0193ADAED2</domeo:uuid>
    <pav:createdOn>2014-07-07 20:10:24 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:977F575F-4B3E-4EAC-BFEA-5E0193ADAED2"/>
    <ao:suffix>. There was a mean ± SD reduction in fluconazole AUC of 23% ± 9% (range: -13 to -42%). Apparent oral clearance of fluconazole increased 32% ± 17% (range: 16 to 72%). Fluconazole half-life decreased from 33.4 ± 4.4 hours to 26.8 ± 3.9 hours. (See PRECAUTI</ao:suffix>
    <ao:exact>fluconazole</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:94BC5217-C389-4C2C-ABA6-22B93B6F70E8">
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A5E637EF-5CA5-4AAC-BD8B-C136A86E17B7</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-07 09:44:18 -0400</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdOn>2014-07-07 09:40:06 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotationset:F37BE993-E972-47AE-896D-FF4D33157ECF</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:D7695313-EC5E-4B88-A948-EC49D5337698"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:71D6757B-3E92-499D-BFB9-13AEB04F23BA">
    <pav:lastSavedOn>2014-07-07 10:03:14 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A5E637EF-5CA5-4AAC-BD8B-C136A86E17B7</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2014-07-07 09:59:42 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotationset:F37BE993-E972-47AE-896D-FF4D33157ECF</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>urn:domeoclient:uuid:53FAA6D0-9A40-44F9-8FE0-3166137CEF10</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:C1A84858-737F-4A61-A1F1-F52D60DE0638"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:18B21DEF-1A61-46FA-A6B1-8FD67130FDC1">
    <pav:lineageUri>urn:domeoserver:annotation:48FB3476-8419-4F8A-B024-23A48B29F6EA</pav:lineageUri>
    <pav:createdOn>2014-07-08 12:21:14 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-07-08 12:21:50 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:DC5F64F1-A5A8-49DE-B3E5-A21D3CDA467A"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:7821C64B-A0CD-480C-9DC8-F790FC33069A</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:DF75E64A-4D45-4393-A03E-A3D34A40FC13">
    <ao:context rdf:resource="urn:domeoclient:uuid:619CBD1A-8FB3-4551-AFD5-9908F5020D1B"/>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:createdOn>2014-07-08 19:43:11 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:lineageUri>urn:domeoserver:annotation:8B7E01C5-9021-432B-878A-50A319D7FFD8</pav:lineageUri>
    <pav:lastSavedOn>2014-07-08 19:43:50 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:body rdf:nodeID="N3cec04f2aca144b3b20db2b7e4051512"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:C9868B04-3F07-42FC-8F5C-D0B3D0DA54B1</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/0DC6D3A9-A74B-4580-A1F6-4B53C8FA2A15">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>lithium</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:fd66d354-8021-4eea-9952-dff9f05f6a15">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:fd66d354-8021-4eea-9952-dff9f05f6a15"/>
    <domeo:uuid></domeo:uuid>
    <ao:prefix>red to the administration of </ao:prefix>
    <ao:suffix> alone. Five subjects experien</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-85.txt.html</ao:hasSource>
    <ao:exact>tacrine</ao:exact>
    <pav:createdOn>2014-07-07 08:07:02 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:350B9B00-4C30-437A-AFE4-38BCE71F4386">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:350B9B00-4C30-437A-AFE4-38BCE71F4386"/>
    <ao:suffix>is a selective monoaminergic antagonist with high affinity (Ki of 0.12 to 7.3 nM) for the serotonin Type 2 (5HT2), dopamine Type 2 (D2), α1 and α2 adrenergic, and H1 histaminergic receptors. Risperidone acts as an antagonist at other receptors, but with </ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:exact>Risperidone </ao:exact>
    <domeo:uuid>350B9B00-4C30-437A-AFE4-38BCE71F4386</domeo:uuid>
    <pav:createdOn>2014-07-07 19:42:37 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F1BAACDB-0382-41E5-B208-2DF9A73756E9">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:F1BAACDB-0382-41E5-B208-2DF9A73756E9"/>
    <domeo:uuid>F1BAACDB-0382-41E5-B208-2DF9A73756E9</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-136.txt.html</ao:hasSource>
    <ao:exact> The effect of short-term administration of ritonavir (200 mg twice daily, 4 doses) on the pharmacokinetics of a single dose of trazodone (50 mg) has been studied in 10 healthy subjects. The Cmax of trazodone increased by 34%, the AUC increased 2.4 fold, the half-life increased by 2.2 fold, and the clearance decreased by 52%. Adverse effects including nausea, hypotension, and syncope were observed when ritonavir and trazodone were coadministered.</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-08 09:27:35 -0400</pav:createdOn>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:prefix>xsd:String</ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:65BFE6BA-907E-4480-A3BF-B6EA54E48B65">
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">3</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2014-07-21 10:02:11 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:60F6E6D9-123E-48EC-9080-2A64EE9B0316"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:32944008-A6C6-4D66-8C43-EE4CF2256965</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotationset:cf593dca-fe93-451b-8f37-2a96e065da13</pav:lineageUri>
    <pav:createdOn>2014-07-21 10:00:38 -0400</pav:createdOn>
    <pav:previousVersion>urn:domeoclient:uuid:21a2d27a-13b1-4797-ba7a-c0517e32bb06</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:AB6F5B33-04B6-4BFF-84B2-C8333F34524C">
    <pav:createdOn>2014-07-08 09:32:51 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotation:889F8A25-7626-4897-AA1C-2FCC0CF5A7BC</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-07-08 09:35:29 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:4AC0C32D-F6D1-41EF-A9B7-5A5E4CE4BEFB"/>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoclient:uuid:423352B3-8ABA-48B7-98CF-B191A7BFC955</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:CCF7E799-D26C-43D3-A179-4B5F71346C97">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:CCF7E799-D26C-43D3-A179-4B5F71346C97"/>
    <ao:exact>fluvoxamine acid</ao:exact>
    <ao:suffix> which, together with its N-acetylated analog, accounted for about 60% of the urinary excretion products. A third metabolite, fluvoxethanol, formed by oxidative deamination, accounted for about 10%.</ao:suffix>
    <pav:createdOn>2014-07-21 10:04:58 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>xsd:String</ao:prefix>
    <domeo:uuid>CCF7E799-D26C-43D3-A179-4B5F71346C97</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-10.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/3950011E-E876-4E30-B0EA-49F04F9A0AAA">
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/39998</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>zonisamide</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A0DA7C50-5C43-428E-8C26-0DEDA41D3FBC">
    <pav:lastSavedOn>2014-07-08 08:46:38 -0400</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:F4CDB8C6-ED4F-4A7C-9BBA-6BBC6817B743"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:23515E27-98AC-4DC9-A4B7-EBFE2991219F</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotationset:57174A7C-3100-4C8F-9C4A-2991CEE124D5</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-07-08 08:40:25 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:8D53677A-2702-40DF-AC2F-37B38591C6F1">
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:2CF24E02-253A-47F5-8A8B-D610852D912D"/>
    <pav:lineageUri>urn:domeoserver:annotationset:57174A7C-3100-4C8F-9C4A-2991CEE124D5</pav:lineageUri>
    <pav:createdOn>2014-07-08 08:43:44 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:23515E27-98AC-4DC9-A4B7-EBFE2991219F</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-08 08:46:38 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:AD0069FC-81F4-4ADA-A610-C999DA509763">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotation:A5F2F9B9-CCB3-463C-83EF-CB8BC9A08475</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-07-07 20:16:04 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-07-07 20:15:01 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:F665F26F-89E0-4E5A-BF79-1108D829C70A"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:B44CD6F1-18F6-4252-9E79-5D5107E7044D</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:4EB69CDA-6FBD-4895-B0C2-F2637FC7DC16">
    <pav:lastSavedOn>2014-07-07 20:10:00 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:8970D075-A578-4CF9-A375-2EC114212349"/>
    <pav:lineageUri>urn:domeoserver:annotation:3CFF9BD7-7F46-4DE4-8F27-9721297C2C94</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:createdOn>2014-07-07 20:08:10 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoclient:uuid:738231FC-4090-4D56-90FB-4FBFF166BD23</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:57682BEC-A9C6-4874-9392-76F313AC2B89">
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:89B6D06A-2F10-49A9-B621-C4CB1F49300D"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:48942F18-B958-4486-930C-C2AC5474075F">
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:49DFB722-44E6-452F-AEF7-2184C3580181"/>
    <pav:lineageUri>urn:domeoserver:annotationset:701D90A9-2BA7-4D65-A3A7-505A77C8FE71</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-07-08 12:10:41 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-07-08 12:10:21 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:BA8F9408-39CC-4619-AA2D-75BA5518E56A</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:4BBB711C-7040-45DF-872C-62117B1760E0">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:4BBB711C-7040-45DF-872C-62117B1760E0"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>xsd:String</ao:prefix>
    <pav:createdOn>2014-07-08 14:05:01 -0400</pav:createdOn>
    <ao:exact>Concomitant administration of rifampin and propafenone in extensive metabolizers decreased the plasma concentrations of propafenone by 67% with a corresponding decrease of 5OH-propafenone by 65%. The concentrations of norpropafenone increased by 30%. In poor metabolizers, there was a 50% decrease in propafenone plasma concentrations and increased the AUC and Cmax of norpropafenone by 74 and 20%, respectively. Urinary excretion of propafenone and its metabolites decreased significantly. Similar results were noted in elderly patients: Both the AUC and Cmax propafenone decreased by 84%, with a corresponding decrease in AUC and Cmax of 5OH-propafenone by 69 and 57%.</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-194.txt.html</ao:hasSource>
    <domeo:uuid>4BBB711C-7040-45DF-872C-62117B1760E0</domeo:uuid>
    <ao:suffix>xsd:String</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:8CF1380F-B77E-41E4-A47C-425B72CC1166">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:8CF1380F-B77E-41E4-A47C-425B72CC1166"/>
    <pav:createdOn>2014-07-07 20:13:30 -0400</pav:createdOn>
    <ao:exact>phenytoin </ao:exact>
    <ao:suffix>AUC was 88% ± 68% (range: 16 to 247%). The absolute magnitude of this interaction is unknown because of the intrinsically nonlinear disposition of phenytoin. (See PRECAUTIONS.)</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>AUC. The mean ± SD increase in </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-25.txt.html</ao:hasSource>
    <domeo:uuid>8CF1380F-B77E-41E4-A47C-425B72CC1166</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:60E6EF68-9B3F-4F29-A307-34BF23344F95">
    <pav:lastSavedOn>2014-07-08 14:10:48 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:lineageUri>urn:domeoserver:annotation:413037A6-8E7F-4113-A040-98CE9A962A60</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:createdOn>2014-07-08 14:09:30 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:77E3EB52-6F5F-4AD8-96BA-3C5C325BD32B"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7E49EB7A-DE0E-4720-82D1-8460BA0C770D</domeo:belongsToSet>
    <ao:body rdf:nodeID="Nc39d15f0d7bd469e9ba089bbed6d34f8"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:5E808C42-45D6-40E3-B8B7-7D4A065EAB02">
    <ao:context rdf:resource="urn:domeoclient:uuid:3F7AD7B4-6D3B-4D15-A88B-43F72DC9BB6F"/>
    <pav:lastSavedOn>2014-07-08 12:21:50 -0400</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:createdOn>2014-07-08 12:21:40 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoclient:uuid:7821C64B-A0CD-480C-9DC8-F790FC33069A</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:5AFD46AD-23C3-4951-989B-C6C4B05637FE</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:623EC985-5556-44FA-806B-B79E427BC8C2">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-07 09:37:30 -0400</pav:createdOn>
    <domeo:uuid>623EC985-5556-44FA-806B-B79E427BC8C2</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <ao:prefix>pharmacologic effects. In patients with pulmonary arterial hypertension, however, the ratio of the metabolite to </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:623EC985-5556-44FA-806B-B79E427BC8C2"/>
    <ao:suffix>is higher. Both sildenafil and the active metabolite have terminal half-lives of about 4 hours.</ao:suffix>
    <ao:exact>sildenafil </ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:3DF18B22-16FE-4820-A49C-487979D41ADD">
    <pav:createdOn>2014-07-08 14:20:12 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>3DF18B22-16FE-4820-A49C-487979D41ADD</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:3DF18B22-16FE-4820-A49C-487979D41ADD"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-197.txt.html</ao:hasSource>
    <ao:exact>AMT</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>. The </ao:prefix>
    <ao:suffix> AUC was one fifth of the </ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:1DCD5B8E-9FFE-4C5C-8D9D-00777470B236">
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2014-07-08 09:22:36 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <domeo:belongsToSet>urn:domeoclient:uuid:D543C3F1-DA54-4DBF-A2A2-25D79FA02724</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotation:5F47DDCB-4B95-451F-9103-DFA1597BB1BD</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:1274CFBF-641E-46E7-9B1E-4CDDA91198ED"/>
    <pav:lastSavedOn>2014-07-08 09:22:59 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F521837B-E550-4F34-A5BD-8C6E842281EC">
    <domeo:belongsToSet>urn:domeoserver:annotationset:A5E637EF-5CA5-4AAC-BD8B-C136A86E17B7</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdOn>2014-07-07 09:36:21 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotationset:F37BE993-E972-47AE-896D-FF4D33157ECF</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-07-07 09:44:18 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:C6FB7880-DBBE-4B26-A4E2-76D0939E308F"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/A8F107DC-5781-4268-AC53-71F6114F4523">
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/4124</dailymed:activeMoietyRxCUI>
    <rdfs:label>ethinyl estradiol</rdfs:label>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:5D92AFF4-E8B2-4D61-BDF8-7BF6DDA84330">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:5D92AFF4-E8B2-4D61-BDF8-7BF6DDA84330"/>
    <ao:suffix>[see Drug Interactions (7.1)]</ao:suffix>
    <domeo:uuid>5D92AFF4-E8B2-4D61-BDF8-7BF6DDA84330</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-08 08:46:35 -0400</pav:createdOn>
    <ao:exact>Concomitant administration of gemfibrozil (600 mg twice daily), an inhibitor of CYP2C8, and rosiglitazone (4 mg once daily) for 7 days increased rosiglitazone AUC by 127%, compared to the administration of rosiglitazone (4 mg once daily) alone. Given the potential for dose-related adverse events with rosiglitazone, a decrease in the dose of rosiglitazone may be needed when gemfibrozil is introduced </ao:exact>
    <ao:prefix>xsd:String</ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B46DBE05-F202-4111-97A3-83A697D3FA62">
    <pav:lineageUri>urn:domeoserver:annotation:CEB5F8C1-B6A6-410D-9109-BF0B58C7126E</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdOn>2014-07-08 12:24:40 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoclient:uuid:D9F8F6A3-1C3D-4E25-9870-A403388D2394</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:983D2637-CECD-4BE0-A42A-DC5E9E0A15C7"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2014-07-08 12:25:29 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C2968B31-3033-4843-913A-6F5D6BB3F163">
    <pav:createdOn>2014-07-08 13:54:09 -0400</pav:createdOn>
    <ao:suffix> which is formed by CYP2D6 and N-depropylpropafenone (norpropafenone) which is formed by both CYP3A4 and CYP1A2. In less than 10% of patients, metabolism of </ao:suffix>
    <ao:exact>5-hydroxypropafenone</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:C2968B31-3033-4843-913A-6F5D6BB3F163"/>
    <ao:prefix> into two active metabolites: </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-195.txt.html</ao:hasSource>
    <domeo:uuid>C2968B31-3033-4843-913A-6F5D6BB3F163</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:CD750D80-AF08-4465-A45F-72F0377642F3">
    <ao:exact>ethinyl estradiol </ao:exact>
    <domeo:uuid>CD750D80-AF08-4465-A45F-72F0377642F3</domeo:uuid>
    <ao:prefix>and oral contraceptives (</ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>and norethindrone), which are predominantly metabolized by CYP3A4.</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:CD750D80-AF08-4465-A45F-72F0377642F3"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-08 08:44:27 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:36325AE6-3B95-478B-91AB-8657B22E41A4">
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:23515E27-98AC-4DC9-A4B7-EBFE2991219F</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotationset:57174A7C-3100-4C8F-9C4A-2991CEE124D5</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-07-08 08:46:38 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-08 08:43:43 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:BD210F23-FBA8-4D41-8E53-C9778F7E185F"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:1A7D29FE-D656-444E-AF88-46433E658EBB">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:A795201D-AF7A-493B-9FCF-3AF6C3B7429B"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:lastSavedOn>2014-07-07 09:44:18 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A5E637EF-5CA5-4AAC-BD8B-C136A86E17B7</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdOn>2014-07-07 09:35:16 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotationset:F37BE993-E972-47AE-896D-FF4D33157ECF</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:8ECB4F98-B732-4BB8-BF5E-356021CB465F">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:8ECB4F98-B732-4BB8-BF5E-356021CB465F"/>
    <ao:suffix> (See PRECAUTIONS.</ao:suffix>
    <domeo:uuid>8ECB4F98-B732-4BB8-BF5E-356021CB465F</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-29.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-07 20:22:40 -0400</pav:createdOn>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:exact>In 13 normal male volunteers, there was significant increase in tolbutamide (500 mg single dose) AUC and Cmax following the administration of fluconazole. There was a mean ± SD increase in tolbutamide AUC of 26% ± 9% (range: 12 to 39%). Tolbutamide Cmax increased 11% ± 9% (range: -6 to 27%).</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7CD04099-BF71-401D-80C8-E62CF5FAFDD8">
    <ao:suffix>.</ao:suffix>
    <ao:exact>AVANDIA</ao:exact>
    <domeo:uuid>7CD04099-BF71-401D-80C8-E62CF5FAFDD8</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:7CD04099-BF71-401D-80C8-E62CF5FAFDD8"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <ao:prefix>(100 mg three times daily) for 7 days in healthy volunteers had no clinically relevant effect on the pharmacokinetics of a single oral dose of </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-08 08:52:16 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:4B88F9C8-DB60-4F0F-978B-CCAC83124AAA">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <ao:suffix>.</ao:suffix>
    <ao:exact>AVANDIA</ao:exact>
    <pav:createdOn>2014-07-08 08:54:05 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:4B88F9C8-DB60-4F0F-978B-CCAC83124AAA"/>
    <domeo:uuid>4B88F9C8-DB60-4F0F-978B-CCAC83124AAA</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>A single administration of a moderate amount of alcohol did not increase the risk of acute hypoglycemia in type 2 diabetes mellitus patients treated with </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:5738340B-DE0D-4110-95FC-8E23D9AA4DF8">
    <ao:suffix>xsd:String</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:5738340B-DE0D-4110-95FC-8E23D9AA4DF8"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-07 10:54:03 -0400</pav:createdOn>
    <ao:exact>Cimetidine (800 mg), a nonspecific CYP inhibitor, caused a 56% increase in plasma sildenafil concentrations when co-administered with sildenafil (50 mg) to healthy volunteers</ao:exact>
    <domeo:uuid>5738340B-DE0D-4110-95FC-8E23D9AA4DF8</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:26E852FF-9AB5-41CB-82A3-AB96066621EA">
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:A9A833B1-C047-4B4F-BA2D-EA6659E4D34B"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/25F2A428-2819-436D-9BE5-515C97BCB896">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/drug-product"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/261455</dailymed:activeMoietyRxCUI>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>avandia</rdfs:label>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:77F1E69B-901A-41F9-8FB0-4F3BD1660D3B">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-07 09:37:55 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:77F1E69B-901A-41F9-8FB0-4F3BD1660D3B"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:exact> N-</ao:exact>
    <ao:prefix>and its</ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>77F1E69B-901A-41F9-8FB0-4F3BD1660D3B</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:2B6220CC-057A-44B0-856A-829A9EE325F9">
    <ao:body rdf:nodeID="N9df1cef55e5345c7950cc3e2f43f41f7"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:7F163E95-074F-45E3-A660-AFC775347CC2"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:lastSavedOn>2014-07-08 19:43:50 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotation:105E4B64-FF8A-4300-8B08-CF820B063F2C</pav:lineageUri>
    <pav:createdOn>2014-07-08 19:43:34 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:C9868B04-3F07-42FC-8F5C-D0B3D0DA54B1</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/28101375-1c53-4a1c-a9cc-c70862ee98f3">
    <domeo:belongsToSet>urn:domeoserver:annotationset:41C13D3C-1D2B-4D38-9EB5-BC4A471BE99A</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotationset:901e52dc-f83e-453e-89f4-185113817c7c</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-07 08:06:43 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-07 08:06:43 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:292c05d3-4b2a-4786-8b3b-33cd47ab03d9"/>
    <rdfs:label>Highlight</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:DA0BDD7D-CA94-49A6-984F-9B740BC66A4D">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:DA0BDD7D-CA94-49A6-984F-9B740BC66A4D"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-139.txt.html</ao:hasSource>
    <ao:exact>Fexofenadine had no effect on the pharmacokinetics of either erythromycin or ketoconazole.</ao:exact>
    <domeo:uuid>DA0BDD7D-CA94-49A6-984F-9B740BC66A4D</domeo:uuid>
    <pav:createdOn>2014-07-08 09:34:54 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:prefix>xsd:String</ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:2F71DACF-2A3A-46D4-833C-35E318369EB4">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:2F71DACF-2A3A-46D4-833C-35E318369EB4"/>
    <ao:prefix>(500 mg single dose) AUC and Cmax following the administration of </ao:prefix>
    <pav:createdOn>2014-07-07 20:22:06 -0400</pav:createdOn>
    <ao:exact>fluconazole</ao:exact>
    <domeo:uuid>2F71DACF-2A3A-46D4-833C-35E318369EB4</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-29.txt.html</ao:hasSource>
    <ao:suffix>. There was a mean ± SD increase in tolbutamide AUC of 26% ± 9% (range: 12 to 39%). Tolbutamide Cmax increased 11% ± 9% (range: -6 to 27%). (See PRECAUTIONS.)</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:5AB1DF7C-39DF-48CE-98A7-046FE021C7D9">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:5AB1DF7C-39DF-48CE-98A7-046FE021C7D9"/>
    <ao:exact>Risperidone (0.25 mg twice daily) did not show a clinically relevant effect on the pharmacokinetics of digoxin</ao:exact>
    <domeo:uuid>5AB1DF7C-39DF-48CE-98A7-046FE021C7D9</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-7.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-08 15:48:28 -0400</pav:createdOn>
    <ao:suffix>xsd:String</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:61CF88E4-7AB3-427C-B456-38D30D24900C">
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:23515E27-98AC-4DC9-A4B7-EBFE2991219F</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-08 08:46:38 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotationset:57174A7C-3100-4C8F-9C4A-2991CEE124D5</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2014-07-08 08:43:15 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:1AAA6CF9-8233-42B7-A65E-599ABED7239A"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:4E3F834F-950A-4AA9-84D2-89C939A0167A">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:4E3F834F-950A-4AA9-84D2-89C939A0167A"/>
    <ao:prefix>100 mg was administered as a single oral dose alone and two hours after a single dose of </ao:prefix>
    <ao:exact>cimetidine </ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-23.txt.html</ao:hasSource>
    <domeo:uuid>4E3F834F-950A-4AA9-84D2-89C939A0167A</domeo:uuid>
    <ao:suffix>400 mg to six healthy male volunteers. After the administration of cimetidine, there was a significant decrease in fluconazole AUC and Cmax. There was a mean ± SD decrease in fluconazole AUC of 13% ± 11% (range: -3.4 to -31%) and Cmax decreased 19% ± 14%</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-07 20:08:07 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoserver:annotationset:F8604E94-3C93-45CC-9E01-EAAC73FDF0B2">
    <permissions:permissions rdf:nodeID="N594fecdc7ef54e7d9e2ed87d5086d47d"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812e52b20002"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <domeo:deleted>false</domeo:deleted>
    <ao:item rdf:resource="urn:domeoclient:uuid:064b871d-11d6-4ea6-b332-4272f2aa3b2f"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:lastSavedOn>2014-07-21 10:07:27 -0400</pav:lastSavedOn>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-11.txt.html</ao:annotatesResource>
    <rdfs:label>NLP Set</rdfs:label>
    <pav:lineageUri>urn:domeoclient:uuid:a5340fcd-34e6-42e1-9b10-79213824de50</pav:lineageUri>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <pav:previousVersion>urn:domeoclient:uuid:d1ec2806-083c-4930-8849-b8ad270cf080</pav:previousVersion>
    <pav:createdOn>2014-07-07 08:02:31 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A21196DB-D986-4EEC-AFC3-96ED188AB549">
    <pav:createdOn>2014-07-07 19:49:03 -0400</pav:createdOn>
    <ao:prefix>, giving essentially all recipients a </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:A21196DB-D986-4EEC-AFC3-96ED188AB549"/>
    <ao:exact>risperidone </ao:exact>
    <ao:suffix>pharmacokinetic profile typical of poor metabolizers. The therapeutic benefits and adverse effects of risperidone in patients receiving quinidine have not been evaluated, but observations in a modest number (N≅70) of poor metabolizers given risperidone d</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>A21196DB-D986-4EEC-AFC3-96ED188AB549</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:6615BAC7-16B0-4FB8-9F2A-D7C425178008">
    <ao:prefix> metabolites have been identified in human urine and feces. The</ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:6615BAC7-16B0-4FB8-9F2A-D7C425178008"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-190.txt.html</ao:hasSource>
    <ao:suffix> (M-2) is the major metabolite and has antiviral activity similar to that of parent drug; however, the concentrations of this metabolite in plasma are low. In vitro studies utilizing human liver microsomes have demonstrated that cytochrome P450 3A (CYP3A</ao:suffix>
    <ao:exact> isopropylthiazole oxidation metabolite</ao:exact>
    <domeo:uuid>6615BAC7-16B0-4FB8-9F2A-D7C425178008</domeo:uuid>
    <pav:createdOn>2014-07-08 14:37:51 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:AD6A21FA-30D4-43BC-8D81-37E51F220FBA">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>This occurs with quinidine, giving essentially all recipients a risperidone pharmacokinetic profile typical of poor metabolizers.</ao:exact>
    <ao:suffix> The therapeutic benefits and adverse effects of</ao:suffix>
    <domeo:uuid>AD6A21FA-30D4-43BC-8D81-37E51F220FBA</domeo:uuid>
    <ao:prefix> [see 7 DRUG INTERACTIONS]. </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:AD6A21FA-30D4-43BC-8D81-37E51F220FBA"/>
    <pav:createdOn>2014-07-07 19:50:34 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C99C25B2-D9D6-43F5-B56D-2BE19D76E9B7">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2014-07-08 12:21:50 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotation:B8F4C68A-14B6-4279-917E-CA7CD78B9C61</pav:lineageUri>
    <pav:createdOn>2014-07-08 12:21:33 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <domeo:belongsToSet>urn:domeoclient:uuid:7821C64B-A0CD-480C-9DC8-F790FC33069A</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:DE892FFE-05EE-445E-A1E5-DB329798F0E9"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:b90c038c-fd66-4f1e-9b69-1afb329a449b">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix> excreted in urine as intact </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-105.txt.html</ao:hasSource>
    <ao:exact>conivaptan</ao:exact>
    <pav:createdOn>2014-07-07 08:06:56 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:b90c038c-fd66-4f1e-9b69-1afb329a449b"/>
    <ao:suffix>. Special Populations Hepati</ao:suffix>
    <domeo:uuid></domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7801AA43-244B-4455-BC62-B1BED0BCE6DA">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:7801AA43-244B-4455-BC62-B1BED0BCE6DA"/>
    <ao:prefix> (</ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix>), are potent inhibitors of neuronal </ao:suffix>
    <pav:createdOn>2014-07-21 09:58:18 -0400</pav:createdOn>
    <domeo:uuid>7801AA43-244B-4455-BC62-B1BED0BCE6DA</domeo:uuid>
    <ao:exact>ODV</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-6.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoserver:annotationset:0E266770-6575-4561-B418-59E9FFE8BEE7">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">3</pav:versionNumber>
    <pav:previousVersion>urn:domeoclient:uuid:33e08252-bd9e-4c79-b6c4-f9f44a6e3c3a</pav:previousVersion>
    <pav:createdOn>2014-07-07 08:07:05 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <ao:item rdf:resource="urn:domeoclient:uuid:5F9E8D23-F285-4C66-8DF7-7C419412D9C9"/>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812e52b20002"/>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-109.txt.html</ao:annotatesResource>
    <ao:item rdf:resource="file:///home/yin2/python-SPL-connector/e7e622e7-cc91-4ca6-b2fb-f9679f5cf2ce"/>
    <pav:lineageUri>urn:domeoserver:annotationset:9d42d74c-ef20-420f-a0c6-3e880a864174</pav:lineageUri>
    <rdfs:label>NER Sets</rdfs:label>
    <dct:description>The NER set is created automatically by NER annotation loading program.</dct:description>
    <permissions:permissions rdf:nodeID="Nafa2cbda1bac4f44bb4e6052698bd456"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <pav:lastSavedOn>2014-07-08 15:59:46 -0400</pav:lastSavedOn>
    <domeo:deleted>false</domeo:deleted>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E91EABBF-C02A-4D53-B504-850B9783818A">
    <ao:prefix>xsd:String</ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-26.txt.html</ao:hasSource>
    <domeo:uuid>E91EABBF-C02A-4D53-B504-850B9783818A</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:E91EABBF-C02A-4D53-B504-850B9783818A"/>
    <ao:exact>Cyclosporine </ao:exact>
    <ao:suffix>AUC and Cmax were determined before and after the administration of fluconazole 200 mg daily for 14 days in eight renal transplant patients who had been on cyclosporine therapy for at least 6 months and on a stable cyclosporine dose for at least 6 weeks.</ao:suffix>
    <pav:createdOn>2014-07-07 20:14:57 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:253AFE47-A2D2-48FA-8046-A75BAD32D2F2">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/4F4DAAF9-DAE5-455A-8F29-B2B127598365"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/935D83E6-8067-4E52-B773-0E99CB0E01C5"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:CE2BC04A-D693-485A-B82C-FEE60FDF69CE">
    <pav:createdOn>2014-07-08 14:24:25 -0400</pav:createdOn>
    <pav:previousVersion>urn:domeoclient:uuid:e75c9d7b-f906-4c66-8a84-e6eef34d0954</pav:previousVersion>
    <ao:body rdf:nodeID="N2ac19a41de314c75ab1bc855f11a23c4"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">3</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-08 14:24:44 -0400</pav:lastSavedOn>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotationset:0f67c012-7596-4b02-a927-63c0ccbc3afa</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:42258B16-6749-4B39-B28D-88C8B63F7A43</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:5A64EFF8-E831-4247-9F0C-434BC8F82BA6"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoserver:annotationset:F9AE7343-DFD7-456E-804F-77E7D6A72935">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">3</pav:versionNumber>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:createdOn>2014-07-07 08:06:34 -0400</pav:createdOn>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812e52b20002"/>
    <pav:previousVersion>urn:domeoclient:uuid:c5bbc5cb-da4e-4da9-97ca-ae54c741b5ce</pav:previousVersion>
    <rdfs:label>NER Sets</rdfs:label>
    <permissions:permissions rdf:nodeID="Na8528f1314f5446082f1d2f49910d3e6"/>
    <dct:description>The NER set is created automatically by NER annotation loading program.</dct:description>
    <ao:item rdf:resource="file:///home/yin2/python-SPL-connector/0f80bca5-6085-4482-b1db-5a8aabde8d34"/>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-179.txt.html</ao:annotatesResource>
    <ao:item rdf:resource="urn:domeoclient:uuid:B33CECFD-3CA7-447A-8B97-83947DDADD1B"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <pav:lineageUri>urn:domeoserver:annotationset:893c800d-6a5b-496c-8182-1911e321d300</pav:lineageUri>
    <pav:lastSavedOn>2014-07-08 13:50:24 -0400</pav:lastSavedOn>
    <domeo:deleted>false</domeo:deleted>
    <ao:item rdf:resource="urn:domeoclient:uuid:9F19E8E3-8FDC-4D25-A5FF-A7B57F0174A3"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:DC5686B5-C58C-428D-9031-BE2DF553F563">
    <ao:suffix>Cmax and a 210% increase in sildenafil AUC.</ao:suffix>
    <ao:exact>sildenafil </ao:exact>
    <ao:prefix>(100 mg single dose) resulted in a 140% increase in </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:DC5686B5-C58C-428D-9031-BE2DF553F563"/>
    <pav:createdOn>2014-07-07 09:42:06 -0400</pav:createdOn>
    <domeo:uuid>DC5686B5-C58C-428D-9031-BE2DF553F563</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:AEF4A18D-0D98-4600-85BC-F76580C44FF6">
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoclient:uuid:FF4D892F-0BD2-4FD8-9160-6124946DB29D</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:79185EAC-2A6F-4345-8338-6415B4318B83</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:0DC71C86-09AB-4E4E-9691-791E19A0DB21"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdOn>2014-07-08 09:24:15 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:lastSavedOn>2014-07-08 09:24:21 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:318A6930-88A3-4F19-9405-FD9AD055008D">
    <ao:exact>sildenafil's </ao:exact>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:318A6930-88A3-4F19-9405-FD9AD055008D"/>
    <domeo:uuid>318A6930-88A3-4F19-9405-FD9AD055008D</domeo:uuid>
    <pav:createdOn>2014-07-07 10:03:44 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:9FAD049C-4CA3-464A-A5A9-9626EA2E4617">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:9FAD049C-4CA3-464A-A5A9-9626EA2E4617"/>
    <pav:createdOn>2014-07-07 10:03:08 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:exact>sildenafil</ao:exact>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <domeo:uuid>9FAD049C-4CA3-464A-A5A9-9626EA2E4617</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:90167837-91E4-4A5F-84B4-A76DEAFA81F6">
    <pav:lineageUri>urn:domeoserver:annotation:99F8B205-2902-41DC-8AF7-B430DF7867CF</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:D9F8F6A3-1C3D-4E25-9870-A403388D2394</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:C7FE8482-AABD-45DD-A614-B05E7CB13A04"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2014-07-08 12:25:30 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-08 12:24:47 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:5A64EFF8-E831-4247-9F0C-434BC8F82BA6">
    <ao:exact>Ribavirin: In vitro data indicate ribavirin reduces phosphorylation of lamivudine, stavudine, and zidovudine. However, no pharmacokinetic (e.g., plasma concentrations or intracellular triphosphorylated active metabolite concentrations) or pharmacodynamic (e.g., loss of HIV-1/HCV virologic suppression) interaction was observed when ribavirin and lamivudine (n = 18), stavudine (n = 10), or zidovudine (n = 6) were coadministered as part of a multi-drug regimen to HIV-1/HCV co-infected patients [see Warnings and Precautions (5.4)].</ao:exact>
    <domeo:uuid>5A64EFF8-E831-4247-9F0C-434BC8F82BA6</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:5A64EFF8-E831-4247-9F0C-434BC8F82BA6"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-08 14:24:25 -0400</pav:createdOn>
    <ao:suffix>xsd:String</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-197.txt.html</ao:hasSource>
    <ao:prefix>xsd:String</ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:3489B8F4-E97C-4984-A371-4751AFB43277">
    <domeo:uuid>3489B8F4-E97C-4984-A371-4751AFB43277</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>in females. Since therapy should be individualized, no dose adjustments are necessary based on gender alone.</ao:suffix>
    <ao:prefix>dent. For a given body mass index (BMI), females tend to have a greater fat mass than males. Since the molecular target PPARγ is expressed in adipose tissues, this differentiating characteristic may account, at least in part, for the greater response to </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:3489B8F4-E97C-4984-A371-4751AFB43277"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-08 08:43:02 -0400</pav:createdOn>
    <ao:exact>AVANDIA </ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:CDC5329A-F9D8-40D0-9126-03010EC40DB9">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:exact>Orlistat may limit the fraction of propafenone available for absorption. In post marketing reports, abrupt cessation of orlistat in patients stabilized on propafenone has resulted in severe adverse events including convulsions, atrioventricular block and acute circulatory failure.</ao:exact>
    <domeo:uuid>CDC5329A-F9D8-40D0-9126-03010EC40DB9</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-194.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-08 14:07:35 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:CDC5329A-F9D8-40D0-9126-03010EC40DB9"/>
    <ao:suffix>xsd:String</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:8E0CE684-2FCB-4277-B658-E94214F3A298">
    <ao:suffix>.</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:8E0CE684-2FCB-4277-B658-E94214F3A298"/>
    <ao:exact>risperidone</ao:exact>
    <ao:prefix> [see 12 CLINICAL PHARMACOLOGY]. Antagonism at receptors other than D2 and 5HT2 [see 12 CLINICAL PHARMACOLOGY] may explain some of the other effects of </ao:prefix>
    <domeo:uuid>8E0CE684-2FCB-4277-B658-E94214F3A298</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-07 19:43:25 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:74B40B0D-80D4-4D6C-A228-565389F7354A">
    <pav:lineageUri>urn:domeoserver:annotationset:F37BE993-E972-47AE-896D-FF4D33157ECF</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>urn:domeoclient:uuid:53FAA6D0-9A40-44F9-8FE0-3166137CEF10</pav:previousVersion>
    <pav:lastSavedOn>2014-07-07 10:03:14 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-07 09:58:42 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A5E637EF-5CA5-4AAC-BD8B-C136A86E17B7</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:7CB45289-CCF2-4F84-BD15-310A349BFDB5"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:1D708CB9-77F7-4855-8BE7-ADFFD605B190">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-07-08 14:38:27 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:90F34130-1F08-4A3C-940C-1142C6D51481"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:C2CFDC7A-D407-48FD-81AA-DFCEA656C0BE</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-08 14:40:40 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotation:32E84257-B3DB-40EA-833F-C1BAAF922E3A</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/D6840DC4-C792-42AB-A34D-D3E3FA29F035">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>carbamazepine</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/2002</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:306D66E1-EEA7-47C1-B74F-BDAB19758905">
    <domeo:uuid>306D66E1-EEA7-47C1-B74F-BDAB19758905</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix>(a moderate inducer of CYP3A, CYP2C9 and possibly of cytochrome P450 2C19) at steady state (125 mg BID) resulted in a 63% decrease of sildenafil AUC and a 55% decrease in sildenafil Cmax. Co-administration resulted in a 50% increase in AUC of bosentan. T</ao:suffix>
    <ao:prefix>at steady state (80 mg TID) with </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:306D66E1-EEA7-47C1-B74F-BDAB19758905"/>
    <pav:createdOn>2014-07-07 09:42:38 -0400</pav:createdOn>
    <ao:exact>bosentan </ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:BE38063F-250C-4F1D-8115-A4F1B32C6CA1">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:BE38063F-250C-4F1D-8115-A4F1B32C6CA1"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-129.txt.html</ao:hasSource>
    <ao:suffix>with cimetidine, a non-specific CYP450 inhibitor, increased propranolol AUC and Cmax by 46% and 35%, respectively. Co-administration with aluminum hydroxide gel (1200 mg) may result in a decrease in propranolol concentrations.</ao:suffix>
    <ao:prefix>Co-administration of </ao:prefix>
    <ao:exact>propranolol </ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>BE38063F-250C-4F1D-8115-A4F1B32C6CA1</domeo:uuid>
    <pav:createdOn>2014-07-08 09:10:10 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:203F5C51-D82C-4FC1-B87D-AD8FF7372848">
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:80394A58-E8DC-4096-B0CF-6FA1584FF51D"/>
    <pav:lastSavedOn>2014-07-21 10:02:11 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-21 10:00:50 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:32944008-A6C6-4D66-8C43-EE4CF2256965</domeo:belongsToSet>
    <pav:previousVersion>urn:domeoclient:uuid:21a2d27a-13b1-4797-ba7a-c0517e32bb06</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">3</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotationset:cf593dca-fe93-451b-8f37-2a96e065da13</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:BA43DC13-BE0A-49DC-97E9-FF50D5B4AB5A">
    <pav:createdOn>2014-07-08 15:32:11 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-07-08 15:34:18 -0400</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:0F235438-66A4-4847-A5E7-8A71C3802072</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:64EE0DE1-0041-4599-B2F7-B51C3F0990FE"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotation:7AFDFE5F-464C-4027-874D-257E06972E4A</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:6CE02D92-3424-4002-ABED-F75BC7CCB60C">
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoclient:uuid:1D51EEDF-FCC9-44E1-A13B-BCE69023F944</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:63F252C5-805D-400B-BBE9-59DA6966187E"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotation:B8D28753-90F8-4589-BAD5-FF43E2478946</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-07-08 09:11:17 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2014-07-08 09:10:11 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoserver:annotationset:2E252AB2-20BD-4522-8B0C-3376444BB437">
    <ao:item rdf:resource="urn:domeoclient:uuid:C44331BB-773C-4338-8049-4956F3685832"/>
    <pav:createdOn>2014-07-07 08:06:27 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">3</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812e52b20002"/>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <domeo:deleted>false</domeo:deleted>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-83.txt.html</ao:annotatesResource>
    <pav:lastSavedOn>2014-07-08 15:03:23 -0400</pav:lastSavedOn>
    <ao:item rdf:resource="file:///home/yin2/python-SPL-connector/24cc7221-ba99-4acb-add6-9b5724969e95"/>
    <rdfs:label>NER Sets</rdfs:label>
    <pav:previousVersion>urn:domeoclient:uuid:d81ba653-3da6-4dc7-9fac-dc5e3395aa57</pav:previousVersion>
    <permissions:permissions rdf:nodeID="N32e2767b22964219bbe06d9a60e77f00"/>
    <dct:description>The NER set is created automatically by NER annotation loading program.</dct:description>
    <pav:lineageUri>urn:domeoserver:annotationset:98d7c315-bece-4703-980c-2aa1d25db5ab</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:C7BE795D-5206-40FE-8E16-CE80148D9C23">
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:B38FF6AA-748B-4206-B206-DD37D92D16C5"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:3E776E26-0F50-415F-B2DE-9AB3D6DE0870">
    <domeo:uuid>3E776E26-0F50-415F-B2DE-9AB3D6DE0870</domeo:uuid>
    <ao:exact>AVANDIA (2 mg twice daily) taken concomitantly with glyburide (3.75 to 10 mg/day) for 7 days did not alter the mean steady-state 24-hour plasma glucose concentrations in diabetic patients stabilized on glyburide therapy. Repeat doses of AVANDIA (8 mg once daily) for 8 days in healthy adult Caucasian subjects caused a decrease in glyburide AUC and Cmax of approximately 30%. In Japanese subjects, glyburide AUC and Cmax slightly increased following coadministration of AVANDIA</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:3E776E26-0F50-415F-B2DE-9AB3D6DE0870"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-08 08:48:53 -0400</pav:createdOn>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>xsd:String</ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:51AF0CA9-6F4C-40EF-8602-AAFBEF302739">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:9AB19197-4B2E-41F0-BA4C-D09863CEB4A9"/>
    <pav:lineageUri>urn:domeoserver:annotationset:57174A7C-3100-4C8F-9C4A-2991CEE124D5</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdOn>2014-07-08 08:48:00 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:23515E27-98AC-4DC9-A4B7-EBFE2991219F</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-08 08:51:47 -0400</pav:lastSavedOn>
    <pav:previousVersion>urn:domeoclient:uuid:5BCE2FDB-C586-44CD-88F7-6EE2BDB6B929</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:2818899E-8D71-4CC1-8C44-C22F75638E6A">
    <pav:createdOn>2014-07-08 16:26:07 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:16D02332-2893-47D6-ADD7-FCEF160CA2DD"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotation:9706A48E-829D-4FE5-90E4-07A03C1EAB4D</pav:lineageUri>
    <pav:lastSavedOn>2014-07-08 16:27:01 -0400</pav:lastSavedOn>
    <ao:body rdf:nodeID="N14a5c68735da4cf88468c47c3cc942be"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:FC706AFD-18B6-480C-8EAA-2B16C3212C10</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:534E4891-ED83-41A7-A95F-9D41BF14A274">
    <pav:createdOn>2014-07-08 19:57:01 -0400</pav:createdOn>
    <ao:exact>Antacids containing magnesium trisilicate, when administered concomitantly with nitrofurantoin, reduce both the rate and extent of absorption. The mechanism for this interaction probably is adsorption of nitrofurantoin onto the surface of magnesium trisilicate.</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:534E4891-ED83-41A7-A95F-9D41BF14A274"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-35.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>534E4891-ED83-41A7-A95F-9D41BF14A274</domeo:uuid>
    <ao:suffix>xsd:String</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>xsd:String</ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:72C25A02-3427-43E4-8A57-878B6B14CF95">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoclient:uuid:E08D4CED-BE06-4A5F-A2AF-BFBC25BA8AE4</domeo:belongsToSet>
    <pav:createdOn>2014-07-07 20:46:08 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:796DD621-ABBA-4C43-A828-7B3F14FF2E3E"/>
    <pav:lineageUri>urn:domeoserver:annotation:83EA6852-E2D5-4B3D-8AAC-44DAE8C8FDCA</pav:lineageUri>
    <pav:lastSavedOn>2014-07-07 20:46:25 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C3C39F76-C9B9-48EB-A990-C0E86CC638AB">
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotation:5292B14E-37DC-46B1-AB67-8F84C7ED5AD5</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoclient:uuid:698327F3-D853-41CB-ADF0-60C4BFEB24F4</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-07-08 09:13:23 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:D6D9407F-3933-43EF-A893-996C0C7E9221"/>
    <pav:createdOn>2014-07-08 09:12:44 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:6A11AA7C-97E0-419E-91D1-4C7C6426A05D">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:6A11AA7C-97E0-419E-91D1-4C7C6426A05D"/>
    <ao:prefix>does not affect the pharmacokinetics of </ao:prefix>
    <domeo:uuid>6A11AA7C-97E0-419E-91D1-4C7C6426A05D</domeo:uuid>
    <ao:suffix>.</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-127.txt.html</ao:hasSource>
    <ao:exact>propranolol</ao:exact>
    <pav:createdOn>2014-07-08 08:59:09 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:DEA5F790-6FA5-446D-AF96-834740301FFC">
    <pav:createdOn>2014-07-08 12:10:17 -0400</pav:createdOn>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:DEA5F790-6FA5-446D-AF96-834740301FFC"/>
    <domeo:uuid>DEA5F790-6FA5-446D-AF96-834740301FFC</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-164.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>xsd:String</ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>Cimetidine</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E21F2C5C-9855-4FD9-BEEF-A994AF27B942">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-197.txt.html</ao:hasSource>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:exact>Phenytoin: Phenytoin plasma levels have been reported to be low in some patients receiving zidovudine, while in one case a high level was documented. However, in a pharmacokinetic interaction study in which 12 HIV-1-positive volunteers received a single 300 mg phenytoin dose alone and during steady-state zidovudine conditions (200 mg every 4 hours), no change in phenytoin kinetics was observed. Although not designed to optimally assess the effect of phenytoin on zidovudine kinetics, a 30% decrease in oral zidovudine clearance was observed with phenytoin.</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>E21F2C5C-9855-4FD9-BEEF-A994AF27B942</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:E21F2C5C-9855-4FD9-BEEF-A994AF27B942"/>
    <ao:suffix>xsd:String</ao:suffix>
    <pav:createdOn>2014-07-08 14:22:29 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:c397168e-bd86-4af2-8e92-d7695f2b25f2">
    <pav:createdOn>2014-07-07 08:07:05 -0400</pav:createdOn>
    <domeo:uuid></domeo:uuid>
    <ao:prefix>Erythromycin: </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:c397168e-bd86-4af2-8e92-d7695f2b25f2"/>
    <ao:exact>Erythromycin</ao:exact>
    <ao:suffix> (500 mg, single dose) did not</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-192.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:21787F97-E99B-41EF-B77B-AB0F5528C723">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>fluconazole </ao:exact>
    <domeo:uuid>21787F97-E99B-41EF-B77B-AB0F5528C723</domeo:uuid>
    <ao:suffix>200 mg daily for 14 days in 16 normal male volunteers. There were significant increases in theophylline AUC, Cmax, and half-life with a corresponding decrease in clearance. The mean ± SD theophylline AUC increased 21% ± 16% (range: -5 to 48%). The Cmax i</ao:suffix>
    <ao:prefix>(6 mg/kg) before and after the oral administration of </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:21787F97-E99B-41EF-B77B-AB0F5528C723"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-28.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-07 20:18:55 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D74138EC-1E07-40A5-B6E5-F8130C30C935">
    <pav:createdOn>2014-07-08 08:46:47 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-07-08 08:51:47 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <pav:previousVersion>urn:domeoclient:uuid:5BCE2FDB-C586-44CD-88F7-6EE2BDB6B929</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:23515E27-98AC-4DC9-A4B7-EBFE2991219F</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotationset:57174A7C-3100-4C8F-9C4A-2991CEE124D5</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:619E6482-4318-4FF7-942F-03EED065FA23"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B1141C88-EFD4-4358-8CBB-BB8F5D8AECE3">
    <domeo:uuid>B1141C88-EFD4-4358-8CBB-BB8F5D8AECE3</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-201.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:B1141C88-EFD4-4358-8CBB-BB8F5D8AECE3"/>
    <pav:createdOn>2014-07-08 12:28:27 -0400</pav:createdOn>
    <ao:exact>phenytoin </ao:exact>
    <ao:prefix>exposure increased to a level comparable to that prior to </ao:prefix>
    <ao:suffix>administration.</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E9596FFF-1508-486F-B332-A0A16717BF8E">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:E9596FFF-1508-486F-B332-A0A16717BF8E"/>
    <ao:suffix>. (See PRECAUTIONS.)</ao:suffix>
    <ao:prefix>AUC was 88% ± 68% (range: 16 to 247%). The absolute magnitude of this interaction is unknown because of the intrinsically nonlinear disposition of </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-25.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>E9596FFF-1508-486F-B332-A0A16717BF8E</domeo:uuid>
    <ao:exact>phenytoin</ao:exact>
    <pav:createdOn>2014-07-07 20:13:34 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:1136F370-BF76-4567-BD4E-BFA1D9631FF0">
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:B491D9E4-8A78-41ED-AF07-786E84BB79D0"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:7DEE78A2-3E4C-4584-8ED9-F698C9F8F9C4</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-07-07 20:31:04 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-07-07 20:31:18 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotation:919593B0-434A-4CAC-9191-C2F3F69FCF1D</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:1D0A9A36-1469-43DB-927C-3422E01D71EA">
    <pav:lineageUri>urn:domeoserver:annotation:11826036-E210-465B-81CA-F797E3CD430E</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:body rdf:nodeID="N5ffd5c60eede4161863c9b4f1987a13a"/>
    <pav:createdOn>2014-07-08 14:01:21 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7E49EB7A-DE0E-4720-82D1-8460BA0C770D</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-07-08 14:10:48 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:7F08BE75-59EE-45B8-84C3-FFD853167892"/>
    <rdfs:label>expertstudy Annotation</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B0779619-A8C5-45DB-812D-D0CCFD025563">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotationset:1DED06A6-8562-4CCF-A58C-CA25748FBD31</pav:lineageUri>
    <pav:lastSavedOn>2014-07-07 19:50:36 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:createdOn>2014-07-07 19:46:33 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5ABD9862-F044-4404-AD04-73DA04ADDA8B</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:8FC5EF9F-EB1B-43BF-850E-AF5E195EFC5C"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:81B87E22-AE85-42A9-BBA1-CDD6698F246F">
    <domeo:uuid>81B87E22-AE85-42A9-BBA1-CDD6698F246F</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:81B87E22-AE85-42A9-BBA1-CDD6698F246F"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>and trazodone were coadministered.</ao:suffix>
    <pav:createdOn>2014-07-08 09:25:35 -0400</pav:createdOn>
    <ao:prefix>increased by 34%, the AUC increased 2.4 fold, the half-life increased by 2.2 fold, and the clearance decreased by 52%. Adverse effects including nausea, hypotension, and syncope were observed when </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-136.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>ritonavir </ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:9A39B986-4679-4FD8-A2EF-330D6AC97D86">
    <ao:body rdf:nodeID="Nff20b33c196a4a36862fcfbc543e21ff"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:createdOn>2014-07-08 19:45:15 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:C2517233-6850-4D46-BB46-D725F456F94C"/>
    <pav:lastSavedOn>2014-07-08 19:45:15 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:B3C0E972-7A26-4B8D-88E8-D7C3C96B8C1E</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:lineageUri>urn:domeoserver:annotation:D6E40EBA-BE35-40CA-907F-3EDAB9EF1B32</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:37635111-1873-4732-862A-B5807BF1EF10">
    <pav:createdOn>2014-07-07 19:46:19 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5ABD9862-F044-4404-AD04-73DA04ADDA8B</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:EF89D3CC-C50F-4914-AA1D-08C4922BB398"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:lastSavedOn>2014-07-07 19:50:36 -0400</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotationset:1DED06A6-8562-4CCF-A58C-CA25748FBD31</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:03AC039F-E307-488D-9444-D362A5683585">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:BBC079C9-773A-469F-9E70-7E00113653C4"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:lastSavedOn>2014-07-08 08:46:38 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-08 08:43:21 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:23515E27-98AC-4DC9-A4B7-EBFE2991219F</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotationset:57174A7C-3100-4C8F-9C4A-2991CEE124D5</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:4B03F850-0F84-438D-85C6-2980A81685A7">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:3A0752AB-B8AB-4C41-926A-E09DFD235B54"/>
    <pav:lineageUri>urn:domeoserver:annotation:3F23D752-A8D8-4316-8B91-9E42491C5DAA</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5B2167F6-4E63-4A7B-85C1-ACA56DDE7073</domeo:belongsToSet>
    <ao:body rdf:nodeID="N92a252c1a6c142dfaf16e84884bb7063"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:createdOn>2014-07-08 15:53:43 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:lastSavedOn>2014-07-08 15:56:00 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:9BACEF41-5562-4C68-9907-012342332FB8">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdOn>2014-07-07 20:49:24 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotation:CD75CA7D-E39B-4366-B7F7-7404B9D95AFF</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoclient:uuid:009F8C96-1AEA-4B59-B278-1C6873AA45B5</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-07 20:49:30 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:71FA060C-5D8C-40BF-84CC-54D05CA7B13F"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C01E1284-4B3F-42C4-B239-BEB354DB3D9C">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:C01E1284-4B3F-42C4-B239-BEB354DB3D9C"/>
    <domeo:uuid>C01E1284-4B3F-42C4-B239-BEB354DB3D9C</domeo:uuid>
    <ao:suffix> (29%), conjugated ODV (26%), or other minor inactive metabolites (27%). Renal elimination of </ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-6.txt.html</ao:hasSource>
    <ao:prefix> (5%), unconjugated </ao:prefix>
    <pav:createdOn>2014-07-21 10:01:13 -0400</pav:createdOn>
    <ao:exact>ODV</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/F30BF7BE-D789-4923-B724-563AB39A2B2F">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>diltiazem</rdfs:label>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/3443</dailymed:activeMoietyRxCUI>
    <dct:description>Referred to the drug in the interaction.</dct:description>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:76BE7025-2F0B-4F5E-9F36-1C8A2CADC27E">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <ao:exact>nifedipine </ao:exact>
    <ao:suffix>and oral contraceptives (ethinyl estradiol and norethindrone), which are predominantly metabolized by CYP3A4.</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:76BE7025-2F0B-4F5E-9F36-1C8A2CADC27E"/>
    <domeo:uuid>76BE7025-2F0B-4F5E-9F36-1C8A2CADC27E</domeo:uuid>
    <ao:prefix>(4 mg twice daily) was shown to have no clinically relevant effect on the pharmacokinetics of </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-08 08:44:23 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:FBC49810-612F-4640-9BAA-70A6E612220E">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-07-07 19:50:36 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotationset:1DED06A6-8562-4CCF-A58C-CA25748FBD31</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdOn>2014-07-07 19:42:28 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:8A8C178E-AD9A-4972-8142-599E34A9DF0E"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5ABD9862-F044-4404-AD04-73DA04ADDA8B</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:60BFFA8D-E145-4DFC-8C66-2E9B95CC3326">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-08 13:54:17 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-07-08 13:56:02 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotation:238C7125-2D40-4216-94B6-5A7356AA20D4</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <rdfs:label>Highlight</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:F49CC39C-9867-4741-BE53-8FD0F781FF27"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:DD05DE56-7B60-4C06-8552-D1DD652D8A79</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:DCAA0D82-9C8F-4404-997E-223F52082CBB">
    <ao:prefix>xsd:String</ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:DCAA0D82-9C8F-4404-997E-223F52082CBB"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>coadministration of fexofenadine hydrochloride with either ketoconazole or erythromycin led to increased plasma concentrations of fexofenadine in healthy adult subjects.</ao:exact>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-139.txt.html</ao:hasSource>
    <domeo:uuid>DCAA0D82-9C8F-4404-997E-223F52082CBB</domeo:uuid>
    <pav:createdOn>2014-07-08 09:34:19 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:4E744ADB-7FE2-4D27-81C7-5803DDC55C0E">
    <ao:suffix>'s </ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-07 10:01:38 -0400</pav:createdOn>
    <ao:exact>ritonavir</ao:exact>
    <domeo:uuid>4E744ADB-7FE2-4D27-81C7-5803DDC55C0E</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:4E744ADB-7FE2-4D27-81C7-5803DDC55C0E"/>
    <ao:prefix>xsd:String</ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:8410EFB2-8516-402D-8897-8A16FB9EF532">
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:23515E27-98AC-4DC9-A4B7-EBFE2991219F</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotationset:57174A7C-3100-4C8F-9C4A-2991CEE124D5</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-07-08 08:46:38 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-08 08:38:50 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:A26943A6-0973-45A0-9E75-B6D2CDDB08C5"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:FC2068AC-90C4-4F49-892E-8BBE8145A240">
    <ao:context rdf:resource="urn:domeoclient:uuid:845B21DC-E1C4-4BD7-97B1-E8B17C1D446E"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotationset:F37BE993-E972-47AE-896D-FF4D33157ECF</pav:lineageUri>
    <pav:lastSavedOn>2014-07-07 09:44:18 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:createdOn>2014-07-07 09:41:53 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A5E637EF-5CA5-4AAC-BD8B-C136A86E17B7</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:335D90D2-87B8-42BC-9C9A-96BEC15A08F2">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdOn>2014-07-21 10:04:58 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotation:F72D5866-019D-4E3C-8481-B7A15F07BAB8</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:CCF7E799-D26C-43D3-A179-4B5F71346C97"/>
    <pav:lastSavedOn>2014-07-21 10:06:08 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:32AE0CCB-E459-4836-ADED-1DE8CB7D4F9E</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:76EBED7C-12A7-419B-A36D-C5164C10E376">
    <ao:exact>In vitro drug metabolism studies reveal that trazodone is a substrate of the cytochrome P450 3A4 (CYP3A4) enzyme and trazodone metabolism can be inhibited by the CYP3A4 inhibitors ketoconazole, ritonavir, and indinavir</ao:exact>
    <ao:suffix>xsd:String</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:76EBED7C-12A7-419B-A36D-C5164C10E376"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-136.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-08 09:26:43 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>76EBED7C-12A7-419B-A36D-C5164C10E376</domeo:uuid>
    <ao:prefix>xsd:String</ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:32790b96-d61d-48f5-9956-2a87cef22bac">
    <domeo:uuid></domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>therapy showed a decrease in </ao:prefix>
    <ao:suffix> susceptibility in cell cultur</ao:suffix>
    <ao:exact>ritonavir</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:32790b96-d61d-48f5-9956-2a87cef22bac"/>
    <pav:createdOn>2014-07-07 08:06:36 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-190.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:62b33602-2d04-4259-80a8-85ea50c8d83e">
    <domeo:uuid></domeo:uuid>
    <ao:prefix>urantoin onto the surface of </ao:prefix>
    <ao:exact>magnesium trisilicate</ao:exact>
    <ao:suffix>.</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:62b33602-2d04-4259-80a8-85ea50c8d83e"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-35.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-07 08:06:34 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:18DE6EED-BC61-4232-95D2-D1FF4AEF6319">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:18DE6EED-BC61-4232-95D2-D1FF4AEF6319"/>
    <ao:exact>Concomitant administration of fluvastatin (40 mg) and itraconazole (100 mg daily x 4 days) does not affect plasma itraconazole or fluvastatin levels.</ao:exact>
    <ao:suffix>xsd:String</ao:suffix>
    <domeo:uuid>18DE6EED-BC61-4232-95D2-D1FF4AEF6319</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-191.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>xsd:String</ao:prefix>
    <pav:createdOn>2014-07-08 14:31:14 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C33B82E4-E381-41F5-928C-AC59F1E43884">
    <pav:createdOn>2014-07-07 09:33:57 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>Sildenafil </ao:exact>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:suffix>is an inhibitor of cGMP specific phosphodiesterase type-5 (PDE5) in the smooth muscle of the pulmonary vasculature, where PDE5 is responsible for degradation of cGMP. Sildenafil, therefore, increases cGMP within pulmonary vascular smooth muscle cells res</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:C33B82E4-E381-41F5-928C-AC59F1E43884"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>C33B82E4-E381-41F5-928C-AC59F1E43884</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F103A6EE-D797-425D-98BB-82013CB76066">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:F103A6EE-D797-425D-98BB-82013CB76066"/>
    <pav:createdOn>2014-07-08 08:42:02 -0400</pav:createdOn>
    <domeo:uuid>F103A6EE-D797-425D-98BB-82013CB76066</domeo:uuid>
    <ao:exact>rosiglitazone </ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <ao:prefix>In vitro data demonstrate that </ao:prefix>
    <ao:suffix>is predominantly metabolized by Cytochrome P450 (CYP) isoenzyme 2C8, with CYP2C9 contributing as a minor pathway.</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C78B2F13-9054-473F-9B5D-E4355D2BB359">
    <pav:createdOn>2014-07-07 20:22:05 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotation:594889E5-957D-4650-8B21-E86A6A6D0EF9</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-07-07 20:22:41 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoclient:uuid:ACDB13DF-BBDB-49E3-A225-176E6DBB207B</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:8F184191-5BAF-4D76-BE92-06B2FD2CE429"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N30b4e2538ff54a9b822c88648d26e442">
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
    <permissions:isLocked>false</permissions:isLocked>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:103130D9-6A2B-476D-B949-4993B0FED3C9">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotation:68B1DE75-D300-45BD-BA6F-CCE6C59E5A3C</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:20410859-8D12-42B9-AE3F-723631B14A50"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-08 09:27:36 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-08 09:25:18 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoclient:uuid:7E425E73-12D2-4B08-9D70-75410DE87447</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:774A9347-D89F-48D7-8DED-5584C9494543">
    <ao:exact>The AUC of propafenone is increased by more than 200% by co-administration of propranolol.</ao:exact>
    <domeo:uuid>774A9347-D89F-48D7-8DED-5584C9494543</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-124.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:774A9347-D89F-48D7-8DED-5584C9494543"/>
    <pav:createdOn>2014-07-08 08:56:08 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:suffix>xsd:String</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:36330B96-6498-4A69-94F9-98F5F003CC11">
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:lastSavedOn>2014-07-08 14:53:28 -0400</pav:lastSavedOn>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotation:3280AC82-F9AE-44C4-BCE3-5E57E41F7AAB</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7C1C282A-E938-4B71-A30D-A7B67DB129EE</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:2D571BD8-9BC9-4872-8CE7-76BD0FBF0490"/>
    <pav:createdOn>2014-07-08 14:53:28 -0400</pav:createdOn>
    <ao:body rdf:nodeID="N29af3c20899b44f4b2a614614701567d"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:0C86AF8B-7C1E-401A-A291-D7EE4238C804">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-08 08:45:53 -0400</pav:createdOn>
    <ao:exact>rosiglitazone </ao:exact>
    <domeo:uuid>0C86AF8B-7C1E-401A-A291-D7EE4238C804</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:0C86AF8B-7C1E-401A-A291-D7EE4238C804"/>
    <ao:suffix>(4 mg once daily) for 7 days increased rosiglitazone AUC by 127%, compared to the administration of rosiglitazone (4 mg once daily) alone. Given the potential for dose-related adverse events with rosiglitazone, a decrease in the dose of rosiglitazone may</ao:suffix>
    <ao:prefix>(600 mg twice daily), an inhibitor of CYP2C8, and </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:0E5B54C1-2569-4948-8208-B602B65C6423">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:0E5B54C1-2569-4948-8208-B602B65C6423"/>
    <domeo:uuid>0E5B54C1-2569-4948-8208-B602B65C6423</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>Co-administration of cholestyramine or colestipol with propranolol resulted in up to 50% decrease in propranolol concentrations</ao:exact>
    <ao:prefix>xsd:String</ao:prefix>
    <pav:createdOn>2014-07-08 09:15:09 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-131.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:5E052BE8-F669-42CA-B1EA-63E254F28C39">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotation:03556150-14A8-4CE0-834F-0C9BCF610B83</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:F139BC06-4E07-4862-B537-2812AD4D34B0"/>
    <pav:lastSavedOn>2014-07-08 09:27:36 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdOn>2014-07-08 09:25:23 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:7E425E73-12D2-4B08-9D70-75410DE87447</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:48A10FCC-D3EB-470D-8C14-4E88B338BE93">
    <pav:lineageUri>urn:domeoserver:annotation:7A13CB7A-40AF-43E9-838E-AD69B6CF7763</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:3857B7A8-EDF2-4956-9CF4-A1B13773E162</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:7872312D-0BC1-4F3D-B41E-15A504540DB2"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:createdOn>2014-07-07 20:16:47 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-07-07 20:18:07 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/3B256923-9EB0-4646-A9CF-69CC04808464">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>rosiglitazone</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/84108</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:4DDBA8A7-CDB3-40B9-800E-825DAC51D276">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotation:BA4CA80F-5DE3-47CA-B200-357C13568B80</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:4C2701B1-6391-4B52-9FAA-57695F47BF9B"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:423352B3-8ABA-48B7-98CF-B191A7BFC955</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdOn>2014-07-08 09:32:27 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2014-07-08 09:35:29 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C87E7139-F2E2-41D8-8701-A510A685DAA1">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5ABD9862-F044-4404-AD04-73DA04ADDA8B</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:F87AD5D5-A5A5-4271-AE1B-1F18BC0619C5"/>
    <pav:createdOn>2014-07-07 19:48:46 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotationset:1DED06A6-8562-4CCF-A58C-CA25748FBD31</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-07-07 19:50:36 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A514DC0A-9A07-48B8-B672-3146345F0952">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2014-07-07 20:05:58 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotation:16497215-72D6-4007-9B50-F2A25C45596E</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:9C4340B2-9EC2-4322-AE35-B6353B6A145F"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-07-07 20:07:11 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoclient:uuid:4A49ACB6-4B71-452F-80EE-8A84DEF45C29</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B741DD60-8DBC-4F77-ADE3-DE177B7357C7">
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdOn>2014-07-08 09:21:17 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-07-08 09:22:07 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotation:123F48A2-43AB-4E27-A53A-B2DDF1DC27C2</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoclient:uuid:C0CE4AC7-F72D-4A94-BD3E-4720F127B810</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:84ACDBE0-2E65-4F1C-A747-BD018A0A7A71"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:512D3C59-8107-469D-B0FE-88AA316A2B12">
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5B2167F6-4E63-4A7B-85C1-ACA56DDE7073</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-08 15:43:16 -0400</pav:lastSavedOn>
    <pav:previousVersion>urn:domeoclient:uuid:42a83e8e-3067-409a-8471-bf6887759cee</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">3</pav:versionNumber>
    <pav:createdOn>2014-07-08 15:42:52 -0400</pav:createdOn>
    <ao:body rdf:nodeID="N6e7a7ce7f1e14afa84f3dd9c66115d6b"/>
    <pav:lineageUri>urn:domeoserver:annotationset:061a21f6-0ef7-497f-bd03-574c24bc0d7c</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:E134A5C2-40CD-489F-AE84-B0040F8D0941"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:423B15D4-DC1C-4348-9BB3-85233ACCD457">
    <ao:suffix>xsd:String</ao:suffix>
    <ao:prefix>xsd:String</ao:prefix>
    <domeo:uuid>423B15D4-DC1C-4348-9BB3-85233ACCD457</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:423B15D4-DC1C-4348-9BB3-85233ACCD457"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>Bosentan</ao:exact>
    <pav:createdOn>2014-07-07 09:42:35 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:2FF7AFF6-AC26-446E-BEDB-AAD17733DA7D">
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:67CFF9B5-80F5-47C2-9CC2-3643ED8CFC60"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:6165FCEB-2550-42FF-A2B1-9784A3303E79">
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotationset:1DED06A6-8562-4CCF-A58C-CA25748FBD31</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:FD4F20A0-B3F7-4D56-A8C0-E8D9D6CC0DB4"/>
    <pav:lastSavedOn>2014-07-07 19:50:36 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5ABD9862-F044-4404-AD04-73DA04ADDA8B</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-07 19:48:34 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:57F0F7FA-4574-4993-9F3B-9298794A1D9C">
    <ao:prefix>xsd:String</ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:57F0F7FA-4574-4993-9F3B-9298794A1D9C"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>xsd:String</ao:suffix>
    <pav:createdOn>2014-07-07 10:03:24 -0400</pav:createdOn>
    <ao:exact>sildenafil</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>57F0F7FA-4574-4993-9F3B-9298794A1D9C</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A795201D-AF7A-493B-9FCF-3AF6C3B7429B">
    <pav:createdOn>2014-07-07 09:35:16 -0400</pav:createdOn>
    <ao:suffix>may be the basis for the enhanced platelet anti-aggregatory activity of nitric oxide observed in vitro, and the mild peripheral arterial-venous dilatation in vivo.</ao:suffix>
    <ao:exact>sildenafil </ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:A795201D-AF7A-493B-9FCF-3AF6C3B7429B"/>
    <domeo:uuid>A795201D-AF7A-493B-9FCF-3AF6C3B7429B</domeo:uuid>
    <ao:prefix>In addition to pulmonary vascular smooth muscle and the corpus cavernosum, PDE5 is also found in other tissues including vascular and visceral smooth muscle and in platelets. The inhibition of PDE5 in these tissues by </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F457AA89-66BE-41F0-BA88-05A76BE2E587">
    <ao:exact>magnesium </ao:exact>
    <pav:createdOn>2014-07-08 09:30:44 -0400</pav:createdOn>
    <domeo:uuid>F457AA89-66BE-41F0-BA88-05A76BE2E587</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:F457AA89-66BE-41F0-BA88-05A76BE2E587"/>
    <ao:prefix>and </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix>containing antacid (Maalox®1) decreased fexofenadine AUC by 41% and Cmax by 43%.</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-139.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:8B6EB8FD-0A13-4C94-ACDC-67E123749800">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/586B177C-B407-4D17-9929-5037CBEF34AA"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/A58E6E05-F48C-444E-A120-7B578B631383"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F82D76EE-0210-4189-A137-BAA0B3A6054C">
    <ao:context rdf:resource="urn:domeoclient:uuid:16F49A5A-3441-4B3B-B195-F94C7D0708EC"/>
    <pav:lineageUri>urn:domeoserver:annotation:9D988EB0-53B6-4EEB-A821-BADB166D2751</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2014-07-08 09:00:25 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-08 08:59:06 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoclient:uuid:86E1DCE1-FFC6-4513-AEF9-EF158A019E6B</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7EEEF385-0BE2-41E2-A72E-4F6918F72180">
    <pav:createdOn>2014-07-08 08:43:02 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:3489B8F4-E97C-4984-A371-4751AFB43277"/>
    <pav:lineageUri>urn:domeoserver:annotationset:57174A7C-3100-4C8F-9C4A-2991CEE124D5</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:23515E27-98AC-4DC9-A4B7-EBFE2991219F</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:lastSavedOn>2014-07-08 08:46:38 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:4431CDD6-C079-428D-91F6-514F2FF5B77B">
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:AE848AF5-F1A3-4443-8C1E-9C3427D1AC4F"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:65A4FA6D-7065-4765-87CF-AB16D8E5A9D4">
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:D0B7DE32-3D78-4C61-966D-2B5132608A55"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A5E637EF-5CA5-4AAC-BD8B-C136A86E17B7</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-07 09:42:19 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-07-07 09:44:18 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotationset:F37BE993-E972-47AE-896D-FF4D33157ECF</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:948FAEC8-F52B-4091-A753-A2E8B169BECA">
    <pav:lastSavedOn>2014-07-08 09:29:51 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotation:E5D356E6-7A00-4C70-97B6-38FCBA041A88</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-08 09:29:40 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:7E32BEF1-7A20-4571-AA29-8F9AC97657A0</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:DDEE6189-D54F-4D1B-BAF9-8CA95706F55C"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F0DC88F4-861D-406C-B0AC-5C984835B925">
    <ao:exact>azithromycin </ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-08 12:02:51 -0400</pav:createdOn>
    <domeo:uuid>F0DC88F4-861D-406C-B0AC-5C984835B925</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:F0DC88F4-861D-406C-B0AC-5C984835B925"/>
    <ao:prefix>at steady-state with a single oral dose of </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-161.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>resulted in increased azithromycin serum concentrations. Although a dose adjustment of azithromycin is not recommended when administered in combination with nelfinavir, close monitoring for known side effects of azithromycin, such as liver enzyme abnorma</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:39AFBC32-AA3F-440F-AF92-CA97278CFD93">
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:4C547F49-FC88-4CBB-B168-644256663CB3"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/3E293358-D96E-49E3-8DF6-F99C2AE5F414">
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/4053</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>erythromycin</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A3086698-5AE9-4E68-B263-4535D1D30820">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-08 08:48:10 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotationset:57174A7C-3100-4C8F-9C4A-2991CEE124D5</pav:lineageUri>
    <pav:previousVersion>urn:domeoclient:uuid:5BCE2FDB-C586-44CD-88F7-6EE2BDB6B929</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:1BBCAD39-EE66-4157-A96B-83905E48F13D"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:23515E27-98AC-4DC9-A4B7-EBFE2991219F</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-08 08:51:47 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:FDD093C9-DBD0-4767-A650-5A8EE28AC78D">
    <domeo:belongsToSet>urn:domeoclient:uuid:7E425E73-12D2-4B08-9D70-75410DE87447</domeo:belongsToSet>
    <pav:createdOn>2014-07-08 09:25:26 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2014-07-08 09:27:36 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:30C086A4-11FE-457B-8508-99D6F941BC90"/>
    <pav:lineageUri>urn:domeoserver:annotation:01A2DC3C-9384-458E-A857-52494F482602</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:64FBA69A-FCA1-4F1F-BD52-0CDF8974E959">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:64FBA69A-FCA1-4F1F-BD52-0CDF8974E959"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>(4 mg once daily) alone. Given the potential for dose-related adverse events with </ao:prefix>
    <ao:suffix>, a decrease in the dose of rosiglitazone may be needed when gemfibrozil is introduced [see Drug Interactions (7.1)].</ao:suffix>
    <pav:createdOn>2014-07-08 08:45:58 -0400</pav:createdOn>
    <ao:exact>rosiglitazone</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <domeo:uuid>64FBA69A-FCA1-4F1F-BD52-0CDF8974E959</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7A39E70C-7BEF-4D74-AEC3-73FD2C720B0D">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix> is conjugated at the 17β-OH position to form sulfate conjugates and, to a lesser extent, glucuronide conjugates in plasma. Significant amounts of conjugated and unconjugated </ao:prefix>
    <ao:suffix> are also present in plasma, along with much smaller amounts of 3α, 5α-tetrahydrolevonorgestrel and 16βhydroxylevonorgestrel. </ao:suffix>
    <domeo:uuid>7A39E70C-7BEF-4D74-AEC3-73FD2C720B0D</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:7A39E70C-7BEF-4D74-AEC3-73FD2C720B0D"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-206.txt.html</ao:hasSource>
    <ao:exact>3α, 5β-tetrahydrolevonorgestrel</ao:exact>
    <pav:createdOn>2014-07-08 15:33:25 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:013BA1D3-957D-4FF5-9CC4-8146EA1581DF">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:013BA1D3-957D-4FF5-9CC4-8146EA1581DF"/>
    <ao:exact>Daily oral dosing of immediate-release paroxetine (30 mg once daily) increased steady-state AUC0-24, Cmax, and Cmin values of procyclidine (5 mg oral once daily) by 35%, 37%, and 67%, respectively, compared to procyclidine alone at steady state. If anticholinergic effects are seen, the dose of procyclidine should be reduced.</ao:exact>
    <ao:suffix>xsd:String</ao:suffix>
    <pav:createdOn>2014-07-07 20:25:12 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-50.txt.html</ao:hasSource>
    <domeo:uuid>013BA1D3-957D-4FF5-9CC4-8146EA1581DF</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>xsd:String</ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:7C4AA39C-93C3-49FA-BD23-FDE9388D7CDF">
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:3C176CE0-79F8-4208-98CF-913AC15E6C5D"/>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A54BFD6B-7482-4F25-BF0E-B47364BE4AE8">
    <domeo:uuid>A54BFD6B-7482-4F25-BF0E-B47364BE4AE8</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:exact>Concurrent administration of AVANDIA (2 mg twice daily) and metformin (500 mg twice daily) in healthy volunteers for 4 days had no effect on the steady-state pharmacokinetics of either metformin or rosiglitazone</ao:exact>
    <pav:createdOn>2014-07-08 08:51:44 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:A54BFD6B-7482-4F25-BF0E-B47364BE4AE8"/>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B2384FAD-44E7-4FC2-B56E-C1E021B49A36">
    <ao:suffix>.</ao:suffix>
    <pav:createdOn>2014-07-08 09:19:02 -0400</pav:createdOn>
    <ao:exact>fluvastatin</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:B2384FAD-44E7-4FC2-B56E-C1E021B49A36"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>did not have an effect on the pharmacokinetics of </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-132.txt.html</ao:hasSource>
    <domeo:uuid>B2384FAD-44E7-4FC2-B56E-C1E021B49A36</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:8F184191-5BAF-4D76-BE92-06B2FD2CE429">
    <ao:suffix>(500 mg single dose) AUC and Cmax following the administration of fluconazole. There was a mean ± SD increase in tolbutamide AUC of 26% ± 9% (range: 12 to 39%). Tolbutamide Cmax increased 11% ± 9% (range: -6 to 27%). (See PRECAUTIONS.)</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:8F184191-5BAF-4D76-BE92-06B2FD2CE429"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>In 13 normal male volunteers, there was significant increase in </ao:prefix>
    <ao:exact>tolbutamide </ao:exact>
    <pav:createdOn>2014-07-07 20:22:05 -0400</pav:createdOn>
    <domeo:uuid>8F184191-5BAF-4D76-BE92-06B2FD2CE429</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-29.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/6877D20B-179B-4477-8400-4C49D09BBE59">
    <rdfs:label>digoxin</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/3407</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:990DFAE4-E36B-4840-866B-401ADB1ACF3A">
    <pav:createdOn>2014-07-08 08:52:14 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix>(100 mg three times daily) for 7 days in healthy volunteers had no clinically relevant effect on the pharmacokinetics of a single oral dose of AVANDIA.</ao:suffix>
    <domeo:uuid>990DFAE4-E36B-4840-866B-401ADB1ACF3A</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>acarbose </ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:990DFAE4-E36B-4840-866B-401ADB1ACF3A"/>
    <ao:prefix>Coadministration of </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/08062b4a-0b21-46e3-9a75-07274829e6ca">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-07-07 08:07:04 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-07-07 08:07:04 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotationset:061a21f6-0ef7-497f-bd03-574c24bc0d7c</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5B2167F6-4E63-4A7B-85C1-ACA56DDE7073</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:60212a27-d4be-4876-9a87-d94e2c0d74a6"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:5FB8459E-CDD4-48C4-9193-B435F97D88AE">
    <pav:createdOn>2014-07-08 08:53:35 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>5FB8459E-CDD4-48C4-9193-B435F97D88AE</domeo:uuid>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:5FB8459E-CDD4-48C4-9193-B435F97D88AE"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <ao:exact>Warfarin</ao:exact>
    <ao:prefix>xsd:String</ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:d3bcbf90-f98c-4c6e-8d1b-a9affec5cf82">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:d3bcbf90-f98c-4c6e-8d1b-a9affec5cf82"/>
    <ao:exact>stavudine</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>ak levels for didanosine and </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-198.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-07 08:07:06 -0400</pav:createdOn>
    <ao:suffix>, with a more significant decr</ao:suffix>
    <domeo:uuid></domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:2A40295A-06C7-4D99-9873-CD21866FED44">
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotation:638D37A9-2DE3-4B69-86F7-D6D64689B75E</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:96252AD4-F350-44FE-8566-9310568DFCC6"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5ABD9862-F044-4404-AD04-73DA04ADDA8B</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdOn>2014-07-07 19:51:24 -0400</pav:createdOn>
    <ao:body rdf:nodeID="Nb5617b7175a84b86937becadf2ebf962"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-07 19:59:12 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:0E77BA1E-518A-45D7-9F12-9B93E41A8F5F">
    <domeo:uuid>0E77BA1E-518A-45D7-9F12-9B93E41A8F5F</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-08 08:40:27 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:0E77BA1E-518A-45D7-9F12-9B93E41A8F5F"/>
    <ao:exact>rosiglitazone </ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>with food resulted in no change in overall exposure (AUC), but there was an approximately 28% decrease in Cmax and a delay in Tmax (1.75 hours). These changes are not likely to be clinically significant; therefore, AVANDIA may be administered with or wit</ao:suffix>
    <ao:prefix>is 99%. Peak plasma concentrations are observed about 1 hour after dosing. Administration of </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:DF9B45EC-5F40-464E-914F-DDB0582BF93D">
    <pav:previousVersion>urn:domeoclient:uuid:21a2d27a-13b1-4797-ba7a-c0517e32bb06</pav:previousVersion>
    <pav:createdOn>2014-07-21 10:01:54 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:BD2C5DEC-48C9-42AD-BA70-1E222E156673"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">3</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotationset:cf593dca-fe93-451b-8f37-2a96e065da13</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:32944008-A6C6-4D66-8C43-EE4CF2256965</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-21 10:02:11 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:20F33871-7B08-46E0-A1BF-CC8A7EB28474">
    <pav:lineageUri>urn:domeoserver:annotationset:F37BE993-E972-47AE-896D-FF4D33157ECF</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:236D4F49-BAB0-4E0E-8A40-4AF081E16AE0"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A5E637EF-5CA5-4AAC-BD8B-C136A86E17B7</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdOn>2014-07-07 09:40:02 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:lastSavedOn>2014-07-07 09:44:18 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:AFA8D73D-B788-4C3E-856C-C22E347F5EBC">
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotation:2175A47B-2389-47A2-9004-BAEC8EAB7D1A</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:lastSavedOn>2014-07-07 19:59:12 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5ABD9862-F044-4404-AD04-73DA04ADDA8B</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:0770C0E2-F30E-4577-B7BD-ECBD88172920"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-07-07 19:57:55 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:B857E3A2-5ED6-4E48-BDCF-81276B042A8E">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/04854F6E-8EE0-4FAD-B060-699C66E8C211"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/6F1D13EC-A669-48BE-8EF0-63DE747D3CA0"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:352EFDCC-85CC-4608-91F1-B7FD7E38CE94">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoclient:uuid:D74AEF81-5B9A-431F-9F0D-1822391A7E30</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:createdOn>2014-07-08 12:02:56 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:2012A094-6453-4FEE-9C05-42D01579A7A6"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-07-08 12:05:20 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotation:A92C31E2-C48E-4D3F-9347-7226D7F22824</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:2C86A542-E5CA-4AE9-80EF-1BFE0D6E2C91">
    <domeo:uuid>2C86A542-E5CA-4AE9-80EF-1BFE0D6E2C91</domeo:uuid>
    <ao:prefix> are dose proportional over the dosing range of 1 to 16 mg daily (0.5 to 8 mg twice daily). Following oral administration of solution or tablet, mean peak plasma concentrations of </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <ao:suffix>occurred at about 1 hour. Peak concentrations of 9-hydroxyrisperidone occurred at about 3 hours in extensive metabolizers, and 17 hours in poor metabolizers. Steady-state concentrations of risperidone are reached in 1 day in extensive metabolizers and wo</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:2C86A542-E5CA-4AE9-80EF-1BFE0D6E2C91"/>
    <ao:exact>risperidone </ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-07 19:46:14 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:214DF6F3-5343-4E38-9F13-ECA8453B5867">
    <pav:createdOn>2014-07-08 15:30:23 -0400</pav:createdOn>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:214DF6F3-5343-4E38-9F13-ECA8453B5867"/>
    <domeo:uuid>214DF6F3-5343-4E38-9F13-ECA8453B5867</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-198.txt.html</ao:hasSource>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:exact>Experimental evidence demonstrated that methadone decreased the AUC and peak levels for didanosine and stavudine, with a more significant decrease for didanosine. Methadone disposition was not substantially altered.</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:9E114CCF-88D8-4F9D-8613-FF14BCC4D2DD">
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotationset:F37BE993-E972-47AE-896D-FF4D33157ECF</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-07 09:41:59 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:C77E15A3-67DF-41E0-BA49-A0EA7F975FE7"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A5E637EF-5CA5-4AAC-BD8B-C136A86E17B7</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2014-07-07 09:44:18 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/C4D64223-F9F7-4D70-BA26-E9CED330DEC2">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>risperidone</rdfs:label>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/35636</dailymed:activeMoietyRxCUI>
    <dct:description>Referred to the drug in the interaction.</dct:description>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoserver:annotationset:42258B16-6749-4B39-B28D-88C8B63F7A43">
    <ao:item rdf:resource="urn:domeoclient:uuid:D7507B01-F0B9-43AE-9F16-A33790165DAB"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:D469FE4A-1758-4F43-9F3C-B139C2F96660"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:6F2B5845-C4F5-4D77-863D-AC80C65DCD9F"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:88A544B4-BDDC-4DCB-8765-7A476A0C7BF2"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:A6119BEE-21EC-4D17-A8B5-EA1E30152F02"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:5BFA15F3-E5F6-4F30-873B-1F1AECDC49D6"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:lastSavedOn>2014-07-08 14:26:16 -0400</pav:lastSavedOn>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812e52b20002"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:item rdf:resource="urn:domeoclient:uuid:4579EAFF-E003-4408-A2BE-920C104981EA"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:124D2456-8575-43D0-8F68-5DABA1446AF3"/>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <ao:item rdf:resource="file:///home/yin2/python-SPL-connector/02ac44a8-840f-4804-a492-bd318355c376"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:04EE78DA-59FA-46D2-9ABF-847B5F283918"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:0F14E241-486F-4C71-B402-4B8875FC3ED0"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:8DE85D27-2DC8-4B45-A385-EC2E0FAC1635"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:B39AD01B-4E98-4457-ACB4-68E4483A286B"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:67DE42F1-8534-47B5-95C0-EB2604B1DD94"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">4</pav:versionNumber>
    <rdfs:label>NER Sets</rdfs:label>
    <ao:item rdf:resource="urn:domeoclient:uuid:2BEDC22E-2EA8-4C42-8B37-9D4196625558"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:EACE1AAA-462E-48A6-8D60-4B6E4719ABD0"/>
    <pav:lineageUri>urn:domeoserver:annotationset:0f67c012-7596-4b02-a927-63c0ccbc3afa</pav:lineageUri>
    <pav:previousVersion>urn:domeoserver:annotationset:DE78473B-3E87-4B55-A906-86E9AE117D96</pav:previousVersion>
    <domeo:deleted>false</domeo:deleted>
    <ao:item rdf:resource="urn:domeoclient:uuid:8609552E-F73C-43EE-BE60-46F60869DC13"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:1272AB51-6930-40DA-BFA9-64BBAF19E4F8"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:19352391-8DA9-4DF4-98FC-6FFC230BD255"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:18EC125D-0EC4-460B-B28A-2212E22F82E9"/>
    <permissions:permissions rdf:nodeID="N54751d99a46940dc87d2db2215faef5d"/>
    <pav:createdOn>2014-07-07 08:06:55 -0400</pav:createdOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:635A8912-2E77-4AD2-81FB-45E1C9894AD9"/>
    <dct:description>The NER set is created automatically by NER annotation loading program.</dct:description>
    <ao:item rdf:resource="urn:domeoclient:uuid:D7023550-028F-4956-B8CA-87F1AF29A164"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:CE2BC04A-D693-485A-B82C-FEE60FDF69CE"/>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-197.txt.html</ao:annotatesResource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:8970D075-A578-4CF9-A375-2EC114212349">
    <ao:exact>fluconazole </ao:exact>
    <domeo:uuid>8970D075-A578-4CF9-A375-2EC114212349</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>AUC and Cmax. There was a mean ± SD decrease in fluconazole AUC of 13% ± 11% (range: -3.4 to -31%) and Cmax decreased 19% ± 14% (range: -5 to -40%). However, the administration of cimetidine 600 mg to 900 mg intravenously over a four-hour period (from on</ao:suffix>
    <pav:createdOn>2014-07-07 20:08:10 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-23.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:8970D075-A578-4CF9-A375-2EC114212349"/>
    <ao:prefix>, there was a significant decrease in </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:8089D978-0806-4028-BD81-F0F8C4FFD1CB">
    <ao:context rdf:resource="urn:domeoclient:uuid:A54BFD6B-7482-4F25-BF0E-B47364BE4AE8"/>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <ao:body rdf:nodeID="Nbd202d0d3288464696567c39ab317f48"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:23515E27-98AC-4DC9-A4B7-EBFE2991219F</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotationset:57174A7C-3100-4C8F-9C4A-2991CEE124D5</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:createdOn>2014-07-08 08:51:44 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:previousVersion>urn:domeoclient:uuid:5BCE2FDB-C586-44CD-88F7-6EE2BDB6B929</pav:previousVersion>
    <pav:lastSavedOn>2014-07-08 08:51:47 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/B676822C-14C1-443E-9666-2159275DC046">
    <rdfs:label>ketoconazole</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/6135</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:5299D5E7-53AE-4520-AE5A-6280B3954B0A">
    <ao:body rdf:nodeID="N4f05bdf122b7424da08d224f9508b605"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:createdOn>2014-07-08 09:27:11 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotation:954C720C-DCE5-41A4-9882-E037192E317C</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:A78E1E5A-8750-46B9-9E70-0549DAF3F010"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:7E425E73-12D2-4B08-9D70-75410DE87447</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:lastSavedOn>2014-07-08 09:27:36 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:9D7E7C43-98FA-48B1-A007-559C7E9E16DF">
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:098066AF-1EFC-46DD-B0DF-59694396B58B"/>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C71EBA4C-AB92-4094-AB7C-2AE0FD34CF7A">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:C71EBA4C-AB92-4094-AB7C-2AE0FD34CF7A"/>
    <ao:exact>ketoconazole </ao:exact>
    <ao:prefix>500 mg every 8 hours or </ao:prefix>
    <domeo:uuid>C71EBA4C-AB92-4094-AB7C-2AE0FD34CF7A</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-139.txt.html</ao:hasSource>
    <ao:suffix>400 mg once daily under steady-state conditions to healthy adult subjects (n = 24, each study). No differences in adverse events or QTc interval were observed when subjects were administered fexofenadine hydrochloride alone or in combination with either </ao:suffix>
    <pav:createdOn>2014-07-08 09:32:13 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/8D44C172-C6F0-4671-9756-C4F28A2B2863">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/6754</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>meperidine</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:399FF35C-A05B-43A2-B4E2-580847186BC6">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:23515E27-98AC-4DC9-A4B7-EBFE2991219F</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-08 08:46:38 -0400</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:76E8E56C-9AAD-4A5A-879F-46EAAD1DF56E"/>
    <pav:createdOn>2014-07-08 08:45:50 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotationset:57174A7C-3100-4C8F-9C4A-2991CEE124D5</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:9B7CF463-6EFD-4D7B-AE5F-CFFFC40C6107">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:9B7CF463-6EFD-4D7B-AE5F-CFFFC40C6107"/>
    <pav:createdOn>2014-07-08 14:20:01 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>GZDV</ao:exact>
    <domeo:uuid>9B7CF463-6EFD-4D7B-AE5F-CFFFC40C6107</domeo:uuid>
    <ao:prefix>. </ao:prefix>
    <ao:suffix> AUC is about 3-fold greater than the </ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-197.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:9F8F3833-59D2-418E-848E-66B8A9611402">
    <domeo:belongsToSet>urn:domeoserver:annotationset:A5E637EF-5CA5-4AAC-BD8B-C136A86E17B7</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:0D6D5C14-8BCC-4BA3-9883-54BDC79B61E5"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2014-07-07 09:41:38 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotationset:F37BE993-E972-47AE-896D-FF4D33157ECF</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2014-07-07 09:44:18 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:06F5C90C-030E-4FE1-8B9D-CE973BCF5CB1">
    <ao:context rdf:resource="urn:domeoclient:uuid:A44B41B9-1491-478F-A1F2-B5977950A14F"/>
    <pav:createdOn>2014-07-08 09:32:11 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotation:BC43E72D-6A8E-437A-95D5-C97C72024F3F</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:423352B3-8ABA-48B7-98CF-B191A7BFC955</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-08 09:35:29 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:6F2B5845-C4F5-4D77-863D-AC80C65DCD9F">
    <pav:lineageUri>urn:domeoserver:annotationset:0f67c012-7596-4b02-a927-63c0ccbc3afa</pav:lineageUri>
    <pav:lastSavedOn>2014-07-08 14:24:44 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:createdOn>2014-07-08 14:20:08 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">3</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:previousVersion>urn:domeoclient:uuid:e75c9d7b-f906-4c66-8a84-e6eef34d0954</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:FD81958B-6AF6-4FD6-AAA0-0B848C953DF2"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:42258B16-6749-4B39-B28D-88C8B63F7A43</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:77BD2F8D-9D87-4DDC-A22F-C446DE12BF30">
    <pav:createdOn>2014-07-08 08:59:07 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2014-07-08 09:00:25 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:BFBB2077-1A80-4B2E-AEB9-4B0C13D522DC"/>
    <pav:lineageUri>urn:domeoserver:annotation:31E0B31E-8C9D-4D71-9255-335C90E27B5D</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoclient:uuid:86E1DCE1-FFC6-4513-AEF9-EF158A019E6B</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:FB87340E-70BC-45FD-9049-CFF3CB56C885">
    <domeo:uuid>FB87340E-70BC-45FD-9049-CFF3CB56C885</domeo:uuid>
    <ao:suffix>[see Contraindications (4.2)]</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-104.txt.html</ao:hasSource>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:exact>Conivaptan is a sensitive substrate of CYP3A. The effect of ketoconazole, a potent CYP3A inhibitor, on the pharmacokinetics of intravenous conivaptan has not been evaluated. Coadministration of oral conivaptan hydrochloride 10 mg with ketoconazole 200 mg resulted in 4- and 11-fold increases in Cmax and AUC of conivaptan, respectively </ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:FB87340E-70BC-45FD-9049-CFF3CB56C885"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-08 16:23:13 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:DBCA122B-BC4C-436B-B180-3AB768003708">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/6F932F0B-7816-45CF-B148-22F02B5B7B6C"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/01C26E45-CF08-4563-A5B1-557526382E74"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:9624A634-CBAF-4D19-8751-5D4FA8D21BF0">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:9624A634-CBAF-4D19-8751-5D4FA8D21BF0"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>and its active</ao:prefix>
    <ao:exact> N-desmethyl</ao:exact>
    <ao:suffix> metabolite were 45% and 57%, respectively.</ao:suffix>
    <domeo:uuid>9624A634-CBAF-4D19-8751-5D4FA8D21BF0</domeo:uuid>
    <pav:createdOn>2014-07-07 09:38:54 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:24A8B748-5958-4D4A-998D-BA9C4302D6A0">
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:FA39732E-D1AD-4544-9A39-20503C4846DA"/>
    <pav:createdOn>2014-07-08 09:32:30 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoclient:uuid:423352B3-8ABA-48B7-98CF-B191A7BFC955</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotation:A5E55158-3EF4-43F4-AB0F-1EBD7BD627C4</pav:lineageUri>
    <pav:lastSavedOn>2014-07-08 09:35:29 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F2EFEF06-B779-484C-B854-043086EB0C5C">
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <domeo:deleted>false</domeo:deleted>
    <permissions:permissions rdf:nodeID="Nb4ca3880c32e4959be4b65b29e2fb7db"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:item rdf:resource="urn:domeoclient:uuid:0B7913F4-388C-4002-8FA4-241C4EC6EFC6"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:2C899ABB-BA3D-4B6D-A232-E2DC49EE1B42"/>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-118.txt.html</ao:annotatesResource>
    <ao:item rdf:resource="urn:domeoclient:uuid:F2AC25E9-648C-455E-B53B-3BEC0E388961"/>
    <pav:createdOn>2014-07-07 20:39:51 -0400</pav:createdOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:E79A8B07-C97C-4FF7-AAE4-9F4E086B09E0"/>
    <rdfs:label>Default Set</rdfs:label>
    <pav:lastSavedOn>2014-07-07 20:44:32 -0400</pav:lastSavedOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:9A08728A-0366-405A-AA48-2BD8B1D0020A"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:654BC67C-55B7-4366-83A3-A8867DBD9F8B"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812e52b20002"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:17F54F78-521F-4253-8066-6179D4917E00"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotationset:27F1051A-2400-4EF3-8FB0-E834C7E06612</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:FCE26E10-B287-4815-9A1E-2DDCDFC0F852">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-07-08 08:46:38 -0400</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2014-07-08 08:45:59 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:B957C19D-4651-4FB6-B157-0A13B8DE6324"/>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:23515E27-98AC-4DC9-A4B7-EBFE2991219F</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotationset:57174A7C-3100-4C8F-9C4A-2991CEE124D5</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:6D7C1380-88CC-4263-8E8D-19DF05403C31">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2014-07-08 13:56:02 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:DD05DE56-7B60-4C06-8552-D1DD652D8A79</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotation:62A71251-FEA5-4770-A22D-C88BBD97B16C</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-07-08 13:55:05 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:CC3F3206-2071-4ED8-BA80-7F860270CBD3"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:37D8DEDE-0751-4949-87AE-3706B36339CD">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-139.txt.html</ao:hasSource>
    <ao:suffix>had no effect on the pharmacokinetics of either erythromycin or ketoconazole. In two separate studies in healthy adult subjects, fexofenadine hydrochloride 120 mg twice daily (240 mg total daily dose) was coadministered with either erythromycin 500 mg ev</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:37D8DEDE-0751-4949-87AE-3706B36339CD"/>
    <ao:prefix>in healthy adult subjects. </ao:prefix>
    <pav:createdOn>2014-07-08 09:32:03 -0400</pav:createdOn>
    <domeo:uuid>37D8DEDE-0751-4949-87AE-3706B36339CD</domeo:uuid>
    <ao:exact>Fexofenadine </ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7AF9EBF8-2117-41ED-AFF0-409C2C82DEF0">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoclient:uuid:738231FC-4090-4D56-90FB-4FBFF166BD23</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:9CE4CEB9-85C0-4430-A721-05FF371838AA"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotation:E4E88FC8-82BF-44F8-9707-E495DD3C4F17</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdOn>2014-07-07 20:08:12 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2014-07-07 20:10:00 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:3CA5C2AE-41CD-4AFA-B575-63B5E8796CBC">
    <pav:lineageUri>urn:domeoserver:annotationset:cf593dca-fe93-451b-8f37-2a96e065da13</pav:lineageUri>
    <pav:createdOn>2014-07-21 10:00:56 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:32944008-A6C6-4D66-8C43-EE4CF2256965</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-21 10:02:11 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:previousVersion>urn:domeoclient:uuid:21a2d27a-13b1-4797-ba7a-c0517e32bb06</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">3</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:90121D3A-A478-4599-82CB-F5DD81CBFBDE"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:4FFCD141-5AA2-436C-9117-F0576C0823F5">
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:947CB97B-D444-436B-ADED-04B03318AEFC"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:BBB93B97-8AD4-4D2E-8D37-22B3781AEF71">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-08 08:54:46 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-07-08 08:52:14 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:23515E27-98AC-4DC9-A4B7-EBFE2991219F</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotation:DF8B7C0E-DF50-42B3-BECF-D9CD781E4F31</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:990DFAE4-E36B-4840-866B-401ADB1ACF3A"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:73EA79BC-116A-4FC3-B42D-B0804CB074E8">
    <ao:suffix>xsd:String</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-53.txt.html</ao:hasSource>
    <domeo:uuid>73EA79BC-116A-4FC3-B42D-B0804CB074E8</domeo:uuid>
    <pav:createdOn>2014-07-07 20:28:25 -0400</pav:createdOn>
    <ao:exact>Perhaps because of competition for the P450 3A4metabolic pathway, quinidine levels rise when ketoconazole is coadministered.</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:73EA79BC-116A-4FC3-B42D-B0804CB074E8"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:407FBD24-344A-40CA-B18B-841C2F55C44D">
    <pav:lastSavedOn>2014-07-07 10:03:14 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-07 09:57:54 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A5E637EF-5CA5-4AAC-BD8B-C136A86E17B7</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:2EBD1022-9ACE-4AD0-8A64-807BD0BEDD5F"/>
    <pav:lineageUri>urn:domeoserver:annotationset:F37BE993-E972-47AE-896D-FF4D33157ECF</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>urn:domeoclient:uuid:53FAA6D0-9A40-44F9-8FE0-3166137CEF10</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7667302E-8FB4-4133-9AA5-8A110A10EBC4">
    <pav:lastSavedOn>2014-07-07 20:38:37 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoclient:uuid:8D643EAC-88DF-4484-A479-D1E798544DF5</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:C4DC9582-5EF5-481D-8D20-F00BC67EBF18"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-07-07 20:38:01 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotation:294C9C77-A787-4F18-A2A6-7261DA89F68C</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:1E1426F8-CEA1-4F14-A350-042797326C36">
    <domeo:belongsToSet>urn:domeoserver:annotationset:A5E637EF-5CA5-4AAC-BD8B-C136A86E17B7</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-07 09:34:25 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:16BBE342-3A77-41E6-8363-68C4C9153AC1"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:lastSavedOn>2014-07-07 09:44:18 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotationset:F37BE993-E972-47AE-896D-FF4D33157ECF</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:4EBBC32F-0A6D-4C7D-A6E8-705144460C2D">
    <ao:suffix>and other oral coumarin anticoagulants, resulting in a prolongation of prothrombin time. This possible drug interaction should be considered when FLAGYL (metronidazole) is prescribed for patients on this type of anticoagulant therapy.</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-120.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-07 20:46:55 -0400</pav:createdOn>
    <domeo:uuid>4EBBC32F-0A6D-4C7D-A6E8-705144460C2D</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:4EBBC32F-0A6D-4C7D-A6E8-705144460C2D"/>
    <ao:prefix>has been reported to potentiate the anticoagulant effect of </ao:prefix>
    <ao:exact>warfarin </ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:77E3EB52-6F5F-4AD8-96BA-3C5C325BD32B">
    <ao:exact>The pharmacokinetics of propafenone was not affected by the coadministration of either propranolol or metoprolol. </ao:exact>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:77E3EB52-6F5F-4AD8-96BA-3C5C325BD32B"/>
    <pav:createdOn>2014-07-08 14:09:30 -0400</pav:createdOn>
    <domeo:uuid>77E3EB52-6F5F-4AD8-96BA-3C5C325BD32B</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-194.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:DFFE09AB-3270-45A4-925E-D7EC0F15E1D5">
    <ao:exact> ethinyl estradiol</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:DFFE09AB-3270-45A4-925E-D7EC0F15E1D5"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-07 20:00:38 -0400</pav:createdOn>
    <ao:suffix> and norethindrone. In this placebo-controlled, double-blind, randomized, two-way crossover study carried out over three cycles of oral contraceptive treatment, fluconazole dosing resulted in small increases in the mean AUCs of ethinyl estradiol and nore</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-21.txt.html</ao:hasSource>
    <domeo:uuid>DFFE09AB-3270-45A4-925E-D7EC0F15E1D5</domeo:uuid>
    <ao:prefix>300 mg to 21 normal females taking an oral contraceptive containing</ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:27B4044D-BAED-42FB-996A-CEFABBB885A4">
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:676B923B-76C4-4DC8-A8B1-EB5F0038B6C7"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:41960471-ACCF-442F-9B2E-192108B22043">
    <pav:lineageUri>urn:domeoserver:annotation:4AD78CF5-8C99-4F0F-A863-7B1A684C7983</pav:lineageUri>
    <pav:lastSavedOn>2014-07-08 08:54:46 -0400</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:06479317-E885-46F1-8D20-E48995D73AC4"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:createdOn>2014-07-08 08:52:48 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:23515E27-98AC-4DC9-A4B7-EBFE2991219F</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:26E74365-668E-4061-AD6C-DA15F81B9DED">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-08 08:44:27 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:23515E27-98AC-4DC9-A4B7-EBFE2991219F</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-08 08:46:38 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:CD750D80-AF08-4465-A45F-72F0377642F3"/>
    <pav:lineageUri>urn:domeoserver:annotationset:57174A7C-3100-4C8F-9C4A-2991CEE124D5</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:9EBCFA10-46A7-47C1-8AAE-609323615F21">
    <domeo:uuid>9EBCFA10-46A7-47C1-8AAE-609323615F21</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:9EBCFA10-46A7-47C1-8AAE-609323615F21"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>AUC and Cmax by 46% and 35%, respectively. Co-administration with aluminum hydroxide gel (1200 mg) may result in a decrease in propranolol concentrations.</ao:suffix>
    <ao:exact>propranolol </ao:exact>
    <ao:prefix>, a non-specific CYP450 inhibitor, increased </ao:prefix>
    <pav:createdOn>2014-07-08 09:10:13 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-129.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:FD4F20A0-B3F7-4D56-A8C0-E8D9D6CC0DB4">
    <pav:createdOn>2014-07-07 19:48:34 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>risperidone </ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <domeo:uuid>FD4F20A0-B3F7-4D56-A8C0-E8D9D6CC0DB4</domeo:uuid>
    <ao:suffix>rapidly into 9-hydroxyrisperidone, whereas poor CYP 2D6 metabolizers convert it much more slowly. Although extensive metabolizers have lower risperidone and higher 9-hydroxyrisperidone concentrations than poor metabolizers, the pharmacokinetics of risper</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:FD4F20A0-B3F7-4D56-A8C0-E8D9D6CC0DB4"/>
    <ao:prefix>. Extensive CYP 2D6 metabolizers convert </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:80BE5846-6376-42D1-BDBD-2FD62537AEF9">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotationset:57174A7C-3100-4C8F-9C4A-2991CEE124D5</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2014-07-08 08:46:38 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-08 08:42:27 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:063DDD2E-07DC-41EA-83C3-DC7D055BB450"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:23515E27-98AC-4DC9-A4B7-EBFE2991219F</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:1CA1EB38-4708-4F0C-8BC7-694C5D3F97F6">
    <pav:lastSavedOn>2014-07-08 13:56:02 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:DD05DE56-7B60-4C06-8552-D1DD652D8A79</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotation:1E27084C-C95F-4D28-ACA3-59263EB1FFCC</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-08 13:54:09 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:C2968B31-3033-4843-913A-6F5D6BB3F163"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:4E32FF86-5504-44C8-8C7C-6A378765B28D">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:4E32FF86-5504-44C8-8C7C-6A378765B28D"/>
    <domeo:uuid>4E32FF86-5504-44C8-8C7C-6A378765B28D</domeo:uuid>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:suffix>(800 mg), a nonspecific CYP inhibitor, caused a 56% increase in plasma sildenafil concentrations when co-administered with sildenafil (50 mg) to healthy volunteers.</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-07 09:41:47 -0400</pav:createdOn>
    <ao:exact>Cimetidine </ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7E6B38CA-10F3-41E5-9A31-80E5F9447237">
    <pav:createdOn>2014-07-07 20:36:57 -0400</pav:createdOn>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-58.txt.html</ao:annotatesResource>
    <pav:lineageUri>urn:domeoserver:annotationset:7762BA78-C3C3-4AEC-937C-AF9F505B0E73</pav:lineageUri>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <pav:lastSavedOn>2014-07-07 20:37:16 -0400</pav:lastSavedOn>
    <rdfs:label>Default Set</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:item rdf:resource="urn:domeoclient:uuid:69181454-C97E-4504-8427-9DD543BDF751"/>
    <domeo:deleted>false</domeo:deleted>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812e52b20002"/>
    <permissions:permissions rdf:nodeID="Ne38c3e54b3d2457da7aa506ad1f94598"/>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:39C356F9-335F-4E0C-A1CD-9C873D70F463"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:904576B5-11ED-425A-99B3-7DAF7EDF432D"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:2D3C474B-0547-4FC1-91FE-9AE5EFAE0DA6">
    <ao:suffix> decreases fexofenadine gastrointestinal secretion, while erythromycin may also decrease biliary excretion.</ao:suffix>
    <pav:createdOn>2014-07-08 09:32:36 -0400</pav:createdOn>
    <ao:exact>ketoconazole</ao:exact>
    <domeo:uuid>2D3C474B-0547-4FC1-91FE-9AE5EFAE0DA6</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-139.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:2D3C474B-0547-4FC1-91FE-9AE5EFAE0DA6"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>may be due to transport-related effects, such as p-glycoprotein. In vivo animal studies also suggest that in addition to enhancing absorption, </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:734AC941-3742-4348-B334-A442FCED1802">
    <pav:createdOn>2014-07-07 20:23:21 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:2580ACE5-64C0-4D85-9807-043744CE64D7"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:lastSavedOn>2014-07-07 20:25:19 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoclient:uuid:5F40D6FC-BF07-4E5A-BB51-EB521FF63890</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotation:FC8C2E17-6B0A-4DF0-8956-6026FC8E93E5</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:6B6E16AF-4BB6-4379-93DA-F5E3F37A8E6A">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>6B6E16AF-4BB6-4379-93DA-F5E3F37A8E6A</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-07 09:35:03 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:6B6E16AF-4BB6-4379-93DA-F5E3F37A8E6A"/>
    <ao:suffix>is only about 10-fold as potent for PDE5 compared to PDE6, an enzyme found in the retina and involved in the phototransduction pathway of the retina. This lower selectivity is thought to be the basis for abnormalities related to color vision observed wit</ao:suffix>
    <ao:prefix>terases (10-fold for PDE6, &gt; 80-fold for PDE1, &gt; 700-fold for PDE2, PDE3, PDE4, PDE7, PDE8, PDE9, PDE10, and PDE11). The approximately 4,000-fold selectivity for PDE5 versus PDE3 is important because PDE3 is involved in control of cardiac contractility. </ao:prefix>
    <ao:exact>Sildenafil </ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/F2055511-1EC5-4FD4-9AF0-6FF994359EA5">
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/261455</dailymed:activeMoietyRxCUI>
    <rdfs:label>avandia</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/drug-product"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:930AAFB6-BA24-4725-8133-8B8E35E9EFDA">
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:E4B983E4-C5EE-4550-8111-73443B99C14D"/>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:52C66958-9EEC-4D18-8497-ED1E2AE2874B">
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotation:E1A7E847-DA40-4020-9004-E18AB5CE7B75</pav:lineageUri>
    <pav:createdOn>2014-07-07 20:22:09 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-07-07 20:22:41 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoclient:uuid:ACDB13DF-BBDB-49E3-A225-176E6DBB207B</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:1269AD96-8843-4C29-B650-67CFC82561F7"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:0DD2BBBF-A36C-4846-BBC8-836F69996988">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>0DD2BBBF-A36C-4846-BBC8-836F69996988</domeo:uuid>
    <ao:suffix>inhibits hepatic gluconeogenesis. The expression of the insulin-regulated glucose transporter GLUT-4 was increased in adipose tissue. Rosiglitazone did not induce hypoglycemia in animal models of type 2 diabetes and/or impaired glucose tolerance.</ao:suffix>
    <ao:prefix>was shown to be mediated by increased sensitivity to insulin’s action in the liver, muscle, and adipose tissues. Pharmacological studies in animal models indicate that </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:0DD2BBBF-A36C-4846-BBC8-836F69996988"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-08 08:39:19 -0400</pav:createdOn>
    <ao:exact>rosiglitazone </ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F4DEE747-44B2-415E-9E6F-F3F338479E38">
    <domeo:belongsToSet>urn:domeoclient:uuid:CE45A5D4-BD84-4E02-AC7B-C9E12233EC3A</domeo:belongsToSet>
    <pav:createdOn>2014-07-07 20:21:37 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:body rdf:nodeID="N384a64adbc6c47c3b80afb9001d29be8"/>
    <pav:lineageUri>urn:domeoserver:annotation:3601B163-451A-4ACD-9CFC-9E2EC8FA3779</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:67290D43-D034-4ECB-BD38-A08DD2769327"/>
    <pav:lastSavedOn>2014-07-07 20:21:40 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:70F265B2-12F9-4BC7-907F-CA98D66A89F8">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>were determined from a single intravenous dose of </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:70F265B2-12F9-4BC7-907F-CA98D66A89F8"/>
    <pav:createdOn>2014-07-07 20:18:53 -0400</pav:createdOn>
    <ao:suffix>(6 mg/kg) before and after the oral administration of fluconazole 200 mg daily for 14 days in 16 normal male volunteers. There were significant increases in theophylline AUC, Cmax, and half-life with a corresponding decrease in clearance. The mean ± SD t</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>aminophylline </ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-28.txt.html</ao:hasSource>
    <domeo:uuid>70F265B2-12F9-4BC7-907F-CA98D66A89F8</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B61D4953-D6C3-4380-900C-143D69B07EAC">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix>AUC by 127%, compared to the administration of rosiglitazone (4 mg once daily) alone. Given the potential for dose-related adverse events with rosiglitazone, a decrease in the dose of rosiglitazone may be needed when gemfibrozil is introduced [see Drug I</ao:suffix>
    <ao:prefix>(4 mg once daily) for 7 days increased </ao:prefix>
    <pav:createdOn>2014-07-08 08:45:54 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:B61D4953-D6C3-4380-900C-143D69B07EAC"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <ao:exact>rosiglitazone </ao:exact>
    <domeo:uuid>B61D4953-D6C3-4380-900C-143D69B07EAC</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:FB9E50B3-3BA9-4033-BB8D-53071BA97002">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:FB9E50B3-3BA9-4033-BB8D-53071BA97002"/>
    <domeo:uuid>FB9E50B3-3BA9-4033-BB8D-53071BA97002</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-106.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix> In four patients with cardiovascular disease, coadministration of</ao:suffix>
    <pav:createdOn>2014-07-08 16:16:08 -0400</pav:createdOn>
    <ao:prefix> concentration. </ao:prefix>
    <ao:exact>In healthy subjects with CYP2D6 extensive metabolizer phenotype, coadministration of quinidine 100 mg and immediate-release metoprolol 200 mg tripled the concentration of S-metoprolol and doubled the metoprolol elimination half-life.</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:8139AF01-AC5F-40BE-8565-A1FD9956367E">
    <pav:lineageUri>urn:domeoserver:annotation:1494CE85-DEED-466A-B1DF-8174CF9FFF9B</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:lastSavedOn>2014-07-07 20:26:26 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-07 20:25:50 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoclient:uuid:25536997-8B2D-4FC8-A79B-A98E343D3101</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:89FA163B-E81A-4575-957E-AB4A89C9439A"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:AF2C79DB-879F-48ED-AAFE-58E59F95753A">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:AF2C79DB-879F-48ED-AAFE-58E59F95753A"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-08 15:55:47 -0400</pav:createdOn>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:exact>In vitro studies indicate that risperidone is a relatively weak inhibitor of CYP 2D6. Therefore, risperidone is not expected to substantially inhibit the clearance of drugs that are metabolized by this enzymatic pathway. In drug interaction studies, risperidone did not significantly affect the pharmacokinetics of donepezil and galantamine, which are metabolized by CYP 2D6</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-7.txt.html</ao:hasSource>
    <domeo:uuid>AF2C79DB-879F-48ED-AAFE-58E59F95753A</domeo:uuid>
    <ao:suffix>xsd:String</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:887DF478-2114-4B46-8877-EB346E75B396">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5ABD9862-F044-4404-AD04-73DA04ADDA8B</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:4A8E6838-34F6-4B17-9D58-A9BC7B731D7C"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotationset:1DED06A6-8562-4CCF-A58C-CA25748FBD31</pav:lineageUri>
    <pav:lastSavedOn>2014-07-07 19:50:36 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:createdOn>2014-07-07 19:49:24 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/a556ea8c-1263-47d2-8fdd-a0ee8b13df5f">
    <ao:context rdf:resource="urn:domeoclient:uuid:1c6446b3-fba1-46a2-96b8-6f03a8c2dde7"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:41C6B392-F8A7-4DBA-AFEF-0BE07588FACF</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-07 08:07:02 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-07-07 08:07:02 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotationset:9bdd3ca4-63da-4da7-a445-d5869be1b040</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:47DC8C8E-41CE-4A4E-9F24-883332884266">
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:createdOn>2014-07-08 08:40:39 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2014-07-08 08:46:38 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:23515E27-98AC-4DC9-A4B7-EBFE2991219F</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotationset:57174A7C-3100-4C8F-9C4A-2991CEE124D5</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:7378A3C6-7673-4D96-9434-F9A9738108A2"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:5B6DD925-BCA7-4CD2-A767-823689EF5780">
    <ao:exact>fluconazole </ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-24.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:5B6DD925-BCA7-4CD2-A767-823689EF5780"/>
    <pav:createdOn>2014-07-07 20:10:21 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>administered as 600 mg daily in eight healthy male volunteers resulted in a significant decrease in </ao:prefix>
    <domeo:uuid>5B6DD925-BCA7-4CD2-A767-823689EF5780</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix>AUC and a significant increase in apparent oral clearance of fluconazole. There was a mean ± SD reduction in fluconazole AUC of 23% ± 9% (range: -13 to -42%). Apparent oral clearance of fluconazole increased 32% ± 17% (range: 16 to 72%). Fluconazole half</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:337FE4E5-D823-4551-923A-D6EF2ACC0F76">
    <pav:lineageUri>urn:domeoserver:annotation:95B1EFFF-1C2C-4742-97BA-AE8631D0EB41</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5ABD9862-F044-4404-AD04-73DA04ADDA8B</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2014-07-07 19:59:12 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-07 19:59:04 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:F5E4B1A3-C7BF-4842-AED6-20FD0118DE74"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:6922A1EC-C9EF-43D2-BB4F-88A72AC0485C">
    <ao:exact>ketoconazole </ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:6922A1EC-C9EF-43D2-BB4F-88A72AC0485C"/>
    <pav:createdOn>2014-07-07 20:27:44 -0400</pav:createdOn>
    <ao:prefix>levels rise when </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-53.txt.html</ao:hasSource>
    <domeo:uuid>6922A1EC-C9EF-43D2-BB4F-88A72AC0485C</domeo:uuid>
    <ao:suffix>is coadministered.</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/61820CD5-0B51-4F89-B183-2912AB3E7DAD">
    <rdfs:label>captopril</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:EACE1AAA-462E-48A6-8D60-4B6E4719ABD0">
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:42258B16-6749-4B39-B28D-88C8B63F7A43</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:C25F055F-A9AA-4B20-A17C-3208554B27FE"/>
    <pav:previousVersion>urn:domeoclient:uuid:e75c9d7b-f906-4c66-8a84-e6eef34d0954</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotationset:0f67c012-7596-4b02-a927-63c0ccbc3afa</pav:lineageUri>
    <pav:lastSavedOn>2014-07-08 14:24:44 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:createdOn>2014-07-08 14:21:05 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">3</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A4DDE736-6991-482F-8FEC-89A3FF535D38">
    <ao:exact> interferon alfa</ao:exact>
    <ao:suffix>. </ao:suffix>
    <ao:prefix>; and additive activity with</ao:prefix>
    <pav:createdOn>2014-07-08 14:25:47 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>A4DDE736-6991-482F-8FEC-89A3FF535D38</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-197.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:A4DDE736-6991-482F-8FEC-89A3FF535D38"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:AED0860A-0698-4A2A-8C7F-C0C3750004A3">
    <domeo:belongsToSet>urn:domeoserver:annotationset:A5E637EF-5CA5-4AAC-BD8B-C136A86E17B7</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotationset:F37BE993-E972-47AE-896D-FF4D33157ECF</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2014-07-07 09:44:18 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-07-07 09:44:06 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:32FCB542-392C-4F5D-83DD-53EC7815F41E"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:1E7CE8F9-62B5-44A0-AABC-50E8FF7C4D9E">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:1E7CE8F9-62B5-44A0-AABC-50E8FF7C4D9E"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-24.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-07 20:10:27 -0400</pav:createdOn>
    <ao:prefix>AUC of 23% ± 9% (range: -13 to -42%). Apparent oral clearance of </ao:prefix>
    <domeo:uuid>1E7CE8F9-62B5-44A0-AABC-50E8FF7C4D9E</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>increased 32% ± 17% (range: 16 to 72%). Fluconazole half-life decreased from 33.4 ± 4.4 hours to 26.8 ± 3.9 hours. (See PRECAUTIONS.)</ao:suffix>
    <ao:exact>fluconazole </ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A25E616C-DFAE-43E7-9DDF-ACDA2E92B74E">
    <ao:context rdf:resource="urn:domeoclient:uuid:A7EEADA2-34CA-40F2-9B7C-ED43FDDCB9DB"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:createdOn>2014-07-08 15:46:27 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotation:BEB698E5-0207-4E0C-A510-9E49BE782C2F</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5B2167F6-4E63-4A7B-85C1-ACA56DDE7073</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:body rdf:nodeID="N9cea969ea75e4d8ea6810dec10deb6d3"/>
    <pav:lastSavedOn>2014-07-08 15:56:00 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:FF239867-DDAA-4EE1-BD31-B9FE9F8EE013">
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:E60A06EA-9B09-4209-978B-BA42D2A6E6F6"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F0697D9D-646C-47A1-8922-F74AE2E2F93A">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-07-08 09:32:39 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoclient:uuid:423352B3-8ABA-48B7-98CF-B191A7BFC955</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:B81F7A57-C2F3-4C53-9A14-2E1BA72D7B7F"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2014-07-08 09:35:29 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotation:EED8F132-D796-4829-8DD6-21F58FF20C82</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:5D143EBD-CAED-45DA-B862-537A83975A7D">
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:114C154E-9AAD-46A3-988D-3FB10EF03E6B"/>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/BD40068E-3501-4592-ABFD-56C81D247946">
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/8787</dailymed:activeMoietyRxCUI>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>propranolol</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:4A5E94F2-5DDE-4570-9865-B005964BD549">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>4A5E94F2-5DDE-4570-9865-B005964BD549</domeo:uuid>
    <ao:suffix>xsd:String</ao:suffix>
    <pav:createdOn>2014-07-07 11:08:44 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:4A5E94F2-5DDE-4570-9865-B005964BD549"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <ao:exact>In a study of healthy male volunteers, co-administration of sildenafil at steady state (80 mg TID) with bosentan (a moderate inducer of CYP3A, CYP2C9 and possibly of cytochrome P450 2C19) at steady state (125 mg BID) resulted in a 63% decrease of sildenafil AUC and a 55% decrease in sildenafil Cmax. Co-administration resulted in a 50% increase in AUC of bosentan. The combination of both drugs did not lead to clinically significant changes in blood pressure (supine or standing). Concomitant administration of potent CYP3A inducers is expected to cause greater decreases in plasma levels of sildenafil.</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C36FACB4-80E8-4D03-B3E7-2142613CAB4A">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotationset:1DED06A6-8562-4CCF-A58C-CA25748FBD31</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:34C79DFC-63F9-4C19-AE17-236F4ABA72C4"/>
    <pav:lastSavedOn>2014-07-07 19:50:36 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5ABD9862-F044-4404-AD04-73DA04ADDA8B</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdOn>2014-07-07 19:47:30 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:EEAED69F-A841-4DBC-BBF5-77CF854BF645">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoclient:uuid:1D51EEDF-FCC9-44E1-A13B-BCE69023F944</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:BE38063F-250C-4F1D-8115-A4F1B32C6CA1"/>
    <pav:lineageUri>urn:domeoserver:annotation:AC026B9D-61F4-4665-B51E-347C3D189DE7</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-07-08 09:11:17 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-08 09:10:10 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:ABDF5E6F-63DD-422A-A52B-E7786B66AB1A">
    <domeo:belongsToSet>urn:domeoserver:annotationset:A5E637EF-5CA5-4AAC-BD8B-C136A86E17B7</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:C33B82E4-E381-41F5-928C-AC59F1E43884"/>
    <pav:lineageUri>urn:domeoserver:annotationset:F37BE993-E972-47AE-896D-FF4D33157ECF</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2014-07-07 09:44:18 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdOn>2014-07-07 09:33:57 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:63F252C5-805D-400B-BBE9-59DA6966187E">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>, a non-specific CYP450 inhibitor, increased propranolol AUC and Cmax by 46% and 35%, respectively. Co-administration with aluminum hydroxide gel (1200 mg) may result in a decrease in propranolol concentrations.</ao:suffix>
    <ao:exact>cimetidine</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:63F252C5-805D-400B-BBE9-59DA6966187E"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-129.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-08 09:10:11 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>63F252C5-805D-400B-BBE9-59DA6966187E</domeo:uuid>
    <ao:prefix>with </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:33BE73AD-3707-4143-B6D0-BA5C84ABC402">
    <ao:suffix>xsd:String</ao:suffix>
    <pav:createdOn>2014-07-08 15:27:47 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-85.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:33BE73AD-3707-4143-B6D0-BA5C84ABC402"/>
    <ao:exact>In a study of 13 healthy, male volunteers, a single 40 mg dose of tacrine added to fluvoxamine 100 mg/day administered at steady-state was associated with five- and eight-fold increases in tacrine Cmax and AUC, respectively, compared to the administration of tacrine alone. Five subjects experienced nausea, vomiting, sweating, and diarrhea following coadministration, consistent with the cholinergic effects of tacrine.</ao:exact>
    <domeo:uuid>33BE73AD-3707-4143-B6D0-BA5C84ABC402</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>xsd:String</ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:DA095187-0CC5-4431-AB91-5E7585F11CFC">
    <domeo:uuid>DA095187-0CC5-4431-AB91-5E7585F11CFC</domeo:uuid>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:exact>Experimental evidence demonstrated that methadone decreased the AUC and peak levels for didanosine and stavudine, with a more significant decrease for didanosine. Methadone disposition was not substantially altered.</ao:exact>
    <pav:createdOn>2014-07-08 15:30:06 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-198.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:DA095187-0CC5-4431-AB91-5E7585F11CFC"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:67DE42F1-8534-47B5-95C0-EB2604B1DD94">
    <pav:lineageUri>urn:domeoserver:annotationset:0f67c012-7596-4b02-a927-63c0ccbc3afa</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:42258B16-6749-4B39-B28D-88C8B63F7A43</domeo:belongsToSet>
    <pav:previousVersion>urn:domeoclient:uuid:e75c9d7b-f906-4c66-8a84-e6eef34d0954</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">3</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:3FA5BB25-CEBA-4007-911C-2781BAE80D1B"/>
    <pav:createdOn>2014-07-08 14:20:20 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-08 14:24:44 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:5BFA15F3-E5F6-4F30-873B-1F1AECDC49D6">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotationset:0f67c012-7596-4b02-a927-63c0ccbc3afa</pav:lineageUri>
    <pav:lastSavedOn>2014-07-08 14:24:44 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">3</pav:versionNumber>
    <pav:createdOn>2014-07-08 14:20:50 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:42258B16-6749-4B39-B28D-88C8B63F7A43</domeo:belongsToSet>
    <pav:previousVersion>urn:domeoclient:uuid:e75c9d7b-f906-4c66-8a84-e6eef34d0954</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:E86FD65C-A7D1-4674-9491-442FB2403EA6"/>
    <rdfs:label>Highlight</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/42898F9B-5014-43C1-9EC8-8305C2D81B57">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>diazepam</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/3322</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:52DF4CCD-81DA-45EC-A5AB-3F14F0A82EE1">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-07-07 09:43:55 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A5E637EF-5CA5-4AAC-BD8B-C136A86E17B7</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotationset:F37BE993-E972-47AE-896D-FF4D33157ECF</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:24ED1E6F-56F1-4237-96E7-5B65C8776EB0"/>
    <pav:lastSavedOn>2014-07-07 09:44:18 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:6834076A-FAEB-482A-9DB7-C25772BDB3DC">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-139.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>aluminum </ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:6834076A-FAEB-482A-9DB7-C25772BDB3DC"/>
    <domeo:uuid>6834076A-FAEB-482A-9DB7-C25772BDB3DC</domeo:uuid>
    <ao:suffix>and magnesium containing antacid (Maalox®1) decreased fexofenadine AUC by 41% and Cmax by 43%.</ao:suffix>
    <pav:createdOn>2014-07-08 09:30:42 -0400</pav:createdOn>
    <ao:prefix> (2 × 60 mg capsule) within 15 minutes of an </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/39FD41C7-82A3-43B9-8C95-EDB6013A5402">
    <rdfs:label>zidovudine</rdfs:label>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/11413</dailymed:activeMoietyRxCUI>
    <dct:description>Referred to the drug in the interaction.</dct:description>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:DE08B357-9C54-458B-8993-B39DAE0D54A4">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:A65792BF-C7C3-4053-BF81-2EC6DC37218A"/>
    <ao:body rdf:nodeID="N117049124655432bafe7633d805b02da"/>
    <pav:lineageUri>urn:domeoserver:annotation:AC91F963-9E18-4B74-B6E3-337214722E31</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <domeo:belongsToSet>urn:domeoclient:uuid:25536997-8B2D-4FC8-A79B-A98E343D3101</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdOn>2014-07-07 20:26:24 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-07-07 20:26:26 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:CACB74BB-5A35-40B2-8307-9910FB41E5E9">
    <pav:createdOn>2014-07-07 09:39:00 -0400</pav:createdOn>
    <domeo:uuid>CACB74BB-5A35-40B2-8307-9910FB41E5E9</domeo:uuid>
    <ao:prefix>In volunteers with mild (CLcr = 50–80 mL/min) and moderate (CLcr = 30–49 mL/min) renal impairment, the pharmacokinetics of a single oral dose of </ao:prefix>
    <ao:exact>sildenafil </ao:exact>
    <ao:suffix>(50 mg) was not altered. In volunteers with severe (CLcr &lt; 30 mL/min) renal impairment, sildenafil clearance was reduced, resulting in approximately doubling of AUC and Cmax compared to age-matched volunteers with no renal impairment. In addition, N-desm</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:CACB74BB-5A35-40B2-8307-9910FB41E5E9"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7784C5C8-C087-4E77-9A96-3470246F49C0">
    <pav:createdOn>2014-07-08 08:48:08 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:previousVersion>urn:domeoclient:uuid:5BCE2FDB-C586-44CD-88F7-6EE2BDB6B929</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotationset:57174A7C-3100-4C8F-9C4A-2991CEE124D5</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:F634ECD3-0C71-4F52-B1B6-33B710A00E05"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-08 08:51:47 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:23515E27-98AC-4DC9-A4B7-EBFE2991219F</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E8841241-0057-420C-85E3-2C0EC4B7CC39">
    <ao:body rdf:nodeID="Nda6e5e534e4f482f9e14e29790f524fb"/>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:214DF6F3-5343-4E38-9F13-ECA8453B5867"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:063A7209-93BB-42E1-A05D-D45CEF402ED2</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:5E431DDB-B235-47B8-9DB0-B0059DEF33C1</pav:lineageUri>
    <pav:createdOn>2014-07-08 15:30:23 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-08 15:30:37 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:34E4ED58-41A8-4A59-AC41-E9419344BB30">
    <domeo:uuid>34E4ED58-41A8-4A59-AC41-E9419344BB30</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:34E4ED58-41A8-4A59-AC41-E9419344BB30"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>and its metabolites. Diazepam does not alter the pharmacokinetics of propranolol.</ao:suffix>
    <ao:exact>diazepam </ao:exact>
    <pav:createdOn>2014-07-08 09:08:00 -0400</pav:createdOn>
    <ao:prefix>, resulting in increased concentrations of </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-128.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:3FD41C4D-A301-4EA2-A72F-08EE8358A099">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotationset:F37BE993-E972-47AE-896D-FF4D33157ECF</pav:lineageUri>
    <pav:createdOn>2014-07-07 09:43:46 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-07-07 09:44:18 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:88317D5F-43A1-48DA-B434-36912C36BECD"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A5E637EF-5CA5-4AAC-BD8B-C136A86E17B7</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:9B8A0C07-FB7E-4123-8198-BCD117B2D02C">
    <ao:suffix>and its N-desmethyl metabolite equivalent to that of a 20 mg oral dose.</ao:suffix>
    <ao:exact>sildenafil </ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:9B8A0C07-FB7E-4123-8198-BCD117B2D02C"/>
    <ao:prefix>Injection is predicted to provide a pharmacological effect of </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>9B8A0C07-FB7E-4123-8198-BCD117B2D02C</domeo:uuid>
    <pav:createdOn>2014-07-07 09:37:49 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:3740D7B2-9B0B-4C7D-98C9-28B70BD55415">
    <pav:lastSavedOn>2014-07-07 09:44:18 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-07 09:44:04 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotationset:F37BE993-E972-47AE-896D-FF4D33157ECF</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A5E637EF-5CA5-4AAC-BD8B-C136A86E17B7</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:4E164FAD-B09D-4789-9CE9-9C3256D72F7D"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoserver:annotationset:DD05DE56-7B60-4C06-8552-D1DD652D8A79">
    <ao:item rdf:resource="urn:domeoclient:uuid:4E670826-BB84-4FC6-9C71-56D5954B67D8"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:item rdf:resource="urn:domeoclient:uuid:1CA1EB38-4708-4F0C-8BC7-694C5D3F97F6"/>
    <domeo:deleted>false</domeo:deleted>
    <ao:item rdf:resource="urn:domeoclient:uuid:60BFFA8D-E145-4DFC-8C66-2E9B95CC3326"/>
    <pav:lineageUri>urn:domeoserver:annotationset:8f2fd34a-0a5c-4e94-b4a5-d7503a4c0137</pav:lineageUri>
    <pav:previousVersion>urn:domeoclient:uuid:61dc5568-fcab-47ee-8068-a81b95cc605e</pav:previousVersion>
    <pav:createdOn>2014-07-07 08:06:59 -0400</pav:createdOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:A1A9EF24-D8A1-45AE-81E7-25DD7BF04427"/>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-195.txt.html</ao:annotatesResource>
    <ao:item rdf:resource="urn:domeoclient:uuid:20339A30-6028-423D-87E1-5386E60BEAB9"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:E737183E-644F-428E-8509-B0ACD6712B9E"/>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <permissions:permissions rdf:nodeID="N172c327ab41f458ab288cae0703380b4"/>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812e52b20002"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:6D7C1380-88CC-4263-8E8D-19DF05403C31"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:33B5B85B-A4D6-4250-A416-8CBD8D621A6F"/>
    <rdfs:label>NER Sets</rdfs:label>
    <pav:lastSavedOn>2014-07-08 13:56:02 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">3</pav:versionNumber>
    <ao:item rdf:resource="urn:domeoclient:uuid:C91AB158-FD90-483E-AE34-00AABE4346B0"/>
    <ao:item rdf:resource="file:///home/yin2/python-SPL-connector/0ffed011-6a9b-485f-a69c-ebe76eb77903"/>
    <dct:description>The NER set is created automatically by NER annotation loading program.</dct:description>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <ao:item rdf:resource="urn:domeoclient:uuid:102525F0-3A81-481E-ABF7-39F13AF8C42F"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/02AD7A69-B306-4B61-A307-74F9427F8412">
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>erythromycin</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/4053</dailymed:activeMoietyRxCUI>
    <dct:description>Referred to the drug in the interaction.</dct:description>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:6D6548E2-7D2B-452A-82BD-490EFFDD8FDF">
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdOn>2014-07-08 12:24:41 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotation:F656D6A1-8406-4B57-A8C4-82E6CE8F9EDD</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:8B476D0C-9B27-4B08-A7C5-2F86AC7912F3"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:lastSavedOn>2014-07-08 12:25:30 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoclient:uuid:D9F8F6A3-1C3D-4E25-9870-A403388D2394</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B15A6265-63A9-410E-AC8A-F808A123B565">
    <ao:context rdf:resource="urn:domeoclient:uuid:86052697-6C0F-4E2F-9991-D28255AC0B0E"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoclient:uuid:D74AEF81-5B9A-431F-9F0D-1822391A7E30</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:createdOn>2014-07-08 12:03:01 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2014-07-08 12:05:20 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotation:6F77AC8A-153C-474D-9245-1B0D3FEC90F9</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:21DE8793-4F0E-4DE8-AB49-FB83D02C8C3A">
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdOn>2014-07-08 08:45:45 -0400</pav:createdOn>
    <ao:body rdf:nodeID="Nfb03440ea9f24e0694ce7337bff52953"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:9B5297FD-0CCC-46CB-B3D6-051A21EC4A28"/>
    <pav:lastSavedOn>2014-07-08 08:46:38 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotationset:57174A7C-3100-4C8F-9C4A-2991CEE124D5</pav:lineageUri>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:23515E27-98AC-4DC9-A4B7-EBFE2991219F</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:83E35C31-8662-4D63-8D75-4E5962696051">
    <ao:body rdf:nodeID="N67994f49c7d746418505f3d25cd62ae1"/>
    <pav:lineageUri>urn:domeoserver:annotation:7C087C10-DC8A-4733-BA3E-84F5B271D446</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:73EA79BC-116A-4FC3-B42D-B0804CB074E8"/>
    <pav:createdOn>2014-07-07 20:28:25 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-07 20:28:50 -0400</pav:lastSavedOn>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <domeo:belongsToSet>urn:domeoclient:uuid:CB4806A3-01B7-46D7-A04A-F22C0AA913DE</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:0EA140F6-E6A7-459C-BD6F-2848A9DDACC5">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:0EA140F6-E6A7-459C-BD6F-2848A9DDACC5"/>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:exact>Rifampin</ao:exact>
    <pav:createdOn>2014-07-08 08:46:44 -0400</pav:createdOn>
    <domeo:uuid>0EA140F6-E6A7-459C-BD6F-2848A9DDACC5</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>xsd:String</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Na46a479b0868494f9b860e5c8d4dabb1">
    <permissions:accessType>urn:person:uuid:080e143046812afe0146812e52b20002</permissions:accessType>
    <permissions:isLocked>false</permissions:isLocked>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F44B6567-1288-433F-AF8E-39F4AC950E60">
    <ao:context rdf:resource="urn:domeoclient:uuid:6C2F9CC6-9435-47F5-9EFD-DCFBD6F053CC"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5ABD9862-F044-4404-AD04-73DA04ADDA8B</domeo:belongsToSet>
    <pav:createdOn>2014-07-07 19:48:43 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotationset:1DED06A6-8562-4CCF-A58C-CA25748FBD31</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-07-07 19:50:36 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7EC09D50-4E84-47E5-9959-BBF2701873AB">
    <pav:createdOn>2014-07-07 20:39:54 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:7EC09D50-4E84-47E5-9959-BBF2701873AB"/>
    <ao:prefix>(repeated oral doses) and </ao:prefix>
    <domeo:uuid>7EC09D50-4E84-47E5-9959-BBF2701873AB</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-118.txt.html</ao:hasSource>
    <ao:suffix>(intravenous bolus dose) in healthy volunteers led to elevated plasma concentrations of these drugs. The Cmax increased by 18% and 14% (median values) and the AUC increased by 44% and 33% for nifedipine and midazolam, respectively.</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>midazolam </ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:3FDD79AE-B4FE-4A32-B94F-86B9FA134E73">
    <domeo:belongsToSet>urn:domeoserver:annotationset:23515E27-98AC-4DC9-A4B7-EBFE2991219F</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-08 08:46:38 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:C4CDC7AA-D0B3-4BE7-9804-2D3ECDA935DA"/>
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotationset:57174A7C-3100-4C8F-9C4A-2991CEE124D5</pav:lineageUri>
    <pav:createdOn>2014-07-08 08:38:45 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:489AEDFE-F9B4-46D2-A1D5-CE787D9B9F27">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotation:ABC2AD96-1EF4-49E0-BC7B-5B56DDF9B1EC</pav:lineageUri>
    <pav:createdOn>2014-07-08 19:47:48 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:body rdf:nodeID="Ne309c6be35c74b0da4df1d44be4fd28b"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:AD5B6A0D-35F7-45B4-AEC9-1F259D4615D1</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:lastSavedOn>2014-07-08 19:47:49 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:995C6B02-7021-4FE7-BA75-B9C34AB69C09"/>
    <rdfs:label>expertstudy Annotation</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D895BF59-A109-46AB-82C8-77658F9BA940">
    <ao:context rdf:resource="urn:domeoclient:uuid:81021877-5153-4A5C-A823-BBBEE218D949"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-08 15:04:44 -0400</pav:createdOn>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotation:EC4649BD-2646-4E24-A402-033A963B7973</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <ao:body rdf:nodeID="N02158c619e844a19bf135a9540c3a74c"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:8B73FE17-4C95-404F-8029-1D158127FC25</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-08 15:05:01 -0400</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:5150A4B8-C71B-4315-88E2-A0ACAEA33BCB">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:5150A4B8-C71B-4315-88E2-A0ACAEA33BCB"/>
    <ao:suffix> are reached in 5 to 6 days (measured in extensive metabolizers).</ao:suffix>
    <pav:createdOn>2014-07-07 19:46:29 -0400</pav:createdOn>
    <domeo:uuid>5150A4B8-C71B-4315-88E2-A0ACAEA33BCB</domeo:uuid>
    <ao:prefix>are reached in 1 day in extensive metabolizers and would be expected to reach steady-state in about 5 days in poor metabolizers. Steady-state concentrations of </ao:prefix>
    <ao:exact>9-hydroxyrisperidone</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7821C64B-A0CD-480C-9DC8-F790FC33069A">
    <pav:lastSavedOn>2014-07-08 12:21:50 -0400</pav:lastSavedOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:C693AD83-B232-413C-A0F6-A65E4A1455AA"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:18B21DEF-1A61-46FA-A6B1-8FD67130FDC1"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:CE0DB488-E5B8-43F0-ADE4-EB39B88A60FA"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <pav:createdOn>2014-07-08 12:21:14 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812e52b20002"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:E1620511-F969-4540-93B1-035D34D82147"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:deleted>false</domeo:deleted>
    <permissions:permissions rdf:nodeID="N32b773b19e5043a99c729e387641b947"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:item rdf:resource="urn:domeoclient:uuid:5E808C42-45D6-40E3-B8B7-7D4A065EAB02"/>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <rdfs:label>Default Set</rdfs:label>
    <ao:item rdf:resource="urn:domeoclient:uuid:C99C25B2-D9D6-43F5-B56D-2BE19D76E9B7"/>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:99255C70-041A-42DF-B255-977CABD47162"/>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-165.txt.html</ao:annotatesResource>
    <pav:lineageUri>urn:domeoserver:annotationset:57713970-49F1-4985-9A90-51BE59B58EC9</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:10343BA1-CFD4-4E42-B692-9AE2060A8BC5">
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:724E7696-829F-4C35-B420-71C3F76F5576"/>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/B2DBECBC-E519-456B-B6A9-CD187A695253">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/83395</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>saquinavir</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:6F2AD00E-0200-441D-8668-3B27C3A3A66A">
    <ao:prefix>AUC was determined after 4 days of </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-25.txt.html</ao:hasSource>
    <domeo:uuid>6F2AD00E-0200-441D-8668-3B27C3A3A66A</domeo:uuid>
    <ao:suffix>dosing (200 mg daily, orally for 3 days followed by 250 mg intravenously for one dose) both with and without the administration of fluconazole (oral fluconazole 200 mg daily for 16 days) in 10 normal male volunteers. There was a significant increase in p</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:6F2AD00E-0200-441D-8668-3B27C3A3A66A"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-07 20:13:22 -0400</pav:createdOn>
    <ao:exact>phenytoin </ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7CFFCD0A-CB23-4373-B8B3-2B3A4C4B8588">
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:37D8DEDE-0751-4949-87AE-3706B36339CD"/>
    <pav:lastSavedOn>2014-07-08 09:35:29 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-08 09:32:03 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotation:EA0A877D-1D52-43B5-81E4-9D3C30549D74</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoclient:uuid:423352B3-8ABA-48B7-98CF-B191A7BFC955</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:38AA06CF-CFD2-443D-82BE-6543FB9C2898">
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:A3C91603-68F9-4C23-A55E-41C206B23CFB"/>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/87B49C8E-24A1-466A-9FB8-10E9639396E3">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/36437</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>sertraline</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:0C4614C9-71A5-41D9-A9D1-9F690873CC7E">
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-07-08 09:11:17 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:9EBCFA10-46A7-47C1-8AAE-609323615F21"/>
    <pav:lineageUri>urn:domeoserver:annotation:F0FB5A45-3E24-49F0-8F8A-0F5BD0FE6821</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoclient:uuid:1D51EEDF-FCC9-44E1-A13B-BCE69023F944</domeo:belongsToSet>
    <pav:createdOn>2014-07-08 09:10:13 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoserver:annotationset:0FEEAD08-987A-4FB4-A1A5-C8AB4B60CF6C">
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812e52b20002"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-08 13:51:14 -0400</pav:lastSavedOn>
    <domeo:deleted>false</domeo:deleted>
    <rdfs:label>NER Sets</rdfs:label>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <dct:description>The NER set is created automatically by NER annotation loading program.</dct:description>
    <pav:createdOn>2014-07-07 08:06:28 -0400</pav:createdOn>
    <pav:previousVersion>urn:domeoclient:uuid:b5000cb6-99cf-4918-9745-8a1b8c66b228</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotationset:569eb43c-544c-4c72-9e28-27efc85c4b70</pav:lineageUri>
    <ao:item rdf:resource="urn:domeoclient:uuid:E29379BB-3B42-46F1-AAD5-9403BAF6750F"/>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-200.txt.html</ao:annotatesResource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">3</pav:versionNumber>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <ao:item rdf:resource="file:///home/yin2/python-SPL-connector/640767f8-b8bf-4d33-a75b-f2719bee2075"/>
    <permissions:permissions rdf:nodeID="Na96265415b00433898977a6b3de62259"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:86E1DCE1-FFC6-4513-AEF9-EF158A019E6B">
    <ao:item rdf:resource="urn:domeoclient:uuid:F82D76EE-0210-4189-A137-BAA0B3A6054C"/>
    <permissions:permissions rdf:nodeID="Nd4aa9a77b49149b09c07e1eada5e953b"/>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812e52b20002"/>
    <pav:createdOn>2014-07-08 08:59:05 -0400</pav:createdOn>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <pav:lastSavedOn>2014-07-08 09:00:25 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-127.txt.html</ao:annotatesResource>
    <ao:item rdf:resource="urn:domeoclient:uuid:0B540045-9C31-4FA7-A8AB-D460F0BAA941"/>
    <rdfs:label>Default Set</rdfs:label>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:item rdf:resource="urn:domeoclient:uuid:88A53C37-C91D-4321-972E-215E698B9BF3"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:A81CDF4E-B534-40E7-AB46-5DB589762ADB"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:item rdf:resource="urn:domeoclient:uuid:AD989DCC-D79F-4B84-A75C-5D12A5840929"/>
    <pav:lineageUri>urn:domeoserver:annotationset:FF2DF58D-3EBA-4902-9121-F7D310925180</pav:lineageUri>
    <ao:item rdf:resource="urn:domeoclient:uuid:C19232C5-C67F-4BDB-B93E-0D5C690AD368"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:5CDFDD7B-38DF-4408-B5D4-B77F373BA882"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:77BD2F8D-9D87-4DDC-A22F-C446DE12BF30"/>
    <domeo:deleted>false</domeo:deleted>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:41602C88-4D14-4A90-A022-DE93CDD7B096">
    <pav:createdOn>2014-07-07 20:46:09 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:41602C88-4D14-4A90-A022-DE93CDD7B096"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>, </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-119.txt.html</ao:hasSource>
    <ao:suffix>or carbapenems. Study JRV 304 enrolled 450 patients (n = 229 Synercid; n= 221 Comparator) and Study JRV 305 enrolled 443 patients (n = 221 Synercid; n = 222 Comparator). </ao:suffix>
    <ao:exact>cephalosporins </ao:exact>
    <domeo:uuid>41602C88-4D14-4A90-A022-DE93CDD7B096</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F598ED30-6E74-4DA9-BC16-082FF843DCBA">
    <pav:previousVersion>urn:domeoclient:uuid:21a2d27a-13b1-4797-ba7a-c0517e32bb06</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:2967BEAF-4FBA-4182-BDBF-1E12F3816AC2"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">3</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2014-07-21 09:58:37 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotationset:cf593dca-fe93-451b-8f37-2a96e065da13</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:32944008-A6C6-4D66-8C43-EE4CF2256965</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-21 10:02:11 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:6FFD9FFA-5CED-4EE2-B68F-77212B4C447D">
    <pav:lastSavedOn>2014-07-08 09:20:18 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:3BF30024-BAFB-47A6-BC6D-3656B7A0EBD6"/>
    <domeo:deleted>false</domeo:deleted>
    <ao:item rdf:resource="urn:domeoclient:uuid:2B28BF73-0F68-4B78-8463-1B7C442CDAD9"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <rdfs:label>Default Set</rdfs:label>
    <ao:item rdf:resource="urn:domeoclient:uuid:6881E425-4339-4018-BEDA-1111C2CBC350"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:B36B628C-1C37-471D-B254-C3AB57FE04EC"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:08C502D4-52C2-4EA2-ACCF-536F3EE7524E"/>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-132.txt.html</ao:annotatesResource>
    <pav:createdOn>2014-07-08 09:18:51 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotationset:5DDFBA61-603C-47B4-B201-7AAFE6850CED</pav:lineageUri>
    <ao:item rdf:resource="urn:domeoclient:uuid:10FC2AE6-3D78-49F7-A50F-BE9A59A3CDC0"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812e52b20002"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:53ADDC78-18B4-44AD-ABBF-A30CDF275DCD"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:item rdf:resource="urn:domeoclient:uuid:51C71B58-C391-4F1C-932F-ABA9EBDD073F"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <permissions:permissions rdf:nodeID="N8a93165935c74feab832de0da8225b33"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:7C040413-A39D-43DF-8875-79B15B405CD2">
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:F384E0B8-1F36-4347-BCD2-B507489DD605"/>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:5F1E24AE-5F51-41CD-9C93-2A6088CE7FE9">
    <pav:lineageUri>urn:domeoserver:annotationset:F37BE993-E972-47AE-896D-FF4D33157ECF</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdOn>2014-07-07 09:37:37 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-07-07 09:44:18 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A5E637EF-5CA5-4AAC-BD8B-C136A86E17B7</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:BA759022-B015-4D11-8039-A1577FD96049"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F634ECD3-0C71-4F52-B1B6-33B710A00E05">
    <ao:suffix>AUC and Cmax of approximately 30%. In Japanese subjects, glyburide AUC and Cmax slightly increased following coadministration of AVANDIA.</ao:suffix>
    <ao:exact>glyburide </ao:exact>
    <domeo:uuid>F634ECD3-0C71-4F52-B1B6-33B710A00E05</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-08 08:48:08 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:F634ECD3-0C71-4F52-B1B6-33B710A00E05"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <ao:prefix>(8 mg once daily) for 8 days in healthy adult Caucasian subjects caused a decrease in </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E1D6ADF1-AE00-4E26-BA74-3E927A4DE5EA">
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:1EC9DEFA-A53D-41B6-AFEB-8FF1AF1315F9"/>
    <pav:lineageUri>urn:domeoserver:annotation:BC22F69F-7FBA-4953-8269-01E8C8581DA4</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5ABD9862-F044-4404-AD04-73DA04ADDA8B</domeo:belongsToSet>
    <pav:createdOn>2014-07-07 19:58:12 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-07-07 19:59:12 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D3FC01A7-CA51-4CBF-AD2B-28D403119A0A">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:D3FC01A7-CA51-4CBF-AD2B-28D403119A0A"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <domeo:uuid>D3FC01A7-CA51-4CBF-AD2B-28D403119A0A</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>, and </ao:prefix>
    <ao:suffix>) with risperidone may cause a decrease in the combined plasma concentrations of risperidone and 9-hydroxyrisperidone [see 7 DRUG INTERACTIONS]. It would also be possible for risperidone to interfere with metabolism of other drugs metabolized by CYP 2D6.</ao:suffix>
    <ao:exact>phenobarbital</ao:exact>
    <pav:createdOn>2014-07-07 19:49:17 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/E30EFB78-74C0-4737-AE5F-F2213012EDF0">
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>propranolol</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/8787</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:630EFBF6-01E4-4465-8FD1-6D3CAD06A978">
    <ao:prefix>, but </ao:prefix>
    <ao:exact>quinidine </ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:630EFBF6-01E4-4465-8FD1-6D3CAD06A978"/>
    <domeo:uuid>630EFBF6-01E4-4465-8FD1-6D3CAD06A978</domeo:uuid>
    <pav:createdOn>2014-07-07 20:29:20 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-54.txt.html</ao:hasSource>
    <ao:suffix>does not alter the kinetics of diltiazem.</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:677DCD4D-7FD4-4EE7-AF77-0C09D142FF98">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:lastSavedOn>2014-07-07 20:30:15 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotation:FA4224AA-EBB2-401B-B4C5-B969CD6CF483</pav:lineageUri>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <ao:body rdf:nodeID="N006a786d97d4430dbd4dceb4aafb2f18"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:06661B74-00AE-4DF7-A9CC-742273A11E94</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:A4A391DA-E5AB-48C9-9A15-DD1F4CCBB417"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:createdOn>2014-07-07 20:29:43 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:EE7C9EAC-785B-4B0C-84E2-41BCACF3E353">
    <pav:createdOn>2014-07-08 08:39:30 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:23515E27-98AC-4DC9-A4B7-EBFE2991219F</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotationset:57174A7C-3100-4C8F-9C4A-2991CEE124D5</pav:lineageUri>
    <pav:lastSavedOn>2014-07-08 08:46:38 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:930DBDA4-D11A-4E4F-9F43-FA805766DC7B"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E0BA825A-F88D-47F9-857E-632807039170">
    <pav:createdOn>2014-07-08 08:55:49 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-07-08 08:56:08 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:35FE2B2F-85BF-4055-BC00-B2EFD1FDE127"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:F62BD12C-2E69-42FB-A04C-B6D7C7FBB29C</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotation:3EEC163C-1D11-4497-914B-70CE07419CEC</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:82622DE7-39C8-4087-A05A-8F6B9B88AE40">
    <pav:lastSavedOn>2014-07-08 15:56:00 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5B2167F6-4E63-4A7B-85C1-ACA56DDE7073</domeo:belongsToSet>
    <pav:createdOn>2014-07-08 15:46:45 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotation:54FDC102-E463-43A9-83AD-F1752C8B4227</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:A7166004-450A-4B74-9142-1D57955CF692"/>
    <rdfs:label>Highlight</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/2EB5BFD8-91D0-4960-AB12-6CA32636AEE3">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>lovastatin</rdfs:label>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/6472</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A4C1675C-830C-42E2-AD7A-7D4C46BBDC10">
    <pav:createdOn>2014-07-08 08:48:01 -0400</pav:createdOn>
    <ao:prefix>(2 mg twice daily) taken concomitantly with </ao:prefix>
    <ao:exact>glyburide </ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <ao:suffix>(3.75 to 10 mg/day) for 7 days did not alter the mean steady-state 24-hour plasma glucose concentrations in diabetic patients stabilized on glyburide therapy. Repeat doses of AVANDIA (8 mg once daily) for 8 days in healthy adult Caucasian subjects caused</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:A4C1675C-830C-42E2-AD7A-7D4C46BBDC10"/>
    <domeo:uuid>A4C1675C-830C-42E2-AD7A-7D4C46BBDC10</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/136A3F0E-A044-4BEE-AE7D-57707845EA15">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>fluconazole</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/4450</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D3377A5F-678E-4E2C-B503-9C0CC3C16A04">
    <domeo:belongsToSet>urn:domeoserver:annotationset:A5E637EF-5CA5-4AAC-BD8B-C136A86E17B7</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotationset:F37BE993-E972-47AE-896D-FF4D33157ECF</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:E4AB0974-9669-4DE7-9384-60B4037F205C"/>
    <pav:createdOn>2014-07-07 09:39:03 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-07-07 09:44:18 -0400</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:FE61C61D-3EF7-4905-B0BB-DC49246A5C29">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/61EDB172-8B70-4F81-A8AF-29810964A17A"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/4A8BE959-FCBB-4145-9ACC-9103097BBE9E"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:301DCA49-781A-4962-BFAE-08B86B9610FE">
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <domeo:belongsToSet>urn:domeoclient:uuid:C0CE4AC7-F72D-4A94-BD3E-4720F127B810</domeo:belongsToSet>
    <pav:createdOn>2014-07-08 09:21:19 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotation:6C3B9A34-816B-4D77-806D-5788C33B609B</pav:lineageUri>
    <pav:lastSavedOn>2014-07-08 09:22:07 -0400</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:DF7F2528-C179-470A-BB1B-211F608C52F9"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:8A79FFFF-6F81-4C50-9759-0264E92AFDCF">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:8A79FFFF-6F81-4C50-9759-0264E92AFDCF"/>
    <ao:prefix>with </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>AVANDIA </ao:exact>
    <pav:createdOn>2014-07-08 08:43:46 -0400</pav:createdOn>
    <ao:suffix>is contraindicated in these patients.</ao:suffix>
    <domeo:uuid>8A79FFFF-6F81-4C50-9759-0264E92AFDCF</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A632B3CF-8D32-42A7-981F-B80010DA6C60">
    <pav:createdOn>2014-07-07 20:45:59 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-07-07 20:46:25 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:DA088FBF-9441-4B29-B79C-9A3099F33A47"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:E08D4CED-BE06-4A5F-A2AF-BFBC25BA8AE4</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotation:D8B0005F-2321-482A-98C8-35741E75A981</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C065E6E2-D8D0-471E-9A02-F7F39A2CED51">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:41C6B392-F8A7-4DBA-AFEF-0BE07588FACF</domeo:belongsToSet>
    <ao:body rdf:nodeID="Nf94d0350f8ba45b6a70b297c83e6598c"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:A3F1FD13-4CD2-4567-893C-0AFE467D43DA"/>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-08 14:51:45 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:lastSavedOn>2014-07-08 14:52:51 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotation:77C4E8A5-CB8E-4647-82BA-24648A203424</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:04501B56-E22B-4072-B48A-DD7DDF7B25F9">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotation:98AE9782-5A32-40BD-B3A0-29E67A30738D</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoclient:uuid:5F40D6FC-BF07-4E5A-BB51-EB521FF63890</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:8AB55D25-77EB-4034-A8F8-42FC9A097E65"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:createdOn>2014-07-07 20:23:19 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-07-07 20:25:19 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:ADF27897-075B-4F06-9D4C-568727330F07">
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:E1DB0015-3BC4-4263-9675-61E793413B41"/>
    <pav:lastSavedOn>2014-07-08 08:51:47 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdOn>2014-07-08 08:49:07 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotationset:57174A7C-3100-4C8F-9C4A-2991CEE124D5</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:23515E27-98AC-4DC9-A4B7-EBFE2991219F</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>urn:domeoclient:uuid:5BCE2FDB-C586-44CD-88F7-6EE2BDB6B929</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:07F30C2A-43FD-4CEE-AA13-00183CE2740B">
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:2BFF8E2A-425A-4FC7-A14C-E1B47EEBF558"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7CB45289-CCF2-4F84-BD15-310A349BFDB5">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:7CB45289-CCF2-4F84-BD15-310A349BFDB5"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>7CB45289-CCF2-4F84-BD15-310A349BFDB5</domeo:uuid>
    <pav:createdOn>2014-07-07 09:58:42 -0400</pav:createdOn>
    <ao:prefix>and the </ao:prefix>
    <ao:exact>active metabolite </ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix> have terminal half-lives of about 4 hours.</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:8ABB3BA6-84B3-4075-AAC2-963166B6BD0F">
    <domeo:belongsToSet>urn:domeoclient:uuid:ACDB13DF-BBDB-49E3-A225-176E6DBB207B</domeo:belongsToSet>
    <ao:body rdf:nodeID="N540d12b887df4ca0a0f079360c63f345"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:8ECB4F98-B732-4BB8-BF5E-356021CB465F"/>
    <pav:lineageUri>urn:domeoserver:annotation:335ED6F6-0582-4421-B2A0-E55DA7B8D127</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:createdOn>2014-07-07 20:22:40 -0400</pav:createdOn>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:lastSavedOn>2014-07-07 20:22:41 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:CC3F3206-2071-4ED8-BA80-7F860270CBD3">
    <ao:prefix> SR, the</ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:CC3F3206-2071-4ED8-BA80-7F860270CBD3"/>
    <ao:suffix> metabolite is usually present in concentrations less than 40% of </ao:suffix>
    <domeo:uuid>CC3F3206-2071-4ED8-BA80-7F860270CBD3</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-195.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact> 5-hydroxypropafenone</ao:exact>
    <pav:createdOn>2014-07-08 13:55:05 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:EBC8A919-3FB5-4437-80FF-7964A1A87A2E">
    <domeo:belongsToSet>urn:domeoserver:annotationset:23515E27-98AC-4DC9-A4B7-EBFE2991219F</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:FEE758AF-9694-4E13-8586-E5A05D6D8C08"/>
    <pav:createdOn>2014-07-08 08:42:16 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotationset:57174A7C-3100-4C8F-9C4A-2991CEE124D5</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2014-07-08 08:46:38 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D42A01CC-DBD2-4020-ABB3-06C1A1DED759">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:81086009-3EF9-4BBC-98D0-68FBC83686B3"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:23515E27-98AC-4DC9-A4B7-EBFE2991219F</domeo:belongsToSet>
    <pav:createdOn>2014-07-08 08:39:36 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotationset:57174A7C-3100-4C8F-9C4A-2991CEE124D5</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2014-07-08 08:46:38 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A815DD75-EEB0-49E8-A779-08BD77F47A89">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix>(repeated oral doses) and midazolam (intravenous bolus dose) in healthy volunteers led to elevated plasma concentrations of these drugs. The Cmax increased by 18% and 14% (median values) and the AUC increased by 44% and 33% for nifedipine and midazolam, </ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:A815DD75-EEB0-49E8-A779-08BD77F47A89"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-118.txt.html</ao:hasSource>
    <domeo:uuid>A815DD75-EEB0-49E8-A779-08BD77F47A89</domeo:uuid>
    <ao:prefix>and </ao:prefix>
    <ao:exact>nifedipine </ao:exact>
    <pav:createdOn>2014-07-07 20:39:53 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D74AEF81-5B9A-431F-9F0D-1822391A7E30">
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:item rdf:resource="urn:domeoclient:uuid:5312764C-8342-437B-90CA-DDB3491161DB"/>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <permissions:permissions rdf:nodeID="Naf87b445ea904f6f896e380f5f4de31a"/>
    <pav:lineageUri>urn:domeoserver:annotationset:F99B762E-241C-4ADA-AA7F-0D4F74E83914</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:item rdf:resource="urn:domeoclient:uuid:C316D717-8120-4EB8-9B24-36447358217A"/>
    <domeo:deleted>false</domeo:deleted>
    <ao:item rdf:resource="urn:domeoclient:uuid:5E480179-EDB1-4A8E-ACC2-B79CCF6CEAA5"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:69E0609F-6686-461A-8738-BCD370887AFD"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812e52b20002"/>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-161.txt.html</ao:annotatesResource>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <rdfs:label>Default Set</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:B15A6265-63A9-410E-AC8A-F808A123B565"/>
    <pav:lastSavedOn>2014-07-08 12:05:19 -0400</pav:lastSavedOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:51B32D0B-8711-4EBD-95FC-74EA8AD113CB"/>
    <pav:createdOn>2014-07-08 12:02:49 -0400</pav:createdOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:352EFDCC-85CC-4608-91F1-B7FD7E38CE94"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7F318094-6E7E-48F0-B2A1-FFD6ED36D9BB">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotation:04091AC4-9844-4370-96A9-B40E9913847B</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:9D31038F-F548-4C1C-941D-543901DA01FE"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdOn>2014-07-07 20:22:07 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-07-07 20:22:41 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoclient:uuid:ACDB13DF-BBDB-49E3-A225-176E6DBB207B</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C12DCA82-CE24-40D6-952A-A3F5395F8D27">
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdOn>2014-07-08 09:31:52 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotation:87F54ABC-93CF-477B-BB0F-222359E12152</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoclient:uuid:423352B3-8ABA-48B7-98CF-B191A7BFC955</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:B26D315F-8E16-41C8-8BB4-BABEB368E117"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-07-08 09:35:29 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/35947A3C-4AA6-4324-963E-A1060E9A91B8">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>diltiazem</rdfs:label>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/3443</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A62379B0-048F-4BBD-908C-20C585F768B6">
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <ao:body rdf:nodeID="Nd33b787970c3490390b5241899f30ccb"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-07-08 09:27:35 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoclient:uuid:7E425E73-12D2-4B08-9D70-75410DE87447</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotation:8B33964F-7040-4D86-A16B-48A9135F7C62</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:lastSavedOn>2014-07-08 09:27:36 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:F1BAACDB-0382-41E5-B208-2DF9A73756E9"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:52EA728D-4B57-4D63-9BBC-0060571DD8C0">
    <pav:previousVersion>urn:domeoserver:annotationset:6C113438-07CB-4840-A14B-360CDF3BD22A</pav:previousVersion>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:8D7BF51F-72A9-4D44-BDC4-91B1CBD96D9B"/>
    <pav:lastSavedOn>2014-07-08 15:45:42 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-08 15:44:53 -0400</pav:createdOn>
    <ao:body rdf:nodeID="Na78067124c114d52bc80faa58848e496"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotationset:061a21f6-0ef7-497f-bd03-574c24bc0d7c</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5B2167F6-4E63-4A7B-85C1-ACA56DDE7073</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">4</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:11D3A139-FD05-43C0-8AA3-D07CA93EB14C">
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdOn>2014-07-07 09:38:50 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-07-07 09:44:18 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotationset:F37BE993-E972-47AE-896D-FF4D33157ECF</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:0FA00623-B592-4E02-8ABA-910E6132FFD6"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A5E637EF-5CA5-4AAC-BD8B-C136A86E17B7</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:3233FF23-797B-4719-814E-5983784E20B1">
    <pav:createdOn>2014-07-08 09:33:02 -0400</pav:createdOn>
    <ao:exact>fexofenadine </ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-139.txt.html</ao:hasSource>
    <ao:suffix>was reduced by 36%. Therefore, to maximize the effects of fexofenadine, it is recommended that fexofenadine hydrochloride tablets should be taken with water [see Clinical Pharmacology (12.3) and Dosage and Administration (2.1)].</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:3233FF23-797B-4719-814E-5983784E20B1"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>3233FF23-797B-4719-814E-5983784E20B1</domeo:uuid>
    <ao:prefix>. The clinical significance of these observations is unknown. In addition, based on the population pharmacokinetics analysis of the combined data from grapefruit and orange juices studies with the data from a bioequivalence study, the bioavailability of </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:ABBCEFA8-F816-416D-87B3-F8BB5696B8F3">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:ABBCEFA8-F816-416D-87B3-F8BB5696B8F3"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix>, thus caution should be used with concomitant administration.</ao:suffix>
    <domeo:uuid>ABBCEFA8-F816-416D-87B3-F8BB5696B8F3</domeo:uuid>
    <ao:exact>acyclovir</ao:exact>
    <ao:prefix>, may be increased by </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-163.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-08 12:06:18 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E512F39B-79C1-4DCF-B972-C4F710C1BCBA">
    <pav:lastSavedOn>2014-07-08 09:35:29 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoclient:uuid:423352B3-8ABA-48B7-98CF-B191A7BFC955</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:9AA35071-3732-4009-A9D0-00F533858E04</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:createdOn>2014-07-08 09:31:53 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:F20CC5F6-7B62-4389-B083-04A7A4139190"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C4A1EB42-6814-4B22-B435-A9D85C6EA9EB">
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-07-21 09:46:26 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:506062D5-8533-4516-863B-C94A942F4B96"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:CEC2E6BB-4A0E-4F14-B024-B1C9027CF3AE</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-07-21 09:43:45 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotation:8936C41E-EA53-45AF-9435-C749C4A88EF2</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:BE5A0D78-7E41-4DAF-99D9-DD715C832E89">
    <pav:createdOn>2014-07-08 09:25:35 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoclient:uuid:7E425E73-12D2-4B08-9D70-75410DE87447</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotation:9BAAD81B-EF9F-4859-99CA-22FECC334CE0</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:81B87E22-AE85-42A9-BBA1-CDD6698F246F"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-07-08 09:27:36 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:56F78626-4EE9-4038-ADA8-61D7D5DDE571">
    <ao:body rdf:nodeID="N83cf286ecbb049219dc191ee472092ed"/>
    <pav:lineageUri>urn:domeoserver:annotationset:def720a3-9364-4d0d-a156-423274fb2386</pav:lineageUri>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:A972F880-764D-466A-8723-37A51E7F0A19"/>
    <pav:previousVersion>urn:domeoclient:uuid:203110ef-d319-4c8c-8da1-19d68e91f895</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7E49EB7A-DE0E-4720-82D1-8460BA0C770D</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">3</pav:versionNumber>
    <pav:createdOn>2014-07-08 13:59:24 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-07-08 13:59:58 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E0EC1D06-E110-4856-97AB-6EE6B8AB317F">
    <pav:lineageUri>urn:domeoserver:annotation:29B74E20-3CEC-4B9E-AA80-DE2E7E8C2AED</pav:lineageUri>
    <pav:createdOn>2014-07-08 09:14:51 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:38DA5B2B-8935-46B8-B188-C98F6F82CBF4"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <domeo:belongsToSet>urn:domeoclient:uuid:54F09193-5CC7-4ED3-9261-88C7428E0572</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2014-07-08 09:15:28 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D0E5A738-3AF8-4916-9A58-DD4E82CA9E9F">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:28BE4EBE-BA7D-4FBE-AB55-3A92D8AFFBF3"/>
    <pav:createdOn>2014-07-07 09:39:37 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotationset:F37BE993-E972-47AE-896D-FF4D33157ECF</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A5E637EF-5CA5-4AAC-BD8B-C136A86E17B7</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-07 09:44:18 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:C3CE169C-F943-430B-8542-3ECB65A617D0">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/555F64D6-85E8-4103-B25B-81DE0BC5656A"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/2EFEC6C2-03E2-4C62-B4F2-7F08370D57F3"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:33D490C1-2CDC-486B-B4B1-DF68A1F97CC7">
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2014-07-07 20:10:00 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:D6A8E94A-D28D-4635-9B7D-D4910DFAAC3B"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2014-07-07 20:08:17 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoclient:uuid:738231FC-4090-4D56-90FB-4FBFF166BD23</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:5B302F2E-6336-4F66-BA3E-92E470A2C77D</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:85BB898D-F66E-44D4-B7CB-0ED0EB4D70A8">
    <pav:lineageUri>urn:domeoserver:annotationset:cf593dca-fe93-451b-8f37-2a96e065da13</pav:lineageUri>
    <pav:previousVersion>urn:domeoclient:uuid:21a2d27a-13b1-4797-ba7a-c0517e32bb06</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:C01E1284-4B3F-42C4-B239-BEB354DB3D9C"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:32944008-A6C6-4D66-8C43-EE4CF2256965</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-21 10:02:11 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdOn>2014-07-21 10:01:13 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">3</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:1B145A34-470A-4CFA-97E7-2D53B9372910">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotation:09A496B3-054D-4996-B1A3-573BC78A5871</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:lastSavedOn>2014-07-08 12:08:36 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:0C47D7EE-6686-4B42-B21C-DE2132583AF4"/>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:15A8BD5A-D46C-4E84-8B70-5066D260486D</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-07-08 12:06:38 -0400</pav:createdOn>
    <ao:body rdf:nodeID="Nf051d5be4bc04cd7af04840c4db3bd8d"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:4B88BC04-B0EB-4FB6-9530-3AB96B6E4E46">
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:23515E27-98AC-4DC9-A4B7-EBFE2991219F</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-08 08:46:38 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotationset:57174A7C-3100-4C8F-9C4A-2991CEE124D5</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:DDA91BB7-5333-423E-AA15-01C0E39F278D"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2014-07-08 08:42:44 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:51B32D0B-8711-4EBD-95FC-74EA8AD113CB">
    <domeo:belongsToSet>urn:domeoclient:uuid:D74AEF81-5B9A-431F-9F0D-1822391A7E30</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-08 12:05:20 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotation:F0901CBD-0FE9-4E20-8237-E76CC76A2D1A</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:8A241659-7402-4319-97F5-5963D71DBD57"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:createdOn>2014-07-08 12:02:49 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:CB32CAD9-A4A5-47F2-8568-BBCE46210DCA">
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-08 08:46:38 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotationset:57174A7C-3100-4C8F-9C4A-2991CEE124D5</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-07-08 08:40:51 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:CA0432B1-CF34-4B94-AD8A-04978AE68C3A"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:23515E27-98AC-4DC9-A4B7-EBFE2991219F</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B81380C7-81CB-4A55-AFE6-3564A2B6FFA3">
    <ao:prefix>xsd:String</ao:prefix>
    <ao:suffix>xsd:String</ao:suffix>
    <domeo:uuid>B81380C7-81CB-4A55-AFE6-3564A2B6FFA3</domeo:uuid>
    <pav:createdOn>2014-07-08 15:59:45 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-109.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:B81380C7-81CB-4A55-AFE6-3564A2B6FFA3"/>
    <ao:exact>Diltiazem: Pretreatment of healthy volunteers with 30 mg or 90 mg t.i.d. diltiazem p.o. increased the AUC of nifedipine after a single dose of 20 mg nifedipine by factors of 2.2 and 3.1, respectively. The corresponding Cmax values of nifedipine increased by factors of 2.0 and 1.7, respectively. Caution should be exercised when coadministering diltiazem and nifedipine and a reduction of the dose of nifedipine should be considered.</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N16c7301a099a456bb280fd21ccf343c4">
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
    <permissions:isLocked>false</permissions:isLocked>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7C818BF8-AA65-4B86-AB2F-52969B6B4B4F">
    <pav:createdOn>2014-07-07 09:36:17 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A5E637EF-5CA5-4AAC-BD8B-C136A86E17B7</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:411EFF57-BDB0-4ADE-9CA0-6A141E246E64"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:lastSavedOn>2014-07-07 09:44:18 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotationset:F37BE993-E972-47AE-896D-FF4D33157ECF</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A68363CC-89C4-4421-AF09-72F49EC3E620">
    <ao:exact>The mean reduction of sildenafil (80 mg tid) bioavailability due to co-administration of epoprostenol was 28%, resulting in about 22% lower mean average steady state concentrations. Therefore, the slight decrease of sildenafil exposure in the presence of epoprostenol is not considered clinically relevant. The effect of sildenafil on epoprostenol pharmacokinetics is not known.</ao:exact>
    <pav:createdOn>2014-07-07 11:10:01 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:A68363CC-89C4-4421-AF09-72F49EC3E620"/>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>A68363CC-89C4-4421-AF09-72F49EC3E620</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>xsd:String</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:AB8171F3-07B9-42F6-9D75-FD10020A5985">
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:64F313A0-19D6-48B5-93D3-2BA905C097F9"/>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7C698764-20DE-4E53-85C8-AA7B6EB906A3">
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotation:A3753B0E-6C08-4610-9C2A-23504B6BE9BE</pav:lineageUri>
    <pav:createdOn>2014-07-08 12:26:32 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:A92286D9-3B1F-4493-AFE3-77FB27A6005F"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:06097890-DF39-4D30-9C17-EEF19190B2D7</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-08 12:26:36 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:5796459D-55EF-4FC9-9D80-8ECBDF39B127">
    <ao:prefix>Maximum plasma concentration (Cmax) and the area under the curve (AUC) of </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>5796459D-55EF-4FC9-9D80-8ECBDF39B127</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:5796459D-55EF-4FC9-9D80-8ECBDF39B127"/>
    <ao:suffix>increase in a dose-proportional manner over the therapeutic dose range (Table 8). The elimination half-life is 3 to 4 hours and is independent of dose.</ao:suffix>
    <pav:createdOn>2014-07-08 08:40:20 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <ao:exact>rosiglitazone </ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:ABBE08B5-9179-4F12-BC4A-EFAB1703FC14">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-07 20:48:02 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotation:4EC1BEEE-C6C5-4040-A52C-FA9BC3693D66</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:6A61BF30-0A71-478D-A329-0FB7BB575023"/>
    <pav:createdOn>2014-07-07 20:47:03 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoclient:uuid:5741C3AA-07D0-4BB3-9A9F-55B13B957620</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:654BC67C-55B7-4366-83A3-A8867DBD9F8B">
    <pav:createdOn>2014-07-07 20:40:00 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotation:52CE5300-4722-4F7A-AC90-5B77A12E021B</pav:lineageUri>
    <pav:lastSavedOn>2014-07-07 20:44:32 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoclient:uuid:F2EFEF06-B779-484C-B854-043086EB0C5C</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:23272370-6EDA-4C06-9199-D13977C538E5"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:FDBFD92B-DC7C-44FB-8F3D-3C3A11A0F0DD">
    <pav:lastSavedOn>2014-07-07 10:03:14 -0400</pav:lastSavedOn>
    <pav:previousVersion>urn:domeoclient:uuid:53FAA6D0-9A40-44F9-8FE0-3166137CEF10</pav:previousVersion>
    <pav:createdOn>2014-07-07 09:57:20 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotationset:F37BE993-E972-47AE-896D-FF4D33157ECF</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:2E1A3A60-E806-4B27-8C91-3F81F0B2226B"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A5E637EF-5CA5-4AAC-BD8B-C136A86E17B7</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:8eee6a59-46ed-4041-8ebd-ab9bd943229b">
    <domeo:uuid></domeo:uuid>
    <ao:exact>propranolol</ao:exact>
    <pav:createdOn>2014-07-07 08:06:51 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:8eee6a59-46ed-4041-8ebd-ab9bd943229b"/>
    <ao:prefix>itant use of propafenone and </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-194.txt.html</ao:hasSource>
    <ao:suffix> in healthy subjects increased</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:79EA7C97-DC71-4F18-8530-A375BD6B0934">
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:CF406020-588D-4EBE-B4C3-7CE73DC72A94"/>
    <pav:createdOn>2014-07-08 09:32:05 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotation:5A328FBF-4CDA-491B-9754-5FECB5F27135</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:423352B3-8ABA-48B7-98CF-B191A7BFC955</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-08 09:35:29 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:053BD548-1DBD-4227-A349-1605741A1114">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotationset:F37BE993-E972-47AE-896D-FF4D33157ECF</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2014-07-07 09:44:18 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A5E637EF-5CA5-4AAC-BD8B-C136A86E17B7</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:0040EE85-0BD0-4541-A221-A6208194C8B8"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2014-07-07 09:42:27 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:6168D465-62D5-4B6C-BE48-0B71373BA594">
    <pav:lineageUri>urn:domeoserver:annotationset:cf593dca-fe93-451b-8f37-2a96e065da13</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:6FD503C3-5967-4368-998D-CD62C6625AA1"/>
    <pav:previousVersion>urn:domeoclient:uuid:21a2d27a-13b1-4797-ba7a-c0517e32bb06</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:32944008-A6C6-4D66-8C43-EE4CF2256965</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-21 10:02:11 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdOn>2014-07-21 09:58:51 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">3</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:8F513DD1-EAE9-468A-ACE8-EA70D5117880">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotationset:F37BE993-E972-47AE-896D-FF4D33157ECF</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A5E637EF-5CA5-4AAC-BD8B-C136A86E17B7</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:EA04B103-7867-4304-97CF-1235741223DF"/>
    <pav:lastSavedOn>2014-07-07 09:44:18 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-07 09:41:33 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:54923395-7267-4B53-A7BA-CD3F8B5B4E2C">
    <pav:createdOn>2014-07-07 20:01:07 -0400</pav:createdOn>
    <ao:suffix>treatment.</ao:suffix>
    <domeo:uuid>54923395-7267-4B53-A7BA-CD3F8B5B4E2C</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:54923395-7267-4B53-A7BA-CD3F8B5B4E2C"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-21.txt.html</ao:hasSource>
    <ao:exact>fluconazole </ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>decreased very slightly (&lt;5%) in 3 of the 21 subjects after </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:1DE6D6F6-8001-4C18-B383-AF52EA3FC9FE">
    <ao:suffix>. Therefore, if an inhibitor or an inducer of CYP2C8 is started or stopped during treatment with rosiglitazone, changes in diabetes treatment may be needed based upon clinical response. [See Clinical Pharmacology (12.4).] </ao:suffix>
    <domeo:uuid>1DE6D6F6-8001-4C18-B383-AF52EA3FC9FE</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-122.txt.html</ao:hasSource>
    <ao:prefix>) may decrease the AUC of </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:1DE6D6F6-8001-4C18-B383-AF52EA3FC9FE"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-07 20:50:02 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>rosiglitazone</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B26D315F-8E16-41C8-8BB4-BABEB368E117">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-08 09:31:52 -0400</pav:createdOn>
    <ao:exact>Ketoconazole</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:B26D315F-8E16-41C8-8BB4-BABEB368E117"/>
    <domeo:uuid>B26D315F-8E16-41C8-8BB4-BABEB368E117</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-139.txt.html</ao:hasSource>
    <ao:prefix> and </ao:prefix>
    <ao:suffix>xsd:String</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7CBA491A-1C36-4A48-8CB0-A8C61E2A139E">
    <pav:lastSavedOn>2014-07-08 08:54:46 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotation:1398BA8F-F691-4D91-A0D2-FC3932C5AC9E</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:23515E27-98AC-4DC9-A4B7-EBFE2991219F</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:7CD04099-BF71-401D-80C8-E62CF5FAFDD8"/>
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdOn>2014-07-08 08:52:16 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:BC6E5452-8DE0-4786-BCEC-6BE8992E2061">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotation:70800E1F-DE3D-464D-B9FA-83276AFE4CF5</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdOn>2014-07-21 09:43:42 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:CEC2E6BB-4A0E-4F14-B024-B1C9027CF3AE</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-07-21 09:46:26 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:8AE6F604-2CDB-4CCB-9934-F0021BE9F5DD"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:1FD751A4-481C-4831-949E-383687C951FB">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>xsd:String</ao:prefix>
    <pav:createdOn>2014-07-08 08:54:44 -0400</pav:createdOn>
    <ao:exact>Pretreatment with ranitidine (150 mg twice daily for 4 days) did not alter the pharmacokinetics of either single oral or intravenous doses of rosiglitazone in healthy volunteers. These results suggest that the absorption of oral rosiglitazone is not altered in conditions accompanied by increases in gastrointestinal pH</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:1FD751A4-481C-4831-949E-383687C951FB"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <ao:suffix>xsd:String</ao:suffix>
    <domeo:uuid>1FD751A4-481C-4831-949E-383687C951FB</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F69143F7-43EE-4FDF-9D56-2651B98E6002">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotationset:F37BE993-E972-47AE-896D-FF4D33157ECF</pav:lineageUri>
    <pav:lastSavedOn>2014-07-07 09:44:18 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:createdOn>2014-07-07 09:37:00 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:BCD6D501-58BB-4255-B1E4-8D43F901ADE6"/>
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A5E637EF-5CA5-4AAC-BD8B-C136A86E17B7</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:8CF617F1-0A51-46A3-96B4-EF79BA037292">
    <pav:createdOn>2014-07-07 20:38:33 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-59.txt.html</ao:hasSource>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:8CF617F1-0A51-46A3-96B4-EF79BA037292"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>Coadministration of carbamazepine with nefazodone results in insufficient plasma concentrations of nefazodone and its active metabolite to achieve a therapeutic effect. Coadministration of carbamazepine with nefazodone is contraindicated (see CONTRAINDICATIONS).</ao:exact>
    <domeo:uuid>8CF617F1-0A51-46A3-96B4-EF79BA037292</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>xsd:String</ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:35FE2B2F-85BF-4055-BC00-B2EFD1FDE127">
    <pav:createdOn>2014-07-08 08:55:49 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:35FE2B2F-85BF-4055-BC00-B2EFD1FDE127"/>
    <ao:exact>propafenone </ao:exact>
    <ao:prefix>The AUC of </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-124.txt.html</ao:hasSource>
    <ao:suffix>is increased by more than 200% by co-administration of propranolol.</ao:suffix>
    <domeo:uuid>35FE2B2F-85BF-4055-BC00-B2EFD1FDE127</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/D9C80643-B2F0-4DC6-9193-A68CBB23B4B2">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/8754</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>propafenone</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/FD45A94A-DBBD-4A14-8FF0-071717BF6599">
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>synercid</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/drug-product"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/135097</dailymed:activeMoietyRxCUI>
    <dct:description>Referred to the drug in the interaction.</dct:description>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/273C8C06-1913-476F-AB03-E93F984B1A43">
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>avandia</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/drug-product"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/261455</dailymed:activeMoietyRxCUI>
    <dct:description>Referred to the drug in the interaction.</dct:description>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:9B7DDCE4-9D55-4D85-BBD1-44E13751C35E">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:9B7DDCE4-9D55-4D85-BBD1-44E13751C35E"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-161.txt.html</ao:hasSource>
    <ao:suffix>, close monitoring for known side effects of azithromycin, such as liver enzyme abnormalities and hearing impairment, is warranted (see ADVERSE REACTIONS).</ao:suffix>
    <pav:createdOn>2014-07-08 12:02:58 -0400</pav:createdOn>
    <domeo:uuid>9B7DDCE4-9D55-4D85-BBD1-44E13751C35E</domeo:uuid>
    <ao:exact>nelfinavir</ao:exact>
    <ao:prefix>is not recommended when administered in combination with </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A59461AD-50B9-4CEB-AE18-C0F87F411CF3">
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdOn>2014-07-08 19:42:52 -0400</pav:createdOn>
    <ao:body rdf:nodeID="N063a286d52b64f2f9e9200b64c650eaf"/>
    <pav:lineageUri>urn:domeoserver:annotation:E9F7D945-866F-4D5A-8F2C-C6D7E82BACE1</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:C9868B04-3F07-42FC-8F5C-D0B3D0DA54B1</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:CC592906-E5A9-448E-9A27-2732D1D3BC1D"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-07-08 19:43:50 -0400</pav:lastSavedOn>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:DB592E95-99A7-412C-9278-470ED93BE6C1">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:DB592E95-99A7-412C-9278-470ED93BE6C1"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:exact>co-administration of known enzyme inducers (e.g., carbamazepine, phenytoin, rifampin, and phenobarbital) with risperidone may cause a decrease in the combined plasma concentrations of risperidone and 9-hydroxyrisperidone</ao:exact>
    <domeo:uuid>DB592E95-99A7-412C-9278-470ED93BE6C1</domeo:uuid>
    <pav:createdOn>2014-07-07 19:52:32 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>xsd:String</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/F66FD94C-0E21-4E46-B074-8DBC81252C1E">
    <rdfs:label>avandia</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/261455</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/drug-product"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C673D49F-D791-4325-A924-0B57680A3527">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-08 08:57:14 -0400</pav:lastSavedOn>
    <domeo:deleted>false</domeo:deleted>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <pav:createdOn>2014-07-08 08:56:41 -0400</pav:createdOn>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <ao:item rdf:resource="urn:domeoclient:uuid:2170C968-DE55-497F-9E90-B298C10C35F0"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812e52b20002"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:item rdf:resource="urn:domeoclient:uuid:428DBABB-8AA6-482D-8708-7398A892816E"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotationset:1E1ED20F-0DAA-4A2B-B823-02CDEEF8AA16</pav:lineageUri>
    <permissions:permissions rdf:nodeID="N11667947c8824a12a94292bb4623d14e"/>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-125.txt.html</ao:annotatesResource>
    <ao:item rdf:resource="urn:domeoclient:uuid:84B48D1F-30B7-47C9-A879-646C36614703"/>
    <rdfs:label>Default Set</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoserver:annotationset:0F235438-66A4-4847-A5E7-8A71C3802072">
    <pav:lineageUri>urn:domeoserver:annotationset:708c0278-9c23-4f80-aa15-44e518b2efed</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <ao:item rdf:resource="urn:domeoclient:uuid:BCD98D80-27EF-4A94-8589-22FBE0E5EF67"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">3</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:1153D11D-21AA-4E03-9C4A-C4185B5F0487"/>
    <dct:description>The NER set is created automatically by NER annotation loading program.</dct:description>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-206.txt.html</ao:annotatesResource>
    <pav:createdOn>2014-07-07 08:07:00 -0400</pav:createdOn>
    <pav:previousVersion>urn:domeoclient:uuid:1cf621fd-ad58-4477-ab1c-dbed46f5648c</pav:previousVersion>
    <rdfs:label>NER Sets</rdfs:label>
    <domeo:deleted>false</domeo:deleted>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-08 15:34:18 -0400</pav:lastSavedOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:BA43DC13-BE0A-49DC-97E9-FF50D5B4AB5A"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:E1E58671-9E95-4492-B482-9DA59AA1D7D1"/>
    <permissions:permissions rdf:nodeID="N50fbdc5ff06b443cbbcfba667c71878c"/>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:56F5125F-1AA7-472B-A219-462D80281246"/>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812e52b20002"/>
    <ao:item rdf:resource="file:///home/yin2/python-SPL-connector/985b1c23-37c3-4c2d-8ee8-dca28833873d"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:27603150-CFA7-4433-AFE0-EE8E29B15E35">
    <domeo:belongsToSet>urn:domeoclient:uuid:7E425E73-12D2-4B08-9D70-75410DE87447</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:FDC1B86E-9081-4995-AC9B-E0F371F56E0E"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2014-07-08 09:27:36 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotation:5BD53950-8E14-483D-AE70-B3D4C5029817</pav:lineageUri>
    <pav:createdOn>2014-07-08 09:25:30 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E432223F-A867-4C08-9D45-C972B81B9B91">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotationset:57174A7C-3100-4C8F-9C4A-2991CEE124D5</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdOn>2014-07-08 08:43:11 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:lastSavedOn>2014-07-08 08:46:38 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:CB1371E2-FBD9-4D1D-B003-5C391C17C73A"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:23515E27-98AC-4DC9-A4B7-EBFE2991219F</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7B5A7AF9-19A2-412F-B6C7-42B4A6C76C1C">
    <ao:prefix>is a substrate of the cytochrome P450 3A4 (CYP3A4) enzyme and </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:7B5A7AF9-19A2-412F-B6C7-42B4A6C76C1C"/>
    <pav:createdOn>2014-07-08 09:25:20 -0400</pav:createdOn>
    <ao:exact>trazodone </ao:exact>
    <ao:suffix>metabolism can be inhibited by the CYP3A4 inhibitors ketoconazole, ritonavir, and indinavir. The effect of short-term administration of ritonavir (200 mg twice daily, 4 doses) on the pharmacokinetics of a single dose of trazodone (50 mg) has been studied</ao:suffix>
    <domeo:uuid>7B5A7AF9-19A2-412F-B6C7-42B4A6C76C1C</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-136.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E1620511-F969-4540-93B1-035D34D82147">
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoclient:uuid:7821C64B-A0CD-480C-9DC8-F790FC33069A</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:374DCAA3-96FC-4D03-8136-CDC7670FCDA9</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-07-08 12:21:41 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:BFF64705-B133-4000-BF04-DB0A786F2F80"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:lastSavedOn>2014-07-08 12:21:50 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:5D918B1F-3225-4686-A401-07868FC465A5">
    <pav:lineageUri>urn:domeoserver:annotation:EB23F4FC-8929-45E0-BCF0-A64F3265EEB1</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <domeo:belongsToSet>urn:domeoclient:uuid:21FE87BA-B7AA-4926-95E7-7E20EA2E4643</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdOn>2014-07-07 20:12:41 -0400</pav:createdOn>
    <ao:body rdf:nodeID="N1d7853f9ea1c4db9861c3374e20686ab"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:4DF2B306-C2AF-4901-AB82-064FD9B17BBF"/>
    <pav:lastSavedOn>2014-07-07 20:12:43 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/A45E5283-1A87-4DDA-B789-CEA168E699ED">
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>digoxin</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/3407</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/985b1c23-37c3-4c2d-8ee8-dca28833873d">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-07-07 08:07:00 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:0F235438-66A4-4847-A5E7-8A71C3802072</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdOn>2014-07-07 08:07:00 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:a6d15f1d-ecfd-45c1-9ef2-8540e7c62052"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotationset:708c0278-9c23-4f80-aa15-44e518b2efed</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7378A3C6-7673-4D96-9434-F9A9738108A2">
    <ao:exact>Rosiglitazone </ao:exact>
    <domeo:uuid>7378A3C6-7673-4D96-9434-F9A9738108A2</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:7378A3C6-7673-4D96-9434-F9A9738108A2"/>
    <pav:createdOn>2014-07-08 08:40:39 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <ao:suffix>is extensively metabolized with no unchanged drug excreted in the urine. The major routes of metabolism were N-demethylation and hydroxylation, followed by conjugation with sulfate and glucuronic acid. All the circulating metabolites are considerably les</ao:suffix>
    <ao:prefix>xsd:String</ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:5D38711D-E2B6-455C-9915-755FA8BE4B5E">
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:23515E27-98AC-4DC9-A4B7-EBFE2991219F</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-08 08:46:38 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotationset:57174A7C-3100-4C8F-9C4A-2991CEE124D5</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:D12FB5C2-47E0-4EB5-B892-3B9DC9806833"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdOn>2014-07-08 08:46:00 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E2B32452-94CE-429F-9E26-4DD8ED692BAA">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:8CF617F1-0A51-46A3-96B4-EF79BA037292"/>
    <pav:lineageUri>urn:domeoserver:annotation:32A9A768-C4AD-4A61-8DE0-A20830EA2C6C</pav:lineageUri>
    <pav:createdOn>2014-07-07 20:38:33 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoclient:uuid:8D643EAC-88DF-4484-A479-D1E798544DF5</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:body rdf:nodeID="N08f94404e59946a8a3bcc0d9b131b56b"/>
    <pav:lastSavedOn>2014-07-07 20:38:37 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:367d682d-4fbb-49e0-94c6-e015fac80bab">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>alone or in combination with </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:367d682d-4fbb-49e0-94c6-e015fac80bab"/>
    <domeo:uuid></domeo:uuid>
    <ao:exact>cimetidine</ao:exact>
    <pav:createdOn>2014-07-07 08:06:50 -0400</pav:createdOn>
    <ao:suffix> 1000 mg q.d. also experienced</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-113.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/0ffed011-6a9b-485f-a69c-ebe76eb77903">
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdOn>2014-07-07 08:06:59 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-07-07 08:06:59 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotationset:8f2fd34a-0a5c-4e94-b4a5-d7503a4c0137</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:67193145-3d5c-4a7d-9f58-b2ca2ec5382b"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:DD05DE56-7B60-4C06-8552-D1DD652D8A79</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C84CAD3E-40CD-44F4-950E-576290E3D6C4">
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:844CFAC6-A916-4941-AA9C-0703CC47B4C3"/>
    <pav:createdOn>2014-07-07 20:19:01 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-07-07 20:21:40 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotation:00602655-7012-464D-A68D-F94B8A0EC0C5</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:CE45A5D4-BD84-4E02-AC7B-C9E12233EC3A</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7BC202B1-7906-4CD6-8994-24D54A06B863">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotationset:cf593dca-fe93-451b-8f37-2a96e065da13</pav:lineageUri>
    <pav:lastSavedOn>2014-07-21 10:02:11 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:32944008-A6C6-4D66-8C43-EE4CF2256965</domeo:belongsToSet>
    <pav:previousVersion>urn:domeoclient:uuid:21a2d27a-13b1-4797-ba7a-c0517e32bb06</pav:previousVersion>
    <pav:createdOn>2014-07-21 10:01:01 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:9408D5E4-DED3-4E79-87C6-1F9EEB33BAC2"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">3</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N71c153f9c38446848998ccd3e03653d3">
    <permissions:accessType>urn:person:uuid:080e143046812afe0146812e52b20002</permissions:accessType>
    <permissions:isLocked>false</permissions:isLocked>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:88A5D137-DCC2-49D2-B766-3D4F86BA4A28">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotationset:F37BE993-E972-47AE-896D-FF4D33157ECF</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:F6088F1B-4F14-4BBC-AC65-20541EBE4ACE"/>
    <pav:lastSavedOn>2014-07-07 09:44:18 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A5E637EF-5CA5-4AAC-BD8B-C136A86E17B7</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2014-07-07 09:44:02 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:EF89D3CC-C50F-4914-AA1D-08C4922BB398">
    <ao:exact>9-hydroxyrisperidone</ao:exact>
    <domeo:uuid>EF89D3CC-C50F-4914-AA1D-08C4922BB398</domeo:uuid>
    <pav:createdOn>2014-07-07 19:46:19 -0400</pav:createdOn>
    <ao:suffix> occurred at about 3 hours in extensive metabolizers, and 17 hours in poor metabolizers. Steady-state concentrations of risperidone are reached in 1 day in extensive metabolizers and would be expected to reach steady-state in about 5 days in poor metabol</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <ao:prefix>occurred at about 1 hour. Peak concentrations of </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:EF89D3CC-C50F-4914-AA1D-08C4922BB398"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/C058CF98-3195-48C4-9708-A3B23586DCA0">
    <rdfs:label>fexofenadine</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/87636</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dct:description>Referred to the drug in the interaction.</dct:description>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:FC065FBE-922F-4D8C-91CF-496EDE482A39">
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:2CC8A112-0992-4F8B-A5D7-F7F36716E952"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:3DF1657C-6AB7-4108-81E9-CFE0C2B7C644">
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:2D934787-5E98-487C-8EC9-10858A122FA8"/>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/FD95F493-0BAA-45A7-99BF-73C7148B90E0">
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>fluconazole</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/4450</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:ECC47BFB-74A2-4ACF-B43B-D8E36122A57C">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:ECC47BFB-74A2-4ACF-B43B-D8E36122A57C"/>
    <ao:prefix>, to parent drug ratio significantly decreased after the administration of </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>fluconazole</ao:exact>
    <ao:suffix>, from 7.6 ± 3.6 to 5.7 ± 2.2.</ao:suffix>
    <pav:createdOn>2014-07-07 20:16:50 -0400</pav:createdOn>
    <domeo:uuid>ECC47BFB-74A2-4ACF-B43B-D8E36122A57C</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-27.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/DC971235-170B-4071-BD69-B8DDDFBF7FCF">
    <rdfs:label>ketoconazole</rdfs:label>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/6135</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:2BEDC22E-2EA8-4C42-8B37-9D4196625558">
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">3</pav:versionNumber>
    <pav:lastSavedOn>2014-07-08 14:24:44 -0400</pav:lastSavedOn>
    <pav:previousVersion>urn:domeoclient:uuid:e75c9d7b-f906-4c66-8a84-e6eef34d0954</pav:previousVersion>
    <pav:createdOn>2014-07-08 14:24:00 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:42258B16-6749-4B39-B28D-88C8B63F7A43</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotationset:0f67c012-7596-4b02-a927-63c0ccbc3afa</pav:lineageUri>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:body rdf:nodeID="N46944551a151472c9e955deaefd346a1"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:CF7A802A-A584-4317-9FE0-3694CBF9A54D"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:021A107C-3FCC-4855-BA60-5783E9898ED4">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:021A107C-3FCC-4855-BA60-5783E9898ED4"/>
    <ao:exact>Rosiglitazone </ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>is approximately 17.6 (30%) liters, based on a population pharmacokinetic analysis. </ao:prefix>
    <ao:suffix>is approximately 99.8% bound to plasma proteins, primarily albumin.</ao:suffix>
    <domeo:uuid>021A107C-3FCC-4855-BA60-5783E9898ED4</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-08 08:40:36 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C13E7833-8C5F-4F29-A3E0-9297D779D6C1">
    <pav:createdOn>2014-07-21 10:00:52 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotationset:cf593dca-fe93-451b-8f37-2a96e065da13</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-21 10:02:11 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:92082388-F929-4C36-B23F-1BDE3DD1144F"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:32944008-A6C6-4D66-8C43-EE4CF2256965</domeo:belongsToSet>
    <pav:previousVersion>urn:domeoclient:uuid:21a2d27a-13b1-4797-ba7a-c0517e32bb06</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">3</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:3916A1F8-D023-4A40-8707-E00BD0D82213">
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">3</pav:versionNumber>
    <ao:body rdf:nodeID="N5e900611943e471da25732676f8d4960"/>
    <pav:previousVersion>urn:domeoclient:uuid:203110ef-d319-4c8c-8da1-19d68e91f895</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:createdOn>2014-07-08 13:59:41 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-07-08 13:59:58 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7E49EB7A-DE0E-4720-82D1-8460BA0C770D</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotationset:def720a3-9364-4d0d-a156-423274fb2386</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:7C8C6B1F-D237-479B-A410-1A3EC5D1D274"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:FDB4919D-6446-4981-9689-7E91247A2B9C">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:FDB4919D-6446-4981-9689-7E91247A2B9C"/>
    <pav:createdOn>2014-07-07 20:15:05 -0400</pav:createdOn>
    <ao:exact>cyclosporine </ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-26.txt.html</ao:hasSource>
    <ao:prefix>dose for at least 6 weeks. There was a significant increase in </ao:prefix>
    <ao:suffix>AUC, Cmax, Cmin (24-hour concentration), and a significant reduction in apparent oral clearance following the administration of fluconazole. The mean ± SD increase in AUC was 92% ± 43% (range: 18 to 147%). The Cmax increased 60% ± 48% (range: -5 to 133%)</ao:suffix>
    <domeo:uuid>FDB4919D-6446-4981-9689-7E91247A2B9C</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:97CC6474-CC25-4439-899B-C8A0633D4912">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-07-07 20:14:34 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotation:61FE2E87-DE02-4E59-888D-31B54D8EEBC6</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoclient:uuid:B41CE612-345D-4E17-94DB-98BD2C6B5559</domeo:belongsToSet>
    <pav:createdOn>2014-07-07 20:13:25 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:328D21B5-4D95-45E2-B811-1DDDD22421D8"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E9862CD5-0A72-430D-AFB1-BF93E2D4E3B1">
    <domeo:uuid>E9862CD5-0A72-430D-AFB1-BF93E2D4E3B1</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:E9862CD5-0A72-430D-AFB1-BF93E2D4E3B1"/>
    <ao:suffix>AUC increased 17% (range: -33 to 141%).</ao:suffix>
    <pav:createdOn>2014-07-07 20:06:03 -0400</pav:createdOn>
    <ao:prefix> AUC was 6% (range: -47 to 108%) and </ao:prefix>
    <ao:exact>levonorgestrel </ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-22.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/45CBDB06-7587-4F83-A091-DD5AA73DC829">
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>sertraline</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/36437</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:61E9853F-DC24-40CC-A092-28A53CDA36EC">
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:2A108741-132A-48F3-8621-A6262F30D450"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7DEE78A2-3E4C-4584-8ED9-F698C9F8F9C4">
    <domeo:deleted>false</domeo:deleted>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:52F38A96-8205-49D5-AF4A-E32A3452FA08"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812e52b20002"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-07-07 20:31:18 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-07 20:31:04 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotationset:66C3190A-D65D-4816-8BD9-0D0BBA69E3A0</pav:lineageUri>
    <permissions:permissions rdf:nodeID="N8b16901010234248975e7a5f368298e9"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:item rdf:resource="urn:domeoclient:uuid:1136F370-BF76-4567-BD4E-BFA1D9631FF0"/>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-55.txt.html</ao:annotatesResource>
    <rdfs:label>Default Set</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:4A49ACB6-4B71-452F-80EE-8A84DEF45C29">
    <ao:item rdf:resource="urn:domeoclient:uuid:58879677-6EC3-48D3-805A-65F3DFA447AB"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <ao:item rdf:resource="urn:domeoclient:uuid:A514DC0A-9A07-48B8-B672-3146345F0952"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:0B4F6D66-C1BC-48DB-8F5E-9FFB84E70EF8"/>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <pav:createdOn>2014-07-07 20:05:50 -0400</pav:createdOn>
    <permissions:permissions rdf:nodeID="Nbc8823dfedf44df38ce609d805fb6da9"/>
    <domeo:deleted>false</domeo:deleted>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-22.txt.html</ao:annotatesResource>
    <ao:item rdf:resource="urn:domeoclient:uuid:BC5C33FE-36D7-48F5-869B-96146A06BE2D"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Default Set</rdfs:label>
    <ao:item rdf:resource="urn:domeoclient:uuid:68D24B02-387E-40C6-B7C6-F02189114494"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-07 20:07:10 -0400</pav:lastSavedOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:21628032-8AFE-4ED6-86E0-4D6E480B1DC0"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:2C8B0EDA-9F75-41C8-96B8-03A4F8A850C7"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:70F5B079-3744-487B-86C2-80B6B7EFA7FA"/>
    <pav:lineageUri>urn:domeoserver:annotationset:F9BF10B8-7C50-4990-9587-4835A7744D56</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812e52b20002"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:5117E723-600D-43FA-A0F5-3B0D6AB776ED">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:5117E723-600D-43FA-A0F5-3B0D6AB776ED"/>
    <ao:prefix>. Therefore, if an inhibitor or an inducer of CYP2C8 is started or stopped during treatment with </ao:prefix>
    <pav:createdOn>2014-07-07 20:50:05 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-122.txt.html</ao:hasSource>
    <ao:exact>rosiglitazone</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>, changes in diabetes treatment may be needed based upon clinical response. [See Clinical Pharmacology (12.4).] </ao:suffix>
    <domeo:uuid>5117E723-600D-43FA-A0F5-3B0D6AB776ED</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:174082AF-53BB-4A5F-A289-F20D7232AFF5">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>Fexofenadine hydrochloride should not be taken closely in time with aluminum and magnesium containing antacids. In healthy adult subjects, administration of 120 mg of fexofenadine hydrochloride (2 × 60 mg capsule) within 15 minutes of an aluminum and magnesium containing antacid (Maalox®1) decreased fexofenadine AUC by 41% and Cmax by 43%</ao:exact>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:suffix>xsd:String</ao:suffix>
    <pav:createdOn>2014-07-08 09:31:24 -0400</pav:createdOn>
    <domeo:uuid>174082AF-53BB-4A5F-A289-F20D7232AFF5</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:174082AF-53BB-4A5F-A289-F20D7232AFF5"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-139.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoserver:annotationset:FC706AFD-18B6-480C-8EAA-2B16C3212C10">
    <ao:item rdf:resource="urn:domeoclient:uuid:246FED77-69AE-4605-9175-2C196767388D"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:1ADD4C68-4EF4-4E45-953D-1EE552C70A7D"/>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812e52b20002"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotationset:252ecf83-cda9-4022-8d2e-563cf1fb984b</pav:lineageUri>
    <ao:item rdf:resource="urn:domeoclient:uuid:E9CDCB47-0AFD-42FA-A005-046710AA7DA9"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:20F2D3B8-1AF0-434F-8139-53E035F90C2A"/>
    <domeo:deleted>false</domeo:deleted>
    <ao:item rdf:resource="urn:domeoclient:uuid:5BFAB712-E552-497E-A61F-9D79D928F612"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">3</pav:versionNumber>
    <ao:item rdf:resource="urn:domeoclient:uuid:2818899E-8D71-4CC1-8C44-C22F75638E6A"/>
    <ao:item rdf:resource="file:///home/yin2/python-SPL-connector/5a2288fb-5e17-44e5-898b-20dede7cb21b"/>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-104.txt.html</ao:annotatesResource>
    <permissions:permissions rdf:nodeID="N682aead81e164d5891cb07472a7b7a3d"/>
    <rdfs:label>NER Sets</rdfs:label>
    <ao:item rdf:resource="urn:domeoclient:uuid:C616CA3F-D5BA-4A06-8DEC-31C84D750966"/>
    <pav:createdOn>2014-07-07 08:06:39 -0400</pav:createdOn>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <pav:lastSavedOn>2014-07-08 16:27:00 -0400</pav:lastSavedOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:0CFD7E69-9F40-4910-8BF8-37AFA7004208"/>
    <dct:description>The NER set is created automatically by NER annotation loading program.</dct:description>
    <pav:previousVersion>urn:domeoclient:uuid:3cd46ae0-e37d-4e9b-9cb9-ef98941679b8</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:67751AC3-CAE1-46D3-8A18-DFA03CCD1681">
    <ao:context rdf:resource="urn:domeoclient:uuid:5A6C89B0-919C-4970-B2AE-E66C2282C770"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5ABD9862-F044-4404-AD04-73DA04ADDA8B</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:createdOn>2014-07-07 19:58:07 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2014-07-07 19:59:12 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotation:1E7DCF8B-95C0-4611-92D4-C03DE9899149</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A8AE7057-B93E-443B-BB31-C7B2C325DF8C">
    <ao:prefix>Co-administration of </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:A8AE7057-B93E-443B-BB31-C7B2C325DF8C"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-131.txt.html</ao:hasSource>
    <domeo:uuid>A8AE7057-B93E-443B-BB31-C7B2C325DF8C</domeo:uuid>
    <ao:exact>cholestyramine </ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-08 09:14:48 -0400</pav:createdOn>
    <ao:suffix>or colestipol with propranolol resulted in up to 50% decrease in propranolol concentrations.</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B0595CA8-74E0-4CB9-B725-D29F0D6CF7FA">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <domeo:uuid>B0595CA8-74E0-4CB9-B725-D29F0D6CF7FA</domeo:uuid>
    <pav:createdOn>2014-07-07 11:11:51 -0400</pav:createdOn>
    <ao:exact>warfarin </ao:exact>
    <ao:prefix>(250 mg) or </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:B0595CA8-74E0-4CB9-B725-D29F0D6CF7FA"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>(40 mg), both of which are metabolized by CYP2C9.</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/C6339ABC-4E8C-4716-A4FA-BEB9FA971BE2">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/10737</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>trazodone</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/24cc7221-ba99-4acb-add6-9b5724969e95">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:14f6e0d2-d451-479b-a9c4-2bee3b2c2021"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotationset:98d7c315-bece-4703-980c-2aa1d25db5ab</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:2E252AB2-20BD-4522-8B0C-3376444BB437</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2014-07-07 08:06:27 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-07 08:06:27 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:33F47466-2571-42C4-A381-03919A7C6041">
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotation:A6EC3F0F-2C72-495F-AC68-21C4BF8941F5</pav:lineageUri>
    <pav:lastSavedOn>2014-07-08 13:48:39 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-08 13:48:38 -0400</pav:createdOn>
    <ao:body rdf:nodeID="N21ed88a7066346808e3bdd5f361a5177"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:4813B8AA-0B59-46E2-A60D-4C599BDB18F2</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:EFBB8C05-50BC-42AC-990B-1894DF82D8A0"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B4B54D7C-0FC0-4205-97CB-C18FFA0599D7">
    <domeo:belongsToSet>urn:domeoclient:uuid:423352B3-8ABA-48B7-98CF-B191A7BFC955</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotation:702BEA06-EFC4-4F49-AAB5-FFE3D52EC044</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:F230EC89-2EB5-41D2-BFB4-DB595A0CAD0C"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:lastSavedOn>2014-07-08 09:35:29 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-08 09:32:28 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:78252549-FC1F-492A-A5A4-76ED9AB6F2CC">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:32944008-A6C6-4D66-8C43-EE4CF2256965</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-21 10:02:11 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotationset:cf593dca-fe93-451b-8f37-2a96e065da13</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:createdOn>2014-07-21 09:59:19 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:previousVersion>urn:domeoclient:uuid:21a2d27a-13b1-4797-ba7a-c0517e32bb06</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">3</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:D5B78B84-5FB5-4745-9B1D-7BD8993BCAC9"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:2FA6F9C2-70F0-4E05-9478-1EE173AD6D95">
    <domeo:belongsToSet>urn:domeoclient:uuid:7E32BEF1-7A20-4571-AA29-8F9AC97657A0</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-07-08 09:29:51 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotation:63B1ECA4-2450-411F-9F1C-2954473AEC8E</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:CBDCC745-54A1-4606-B0CC-4555E785D9A4"/>
    <pav:createdOn>2014-07-08 09:29:46 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:69ACFA9C-E971-46A5-A2A0-41C68EB72592">
    <ao:prefix>In volunteers with mild to moderate hepatic cirrhosis (Child-Pugh class A and B),</ao:prefix>
    <ao:suffix> was reduced, resulting in increases in AUC (84%) and Cmax (47%) compared to age-matched volunteers with no hepatic impairment. Patients with severe hepatic impairment (Child-Pugh class C) have not been studied.</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:69ACFA9C-E971-46A5-A2A0-41C68EB72592"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact> sildenafil clearance</ao:exact>
    <domeo:uuid>69ACFA9C-E971-46A5-A2A0-41C68EB72592</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-07 09:39:22 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:569DC956-53BD-4E43-849C-88221ACE29B1">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotation:9AB53A6E-752A-47AD-A706-4AF672A77E9D</pav:lineageUri>
    <pav:createdOn>2014-07-08 09:12:47 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:B342A310-4F6C-4D9A-97A7-A6E4A8716120"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoclient:uuid:698327F3-D853-41CB-ADF0-60C4BFEB24F4</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-07-08 09:13:23 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:3A3C3AB7-425B-41ED-BC9B-F0435A0297DB">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-07 19:50:36 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotationset:1DED06A6-8562-4CCF-A58C-CA25748FBD31</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2014-07-07 19:49:16 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5ABD9862-F044-4404-AD04-73DA04ADDA8B</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:CA3FC337-1E48-443B-B3B8-481C893B954A"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A6F2702F-9127-4851-8993-25C4F8A959BD">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:A6F2702F-9127-4851-8993-25C4F8A959BD"/>
    <domeo:uuid>A6F2702F-9127-4851-8993-25C4F8A959BD</domeo:uuid>
    <ao:suffix> have not been evaluated, but observations in a modest number (N≅70) of poor metabolizers given risperidone do not suggest important differences between poor and extensive metabolizers. Second, co-administration of known enzyme inducers (e.g., carbamazep</ao:suffix>
    <pav:createdOn>2014-07-07 19:49:07 -0400</pav:createdOn>
    <ao:exact>quinidine</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>in patients receiving </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:02D1A810-D529-4164-B732-BD1045B92C6F">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:02D1A810-D529-4164-B732-BD1045B92C6F"/>
    <ao:exact>Co-administration of long-acting propranolol at doses greater than or equal to 160 mg/day resulted in increased thioridazine plasma concentrations ranging from 55% to 369% and increased thioridazine metabolite (mesoridazine) concentrations ranging from 33% to 209%.</ao:exact>
    <ao:suffix>xsd:String</ao:suffix>
    <pav:createdOn>2014-07-08 09:21:49 -0400</pav:createdOn>
    <domeo:uuid>02D1A810-D529-4164-B732-BD1045B92C6F</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-133.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>xsd:String</ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:AE848AF5-F1A3-4443-8C1E-9C3427D1AC4F">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/91508FEF-0959-4477-AE90-C239D7B3B3D5"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/2E948120-9C8C-416C-B96B-017E148E7A69"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E1E58671-9E95-4492-B482-9DA59AA1D7D1">
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-07-08 15:34:18 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotation:7CB368C3-378A-49BD-8F5C-F0F3C1B378CF</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-08 15:33:31 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:D1D6A188-FAA5-4A52-93C7-35D7CB74E48A"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:0F235438-66A4-4847-A5E7-8A71C3802072</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D5D0F893-0B95-42AE-8D93-3B2DFD7E8FB4">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:6B178133-9B11-445F-A5BB-EF967EA53386</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotation:F7EA3686-D1F1-4BB8-AA90-703AF3EF674C</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-07-08 12:28:19 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:F875C480-C489-4D5E-8ACF-2257999879DD"/>
    <pav:lastSavedOn>2014-07-08 12:29:01 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:3E78683D-D035-4F7E-9A8A-14A3381527CA">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:195820D4-650C-4B61-BC8B-E3BE7F0E7D16"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2014-07-07 19:59:12 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5ABD9862-F044-4404-AD04-73DA04ADDA8B</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotation:7BA12ECC-9276-4992-A7AF-F0FD15D7CFB0</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdOn>2014-07-07 19:58:10 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:2DBAC4D6-E498-4781-B492-2552C42FD677">
    <domeo:belongsToSet>urn:domeoserver:annotationset:A5E637EF-5CA5-4AAC-BD8B-C136A86E17B7</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:87B81289-98D7-49FE-9CDF-213F4BF3D91D"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotationset:F37BE993-E972-47AE-896D-FF4D33157ECF</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdOn>2014-07-07 09:38:32 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-07-07 09:44:18 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F85D7215-5E2B-4614-AEB9-BCFF1B459F34">
    <pav:lineageUri>urn:domeoserver:annotationset:57174A7C-3100-4C8F-9C4A-2991CEE124D5</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2014-07-08 08:38:22 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2014-07-08 08:46:38 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:23515E27-98AC-4DC9-A4B7-EBFE2991219F</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:5A744604-3A8D-4358-A786-28AEBB5D92D3"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7F34F894-7585-47C8-9ADF-AD1FB473036B">
    <domeo:belongsToSet>urn:domeoclient:uuid:54F09193-5CC7-4ED3-9261-88C7428E0572</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:0E5B54C1-2569-4948-8208-B602B65C6423"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotation:A9F82E0D-39B3-490C-9ADA-0F7D40335C42</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <ao:body rdf:nodeID="N7f31acf777024b738b59aecba5d3b02a"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:createdOn>2014-07-08 09:15:09 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-07-08 09:15:28 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:0B4F6D66-C1BC-48DB-8F5E-9FFB84E70EF8">
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-07-07 20:07:11 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:D5E714D9-FDCD-42A5-8E78-87DE7206FFDB"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-07 20:05:56 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoclient:uuid:4A49ACB6-4B71-452F-80EE-8A84DEF45C29</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotation:3064E813-AD79-4651-904B-25D4FD777B7B</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F139BC06-4E07-4862-B537-2812AD4D34B0">
    <ao:suffix>, and indinavir. The effect of short-term administration of ritonavir (200 mg twice daily, 4 doses) on the pharmacokinetics of a single dose of trazodone (50 mg) has been studied in 10 healthy subjects. The Cmax of trazodone increased by 34%, the AUC inc</ao:suffix>
    <domeo:uuid>F139BC06-4E07-4862-B537-2812AD4D34B0</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:F139BC06-4E07-4862-B537-2812AD4D34B0"/>
    <ao:exact>ritonavir</ao:exact>
    <pav:createdOn>2014-07-08 09:25:23 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>, </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-136.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/59D9ECD3-E41B-4231-9AF0-2BDE7B69432D">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>cyclosporine</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/3008</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:FE03C3B3-B16C-4BEF-86C5-45AB7FF59385">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:949C5F18-81B3-41C6-BE8B-1AFA953A5286"/>
    <pav:lastSavedOn>2014-07-07 19:50:36 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5ABD9862-F044-4404-AD04-73DA04ADDA8B</domeo:belongsToSet>
    <pav:createdOn>2014-07-07 19:48:52 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotationset:1DED06A6-8562-4CCF-A58C-CA25748FBD31</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:BA224B85-9213-4D9B-ABE6-F8C7AAD2D473">
    <pav:lastSavedOn>2014-07-07 09:44:18 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotationset:F37BE993-E972-47AE-896D-FF4D33157ECF</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A5E637EF-5CA5-4AAC-BD8B-C136A86E17B7</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2014-07-07 09:40:33 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:0A2041A1-9C79-4A4F-91BA-2A9370192C5F"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:6B0031D3-964D-4140-8715-70FC390ADF58">
    <ao:suffix> (See PRECAUTIONS.</ao:suffix>
    <domeo:uuid>6B0031D3-964D-4140-8715-70FC390ADF58</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:6B0031D3-964D-4140-8715-70FC390ADF58"/>
    <pav:createdOn>2014-07-07 20:15:59 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:exact>Cyclosporine AUC and Cmax were determined before and after the administration of fluconazole 200 mg daily for 14 days in eight renal transplant patients who had been on cyclosporine therapy for at least 6 months and on a stable cyclosporine dose for at least 6 weeks. There was a significant increase in cyclosporine AUC, Cmax, Cmin (24-hour concentration), and a significant reduction in apparent oral clearance following the administration of fluconazole. The mean ± SD increase in AUC was 92% ± 43% (range: 18 to 147%). The Cmax increased 60% ± 48% (range: -5 to 133%). The Cmin increased 157% ± 96% (range: 33 to 360%). The apparent oral clearance decreased 45% ± 15% (range: -15 to -60%).</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-26.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:8A876274-D553-4BE5-8E65-126846D61286">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:exact>Phenytoin: Nifedipine is metabolized by CYP3A4. Coadministration of nifedipine 10 mg capsule and 60 mg nifedipine coat-core tablet with phenytoin, an inducer of CYP3A4, lowered the AUC and Cmax of nifedipine by approximately 70%. When using nifedipine with phenytoin, the clinical response to nifedipine should be monitored and its dose adjusted if necessary.</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-115.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-08 14:48:48 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:8A876274-D553-4BE5-8E65-126846D61286"/>
    <domeo:uuid>8A876274-D553-4BE5-8E65-126846D61286</domeo:uuid>
    <ao:suffix>xsd:String</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/787A9872-C820-49C3-952B-1F9E77649F9C">
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/9143</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>ranitidine</rdfs:label>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:5CFA2EBB-041F-42ED-B805-74B3976B05B2">
    <ao:suffix> is similar in the two groups and </ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix> and </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:5CFA2EBB-041F-42ED-B805-74B3976B05B2"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-6.txt.html</ao:hasSource>
    <ao:exact>ODV</ao:exact>
    <pav:createdOn>2014-07-21 10:01:09 -0400</pav:createdOn>
    <domeo:uuid>5CFA2EBB-041F-42ED-B805-74B3976B05B2</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:19352391-8DA9-4DF4-98FC-6FFC230BD255">
    <ao:body rdf:nodeID="N1e76db275f2e49279b7412eadc62e985"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:E21F2C5C-9855-4FD9-BEEF-A994AF27B942"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:42258B16-6749-4B39-B28D-88C8B63F7A43</domeo:belongsToSet>
    <pav:previousVersion>urn:domeoclient:uuid:e75c9d7b-f906-4c66-8a84-e6eef34d0954</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">3</pav:versionNumber>
    <pav:lastSavedOn>2014-07-08 14:24:44 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-08 14:22:29 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotationset:0f67c012-7596-4b02-a927-63c0ccbc3afa</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:50D4EE64-0052-490F-9CA0-76253C39A1FD">
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2014-07-07 09:44:18 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:C22A1B89-EC18-484C-B641-2F1ED7A00D4F"/>
    <pav:lineageUri>urn:domeoserver:annotationset:F37BE993-E972-47AE-896D-FF4D33157ECF</pav:lineageUri>
    <pav:createdOn>2014-07-07 09:40:21 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A5E637EF-5CA5-4AAC-BD8B-C136A86E17B7</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:9415067E-1AD4-4CC2-B7A1-9C64B0E76DA7">
    <pav:createdOn>2014-07-08 15:57:35 -0400</pav:createdOn>
    <ao:prefix> is a substrate of CYP3A and has been shown to inhibit CYP3A in vitro. </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-108.txt.html</ao:hasSource>
    <ao:exact>Coadministration of multiple doses of quinidine sulfate, 200 mg t.i.d., and nifedipine, 20 mg t.i.d., increased Cmax and AUC of nifedipine in healthy volunteers by factors of 2.30 and 1.37, respectively.</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:9415067E-1AD4-4CC2-B7A1-9C64B0E76DA7"/>
    <domeo:uuid>9415067E-1AD4-4CC2-B7A1-9C64B0E76DA7</domeo:uuid>
    <ao:suffix> The heart rate in the initial interval after drug administration was increased by up to 17.9 beats/minute. The exposure to</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:8AA734F5-542D-41CD-9EDE-DACB98D2EA8C">
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotationset:1DED06A6-8562-4CCF-A58C-CA25748FBD31</pav:lineageUri>
    <pav:createdOn>2014-07-07 19:46:06 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-07-07 19:50:36 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5ABD9862-F044-4404-AD04-73DA04ADDA8B</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:6F8497C4-E271-4453-9F18-EB2A7ED370E8"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:04AA4052-1F92-4C89-B2F0-46529989DBBF">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:04AA4052-1F92-4C89-B2F0-46529989DBBF"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-139.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-08 09:32:21 -0400</pav:createdOn>
    <ao:suffix>. The findings of these studies are summarized in the following table:</ao:suffix>
    <ao:prefix>or </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>ketoconazole</ao:exact>
    <domeo:uuid>04AA4052-1F92-4C89-B2F0-46529989DBBF</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/174851CD-339E-4EB2-9D68-23B44533AF1D">
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/703</dailymed:activeMoietyRxCUI>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>amiodarone</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D7B3EBC0-5C8D-4ED2-BA17-F32776FBE7E3">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:D7B3EBC0-5C8D-4ED2-BA17-F32776FBE7E3"/>
    <ao:exact>Drugs that inhibit CYP2D6 (such as desipramine, paroxetine, ritonavir, sertraline) and CYP3A4 (such as ketoconazole, ritonavir, saquinavir, erythromycin, and grapefruit juice) can be expected to cause increased plasma levels of propafenone. The combination of CYP3A4 inhibition and either CYP2D6 deficiency or CYP2D6 inhibition with administration of propafenone may increase the risk of adverse reactions, including proarrhythmia. Therefore, simultaneous use of RYTHMOL SR with both a CYP2D6 inhibitor and a CYP3A4 inhibitor should be avoided</ao:exact>
    <ao:suffix>xsd:String</ao:suffix>
    <pav:createdOn>2014-07-08 13:58:33 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-194.txt.html</ao:hasSource>
    <domeo:uuid>D7B3EBC0-5C8D-4ED2-BA17-F32776FBE7E3</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:DE560C91-21D6-4968-95FA-224203CA8EF9">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotation:BF9D74DC-F60D-4230-8E3B-72D7C1C60576</pav:lineageUri>
    <ao:body rdf:nodeID="N80fa97d4ea264918a086f6ad7c01e86c"/>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-08 15:41:15 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A7033EE8-62A2-4AAF-AD21-7D4F7611919F</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:F9609A5E-97AD-401C-B5AD-3228508C73BD"/>
    <pav:lastSavedOn>2014-07-08 15:41:14 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:81F2A979-244B-45F4-8FC4-8C849AAFC0A7">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:81F2A979-244B-45F4-8FC4-8C849AAFC0A7"/>
    <pav:createdOn>2014-07-08 08:54:11 -0400</pav:createdOn>
    <ao:prefix>(150 mg twice daily for 4 days) did not alter the pharmacokinetics of either single oral or intravenous doses of </ao:prefix>
    <domeo:uuid>81F2A979-244B-45F4-8FC4-8C849AAFC0A7</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix>in healthy volunteers. These results suggest that the absorption of oral rosiglitazone is not altered in conditions accompanied by increases in gastrointestinal pH.</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <ao:exact>rosiglitazone </ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:24ED1E6F-56F1-4237-96E7-5B65C8776EB0">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:24ED1E6F-56F1-4237-96E7-5B65C8776EB0"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix>was 28%, resulting in about 22% lower mean average steady state concentrations. Therefore, the slight decrease of sildenafil exposure in the presence of epoprostenol is not considered clinically relevant. The effect of sildenafil on </ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>epoprostenol </ao:exact>
    <pav:createdOn>2014-07-07 09:43:55 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <ao:prefix>(80 mg tid) bioavailability due to co-administration of </ao:prefix>
    <domeo:uuid>24ED1E6F-56F1-4237-96E7-5B65C8776EB0</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:52F38A96-8205-49D5-AF4A-E32A3452FA08">
    <ao:context rdf:resource="urn:domeoclient:uuid:352F50E0-9FEF-4A92-BC4B-D74AAF3B3356"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotation:A3F210ED-85DF-4EED-962B-AA994BBF690B</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:createdOn>2014-07-07 20:31:07 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoclient:uuid:7DEE78A2-3E4C-4584-8ED9-F698C9F8F9C4</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-07-07 20:31:18 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoserver:annotationset:41C6B392-F8A7-4DBA-AFEF-0BE07588FACF">
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:createdOn>2014-07-07 08:07:02 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">3</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:D83F7899-4FE7-41D8-9B1D-F0858AB1EA1F"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:3A678043-ADA2-4E23-A2ED-84615B586C07"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:item rdf:resource="file:///home/yin2/python-SPL-connector/a556ea8c-1263-47d2-8fdd-a0ee8b13df5f"/>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-114.txt.html</ao:annotatesResource>
    <ao:item rdf:resource="urn:domeoclient:uuid:C065E6E2-D8D0-471E-9A02-F7F39A2CED51"/>
    <permissions:permissions rdf:nodeID="N108ba8f9c86342028a1306cddd46710b"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:E473FFA3-3057-44B1-81C6-97BACFE87878"/>
    <pav:lineageUri>urn:domeoserver:annotationset:9bdd3ca4-63da-4da7-a445-d5869be1b040</pav:lineageUri>
    <pav:previousVersion>urn:domeoclient:uuid:36f418d1-c6f8-44f8-bbe3-e43a1d358a94</pav:previousVersion>
    <dct:description>The NER set is created automatically by NER annotation loading program.</dct:description>
    <pav:lastSavedOn>2014-07-08 14:52:51 -0400</pav:lastSavedOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:AD84FE45-DF82-45A5-87B4-392E47C82B60"/>
    <domeo:deleted>false</domeo:deleted>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812e52b20002"/>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <rdfs:label>NER Sets</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:5ACE5352-0C92-4C41-9C1B-D942B3D9A931">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:5ACE5352-0C92-4C41-9C1B-D942B3D9A931"/>
    <ao:suffix> [see Dosage and Administration (2.1)].</ao:suffix>
    <pav:createdOn>2014-07-08 14:21:08 -0400</pav:createdOn>
    <ao:prefix>. After intravenous dosing, about 29% of the dose was excreted in the urine unchanged, and about 45% of the dose was excreted as </ao:prefix>
    <ao:exact>GZDV</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-197.txt.html</ao:hasSource>
    <domeo:uuid>5ACE5352-0C92-4C41-9C1B-D942B3D9A931</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:6DA8A644-B7CA-454E-9039-433003CE8C04">
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdOn>2014-07-08 09:32:42 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotation:F50E8DFA-4AB7-45DA-BB6B-4D6A7F7B3FD9</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:1761CE3B-543E-4D8E-BC57-62759E6DF137"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:423352B3-8ABA-48B7-98CF-B191A7BFC955</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-08 09:35:29 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C273DCAA-0AA8-4910-A572-AA71F5F193CB">
    <pav:lineageUri>urn:domeoserver:annotationset:57174A7C-3100-4C8F-9C4A-2991CEE124D5</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdOn>2014-07-08 08:42:02 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2014-07-08 08:46:38 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:F103A6EE-D797-425D-98BB-82013CB76066"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:23515E27-98AC-4DC9-A4B7-EBFE2991219F</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C8C9F708-F5BD-4426-B856-1ADCF06AA85C">
    <pav:createdOn>2014-07-07 09:37:52 -0400</pav:createdOn>
    <ao:prefix>and its N-</ao:prefix>
    <ao:exact>desmethyl </ao:exact>
    <ao:suffix>metabolite equivalent to that of a 20 mg oral dose.</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:C8C9F708-F5BD-4426-B856-1ADCF06AA85C"/>
    <domeo:uuid>C8C9F708-F5BD-4426-B856-1ADCF06AA85C</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:32FB6318-B011-402B-AA12-D80ECA69CF0A">
    <domeo:uuid>32FB6318-B011-402B-AA12-D80ECA69CF0A</domeo:uuid>
    <pav:createdOn>2014-07-08 09:32:04 -0400</pav:createdOn>
    <ao:suffix>or ketoconazole. In two separate studies in healthy adult subjects, fexofenadine hydrochloride 120 mg twice daily (240 mg total daily dose) was coadministered with either erythromycin 500 mg every 8 hours or ketoconazole 400 mg once daily under steady-st</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:32FB6318-B011-402B-AA12-D80ECA69CF0A"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>erythromycin </ao:exact>
    <ao:prefix>had no effect on the pharmacokinetics of either </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-139.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:8AD1102B-2F90-459C-AD9E-FB512EDA7542">
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:lastSavedOn>2014-07-08 08:46:38 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotationset:57174A7C-3100-4C8F-9C4A-2991CEE124D5</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:0E77BA1E-518A-45D7-9F12-9B93E41A8F5F"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:23515E27-98AC-4DC9-A4B7-EBFE2991219F</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-08 08:40:27 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:413E8823-E641-4B6C-8233-7C509C86A346">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:413E8823-E641-4B6C-8233-7C509C86A346"/>
    <pav:createdOn>2014-07-07 09:37:15 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>413E8823-E641-4B6C-8233-7C509C86A346</domeo:uuid>
    <ao:prefix>is cleared predominantly by the CYP3A (major route) and cytochrome P450 2C9 (CYP2C9, minor route) hepatic microsomal isoenzymes. The major circulating metabolite results from N-desmethylation of </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <ao:exact>sildenafil</ao:exact>
    <ao:suffix>, and is, itself, further metabolized. This metabolite has a phosphodiesterase selectivity profile similar to sildenafil and an in vitro potency for PDE5 approximately 50% of the parent drug. In healthy volunteers, plasma concentrations of this metabolit</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F20CC5F6-7B62-4389-B083-04A7A4139190">
    <pav:createdOn>2014-07-08 09:31:53 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-139.txt.html</ao:hasSource>
    <domeo:uuid>F20CC5F6-7B62-4389-B083-04A7A4139190</domeo:uuid>
    <ao:suffix>has been shown to exhibit minimal (ca. 5%) metabolism. However, coadministration of fexofenadine hydrochloride with either ketoconazole or erythromycin led to increased plasma concentrations of fexofenadine in healthy adult subjects. Fexofenadine had no </ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:F20CC5F6-7B62-4389-B083-04A7A4139190"/>
    <ao:exact>Fexofenadine </ao:exact>
    <ao:prefix>xsd:String</ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:BC031B07-0984-4C88-9A32-7B2B0C2A80FC">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:BC031B07-0984-4C88-9A32-7B2B0C2A80FC"/>
    <ao:exact>Metformin</ao:exact>
    <pav:createdOn>2014-07-08 08:50:18 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>BC031B07-0984-4C88-9A32-7B2B0C2A80FC</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:598F70E5-78CC-40CD-B003-2ECF5F1F07CB">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-07-07 19:46:14 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:2C86A542-E5CA-4AE9-80EF-1BFE0D6E2C91"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotationset:1DED06A6-8562-4CCF-A58C-CA25748FBD31</pav:lineageUri>
    <pav:lastSavedOn>2014-07-07 19:50:36 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5ABD9862-F044-4404-AD04-73DA04ADDA8B</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C56FAF33-D751-43EF-B31E-95E23B8E733A">
    <pav:lastSavedOn>2014-07-07 20:36:25 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-07 20:35:28 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotationset:EC7013F6-EFBC-45E5-937C-092DE48467F1</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:8B2D8833-1AE4-41FA-B72A-180709AECC86"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:0D772D07-6BFF-4E1B-A011-9A28BF92D56C"/>
    <permissions:permissions rdf:nodeID="N23e4a5448931432183b93fe3d9c6411a"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812e52b20002"/>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-57.txt.html</ao:annotatesResource>
    <domeo:deleted>false</domeo:deleted>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:item rdf:resource="urn:domeoclient:uuid:E236639E-7D4F-4C38-A396-CBBC20E12C95"/>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <rdfs:label>Default Set</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:428DBABB-8AA6-482D-8708-7398A892816E">
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2014-07-08 08:57:14 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:9BC311BC-A0C1-4FAE-9E74-D9C420B6A90A"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:C673D49F-D791-4325-A924-0B57680A3527</domeo:belongsToSet>
    <pav:createdOn>2014-07-08 08:56:43 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotation:BC7C3E31-0DFE-4820-82AD-832B317D34C9</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:633D2E0F-780A-4E6C-BA61-79419C3284D5">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:suffix>xsd:String</ao:suffix>
    <domeo:uuid>633D2E0F-780A-4E6C-BA61-79419C3284D5</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:633D2E0F-780A-4E6C-BA61-79419C3284D5"/>
    <ao:exact>Oral contraceptives were administered as a single dose both before and after the oral administration of fluconazole 50 mg once daily for 10 days in 10 healthy women. There was no significant difference in ethinyl estradiol or levonorgestrel AUC after the administration of 50 mg of fluconazole. The mean increase in ethinyl estradiol AUC was 6% (range: -47 to 108%) and levonorgestrel AUC increased 17% (range: -33 to 141%).</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-22.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-07 20:06:44 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:CAA6775D-8044-4806-8565-503A0E33EE07">
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:25B2E67D-ACC9-4BF4-BD21-6D415CC88B22"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:5741C3AA-07D0-4BB3-9A9F-55B13B957620">
    <domeo:deleted>false</domeo:deleted>
    <pav:lineageUri>urn:domeoserver:annotationset:9B0DEE56-C601-4404-AB7D-3BDBE330DCB9</pav:lineageUri>
    <permissions:permissions rdf:nodeID="N68cb233e4ef8440f897d557ab3e8db96"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:388D8AC2-947B-41E8-A79A-82BB3937BC8D"/>
    <pav:lastSavedOn>2014-07-07 20:48:02 -0400</pav:lastSavedOn>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:ABBE08B5-9179-4F12-BC4A-EFAB1703FC14"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:A563C94C-390B-4766-84EA-66BBD84F420D"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812e52b20002"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:85BC7B1F-9961-47FC-9A7E-0A309C19F4CA"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-120.txt.html</ao:annotatesResource>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <ao:item rdf:resource="urn:domeoclient:uuid:3F955BFA-EB21-4D9D-A158-F8EF51127ABC"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdOn>2014-07-07 20:46:54 -0400</pav:createdOn>
    <rdfs:label>Default Set</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7B1B6A74-1A7B-48D3-AC89-A5842AFC360D">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2014-07-08 08:44:20 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:5DA3E7EC-AAFD-413F-8CBA-43DD92E2FB7C"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:lastSavedOn>2014-07-08 08:46:38 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:23515E27-98AC-4DC9-A4B7-EBFE2991219F</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotationset:57174A7C-3100-4C8F-9C4A-2991CEE124D5</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:379A0F46-7ADB-481E-AF85-823E62AA538B">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-07-21 10:05:07 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:24FCFD9B-9FA2-4392-BA4F-FE3C1E676D24"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:32AE0CCB-E459-4836-ADED-1DE8CB7D4F9E</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:BF87892F-EDB3-43F6-A43F-620721E3F03A</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:lastSavedOn>2014-07-21 10:06:08 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A8E93BE5-3F12-47E6-8B5E-3AC5C1255745">
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:lastSavedOn>2014-07-08 12:26:36 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoclient:uuid:06097890-DF39-4D30-9C17-EEF19190B2D7</domeo:belongsToSet>
    <pav:createdOn>2014-07-08 12:26:22 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotation:45965153-7B30-4F95-BF14-589506209695</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:F0E086BE-BE55-423E-8698-BE529EBD322E"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:CBDCC745-54A1-4606-B0CC-4555E785D9A4">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:CBDCC745-54A1-4606-B0CC-4555E785D9A4"/>
    <domeo:uuid>CBDCC745-54A1-4606-B0CC-4555E785D9A4</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-08 09:29:46 -0400</pav:createdOn>
    <ao:prefix> tablets should be taken shortly after a meal or light snack. Symptomatic relief may be seen during the first week, with optimal antidepressant effects typically evident within two weeks. Twenty-five percent of those who respond to </ao:prefix>
    <ao:exact>trazodone </ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-138.txt.html</ao:hasSource>
    <ao:suffix>require more than two weeks (up to four weeks) of drug administration.</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoserver:annotationset:5B2167F6-4E63-4A7B-85C1-ACA56DDE7073">
    <ao:item rdf:resource="urn:domeoclient:uuid:A25E616C-DFAE-43E7-9DDF-ACDA2E92B74E"/>
    <ao:item rdf:resource="file:///home/yin2/python-SPL-connector/08062b4a-0b21-46e3-9a75-07274829e6ca"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">5</pav:versionNumber>
    <ao:item rdf:resource="urn:domeoclient:uuid:B17DEDF7-5117-4719-B40F-88EDC0752913"/>
    <pav:previousVersion>urn:domeoserver:annotationset:538503CE-FEE6-4385-9E54-AA36E80012CC</pav:previousVersion>
    <ao:item rdf:resource="urn:domeoclient:uuid:2A953CC4-23F6-4525-849F-0A5A2C32E759"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:82622DE7-39C8-4087-A05A-8F6B9B88AE40"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:41EC1F70-B919-4563-BA6C-23B2DE0ACFF8"/>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:1D6456DE-2785-4888-87AC-4EFB4B133035"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:419C7F38-E49C-4AA8-98BE-BD8D59B65810"/>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812e52b20002"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:512D3C59-8107-469D-B0FE-88AA316A2B12"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:E0C7F5D3-3AB4-4981-99E9-08634670F1AF"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:04CD5AFF-A9E0-42FF-B3F8-82385101DD14"/>
    <rdfs:label>NER Sets</rdfs:label>
    <ao:item rdf:resource="urn:domeoclient:uuid:21F405B7-4F22-4193-BD1F-3752F9723002"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:deleted>false</domeo:deleted>
    <ao:item rdf:resource="urn:domeoclient:uuid:52EA728D-4B57-4D63-9BBC-0060571DD8C0"/>
    <dct:description>The NER set is created automatically by NER annotation loading program.</dct:description>
    <pav:lastSavedOn>2014-07-08 15:56:00 -0400</pav:lastSavedOn>
    <permissions:permissions rdf:nodeID="N71c153f9c38446848998ccd3e03653d3"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:A899C9F5-4260-4BFA-B02D-21CC29BE7E52"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <ao:item rdf:resource="urn:domeoclient:uuid:0CE9A1DF-8DE2-490C-BDED-1F28F4629E27"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:91239536-9595-4DEC-9FCC-6F4DE09C1950"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:18BC6B83-DB23-457C-B70A-397945920538"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:464BFA2C-135D-42E7-BAF8-E1621BE503F2"/>
    <pav:lineageUri>urn:domeoserver:annotationset:061a21f6-0ef7-497f-bd03-574c24bc0d7c</pav:lineageUri>
    <ao:item rdf:resource="urn:domeoclient:uuid:B8024119-B326-4A20-9801-460A2876BCEE"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:964D229E-7742-4278-8030-45571F6470DC"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:C799DD5F-A65F-405A-8A34-C4328849306F"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:9B2C0E07-15F0-43CE-923F-D26DDE71CE6C"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:4B03F850-0F84-438D-85C6-2980A81685A7"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:B5CA50CB-8AAD-42D1-ADB9-A524369D214B"/>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-7.txt.html</ao:annotatesResource>
    <pav:createdOn>2014-07-07 08:07:04 -0400</pav:createdOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:327BB2AE-CC56-4759-9D3F-CDAD46111F6C"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:33292E01-9C31-4824-B80E-DC8033F8CFC9">
    <ao:suffix>. Since metformin is contraindicated in patients with renal impairment, coadministration of metformin with AVANDIA is contraindicated in these patients.</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:33292E01-9C31-4824-B80E-DC8033F8CFC9"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>in patients with mild to severe renal impairment or in hemodialysis-dependent patients compared to subjects with normal renal function. No dosage adjustment is therefore required in such patients receiving </ao:prefix>
    <ao:exact>AVANDIA</ao:exact>
    <domeo:uuid>33292E01-9C31-4824-B80E-DC8033F8CFC9</domeo:uuid>
    <pav:createdOn>2014-07-08 08:43:41 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:EF3AEA47-BC2D-46E8-8DEF-D15CEE83AC74">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:EF3AEA47-BC2D-46E8-8DEF-D15CEE83AC74"/>
    <ao:exact>erythromycin</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>was co-administered with </ao:prefix>
    <domeo:uuid>EF3AEA47-BC2D-46E8-8DEF-D15CEE83AC74</domeo:uuid>
    <ao:suffix>, a CYP3A inhibitor, at steady state (500 mg BID for 5 days), there was a 182% increase in sildenafil systemic exposure (AUC).</ao:suffix>
    <pav:createdOn>2014-07-07 09:41:54 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A38EEBF0-E48A-401A-8476-8FDBD696DDFD">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <ao:prefix>4 mg twice daily. The corresponding values for glyburide were 3.2, 3.1, and 2.9. The differences in change from baseline between </ao:prefix>
    <ao:exact>AVANDIA </ao:exact>
    <domeo:uuid>A38EEBF0-E48A-401A-8476-8FDBD696DDFD</domeo:uuid>
    <ao:suffix>and glyburide at week 52 were statistically significant.</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:A38EEBF0-E48A-401A-8476-8FDBD696DDFD"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-08 08:39:52 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N1d7853f9ea1c4db9861c3374e20686ab">
    <domeo:sets rdf:resource="urn:pddi:uuid:297EB28E-F930-4764-85C7-ED2F52B1F6EB"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7579EDB7-667C-4606-9F8F-BE3B39EAB203">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:7579EDB7-667C-4606-9F8F-BE3B39EAB203"/>
    <pav:createdOn>2014-07-07 20:00:33 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>A third study evaluated the potential interaction of once weekly dosing of </ao:prefix>
    <ao:exact>fluconazole </ao:exact>
    <ao:suffix>300 mg to 21 normal females taking an oral contraceptive containing ethinyl estradiol and norethindrone. In this placebo-controlled, double-blind, randomized, two-way crossover study carried out over three cycles of oral contraceptive treatment, fluconaz</ao:suffix>
    <domeo:uuid>7579EDB7-667C-4606-9F8F-BE3B39EAB203</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-21.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/35E575CF-A8D9-4836-A122-AEAD931648B0">
    <rdfs:label>cimetidine</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/2541</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:2121B846-6089-4E40-A066-5AC8E257CE35">
    <domeo:belongsToSet>urn:domeoclient:uuid:ACDB13DF-BBDB-49E3-A225-176E6DBB207B</domeo:belongsToSet>
    <pav:createdOn>2014-07-07 20:22:06 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotation:7AF3AA01-E7F7-43C2-80FA-2F6DF24645F8</pav:lineageUri>
    <pav:lastSavedOn>2014-07-07 20:22:41 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:2F71DACF-2A3A-46D4-833C-35E318369EB4"/>
    <rdfs:label>Highlight</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoserver:annotationset:9432C436-030D-4F96-AC0D-73DA640746E2">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-07 08:06:50 -0400</pav:createdOn>
    <domeo:deleted>false</domeo:deleted>
    <dct:description>The NER set is created automatically by NER annotation loading program.</dct:description>
    <pav:lastSavedOn>2014-07-08 15:00:05 -0400</pav:lastSavedOn>
    <permissions:permissions rdf:nodeID="N999fe5bc11d3499bbf629d148915e165"/>
    <pav:lineageUri>urn:domeoserver:annotationset:40d1f7ac-a4d3-4319-971a-f582165db20e</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <pav:previousVersion>urn:domeoclient:uuid:a4d21be5-c4b5-4c73-bca7-0d04ffdc776e</pav:previousVersion>
    <ao:item rdf:resource="file:///home/yin2/python-SPL-connector/d759aa74-17a7-4350-a348-8a76f5c19cd2"/>
    <rdfs:label>NER Sets</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">3</pav:versionNumber>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812e52b20002"/>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-113.txt.html</ao:annotatesResource>
    <ao:item rdf:resource="urn:domeoclient:uuid:6B30932B-00C6-46E8-8CDE-7D8631A0CB5B"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:0FA00623-B592-4E02-8ABA-910E6132FFD6">
    <ao:suffix>and its active N-desmethyl metabolite were 45% and 57%, respectively.</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:0FA00623-B592-4E02-8ABA-910E6132FFD6"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-07 09:38:50 -0400</pav:createdOn>
    <ao:exact>sildenafil </ao:exact>
    <ao:prefix> metabolite, respectively, compared to those seen in healthy younger volunteers (18–45 years). Due to age-differences in plasma protein binding, the corresponding increase in the AUC of free (unbound) </ao:prefix>
    <domeo:uuid>0FA00623-B592-4E02-8ABA-910E6132FFD6</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:885F403E-C357-4B40-9CD3-954956D19A4A">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/ABE75BCD-13B4-4B31-BF5F-12D04B91FA6B"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/CC07EA99-C961-471D-8B94-5104B5BC8199"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:8874DAF5-8FBD-4442-9EBC-110E9D81AE31">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/16D343DF-2D5F-4267-B97E-81BB056B2EB1"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/F2055511-1EC5-4FD4-9AF0-6FF994359EA5"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:2012A094-6453-4FEE-9C05-42D01579A7A6">
    <domeo:uuid>2012A094-6453-4FEE-9C05-42D01579A7A6</domeo:uuid>
    <pav:createdOn>2014-07-08 12:02:56 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:2012A094-6453-4FEE-9C05-42D01579A7A6"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix>is not recommended when administered in combination with nelfinavir, close monitoring for known side effects of azithromycin, such as liver enzyme abnormalities and hearing impairment, is warranted (see ADVERSE REACTIONS).</ao:suffix>
    <ao:exact>azithromycin </ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-161.txt.html</ao:hasSource>
    <ao:prefix>serum concentrations. Although a dose adjustment of </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:0AED07DB-D873-46A2-A8AB-26F80E17A2CC">
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotationset:F37BE993-E972-47AE-896D-FF4D33157ECF</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-07 09:44:18 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:7844EA3E-1BD1-4F53-BBF2-97F005CEF6CE"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-07-07 09:41:50 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A5E637EF-5CA5-4AAC-BD8B-C136A86E17B7</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:6D392C36-EFE2-4294-A383-4E8079828BE8">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:suffix>xsd:String</ao:suffix>
    <pav:createdOn>2014-07-08 09:13:22 -0400</pav:createdOn>
    <domeo:uuid>6D392C36-EFE2-4294-A383-4E8079828BE8</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:6D392C36-EFE2-4294-A383-4E8079828BE8"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-130.txt.html</ao:hasSource>
    <ao:exact>Co-administration of metoclopramide with the long-acting propranolol did not have a significant effect on propranolol’s pharmacokinetics.</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F7DE20BC-6042-49BF-84F2-D1173B6F4291">
    <domeo:uuid>F7DE20BC-6042-49BF-84F2-D1173B6F4291</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <ao:prefix>had no clinically relevant effect on the steady-state pharmacokinetics of </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:F7DE20BC-6042-49BF-84F2-D1173B6F4291"/>
    <pav:createdOn>2014-07-08 08:53:29 -0400</pav:createdOn>
    <ao:exact>warfarin </ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix>enantiomers.</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:834C81A5-0020-416F-9B77-7242D8278517">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:834C81A5-0020-416F-9B77-7242D8278517"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <ao:exact>sildenafil </ao:exact>
    <domeo:uuid>834C81A5-0020-416F-9B77-7242D8278517</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>and an in vitro potency for PDE5 approximately 50% of the parent drug. In healthy volunteers, plasma concentrations of this metabolite are approximately 40% of those seen for sildenafil, so that the metabolite accounts for about 20% of sildenafil's pharm</ao:suffix>
    <ao:prefix>, and is, itself, further metabolized. This metabolite has a phosphodiesterase selectivity profile similar to </ao:prefix>
    <pav:createdOn>2014-07-07 09:37:19 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:904576B5-11ED-425A-99B3-7DAF7EDF432D">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotation:36228235-402C-407C-862C-93DECF827BD3</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <domeo:belongsToSet>urn:domeoclient:uuid:7E6B38CA-10F3-41E5-9A31-80E5F9447237</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:F7DD2319-D95F-4678-8C14-F3A97597ECB0"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2014-07-07 20:37:16 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-07 20:36:57 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/7011C888-1DBD-407F-BF39-7F15390D0EE1">
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>meperidine</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/6754</dailymed:activeMoietyRxCUI>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/0BDAF8E9-DD98-4554-9ED9-A766580D5592">
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>lidocaine</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/21E36C1E-B88A-4461-9263-C02A58739F96">
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/4719</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>gemfibrozil</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:81151024-3DB0-42AD-B773-62D7D6CEF0C4">
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:createdOn>2014-07-07 20:23:16 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoclient:uuid:5F40D6FC-BF07-4E5A-BB51-EB521FF63890</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:992E7A10-4A9E-4A7A-AF1A-AD11F9C38A11"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-07 20:25:19 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotation:13FAC254-F941-42DB-88BA-2ECB1129F65B</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D738283F-367A-4514-A1FA-3C792F0DB088">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotationset:F37BE993-E972-47AE-896D-FF4D33157ECF</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdOn>2014-07-07 09:41:45 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-07-07 09:44:18 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:6088A1D3-834D-4614-BEC7-94E6DE5B99D1"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A5E637EF-5CA5-4AAC-BD8B-C136A86E17B7</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7E32BEF1-7A20-4571-AA29-8F9AC97657A0">
    <rdfs:label>Default Set</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotationset:B40548E6-67CB-4ACD-88E5-8EE8900ABC29</pav:lineageUri>
    <permissions:permissions rdf:nodeID="Naee197a63b1b4151877ffb88086ca19e"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:createdOn>2014-07-08 09:29:40 -0400</pav:createdOn>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:2FA6F9C2-70F0-4E05-9478-1EE173AD6D95"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-138.txt.html</ao:annotatesResource>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <pav:lastSavedOn>2014-07-08 09:29:51 -0400</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812e52b20002"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:948FAEC8-F52B-4091-A753-A2E8B169BECA"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:deleted>false</domeo:deleted>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:51A70545-FD58-441C-9E45-815D0E26D0ED">
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:1FAA43A7-B3D9-40CC-BFEF-F1012A394ACA"/>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:850BCCCD-2F22-4F0E-8FB6-6648E690DCB1">
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:A08A88A9-81EE-48F0-8E02-4BBE38B2E99A"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E79A8B07-C97C-4FF7-AAE4-9F4E086B09E0">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:8477A386-415F-4AE0-883E-F937CC36A7A3"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:createdOn>2014-07-07 20:44:08 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-07-07 20:44:32 -0400</pav:lastSavedOn>
    <ao:body rdf:nodeID="N8b500c41c6904297bab35004945ddea7"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:F2EFEF06-B779-484C-B854-043086EB0C5C</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:305606F8-6CD9-4454-AA3D-607CC09B0446</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D469FE4A-1758-4F43-9F3C-B139C2F96660">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:5ACE5352-0C92-4C41-9C1B-D942B3D9A931"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdOn>2014-07-08 14:21:08 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">3</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:42258B16-6749-4B39-B28D-88C8B63F7A43</domeo:belongsToSet>
    <pav:previousVersion>urn:domeoclient:uuid:e75c9d7b-f906-4c66-8a84-e6eef34d0954</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotationset:0f67c012-7596-4b02-a927-63c0ccbc3afa</pav:lineageUri>
    <pav:lastSavedOn>2014-07-08 14:24:44 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:23FA430E-D94F-4E0A-B792-4598E29FCFD1">
    <ao:exact>REVATIO </ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:23FA430E-D94F-4E0A-B792-4598E29FCFD1"/>
    <ao:suffix>has been characterized following intravenous administration. A 10 mg dose of REVATIO Injection is predicted to provide a pharmacological effect of sildenafil and its N-desmethyl metabolite equivalent to that of a 20 mg oral dose.</ao:suffix>
    <pav:createdOn>2014-07-07 09:37:45 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>23FA430E-D94F-4E0A-B792-4598E29FCFD1</domeo:uuid>
    <ao:prefix>Injection: The pharmacokinetic profile of </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:3D2DB395-0FF8-444E-A19D-E69F5D5AAAB1">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-07 09:38:43 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:391F9F2D-B990-4A7F-AB0A-29238C621196"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotationset:F37BE993-E972-47AE-896D-FF4D33157ECF</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2014-07-07 09:44:18 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A5E637EF-5CA5-4AAC-BD8B-C136A86E17B7</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A78E1E5A-8750-46B9-9E70-0549DAF3F010">
    <ao:exact>In vitro drug metabolism studies reveal that trazodone is a substrate of the cytochrome P450 3A4 (CYP3A4) enzyme and trazodone metabolism can be inhibited by the CYP3A4 inhibitors ketoconazole, ritonavir, and indinavir</ao:exact>
    <pav:createdOn>2014-07-08 09:27:11 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-136.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:A78E1E5A-8750-46B9-9E70-0549DAF3F010"/>
    <ao:prefix>xsd:String</ao:prefix>
    <domeo:uuid>A78E1E5A-8750-46B9-9E70-0549DAF3F010</domeo:uuid>
    <ao:suffix>xsd:String</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:4212DEFB-18BD-45B7-9672-279543486F2E">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix> and </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:4212DEFB-18BD-45B7-9672-279543486F2E"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-21.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-07 20:00:49 -0400</pav:createdOn>
    <ao:exact>norethindrone</ao:exact>
    <domeo:uuid>4212DEFB-18BD-45B7-9672-279543486F2E</domeo:uuid>
    <ao:suffix> compared to similar placebo dosing. The mean AUCs of ethinyl estradiol and norethindrone increased by 24% (95% C.I. range 18 to 31%) and 13% (95% C.I. range 8 to 18%), respectively relative to placebo. Fluconazole treatment did not cause a decrease in t</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/E6EDD096-EEE1-4016-85F5-5D89B786AC88">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>amlodipine</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/17767</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoserver:annotationset:31BF5260-976E-4243-A257-4879A500F1C6">
    <rdfs:label>NER Sets</rdfs:label>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812e52b20002"/>
    <permissions:permissions rdf:nodeID="N8c62c3f2081f4914a47c0e05353c57a3"/>
    <pav:createdOn>2014-07-07 08:06:34 -0400</pav:createdOn>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <dct:description>The NER set is created automatically by NER annotation loading program.</dct:description>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:previousVersion>urn:domeoclient:uuid:21bea58a-d035-4058-98e3-c0939574683a</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-35.txt.html</ao:annotatesResource>
    <domeo:deleted>false</domeo:deleted>
    <ao:item rdf:resource="urn:domeoclient:uuid:E78B48BE-9D1F-4F71-93E3-934B0E1BA43D"/>
    <pav:lastSavedOn>2014-07-08 19:57:01 -0400</pav:lastSavedOn>
    <ao:item rdf:resource="file:///home/yin2/python-SPL-connector/8ef630a1-4580-4c84-b0a2-dd063e91b594"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">3</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotationset:ec7c35b0-89da-4e71-92ef-3c6ed6456c23</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D82AA03C-CE3D-4F97-93AE-E2F464DED5F8">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-07 19:46:24 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-07-07 19:50:36 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotationset:1DED06A6-8562-4CCF-A58C-CA25748FBD31</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5ABD9862-F044-4404-AD04-73DA04ADDA8B</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:E606D7B6-14FA-4E2D-BCC8-D22226EA970D"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:0CA59AE8-1A92-466F-B216-0940DA19A0C8">
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:7AD90DF1-436B-401A-98CC-DE8342562E62"/>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D0362821-2FFA-4FE0-97C8-4B8F9F3416FD">
    <ao:suffix>. Any dose adjustment should be guided by clinical effect (tolerability and efficacy). </ao:suffix>
    <ao:prefix>significantly decreased plasma levels of </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:D0362821-2FFA-4FE0-97C8-4B8F9F3416FD"/>
    <pav:createdOn>2014-07-07 20:25:55 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>paroxetine</ao:exact>
    <domeo:uuid>D0362821-2FFA-4FE0-97C8-4B8F9F3416FD</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-51.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:980D8375-2A34-47AE-9648-D44F8E1E5609">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoclient:uuid:A927CF27-CC1C-4BE1-9435-0875A6356C3E</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:lastSavedOn>2014-07-08 08:58:29 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-08 08:58:29 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:234802F1-72E6-403E-AB88-E5B255950B39"/>
    <pav:lineageUri>urn:domeoserver:annotation:EA6E4C21-66F8-4B14-BF61-042D2071C190</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:body rdf:nodeID="N82b56864af014f968b08de96ad4b3c7d"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/D615845B-266A-47AB-860F-91DB6A6DB3E8">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/32937</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>paroxetine</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/A08A1833-AC3A-48ED-9E14-C0222DE73198">
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>sertraline</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/36437</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dct:description>Referred to the drug in the interaction.</dct:description>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:8A6C73C6-3A1F-461F-9817-855065C77FE9">
    <pav:lastSavedOn>2014-07-07 19:50:36 -0400</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdOn>2014-07-07 19:49:18 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotationset:1DED06A6-8562-4CCF-A58C-CA25748FBD31</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5ABD9862-F044-4404-AD04-73DA04ADDA8B</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:C0CC88E7-DAE2-4FEE-B0C4-B320E566491F"/>
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Na925a6d6098d4ad4a413f38199be1565">
    <domeo:sets rdf:resource="urn:pddi:uuid:A63BDBB5-15F1-4DEB-B8BD-C390C13121EE"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:FC4FF959-6C60-4B14-86FE-4FB2A5D97DD0">
    <ao:exact>theophylline </ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-28.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:FC4FF959-6C60-4B14-86FE-4FB2A5D97DD0"/>
    <ao:suffix>AUC, Cmax, and half-life with a corresponding decrease in clearance. The mean ± SD theophylline AUC increased 21% ± 16% (range: -5 to 48%). The Cmax increased 13% ± 17% (range: -13 to 40%). Theophylline clearance decreased 16% ± 11 % (range: -32 to 5%). </ao:suffix>
    <ao:prefix>200 mg daily for 14 days in 16 normal male volunteers. There were significant increases in </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-07 20:18:57 -0400</pav:createdOn>
    <domeo:uuid>FC4FF959-6C60-4B14-86FE-4FB2A5D97DD0</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:51B5C904-6027-4CA8-B4DA-1DF2AAB2ACF4">
    <domeo:uuid>51B5C904-6027-4CA8-B4DA-1DF2AAB2ACF4</domeo:uuid>
    <ao:suffix>AUC of 23% ± 9% (range: -13 to -42%). Apparent oral clearance of fluconazole increased 32% ± 17% (range: 16 to 72%). Fluconazole half-life decreased from 33.4 ± 4.4 hours to 26.8 ± 3.9 hours. (See PRECAUTIONS.)</ao:suffix>
    <ao:prefix>. There was a mean ± SD reduction in </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:51B5C904-6027-4CA8-B4DA-1DF2AAB2ACF4"/>
    <ao:exact>fluconazole </ao:exact>
    <pav:createdOn>2014-07-07 20:10:25 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-24.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:CEFBAE30-68A1-447B-B8EB-87DCBC0E389B">
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotation:AD24BC55-0F5E-43A5-BD48-388FAC24762C</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:FF0CAD74-6572-4208-9681-F420B73A83E2"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoclient:uuid:423352B3-8ABA-48B7-98CF-B191A7BFC955</domeo:belongsToSet>
    <pav:createdOn>2014-07-08 09:30:30 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-07-08 09:35:29 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:AF6B9F95-6740-4A37-88A8-917C5CE4F19E">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:C374BF68-C689-431A-A44F-409A3C6D2617"/>
    <pav:lineageUri>urn:domeoserver:annotation:58D689F9-9D2B-4249-A054-99D0E2490B3F</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:lastSavedOn>2014-07-07 20:21:40 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoclient:uuid:CE45A5D4-BD84-4E02-AC7B-C9E12233EC3A</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdOn>2014-07-07 20:18:51 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/57C3952B-3E4F-45C6-A803-6EF548827610">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>fexofenadine hydrochloride</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/236474</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/F0A44968-9104-4A52-8182-BAD78F48C11F">
    <rdfs:label>risperidone</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/35636</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoserver:annotationset:32AE0CCB-E459-4836-ADED-1DE8CB7D4F9E">
    <ao:item rdf:resource="urn:domeoclient:uuid:335D90D2-87B8-42BC-9C9A-96BEC15A08F2"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <rdfs:label>NER Sets</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">3</pav:versionNumber>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <pav:lineageUri>urn:domeoserver:annotationset:d6d4846f-77a8-4eb2-b619-b7bbdf84c4ab</pav:lineageUri>
    <dct:description>The NER set is created automatically by NER annotation loading program.</dct:description>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-21 10:06:08 -0400</pav:lastSavedOn>
    <domeo:deleted>false</domeo:deleted>
    <pav:previousVersion>urn:domeoclient:uuid:8f70a743-a8c5-4282-a783-9749917c2338</pav:previousVersion>
    <ao:item rdf:resource="urn:domeoclient:uuid:BA84D1FF-D91E-4842-AEE3-D36985F0A1E3"/>
    <pav:createdOn>2014-07-07 08:07:07 -0400</pav:createdOn>
    <permissions:permissions rdf:nodeID="N662226fb7e55472996a4dfcc368d28a6"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812e52b20002"/>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-10.txt.html</ao:annotatesResource>
    <ao:item rdf:resource="urn:domeoclient:uuid:379A0F46-7ADB-481E-AF85-823E62AA538B"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:08720F0F-1C3C-42A0-85E9-8A5D17EC8811"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:30946630-56C3-41E1-B676-2074DA88BD79">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:30946630-56C3-41E1-B676-2074DA88BD79"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-7.txt.html</ao:hasSource>
    <ao:suffix> Co-administration of other known enzyme inducers (e.g.,</ao:suffix>
    <ao:exact>Carbamazepine co-administration decreased the steady-state plasma concentrations of risperidone and 9-hydroxyrisperidone by about 50%. Plasma concentrations of carbamazepine did not appear to be affected. The dose of risperidone may need to be titrated accordingly for patients receiving carbamazepine, particularly during initiation or discontinuation of carbamazepine therapy.</ao:exact>
    <pav:createdOn>2014-07-08 15:53:01 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>30946630-56C3-41E1-B676-2074DA88BD79</domeo:uuid>
    <ao:prefix>xsd:String</ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:08A3DC90-84E8-4276-877E-061AC357DDA3">
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2014-07-07 19:59:12 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotation:16899511-0DDD-48A6-9DAB-06AAD72AD3C4</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:43EDED30-FAB5-4F26-8585-2ED0B4C7D300"/>
    <pav:createdOn>2014-07-07 19:58:29 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5ABD9862-F044-4404-AD04-73DA04ADDA8B</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/E23B4D2D-34FE-4CDD-A2D4-AB290C2DEFCA">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>nifedipine</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/7417</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F0458405-B95E-4B40-9826-2980D5D136E9">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:F0458405-B95E-4B40-9826-2980D5D136E9"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <domeo:uuid>F0458405-B95E-4B40-9826-2980D5D136E9</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>In study in healthy volunteers, co-administration with </ao:prefix>
    <ao:exact>ritonavir</ao:exact>
    <ao:suffix>, a potent CYP3A inhibitor, at steady state (500 mg BID) with sildenafil (100 mg single dose) resulted in a 300% (4-fold) increase in sildenafil Cmax and a 1000% (11-fold) increase in sildenafil plasma AUC. At 24 hours, the plasma levels of sildenafil we</ao:suffix>
    <pav:createdOn>2014-07-07 09:40:04 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/635890C4-55D3-4AB0-B86F-8D50D190FDB3">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>risperidone</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/35636</dailymed:activeMoietyRxCUI>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C374BF68-C689-431A-A44F-409A3C6D2617">
    <ao:prefix>The pharmacokinetics of </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:C374BF68-C689-431A-A44F-409A3C6D2617"/>
    <pav:createdOn>2014-07-07 20:18:51 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>C374BF68-C689-431A-A44F-409A3C6D2617</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-28.txt.html</ao:hasSource>
    <ao:suffix>were determined from a single intravenous dose of aminophylline (6 mg/kg) before and after the oral administration of fluconazole 200 mg daily for 14 days in 16 normal male volunteers. There were significant increases in theophylline AUC, Cmax, and half-</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>theophylline </ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7DECDAF5-0D11-4B62-8E1A-BAB596ADEB98">
    <domeo:uuid>7DECDAF5-0D11-4B62-8E1A-BAB596ADEB98</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:7DECDAF5-0D11-4B62-8E1A-BAB596ADEB98"/>
    <pav:createdOn>2014-07-07 20:45:54 -0400</pav:createdOn>
    <ao:suffix>(2g q6h iv) in the first study (JRV 304) and cefazolin (1g q8h iv) in the second study (JRV 305); however, in both studies vancomycin (1g q12h iv) could be substituted for the specified comparator if the causative pathogen was suspected or confirmed meth</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>oxacillin </ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-119.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>(7.5 mg/kg q12h intravenously [iv]) in the treatment of complicated skin and skin structure infections were performed. The comparator drug was </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:BDB01C77-508F-48F5-99B7-1196E16FF47F">
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:C755BB2A-5541-440B-AEE6-51B8F4C9E01D"/>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:5F9E8D23-F285-4C66-8DF7-7C419412D9C9">
    <pav:lineageUri>urn:domeoserver:annotation:C550972C-84AB-417A-9500-9A2F51592AAA</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:createdOn>2014-07-08 15:59:45 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:0E266770-6575-4561-B418-59E9FFE8BEE7</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:B81380C7-81CB-4A55-AFE6-3564A2B6FFA3"/>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <ao:body rdf:nodeID="N7a37923d86f04459acb1f4f161b242b6"/>
    <pav:lastSavedOn>2014-07-08 15:59:46 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:BA84D1FF-D91E-4842-AEE3-D36985F0A1E3">
    <pav:lineageUri>urn:domeoserver:annotation:2CEAFABC-6A8C-4A9D-A24B-9B1174E46764</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-07-21 10:06:08 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:32AE0CCB-E459-4836-ADED-1DE8CB7D4F9E</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:AF463AE0-BCFA-44C8-B6DD-9CB1162FFB57"/>
    <pav:createdOn>2014-07-21 10:05:03 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:3B812E4A-068C-4297-829E-92BE73C93CF2">
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:F940A75F-56E5-47F9-A053-09C49A2E4491"/>
    <pav:lastSavedOn>2014-07-07 19:50:36 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotationset:1DED06A6-8562-4CCF-A58C-CA25748FBD31</pav:lineageUri>
    <pav:createdOn>2014-07-07 19:48:50 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5ABD9862-F044-4404-AD04-73DA04ADDA8B</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:709ADA7F-2CEF-4136-B746-E33B1F161FEB">
    <pav:createdOn>2014-07-07 20:29:19 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotation:DCC2EAF0-A0E3-4156-925F-C6BFDC755582</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2014-07-07 20:30:15 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:2060940A-BAB5-4249-9194-D54B0DB0122C"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoclient:uuid:06661B74-00AE-4DF7-A9CC-742273A11E94</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/F561A4CA-25B4-4436-94B2-027E1D99C26D">
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/10635</dailymed:activeMoietyRxCUI>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>tolbutamide</rdfs:label>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A58B1992-5F7F-4BE1-8F71-3FA87F036371">
    <ao:context rdf:resource="urn:domeoclient:uuid:BE5BBB91-BFBC-4A97-A6BF-09DF9AD3ACB7"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:createdOn>2014-07-08 12:28:22 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoclient:uuid:6B178133-9B11-445F-A5BB-EF967EA53386</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-08 12:29:01 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotation:A328D9CA-7EBF-40E8-B084-D428542BC310</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:34E99F90-2EA2-441E-B41B-3E236115FFEC">
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdOn>2014-07-07 20:32:25 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-07-07 20:34:18 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotation:BB77945C-8D95-4B10-BD5A-D29DBD6ED6F7</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoclient:uuid:51AE28A6-A4F5-4551-AD8B-8ADDDCA82257</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:040BF857-F51E-4826-A84B-513FC081772B"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:81D862BF-6755-45B3-8EAE-F922FD9F4239">
    <pav:createdOn>2014-07-08 08:50:22 -0400</pav:createdOn>
    <ao:exact>metformin </ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:81D862BF-6755-45B3-8EAE-F922FD9F4239"/>
    <domeo:uuid>81D862BF-6755-45B3-8EAE-F922FD9F4239</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>(500 mg twice daily) in healthy volunteers for 4 days had no effect on the steady-state pharmacokinetics of either </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix>or rosiglitazone.</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:25536997-8B2D-4FC8-A79B-A98E343D3101">
    <permissions:permissions rdf:nodeID="Nfbd826c802584448b68537059a93a48a"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:48F1AED5-61EA-4859-A9DA-74D16F93CA0C"/>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <ao:item rdf:resource="urn:domeoclient:uuid:DE08B357-9C54-458B-8993-B39DAE0D54A4"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:8061F928-43C7-4E80-9544-E961A1F30C1D"/>
    <rdfs:label>Default Set</rdfs:label>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <domeo:deleted>false</domeo:deleted>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:8139AF01-AC5F-40BE-8565-A1FD9956367E"/>
    <pav:createdOn>2014-07-07 20:25:50 -0400</pav:createdOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:19046288-FBF6-4360-A48C-097CE42F9F04"/>
    <pav:lastSavedOn>2014-07-07 20:26:26 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812e52b20002"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-51.txt.html</ao:annotatesResource>
    <pav:lineageUri>urn:domeoserver:annotationset:7AE7EC7F-096D-4A70-9C4B-4BB25B35A26F</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:BB822DA9-9165-43B8-87AA-B14F889A5494">
    <pav:lastSavedOn>2014-07-08 08:46:38 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotationset:57174A7C-3100-4C8F-9C4A-2991CEE124D5</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:body rdf:nodeID="N470b4faa261f432a935d80ff33e7e586"/>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:23515E27-98AC-4DC9-A4B7-EBFE2991219F</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:1C021AB0-72D6-4EB8-B9DB-38B652CD3E1D"/>
    <pav:createdOn>2014-07-08 08:45:25 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/64B75E1D-444B-46D0-B066-B6098DBEBFDB">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>diazepam</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/3322</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:6C4881EE-692B-43EF-89CA-3564DF645FEE">
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:9E42F185-8094-4BFF-A454-C4C8D38C7000"/>
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:4337DB52-8336-44F2-B382-46DDFA2386A0">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:0DD2BBBF-A36C-4846-BBC8-836F69996988"/>
    <pav:lineageUri>urn:domeoserver:annotationset:57174A7C-3100-4C8F-9C4A-2991CEE124D5</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdOn>2014-07-08 08:39:19 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:23515E27-98AC-4DC9-A4B7-EBFE2991219F</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-08 08:46:38 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/BD9CA01A-55E5-4356-AD8A-5527CC3559FF">
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/8787</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>propranolol</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dct:description>Referred to the drug in the interaction.</dct:description>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:55DE2655-F516-43B2-9BD9-788B44D396AC">
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdOn>2014-07-07 19:58:22 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5ABD9862-F044-4404-AD04-73DA04ADDA8B</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotation:88488C09-885B-469F-95BE-D014EF97160E</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:D0216212-AE15-4734-9E3C-6AE7C23DFC17"/>
    <pav:lastSavedOn>2014-07-07 19:59:12 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:82C30C3D-B4DB-4D33-98E2-40A5A667E03F">
    <pav:createdOn>2014-07-08 09:25:24 -0400</pav:createdOn>
    <domeo:uuid>82C30C3D-B4DB-4D33-98E2-40A5A667E03F</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:82C30C3D-B4DB-4D33-98E2-40A5A667E03F"/>
    <ao:suffix>. The effect of short-term administration of ritonavir (200 mg twice daily, 4 doses) on the pharmacokinetics of a single dose of trazodone (50 mg) has been studied in 10 healthy subjects. The Cmax of trazodone increased by 34%, the AUC increased 2.4 fold</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>indinavir</ao:exact>
    <ao:prefix>, and </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-136.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:B55091DF-79BD-4E15-9803-8FB9D85822A5">
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:DCF51EA4-ED9F-4B02-9629-083F4CF8C4B9"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:48099A33-8250-4530-925A-76809DBF9B83">
    <ao:prefix>Results of the population pharmacokinetics analysis showed that the mean oral clearance of </ao:prefix>
    <ao:suffix>in female patients (n = 405) was approximately 6% lower compared to male patients of the same body weight (n = 642).</ao:suffix>
    <pav:createdOn>2014-07-08 08:42:41 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:48099A33-8250-4530-925A-76809DBF9B83"/>
    <ao:exact>rosiglitazone </ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>48099A33-8250-4530-925A-76809DBF9B83</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:9B2D885E-A860-4489-B5DF-D35BB6908AE7">
    <pav:createdOn>2014-07-07 19:46:56 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2014-07-07 19:50:36 -0400</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:C76F01B7-B793-4BB1-9ACF-8CC577A3F9BF"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5ABD9862-F044-4404-AD04-73DA04ADDA8B</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotationset:1DED06A6-8562-4CCF-A58C-CA25748FBD31</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:4D60C3ED-A808-4189-A99A-5A90B43F2521">
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:23515E27-98AC-4DC9-A4B7-EBFE2991219F</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:7055BC1F-17EA-44CF-878C-8B64C98F7D1E"/>
    <pav:lineageUri>urn:domeoserver:annotationset:57174A7C-3100-4C8F-9C4A-2991CEE124D5</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-07-08 08:39:16 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-07-08 08:46:38 -0400</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:FADB1D60-DCB2-40A1-A37B-321DD9EB3027">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:FADB1D60-DCB2-40A1-A37B-321DD9EB3027"/>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-127.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>FADB1D60-DCB2-40A1-A37B-321DD9EB3027</domeo:uuid>
    <pav:createdOn>2014-07-08 08:59:57 -0400</pav:createdOn>
    <ao:prefix>xsd:String</ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>Propranolol does not affect the pharmacokinetics of verapamil and norverapamil. Verapamil does not affect the pharmacokinetics of propranolol</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E18A76D4-19FB-496D-8162-8C60CAD2D009">
    <domeo:uuid>E18A76D4-19FB-496D-8162-8C60CAD2D009</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix>is metabolized through three primary routes: aromatic hydroxylation (mainly 4-hydroxylation), N-dealkylation followed by further side-chain oxidation, and direct glucuronidation. It has been estimated that the percentage contributions of these routes to </ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:E18A76D4-19FB-496D-8162-8C60CAD2D009"/>
    <ao:exact>Propranolol </ao:exact>
    <ao:prefix>is extensively metabolized with most metabolites appearing in the urine. </ao:prefix>
    <pav:createdOn>2014-07-08 09:23:58 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-135.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:FB923729-1203-488D-9A56-696B720C1DD3">
    <ao:body rdf:nodeID="N95348413915c4fffbd74d962a08d6d3a"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:063A7209-93BB-42E1-A05D-D45CEF402ED2</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:DB0CF638-0598-4B41-A77B-7A38CD787732"/>
    <pav:createdOn>2014-07-08 15:30:37 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotation:E14E95F3-7C3D-48F4-8DB3-2E3522D8D7FC</pav:lineageUri>
    <pav:lastSavedOn>2014-07-08 15:30:37 -0400</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/CE7FEF8E-0597-493A-B9DE-0605AB63DB26">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>methadone</rdfs:label>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/6813</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E808FC5F-C42C-4A63-8F24-AF42F13FD845">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:E808FC5F-C42C-4A63-8F24-AF42F13FD845"/>
    <domeo:uuid>E808FC5F-C42C-4A63-8F24-AF42F13FD845</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-7.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>xsd:String</ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>In vitro studies indicate that risperidone is a relatively weak inhibitor of CYP 2D6. Therefore, risperidone is not expected to substantially inhibit the clearance of drugs that are metabolized by this enzymatic pathway. In drug interaction studies, risperidone did not significantly affect the pharmacokinetics of donepezil and galantamine, which are metabolized by CYP 2D6</ao:exact>
    <ao:suffix>xsd:String</ao:suffix>
    <pav:createdOn>2014-07-08 15:56:00 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/9AB050DC-B5A0-4118-B232-CD9F387B7376">
    <rdfs:label>propranolol</rdfs:label>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/8787</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/8DA51822-E520-4CD7-B9E6-5C34841D70B7">
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/3364</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>didanosine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:6B30932B-00C6-46E8-8CDE-7D8631A0CB5B">
    <pav:createdOn>2014-07-08 15:00:04 -0400</pav:createdOn>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:5323E4F3-3BE3-400B-AA93-AB47E8EB9EF5"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <ao:body rdf:nodeID="Nc090325e59624d298fb73966ea2c9a3f"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotation:F11976D7-0BEA-4613-9799-0049FB5B3C38</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9432C436-030D-4F96-AC0D-73DA640746E2</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-08 15:00:05 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoserver:annotationset:681FEB9B-2D56-48DF-9FEF-30ED029A67B1">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <pav:lastSavedOn>2014-07-21 10:09:44 -0400</pav:lastSavedOn>
    <pav:previousVersion>urn:domeoclient:uuid:bb0dfd7c-d753-4047-b7da-abead5721450</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:deleted>false</domeo:deleted>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812e52b20002"/>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <permissions:permissions rdf:nodeID="Nd891230a6eaf41d6a0d376f7b2a678c0"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <pav:lineageUri>urn:domeoclient:uuid:c03428cf-114e-4bd4-88e6-b09d3a70f259</pav:lineageUri>
    <ao:item rdf:resource="urn:domeoclient:uuid:e0172491-3cfc-4bff-ad5e-35ccc1fe20c4"/>
    <pav:createdOn>2014-07-07 08:02:55 -0400</pav:createdOn>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-12.txt.html</ao:annotatesResource>
    <rdfs:label>NLP Set</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:19046288-FBF6-4360-A48C-097CE42F9F04">
    <pav:lastSavedOn>2014-07-07 20:26:26 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotation:9D8D3616-AB51-4084-A16D-59A47C9EE442</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:25536997-8B2D-4FC8-A79B-A98E343D3101</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-07-07 20:25:55 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:D0362821-2FFA-4FE0-97C8-4B8F9F3416FD"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/FB757EE1-994D-4CD6-8BB6-BB8D93075EC8">
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>midazolam</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/6960</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:EF9C08F2-1B30-49C0-831D-4BC4BFD6AE48">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:EF9C08F2-1B30-49C0-831D-4BC4BFD6AE48"/>
    <ao:exact>risperidone </ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-07 19:46:38 -0400</pav:createdOn>
    <ao:prefix>is rapidly distributed. The volume of distribution is 1 to 2 L/kg. In plasma, </ao:prefix>
    <domeo:uuid>EF9C08F2-1B30-49C0-831D-4BC4BFD6AE48</domeo:uuid>
    <ao:suffix>is bound to albumin and α1-acid glycoprotein. The plasma protein binding of risperidone is 90%, and that of its major metabolite, 9-hydroxyrisperidone, is 77%. Neither risperidone nor 9-hydroxyrisperidone displaces each other from plasma binding sites. H</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A10DDC7F-3198-42E3-82DB-01779514C248">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>fexofenadine hydrochloride</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:A10DDC7F-3198-42E3-82DB-01779514C248"/>
    <domeo:uuid>A10DDC7F-3198-42E3-82DB-01779514C248</domeo:uuid>
    <pav:createdOn>2014-07-08 09:30:40 -0400</pav:createdOn>
    <ao:suffix> (2 × 60 mg capsule) within 15 minutes of an aluminum and magnesium containing antacid (Maalox®1) decreased fexofenadine AUC by 41% and Cmax by 43%.</ao:suffix>
    <ao:prefix>containing antacids. In healthy adult subjects, administration of 120 mg of </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-139.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F0107AFB-72DB-4880-85F1-BC51F3724590">
    <domeo:belongsToSet>urn:domeoclient:uuid:A927CF27-CC1C-4BE1-9435-0875A6356C3E</domeo:belongsToSet>
    <pav:createdOn>2014-07-08 08:58:12 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotation:334351A0-08BC-476C-BAA0-60E11F781E9E</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2014-07-08 08:58:29 -0400</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:01B6CC9C-1F62-408E-91EB-171F92613A4B"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D2035610-1F9A-4358-A464-068664EB4D73">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <ao:exact>rosiglitazone </ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:D2035610-1F9A-4358-A464-068664EB4D73"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-08 08:40:34 -0400</pav:createdOn>
    <domeo:uuid>D2035610-1F9A-4358-A464-068664EB4D73</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>is approximately 17.6 (30%) liters, based on a population pharmacokinetic analysis. Rosiglitazone is approximately 99.8% bound to plasma proteins, primarily albumin.</ao:suffix>
    <ao:prefix>The mean (CV%) oral volume of distribution (Vss/F) of </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:CF904069-6E2E-4CB6-A610-70066165AC89">
    <pav:lastSavedOn>2014-07-07 19:50:36 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotationset:1DED06A6-8562-4CCF-A58C-CA25748FBD31</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5ABD9862-F044-4404-AD04-73DA04ADDA8B</domeo:belongsToSet>
    <pav:createdOn>2014-07-07 19:47:05 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:840922AD-3EF4-45A4-8396-70D5BD15E549"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:33221D93-3764-4F8F-AA93-267D5204ACE2">
    <ao:prefix>plus </ao:prefix>
    <domeo:uuid>33221D93-3764-4F8F-AA93-267D5204ACE2</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <ao:exact>9-hydroxyrisperidone</ao:exact>
    <ao:suffix> are dose proportional over the dosing range of 1 to 16 mg daily (0.5 to 8 mg twice daily). Following oral administration of solution or tablet, mean peak plasma concentrations of risperidone occurred at about 1 hour. Peak concentrations of 9-hydroxyrisp</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:33221D93-3764-4F8F-AA93-267D5204ACE2"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-07 19:46:09 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:D8C85CA5-4085-4727-9E5E-B29A85F0174D">
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:3BC8DEA6-A36F-49F1-87EA-75EBD682F9D2"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C1A463F7-64C8-4DC4-83EA-60E4A57F63F3">
    <ao:context rdf:resource="urn:domeoclient:uuid:761B10E4-4950-40A7-9DFE-73826A9C6CFF"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <pav:lastSavedOn>2014-07-07 10:03:14 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A5E637EF-5CA5-4AAC-BD8B-C136A86E17B7</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2014-07-07 10:02:43 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <pav:previousVersion>urn:domeoclient:uuid:53FAA6D0-9A40-44F9-8FE0-3166137CEF10</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotationset:F37BE993-E972-47AE-896D-FF4D33157ECF</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:68D24B02-387E-40C6-B7C6-F02189114494">
    <pav:createdOn>2014-07-07 20:07:04 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-07-07 20:07:11 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <ao:body rdf:nodeID="N4ecbbff1c01743e58ea623a683bfad04"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:4A49ACB6-4B71-452F-80EE-8A84DEF45C29</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:561D7087-1244-4DCD-87C7-E8BA92EA0E48</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:4B9AE825-7422-4188-A7F7-45AEA39061D5"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/8655CFA8-7A82-44B7-B3AA-CD0D5FD18BBA">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/8754</dailymed:activeMoietyRxCUI>
    <rdfs:label>propafenone</rdfs:label>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B357B7CE-D3BD-4F1D-9BC9-22CDEFC21C06">
    <ao:prefix>xsd:String</ao:prefix>
    <ao:exact>VAPRISOL 40 mg/day increased the mean AUC values by approximately 2- and 3-fold for 1 mg intravenous or 2 mg oral doses of midazolam, respectively.</ao:exact>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:B357B7CE-D3BD-4F1D-9BC9-22CDEFC21C06"/>
    <domeo:uuid>B357B7CE-D3BD-4F1D-9BC9-22CDEFC21C06</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-08 16:24:21 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-104.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C02F267C-77D9-453C-840C-8AB33EDB7019">
    <pav:createdOn>2014-07-07 09:40:24 -0400</pav:createdOn>
    <ao:prefix>. At 24 hours, the plasma levels of </ao:prefix>
    <domeo:uuid>C02F267C-77D9-453C-840C-8AB33EDB7019</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <ao:exact>sildenafil </ao:exact>
    <ao:suffix>were still approximately 200 ng/mL, compared to approximately 5 ng/mL when sildenafil was dosed alone. This is consistent with ritonavir's marked effects on a broad range of P450 substrates. Although the interaction between other protease inhibitors (exc</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:C02F267C-77D9-453C-840C-8AB33EDB7019"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A4B747AB-66DF-46F5-AD34-DC8247F1C83C">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>A4B747AB-66DF-46F5-AD34-DC8247F1C83C</domeo:uuid>
    <ao:prefix>is 70% (CV=25%). The relative oral bioavailability of </ao:prefix>
    <pav:createdOn>2014-07-07 19:43:30 -0400</pav:createdOn>
    <ao:suffix>from a tablet is 94% (CV=10%) when compared to a solution.</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <ao:exact>risperidone </ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:A4B747AB-66DF-46F5-AD34-DC8247F1C83C"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7D1C2D83-F022-46FF-BB88-033A263EDC15">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotationset:1DED06A6-8562-4CCF-A58C-CA25748FBD31</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdOn>2014-07-07 19:46:35 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-07-07 19:50:36 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:D300FAFB-DA5E-4FB9-B03D-5907F592F1F8"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5ABD9862-F044-4404-AD04-73DA04ADDA8B</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F8266BC9-0FBE-4F89-99BF-28181281C00F">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-07-07 20:00:02 -0400</pav:lastSavedOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:0F97BB98-A4A8-4794-9B98-50ED646AB72D"/>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812e52b20002"/>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:deleted>false</domeo:deleted>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-20.txt.html</ao:annotatesResource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <permissions:permissions rdf:nodeID="N7c0e682c0fe541a4a85f6301b6423698"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:D250DCBF-F9BC-4E75-8349-F12095136AA9"/>
    <pav:createdOn>2014-07-07 19:59:48 -0400</pav:createdOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:C9102084-C282-4E15-B574-E2F9B43D3401"/>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotationset:6631007D-D120-45D0-8A85-AC99F1024EA1</pav:lineageUri>
    <rdfs:label>Default Set</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:AB39CE70-06A3-4B7C-9F42-04D29726E1D3">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-07-07 19:46:09 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-07-07 19:50:36 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotationset:1DED06A6-8562-4CCF-A58C-CA25748FBD31</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5ABD9862-F044-4404-AD04-73DA04ADDA8B</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:33221D93-3764-4F8F-AA93-267D5204ACE2"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C5825E02-3090-4552-BDE0-3C3A833DF951">
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:createdOn>2014-07-08 09:32:37 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotation:9C8C911A-9908-4674-B1EE-29FFAF8225BA</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:1569F388-68F2-4105-9806-F73C9D7B1FA0"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoclient:uuid:423352B3-8ABA-48B7-98CF-B191A7BFC955</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-08 09:35:29 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N29af3c20899b44f4b2a614614701567d">
    <domeo:sets rdf:resource="urn:pddi:uuid:097B1A34-716D-4A0E-95FE-A452BE7F5D92"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:6A23345D-2B18-41F9-B907-989DBB2E341E">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoclient:uuid:738231FC-4090-4D56-90FB-4FBFF166BD23</domeo:belongsToSet>
    <pav:createdOn>2014-07-07 20:08:20 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:04639316-05E5-427A-9233-CC96F2B8D704"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotation:695B8DE6-9ECB-4F42-9723-265ECD76554F</pav:lineageUri>
    <pav:lastSavedOn>2014-07-07 20:10:00 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:1D51EEDF-FCC9-44E1-A13B-BCE69023F944">
    <pav:lineageUri>urn:domeoserver:annotationset:7CAC9CB6-FF08-4E96-BE93-8D4FB17E8BE8</pav:lineageUri>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812e52b20002"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Default Set</rdfs:label>
    <domeo:deleted>false</domeo:deleted>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:item rdf:resource="urn:domeoclient:uuid:E9F154A7-885F-4423-BC72-8B64186E3C91"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:item rdf:resource="urn:domeoclient:uuid:B971C988-9D81-4BB3-838D-473FFB89951B"/>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-129.txt.html</ao:annotatesResource>
    <pav:lastSavedOn>2014-07-08 09:11:17 -0400</pav:lastSavedOn>
    <permissions:permissions rdf:nodeID="N30b4e2538ff54a9b822c88648d26e442"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:EEAED69F-A841-4DBC-BBF5-77CF854BF645"/>
    <pav:createdOn>2014-07-08 09:10:10 -0400</pav:createdOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:6CE02D92-3424-4002-ABED-F75BC7CCB60C"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:9804C8C5-3201-4A0F-9FA1-C6E8E1B1E28D"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:6FD7B9B1-ABD3-457C-AFF2-4807BF097EA4"/>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <ao:item rdf:resource="urn:domeoclient:uuid:0C4614C9-71A5-41D9-A9D1-9F690873CC7E"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:8C7C035E-1863-43C3-9F69-DDB013B30715">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoclient:uuid:738231FC-4090-4D56-90FB-4FBFF166BD23</domeo:belongsToSet>
    <ao:body rdf:nodeID="Na00d5847535349b290e0b3610007f938"/>
    <pav:lineageUri>urn:domeoserver:annotation:AB02B29C-EF30-41F5-9268-2EA0FB627541</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-07 20:10:00 -0400</pav:lastSavedOn>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:createdOn>2014-07-07 20:09:35 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:0A6ECB26-7E88-457C-9908-8D6F2BD3CFE9"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:4AC0C32D-F6D1-41EF-A9B7-5A5E4CE4BEFB">
    <domeo:uuid>4AC0C32D-F6D1-41EF-A9B7-5A5E4CE4BEFB</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-08 09:32:51 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:4AC0C32D-F6D1-41EF-A9B7-5A5E4CE4BEFB"/>
    <ao:prefix>. This is based on the results from three clinical studies using histamine induced skin wheals and flares coupled with population pharmacokinetic analysis. The size of wheal and flare were significantly larger when</ao:prefix>
    <ao:exact> fexofenadine hydrochloride</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-139.txt.html</ao:hasSource>
    <ao:suffix> was administered with either grapefruit or orange juices compared to water. Based on the literature reports, the same effects may be extrapolated to other fruit juices such as apple juice. The clinical significance of these observations is unknown. In a</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B752AAB8-6B04-4816-88CD-EB70ADF809A9">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-07-08 08:46:38 -0400</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:34DF20A0-C194-4F9B-AD0F-A6A5666F60E6"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:23515E27-98AC-4DC9-A4B7-EBFE2991219F</domeo:belongsToSet>
    <pav:createdOn>2014-07-08 08:44:31 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotationset:57174A7C-3100-4C8F-9C4A-2991CEE124D5</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E86FD65C-A7D1-4674-9491-442FB2403EA6">
    <ao:exact>GZDV</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>, whereas </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:E86FD65C-A7D1-4674-9491-442FB2403EA6"/>
    <pav:createdOn>2014-07-08 14:20:50 -0400</pav:createdOn>
    <domeo:uuid>E86FD65C-A7D1-4674-9491-442FB2403EA6</domeo:uuid>
    <ao:suffix> elimination was enhanced. A dosage adjustment is recommended for patients undergoing hemodialysis or peritoneal dialysis [see Dosage and Administration (2.4)].</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-197.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:40BDF605-2878-474E-A0F5-2447B35A08D4">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>xsd:String</ao:prefix>
    <pav:createdOn>2014-07-08 12:25:28 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:40BDF605-2878-474E-A0F5-2447B35A08D4"/>
    <ao:exact>Penicillins may reduce the renal clearance of methotrexate; increased serum concentrations of methotrexate with concomitant hematologic and gastrointestinal toxicity have been observed with methotrexate. Use of methotrexate with penicillins should be carefully monitored.</ao:exact>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-166.txt.html</ao:hasSource>
    <domeo:uuid>40BDF605-2878-474E-A0F5-2447B35A08D4</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:ACDFA635-44FF-495A-9275-7BD45253B01E">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>Phenytoin</ao:exact>
    <ao:prefix>xsd:String</ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:ACDFA635-44FF-495A-9275-7BD45253B01E"/>
    <ao:suffix>xsd:String</ao:suffix>
    <pav:createdOn>2014-07-08 12:28:16 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-201.txt.html</ao:hasSource>
    <domeo:uuid>ACDFA635-44FF-495A-9275-7BD45253B01E</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:1BBCAD39-EE66-4157-A96B-83905E48F13D">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-08 08:48:10 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:1BBCAD39-EE66-4157-A96B-83905E48F13D"/>
    <ao:exact>glyburide </ao:exact>
    <ao:prefix>AUC and Cmax of approximately 30%. In Japanese subjects, </ao:prefix>
    <domeo:uuid>1BBCAD39-EE66-4157-A96B-83905E48F13D</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix>AUC and Cmax slightly increased following coadministration of AVANDIA.</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:10096701-5979-4E64-8E76-15CB321AC27A">
    <domeo:belongsToSet>urn:domeoserver:annotationset:A5E637EF-5CA5-4AAC-BD8B-C136A86E17B7</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:F30C724A-EBE5-4CD7-B5BE-2399F7E6F1FC"/>
    <pav:createdOn>2014-07-07 09:36:44 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:lastSavedOn>2014-07-07 09:44:18 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotationset:F37BE993-E972-47AE-896D-FF4D33157ECF</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/23D62F01-0BBA-43A9-8331-4DBCF067DE39">
    <rdfs:label>pravastatin</rdfs:label>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/42463</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dct:description>Referred to the drug in the interaction.</dct:description>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E775A1D2-4888-4131-8716-573B16777670">
    <domeo:uuid>E775A1D2-4888-4131-8716-573B16777670</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:E775A1D2-4888-4131-8716-573B16777670"/>
    <ao:suffix>acts as an antagonist at other receptors, but with lower potency. Risperidone has low to moderate affinity (Ki of 47 to 253 nM) for the serotonin 5HT1C, 5HT1D, and 5HT1A receptors, weak affinity (Ki of 620 to 800 nM) for the dopamine D1 and haloperidol-s</ao:suffix>
    <ao:prefix>is a selective monoaminergic antagonist with high affinity (Ki of 0.12 to 7.3 nM) for the serotonin Type 2 (5HT2), dopamine Type 2 (D2), α1 and α2 adrenergic, and H1 histaminergic receptors. </ao:prefix>
    <ao:exact>Risperidone </ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-07 19:42:42 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:58879677-6EC3-48D3-805A-65F3DFA447AB">
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-07-07 20:07:11 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:77992245-2A09-487C-9288-2429C3D41073"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-07-07 20:05:50 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoclient:uuid:4A49ACB6-4B71-452F-80EE-8A84DEF45C29</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotation:D55FE0A7-6F31-4A50-8C7F-21B76E911EF0</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:5C6CE9E5-AE81-4BEB-B698-F027E2D10804">
    <ao:prefix>is well absorbed. The absolute oral bioavailability of </ao:prefix>
    <ao:exact>risperidone </ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:5C6CE9E5-AE81-4BEB-B698-F027E2D10804"/>
    <ao:suffix>is 70% (CV=25%). The relative oral bioavailability of risperidone from a tablet is 94% (CV=10%) when compared to a solution.</ao:suffix>
    <pav:createdOn>2014-07-07 19:43:28 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>5C6CE9E5-AE81-4BEB-B698-F027E2D10804</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:98C467B9-B912-42D8-87FF-A9575405F201">
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:182B9D0A-8D41-4C8C-B599-7C8DB2DEDD2C"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7B86D6B5-8B50-4756-92C6-5C423800ACBE">
    <ao:body rdf:nodeID="N11cdabcddb904199af2da1b4763f64ff"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:45496314-6BF2-4A53-98BB-B5A1361F6D61"/>
    <pav:lineageUri>urn:domeoserver:annotation:B6717DAA-011A-4D8E-A9C6-809B3E4CFED3</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:createdOn>2014-07-08 15:05:01 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-07-08 15:05:01 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:8B73FE17-4C95-404F-8029-1D158127FC25</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>expertstudy Annotation</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F0F6F527-9A8C-4E31-AA18-E9567E23FF05">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:F0F6F527-9A8C-4E31-AA18-E9567E23FF05"/>
    <ao:prefix>xsd:String</ao:prefix>
    <domeo:uuid>F0F6F527-9A8C-4E31-AA18-E9567E23FF05</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>Propranolol </ao:exact>
    <ao:suffix>does not affect the pharmacokinetics of verapamil and norverapamil. Verapamil does not affect the pharmacokinetics of propranolol.</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-127.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-08 08:59:05 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:CC0CF3E2-96EB-4CF2-AB3E-74D28222CAFB">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/16A7EFEF-5084-4E85-BE25-7F496A380249"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/34ED9A58-0FFA-4618-A4E3-C0DDE772538F"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:71FA060C-5D8C-40BF-84CC-54D05CA7B13F">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>71FA060C-5D8C-40BF-84CC-54D05CA7B13F</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:71FA060C-5D8C-40BF-84CC-54D05CA7B13F"/>
    <ao:suffix>at high doses for extended periods of time. A cause and effect relationship has not been established. Crohn's disease is not an approved indication for FLAGYL.</ao:suffix>
    <pav:createdOn>2014-07-07 20:49:24 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-121.txt.html</ao:hasSource>
    <ao:prefix>s disease patients are known to have an increased incidence of gastrointestinal and certain extraintestinal cancers. There have been some reports in the medical literature of breast and colon cancer in Crohn's disease patients who have been treated with </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>metronidazole </ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:BDBB4C34-2A25-4D80-977D-F5AD5B96B02C">
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:C8C9F708-F5BD-4426-B856-1ADCF06AA85C"/>
    <pav:createdOn>2014-07-07 09:37:52 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotationset:F37BE993-E972-47AE-896D-FF4D33157ECF</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A5E637EF-5CA5-4AAC-BD8B-C136A86E17B7</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2014-07-07 09:44:18 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:2FA201F3-9541-4F59-9B85-2A444A0D4F87">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotation:665FF981-B4E3-4665-88EF-3C4DCD36CEEA</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdOn>2014-07-08 08:54:08 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:63ADCA1A-4987-41CC-9143-0CC08C9EA4FB"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:lastSavedOn>2014-07-08 08:54:46 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:23515E27-98AC-4DC9-A4B7-EBFE2991219F</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:4A8E6838-34F6-4B17-9D58-A9BC7B731D7C">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:4A8E6838-34F6-4B17-9D58-A9BC7B731D7C"/>
    <ao:prefix>and </ao:prefix>
    <ao:exact>9-hydroxyrisperidone</ao:exact>
    <ao:suffix> [see 7 DRUG INTERACTIONS]. It would also be possible for risperidone to interfere with metabolism of other drugs metabolized by CYP 2D6. Relatively weak binding of risperidone to the enzyme suggests this is unlikely [see 7 DRUG INTERACTIONS].</ao:suffix>
    <pav:createdOn>2014-07-07 19:49:24 -0400</pav:createdOn>
    <domeo:uuid>4A8E6838-34F6-4B17-9D58-A9BC7B731D7C</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/CC55E1F0-319D-4047-B49B-96BD7B80EB24">
    <rdfs:label>carbamazepine</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/2002</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:09E5CBBF-225B-47F1-A546-8C855C0B0ACC">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-127.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-08 08:59:29 -0400</pav:createdOn>
    <ao:suffix>xsd:String</ao:suffix>
    <domeo:uuid>09E5CBBF-225B-47F1-A546-8C855C0B0ACC</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:09E5CBBF-225B-47F1-A546-8C855C0B0ACC"/>
    <ao:exact>Propranolol does not affect the pharmacokinetics of verapamil and norverapamil. Verapamil does not affect the pharmacokinetics of propranolol</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D0C372FF-08E3-4674-8762-7CAB3CFC5C0D">
    <pav:lastSavedOn>2014-07-08 09:35:29 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-08 09:30:44 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <domeo:belongsToSet>urn:domeoclient:uuid:423352B3-8ABA-48B7-98CF-B191A7BFC955</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:F457AA89-66BE-41F0-BA88-05A76BE2E587"/>
    <pav:lineageUri>urn:domeoserver:annotation:B7742BDD-3C8D-43DE-BE15-B8C71AE8ADCC</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:6CD68BE2-BB72-4BBC-8CA7-85C894173C78">
    <domeo:uuid>6CD68BE2-BB72-4BBC-8CA7-85C894173C78</domeo:uuid>
    <ao:exact>ODV</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-6.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:6CD68BE2-BB72-4BBC-8CA7-85C894173C78"/>
    <ao:suffix>) and later Tmax(5.5 hours for </ao:suffix>
    <pav:createdOn>2014-07-21 09:59:50 -0400</pav:createdOn>
    <ao:prefix> and 260 ng/mL for </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:518AD2AC-4AF1-4A5C-9EBC-A0A09E2F4BCE">
    <ao:prefix>, and </ao:prefix>
    <ao:suffix>.</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:518AD2AC-4AF1-4A5C-9EBC-A0A09E2F4BCE"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-135.txt.html</ao:hasSource>
    <domeo:uuid>518AD2AC-4AF1-4A5C-9EBC-A0A09E2F4BCE</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>sulfate conjugates of 4-hydroxy propranolol</ao:exact>
    <pav:createdOn>2014-07-08 09:24:19 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:AD03DC07-5AB6-455E-9A9D-67D1255446D4">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:DC1D393E-F328-497D-A3FA-0BC8D9F870A1"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:4E43D844-2E5A-46D2-8797-09878034F22F</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-07-08 09:08:02 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotation:38A7DFE3-B057-4CBB-B315-D67D62BC4D5B</pav:lineageUri>
    <pav:lastSavedOn>2014-07-08 09:08:48 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:840922AD-3EF4-45A4-8396-70D5BD15E549">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:840922AD-3EF4-45A4-8396-70D5BD15E549"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <domeo:uuid>840922AD-3EF4-45A4-8396-70D5BD15E549</domeo:uuid>
    <pav:createdOn>2014-07-07 19:47:05 -0400</pav:createdOn>
    <ao:exact>risperidone </ao:exact>
    <ao:suffix>at 10 ng/mL and 9-hydroxyrisperidone at 50 ng/mL, changes of unknown clinical significance.</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>(10 mcg/mL) caused only a slight increase in the free fraction of </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:88A544B4-BDDC-4DCB-8765-7A476A0C7BF2">
    <domeo:belongsToSet>urn:domeoserver:annotationset:42258B16-6749-4B39-B28D-88C8B63F7A43</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotationset:0f67c012-7596-4b02-a927-63c0ccbc3afa</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>urn:domeoclient:uuid:e75c9d7b-f906-4c66-8a84-e6eef34d0954</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:97B076E9-5A06-41B3-A7E3-7DFE6F39C69A"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">3</pav:versionNumber>
    <pav:lastSavedOn>2014-07-08 14:24:44 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-08 14:20:44 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:14126FF0-58E7-4C3F-854A-32C0BA20B0B0">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:exact>co-administration of known enzyme inducers (e.g., carbamazepine, phenytoin, rifampin, and phenobarbital) with risperidone may cause a decrease in the combined plasma concentrations of risperidone and 9-hydroxyrisperidone</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:14126FF0-58E7-4C3F-854A-32C0BA20B0B0"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <domeo:uuid>14126FF0-58E7-4C3F-854A-32C0BA20B0B0</domeo:uuid>
    <pav:createdOn>2014-07-07 19:52:07 -0400</pav:createdOn>
    <ao:suffix>xsd:String</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:BEAF542C-A1B3-43E5-B015-1C4102CECFD7">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotation:E3743691-6FD9-44E4-A382-1874B0046820</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoclient:uuid:CE45A5D4-BD84-4E02-AC7B-C9E12233EC3A</domeo:belongsToSet>
    <pav:createdOn>2014-07-07 20:19:03 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:E0AAF781-9F53-4AB3-9C98-378CA5773E9C"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:lastSavedOn>2014-07-07 20:21:40 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B4E6B43A-C912-4D44-8848-19C5654AB69F">
    <ao:prefix>, the incidence of withdrawal symptoms decreased and </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-201.txt.html</ao:hasSource>
    <ao:suffix>exposure increased to a level comparable to that prior to phenytoin administration.</ao:suffix>
    <pav:createdOn>2014-07-08 12:28:26 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:B4E6B43A-C912-4D44-8848-19C5654AB69F"/>
    <domeo:uuid>B4E6B43A-C912-4D44-8848-19C5654AB69F</domeo:uuid>
    <ao:exact>methadone </ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A3FEA294-9E0E-452E-9F32-77BD7358CCB4">
    <pav:lineageUri>urn:domeoserver:annotationset:F37BE993-E972-47AE-896D-FF4D33157ECF</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdOn>2014-07-07 09:42:23 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:FF0495DC-B940-41F7-B322-700005CB46DB"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:lastSavedOn>2014-07-07 09:44:18 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A5E637EF-5CA5-4AAC-BD8B-C136A86E17B7</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:DDEE6189-D54F-4D1B-BAF9-8CA95706F55C">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:DDEE6189-D54F-4D1B-BAF9-8CA95706F55C"/>
    <ao:exact> Trazodone hydrochloride</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-138.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-08 09:29:40 -0400</pav:createdOn>
    <ao:suffix> tablets should be taken shortly after a meal or light snack. Symptomatic relief may be seen during the first week, with optimal antidepressant effects typically evident within two weeks. Twenty-five percent of those who respond to trazodone require more</ao:suffix>
    <domeo:uuid>DDEE6189-D54F-4D1B-BAF9-8CA95706F55C</domeo:uuid>
    <ao:prefix>ge should be initiated at a low level and increased gradually, noting the clinical response and any evidence of intolerance. Occurrence of drowsiness may require the administration of a major portion of the daily dose at bedtime or a reduction of dosage.</ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:EC38A969-37CF-4F97-8F26-1782C1E8F202">
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2014-07-08 09:14:48 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoclient:uuid:54F09193-5CC7-4ED3-9261-88C7428E0572</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotation:36651E86-66A6-4874-AF34-549D0E7B7901</pav:lineageUri>
    <pav:lastSavedOn>2014-07-08 09:15:28 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:A8AE7057-B93E-443B-BB31-C7B2C325DF8C"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:220B9DDC-DB2B-4FCB-BEE0-EF9AFEBF6C70">
    <pav:createdOn>2014-07-08 09:25:22 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoclient:uuid:7E425E73-12D2-4B08-9D70-75410DE87447</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotation:CA781F75-84DD-4119-BEB8-05F2685DB9E9</pav:lineageUri>
    <pav:lastSavedOn>2014-07-08 09:27:36 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:9DC2DB77-A9C1-4AD6-9A3F-B01C7D52043B"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:327f8345-cd13-4713-a184-3fa1b9e4e31e">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix> on the pharmacokinetics of fl</ao:suffix>
    <domeo:uuid></domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:327f8345-cd13-4713-a184-3fa1b9e4e31e"/>
    <ao:exact>azithromycin</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-07 08:06:41 -0400</pav:createdOn>
    <ao:prefix>in as well as the effects of </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-33.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:276B1B42-AC40-49BB-AA5C-52AF3D8570FD">
    <ao:exact>Risperidone </ao:exact>
    <domeo:uuid>276B1B42-AC40-49BB-AA5C-52AF3D8570FD</domeo:uuid>
    <ao:prefix>Excretion: </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>and its metabolites are eliminated via the urine and, to a much lesser extent, via the feces. As illustrated by a mass balance study of a single 1 mg oral dose of 14C-risperidone administered as solution to three healthy male volunteers, total recovery o</ao:suffix>
    <pav:createdOn>2014-07-07 19:49:30 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:276B1B42-AC40-49BB-AA5C-52AF3D8570FD"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:4E670826-BB84-4FC6-9C71-56D5954B67D8">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-08 13:56:02 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotation:93EA001E-ECEC-4930-8626-71F8E4F20A3B</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdOn>2014-07-08 13:55:08 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:DD05DE56-7B60-4C06-8552-D1DD652D8A79</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:4C95EFBB-D305-46B6-B43B-65EBD8A79E89"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/B0E08964-375C-4F20-9B1B-C43DF7C0AF1C">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/drug-product"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/581642</dailymed:activeMoietyRxCUI>
    <rdfs:label>revatio</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:E58C7387-8AE7-4492-A62F-4391AE4A1C2C">
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:35CB69EC-6BE2-45B8-88CA-A6C6CB1E94E7"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:9D43D92D-A158-4401-9166-0FF62DFFDC47">
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2014-07-08 12:10:19 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:AE8C7255-F2EA-4BC2-9930-11E8E9637DA1"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotationset:701D90A9-2BA7-4D65-A3A7-505A77C8FE71</pav:lineageUri>
    <pav:lastSavedOn>2014-07-08 12:10:41 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:BA8F9408-39CC-4619-AA2D-75BA5518E56A</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/FE843A57-1C85-4A34-9967-7859486CFF70">
    <rdfs:label>clozapine</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/2626</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:08720F0F-1C3C-42A0-85E9-8A5D17EC8811">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-21 10:05:11 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:C582A2B1-BAC3-49A8-9F75-FC45877B4DE6"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotation:7F0BF770-601C-429A-9747-7ABCBF93153E</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-07-21 10:06:08 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:32AE0CCB-E459-4836-ADED-1DE8CB7D4F9E</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F87AD5D5-A5A5-4271-AE1B-1F18BC0619C5">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-07 19:48:46 -0400</pav:createdOn>
    <ao:suffix>and 9-hydroxyrisperidone combined, after single and multiple doses, are similar in extensive and poor metabolizers.</ao:suffix>
    <ao:prefix> concentrations than poor metabolizers, the pharmacokinetics of </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>F87AD5D5-A5A5-4271-AE1B-1F18BC0619C5</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <ao:exact>risperidone </ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:F87AD5D5-A5A5-4271-AE1B-1F18BC0619C5"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:34750E55-254E-4B35-BA70-AE39B36453B5">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:390AE58E-C470-422B-8044-D7F163F66800"/>
    <pav:lineageUri>urn:domeoserver:annotationset:57174A7C-3100-4C8F-9C4A-2991CEE124D5</pav:lineageUri>
    <pav:createdOn>2014-07-08 08:46:48 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:previousVersion>urn:domeoclient:uuid:5BCE2FDB-C586-44CD-88F7-6EE2BDB6B929</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:23515E27-98AC-4DC9-A4B7-EBFE2991219F</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-08 08:51:47 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:89B6D06A-2F10-49A9-B621-C4CB1F49300D">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/8BAF963A-578A-4CDA-B28C-2B0C856CC916"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/FB696F7E-A0E1-4A9F-A31F-A6D4E833586C"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:74D8AFB7-D947-414D-9128-32F176727620">
    <ao:prefix>plasma concentrations ranging from 55% to 369% and increased </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>metabolite (mesoridazine) concentrations ranging from 33% to 209%.</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:74D8AFB7-D947-414D-9128-32F176727620"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-133.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>74D8AFB7-D947-414D-9128-32F176727620</domeo:uuid>
    <pav:createdOn>2014-07-08 09:21:20 -0400</pav:createdOn>
    <ao:exact>thioridazine </ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:84BC69AA-E94C-4A46-B55A-44D7D84F953C">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-165.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:84BC69AA-E94C-4A46-B55A-44D7D84F953C"/>
    <domeo:uuid>84BC69AA-E94C-4A46-B55A-44D7D84F953C</domeo:uuid>
    <pav:createdOn>2014-07-08 12:21:37 -0400</pav:createdOn>
    <ao:suffix>are administered over the course of several hours while the patient's condition and vital signs are under careful observation. (Intravenous hydrocortisone or prednisolone have been used to treat severe reactions, with the addition of intravenous chlorpro</ao:suffix>
    <ao:exact>morphine </ao:exact>
    <ao:prefix>. If a narcotic is needed in such patients, a sensitivity test should be performed in which repeated, small, incremental doses of </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:387390E9-9E04-4360-86B2-8961770F29DC">
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:createdOn>2014-07-07 20:45:50 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-07-07 20:46:25 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotation:E714F6B0-C7DC-4938-B968-358D18EA6EFA</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:A5C2D609-8291-4340-B158-FC436DC5B81F"/>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoclient:uuid:E08D4CED-BE06-4A5F-A2AF-BFBC25BA8AE4</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N4ed58351f9c44e039be63bf0e09af817">
    <permissions:isLocked>false</permissions:isLocked>
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:15855941-9FDC-41F8-9C9C-27A5F2113767">
    <ao:suffix>xsd:String</ao:suffix>
    <ao:exact>Fluoxetine and Paroxetine: Fluoxetine (20 mg once daily) and paroxetine (20 mg once daily) have been shown to increase the plasma concentration of risperidone 2.5 to 2.8 fold and 3 to 9 fold, respectively. Fluoxetine did not affect the plasma concentration of 9-hydroxyrisperidone. Paroxetine lowered the concentration of 9-hydroxyrisperidone by about 10%. When either concomitant fluoxetine or paroxetine is initiated or discontinued, the physician should re-evaluate the dosing of risperidone. The effects of discontinuation of concomitant fluoxetine or paroxetine therapy on the pharmacokinetics of risperidone and 9-hydroxyrisperidone have not been studied.</ao:exact>
    <domeo:uuid>15855941-9FDC-41F8-9C9C-27A5F2113767</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-7.txt.html</ao:hasSource>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:15855941-9FDC-41F8-9C9C-27A5F2113767"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-08 15:50:07 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:0C2E2974-A103-4F0D-BF11-202AAD2FA481">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2014-07-07 20:14:34 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotation:811670DB-2C70-4B87-A30C-0386C34E12A6</pav:lineageUri>
    <pav:createdOn>2014-07-07 20:13:22 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoclient:uuid:B41CE612-345D-4E17-94DB-98BD2C6B5559</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:6F2AD00E-0200-441D-8668-3B27C3A3A66A"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/7ae3a17c-18f8-436e-b816-ba09f3ff1dcd">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:B584DAF4-7AB3-43F0-AA6F-6463A34A4831</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotationset:a7dfba5e-79ae-4a48-ab23-f16a539121db</pav:lineageUri>
    <pav:createdOn>2014-07-07 08:07:05 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:c397168e-bd86-4af2-8e92-d7695f2b25f2"/>
    <pav:lastSavedOn>2014-07-07 08:07:05 -0400</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A2EB0E75-194D-44CC-A447-85CB6FC8E94B">
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdOn>2014-07-08 08:45:51 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-07-08 08:46:38 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotationset:57174A7C-3100-4C8F-9C4A-2991CEE124D5</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:FA10B71B-CEE2-400B-8D1A-0151B5F4CD95"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:23515E27-98AC-4DC9-A4B7-EBFE2991219F</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/D6690764-EECE-40AB-892E-50BBA7F581D0">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/metabolite"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/</dailymed:activeMoietyRxCUI>
    <rdfs:label>gzdv</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:4D82CCD7-A841-4857-B182-D7EC99071EF0">
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:D399BCC8-CC65-4CC4-B163-F49A409E7F12"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D31028B6-43FD-43E4-9CA5-59C6B2336813">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoclient:uuid:738231FC-4090-4D56-90FB-4FBFF166BD23</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdOn>2014-07-07 20:08:05 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotation:9D76F2D5-CC44-49EB-A637-22CDB4359C80</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2014-07-07 20:10:00 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:FEF5CA78-71CF-4EF3-BF08-112BBC927A98"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:4DF2B306-C2AF-4901-AB82-064FD9B17BBF">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:4DF2B306-C2AF-4901-AB82-064FD9B17BBF"/>
    <pav:createdOn>2014-07-07 20:12:41 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:exact>Administration of a single oral 200 mg dose of fluconazole after 15 days of rifampin administered as 600 mg daily in eight healthy male volunteers resulted in a significant decrease in fluconazole AUC and a significant increase in apparent oral clearance of fluconazole. There was a mean ± SD reduction in fluconazole AUC of 23% ± 9% (range: -13 to -42%). Apparent oral clearance of fluconazole increased 32% ± 17% (range: 16 to 72%). Fluconazole half-life decreased from 33.4 ± 4.4 hours to 26.8 ± 3.9 hours.</ao:exact>
    <domeo:uuid>4DF2B306-C2AF-4901-AB82-064FD9B17BBF</domeo:uuid>
    <ao:suffix> (See PRECAUTIONS.</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-24.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/C773EABA-6050-40AF-B6A4-222438562519">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>phenytoin</rdfs:label>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/8183</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:FCF20AEC-F7C8-470C-A47C-D84769733981">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-137.txt.html</ao:hasSource>
    <ao:prefix>xsd:String</ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:FCF20AEC-F7C8-470C-A47C-D84769733981"/>
    <ao:suffix>xsd:String</ao:suffix>
    <domeo:uuid>FCF20AEC-F7C8-470C-A47C-D84769733981</domeo:uuid>
    <ao:exact>Carbamazepine induces CYP3A4. Following coadministration of carbamazepine 400 mg/day with trazodone 100 mg to 300 mg daily, carbamazepine reduced plasma concentrations of trazodone (as well as mCPP) by 76 and 60%, respectively, compared to pre-carbamazepine values.</ao:exact>
    <pav:createdOn>2014-07-08 09:28:39 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:506AE58E-EAC3-40CC-B55A-1659A3D9B3AE">
    <ao:suffix>in healthy adult subjects. Fexofenadine had no effect on the pharmacokinetics of either erythromycin or ketoconazole. In two separate studies in healthy adult subjects, fexofenadine hydrochloride 120 mg twice daily (240 mg total daily dose) was coadminis</ao:suffix>
    <pav:createdOn>2014-07-08 09:32:01 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-139.txt.html</ao:hasSource>
    <ao:exact>fexofenadine </ao:exact>
    <domeo:uuid>506AE58E-EAC3-40CC-B55A-1659A3D9B3AE</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:506AE58E-EAC3-40CC-B55A-1659A3D9B3AE"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>led to increased plasma concentrations of </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:59265737-F0DD-4FFD-B986-FCAEB3962E0B">
    <ao:context rdf:resource="urn:domeoclient:uuid:5F9DB5F2-4005-4062-B633-29BB2F5B94EC"/>
    <pav:createdOn>2014-07-07 19:49:26 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5ABD9862-F044-4404-AD04-73DA04ADDA8B</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotationset:1DED06A6-8562-4CCF-A58C-CA25748FBD31</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-07-07 19:50:36 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/9FF2C3C3-B69C-43B4-B33D-08E0833F429A">
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/8754</dailymed:activeMoietyRxCUI>
    <rdfs:label>propafenone</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:D510B1DE-D0F4-412E-93BD-FCC4D13BAB1B">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/E6EDD096-EEE1-4016-85F5-5D89B786AC88"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/854A3D13-94BA-4398-986C-292EFE511072"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/6d2dbaa6-b88b-48e3-b370-03755b3314bc">
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:C2CFDC7A-D407-48FD-81AA-DFCEA656C0BE</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotationset:a53fd137-a94f-4129-a486-d01a63449dec</pav:lineageUri>
    <pav:lastSavedOn>2014-07-07 08:06:36 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-07 08:06:36 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:32790b96-d61d-48f5-9956-2a87cef22bac"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:1E1CDA40-88A4-4918-BA32-5F6D653CF308">
    <domeo:uuid>1E1CDA40-88A4-4918-BA32-5F6D653CF308</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <ao:prefix>does not inhibit any of the major P450 enzymes at clinically relevant concentrations. In vitro data demonstrate that </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:1E1CDA40-88A4-4918-BA32-5F6D653CF308"/>
    <pav:createdOn>2014-07-08 08:44:18 -0400</pav:createdOn>
    <ao:suffix>is predominantly metabolized by CYP2C8, and to a lesser extent, 2C9. AVANDIA (4 mg twice daily) was shown to have no clinically relevant effect on the pharmacokinetics of nifedipine and oral contraceptives (ethinyl estradiol and norethindrone), which are</ao:suffix>
    <ao:exact>rosiglitazone </ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/DCC6BEF8-EAC0-4911-9DFC-B36D0D3B586D">
    <rdfs:label>fexofenadine</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/87636</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dct:description>Referred to the drug in the interaction.</dct:description>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E1DB0015-3BC4-4263-9675-61E793413B41">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <ao:suffix>(8 mg once daily) for 8 days in healthy adult subjects.</ao:suffix>
    <domeo:uuid>E1DB0015-3BC4-4263-9675-61E793413B41</domeo:uuid>
    <ao:prefix>AUC and Cmax were observed after repeat doses of </ao:prefix>
    <pav:createdOn>2014-07-08 08:49:07 -0400</pav:createdOn>
    <ao:exact>AVANDIA </ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:E1DB0015-3BC4-4263-9675-61E793413B41"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:816AFB9C-4A0A-4DE1-87DB-B5EF38823F10">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2014-07-07 19:49:14 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5ABD9862-F044-4404-AD04-73DA04ADDA8B</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotationset:1DED06A6-8562-4CCF-A58C-CA25748FBD31</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-07-07 19:50:36 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:43E8F576-741A-42DD-B286-791DFAFFBBF3"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/7FBEF37B-C286-4C21-880E-2EEC16F03F5E">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/11289</dailymed:activeMoietyRxCUI>
    <rdfs:label>warfarin</rdfs:label>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoserver:annotationset:41C13D3C-1D2B-4D38-9EB5-BC4A471BE99A">
    <ao:item rdf:resource="urn:domeoclient:uuid:268F088F-6652-4DC8-BE01-1C667AE682BC"/>
    <rdfs:label>NER Sets</rdfs:label>
    <ao:item rdf:resource="file:///home/yin2/python-SPL-connector/28101375-1c53-4a1c-a9cc-c70862ee98f3"/>
    <pav:lineageUri>urn:domeoserver:annotationset:901e52dc-f83e-453e-89f4-185113817c7c</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">3</pav:versionNumber>
    <pav:lastSavedOn>2014-07-08 14:57:00 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-111.txt.html</ao:annotatesResource>
    <domeo:deleted>false</domeo:deleted>
    <dct:description>The NER set is created automatically by NER annotation loading program.</dct:description>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:BA4FC9A4-D363-4102-A981-9BB361F8EC8C"/>
    <pav:createdOn>2014-07-07 08:06:43 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:previousVersion>urn:domeoclient:uuid:c7f98fbb-80e2-408a-ab40-824f388f9dcd</pav:previousVersion>
    <permissions:permissions rdf:nodeID="N763d82b7c17348188c745d909298c124"/>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812e52b20002"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:9B2C0E07-15F0-43CE-923F-D26DDE71CE6C">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:body rdf:nodeID="Nf63bfafdd677429681ed8054e4c1da6f"/>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:lineageUri>urn:domeoserver:annotation:F0A11FFF-559B-4753-8CAD-DF7AA947B59D</pav:lineageUri>
    <pav:createdOn>2014-07-08 15:51:35 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-07-08 15:56:00 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:7BAA9796-5131-4A84-B043-5720DE0A59C7"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5B2167F6-4E63-4A7B-85C1-ACA56DDE7073</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:9AFEC25A-7770-4D4D-97CA-8F2103A062E7">
    <pav:createdOn>2014-07-08 09:31:24 -0400</pav:createdOn>
    <ao:body rdf:nodeID="N2ba9723d055442c0b074f14f3340e99e"/>
    <pav:lastSavedOn>2014-07-08 09:35:29 -0400</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:174082AF-53BB-4A5F-A289-F20D7232AFF5"/>
    <pav:lineageUri>urn:domeoserver:annotation:D921ED3D-40F5-47DF-8FFE-92312BDDDEBB</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <domeo:belongsToSet>urn:domeoclient:uuid:423352B3-8ABA-48B7-98CF-B191A7BFC955</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:0E7F8A35-8A3C-40EF-B23B-AEC812DB30D8">
    <pav:createdOn>2014-07-08 09:10:19 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:0E7F8A35-8A3C-40EF-B23B-AEC812DB30D8"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-129.txt.html</ao:hasSource>
    <domeo:uuid>0E7F8A35-8A3C-40EF-B23B-AEC812DB30D8</domeo:uuid>
    <ao:prefix>AUC and Cmax by 46% and 35%, respectively. Co-administration with</ao:prefix>
    <ao:exact> aluminum hydroxide gel</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix> (1200 mg) may result in a decrease in propranolol concentrations.</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:1AEBA1F8-7388-4240-AD4F-BB2A2C16FADC">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/9EA5D626-46B7-4466-AC62-473998053FD1"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/DC78EBFC-1228-41D5-AFE9-3F54A9457DAB"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A413330D-2AA0-42F9-AD8F-DA7BBCBD4BCC">
    <ao:exact>rosiglitazone</ao:exact>
    <ao:suffix> and an inducer of CYP2C8 (e.g., rifampin) may decrease the AUC of rosiglitazone. Therefore, if an inhibitor or an inducer of CYP2C8 is started or stopped during treatment with rosiglitazone, changes in diabetes treatment may be needed based upon clinica</ao:suffix>
    <pav:createdOn>2014-07-07 20:49:59 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-122.txt.html</ao:hasSource>
    <ao:prefix>) may increase the AUC of </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:A413330D-2AA0-42F9-AD8F-DA7BBCBD4BCC"/>
    <domeo:uuid>A413330D-2AA0-42F9-AD8F-DA7BBCBD4BCC</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D250DCBF-F9BC-4E75-8349-F12095136AA9">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2014-07-07 19:59:54 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-07-07 20:00:02 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:B246ADC4-BE56-4B04-B17C-94F12339D19A"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoclient:uuid:F8266BC9-0FBE-4F89-99BF-28181281C00F</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotation:9A7C51EC-D58F-4346-B66A-9565496FC6FD</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C0CE4AC7-F72D-4A94-BD3E-4720F127B810">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:deleted>false</domeo:deleted>
    <ao:item rdf:resource="urn:domeoclient:uuid:B741DD60-8DBC-4F77-ADE3-DE177B7357C7"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:AFEFD3AD-1966-407E-976D-386025B0CE8D"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:4D94D8DA-765F-4B95-9FBC-EEBDCE757246"/>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <ao:item rdf:resource="urn:domeoclient:uuid:301DCA49-781A-4962-BFAE-08B86B9610FE"/>
    <pav:lineageUri>urn:domeoserver:annotationset:CE6DB03A-C545-48CA-B0FF-ADCA980A9A10</pav:lineageUri>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812e52b20002"/>
    <pav:lastSavedOn>2014-07-08 09:22:07 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-08 09:21:17 -0400</pav:createdOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:5A0DE6C2-68AC-4515-8616-46FB047F6410"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:A6E4CE45-BCB0-440E-8EE0-970472A2D684"/>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-133.txt.html</ao:annotatesResource>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Default Set</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <permissions:permissions rdf:nodeID="Ned89cd995ef740b49180f2b2c4a5d80c"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:27755963-0AD3-46C8-A60E-34C4AFFDA890">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:27755963-0AD3-46C8-A60E-34C4AFFDA890"/>
    <ao:suffix>did not have a significant effect on propranolol’s pharmacokinetics.</ao:suffix>
    <domeo:uuid>27755963-0AD3-46C8-A60E-34C4AFFDA890</domeo:uuid>
    <ao:prefix>with the long-acting </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>propranolol </ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-130.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-08 09:12:45 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:9E691305-649C-45E1-80A7-3CD32A5FD422">
    <domeo:belongsToSet>urn:domeoserver:annotationset:A5E637EF-5CA5-4AAC-BD8B-C136A86E17B7</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:64010148-6206-423A-B586-75B62D61CE15"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:lastSavedOn>2014-07-07 09:44:18 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotationset:F37BE993-E972-47AE-896D-FF4D33157ECF</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-07 09:36:24 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:FEF5CA78-71CF-4EF3-BF08-112BBC927A98">
    <domeo:uuid>FEF5CA78-71CF-4EF3-BF08-112BBC927A98</domeo:uuid>
    <pav:createdOn>2014-07-07 20:08:05 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:FEF5CA78-71CF-4EF3-BF08-112BBC927A98"/>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-23.txt.html</ao:hasSource>
    <ao:exact>Fluconazole </ao:exact>
    <ao:suffix>100 mg was administered as a single oral dose alone and two hours after a single dose of cimetidine 400 mg to six healthy male volunteers. After the administration of cimetidine, there was a significant decrease in fluconazole AUC and Cmax. There was a m</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E055844E-921A-44DC-B47A-D5FDBB96AEA9">
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:0E96FF17-2659-44E0-B125-6B2E95C6E2D6"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5ABD9862-F044-4404-AD04-73DA04ADDA8B</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:body rdf:nodeID="N11e31bc86b46416ab06f8a1e2207e3a2"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:lineageUri>urn:domeoserver:annotation:F6D0872E-A8E8-4198-A239-1FBCC7CDE316</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:createdOn>2014-07-07 19:53:25 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-07-07 19:59:12 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:0134AD2A-C253-4CDE-AF90-97772789E401">
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotation:3A7CE1DD-DCAE-4BA9-A43D-1CAB19FCC29B</pav:lineageUri>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:013BA1D3-957D-4FF5-9CC4-8146EA1581DF"/>
    <pav:createdOn>2014-07-07 20:25:12 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:body rdf:nodeID="Nfb1f791c4e1f4a0b8bbd85454357c951"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:5F40D6FC-BF07-4E5A-BB51-EB521FF63890</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:lastSavedOn>2014-07-07 20:25:19 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/83bea31c-3d59-49fb-a576-f7ec00da9c05">
    <pav:lineageUri>urn:domeoserver:annotationset:9585bd87-bb79-42b2-932f-d6b8a0043a90</pav:lineageUri>
    <pav:lastSavedOn>2014-07-07 08:06:45 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:2CD5EC60-6C64-4F1C-8293-A4D163CC9362</domeo:belongsToSet>
    <pav:createdOn>2014-07-07 08:06:45 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:b1a4941a-3331-422c-9873-68f122f30adc"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:6FCD0EEA-F2CD-4F0C-807C-1511D1B0FDF5">
    <ao:exact>methotrexate</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:6FCD0EEA-F2CD-4F0C-807C-1511D1B0FDF5"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>. Use of methotrexate with penicillins should be carefully monitored.</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-166.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-08 12:24:44 -0400</pav:createdOn>
    <ao:prefix>with concomitant hematologic and gastrointestinal toxicity have been observed with </ao:prefix>
    <domeo:uuid>6FCD0EEA-F2CD-4F0C-807C-1511D1B0FDF5</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/8BEB2377-350D-4F73-AC83-E152716A168D">
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>risperidone</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/35636</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:777C9E4C-1B03-4921-9AE5-9EE6928B3C02">
    <ao:prefix>xsd:String</ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:777C9E4C-1B03-4921-9AE5-9EE6928B3C02"/>
    <pav:createdOn>2014-07-08 16:24:47 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>777C9E4C-1B03-4921-9AE5-9EE6928B3C02</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-104.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>VAPRISOL 30 mg/day resulted in a 3-fold increase in the AUC of simvastatin.</ao:exact>
    <ao:suffix> Oral</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:EA8D1AB0-084B-4213-A2B6-1945772CCA25">
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:ECA03730-59C3-491E-AA93-9E902289EBF6"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoclient:uuid:BCC9EB2F-25E7-44FF-83F2-904B4F4819EC</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-07-08 09:28:41 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotation:2D161F30-6B48-4C7F-8475-997465E7C317</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2014-07-08 09:28:15 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoserver:annotationset:CEC2E6BB-4A0E-4F14-B024-B1C9027CF3AE">
    <domeo:deleted>false</domeo:deleted>
    <pav:previousVersion>urn:domeoclient:uuid:96e04ed6-f934-4393-a2a2-44ed8bf87d31</pav:previousVersion>
    <dct:description>The NER set is created automatically by NER annotation loading program.</dct:description>
    <pav:lastSavedOn>2014-07-21 09:46:25 -0400</pav:lastSavedOn>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <permissions:permissions rdf:nodeID="Nb91e8c7c9d9944178ac0fb5fda3339d9"/>
    <pav:lineageUri>urn:domeoserver:annotationset:a54cadb3-7650-4db0-b96f-ce26cf3a1ef6</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812e52b20002"/>
    <pav:createdOn>2014-07-07 08:06:49 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <rdfs:label>NER Sets</rdfs:label>
    <ao:item rdf:resource="file:///home/yin2/python-SPL-connector/b964f0b6-1110-4a58-aa44-a490eabead47"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">3</pav:versionNumber>
    <ao:item rdf:resource="urn:domeoclient:uuid:BC6E5452-8DE0-4786-BCEC-6BE8992E2061"/>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-2.txt.html</ao:annotatesResource>
    <ao:item rdf:resource="urn:domeoclient:uuid:C4A1EB42-6814-4B22-B435-A9D85C6EA9EB"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:22717717-F84A-439E-81E0-413A56482DD1">
    <pav:previousVersion>urn:domeoclient:uuid:21a2d27a-13b1-4797-ba7a-c0517e32bb06</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:32944008-A6C6-4D66-8C43-EE4CF2256965</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:259BE027-3543-490B-ADFA-0EAA9F6709FE"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotationset:cf593dca-fe93-451b-8f37-2a96e065da13</pav:lineageUri>
    <pav:lastSavedOn>2014-07-21 10:02:11 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">3</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:createdOn>2014-07-21 09:59:01 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/B8C03BBA-FE59-4DA0-BC00-C39F46BA0681">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>fluconazole</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/4450</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E9F154A7-885F-4423-BC72-8B64186E3C91">
    <ao:context rdf:resource="urn:domeoclient:uuid:18D8786F-1216-4DDA-8591-252576279D62"/>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotation:2AB888B4-5D78-4140-B93E-D9B1D7C42EFD</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:body rdf:nodeID="N5f766e7bf2a7439eae196604a3f97883"/>
    <pav:createdOn>2014-07-08 09:10:45 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:lastSavedOn>2014-07-08 09:11:17 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoclient:uuid:1D51EEDF-FCC9-44E1-A13B-BCE69023F944</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D730927A-7A5C-4283-B110-CA21BC2EF052">
    <pav:lineageUri>urn:domeoserver:annotation:0BCE0374-3C69-4FAA-8394-007867E3FB33</pav:lineageUri>
    <ao:body rdf:nodeID="N4787a183562e432fb60deaf74f4ffc74"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:B3C0E972-7A26-4B8D-88E8-D7C3C96B8C1E</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:createdOn>2014-07-08 19:44:57 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-07-08 19:45:15 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:D60C171F-5691-4457-A14E-20D46B82B988"/>
    <rdfs:label>expertstudy Annotation</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:D7BCED1A-9822-4118-8E30-EDD14522080A">
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:4CC2ED68-5F57-44BC-8831-AC44D49F2EDA"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:50BEF9AF-E12A-4A36-BB4A-285EF838E096">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotationset:57174A7C-3100-4C8F-9C4A-2991CEE124D5</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:23515E27-98AC-4DC9-A4B7-EBFE2991219F</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:444669EA-407A-4639-A8CA-72F7B927C60B"/>
    <pav:createdOn>2014-07-08 08:40:10 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-07-08 08:46:38 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:6719DB2A-15BD-434A-9E47-DC8CC9574E56">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-07-08 08:46:38 -0400</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2014-07-08 08:45:54 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:23515E27-98AC-4DC9-A4B7-EBFE2991219F</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotationset:57174A7C-3100-4C8F-9C4A-2991CEE124D5</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:B61D4953-D6C3-4380-900C-143D69B07EAC"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:58BF3512-922E-41A4-AFD3-021EAD6B68E2">
    <ao:context rdf:resource="urn:domeoclient:uuid:D293E876-8F50-4829-B6FA-4940DB41BD06"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:lastSavedOn>2014-07-08 15:41:14 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-07-08 15:41:00 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A7033EE8-62A2-4AAF-AD21-7D4F7611919F</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <ao:body rdf:nodeID="N2b13e9878164449e9a2325a44e3dc0bb"/>
    <pav:lineageUri>urn:domeoserver:annotation:395E496E-D770-41E2-B1C2-61DEFB0DF989</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:457516BA-A108-484A-A95F-27847AC4C3A6">
    <ao:suffix>Since the highest recommended </ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-21 10:10:49 -0400</pav:createdOn>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:457516BA-A108-484A-A95F-27847AC4C3A6"/>
    <ao:exact>In a controlled study of a single dose (2 mg) of pimozide, 200 mg sertraline (q.d.) co-adminis-tration to steady state was associated with a mean increase in pimozide AUC and C max of about 40%, but was not associated with any changes in EKG. </ao:exact>
    <domeo:uuid>457516BA-A108-484A-A95F-27847AC4C3A6</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-14.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:EA070005-07F9-4514-9D25-BBAB543B971D">
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:A49E799F-F9F2-49F3-97FB-7B01C8E2B837"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5ABD9862-F044-4404-AD04-73DA04ADDA8B</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:lastSavedOn>2014-07-07 19:50:36 -0400</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotationset:1DED06A6-8562-4CCF-A58C-CA25748FBD31</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-07 19:47:14 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:CF0C75CF-03DD-494F-B816-5CEBCCB4109E">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:CF0C75CF-03DD-494F-B816-5CEBCCB4109E"/>
    <ao:suffix>(0.375 mg once daily) in healthy volunteers.</ao:suffix>
    <ao:exact>digoxin </ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <ao:prefix>(8 mg once daily) for 14 days did not alter the steady-state pharmacokinetics of </ao:prefix>
    <pav:createdOn>2014-07-08 08:52:51 -0400</pav:createdOn>
    <domeo:uuid>CF0C75CF-03DD-494F-B816-5CEBCCB4109E</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:40BD8465-AF56-4B52-BBD3-F43CC99AA884">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>Pharmacokinetic studies showed that </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:40BD8465-AF56-4B52-BBD3-F43CC99AA884"/>
    <ao:exact>risperidone </ao:exact>
    <pav:createdOn>2014-07-07 19:43:33 -0400</pav:createdOn>
    <domeo:uuid>40BD8465-AF56-4B52-BBD3-F43CC99AA884</domeo:uuid>
    <ao:suffix>oral solution is bioequivalent to risperidone tablets.</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:18BC6B83-DB23-457C-B70A-397945920538">
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">4</pav:versionNumber>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5B2167F6-4E63-4A7B-85C1-ACA56DDE7073</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-08 15:43:42 -0400</pav:createdOn>
    <pav:previousVersion>urn:domeoserver:annotationset:6C113438-07CB-4840-A14B-360CDF3BD22A</pav:previousVersion>
    <pav:lastSavedOn>2014-07-08 15:45:42 -0400</pav:lastSavedOn>
    <ao:body rdf:nodeID="N7338ee47b7884d81aa08b211f62bbe1a"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:DC3FD236-F1CF-4BDE-A027-FFB3BB8CC69C"/>
    <pav:lineageUri>urn:domeoserver:annotationset:061a21f6-0ef7-497f-bd03-574c24bc0d7c</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7F163E95-074F-45E3-A660-AFC775347CC2">
    <domeo:uuid>7F163E95-074F-45E3-A660-AFC775347CC2</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:7F163E95-074F-45E3-A660-AFC775347CC2"/>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-38.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-08 19:43:34 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>The effect of fluvoxamine (25 mg b.i.d. for one week) on thioridazine steady-state concentration was evaluated in ten male inpatients with schizophrenia. Concentrations of thioridazine and its two active metabolites, mesoridazine and sulforidazine, increased 3-fold following coadministration of fluvoxamine. Fluvoxamine and thioridazine should not be coadministered</ao:exact>
    <ao:prefix>xsd:String</ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/640767f8-b8bf-4d33-a75b-f2719bee2075">
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotationset:569eb43c-544c-4c72-9e28-27efc85c4b70</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2014-07-07 08:06:28 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-07-07 08:06:28 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:8724ee1c-ce76-41b0-b020-ddbf101fa416"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:0FEEAD08-987A-4FB4-A1A5-C8AB4B60CF6C</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/70AA207A-68D2-4FD4-9EA8-5885D4F53473">
    <rdfs:label>procyclidine</rdfs:label>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/</dailymed:activeMoietyRxCUI>
    <dct:description>Referred to the drug in the interaction.</dct:description>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:51AE28A6-A4F5-4551-AD8B-8ADDDCA82257">
    <ao:item rdf:resource="urn:domeoclient:uuid:34E99F90-2EA2-441E-B41B-3E236115FFEC"/>
    <domeo:deleted>false</domeo:deleted>
    <pav:lastSavedOn>2014-07-07 20:34:18 -0400</pav:lastSavedOn>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <rdfs:label>Default Set</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:D19B9A2C-9CC4-4AE1-BB61-F344D5904F19"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:49BD4B70-AFF1-4952-A6B1-201F15A44B42"/>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812e52b20002"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:4C4D70A4-7E29-4CD9-A33B-0C238E448F70"/>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <ao:item rdf:resource="urn:domeoclient:uuid:1979CA28-E9EF-4A66-A53F-53E29B63A7A7"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:808D82BB-EA92-41E7-A49E-919E3DC14991"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotationset:2C9571AE-7D49-43AC-BF70-3A2246A3A24C</pav:lineageUri>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-56.txt.html</ao:annotatesResource>
    <pav:createdOn>2014-07-07 20:32:08 -0400</pav:createdOn>
    <permissions:permissions rdf:nodeID="N6d3a3a35d06b43848acc6998e1d606ec"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:item rdf:resource="urn:domeoclient:uuid:491654FF-D757-49BB-ADF3-AADC51B4BB4A"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:C16B9331-360B-4263-84B6-78CEF02D1351"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:E01A1671-01BD-4FBC-ADA4-1A16F80BDAE1"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:9408D5E4-DED3-4E79-87C6-1F9EEB33BAC2">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix> compared to people with normal CYP2D6 ("extensive metabolizers"). The differences between the CYP2D6 poor and extensive metabolizers, however, are not expected to be clinically important because the sum of </ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:9408D5E4-DED3-4E79-87C6-1F9EEB33BAC2"/>
    <ao:exact> ODV</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-6.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-21 10:01:01 -0400</pav:createdOn>
    <ao:prefix> and reduced levels of</ao:prefix>
    <domeo:uuid>9408D5E4-DED3-4E79-87C6-1F9EEB33BAC2</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:3A0752AB-B8AB-4C41-926A-E09DFD235B54">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:3A0752AB-B8AB-4C41-926A-E09DFD235B54"/>
    <domeo:uuid>3A0752AB-B8AB-4C41-926A-E09DFD235B54</domeo:uuid>
    <ao:prefix>xsd:String</ao:prefix>
    <pav:createdOn>2014-07-08 15:53:43 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>Carbamazepine co-administration decreased the steady-state plasma concentrations of risperidone and 9-hydroxyrisperidone by about 50%. Plasma concentrations of carbamazepine did not appear to be affected. The dose of risperidone may need to be titrated accordingly for patients receiving carbamazepine, particularly during initiation or discontinuation of carbamazepine therapy.</ao:exact>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-7.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:EA91700D-D73A-43DE-A1B4-8B33328FE90E">
    <ao:prefix> by the enzyme, CYP 2D6. A minor metabolic pathway is through N-dealkylation. The main metabolite,</ao:prefix>
    <pav:createdOn>2014-07-07 19:47:28 -0400</pav:createdOn>
    <ao:exact> 9-hydroxyrisperidone</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:EA91700D-D73A-43DE-A1B4-8B33328FE90E"/>
    <ao:suffix>, has similar pharmacological activity as risperidone. Consequently, the clinical effect of the drug results from the combined concentrations of risperidone plus 9-hydroxyrisperidone.</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <domeo:uuid>EA91700D-D73A-43DE-A1B4-8B33328FE90E</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:5A0DE6C2-68AC-4515-8616-46FB047F6410">
    <pav:createdOn>2014-07-08 09:22:05 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotation:7261FCA6-7414-4F1D-969D-94231C16F661</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:lastSavedOn>2014-07-08 09:22:07 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoclient:uuid:C0CE4AC7-F72D-4A94-BD3E-4720F127B810</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:2735C95B-2AB7-40E5-936D-BF99AE7B09F8"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:body rdf:nodeID="N2c41716d52724e45b5a003f8586ae5d3"/>
    <rdfs:label>expertstudy Annotation</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:a6d15f1d-ecfd-45c1-9ef2-8540e7c62052">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:a6d15f1d-ecfd-45c1-9ef2-8540e7c62052"/>
    <ao:exact>levonorgestrel</ao:exact>
    <pav:createdOn>2014-07-07 08:07:00 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid></domeo:uuid>
    <ao:prefix> studies were conducted with </ao:prefix>
    <ao:suffix> tablets [see DRUG INTERACTION</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-206.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7E0CFC7F-65D4-4237-A8ED-2B7239AB9784">
    <ao:body rdf:nodeID="Nb48dfab9835b45298ae8f95211e4e4d6"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7E49EB7A-DE0E-4720-82D1-8460BA0C770D</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:92E6B82B-0CB3-4359-ADB2-A9EE3DB5A351"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotation:7D5DD553-213F-464E-82AB-6F5723B89C1B</pav:lineageUri>
    <pav:lastSavedOn>2014-07-08 14:10:48 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-08 14:09:11 -0400</pav:createdOn>
    <rdfs:label>expertstudy Annotation</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:80D626B6-9F56-4E5F-BE82-765A7A7AED16">
    <domeo:uuid>80D626B6-9F56-4E5F-BE82-765A7A7AED16</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>were variable and were generally not statistically different from placebo or </ao:prefix>
    <ao:exact>glyburide </ao:exact>
    <ao:suffix>controls.</ao:suffix>
    <pav:createdOn>2014-07-08 08:40:16 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:80D626B6-9F56-4E5F-BE82-765A7A7AED16"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:9C40151B-89FE-439C-8660-16B7812A9785">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>Ribavirin: In vitro data indicate ribavirin reduces phosphorylation of lamivudine, stavudine, and zidovudine. However, no pharmacokinetic (e.g., plasma concentrations or intracellular triphosphorylated active metabolite concentrations) or pharmacodynamic (e.g., loss of HIV-1/HCV virologic suppression) interaction was observed when ribavirin and lamivudine (n = 18), stavudine (n = 10), or zidovudine (n = 6) were coadministered as part of a multi-drug regimen to HIV-1/HCV co-infected patients [see Warnings and Precautions (5.4)].</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:9C40151B-89FE-439C-8660-16B7812A9785"/>
    <ao:suffix>xsd:String</ao:suffix>
    <domeo:uuid>9C40151B-89FE-439C-8660-16B7812A9785</domeo:uuid>
    <pav:createdOn>2014-07-08 14:24:43 -0400</pav:createdOn>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-197.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E26D6177-D8B1-4F96-9181-786D41BF0F0E">
    <domeo:belongsToSet>urn:domeoclient:uuid:D543C3F1-DA54-4DBF-A2A2-25D79FA02724</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:8745D68D-BCAE-4EEB-B4CB-F68614392150</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-08 09:22:59 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:843FC03C-9B2F-41DA-AC2E-992179D1B23C"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2014-07-08 09:22:37 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:2831B1E5-422A-4596-84B5-3924AA0D86E8">
    <ao:exact>16βhydroxylevonorgestrel</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:2831B1E5-422A-4596-84B5-3924AA0D86E8"/>
    <ao:suffix>. </ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>2831B1E5-422A-4596-84B5-3924AA0D86E8</domeo:uuid>
    <pav:createdOn>2014-07-08 15:33:35 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix> and </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-206.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:0E223290-8363-415F-9D4D-EE3BB5F3F7C6">
    <pav:createdOn>2014-07-07 19:42:44 -0400</pav:createdOn>
    <domeo:uuid>0E223290-8363-415F-9D4D-EE3BB5F3F7C6</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:0E223290-8363-415F-9D4D-EE3BB5F3F7C6"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>acts as an antagonist at other receptors, but with lower potency. </ao:prefix>
    <ao:suffix>has low to moderate affinity (Ki of 47 to 253 nM) for the serotonin 5HT1C, 5HT1D, and 5HT1A receptors, weak affinity (Ki of 620 to 800 nM) for the dopamine D1 and haloperidol-sensitive sigma site, and no affinity (when tested at concentrations &gt;10-5 M) f</ao:suffix>
    <ao:exact>Risperidone </ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:19759B42-A673-4877-B3AF-CDBC44302F63">
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotation:491E6BFC-25AB-48E9-9ADD-9EEC7890DBFB</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:createdOn>2014-07-07 19:53:46 -0400</pav:createdOn>
    <ao:body rdf:nodeID="N2663075b8c914761ad6725c342c16376"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:67F3B4FB-2639-40F2-86FB-C5E280F33F53"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5ABD9862-F044-4404-AD04-73DA04ADDA8B</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-07-07 19:59:12 -0400</pav:lastSavedOn>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:4E43D844-2E5A-46D2-8797-09878034F22F">
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <domeo:deleted>false</domeo:deleted>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812e52b20002"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:12534F44-8FD4-4F21-9E61-2A4EA1AF6718"/>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <pav:createdOn>2014-07-08 09:07:58 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <ao:item rdf:resource="urn:domeoclient:uuid:3DEE2593-CF46-4671-BDFE-E99A43F1EA44"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:EED1D7DF-CF12-4B75-88EB-142933594019"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-128.txt.html</ao:annotatesResource>
    <ao:item rdf:resource="urn:domeoclient:uuid:AD03DC07-5AB6-455E-9A9D-67D1255446D4"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:B7E3A840-6FAE-4775-9068-98BD07D35A26"/>
    <rdfs:label>Default Set</rdfs:label>
    <permissions:permissions rdf:nodeID="N4e7ac1a61b7147279c293bd846a6a49c"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:F18CDAEB-614F-4670-B2F1-093666B82181"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:3E405ADF-726C-4732-9DBD-459D74270D9F"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-07-08 09:08:47 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotationset:A0F5EF15-D1C5-4BCE-9D42-48444911349B</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:502B7512-035A-4DD5-8452-73F76F70C976">
    <pav:createdOn>2014-07-08 14:58:33 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <ao:body rdf:nodeID="N3a5d4b4e632847ebb420010ff2a67651"/>
    <pav:lineageUri>urn:domeoserver:annotation:3374B32F-8E37-473F-A320-ED5870487F6E</pav:lineageUri>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:14325892-77B6-46EF-8E79-D137D813786C"/>
    <pav:lastSavedOn>2014-07-08 14:58:34 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:F308746E-1B09-48A9-A699-A66CF195F2F7</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F0A31D46-263C-4433-B1ED-DF6F1406E547">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:F0A31D46-263C-4433-B1ED-DF6F1406E547"/>
    <domeo:uuid>F0A31D46-263C-4433-B1ED-DF6F1406E547</domeo:uuid>
    <ao:exact>glyburide </ao:exact>
    <pav:createdOn>2014-07-08 08:48:04 -0400</pav:createdOn>
    <ao:suffix>therapy. Repeat doses of AVANDIA (8 mg once daily) for 8 days in healthy adult Caucasian subjects caused a decrease in glyburide AUC and Cmax of approximately 30%. In Japanese subjects, glyburide AUC and Cmax slightly increased following coadministration</ao:suffix>
    <ao:prefix>(3.75 to 10 mg/day) for 7 days did not alter the mean steady-state 24-hour plasma glucose concentrations in diabetic patients stabilized on </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:FC00AF1F-FFB0-4DE4-9A24-C9F2FC666B98">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:FC00AF1F-FFB0-4DE4-9A24-C9F2FC666B98"/>
    <pav:createdOn>2014-07-08 12:24:43 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>; increased serum concentrations of </ao:prefix>
    <ao:suffix>with concomitant hematologic and gastrointestinal toxicity have been observed with methotrexate. Use of methotrexate with penicillins should be carefully monitored.</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-166.txt.html</ao:hasSource>
    <domeo:uuid>FC00AF1F-FFB0-4DE4-9A24-C9F2FC666B98</domeo:uuid>
    <ao:exact>methotrexate </ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:2580ACE5-64C0-4D85-9807-043744CE64D7">
    <domeo:uuid>2580ACE5-64C0-4D85-9807-043744CE64D7</domeo:uuid>
    <ao:exact>procyclidine </ao:exact>
    <ao:prefix>alone at steady state. If anticholinergic effects are seen, the dose of </ao:prefix>
    <ao:suffix>should be reduced.</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-07 20:23:21 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:2580ACE5-64C0-4D85-9807-043744CE64D7"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-50.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:5093F3FF-29BF-42B4-9DC6-DEA357DA4394">
    <ao:exact>risperidone </ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:5093F3FF-29BF-42B4-9DC6-DEA357DA4394"/>
    <ao:suffix>and 9-hydroxyrisperidone was decreased, and elimination half-lives were prolonged compared to young healthy subjects. Dosing should be modified accordingly in the elderly patients [see 2 DOSAGE AND ADMINISTRATION].</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-07 19:58:35 -0400</pav:createdOn>
    <domeo:uuid>5093F3FF-29BF-42B4-9DC6-DEA357DA4394</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>Elderly: In healthy elderly subjects, renal clearance of both </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:9E934103-8948-4317-83F6-3946F62BD7A5">
    <ao:suffix>xsd:String</ao:suffix>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-07 10:02:48 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:9E934103-8948-4317-83F6-3946F62BD7A5"/>
    <ao:exact>sildenafil</ao:exact>
    <domeo:uuid>9E934103-8948-4317-83F6-3946F62BD7A5</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:3A678043-ADA2-4E23-A2ED-84615B586C07">
    <ao:body rdf:nodeID="N5fb4fd66869f46b5882e1d2b549a69a3"/>
    <pav:lastSavedOn>2014-07-08 14:52:51 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:41C6B392-F8A7-4DBA-AFEF-0BE07588FACF</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:createdOn>2014-07-08 14:52:01 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:C2BA26F9-AC03-431C-BDFF-02DC0B51B78C"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotation:1452D115-4081-43CC-BBB3-243C5A4978FC</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:84281820-7E4B-45D0-B3A3-06DFBF19FD17">
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:C75EF972-9D73-45F3-8C60-EF1D58AF29F9"/>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:81A3A3E1-22A9-4374-92CF-BCB6D0B5025C">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-08 08:49:05 -0400</pav:createdOn>
    <ao:suffix>AUC and Cmax were observed after repeat doses of AVANDIA (8 mg once daily) for 8 days in healthy adult subjects.</ao:suffix>
    <domeo:uuid>81A3A3E1-22A9-4374-92CF-BCB6D0B5025C</domeo:uuid>
    <ao:prefix>. No clinically significant reductions in </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:81A3A3E1-22A9-4374-92CF-BCB6D0B5025C"/>
    <ao:exact>glimepiride </ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C2CA98EF-6FC7-4DAD-A0A2-66784F962B31">
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A5E637EF-5CA5-4AAC-BD8B-C136A86E17B7</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:CCBEC9F5-7E23-4A91-AAFB-F31A5F1B3C47"/>
    <pav:createdOn>2014-07-07 09:40:12 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotationset:F37BE993-E972-47AE-896D-FF4D33157ECF</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-07-07 09:44:18 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:e926fa75-b7de-4d6e-844f-e3a3322c355e">
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotation:d586fd6a-902b-4f0d-bd45-53300328bf5b</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:841E9565-FA63-4F5B-B42F-81A2A5F8AC58</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-07-07 08:02:55 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-07-21 10:09:44 -0400</pav:lastSavedOn>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:7BB5C7CC-5AEF-4D00-829C-6C8F0E50D486"/>
    <ao:body rdf:nodeID="N0861eaedbdab40f1b5b4de99c9e07070"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:72D22D36-D0B1-4EDA-A452-24416E0EFAF1">
    <domeo:uuid>72D22D36-D0B1-4EDA-A452-24416E0EFAF1</domeo:uuid>
    <ao:suffix>(100 mcg/mL), warfarin (10 mcg/mL), and carbamazepine (10 mcg/mL) caused only a slight increase in the free fraction of risperidone at 10 ng/mL and 9-hydroxyrisperidone at 50 ng/mL, changes of unknown clinical significance.</ao:suffix>
    <ao:prefix> displaces each other from plasma binding sites. High therapeutic concentrations of </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-07 19:47:01 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:72D22D36-D0B1-4EDA-A452-24416E0EFAF1"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>sulfamethazine </ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E43E2315-081D-4703-B4E6-7A9270E74E0C">
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <ao:body rdf:nodeID="N4c708d362f1e454e958c94b0ee1a6a4b"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:lastSavedOn>2014-07-08 15:30:37 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotation:44A2AB36-CB41-4873-9F72-5AEB679968F9</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:063A7209-93BB-42E1-A05D-D45CEF402ED2</domeo:belongsToSet>
    <pav:createdOn>2014-07-08 15:29:46 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:18C81208-4F0B-4465-A81D-C8ABBAE695A3"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:73FD549E-291A-4B42-8D79-D565B6BC56D6">
    <ao:context rdf:resource="urn:domeoclient:uuid:0CF6D389-9007-4813-A39A-F02AC2F194BF"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2014-07-08 08:40:13 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotationset:57174A7C-3100-4C8F-9C4A-2991CEE124D5</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-07-08 08:46:38 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:23515E27-98AC-4DC9-A4B7-EBFE2991219F</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:AF2D7E22-ECE6-4B27-AB7C-5654B17AD443">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:AF2D7E22-ECE6-4B27-AB7C-5654B17AD443"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>Sildenafil </ao:exact>
    <domeo:uuid>AF2D7E22-ECE6-4B27-AB7C-5654B17AD443</domeo:uuid>
    <pav:createdOn>2014-07-07 09:36:55 -0400</pav:createdOn>
    <ao:suffix>and its major circulating N-desmethyl metabolite are both approximately 96% bound to plasma proteins. Protein binding is independent of total drug concentrations.</ao:suffix>
    <ao:prefix>n with a high-fat meal, the rate of absorption is reduced, with a mean delay in Tmax of 60 minutes and a mean reduction in Cmax of 29%. The mean steady state volume of distribution (Vss) for sildenafil is 105 L, indicating distribution into the tissues. </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:5A0AED5D-2E08-4D62-B0A9-40B016E82D27">
    <ao:suffix>and midazolam, respectively.</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-118.txt.html</ao:hasSource>
    <ao:prefix>(intravenous bolus dose) in healthy volunteers led to elevated plasma concentrations of these drugs. The Cmax increased by 18% and 14% (median values) and the AUC increased by 44% and 33% for </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:5A0AED5D-2E08-4D62-B0A9-40B016E82D27"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-07 20:39:58 -0400</pav:createdOn>
    <domeo:uuid>5A0AED5D-2E08-4D62-B0A9-40B016E82D27</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>nifedipine </ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:8CEB663C-0774-4A6A-AB56-617AB8F10603">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-133.txt.html</ao:hasSource>
    <ao:suffix>) concentrations ranging from 33% to 209%.</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:8CEB663C-0774-4A6A-AB56-617AB8F10603"/>
    <ao:exact>mesoridazine</ao:exact>
    <domeo:uuid>8CEB663C-0774-4A6A-AB56-617AB8F10603</domeo:uuid>
    <pav:createdOn>2014-07-08 09:21:21 -0400</pav:createdOn>
    <ao:prefix>metabolite (</ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:CA2A6108-D730-43DF-9BCF-AD1DE31C2743">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>Population data from patients in clinical trials indicated a reduction in </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:CA2A6108-D730-43DF-9BCF-AD1DE31C2743"/>
    <pav:createdOn>2014-07-07 09:41:26 -0400</pav:createdOn>
    <ao:exact>sildenafil </ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix>clearance when it was co-administered with CYP3A inhibitors. Sildenafil exposure without concomitant medication is shown to be 5-fold higher at a dose of 80 mg TID compared to its exposure at a dose of 20 mg TID. This concentration range covers the same </ao:suffix>
    <domeo:uuid>CA2A6108-D730-43DF-9BCF-AD1DE31C2743</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:AA70235E-0C4F-49BA-8DCD-EBA299F33730">
    <pav:createdOn>2014-07-08 14:10:30 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7E49EB7A-DE0E-4720-82D1-8460BA0C770D</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <ao:body rdf:nodeID="Nc79f26437c984f0797e66f5f44e7614a"/>
    <pav:lineageUri>urn:domeoserver:annotation:31057C9C-E329-48ED-8828-2220EE567B21</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:lastSavedOn>2014-07-08 14:10:48 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:EE0AF78A-72D1-4F81-B050-E9476D92EDD7"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:1C971DC5-F04F-473E-9509-6E1B9DE2F91E">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotationset:F37BE993-E972-47AE-896D-FF4D33157ECF</pav:lineageUri>
    <pav:createdOn>2014-07-07 10:00:00 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A5E637EF-5CA5-4AAC-BD8B-C136A86E17B7</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <pav:lastSavedOn>2014-07-07 10:03:14 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:F2F67FFA-C8CC-4C69-BA89-71EE02913503"/>
    <pav:previousVersion>urn:domeoclient:uuid:53FAA6D0-9A40-44F9-8FE0-3166137CEF10</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:5562FCAA-167D-4389-8046-E0C3CD11A57D">
    <pav:lastSavedOn>2014-07-08 08:51:47 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:23515E27-98AC-4DC9-A4B7-EBFE2991219F</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:createdOn>2014-07-08 08:49:01 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotationset:57174A7C-3100-4C8F-9C4A-2991CEE124D5</pav:lineageUri>
    <pav:previousVersion>urn:domeoclient:uuid:5BCE2FDB-C586-44CD-88F7-6EE2BDB6B929</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:E27A16CE-6580-45E8-8355-59330E7DE10B"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/9C08BFE1-3C39-43F6-A44F-C1258C7BC980">
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/2541</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>cimetidine</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F5726C15-2670-4EC9-A123-CC04284FE8BB">
    <ao:prefix>400 mg to six healthy male volunteers. After the administration of </ao:prefix>
    <pav:createdOn>2014-07-07 20:08:09 -0400</pav:createdOn>
    <ao:suffix>, there was a significant decrease in fluconazole AUC and Cmax. There was a mean ± SD decrease in fluconazole AUC of 13% ± 11% (range: -3.4 to -31%) and Cmax decreased 19% ± 14% (range: -5 to -40%). However, the administration of cimetidine 600 mg to 900</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:F5726C15-2670-4EC9-A123-CC04284FE8BB"/>
    <domeo:uuid>F5726C15-2670-4EC9-A123-CC04284FE8BB</domeo:uuid>
    <ao:exact>cimetidine</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-23.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:297398A4-DB9A-4685-8F5A-232BC8FD4BAE">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:297398A4-DB9A-4685-8F5A-232BC8FD4BAE"/>
    <ao:suffix> [see Warnings and Precautions (5.2) and Dosage and Administration (2)]</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>xsd:String</ao:prefix>
    <domeo:uuid>297398A4-DB9A-4685-8F5A-232BC8FD4BAE</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-194.txt.html</ao:hasSource>
    <ao:exact>Drugs that inhibit CYP2D6 (such as desipramine, paroxetine, ritonavir, sertraline) and CYP3A4 (such as ketoconazole, ritonavir, saquinavir, erythromycin, and grapefruit juice) can be expected to cause increased plasma levels of propafenone. The combination of CYP3A4 inhibition and either CYP2D6 deficiency or CYP2D6 inhibition with administration of propafenone may increase the risk of adverse reactions, including proarrhythmia. Therefore, simultaneous use of RYTHMOL SR with both a CYP2D6 inhibitor and a CYP3A4 inhibitor should be avoided</ao:exact>
    <pav:createdOn>2014-07-08 13:58:12 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B44CD6F1-18F6-4252-9E79-5D5107E7044D">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812e52b20002"/>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:F1E73FC8-A1AF-4584-97F4-1342666BD5FA"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:8B8E52BE-280D-42B8-A550-ACAFE604C677"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:item rdf:resource="urn:domeoclient:uuid:8126EEBF-25D2-48D6-A8EB-D15CF571A623"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:AEFB34F5-676C-4384-9B02-311075C59D2B"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:AD0069FC-81F4-4ADA-A610-C999DA509763"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotationset:08976696-BDAD-4906-8500-A3D6AD5F99CA</pav:lineageUri>
    <pav:createdOn>2014-07-07 20:14:57 -0400</pav:createdOn>
    <rdfs:label>Default Set</rdfs:label>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-26.txt.html</ao:annotatesResource>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <ao:item rdf:resource="urn:domeoclient:uuid:902AF6DE-7CF7-4B84-AC6F-B07989802523"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:419F7D5E-2124-4BF8-8E9E-10E59820BB3F"/>
    <permissions:permissions rdf:nodeID="N7170e779e71c4c07ad5d26e134ded7e3"/>
    <domeo:deleted>false</domeo:deleted>
    <pav:lastSavedOn>2014-07-07 20:16:03 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/E6B1176F-0D33-46DC-8F64-B31BCA0CA119">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/28031</dailymed:activeMoietyRxCUI>
    <rdfs:label>itraconazole</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:48D61CA1-37E6-4FCA-AE42-448CBEA41CD4">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2014-07-08 08:40:20 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:5796459D-55EF-4FC9-9D80-8ECBDF39B127"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:23515E27-98AC-4DC9-A4B7-EBFE2991219F</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-07-08 08:46:38 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotationset:57174A7C-3100-4C8F-9C4A-2991CEE124D5</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/2A2722D8-9183-4738-9882-DF85987C17F1">
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/261455</dailymed:activeMoietyRxCUI>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>avandia</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/drug-product"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C49BA751-1E41-4789-8530-81D4EAEC1D57">
    <pav:createdOn>2014-07-08 08:44:23 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2014-07-08 08:46:38 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:23515E27-98AC-4DC9-A4B7-EBFE2991219F</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotationset:57174A7C-3100-4C8F-9C4A-2991CEE124D5</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:76BE7025-2F0B-4F5E-9F36-1C8A2CADC27E"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/C49FAE86-1ECA-48BD-99AC-0E69425593E3">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>phenytoin</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/8183</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A8BEE8F3-D849-420F-B702-9E0D9766DAEB">
    <pav:previousVersion>urn:domeoclient:uuid:21a2d27a-13b1-4797-ba7a-c0517e32bb06</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">3</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:CDFD2463-4A00-4BEF-AEE9-ED3BF98C439C"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2014-07-21 09:58:56 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotationset:cf593dca-fe93-451b-8f37-2a96e065da13</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-21 10:02:11 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:32944008-A6C6-4D66-8C43-EE4CF2256965</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:61C3F83D-35C4-4073-8027-13127C4B0AAA">
    <pav:lineageUri>urn:domeoserver:annotationset:57174A7C-3100-4C8F-9C4A-2991CEE124D5</pav:lineageUri>
    <ao:body rdf:nodeID="N9dc55c89f01a4a128eed91f40ae18879"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:23515E27-98AC-4DC9-A4B7-EBFE2991219F</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:previousVersion>urn:domeoclient:uuid:5BCE2FDB-C586-44CD-88F7-6EE2BDB6B929</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:82716E9E-8396-4935-B77D-E0FFECFEC71F"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:lastSavedOn>2014-07-08 08:51:47 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-08 08:49:43 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/2336CD05-F58E-4A57-BFFA-5855A4F3A62F">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>midazolam</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/6960</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:93915E60-0340-4F12-8A8A-F95F8DA176F5">
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-07-08 09:32:20 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-07-08 09:35:29 -0400</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotation:D1DAA344-34E5-4EF4-BBC4-F00E9FF5438E</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoclient:uuid:423352B3-8ABA-48B7-98CF-B191A7BFC955</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:0101CEE0-FF8F-4DA5-90C1-2C4D9B03752E"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7831E286-91D4-4126-919B-883E1EA69CBA">
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:2D30A04F-52B9-41D6-80B3-E687377067CA"/>
    <pav:lineageUri>urn:domeoserver:annotationset:1DED06A6-8562-4CCF-A58C-CA25748FBD31</pav:lineageUri>
    <pav:lastSavedOn>2014-07-07 19:50:36 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5ABD9862-F044-4404-AD04-73DA04ADDA8B</domeo:belongsToSet>
    <pav:createdOn>2014-07-07 19:49:05 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:84C2BF02-AD2D-4601-A426-D70EE999C0B1">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>100 mg administered to healthy volunteers produced decreases in supine blood pressure (mean maximum decrease in systolic/diastolic blood pressure of 8/5 mmHg). The decrease in blood pressure was most notable approximately 1–2 hours after dosing, and was </ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:84C2BF02-AD2D-4601-A426-D70EE999C0B1"/>
    <ao:prefix>Single oral doses of </ao:prefix>
    <ao:exact>sildenafil </ao:exact>
    <pav:createdOn>2014-07-07 09:35:35 -0400</pav:createdOn>
    <domeo:uuid>84C2BF02-AD2D-4601-A426-D70EE999C0B1</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:2B0B133F-3636-48C3-B972-A6B55BE02576">
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:7F55385D-7971-4B91-8841-7E619722B72E"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E01A1671-01BD-4FBC-ADA4-1A16F80BDAE1">
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoclient:uuid:51AE28A6-A4F5-4551-AD8B-8ADDDCA82257</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:E3D19020-BB20-4840-8BF5-90D2C734F743</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:4DDB8C1A-18B8-4AE2-823E-A4C0817C7FFE"/>
    <pav:createdOn>2014-07-07 20:32:10 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-07 20:34:18 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/73E79438-B92C-497E-BE60-91BD62FF6502">
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/3364</dailymed:activeMoietyRxCUI>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>didanosine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:2F772F9A-A059-49D1-8FD1-A685F5D44261">
    <ao:exact>carbamazepine </ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:2F772F9A-A059-49D1-8FD1-A685F5D44261"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>(as well as mCPP) by 76 and 60%, respectively, compared to pre-</ao:prefix>
    <pav:createdOn>2014-07-08 09:28:20 -0400</pav:createdOn>
    <domeo:uuid>2F772F9A-A059-49D1-8FD1-A685F5D44261</domeo:uuid>
    <ao:suffix>values.</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-137.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/5770B439-9C56-4747-891A-E4CE950D918B">
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>propranolol</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/8787</dailymed:activeMoietyRxCUI>
    <dct:description>Referred to the drug in the interaction.</dct:description>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:93363706-45F5-45F5-8137-37B08C2D8C5C">
    <ao:exact>Propranolol </ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-135.txt.html</ao:hasSource>
    <ao:prefix>xsd:String</ao:prefix>
    <pav:createdOn>2014-07-08 09:23:56 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:93363706-45F5-45F5-8137-37B08C2D8C5C"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>93363706-45F5-45F5-8137-37B08C2D8C5C</domeo:uuid>
    <ao:suffix>is extensively metabolized with most metabolites appearing in the urine. Propranolol is metabolized through three primary routes: aromatic hydroxylation (mainly 4-hydroxylation), N-dealkylation followed by further side-chain oxidation, and direct glucuro</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:0E873785-F977-4ADC-BA20-F9C47B72690A">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-21.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-07 20:00:46 -0400</pav:createdOn>
    <domeo:uuid>0E873785-F977-4ADC-BA20-F9C47B72690A</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:0E873785-F977-4ADC-BA20-F9C47B72690A"/>
    <ao:exact> ethinyl estradiol</ao:exact>
    <ao:suffix> and norethindrone compared to similar placebo dosing. The mean AUCs of ethinyl estradiol and norethindrone increased by 24% (95% C.I. range 18 to 31%) and 13% (95% C.I. range 8 to 18%), respectively relative to placebo. Fluconazole treatment did not cau</ao:suffix>
    <ao:prefix>dosing resulted in small increases in the mean AUCs of</ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:BFBA5C57-7297-4D17-B1ED-B12C0FFB6D77">
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <ao:body rdf:nodeID="N82e0e62c52c74da8962365b26018a4ec"/>
    <pav:lastSavedOn>2014-07-07 19:59:12 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5ABD9862-F044-4404-AD04-73DA04ADDA8B</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotation:3B148FFC-D485-42EF-9A49-77F68A00F39E</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:DE6BBBA2-E835-420D-88DD-35B02A3B87C1"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:createdOn>2014-07-07 19:51:49 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/935D83E6-8067-4E52-B773-0E99CB0E01C5">
    <rdfs:label>fluconazole</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/4450</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:CD88686C-2177-4B29-9DB1-376688CC99AD">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-08 08:50:23 -0400</pav:createdOn>
    <ao:prefix>or </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>CD88686C-2177-4B29-9DB1-376688CC99AD</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:CD88686C-2177-4B29-9DB1-376688CC99AD"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <ao:suffix>.</ao:suffix>
    <ao:exact>rosiglitazone</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:04639316-05E5-427A-9233-CC96F2B8D704">
    <domeo:uuid>04639316-05E5-427A-9233-CC96F2B8D704</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:04639316-05E5-427A-9233-CC96F2B8D704"/>
    <pav:createdOn>2014-07-07 20:08:20 -0400</pav:createdOn>
    <ao:suffix>in 24 healthy male volunteers.</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-23.txt.html</ao:hasSource>
    <ao:prefix>200 mg) did not affect the bioavailability or pharmacokinetics of </ao:prefix>
    <ao:exact>fluconazole </ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D6A8E94A-D28D-4635-9B7D-D4910DFAAC3B">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>D6A8E94A-D28D-4635-9B7D-D4910DFAAC3B</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:D6A8E94A-D28D-4635-9B7D-D4910DFAAC3B"/>
    <pav:createdOn>2014-07-07 20:08:17 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-23.txt.html</ao:hasSource>
    <ao:exact>fluconazole </ao:exact>
    <ao:prefix>600 mg to 900 mg intravenously over a four-hour period (from one hour before to 3 hours after a single oral dose of </ao:prefix>
    <ao:suffix>200 mg) did not affect the bioavailability or pharmacokinetics of fluconazole in 24 healthy male volunteers.</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:98851836-9069-4A89-8A59-0D6CBB2433E5">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:98851836-9069-4A89-8A59-0D6CBB2433E5"/>
    <ao:suffix>. The mean ± SD increase in AUC was 20% ± 32% (range: -27 to 104%). The metabolite, GZDV, to parent drug ratio significantly decreased after the administration of fluconazole, from 7.6 ± 3.6 to 5.7 ± 2.2.</ao:suffix>
    <ao:exact>fluconazole</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>AUC following the administration of </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-27.txt.html</ao:hasSource>
    <domeo:uuid>98851836-9069-4A89-8A59-0D6CBB2433E5</domeo:uuid>
    <pav:createdOn>2014-07-07 20:16:43 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:BCD98D80-27EF-4A94-8589-22FBE0E5EF67">
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-07-08 15:34:18 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-08 15:34:08 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotation:C82AF389-62EF-4BCB-A6DD-59D0B83484DC</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:B5492D58-02A9-4548-B4B3-82DC9DEB1410"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:0F235438-66A4-4847-A5E7-8A71C3802072</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:8E3D9621-F584-43BA-8EFA-739CAF26EEAC">
    <ao:suffix>concentrations when co-administered with sildenafil (50 mg) to healthy volunteers.</ao:suffix>
    <pav:createdOn>2014-07-07 09:41:49 -0400</pav:createdOn>
    <ao:exact>sildenafil </ao:exact>
    <domeo:uuid>8E3D9621-F584-43BA-8EFA-739CAF26EEAC</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:8E3D9621-F584-43BA-8EFA-739CAF26EEAC"/>
    <ao:prefix>(800 mg), a nonspecific CYP inhibitor, caused a 56% increase in plasma </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:6DDD95C8-AF2D-4439-9E24-0F6D2346A962">
    <ao:suffix>in combination with other hypoglycemic agents were generally similar to those seen with AVANDIA in monotherapy.</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:6DDD95C8-AF2D-4439-9E24-0F6D2346A962"/>
    <pav:createdOn>2014-07-08 08:40:08 -0400</pav:createdOn>
    <ao:prefix>The pattern of LDL and HDL changes following therapy with </ao:prefix>
    <ao:exact>AVANDIA </ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <domeo:uuid>6DDD95C8-AF2D-4439-9E24-0F6D2346A962</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Ncb8170a89a934e38a1ecadc24118b2f0">
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
    <permissions:isLocked>false</permissions:isLocked>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F533733D-05CF-40C9-9FAA-8FAFB5EFC64E">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:F533733D-05CF-40C9-9FAA-8FAFB5EFC64E"/>
    <ao:exact>dalfopristin</ao:exact>
    <domeo:uuid>F533733D-05CF-40C9-9FAA-8FAFB5EFC64E</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-114.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-08 14:50:09 -0400</pav:createdOn>
    <ao:prefix>/</ao:prefix>
    <ao:suffix> and </ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:8B8E52BE-280D-42B8-A550-ACAFE604C677">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:6B0031D3-964D-4140-8715-70FC390ADF58"/>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <domeo:belongsToSet>urn:domeoclient:uuid:B44CD6F1-18F6-4252-9E79-5D5107E7044D</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:body rdf:nodeID="N7b56766e55bf4f4390027e0f5c4c3d4b"/>
    <pav:createdOn>2014-07-07 20:15:59 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-07-07 20:16:04 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotation:F38F81E2-99A0-4640-A6F3-5FCCB7033DB3</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:20C1B844-001A-4CA9-97FA-D4E6A5AC2069">
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:866B9D61-E16F-4706-BECB-2F73AB4474F2"/>
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:4D94D8DA-765F-4B95-9FBC-EEBDCE757246">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:lastSavedOn>2014-07-08 09:22:07 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoclient:uuid:C0CE4AC7-F72D-4A94-BD3E-4720F127B810</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:8CEB663C-0774-4A6A-AB56-617AB8F10603"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotation:FF2A4DF4-1644-4C5E-BB2F-9F350DCBE8C4</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdOn>2014-07-08 09:21:21 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:0BB35202-8DFA-4B2E-A72C-E1C0C685AD3E">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:585E91D0-9B2C-4600-8081-6187C738FC73"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:B41CE612-345D-4E17-94DB-98BD2C6B5559</domeo:belongsToSet>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:body rdf:nodeID="Nebe2b41b8b9441009e5c13e5f7e10d76"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdOn>2014-07-07 20:14:29 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotation:F0834A2E-16ED-4607-9D11-9220DBB428B9</pav:lineageUri>
    <pav:lastSavedOn>2014-07-07 20:14:34 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:583AC4E3-86F9-4998-A7D6-2C8269DE79CF">
    <domeo:belongsToSet>urn:domeoserver:annotationset:BA8F9408-39CC-4619-AA2D-75BA5518E56A</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:DEA5F790-6FA5-446D-AF96-834740301FFC"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2014-07-08 12:10:17 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-07-08 12:10:41 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotationset:701D90A9-2BA7-4D65-A3A7-505A77C8FE71</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/ec50bbd0-119c-4595-8b2e-59f79b86e7f0">
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:f714af22-9495-418f-aca9-54a2066b10f0"/>
    <pav:lineageUri>urn:domeoserver:annotationset:9dfd7548-433e-473e-a57e-dbf0a5e8ce4a</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:CF899881-76E1-4005-BE12-FE1112B9CEF9</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-07-07 08:06:48 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-07 08:06:48 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/30F837D7-0FB7-4976-B0BD-225960FF74DA">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/83395</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>saquinavir</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:70B7DA9E-F576-4293-860C-7002C6B075A4">
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoclient:uuid:15A8BD5A-D46C-4E84-8B70-5066D260486D</domeo:belongsToSet>
    <pav:createdOn>2014-07-08 12:06:15 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-08 12:08:36 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:1E02046D-5245-46AE-9208-717405D7DF80"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotation:024F06CE-C274-424F-AC90-60D8072164D9</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/1D2BA564-4D1D-4BAF-98C0-C9BEF56EA87A">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/8787</dailymed:activeMoietyRxCUI>
    <rdfs:label>propranolol</rdfs:label>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B62C9921-205A-437D-AB79-A525799C2D90">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:9624A634-CBAF-4D19-8751-5D4FA8D21BF0"/>
    <pav:createdOn>2014-07-07 09:38:54 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A5E637EF-5CA5-4AAC-BD8B-C136A86E17B7</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotationset:F37BE993-E972-47AE-896D-FF4D33157ECF</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-07 09:44:18 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:EB32DF82-19F1-4506-BA93-CF38DE05C68A">
    <pav:lastSavedOn>2014-07-07 20:04:45 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-07 20:04:28 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoclient:uuid:921213C5-987C-46D2-9095-A8DDC2B714AB</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:40501BB8-EF48-40F1-AFFD-CE5741575FFF"/>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <ao:body rdf:nodeID="N99d745f22930446196d0b562f4a9a5a7"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotation:AA3C0F6C-EBA3-4119-B92F-0FACDB974064</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N174116b6ae1a4e1a939b5831b2b1c1db">
    <domeo:sets rdf:resource="urn:pddi:uuid:EA167485-6E91-4D6C-A288-E53574EB0CB4"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/7D1A908A-5C31-4797-9FE9-F3A966262FA3">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>quinidine</rdfs:label>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/9068</dailymed:activeMoietyRxCUI>
    <dct:description>Referred to the drug in the interaction.</dct:description>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:A0840F01-8503-4B3F-B653-98AB1ED1E2DD">
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:01B4DFB6-1E6D-448E-8813-3E2BAD66E729"/>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B971C988-9D81-4BB3-838D-473FFB89951B">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-08 09:10:19 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotation:9273B185-74D3-4A34-962A-B732A5EFF0E3</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoclient:uuid:1D51EEDF-FCC9-44E1-A13B-BCE69023F944</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-08 09:11:17 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:0E7F8A35-8A3C-40EF-B23B-AEC812DB30D8"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:16D02332-2893-47D6-ADD7-FCEF160CA2DD">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-104.txt.html</ao:hasSource>
    <ao:exact>VAPRISOL (40 mg/day for 4 days) administered with a single 25 mg dose of warfarin, which undergoes major metabolism by CYP2C9 and minor metabolism by CYP3A, increased the mean S-warfarin AUC and S-warfarin Cmax by 14% and 17%, respectively. The corresponding prothrombin time and international normalized ratio values were unchanged.</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:16D02332-2893-47D6-ADD7-FCEF160CA2DD"/>
    <pav:createdOn>2014-07-08 16:26:07 -0400</pav:createdOn>
    <ao:prefix>xsd:String</ao:prefix>
    <domeo:uuid>16D02332-2893-47D6-ADD7-FCEF160CA2DD</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>xsd:String</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoserver:annotationset:AFA31957-0959-46DF-B640-AD0687F186D6">
    <pav:previousVersion>urn:domeoclient:uuid:c2192274-3130-48d1-9c1c-0ccd98add853</pav:previousVersion>
    <domeo:deleted>false</domeo:deleted>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-105.txt.html</ao:annotatesResource>
    <ao:item rdf:resource="urn:domeoclient:uuid:AB22A180-DD58-40D6-9FC7-E65A1AFC9D85"/>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812e52b20002"/>
    <rdfs:label>NER Sets</rdfs:label>
    <pav:createdOn>2014-07-07 08:06:56 -0400</pav:createdOn>
    <ao:item rdf:resource="file:///home/yin2/python-SPL-connector/36bf1ceb-9ee3-475a-9565-323ce4c6e4c6"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotationset:e2189d4e-f5e1-4d47-aaf1-f7ab8dd8e62f</pav:lineageUri>
    <permissions:permissions rdf:nodeID="Nb5d07bd24c94494b833e86046d9a8ba8"/>
    <dct:description>The NER set is created automatically by NER annotation loading program.</dct:description>
    <pav:lastSavedOn>2014-07-08 19:40:31 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">3</pav:versionNumber>
    <ao:item rdf:resource="urn:domeoclient:uuid:C6A24744-4135-4C9F-A637-7703EFEA0D59"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B36B628C-1C37-471D-B254-C3AB57FE04EC">
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoclient:uuid:6FFD9FFA-5CED-4EE2-B68F-77212B4C447D</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotation:FA687CEC-95D5-469C-A338-231DF150D5CC</pav:lineageUri>
    <pav:createdOn>2014-07-08 09:18:57 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:4A90EC65-D119-4C69-9F09-14B07DEC6E87"/>
    <pav:lastSavedOn>2014-07-08 09:20:18 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:08F1DD6D-5B4C-4E48-AC58-284431A52EA7">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/23D62F01-0BBA-43A9-8331-4DBCF067DE39"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/B8452916-45CA-4FB2-BC6D-33F06AF4ECE8"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E161FE99-2F94-4F2C-971C-29FC6EB3FDA5">
    <pav:lastSavedOn>2014-07-21 10:02:11 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotationset:cf593dca-fe93-451b-8f37-2a96e065da13</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:32944008-A6C6-4D66-8C43-EE4CF2256965</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:59CDDEDF-00A5-4DF8-A2C0-E36773BF2D0E"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">3</pav:versionNumber>
    <pav:createdOn>2014-07-21 10:01:51 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:previousVersion>urn:domeoclient:uuid:21a2d27a-13b1-4797-ba7a-c0517e32bb06</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:57505AB0-C496-4EE9-96B3-7C5E98ADC57F">
    <pav:createdOn>2014-07-08 08:54:44 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:1FD751A4-481C-4831-949E-383687C951FB"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:23515E27-98AC-4DC9-A4B7-EBFE2991219F</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotation:CBCF8A04-A7C4-453C-8F67-19CCACCBFCA4</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:lastSavedOn>2014-07-08 08:54:46 -0400</pav:lastSavedOn>
    <ao:body rdf:nodeID="N6ea66fc4ceb2412fa021dfb41d134ba4"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:0AE5EBB3-4BC0-4820-A3BB-8BB34491757D">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:0AE5EBB3-4BC0-4820-A3BB-8BB34491757D"/>
    <ao:suffix>.</ao:suffix>
    <ao:prefix>perienced an event on at least one occasion. All events are included except those already listed in the previous table or discussed in WARNINGS or PRECAUTIONS, trivial events, those too general to be informative, and those not reasonably associated with </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-58.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-07 20:37:13 -0400</pav:createdOn>
    <ao:exact>zonisamide</ao:exact>
    <domeo:uuid>0AE5EBB3-4BC0-4820-A3BB-8BB34491757D</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N02158c619e844a19bf135a9540c3a74c">
    <domeo:sets rdf:resource="urn:pddi:uuid:95CCB727-C04A-42A4-87E0-858322F5C26C"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:117052E4-6784-41A4-B815-9E3518A1CCFB">
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdOn>2014-07-07 19:42:42 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotationset:1DED06A6-8562-4CCF-A58C-CA25748FBD31</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:E775A1D2-4888-4131-8716-573B16777670"/>
    <pav:lastSavedOn>2014-07-07 19:50:36 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5ABD9862-F044-4404-AD04-73DA04ADDA8B</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N8de17b4fc9c14bfb99b4abd91fc1b88c">
    <permissions:accessType>urn:person:uuid:080e143046812afe0146812e52b20002</permissions:accessType>
    <permissions:isLocked>false</permissions:isLocked>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7E425E73-12D2-4B08-9D70-75410DE87447">
    <ao:item rdf:resource="urn:domeoclient:uuid:103130D9-6A2B-476D-B949-4993B0FED3C9"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:A02B1A5E-2703-4702-BEE8-179076130E88"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:0366BEB6-FA24-4F5A-932F-9F16FA62E889"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotationset:68C58E28-E640-4740-B6EF-DE14E4B45E78</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:item rdf:resource="urn:domeoclient:uuid:A62379B0-048F-4BBD-908C-20C585F768B6"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:C52EEE5D-519C-4CE5-BD28-6C0C2DFCF52A"/>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812e52b20002"/>
    <pav:createdOn>2014-07-08 09:25:18 -0400</pav:createdOn>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:7A82298A-C721-4D5E-8E8D-DF02586C8C9D"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:item rdf:resource="urn:domeoclient:uuid:FDD093C9-DBD0-4767-A650-5A8EE28AC78D"/>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <ao:item rdf:resource="urn:domeoclient:uuid:5299D5E7-53AE-4520-AE5A-6280B3954B0A"/>
    <permissions:permissions rdf:nodeID="N04a6c3d47e9043f7b0aa8f48ee8413ae"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:5E052BE8-F669-42CA-B1EA-63E254F28C39"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:2CAD8348-0228-4994-BBA4-56ABFD115ABA"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:AB44741D-BFF6-47E0-B101-48CB77C6FFE7"/>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-136.txt.html</ao:annotatesResource>
    <rdfs:label>Default Set</rdfs:label>
    <ao:item rdf:resource="urn:domeoclient:uuid:5C0759EF-E008-4093-B19D-5A077456D59D"/>
    <pav:lastSavedOn>2014-07-08 09:27:35 -0400</pav:lastSavedOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:BE5A0D78-7E41-4DAF-99D9-DD715C832E89"/>
    <domeo:deleted>false</domeo:deleted>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:item rdf:resource="urn:domeoclient:uuid:27603150-CFA7-4433-AFE0-EE8E29B15E35"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:220B9DDC-DB2B-4FCB-BEE0-EF9AFEBF6C70"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:359FE0D1-F23A-437F-9FB6-775E88D87C91">
    <domeo:uuid>359FE0D1-F23A-437F-9FB6-775E88D87C91</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-07 09:57:49 -0400</pav:createdOn>
    <ao:exact> N-desmethyl metabolite</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:359FE0D1-F23A-437F-9FB6-775E88D87C91"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix> were 45% and 57%, respectively</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>xsd:String</ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:79EF1544-DE9E-4DAB-B25D-7FE39CCD711D">
    <pav:createdOn>2014-07-08 15:53:19 -0400</pav:createdOn>
    <ao:exact>Carbamazepine co-administration decreased the steady-state plasma concentrations of risperidone and 9-hydroxyrisperidone by about 50%. Plasma concentrations of carbamazepine did not appear to be affected. The dose of risperidone may need to be titrated accordingly for patients receiving carbamazepine, particularly during initiation or discontinuation of carbamazepine therapy.</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>xsd:String</ao:prefix>
    <domeo:uuid>79EF1544-DE9E-4DAB-B25D-7FE39CCD711D</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-7.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:79EF1544-DE9E-4DAB-B25D-7FE39CCD711D"/>
    <ao:suffix>xsd:String</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A52945FE-9967-4CFD-B2D9-8505FDDB41ED">
    <ao:prefix>were still approximately 200 ng/mL, compared to approximately 5 ng/mL when </ao:prefix>
    <ao:exact>sildenafil </ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:A52945FE-9967-4CFD-B2D9-8505FDDB41ED"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>was dosed alone. This is consistent with ritonavir's marked effects on a broad range of P450 substrates. Although the interaction between other protease inhibitors (except saquinavir) and REVATIO has not been studied, their concomitant use is expected to</ao:suffix>
    <domeo:uuid>A52945FE-9967-4CFD-B2D9-8505FDDB41ED</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-07 09:40:26 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:5A744604-3A8D-4358-A786-28AEBB5D92D3">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:5A744604-3A8D-4358-A786-28AEBB5D92D3"/>
    <ao:suffix>, a member of the thiazolidinedione class of antidiabetic agents, improves glycemic control by improving insulin sensitivity. Rosiglitazone is a highly selective and potent agonist for the peroxisome proliferator-activated receptor-gamma (PPARγ). In huma</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-08 08:38:22 -0400</pav:createdOn>
    <domeo:uuid>5A744604-3A8D-4358-A786-28AEBB5D92D3</domeo:uuid>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:exact>Rosiglitazone</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:93699E01-A44B-40BD-A675-E1DF78CB3A81">
    <ao:suffix>and its major metabolite, 9-hydroxyrisperidone [see 12 CLINICAL PHARMACOLOGY]. Antagonism at receptors other than D2 and 5HT2 [see 12 CLINICAL PHARMACOLOGY] may explain some of the other effects of risperidone.</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-07 19:43:12 -0400</pav:createdOn>
    <ao:prefix>results from the combined concentrations of </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:93699E01-A44B-40BD-A675-E1DF78CB3A81"/>
    <domeo:uuid>93699E01-A44B-40BD-A675-E1DF78CB3A81</domeo:uuid>
    <ao:exact>risperidone </ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:844CFAC6-A916-4941-AA9C-0703CC47B4C3">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-07 20:19:01 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:844CFAC6-A916-4941-AA9C-0703CC47B4C3"/>
    <ao:exact>Theophylline </ao:exact>
    <domeo:uuid>844CFAC6-A916-4941-AA9C-0703CC47B4C3</domeo:uuid>
    <ao:prefix>AUC increased 21% ± 16% (range: -5 to 48%). The Cmax increased 13% ± 17% (range: -13 to 40%). </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-28.txt.html</ao:hasSource>
    <ao:suffix>clearance decreased 16% ± 11 % (range: -32 to 5%). The half-life of theophylline increased from 6.6 ± 1.7 hours to 7.9 ± 1.5 hours. (See PRECAUTIONS.)</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/DE864991-F77F-45BB-ACCE-ED7313AE49A6">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/9384</dailymed:activeMoietyRxCUI>
    <rdfs:label>rifampin</rdfs:label>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/DE8413F2-03D2-4A31-BFA6-A6A9333B0A2D">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>nifedipine</rdfs:label>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/7417</dailymed:activeMoietyRxCUI>
    <dct:description>Referred to the drug in the interaction.</dct:description>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F7DD2319-D95F-4678-8C14-F3A97597ECB0">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-58.txt.html</ao:hasSource>
    <ao:exact>Zonisamide </ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-07 20:36:57 -0400</pav:createdOn>
    <ao:prefix>xsd:String</ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix>has been administered to 1,598 individuals during all clinical trials, only some of which were placebo-controlled. During these trials, all events were recorded by the investigators using their own terms. To provide a useful estimate of the proportion of</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:F7DD2319-D95F-4678-8C14-F3A97597ECB0"/>
    <domeo:uuid>F7DD2319-D95F-4678-8C14-F3A97597ECB0</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/76B37439-260F-48CE-B23E-0D570EF0A919">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/4493</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>fluoxetine</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/C195D96F-1230-45AA-BB89-7D58FDD0E249">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>propafenone</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/8754</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/7325E7C2-1A5F-458D-A0BA-520A8C606134">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/8183</dailymed:activeMoietyRxCUI>
    <rdfs:label>phenytoin</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:de0a7789-8d6c-49a1-95fc-556021933023">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:de0a7789-8d6c-49a1-95fc-556021933023"/>
    <pav:createdOn>2014-07-07 08:07:06 -0400</pav:createdOn>
    <domeo:uuid></domeo:uuid>
    <ao:suffix> because beta-blockers may exa</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>re the gradual withdrawal of </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-106.txt.html</ao:hasSource>
    <ao:exact>clonidine</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:55E3FF4C-A1A8-4D4F-AD9B-91B6BD60C2ED">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:55E3FF4C-A1A8-4D4F-AD9B-91B6BD60C2ED"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>oral solution is bioequivalent to </ao:prefix>
    <ao:suffix>tablets.</ao:suffix>
    <pav:createdOn>2014-07-07 19:43:35 -0400</pav:createdOn>
    <ao:exact>risperidone </ao:exact>
    <domeo:uuid>55E3FF4C-A1A8-4D4F-AD9B-91B6BD60C2ED</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:0B7913F4-388C-4002-8FA4-241C4EC6EFC6">
    <pav:lineageUri>urn:domeoserver:annotation:D115A060-E408-4187-9A61-CE89336FFEB9</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:A815DD75-EEB0-49E8-A779-08BD77F47A89"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoclient:uuid:F2EFEF06-B779-484C-B854-043086EB0C5C</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-07 20:44:32 -0400</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdOn>2014-07-07 20:39:53 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:352F50E0-9FEF-4A92-BC4B-D74AAF3B3356">
    <pav:createdOn>2014-07-07 20:31:07 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix> (249 mg of quinidine base) in a formulation to provide extended release; the inactive ingredients are: fumaric acid, hypromellose, lactose monohydrate, magnesium stearate, polydextrose, polyethylene glycol, povidone, triacetin and titanium dioxide.</ao:suffix>
    <domeo:uuid>352F50E0-9FEF-4A92-BC4B-D74AAF3B3356</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:352F50E0-9FEF-4A92-BC4B-D74AAF3B3356"/>
    <ao:prefix> Extended-release Tablet contains 300 mg of </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-55.txt.html</ao:hasSource>
    <ao:exact>quinidine sulfate</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D00E402A-6BAB-4252-8071-8444AEF24E9B">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:23515E27-98AC-4DC9-A4B7-EBFE2991219F</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:311056FB-C736-4832-AA31-5105D423B0C2"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2014-07-08 08:54:46 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotation:04D247AF-9891-4395-AB09-9F12DB586A28</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdOn>2014-07-08 08:54:14 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:de37c2f8-5802-4c55-8257-2f95332a49c0">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>midazolam</ao:exact>
    <ao:suffix> were significantly increased </ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:de37c2f8-5802-4c55-8257-2f95332a49c0"/>
    <domeo:uuid></domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-32.txt.html</ao:hasSource>
    <ao:prefix>. The psychomotor effects of </ao:prefix>
    <pav:createdOn>2014-07-07 08:07:00 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:1AB37877-FF60-406C-B294-16B8DA972E2F">
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:lastSavedOn>2014-07-08 14:31:52 -0400</pav:lastSavedOn>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:2CD5EC60-6C64-4F1C-8293-A4D163CC9362</domeo:belongsToSet>
    <pav:createdOn>2014-07-08 14:31:14 -0400</pav:createdOn>
    <ao:body rdf:nodeID="Nea24a2bb750a42e9be30c4f8813e3dad"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:18DE6EED-BC61-4232-95D2-D1FF4AEF6319"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotation:B50BD86A-91A3-46DE-B3A3-81578CA34F03</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:5E480179-EDB1-4A8E-ACC2-B79CCF6CEAA5">
    <ao:context rdf:resource="urn:domeoclient:uuid:FBDBB1ED-7C40-442B-94E8-A15DD3E5AF6B"/>
    <pav:lineageUri>urn:domeoserver:annotation:62B8BF91-6E24-4DC6-9F45-1DBEAC405B50</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:body rdf:nodeID="N5da9653fcb464c529b68189c6f12ece4"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <domeo:belongsToSet>urn:domeoclient:uuid:D74AEF81-5B9A-431F-9F0D-1822391A7E30</domeo:belongsToSet>
    <pav:createdOn>2014-07-08 12:05:19 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-07-08 12:05:20 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B39AD01B-4E98-4457-ACB4-68E4483A286B">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotation:6D16708A-6D8C-444F-A5C8-9D605B349B99</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:A4DDE736-6991-482F-8FEC-89A3FF535D38"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:42258B16-6749-4B39-B28D-88C8B63F7A43</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-08 14:26:16 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdOn>2014-07-08 14:25:47 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A5C2D609-8291-4340-B158-FC436DC5B81F">
    <ao:suffix>(7.5 mg/kg q12h intravenously [iv]) in the treatment of complicated skin and skin structure infections were performed. The comparator drug was oxacillin (2g q6h iv) in the first study (JRV 304) and cefazolin (1g q8h iv) in the second study (JRV 305); how</ao:suffix>
    <ao:prefix>Two randomized, open-label, controlled clinical trials of </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:A5C2D609-8291-4340-B158-FC436DC5B81F"/>
    <domeo:uuid>A5C2D609-8291-4340-B158-FC436DC5B81F</domeo:uuid>
    <ao:exact>Synercid </ao:exact>
    <pav:createdOn>2014-07-07 20:45:50 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-119.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:BBE5812F-4BD5-46A9-983B-F7350B4B8065">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-07 11:12:49 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-07 11:09:19 -0400</pav:createdOn>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <ao:body rdf:nodeID="N6cc9c06eb0d34c728fe8fd14c9bf9d98"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:F090DBDF-A110-4DE9-80B1-119A6E43488A"/>
    <pav:lineageUri>urn:domeoserver:annotation:6BB55DF8-B1B1-4C29-BE8B-0811D0A204EE</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A5E637EF-5CA5-4AAC-BD8B-C136A86E17B7</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:8AB55D25-77EB-4034-A8F8-42FC9A097E65">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-50.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:8AB55D25-77EB-4034-A8F8-42FC9A097E65"/>
    <pav:createdOn>2014-07-07 20:23:19 -0400</pav:createdOn>
    <ao:exact>procyclidine </ao:exact>
    <ao:suffix>alone at steady state. If anticholinergic effects are seen, the dose of procyclidine should be reduced.</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>(5 mg oral once daily) by 35%, 37%, and 67%, respectively, compared to </ao:prefix>
    <domeo:uuid>8AB55D25-77EB-4034-A8F8-42FC9A097E65</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:15A8BD5A-D46C-4E84-8B70-5066D260486D">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:item rdf:resource="urn:domeoclient:uuid:16F384F2-6BA5-4604-ADEC-3707AB4DACDF"/>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <ao:item rdf:resource="urn:domeoclient:uuid:DEF403A7-A195-4A96-8530-9C1D07D3A545"/>
    <domeo:deleted>false</domeo:deleted>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-163.txt.html</ao:annotatesResource>
    <ao:item rdf:resource="urn:domeoclient:uuid:70B7DA9E-F576-4293-860C-7002C6B075A4"/>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812e52b20002"/>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <rdfs:label>Default Set</rdfs:label>
    <pav:lastSavedOn>2014-07-08 12:08:36 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotationset:78DADEA9-FA84-48B4-97F6-33DBFD0A1CA6</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <permissions:permissions rdf:nodeID="N0c9b20489806461aa5e9b055c69c1fa2"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:6A33E692-FE6C-4ED9-BB29-3C4EAA599090"/>
    <pav:createdOn>2014-07-08 12:06:15 -0400</pav:createdOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:1B145A34-470A-4CFA-97E7-2D53B9372910"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:09FA0E94-1FC3-4C97-8B13-295C5963F698">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>at steady state (80 mg TID) with bosentan (a moderate inducer of CYP3A, CYP2C9 and possibly of cytochrome P450 2C19) at steady state (125 mg BID) resulted in a 63% decrease of sildenafil AUC and a 55% decrease in sildenafil Cmax. Co-administration result</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:09FA0E94-1FC3-4C97-8B13-295C5963F698"/>
    <ao:exact>sildenafil </ao:exact>
    <domeo:uuid>09FA0E94-1FC3-4C97-8B13-295C5963F698</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>In a study of healthy male volunteers, co-administration of </ao:prefix>
    <pav:createdOn>2014-07-07 09:42:36 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/f93b2d38-4cf2-4c3d-9dd6-6a79b9a8d884">
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotationset:9dbc20ea-3552-4427-930a-52eb84c9e230</pav:lineageUri>
    <pav:createdOn>2014-07-07 08:06:39 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:be3a0971-7e05-4fc6-b8bd-a2a56d82b51a"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A7033EE8-62A2-4AAF-AD21-7D4F7611919F</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-07 08:06:39 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:411AED3B-F654-4C24-B918-A9E737A89AD0">
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotation:84E013BB-0D8B-4E02-9E89-13BAEA2401D2</pav:lineageUri>
    <pav:lastSavedOn>2014-07-08 08:54:46 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-08 08:52:22 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:23515E27-98AC-4DC9-A4B7-EBFE2991219F</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:8F31A6C4-0092-4AC8-862A-2F69A4C04CAC"/>
    <rdfs:label>Highlight</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:18F45C11-AE96-46E1-B6CE-AB9E2F4A137C">
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-07-08 12:10:41 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-08 12:10:18 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:BA8F9408-39CC-4619-AA2D-75BA5518E56A</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotationset:701D90A9-2BA7-4D65-A3A7-505A77C8FE71</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:B47A1CB6-870C-4FBF-A075-53C17B33C855"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:07942BD0-56D4-4AFD-A94E-19C5FFA2451E">
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:AF9BBA5D-B17E-4B8C-BD7E-9F298BD9EC7C"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:01CE3AEB-76EE-4C9B-B5BC-DD09469BE1C6">
    <pav:createdOn>2014-07-08 08:42:06 -0400</pav:createdOn>
    <ao:prefix>Following oral or intravenous administration of [14C]</ao:prefix>
    <domeo:uuid>01CE3AEB-76EE-4C9B-B5BC-DD09469BE1C6</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:01CE3AEB-76EE-4C9B-B5BC-DD09469BE1C6"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>rosiglitazone </ao:exact>
    <ao:suffix>maleate, approximately 64% and 23% of the dose was eliminated in the urine and in the feces, respectively. The plasma half-life of [14C]related material ranged from 103 to 158 hours.</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:0D772D07-6BFF-4E1B-A011-9A28BF92D56C">
    <pav:lastSavedOn>2014-07-07 20:36:25 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:9D7F86CC-36BD-44E4-B672-4E3A28FD3416"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-07 20:35:28 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotation:C9C0BF68-E1D5-49B9-8E05-3093B6D46BFC</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <domeo:belongsToSet>urn:domeoclient:uuid:C56FAF33-D751-43EF-B31E-95E23B8E733A</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:AD68EA56-80D0-40F0-8AAD-E711ED29F200">
    <domeo:uuid>AD68EA56-80D0-40F0-8AAD-E711ED29F200</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-07 19:46:54 -0400</pav:createdOn>
    <ao:suffix>e displaces each other from plasma binding sites. High therapeutic concentrations of sulfamethazine (100 mcg/mL), warfarin (10 mcg/mL), and carbamazepine (10 mcg/mL) caused only a slight increase in the free fraction of risperidone at 10 ng/mL and 9-hydr</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:AD68EA56-80D0-40F0-8AAD-E711ED29F200"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <ao:prefix> nor </ao:prefix>
    <ao:exact>9-hydroxyrisperidon</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:01B6CC9C-1F62-408E-91EB-171F92613A4B">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-126.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-08 08:58:12 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>propranolol</ao:exact>
    <domeo:uuid>01B6CC9C-1F62-408E-91EB-171F92613A4B</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:01B6CC9C-1F62-408E-91EB-171F92613A4B"/>
    <ao:suffix>.</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>are increased by 64% and 79%, respectively, by co-administration of </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:14325892-77B6-46EF-8E79-D137D813786C">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:14325892-77B6-46EF-8E79-D137D813786C"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-110.txt.html</ao:hasSource>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:exact>Irbesartan: In vitro studies show significant inhibition of the formation of oxidized irbesartan metabolites by nifedipine. However, in clinical studies, concomitant nifedipine had no effect on irbesartan pharmacokinetics.</ao:exact>
    <pav:createdOn>2014-07-08 14:58:33 -0400</pav:createdOn>
    <domeo:uuid>14325892-77B6-46EF-8E79-D137D813786C</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:6D58C87F-6507-4CBE-A71C-249E52E6A189">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:6D58C87F-6507-4CBE-A71C-249E52E6A189"/>
    <ao:exact> ODV</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-21 10:01:16 -0400</pav:createdOn>
    <ao:suffix> (26%), or other minor inactive metabolites (27%). Renal elimination of </ao:suffix>
    <ao:prefix> (29%), conjugated</ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-6.txt.html</ao:hasSource>
    <domeo:uuid>6D58C87F-6507-4CBE-A71C-249E52E6A189</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/7F244531-ACB3-49A1-9C69-FB96F337AFE1">
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>phenytoin</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/8183</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:20410859-8D12-42B9-AE3F-723631B14A50">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:20410859-8D12-42B9-AE3F-723631B14A50"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-136.txt.html</ao:hasSource>
    <ao:exact>trazodone </ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>In vitro drug metabolism studies reveal that </ao:prefix>
    <domeo:uuid>20410859-8D12-42B9-AE3F-723631B14A50</domeo:uuid>
    <ao:suffix>is a substrate of the cytochrome P450 3A4 (CYP3A4) enzyme and trazodone metabolism can be inhibited by the CYP3A4 inhibitors ketoconazole, ritonavir, and indinavir. The effect of short-term administration of ritonavir (200 mg twice daily, 4 doses) on the</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-08 09:25:18 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:CB98CB58-0E88-47D6-BE17-C8B7765876D3">
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotationset:1DED06A6-8562-4CCF-A58C-CA25748FBD31</pav:lineageUri>
    <pav:lastSavedOn>2014-07-07 19:50:36 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-07 19:49:21 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:9AC3A15C-32E3-4412-9825-AB5FBC4D13EE"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5ABD9862-F044-4404-AD04-73DA04ADDA8B</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:101BF336-26FE-483C-89AB-6013CA4CD0BF">
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:4E32FF86-5504-44C8-8C7C-6A378765B28D"/>
    <pav:createdOn>2014-07-07 09:41:47 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-07-07 09:44:18 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotationset:F37BE993-E972-47AE-896D-FF4D33157ECF</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A5E637EF-5CA5-4AAC-BD8B-C136A86E17B7</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:person:uuid:080e143046812afe0146812e52b20002">
    <foafx:homepage></foafx:homepage>
    <foafx:name>nonexpert1</foafx:name>
    <rdfs:label>nonexpert1</rdfs:label>
    <foafx:firstname>nonexpert</foafx:firstname>
    <foafx:picture>http://www.hcklab.org/images/me/paolo%20ciccarese-boston.jpg</foafx:picture>
    <foafx:lastname>1</foafx:lastname>
    <foafx:email>nonexpert1@gmail.com</foafx:email>
    <rdf:type rdf:resource="http://xmlns.com/foaf/0.1/Person"/>
    <foafx:title>nonexpert1</foafx:title>
    <foafx:middlename></foafx:middlename>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F4054B29-6745-4EE5-B992-FD07D7BE3230">
    <rdfs:label>Highlight</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:350B9B00-4C30-437A-AFE4-38BCE71F4386"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotationset:1DED06A6-8562-4CCF-A58C-CA25748FBD31</pav:lineageUri>
    <pav:lastSavedOn>2014-07-07 19:50:36 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-07 19:42:37 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5ABD9862-F044-4404-AD04-73DA04ADDA8B</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:CA350370-39D0-4795-8E06-297CBD95A542">
    <domeo:belongsToSet>urn:domeoserver:annotationset:C2CFDC7A-D407-48FD-81AA-DFCEA656C0BE</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-07-08 14:37:51 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotation:2BF2FF86-E81F-4BD9-9837-B689EF664FF4</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2014-07-08 14:40:40 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:6615BAC7-16B0-4FB8-9F2A-D7C425178008"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D705184F-D0E2-4344-B3D4-EB88BD052E18">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:9B8A0C07-FB7E-4123-8198-BCD117B2D02C"/>
    <pav:lastSavedOn>2014-07-07 09:44:18 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-07 09:37:49 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A5E637EF-5CA5-4AAC-BD8B-C136A86E17B7</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotationset:F37BE993-E972-47AE-896D-FF4D33157ECF</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A563C94C-390B-4766-84EA-66BBD84F420D">
    <pav:lineageUri>urn:domeoserver:annotation:0483C559-3E82-4039-86FD-DBF4A0D761CC</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:createdOn>2014-07-07 20:46:54 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:A425A546-8265-4937-89D6-C752CFE5EC29"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:5741C3AA-07D0-4BB3-9A9F-55B13B957620</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-07 20:48:02 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:6DF383E4-F15A-49B5-8192-02F522393878">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <ao:body rdf:nodeID="N9f57dd9ba0e8438ea05029499dcf44d8"/>
    <pav:lastSavedOn>2014-07-07 11:12:49 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A5E637EF-5CA5-4AAC-BD8B-C136A86E17B7</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:E8F2D12E-3D8C-489B-866C-FC88D981FD71"/>
    <pav:createdOn>2014-07-07 11:11:22 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotation:288EF1E8-1D64-4473-851A-99F77066A567</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:78766AFA-FB26-436F-9FBE-744E65FC2DA1">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotation:B8EED93F-279E-4712-BC52-CBD80D5D04C4</pav:lineageUri>
    <pav:lastSavedOn>2014-07-07 11:12:49 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A5E637EF-5CA5-4AAC-BD8B-C136A86E17B7</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:B0595CA8-74E0-4CB9-B725-D29F0D6CF7FA"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdOn>2014-07-07 11:11:51 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/D02B5306-AE97-46DE-8D5C-ACE5DD1F4920">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>amiodarone</rdfs:label>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/703</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:C0FBEBCF-3474-4EF0-82C4-429CF3F5D004">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/B745E074-30FB-4142-81F6-BD02946EC3D1"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/099D3005-17B5-4D7E-9FCD-3988CF551CF0"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:6452DB33-D852-46C0-ADE8-10740D1A89C7">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>The AUC and Cmax of glipizide (2.5 mg single dose) were significantly increased following the administration of fluconazole in 13 normal male volunteers. There was a mean ± SD increase in AUC of 49% ± 13% (range: 27 to 73%) and an increase in Cmax of 19% ± 23% (range: -11 to 79%)</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:6452DB33-D852-46C0-ADE8-10740D1A89C7"/>
    <ao:prefix>xsd:String</ao:prefix>
    <pav:createdOn>2014-07-08 19:52:51 -0400</pav:createdOn>
    <domeo:uuid>6452DB33-D852-46C0-ADE8-10740D1A89C7</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix>. (See PRECAUTIONS.</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-30.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:98038435-9EF8-454F-93AA-0900F0475D30">
    <pav:createdOn>2014-07-07 20:16:39 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>dose for at least two weeks. There was a significant increase in zidovudine AUC following the administration of fluconazole. The mean ± SD increase in AUC was 20% ± 32% (range: -27 to 104%). The metabolite, GZDV, to parent drug ratio significantly decrea</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:98038435-9EF8-454F-93AA-0900F0475D30"/>
    <ao:prefix>200 mg daily for 15 days) in 13 volunteers with AIDS or ARC who were on a stable </ao:prefix>
    <ao:exact>zidovudine </ao:exact>
    <domeo:uuid>98038435-9EF8-454F-93AA-0900F0475D30</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-27.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:33B5B85B-A4D6-4250-A416-8CBD8D621A6F">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdOn>2014-07-08 13:54:32 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotation:D7C3EBAB-AF00-48E1-93D1-3F18B5483E6B</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-07-08 13:56:02 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:DD05DE56-7B60-4C06-8552-D1DD652D8A79</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:C1B9032F-3327-47BD-86C2-0CFC399B1808"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/CC07EA99-C961-471D-8B94-5104B5BC8199">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/6918</dailymed:activeMoietyRxCUI>
    <rdfs:label>metoprolol</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:30A7C621-CE0B-4F38-9093-2C12DF3A6185">
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:DD3B7CB1-50CE-40F2-9924-420A9DBAC79F"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:EA11E66F-660C-46D5-B222-C541A09953D4">
    <pav:createdOn>2014-07-08 14:05:39 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7E49EB7A-DE0E-4720-82D1-8460BA0C770D</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-08 14:10:48 -0400</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <ao:body rdf:nodeID="N3d52ae6291a04881970e84d7c3d3b9b0"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:3033A046-FC95-44E4-BDBD-5185E9AE5A27"/>
    <pav:lineageUri>urn:domeoserver:annotation:C234D674-6150-4825-AF87-43D883489042</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:38D25A1F-8E25-4571-9547-3CA72D3D56A7">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:42E149BE-DCF1-4C4A-A6DE-2843E6EFC9E2"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <ao:body rdf:nodeID="N6137a252339641bda53ea6882b951f12"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:lastSavedOn>2014-07-08 09:22:59 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-08 09:22:59 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoclient:uuid:D543C3F1-DA54-4DBF-A2A2-25D79FA02724</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotation:58675184-710B-480B-B530-AB280BB9F129</pav:lineageUri>
    <rdfs:label>expertstudy Annotation</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:771F6C88-6D8B-47F6-B6F2-55064E77133B">
    <domeo:belongsToSet>urn:domeoclient:uuid:FF4D892F-0BD2-4FD8-9160-6124946DB29D</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-07-08 09:24:09 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-07-08 09:24:21 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotation:D0536406-3175-4959-BECC-2E75D255BB3B</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:7BD07360-3C6E-4CEF-9BC7-C8FD2A61F0B1"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:06EDFED5-3057-4E24-8162-4B0F2B8C6F1C">
    <pav:lastSavedOn>2014-07-08 08:46:38 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-08 08:45:58 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotationset:57174A7C-3100-4C8F-9C4A-2991CEE124D5</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:64FBA69A-FCA1-4F1F-BD52-0CDF8974E959"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:23515E27-98AC-4DC9-A4B7-EBFE2991219F</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:5400C9BE-1E8F-4890-B33D-D6F64B94D117">
    <domeo:uuid>5400C9BE-1E8F-4890-B33D-D6F64B94D117</domeo:uuid>
    <pav:createdOn>2014-07-07 19:57:59 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:5400C9BE-1E8F-4890-B33D-D6F64B94D117"/>
    <ao:prefix>The apparent half-life of </ao:prefix>
    <ao:exact>risperidone </ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <ao:suffix>was 3 hours (CV=30%) in extensive metabolizers and 20 hours (CV=40%) in poor metabolizers. The apparent half-life of 9-hydroxyrisperidone was about 21 hours (CV=20%) in extensive metabolizers and 30 hours (CV=25%) in poor metabolizers. The pharmacokineti</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:AB44741D-BFF6-47E0-B101-48CB77C6FFE7">
    <ao:body rdf:nodeID="N3cf276e60ae94f4da0c9a4d640367fa8"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <domeo:belongsToSet>urn:domeoclient:uuid:7E425E73-12D2-4B08-9D70-75410DE87447</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-08 09:27:36 -0400</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotation:FD9DC734-F44D-448F-A181-5ABDBB503681</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:76EBED7C-12A7-419B-A36D-C5164C10E376"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:createdOn>2014-07-08 09:26:43 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:4F68FF3B-A357-479D-A040-E265F4DED0D7">
    <pav:createdOn>2014-07-07 19:46:00 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5ABD9862-F044-4404-AD04-73DA04ADDA8B</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:3729EE77-B980-41A7-B3A7-1160C8DCBDB0"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:lastSavedOn>2014-07-07 19:50:36 -0400</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotationset:1DED06A6-8562-4CCF-A58C-CA25748FBD31</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:1AD45413-AE14-4440-8748-CB2433A309DC">
    <ao:context rdf:resource="urn:domeoclient:uuid:84C2BF02-AD2D-4601-A426-D70EE999C0B1"/>
    <pav:createdOn>2014-07-07 09:35:35 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:lastSavedOn>2014-07-07 09:44:18 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotationset:F37BE993-E972-47AE-896D-FF4D33157ECF</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A5E637EF-5CA5-4AAC-BD8B-C136A86E17B7</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:9701169E-B533-44C4-8108-EE3B9D4FC032">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:9701169E-B533-44C4-8108-EE3B9D4FC032"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-195.txt.html</ao:hasSource>
    <domeo:uuid>9701169E-B533-44C4-8108-EE3B9D4FC032</domeo:uuid>
    <ao:prefix>, the main metabolite, </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix>, has similar sodium and calcium channel activity, but about 10 times less beta-blocking activity (N-depropylpropafenone has weaker sodium channel activity but equivalent affinity for beta-receptors).</ao:suffix>
    <ao:exact>5-hydroxypropafenone</ao:exact>
    <pav:createdOn>2014-07-08 13:52:49 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:110012FA-E5E5-4A1B-B382-8E109A7FA4C1">
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:DA801614-F554-4AFC-848A-FFA649DAB1A6"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:03E0AB5B-5F5B-4DF0-9D97-01607B82D9CB">
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2014-07-07 20:04:45 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:0E873785-F977-4ADC-BA20-F9C47B72690A"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoclient:uuid:921213C5-987C-46D2-9095-A8DDC2B714AB</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotation:BEA62651-A48E-4973-9C14-695093D3DE4E</pav:lineageUri>
    <pav:createdOn>2014-07-07 20:00:46 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C16B9331-360B-4263-84B6-78CEF02D1351">
    <pav:lastSavedOn>2014-07-07 20:34:18 -0400</pav:lastSavedOn>
    <ao:body rdf:nodeID="N61ae5f846f6a4f5ebd74741e8362c9bb"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-07-07 20:34:01 -0400</pav:createdOn>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotation:E3A63824-3833-46E4-A1EA-87905DDE9471</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoclient:uuid:51AE28A6-A4F5-4551-AD8B-8ADDDCA82257</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:2B74AE9D-C80C-4DC2-A338-FD5823416713"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:78AEBBA1-68CE-48E9-B84C-23572AB7A535">
    <ao:prefix>xsd:String</ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:78AEBBA1-68CE-48E9-B84C-23572AB7A535"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>xsd:String</ao:suffix>
    <domeo:uuid>78AEBBA1-68CE-48E9-B84C-23572AB7A535</domeo:uuid>
    <pav:createdOn>2014-07-08 15:44:00 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>Cimetidine and ranitidine increased the bioavailability of risperidone by 64% and 26%, respectively</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-7.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/61F96D9A-FC5F-43A2-8933-84144095EC09">
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/261455</dailymed:activeMoietyRxCUI>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>avandia</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/drug-product"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:88DF9883-0917-4393-BB07-BC836EA33919">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>Concomitant administration of propafenone and fluoxetine in extensive metabolizers increased the S propafenone Cmax and AUC by 39 and 50% and the R propafenone Cmax and AUC by 71 and 50%</ao:exact>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:88DF9883-0917-4393-BB07-BC836EA33919"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-08 14:02:32 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-194.txt.html</ao:hasSource>
    <ao:suffix>xsd:String</ao:suffix>
    <domeo:uuid>88DF9883-0917-4393-BB07-BC836EA33919</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:2D571BD8-9BC9-4872-8CE7-76BD0FBF0490">
    <ao:prefix>xsd:String</ao:prefix>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-88.txt.html</ao:hasSource>
    <ao:exact>SEPTRA may inhibit the hepatic metabolism of phenytoin. SEPTRA, given at a common clinical dosage, increased the phenytoin half-life by 39% and decreased the phenytoin metabolic clearance rate by 27%. When administering these drugs concurrently, one should be alert for possible excessive phenytoin effect.</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:2D571BD8-9BC9-4872-8CE7-76BD0FBF0490"/>
    <pav:createdOn>2014-07-08 14:53:28 -0400</pav:createdOn>
    <domeo:uuid>2D571BD8-9BC9-4872-8CE7-76BD0FBF0490</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N99b47ea908b14204bebdb7872f6bf9a1">
    <domeo:sets rdf:resource="urn:pddi:uuid:183B860F-535B-409C-92E2-DF860F681774"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:2295CCE9-3A07-4B53-B46F-5AFFD19002AE">
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:44A07F1C-B80C-4F44-B76D-D603846E38E2"/>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E08D4CED-BE06-4A5F-A2AF-BFBC25BA8AE4">
    <ao:item rdf:resource="urn:domeoclient:uuid:72C25A02-3427-43E4-8A57-878B6B14CF95"/>
    <pav:lastSavedOn>2014-07-07 20:46:25 -0400</pav:lastSavedOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:3F0B4B58-5C9C-4E04-AE2B-42F38AB95BC3"/>
    <rdfs:label>Default Set</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-119.txt.html</ao:annotatesResource>
    <ao:item rdf:resource="urn:domeoclient:uuid:387390E9-9E04-4360-86B2-8961770F29DC"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:FE578436-DEA3-4835-8703-49F739FC71ED"/>
    <domeo:deleted>false</domeo:deleted>
    <ao:item rdf:resource="urn:domeoclient:uuid:D24C42FB-BDF9-4C29-B4A3-83C19B89B73F"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <permissions:permissions rdf:nodeID="N16c7301a099a456bb280fd21ccf343c4"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotationset:FA956F2D-2A61-4470-BA3A-20B3C4165227</pav:lineageUri>
    <ao:item rdf:resource="urn:domeoclient:uuid:7C35B213-1F60-4449-B8A4-D340FDD66F1E"/>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812e52b20002"/>
    <pav:createdOn>2014-07-07 20:45:50 -0400</pav:createdOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:A632B3CF-8D32-42A7-981F-B80010DA6C60"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:73E9EFE7-3251-4EBB-A0D6-127592063D5B">
    <pav:lastSavedOn>2014-07-07 19:50:36 -0400</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdOn>2014-07-07 19:49:03 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotationset:1DED06A6-8562-4CCF-A58C-CA25748FBD31</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:A21196DB-D986-4EEC-AFC3-96ED188AB549"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5ABD9862-F044-4404-AD04-73DA04ADDA8B</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:8C8566AB-DEEC-49B5-AB41-B5CC8114ADE7">
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-07-07 20:04:45 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotation:F5F95200-2247-400D-8850-6D919CC7D8E5</pav:lineageUri>
    <pav:createdOn>2014-07-07 20:00:55 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoclient:uuid:921213C5-987C-46D2-9095-A8DDC2B714AB</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:21CFAE08-6A9C-4582-9FB0-44FCE6B9D0B8"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:4F2A8991-53A7-4DF5-8084-52158EDD3F0F">
    <ao:prefix>xsd:String</ao:prefix>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:exact>mexiletine </ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:4F2A8991-53A7-4DF5-8084-52158EDD3F0F"/>
    <pav:createdOn>2014-07-08 12:01:59 -0400</pav:createdOn>
    <domeo:uuid>4F2A8991-53A7-4DF5-8084-52158EDD3F0F</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-160.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D293E876-8F50-4829-B6FA-4940DB41BD06">
    <ao:exact>There is a potentially relevant interaction between diazepam and compounds which inhibit certain hepatic enzymes (particularly cytochrome P450 3A and 2C19). Data indicate that these compounds influence the pharmacokinetics of diazepam and may lead to increased and prolonged sedation. At present, this reaction is known to occur with cimetidine, ketoconazole, fluvoxamine, fluoxetine, and omeprazole</ao:exact>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:D293E876-8F50-4829-B6FA-4940DB41BD06"/>
    <domeo:uuid>D293E876-8F50-4829-B6FA-4940DB41BD06</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>xsd:String</ao:prefix>
    <pav:createdOn>2014-07-08 15:41:00 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-177.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:599F96F6-5F17-4537-A258-6339B57FADDE">
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2014-07-08 08:43:05 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotationset:57174A7C-3100-4C8F-9C4A-2991CEE124D5</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:20D893AB-9EDF-4151-BDFE-9E866F3EA66E"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:23515E27-98AC-4DC9-A4B7-EBFE2991219F</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-08 08:46:38 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:042FD13F-4820-41DF-9E7F-B53A0D5AD8ED">
    <pav:createdOn>2014-07-21 09:58:16 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix> (ODV), are potent inhibitors of neuronal </ao:suffix>
    <domeo:uuid>042FD13F-4820-41DF-9E7F-B53A0D5AD8ED</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-6.txt.html</ao:hasSource>
    <ao:prefix> and its active metabolite, </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:042FD13F-4820-41DF-9E7F-B53A0D5AD8ED"/>
    <ao:exact>O-desmethylvenlafaxine</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:735DC3EF-FC0F-4358-8149-5513CF9C8EF3">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:735DC3EF-FC0F-4358-8149-5513CF9C8EF3"/>
    <ao:suffix>. No clinically significant reductions in glimepiride AUC and Cmax were observed after repeat doses of AVANDIA (8 mg once daily) for 8 days in healthy adult subjects.</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>AVANDIA</ao:exact>
    <domeo:uuid>735DC3EF-FC0F-4358-8149-5513CF9C8EF3</domeo:uuid>
    <ao:prefix>in 14 healthy adult subjects had no clinically significant effect on the steady-state pharmacokinetics of </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-08 08:49:03 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C77E15A3-67DF-41E0-BA49-A0EA7F975FE7">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix>systemic exposure (AUC).</ao:suffix>
    <domeo:uuid>C77E15A3-67DF-41E0-BA49-A0EA7F975FE7</domeo:uuid>
    <ao:exact>sildenafil </ao:exact>
    <pav:createdOn>2014-07-07 09:41:59 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:C77E15A3-67DF-41E0-BA49-A0EA7F975FE7"/>
    <ao:prefix>, a CYP3A inhibitor, at steady state (500 mg BID for 5 days), there was a 182% increase in </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:69F6D661-D368-4573-82A2-50A2E595A757">
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:2C26BC1F-A06D-41FA-A11C-92D12A631B4E"/>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N8c62c3f2081f4914a47c0e05353c57a3">
    <permissions:accessType>urn:person:uuid:080e143046812afe0146812e52b20002</permissions:accessType>
    <permissions:isLocked>false</permissions:isLocked>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:E52729A4-0084-4CFA-BE82-D80D665A77B5">
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:2590A94C-B94E-43C0-9310-7F6EEAF8C072"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:70B9F308-2B30-4DA6-BA01-B62ED8CB1A0B">
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:D9D2D21A-F876-40E7-971B-098FE7CBA0D7"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/932AB148-37D7-4E0A-87A8-C43AA4F6E7B7">
    <rdfs:label>propranolol</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/8787</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N79a4fb7592f247a0bb623a70501d0d00">
    <domeo:sets rdf:resource="urn:pddi:uuid:AA9C22DF-5C95-4367-BE71-B2810297B2A7"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/0AFFD176-DC9D-49E4-90F6-E40F8DB81C2A">
    <rdfs:label>propafenone</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/8754</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:21628032-8AFE-4ED6-86E0-4D6E480B1DC0">
    <domeo:belongsToSet>urn:domeoclient:uuid:4A49ACB6-4B71-452F-80EE-8A84DEF45C29</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:body rdf:nodeID="N23e8a45963d24d60bfbf45b26062bca8"/>
    <pav:createdOn>2014-07-07 20:06:44 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-07-07 20:07:11 -0400</pav:lastSavedOn>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotation:FF6D01F6-B808-41BB-B1F6-7FD3A539C85E</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:633D2E0F-780A-4E6C-BA61-79419C3284D5"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F8BBB30D-F0CB-417D-9159-5C527A334E06">
    <pav:createdOn>2014-07-08 09:31:58 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-139.txt.html</ao:hasSource>
    <ao:exact>ketoconazole </ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:F8BBB30D-F0CB-417D-9159-5C527A334E06"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix> with either </ao:prefix>
    <domeo:uuid>F8BBB30D-F0CB-417D-9159-5C527A334E06</domeo:uuid>
    <ao:suffix>or erythromycin led to increased plasma concentrations of fexofenadine in healthy adult subjects. Fexofenadine had no effect on the pharmacokinetics of either erythromycin or ketoconazole. In two separate studies in healthy adult subjects, fexofenadine h</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/B68D0CDC-632E-4907-A731-70041A95EBBA">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/35636</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>risperidone</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:894B3EA8-D95B-418B-89A2-DB5D9F3AC0D5">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:894B3EA8-D95B-418B-89A2-DB5D9F3AC0D5"/>
    <ao:prefix>or </ao:prefix>
    <ao:exact>erythromycin </ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-08 09:31:59 -0400</pav:createdOn>
    <domeo:uuid>894B3EA8-D95B-418B-89A2-DB5D9F3AC0D5</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-139.txt.html</ao:hasSource>
    <ao:suffix>led to increased plasma concentrations of fexofenadine in healthy adult subjects. Fexofenadine had no effect on the pharmacokinetics of either erythromycin or ketoconazole. In two separate studies in healthy adult subjects, fexofenadine hydrochloride 120</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E454987A-BDD5-4CA4-A48D-D2934210F971">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>Synercid </ao:exact>
    <ao:prefix>Concomitant administration of </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:E454987A-BDD5-4CA4-A48D-D2934210F971"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-118.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-07 20:39:51 -0400</pav:createdOn>
    <ao:suffix>and nifedipine (repeated oral doses) and midazolam (intravenous bolus dose) in healthy volunteers led to elevated plasma concentrations of these drugs. The Cmax increased by 18% and 14% (median values) and the AUC increased by 44% and 33% for nifedipine </ao:suffix>
    <domeo:uuid>E454987A-BDD5-4CA4-A48D-D2934210F971</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:84ACDBE0-2E65-4F1C-A747-BD018A0A7A71">
    <ao:exact>propranolol </ao:exact>
    <domeo:uuid>84ACDBE0-2E65-4F1C-A747-BD018A0A7A71</domeo:uuid>
    <pav:createdOn>2014-07-08 09:21:17 -0400</pav:createdOn>
    <ao:suffix>at doses greater than or equal to 160 mg/day resulted in increased thioridazine plasma concentrations ranging from 55% to 369% and increased thioridazine metabolite (mesoridazine) concentrations ranging from 33% to 209%.</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:84ACDBE0-2E65-4F1C-A747-BD018A0A7A71"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-133.txt.html</ao:hasSource>
    <ao:prefix>Co-administration of long-acting </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:76E8E56C-9AAD-4A5A-879F-46EAAD1DF56E">
    <domeo:uuid>76E8E56C-9AAD-4A5A-879F-46EAAD1DF56E</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:76E8E56C-9AAD-4A5A-879F-46EAAD1DF56E"/>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:exact>Gemfibrozil</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-08 08:45:50 -0400</pav:createdOn>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:90121D3A-A478-4599-82CB-F5DD81CBFBDE">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-6.txt.html</ao:hasSource>
    <ao:exact>ODV</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:90121D3A-A478-4599-82CB-F5DD81CBFBDE"/>
    <domeo:uuid>90121D3A-A478-4599-82CB-F5DD81CBFBDE</domeo:uuid>
    <pav:createdOn>2014-07-21 10:00:56 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>, and other minor metabolites. In vitro studies indicate that the formation of </ao:prefix>
    <ao:suffix> is catalyzed by CYP2D6; this has been confirmed in a clinical study showing that patients with low CYP2D6 levels ("poor metabolizers") had increased levels of </ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:015D5A24-BF53-471A-BE49-003F94EB1552">
    <ao:exact>Cimetidine reduced the clearance and volume of distribution of meperidine and also the formation of the metabolite, normeperidine, in healthy subjects and thus, caution should be used with concomitant administration.</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:015D5A24-BF53-471A-BE49-003F94EB1552"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-164.txt.html</ao:hasSource>
    <ao:prefix>xsd:String</ao:prefix>
    <pav:createdOn>2014-07-08 12:10:40 -0400</pav:createdOn>
    <domeo:uuid>015D5A24-BF53-471A-BE49-003F94EB1552</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>xsd:String</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:9ADDA684-1D80-4FB0-AACD-815525325B37">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/2EB5BFD8-91D0-4960-AB12-6CA32636AEE3"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/A3AA3D34-8E43-4492-8637-CCA7838E6BCB"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7E72F842-35CE-4CEB-A2D4-8D5B03DB4C8A">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:7E72F842-35CE-4CEB-A2D4-8D5B03DB4C8A"/>
    <ao:exact>Verapamil does not affect the pharmacokinetics of propranolol</ao:exact>
    <ao:prefix>xsd:String</ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-08 09:00:24 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-127.txt.html</ao:hasSource>
    <domeo:uuid>7E72F842-35CE-4CEB-A2D4-8D5B03DB4C8A</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:8477A386-415F-4AE0-883E-F937CC36A7A3">
    <ao:prefix>xsd:String</ao:prefix>
    <pav:createdOn>2014-07-07 20:44:08 -0400</pav:createdOn>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:8477A386-415F-4AE0-883E-F937CC36A7A3"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>Concomitant administration of Synercid and nifedipine (repeated oral doses) and midazolam (intravenous bolus dose) in healthy volunteers led to elevated plasma concentrations of these drugs. The Cmax increased by 18% and 14% (median values) and the AUC increased by 44% and 33% for nifedipine and midazolam, respectively</ao:exact>
    <domeo:uuid>8477A386-415F-4AE0-883E-F937CC36A7A3</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-118.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7C35B213-1F60-4449-B8A4-D340FDD66F1E">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-07-07 20:45:54 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-07-07 20:46:25 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotation:9108F3D0-1FBE-489E-81B2-58869A4792FA</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoclient:uuid:E08D4CED-BE06-4A5F-A2AF-BFBC25BA8AE4</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:7DECDAF5-0D11-4B62-8E1A-BAB596ADEB98"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A53D0229-93AB-4F53-A1CC-AA722907E689">
    <pav:lastSavedOn>2014-07-07 20:21:40 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdOn>2014-07-07 20:18:53 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotation:B1209E84-D207-4540-B292-5883F58FE8E5</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:70F265B2-12F9-4BC7-907F-CA98D66A89F8"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:CE45A5D4-BD84-4E02-AC7B-C9E12233EC3A</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/5EA05A06-BCD5-4338-8FF9-7C01CFDC9D99">
    <rdfs:label>propafenone</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/8754</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:1086D8AE-9571-4279-BF24-48DE0417DC58">
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:FE61C61D-3EF7-4905-B0BB-DC49246A5C29"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:e0172491-3cfc-4bff-ad5e-35ccc1fe20c4">
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:681FEB9B-2D56-48DF-9FEF-30ED029A67B1</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:50caf9c4-484d-4ebb-b80f-3b6c0ebb4090</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:F386BE12-0116-489D-AD53-AFB673B02FE7"/>
    <pav:createdOn>2014-07-07 08:02:55 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-07-21 10:09:44 -0400</pav:lastSavedOn>
    <ao:body rdf:nodeID="N1e21821254e04efd966f5a7bda5503f9"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D6D9407F-3933-43EF-A893-996C0C7E9221">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:D6D9407F-3933-43EF-A893-996C0C7E9221"/>
    <domeo:uuid>D6D9407F-3933-43EF-A893-996C0C7E9221</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-08 09:12:44 -0400</pav:createdOn>
    <ao:prefix>Co-administration of </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-130.txt.html</ao:hasSource>
    <ao:exact>metoclopramide </ao:exact>
    <ao:suffix>with the long-acting propranolol did not have a significant effect on propranolol’s pharmacokinetics.</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B93C6BA7-9F30-4002-A557-1C9C46C308F7">
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdOn>2014-07-07 19:46:42 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotationset:1DED06A6-8562-4CCF-A58C-CA25748FBD31</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-07-07 19:50:36 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5ABD9862-F044-4404-AD04-73DA04ADDA8B</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:C9FCC72A-F1EC-478F-B94F-5EFF2CA1E33B"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:CCFE1C13-B2A8-4E11-91F5-9E9AC9A08608">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5ABD9862-F044-4404-AD04-73DA04ADDA8B</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:B5431951-FA35-4BD7-9027-C69F56975D5D"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:lastSavedOn>2014-07-07 19:50:36 -0400</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotationset:1DED06A6-8562-4CCF-A58C-CA25748FBD31</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdOn>2014-07-07 19:47:21 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:B7E0294C-F193-4CB1-8AB8-83C562AD21DC">
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:F406802A-8A0C-434F-AE23-CB449ABB6F23"/>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/7F4AF0FC-C024-4D2F-BBED-D534227D90D4">
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/3155</dailymed:activeMoietyRxCUI>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>desmethyldiazepam</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/CC251E12-645E-4DAF-9284-02CE70210D23">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/8183</dailymed:activeMoietyRxCUI>
    <rdfs:label>phenytoin</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C3C90736-8577-44AC-A28B-2C4F3547DF63">
    <ao:exact> The exposure to quinidine was not importantly changed in the presence of nifedipine.</ao:exact>
    <ao:prefix> The heart rate in the initial interval after drug administration was increased by up to 17.9 beats/minute.</ao:prefix>
    <pav:createdOn>2014-07-08 15:58:02 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:C3C90736-8577-44AC-A28B-2C4F3547DF63"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix> Monitoring of heart rate and adjustment of the</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-108.txt.html</ao:hasSource>
    <domeo:uuid>C3C90736-8577-44AC-A28B-2C4F3547DF63</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/5745BEC0-963C-402D-A4E8-FA2EC4385EF6">
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>paroxetine</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/32937</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:619CBD1A-8FB3-4551-AFD5-9908F5020D1B">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:619CBD1A-8FB3-4551-AFD5-9908F5020D1B"/>
    <ao:exact>The effect of fluvoxamine (25 mg b.i.d. for one week) on thioridazine steady-state concentration was evaluated in ten male inpatients with schizophrenia. Concentrations of thioridazine and its two active metabolites, mesoridazine and sulforidazine, increased 3-fold following coadministration of fluvoxamine. Fluvoxamine and thioridazine should not be coadministered</ao:exact>
    <domeo:uuid>619CBD1A-8FB3-4551-AFD5-9908F5020D1B</domeo:uuid>
    <pav:createdOn>2014-07-08 19:43:49 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-38.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:CE45A5D4-BD84-4E02-AC7B-C9E12233EC3A">
    <ao:item rdf:resource="urn:domeoclient:uuid:AF6B9F95-6740-4A37-88A8-917C5CE4F19E"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:8DD896DF-7FBD-4E79-9415-D948A381C673"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:593C4E07-8641-4432-8F40-A2A764150D7C"/>
    <pav:createdOn>2014-07-07 20:18:51 -0400</pav:createdOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:A619E03D-B353-436C-B34F-AA16F0D5282C"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:F4DEE747-44B2-415E-9E6F-F3F338479E38"/>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <permissions:permissions rdf:nodeID="Na08af156a1d944e6956d8cbb92973526"/>
    <pav:lineageUri>urn:domeoserver:annotationset:3118C8D9-B776-4AB9-958B-96985D0255A9</pav:lineageUri>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-28.txt.html</ao:annotatesResource>
    <pav:lastSavedOn>2014-07-07 20:21:40 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <ao:item rdf:resource="urn:domeoclient:uuid:C84CAD3E-40CD-44F4-950E-576290E3D6C4"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812e52b20002"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:A53D0229-93AB-4F53-A1CC-AA722907E689"/>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <ao:item rdf:resource="urn:domeoclient:uuid:BEAF542C-A1B3-43E5-B015-1C4102CECFD7"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:02C166B8-5A74-4505-97D6-FF5E4E01C52A"/>
    <domeo:deleted>false</domeo:deleted>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Default Set</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:2C652B3B-EC12-46BC-9363-CD63A2499ACD">
    <pav:lineageUri>urn:domeoserver:annotation:B0BE86C8-52E9-4FCE-B62A-81985F52E03A</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:61AFB096-D032-4484-98D0-1E1435D6BA6C"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdOn>2014-07-08 12:28:18 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:lastSavedOn>2014-07-08 12:29:01 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoclient:uuid:6B178133-9B11-445F-A5BB-EF967EA53386</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:29FCBA5D-B9E2-4B61-A0D1-201E0003999F">
    <ao:body rdf:nodeID="N3c25829d115a42e6b9f5bf63641d69b4"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:015D5A24-BF53-471A-BE49-003F94EB1552"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotationset:701D90A9-2BA7-4D65-A3A7-505A77C8FE71</pav:lineageUri>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:BA8F9408-39CC-4619-AA2D-75BA5518E56A</domeo:belongsToSet>
    <pav:createdOn>2014-07-08 12:10:40 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-07-08 12:10:41 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:AE8C7255-F2EA-4BC2-9930-11E8E9637DA1">
    <domeo:uuid>AE8C7255-F2EA-4BC2-9930-11E8E9637DA1</domeo:uuid>
    <ao:suffix>and also the formation of the metabolite, normeperidine, in healthy subjects and thus, caution should be used with concomitant administration.</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:AE8C7255-F2EA-4BC2-9930-11E8E9637DA1"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-08 12:10:19 -0400</pav:createdOn>
    <ao:prefix>reduced the clearance and volume of distribution of </ao:prefix>
    <ao:exact>meperidine </ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-164.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:2CAD8348-0228-4994-BBA4-56ABFD115ABA">
    <pav:lastSavedOn>2014-07-08 09:27:36 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2014-07-08 09:25:23 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotation:C9BE0457-045E-4863-A07D-73FF783A67ED</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoclient:uuid:7E425E73-12D2-4B08-9D70-75410DE87447</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:C5008EE9-521F-4EEA-93D7-45CB50B81E97"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:EEB964D6-E299-4CC6-9980-96352ECB3A5E">
    <ao:suffix>xsd:String</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:EEB964D6-E299-4CC6-9980-96352ECB3A5E"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:exact>The metabolism of propranolol is reduced by co-administration of quinidine, leading to a two-three fold increased blood concentration and greater degrees of clinical beta-blockade.</ao:exact>
    <pav:createdOn>2014-07-08 08:57:13 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-125.txt.html</ao:hasSource>
    <domeo:uuid>EEB964D6-E299-4CC6-9980-96352ECB3A5E</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/FB5D8B58-E9B0-4F9F-B0F6-C2F3C5C50455">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/8754</dailymed:activeMoietyRxCUI>
    <rdfs:label>propafenone</rdfs:label>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:E7CA2C0E-E8F6-4E24-AD53-4E4D701715AD">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/40617CEE-F38C-43AD-9163-82281743D868"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/B676822C-14C1-443E-9666-2159275DC046"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:FD63354B-6615-453C-8145-6C8E2C0841EF">
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotation:8AE6D1F5-C403-45E3-9D4B-44D9EE478B05</pav:lineageUri>
    <pav:createdOn>2014-07-08 12:24:43 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:FC00AF1F-FFB0-4DE4-9A24-C9F2FC666B98"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:lastSavedOn>2014-07-08 12:25:30 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoclient:uuid:D9F8F6A3-1C3D-4E25-9870-A403388D2394</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:61F7D186-E350-44AC-A3F2-F9FBDA3C1764">
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:7F129B4B-B024-45DF-AF73-131C4BA12EAB"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A5E637EF-5CA5-4AAC-BD8B-C136A86E17B7</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-07-07 09:41:29 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotationset:F37BE993-E972-47AE-896D-FF4D33157ECF</pav:lineageUri>
    <pav:lastSavedOn>2014-07-07 09:44:18 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:17F54F78-521F-4253-8066-6179D4917E00">
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:7EC09D50-4E84-47E5-9959-BBF2701873AB"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:lastSavedOn>2014-07-07 20:44:32 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotation:4A7FB85C-7AC0-4D8F-A564-AA1CB1E099D8</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-07-07 20:39:54 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoclient:uuid:F2EFEF06-B779-484C-B854-043086EB0C5C</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/15579BF0-688E-4BD6-A314-9E23151F9DD3">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/1294548</dailymed:activeMoietyRxCUI>
    <rdfs:label>conivaptan hydrochloride</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/8AE291B8-ECE2-46D1-AD69-E23C7E415BCC">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>midazolam</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/6960</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:5F8045C8-5AD4-45EF-AD66-B283A265353D">
    <pav:createdOn>2014-07-08 09:32:32 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoclient:uuid:423352B3-8ABA-48B7-98CF-B191A7BFC955</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotation:F904CB71-9DAB-4B94-B837-19BD3341CB8D</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:lastSavedOn>2014-07-08 09:35:29 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:E3CCD1DD-6135-4FC9-96D3-8EE39DBD3A70"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:9B0E5A58-4948-43CE-8D14-EEFE932458AA">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:9B0E5A58-4948-43CE-8D14-EEFE932458AA"/>
    <ao:exact>Repeated oral doses of risperidone (3 mg twice daily) did not affect the exposure (AUC) or peak plasma concentrations (Cmax) of lithium (N=13)</ao:exact>
    <ao:suffix>xsd:String</ao:suffix>
    <domeo:uuid>9B0E5A58-4948-43CE-8D14-EEFE932458AA</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-7.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-08 15:47:13 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N4c155d40d11a44fbb962ddfc7d3b3af9">
    <permissions:isLocked>false</permissions:isLocked>
    <permissions:accessType>urn:person:uuid:080e143046812afe0146812e52b20002</permissions:accessType>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoserver:annotationset:C2CFDC7A-D407-48FD-81AA-DFCEA656C0BE">
    <pav:lastSavedOn>2014-07-08 14:40:40 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">3</pav:versionNumber>
    <rdfs:label>NER Sets</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <ao:item rdf:resource="urn:domeoclient:uuid:1D708CB9-77F7-4855-8BE7-ADFFD605B190"/>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812e52b20002"/>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-190.txt.html</ao:annotatesResource>
    <ao:item rdf:resource="urn:domeoclient:uuid:B1A1E1B5-B433-4F1E-9163-D3CA4290CAE8"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:CA350370-39D0-4795-8E06-297CBD95A542"/>
    <domeo:deleted>false</domeo:deleted>
    <dct:description>The NER set is created automatically by NER annotation loading program.</dct:description>
    <pav:previousVersion>urn:domeoclient:uuid:ec0bdfaa-ae14-44ab-a924-c1f792e4970c</pav:previousVersion>
    <ao:item rdf:resource="file:///home/yin2/python-SPL-connector/6d2dbaa6-b88b-48e3-b370-03755b3314bc"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:EAEE7E8B-FF76-4E91-ACE4-5F9CDED0BE04"/>
    <pav:createdOn>2014-07-07 08:06:36 -0400</pav:createdOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:07BF8C39-D9C6-446D-9F23-C06F132088A4"/>
    <permissions:permissions rdf:nodeID="Nca36b37233f844bcb0147ecec44858fa"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotationset:a53fd137-a94f-4129-a486-d01a63449dec</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:AFEFD3AD-1966-407E-976D-386025B0CE8D">
    <domeo:belongsToSet>urn:domeoclient:uuid:C0CE4AC7-F72D-4A94-BD3E-4720F127B810</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-08 09:22:07 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:74D8AFB7-D947-414D-9128-32F176727620"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotation:BA887445-ADEB-4A00-AA9D-142A0FC33A94</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdOn>2014-07-08 09:21:20 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:EE0AF78A-72D1-4F81-B050-E9476D92EDD7">
    <pav:createdOn>2014-07-08 14:10:30 -0400</pav:createdOn>
    <ao:suffix> However, concomitant use of</ao:suffix>
    <ao:exact>No significant effects on the pharmacokinetics of propafenone or lidocaine have been seen following their concomitant use in patients.</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:EE0AF78A-72D1-4F81-B050-E9476D92EDD7"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>xsd:String</ao:prefix>
    <domeo:uuid>EE0AF78A-72D1-4F81-B050-E9476D92EDD7</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-194.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/DBE7AE9D-51F6-4790-98F3-E24A4410C8B9">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>fluconazole</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/4450</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A48848C7-4C13-47C4-9C63-54788AD8ED68">
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:69ACFA9C-E971-46A5-A2A0-41C68EB72592"/>
    <pav:createdOn>2014-07-07 09:39:22 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-07-07 09:44:18 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A5E637EF-5CA5-4AAC-BD8B-C136A86E17B7</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotationset:F37BE993-E972-47AE-896D-FF4D33157ECF</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:CEFE9AD2-4EDB-439A-9934-38F95F4E811E">
    <pav:lastSavedOn>2014-07-08 12:29:01 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:B1141C88-EFD4-4358-8CBB-BB8F5D8AECE3"/>
    <pav:createdOn>2014-07-08 12:28:27 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoclient:uuid:6B178133-9B11-445F-A5BB-EF967EA53386</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotation:4B15A7F5-3C53-4F50-9FFD-EBB44FE0925C</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E8F2D12E-3D8C-489B-866C-FC88D981FD71">
    <ao:suffix>xsd:String</ao:suffix>
    <domeo:uuid>E8F2D12E-3D8C-489B-866C-FC88D981FD71</domeo:uuid>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:E8F2D12E-3D8C-489B-866C-FC88D981FD71"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-07 11:11:22 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <ao:exact>In a study of healthy volunteers, sildenafil (100 mg) did not affect the steady-state pharmacokinetics of the HIV protease inhibitors saquinavir and ritonavir, both of which are CYP3A substrates.</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/EAAF223B-3DAD-4A1B-8640-D67514B27778">
    <rdfs:label>propafenone</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/8754</dailymed:activeMoietyRxCUI>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/1C04E62E-27D3-4E59-BCF4-B199E87D8C71">
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>azithromycin</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/18631</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F49CC39C-9867-4741-BE53-8FD0F781FF27">
    <domeo:uuid>F49CC39C-9867-4741-BE53-8FD0F781FF27</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-195.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>norpropafenone</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:F49CC39C-9867-4741-BE53-8FD0F781FF27"/>
    <ao:suffix>) which is formed by both CYP3A4 and CYP1A2. In less than 10% of patients, metabolism of </ao:suffix>
    <pav:createdOn>2014-07-08 13:54:17 -0400</pav:createdOn>
    <ao:prefix> (</ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C6FB7880-DBBE-4B26-A4E2-76D0939E308F">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>sildenafil </ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:C6FB7880-DBBE-4B26-A4E2-76D0939E308F"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix>to patients with systemic hypertension, the mean change from baseline in systolic and diastolic blood pressures was a decrease of 9.4 mmHg and 9.1 mmHg, respectively.</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <domeo:uuid>C6FB7880-DBBE-4B26-A4E2-76D0939E308F</domeo:uuid>
    <ao:prefix>After chronic dosing of 80 mg TID </ao:prefix>
    <pav:createdOn>2014-07-07 09:36:21 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:51166EA0-74CD-429C-AFAE-CE03BDFF84DB">
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:CEBD26AA-9CF9-41E1-A1B9-84D97923F68D"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/1E4E8F6A-3A48-4092-AAF6-AC5D3FAF61DE">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/39998</dailymed:activeMoietyRxCUI>
    <rdfs:label>zonisamide</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:ACDB13DF-BBDB-49E3-A225-176E6DBB207B">
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <ao:item rdf:resource="urn:domeoclient:uuid:7F318094-6E7E-48F0-B2A1-FFD6ED36D9BB"/>
    <pav:lineageUri>urn:domeoserver:annotationset:2FC113AC-1C6C-464D-9781-52596D2707AA</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:deleted>false</domeo:deleted>
    <pav:lastSavedOn>2014-07-07 20:22:41 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812e52b20002"/>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <rdfs:label>Default Set</rdfs:label>
    <permissions:permissions rdf:nodeID="N92c6456254d145ed9b16f64beebcd6e1"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:8ABB3BA6-84B3-4075-AAC2-963166B6BD0F"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:52C66958-9EEC-4D18-8497-ED1E2AE2874B"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:C78B2F13-9054-473F-9B5D-E4355D2BB359"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:2121B846-6089-4E40-A066-5AC8E257CE35"/>
    <pav:createdOn>2014-07-07 20:22:05 -0400</pav:createdOn>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-29.txt.html</ao:annotatesResource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A7A1044A-5798-4AC3-8C4C-D73C3DB57AF5">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-07-08 15:39:43 -0400</pav:createdOn>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A7033EE8-62A2-4AAF-AD21-7D4F7611919F</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotation:08F81DA2-1B74-4312-A4AE-1AEED8D10A8E</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:B6740B2E-1BA9-49F2-8EF9-E97DC128FEC5"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:body rdf:nodeID="N20f3cb9c829842ab98043ff37e16dfea"/>
    <pav:lastSavedOn>2014-07-08 15:41:14 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:ECA03730-59C3-491E-AA93-9E902289EBF6">
    <domeo:uuid>ECA03730-59C3-491E-AA93-9E902289EBF6</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:ECA03730-59C3-491E-AA93-9E902289EBF6"/>
    <pav:createdOn>2014-07-08 09:28:15 -0400</pav:createdOn>
    <ao:exact>carbamazepine </ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>induces CYP3A4. Following coadministration of </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-137.txt.html</ao:hasSource>
    <ao:suffix>400 mg/day with trazodone 100 mg to 300 mg daily, carbamazepine reduced plasma concentrations of trazodone (as well as mCPP) by 76 and 60%, respectively, compared to pre-carbamazepine values.</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/DFC77010-ACAE-46CC-A0AF-4594577A8729">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>zidovudine</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/11413</dailymed:activeMoietyRxCUI>
    <dct:description>Referred to the drug in the interaction.</dct:description>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:2B73BEE2-E8B0-497C-93BD-D085C7A765ED">
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:5550D10C-1548-447C-BE34-823232268511"/>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/FADA78F7-F25A-4A0C-ADB8-883B05FCC8C6">
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>rosiglitazone</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/84108</dailymed:activeMoietyRxCUI>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:92066FE5-1405-41B1-85CA-8A8C29A94EB7">
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-08 14:47:41 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:E3560C9E-9D75-4969-8C76-9E09CBC067AE"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:B584DAF4-7AB3-43F0-AA6F-6463A34A4831</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:F3489998-E4E2-4665-8F8C-24D26E940E63</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdOn>2014-07-08 14:47:41 -0400</pav:createdOn>
    <ao:body rdf:nodeID="N816ffd2194374767bf66e283e2865241"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:9F611555-5361-4C0E-A4A4-F71A543874F2">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2014-07-07 20:18:07 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdOn>2014-07-07 20:16:37 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:415010FA-44FA-419C-8964-E89BA87BBF93"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:3857B7A8-EDF2-4956-9CF4-A1B13773E162</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:760604A3-DEF1-48C0-98F6-853FDE0F172E</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:6881E425-4339-4018-BEDA-1111C2CBC350">
    <domeo:belongsToSet>urn:domeoclient:uuid:6FFD9FFA-5CED-4EE2-B68F-77212B4C447D</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:450E7451-5300-4833-9BED-8738A8D83B21"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotation:7DF17A02-3AFE-4ADD-AA15-E968E0D1096D</pav:lineageUri>
    <ao:body rdf:nodeID="N16fbeb976465444d8810c50e32c7d00b"/>
    <pav:lastSavedOn>2014-07-08 09:20:18 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-08 09:20:18 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:CCA45320-FC3E-4533-A916-4F4B67DB1F3C">
    <ao:suffix> is supplied for oral administration as scored tablets containing sertraline hydrochloride equivalent to 25, 50, 100, 150 and 200 mg of sertraline and the following inactive ingredients: dibasic calcium phosphate dihydrate, hydroxypropyl cellulose, hypro</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:CCA45320-FC3E-4533-A916-4F4B67DB1F3C"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>xsd:String</ao:prefix>
    <pav:createdOn>2014-07-07 19:59:48 -0400</pav:createdOn>
    <ao:exact>Sertraline hydrochloride</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-20.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>CCA45320-FC3E-4533-A916-4F4B67DB1F3C</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/A37E3538-05E4-4038-A1A4-D26BD899F8A0">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>rosiglitazone</rdfs:label>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/84108</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B46A4A55-C807-49A7-A9A2-D2F68349C0C3">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:B46A4A55-C807-49A7-A9A2-D2F68349C0C3"/>
    <ao:suffix>xsd:String</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-56.txt.html</ao:hasSource>
    <ao:exact>Zonisamide had no appreciable effect on the steady-state plasma concentrations of phenytoin, carbamazepine, or valproate during clinical trials. Zonisamide did not inhibit mixed-function liver oxidase enzymes (cytochrome P450), as measured in human liver microsomal preparations, in vitro. Zonisamide is not expected to interfere with the metabolism of other drugs that are metabolized by cytochrome P450 isozymes.</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>B46A4A55-C807-49A7-A9A2-D2F68349C0C3</domeo:uuid>
    <ao:prefix>xsd:String</ao:prefix>
    <pav:createdOn>2014-07-07 20:33:43 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/C0825640-E0E2-4D2F-B013-A6305C0932F0">
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/9068</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>quinidine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nb6c1c4213e2a4e4e8e1a9c21c52587db">
    <permissions:accessType>urn:person:uuid:080e143046812afe0146812e52b20002</permissions:accessType>
    <permissions:isLocked>false</permissions:isLocked>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:92b5f083-f97c-4445-8f21-6b9f6e7fc3f9">
    <ao:exact>nifedipine</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:92b5f083-f97c-4445-8f21-6b9f6e7fc3f9"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix> had no effect on irbesartan p</ao:suffix>
    <pav:createdOn>2014-07-07 08:06:39 -0400</pav:createdOn>
    <domeo:uuid></domeo:uuid>
    <ao:prefix>linical studies, concomitant </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-110.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/0A8DF056-7E31-4E84-A5BD-033D5164416E">
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/4053</dailymed:activeMoietyRxCUI>
    <rdfs:label>erythromycin</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B10D9255-1757-4789-B2A6-45B024A9EA97">
    <ao:exact>theophylline </ao:exact>
    <ao:suffix>AUC increased 21% ± 16% (range: -5 to 48%). The Cmax increased 13% ± 17% (range: -13 to 40%). Theophylline clearance decreased 16% ± 11 % (range: -32 to 5%). The half-life of theophylline increased from 6.6 ± 1.7 hours to 7.9 ± 1.5 hours. (See PRECAUTION</ao:suffix>
    <pav:createdOn>2014-07-07 20:18:59 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>B10D9255-1757-4789-B2A6-45B024A9EA97</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:B10D9255-1757-4789-B2A6-45B024A9EA97"/>
    <ao:prefix>AUC, Cmax, and half-life with a corresponding decrease in clearance. The mean ± SD </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-28.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:2D515E32-15EF-4D9F-A77C-90EEB262FE6A">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:2D515E32-15EF-4D9F-A77C-90EEB262FE6A"/>
    <ao:suffix>.</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-07 09:43:53 -0400</pav:createdOn>
    <domeo:uuid>2D515E32-15EF-4D9F-A77C-90EEB262FE6A</domeo:uuid>
    <ao:exact>sildenafil</ao:exact>
    <ao:prefix>. The combination of both drugs did not lead to clinically significant changes in blood pressure (supine or standing). Concomitant administration of potent CYP3A inducers is expected to cause greater decreases in plasma levels of </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:1AAA6CF9-8233-42B7-A65E-599ABED7239A">
    <ao:prefix>xsd:String</ao:prefix>
    <domeo:uuid>1AAA6CF9-8233-42B7-A65E-599ABED7239A</domeo:uuid>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:exact>AVANDIA </ao:exact>
    <pav:createdOn>2014-07-08 08:43:15 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:1AAA6CF9-8233-42B7-A65E-599ABED7239A"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:04EE78DA-59FA-46D2-9ABF-847B5F283918">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:470EC20A-1CAB-484C-BCAC-85674D6119F7"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:previousVersion>urn:domeoclient:uuid:e75c9d7b-f906-4c66-8a84-e6eef34d0954</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-08 14:24:44 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotationset:0f67c012-7596-4b02-a927-63c0ccbc3afa</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:createdOn>2014-07-08 14:20:00 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:42258B16-6749-4B39-B28D-88C8B63F7A43</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">3</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D5F1D8D1-230B-4686-8A52-6BE91F89A5CB">
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotation:FE4E82B5-7F0E-45E5-BCDA-823468FAD103</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:AFED3911-9323-4C42-AC39-E1CB44107AE7"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2014-07-08 09:30:36 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoclient:uuid:423352B3-8ABA-48B7-98CF-B191A7BFC955</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-08 09:35:29 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:DC3FD236-F1CF-4BDE-A027-FFB3BB8CC69C">
    <ao:exact>Cimetidine and ranitidine increased the bioavailability of risperidone by 64% and 26%, respectively</ao:exact>
    <domeo:uuid>DC3FD236-F1CF-4BDE-A027-FFB3BB8CC69C</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:DC3FD236-F1CF-4BDE-A027-FFB3BB8CC69C"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>xsd:String</ao:prefix>
    <pav:createdOn>2014-07-08 15:43:42 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-7.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>. However,</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7C133996-DAAF-4D29-88DA-98631B0B3BB8">
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A5E637EF-5CA5-4AAC-BD8B-C136A86E17B7</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotationset:F37BE993-E972-47AE-896D-FF4D33157ECF</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-07 09:44:18 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:423B15D4-DC1C-4348-9BB3-85233ACCD457"/>
    <pav:createdOn>2014-07-07 09:42:35 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:DCDE5E75-6026-4866-87C6-43FEF0091162">
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotationset:1DED06A6-8562-4CCF-A58C-CA25748FBD31</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:E8EC66C6-270E-4A0B-8EFF-F6E14DB619E4"/>
    <pav:createdOn>2014-07-07 19:48:41 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-07-07 19:50:36 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5ABD9862-F044-4404-AD04-73DA04ADDA8B</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:80394A58-E8DC-4096-B0CF-6FA1584FF51D">
    <ao:prefix>, but also to </ao:prefix>
    <domeo:uuid>80394A58-E8DC-4096-B0CF-6FA1584FF51D</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-6.txt.html</ao:hasSource>
    <ao:suffix>, N,O-didesmethylvenlafaxine, and other minor metabolites. In vitro studies indicate that the formation of ODV is catalyzed by CYP2D6; this has been confirmed in a clinical study showing that patients with low CYP2D6 levels ("poor metabolizers") had incr</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:80394A58-E8DC-4096-B0CF-6FA1584FF51D"/>
    <pav:createdOn>2014-07-21 10:00:50 -0400</pav:createdOn>
    <ao:exact>N-desmethylvenlafaxine</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:CEFEAC9B-2F87-4A0C-818F-348955395F23">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>CEFEAC9B-2F87-4A0C-818F-348955395F23</domeo:uuid>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:CEFEAC9B-2F87-4A0C-818F-348955395F23"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-07 20:47:53 -0400</pav:createdOn>
    <ao:exact>Metronidazole has been reported to potentiate the anticoagulant effect of warfarin and other oral coumarin anticoagulants, resulting in a prolongation of prothrombin time. This possible drug interaction should be considered when FLAGYL (metronidazole) is prescribed for patients on this type of anticoagulant therapy</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-120.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N0c9b20489806461aa5e9b055c69c1fa2">
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
    <permissions:isLocked>false</permissions:isLocked>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:6BD55200-00BD-42E2-9C53-8DD2867F80DC">
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:60B2F624-82F3-4850-A07E-C14BE5C50B7D"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:C7464E88-A023-4DF0-9F65-40825A35F919">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/1C04E62E-27D3-4E59-BCF4-B199E87D8C71"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/FEFF941F-51C6-4218-A0D7-EEE4AF29B30E"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoserver:annotationset:930FE356-9730-4335-9929-D854A7CE2092">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <pav:createdOn>2014-07-07 08:06:55 -0400</pav:createdOn>
    <pav:previousVersion>urn:domeoclient:uuid:2831fb76-ef13-48e9-a40a-9089315d136a</pav:previousVersion>
    <ao:item rdf:resource="urn:domeoclient:uuid:BC8DFC77-19FE-42F8-93A9-FBB9DEE32C41"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:0F98760D-1183-41B4-9BFC-7410F6D25503"/>
    <rdfs:label>NER Sets</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <permissions:permissions rdf:nodeID="Nac2643dd578d4eb8901fdaf355e735bf"/>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-108.txt.html</ao:annotatesResource>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">3</pav:versionNumber>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <pav:lineageUri>urn:domeoserver:annotationset:ae7139a4-efa1-41da-97f5-562a9e551f1d</pav:lineageUri>
    <pav:lastSavedOn>2014-07-08 15:58:01 -0400</pav:lastSavedOn>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812e52b20002"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <dct:description>The NER set is created automatically by NER annotation loading program.</dct:description>
    <domeo:deleted>false</domeo:deleted>
    <ao:item rdf:resource="file:///home/yin2/python-SPL-connector/f4612399-d05c-4616-80ca-a71b1b7ca43e"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:BCC9EB2F-25E7-44FF-83F2-904B4F4819EC">
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812e52b20002"/>
    <rdfs:label>Default Set</rdfs:label>
    <ao:item rdf:resource="urn:domeoclient:uuid:2E2A04B6-D35B-4539-A6D7-FDA17AD8C196"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <ao:item rdf:resource="urn:domeoclient:uuid:DB57EF22-CD62-4A86-80A0-79B1F2AD9319"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <pav:createdOn>2014-07-08 09:28:14 -0400</pav:createdOn>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-137.txt.html</ao:annotatesResource>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <permissions:permissions rdf:nodeID="N9b212d98657842029f425b2b4bcf4e22"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:deleted>false</domeo:deleted>
    <pav:lastSavedOn>2014-07-08 09:28:41 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:item rdf:resource="urn:domeoclient:uuid:B238DEAE-5735-47B7-B2B9-C89091DFDDAA"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:5E82EA3B-FCBE-4273-A007-E3672C43D525"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:EA8D1AB0-084B-4213-A2B6-1945772CCA25"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotationset:6DBF345E-E15C-4CBC-9DAC-608BC32D3286</pav:lineageUri>
    <ao:item rdf:resource="urn:domeoclient:uuid:DCE4E80E-B2DD-4A92-854A-C154970AB4EA"/>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoserver:annotationset:A47D6F17-8EA5-4B0F-865B-11F52CA654C7">
    <pav:lineageUri>urn:domeoclient:uuid:eb9f5433-eecf-4fef-8b65-07b0202b5674</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <permissions:permissions rdf:nodeID="Nab6d7fbc121a4d21b2c611f3f8cac413"/>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <domeo:deleted>false</domeo:deleted>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:1d1ec785-9a2d-4f94-91f7-b2fd4938a609"/>
    <pav:lastSavedOn>2014-07-21 10:11:48 -0400</pav:lastSavedOn>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-15.txt.html</ao:annotatesResource>
    <rdfs:label>NLP Set</rdfs:label>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812e52b20002"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <pav:createdOn>2014-07-07 08:02:28 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:previousVersion>urn:domeoclient:uuid:a31de315-757b-478f-af94-ff103e83505d</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/385EB5E0-1B0B-45AA-8E02-9A80114BBC16">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/drug-product"/>
    <rdfs:label>vaprisol</rdfs:label>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/5B2AFCE3-904C-4C03-865C-A3CA1AC1EA68">
    <rdfs:label>cimetidine</rdfs:label>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/2541</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F9FFF331-4555-417B-A31B-B9FD56920E60">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-07-07 09:40:04 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotationset:F37BE993-E972-47AE-896D-FF4D33157ECF</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2014-07-07 09:44:18 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A5E637EF-5CA5-4AAC-BD8B-C136A86E17B7</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:F0458405-B95E-4B40-9826-2980D5D136E9"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:AFC6F324-041F-49E5-95F8-8106928974F3">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">3</pav:versionNumber>
    <pav:previousVersion>urn:domeoclient:uuid:203110ef-d319-4c8c-8da1-19d68e91f895</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7E49EB7A-DE0E-4720-82D1-8460BA0C770D</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-08 13:59:58 -0400</pav:lastSavedOn>
    <ao:body rdf:nodeID="Na925a6d6098d4ad4a413f38199be1565"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:DFAAB2F1-188D-4D4B-8AEC-6A3AF9A0725E"/>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:lineageUri>urn:domeoserver:annotationset:def720a3-9364-4d0d-a156-423274fb2386</pav:lineageUri>
    <pav:createdOn>2014-07-08 13:59:58 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/F80C79CE-7884-4960-BFF4-EECCB3DF9C3D">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>metoclopramide</rdfs:label>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/6915</dailymed:activeMoietyRxCUI>
    <dct:description>Referred to the drug in the interaction.</dct:description>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:3E5B6F57-ECEC-478D-9EBF-025B19048464">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:3E5B6F57-ECEC-478D-9EBF-025B19048464"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>sildenafil </ao:exact>
    <ao:suffix>pharmacokinetics in patients with PAH.</ao:suffix>
    <ao:prefix> in patients with PAH. The dataset available for the population pharmacokinetic evaluation contained a wide range of demographic data and laboratory parameters associated with hepatic and renal function. None of these factors had a significant impact on </ao:prefix>
    <pav:createdOn>2014-07-07 09:38:08 -0400</pav:createdOn>
    <domeo:uuid>3E5B6F57-ECEC-478D-9EBF-025B19048464</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:16F49A5A-3441-4B3B-B195-F94C7D0708EC">
    <pav:createdOn>2014-07-08 08:59:06 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-127.txt.html</ao:hasSource>
    <domeo:uuid>16F49A5A-3441-4B3B-B195-F94C7D0708EC</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:16F49A5A-3441-4B3B-B195-F94C7D0708EC"/>
    <ao:suffix>and norverapamil. Verapamil does not affect the pharmacokinetics of propranolol.</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>does not affect the pharmacokinetics of </ao:prefix>
    <ao:exact>verapamil </ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:8f8d748e-69b8-427e-98ce-8ad83e6339df">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-81.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-07 08:07:00 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:8f8d748e-69b8-427e-98ce-8ad83e6339df"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>locker metoprolol. Increased </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix> plasma levels have been assoc</ao:suffix>
    <ao:exact>metoprolol</ao:exact>
    <domeo:uuid></domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/82149602-CB19-488F-AB4D-5DB7465DFE9C">
    <rdfs:label>propafenone</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/8754</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D386F873-0ADA-4CA7-BF06-CA1FF9673B34">
    <pav:createdOn>2014-07-21 09:59:07 -0400</pav:createdOn>
    <ao:prefix> and </ao:prefix>
    <domeo:uuid>D386F873-0ADA-4CA7-BF06-CA1FF9673B34</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:D386F873-0ADA-4CA7-BF06-CA1FF9673B34"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>ODV</ao:exact>
    <ao:suffix> are minimally bound at therapeutic concentrations to plasma proteins (27% and 30%, respectively).</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-6.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/00C15DAE-759C-4B42-ABD0-2C1FDB5AAD8D">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>risperidone</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/35636</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/2A91DFDD-1E15-471E-90AC-E705C49E07AF">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>diazepam</rdfs:label>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/3322</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D7BA4EF5-2D70-4B7B-A774-E3ADF8397E7D">
    <ao:prefix>therapy. Repeat doses of </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:D7BA4EF5-2D70-4B7B-A774-E3ADF8397E7D"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>D7BA4EF5-2D70-4B7B-A774-E3ADF8397E7D</domeo:uuid>
    <ao:exact>AVANDIA </ao:exact>
    <pav:createdOn>2014-07-08 08:48:06 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix> (8 mg once daily) for 8 days in healthy adult Caucasian subjects caused a decrease in glyburide AUC and Cmax of approximately 30%. In Japanese subjects, glyburide AUC and Cmax slightly increased following coadministration of AVANDIA.</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:AA4CD511-5DB6-4C87-B4A7-2867E9097700">
    <domeo:belongsToSet>urn:domeoserver:annotationset:23515E27-98AC-4DC9-A4B7-EBFE2991219F</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotationset:57174A7C-3100-4C8F-9C4A-2991CEE124D5</pav:lineageUri>
    <ao:body rdf:nodeID="N912f6bbbd244421eb0fb70ae43060232"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:5D92AFF4-E8B2-4D61-BDF8-7BF6DDA84330"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:lastSavedOn>2014-07-08 08:46:38 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-08 08:46:35 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:64405421-2608-4CFF-B9B7-24BEF8D08CD1">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:179EC496-B79D-4BB5-9503-8E3A9D0133FB"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:createdOn>2014-07-08 08:45:09 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:23515E27-98AC-4DC9-A4B7-EBFE2991219F</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:body rdf:nodeID="N0dd4c58eaaa6421da49977ab5f3c4a58"/>
    <pav:lineageUri>urn:domeoserver:annotationset:57174A7C-3100-4C8F-9C4A-2991CEE124D5</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-07-08 08:46:38 -0400</pav:lastSavedOn>
    <rdfs:label>expertstudy Annotation</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F875C480-C489-4D5E-8ACF-2257999879DD">
    <domeo:uuid>F875C480-C489-4D5E-8ACF-2257999879DD</domeo:uuid>
    <ao:prefix>maintenance therapy, </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:F875C480-C489-4D5E-8ACF-2257999879DD"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-08 12:28:19 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-201.txt.html</ao:hasSource>
    <ao:exact>phenytoin </ao:exact>
    <ao:suffix>administration (250 mg b.i.d. initially for 1 day followed by 300 mg QD for 3 to 4 days) resulted in an approximately 50% reduction in methadone exposure and withdrawal symptoms occurred concurrently. Upon discontinuation of phenytoin, the incidence of w</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/A325A5F6-908B-4158-9D68-0AFC3F95C7D8">
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/3407</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>digoxin</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:B8FAC4A2-6DD2-4B0B-BB1D-A40E87B33736">
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:35854C63-4A4D-4E2A-A517-034C635FEDEA"/>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:49BB1687-760C-4132-803F-8929B3CEA2D8">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:body rdf:nodeID="N065d126d033442f58138d3eee5b0857d"/>
    <pav:createdOn>2014-07-07 20:30:12 -0400</pav:createdOn>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoclient:uuid:06661B74-00AE-4DF7-A9CC-742273A11E94</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:006C0ED2-D661-42AD-8D59-EF2EF2C640AA"/>
    <pav:lineageUri>urn:domeoserver:annotation:A56E1ABE-BFE9-4E70-AE21-FFEAB96F284C</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:lastSavedOn>2014-07-07 20:30:15 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/DC5917AD-D3D2-44C0-BD0B-254C700B3EA3">
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>fluconazole</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/4450</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7EE21BFF-9BDF-4EF9-BC7C-3814AD40BC5B">
    <domeo:uuid>7EE21BFF-9BDF-4EF9-BC7C-3814AD40BC5B</domeo:uuid>
    <ao:prefix>An inhibitor of CYP2C8 (e.g., </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-122.txt.html</ao:hasSource>
    <ao:suffix>) may increase the AUC of rosiglitazone and an inducer of CYP2C8 (e.g., rifampin) may decrease the AUC of rosiglitazone. Therefore, if an inhibitor or an inducer of CYP2C8 is started or stopped during treatment with rosiglitazone, changes in diabetes tre</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:7EE21BFF-9BDF-4EF9-BC7C-3814AD40BC5B"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-07 20:49:58 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>gemfibrozil</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C799DD5F-A65F-405A-8A34-C4328849306F">
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotationset:061a21f6-0ef7-497f-bd03-574c24bc0d7c</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-08 15:44:00 -0400</pav:createdOn>
    <ao:body rdf:nodeID="Nbd2429a4f70d467cb4c0abbfcfac9130"/>
    <pav:lastSavedOn>2014-07-08 15:45:42 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">4</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5B2167F6-4E63-4A7B-85C1-ACA56DDE7073</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:78AEBBA1-68CE-48E9-B84C-23572AB7A535"/>
    <pav:previousVersion>urn:domeoserver:annotationset:6C113438-07CB-4840-A14B-360CDF3BD22A</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:79337B16-22ED-4E24-8E1B-97AAA870A411">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-195.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>The </ao:prefix>
    <ao:suffix> and norpropafenone metabolites have electrophysiologic properties similar to </ao:suffix>
    <pav:createdOn>2014-07-08 13:54:57 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:79337B16-22ED-4E24-8E1B-97AAA870A411"/>
    <ao:exact>5-hydroxypropafenone</ao:exact>
    <domeo:uuid>79337B16-22ED-4E24-8E1B-97AAA870A411</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/B2341A2E-8D14-49D7-A1C5-3AE702B50889">
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/302285</dailymed:activeMoietyRxCUI>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>conivaptan</rdfs:label>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F31B7B89-739C-4B70-9004-4813A7C9F4E9">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:894B3EA8-D95B-418B-89A2-DB5D9F3AC0D5"/>
    <pav:createdOn>2014-07-08 09:31:59 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoclient:uuid:423352B3-8ABA-48B7-98CF-B191A7BFC955</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotation:5B03056E-E423-47FE-9EA4-8FBDF37117C0</pav:lineageUri>
    <pav:lastSavedOn>2014-07-08 09:35:29 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B723CBE3-00ED-4773-B4C9-85758048822D">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:B723CBE3-00ED-4773-B4C9-85758048822D"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix> should not be taken closely in time with </ao:prefix>
    <pav:createdOn>2014-07-08 09:30:35 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-139.txt.html</ao:hasSource>
    <domeo:uuid>B723CBE3-00ED-4773-B4C9-85758048822D</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>and magnesium containing antacids. In healthy adult subjects, administration of 120 mg of fexofenadine hydrochloride (2 × 60 mg capsule) within 15 minutes of an aluminum and magnesium containing antacid (Maalox®1) decreased fexofenadine AUC by 41% and Cm</ao:suffix>
    <ao:exact>aluminum </ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/8623D3EF-4558-43BF-81E6-F4E924429C85">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>desipramine</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/3247</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/A58E6E05-F48C-444E-A120-7B578B631383">
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/679314</dailymed:activeMoietyRxCUI>
    <rdfs:label>9-hydroxyrisperidone</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/metabolite"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:CD5613AC-945E-4FC7-A565-D7E9BE8DEF19">
    <domeo:belongsToSet>urn:domeoclient:uuid:29AAB777-4FBF-49C4-ACFD-F2FC169A463D</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-07-07 20:51:02 -0400</pav:lastSavedOn>
    <ao:body rdf:nodeID="N6f7fb1e00638415193eb32ba67aee72a"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:createdOn>2014-07-07 20:50:58 -0400</pav:createdOn>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:34EF3EBF-8EEC-484A-BE29-FA1A508BCD46"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotation:DF3C9B26-C7ED-4361-935E-874232C4AEE1</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:DA088FBF-9441-4B29-B79C-9A3099F33A47">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-119.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:DA088FBF-9441-4B29-B79C-9A3099F33A47"/>
    <pav:createdOn>2014-07-07 20:45:59 -0400</pav:createdOn>
    <ao:exact>vancomycin </ao:exact>
    <ao:prefix>(1g q8h iv) in the second study (JRV 305); however, in both studies </ao:prefix>
    <domeo:uuid>DA088FBF-9441-4B29-B79C-9A3099F33A47</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix>(1g q12h iv) could be substituted for the specified comparator if the causative pathogen was suspected or confirmed methicillin-resistant staphylococcus or if the patient was allergic to penicillins, cephalosporins or carbapenems. Study JRV 304 enrolled </ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:0B540045-9C31-4FA7-A8AB-D460F0BAA941">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2014-07-08 09:00:25 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoclient:uuid:86E1DCE1-FFC6-4513-AEF9-EF158A019E6B</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:3A568E85-0F74-41C8-9FBD-C2915444AED0"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotation:101F841C-A545-41FD-BE6D-F1A5790805ED</pav:lineageUri>
    <pav:createdOn>2014-07-08 08:59:08 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:07B006D3-C156-4713-8F3B-12933069FD58">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-6.txt.html</ao:hasSource>
    <ao:prefix> and </ao:prefix>
    <ao:suffix> would be similar for the two treatments. </ao:suffix>
    <domeo:uuid>07B006D3-C156-4713-8F3B-12933069FD58</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:07B006D3-C156-4713-8F3B-12933069FD58"/>
    <pav:createdOn>2014-07-21 10:00:06 -0400</pav:createdOn>
    <ao:exact>ODV</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:585E91D0-9B2C-4600-8081-6187C738FC73">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:585E91D0-9B2C-4600-8081-6187C738FC73"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-25.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-07 20:14:29 -0400</pav:createdOn>
    <domeo:uuid>585E91D0-9B2C-4600-8081-6187C738FC73</domeo:uuid>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:suffix> (See PRECAUTIONS.</ao:suffix>
    <ao:exact>Phenytoin AUC was determined after 4 days of phenytoin dosing (200 mg daily, orally for 3 days followed by 250 mg intravenously for one dose) both with and without the administration of fluconazole (oral fluconazole 200 mg daily for 16 days) in 10 normal male volunteers. There was a significant increase in phenytoin AUC. The mean ± SD increase in phenytoin AUC was 88% ± 68% (range: 16 to 247%). The absolute magnitude of this interaction is unknown because of the intrinsically nonlinear disposition of phenytoin.</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:3E405ADF-726C-4732-9DBD-459D74270D9F">
    <ao:context rdf:resource="urn:domeoclient:uuid:59F64E10-91D1-4EB7-8B16-23D4CBDFA6A4"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoclient:uuid:4E43D844-2E5A-46D2-8797-09878034F22F</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotation:0C8615AB-6DD3-4125-B1C3-931A17DE8116</pav:lineageUri>
    <pav:lastSavedOn>2014-07-08 09:08:48 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdOn>2014-07-08 09:07:58 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:4DDB7604-39B2-403D-962F-0AAD8F6547AD">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:4DDB7604-39B2-403D-962F-0AAD8F6547AD"/>
    <ao:suffix>(100 mg single dose) resulted in a 140% increase in sildenafil Cmax and a 210% increase in sildenafil AUC.</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>4DDB7604-39B2-403D-962F-0AAD8F6547AD</domeo:uuid>
    <pav:createdOn>2014-07-07 09:42:03 -0400</pav:createdOn>
    <ao:exact>sildenafil </ao:exact>
    <ao:prefix>In a study performed in healthy volunteers, co-administration of the HIV protease inhibitor saquinavir, a CYP3A inhibitor, at steady state (1200 mg TID) with </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B6740B2E-1BA9-49F2-8EF9-E97DC128FEC5">
    <pav:createdOn>2014-07-08 15:39:43 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:B6740B2E-1BA9-49F2-8EF9-E97DC128FEC5"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-177.txt.html</ao:hasSource>
    <domeo:uuid>B6740B2E-1BA9-49F2-8EF9-E97DC128FEC5</domeo:uuid>
    <ao:exact>There is a potentially relevant interaction between diazepam and compounds which inhibit certain hepatic enzymes (particularly cytochrome P450 3A and 2C19). Data indicate that these compounds influence the pharmacokinetics of diazepam and may lead to increased and prolonged sedation. At present, this reaction is known to occur with cimetidine, ketoconazole, fluvoxamine, fluoxetine, and omeprazole</ao:exact>
    <ao:suffix>xsd:String</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:CB6F6828-0358-4241-8207-69A8687C9B37">
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:createdOn>2014-07-08 14:02:11 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:body rdf:nodeID="N389f9389a9e74edb9d373a938d70c8fb"/>
    <pav:lineageUri>urn:domeoserver:annotation:0774AFCA-FABB-4417-94ED-3A9045F9F1B3</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:9524D5E6-725D-4392-B518-A9F156431770"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7E49EB7A-DE0E-4720-82D1-8460BA0C770D</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-08 14:10:48 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:419F7D5E-2124-4BF8-8E9E-10E59820BB3F">
    <domeo:belongsToSet>urn:domeoclient:uuid:B44CD6F1-18F6-4252-9E79-5D5107E7044D</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotation:E8885A31-B3C0-40F9-B76E-6899E2CA30BE</pav:lineageUri>
    <pav:createdOn>2014-07-07 20:15:03 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:DA4E7EF4-590C-4EAD-9A7F-FF98FC7AD5ED"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-07-07 20:16:04 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:1d1ec785-9a2d-4f94-91f7-b2fd4938a609">
    <pav:lineageUri>urn:domeoserver:annotation:c3e63367-2170-48dc-a17e-3fef3797da4a</pav:lineageUri>
    <ao:body rdf:nodeID="Nb9996d9958824481aee1fbc979222b47"/>
    <pav:createdOn>2014-07-07 08:02:28 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:489511C5-BDE6-405C-A125-B8745F0FBA19"/>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:lastSavedOn>2014-07-21 10:11:48 -0400</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A47D6F17-8EA5-4B0F-865B-11F52CA654C7</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C582A2B1-BAC3-49A8-9F75-FC45877B4DE6">
    <ao:exact>fluvoxethanol</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:C582A2B1-BAC3-49A8-9F75-FC45877B4DE6"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix> were tested in an in vitro assay of </ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix> and </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-10.txt.html</ao:hasSource>
    <domeo:uuid>C582A2B1-BAC3-49A8-9F75-FC45877B4DE6</domeo:uuid>
    <pav:createdOn>2014-07-21 10:05:11 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:EA04B103-7867-4304-97CF-1235741223DF">
    <domeo:uuid>EA04B103-7867-4304-97CF-1235741223DF</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:EA04B103-7867-4304-97CF-1235741223DF"/>
    <ao:prefix>clearance when it was co-administered with CYP3A inhibitors. </ao:prefix>
    <ao:exact>Sildenafil </ao:exact>
    <ao:suffix>exposure without concomitant medication is shown to be 5-fold higher at a dose of 80 mg TID compared to its exposure at a dose of 20 mg TID. This concentration range covers the same increased sildenafil exposure observed in specifically-designed drug int</ao:suffix>
    <pav:createdOn>2014-07-07 09:41:33 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:497D456F-A9F4-418D-A6E6-8C644760649B">
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:lastSavedOn>2014-07-08 08:51:47 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2014-07-08 08:48:01 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotationset:57174A7C-3100-4C8F-9C4A-2991CEE124D5</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:23515E27-98AC-4DC9-A4B7-EBFE2991219F</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:A4C1675C-830C-42E2-AD7A-7D4C46BBDC10"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>urn:domeoclient:uuid:5BCE2FDB-C586-44CD-88F7-6EE2BDB6B929</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E0AAF781-9F53-4AB3-9C98-378CA5773E9C">
    <ao:suffix>increased from 6.6 ± 1.7 hours to 7.9 ± 1.5 hours. (See PRECAUTIONS.)</ao:suffix>
    <ao:exact>theophylline </ao:exact>
    <domeo:uuid>E0AAF781-9F53-4AB3-9C98-378CA5773E9C</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:E0AAF781-9F53-4AB3-9C98-378CA5773E9C"/>
    <pav:createdOn>2014-07-07 20:19:03 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>clearance decreased 16% ± 11 % (range: -32 to 5%). The half-life of </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-28.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:124D2456-8575-43D0-8F68-5DABA1446AF3">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">3</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotationset:0f67c012-7596-4b02-a927-63c0ccbc3afa</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:42258B16-6749-4B39-B28D-88C8B63F7A43</domeo:belongsToSet>
    <pav:previousVersion>urn:domeoclient:uuid:e75c9d7b-f906-4c66-8a84-e6eef34d0954</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-08 14:20:12 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:3DF18B22-16FE-4820-A49C-487979D41ADD"/>
    <pav:lastSavedOn>2014-07-08 14:24:44 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:773D6F85-78D5-455C-8B18-BCB2E1E1B6F8">
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotationset:1DED06A6-8562-4CCF-A58C-CA25748FBD31</pav:lineageUri>
    <pav:lastSavedOn>2014-07-07 19:50:36 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:D1E2CD3F-B149-4606-932A-7ABF131FC2DE"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-07 19:49:10 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5ABD9862-F044-4404-AD04-73DA04ADDA8B</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:48DCEB49-16E5-4D13-AA11-E59D34114D77">
    <pav:createdOn>2014-07-07 19:42:49 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5ABD9862-F044-4404-AD04-73DA04ADDA8B</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotationset:1DED06A6-8562-4CCF-A58C-CA25748FBD31</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:A8872B26-D49E-47E8-8F7B-7E0AC440B47C"/>
    <pav:lastSavedOn>2014-07-07 19:50:36 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:743B29FF-A999-476C-951A-9B2D5CC1C8D9">
    <ao:context rdf:resource="urn:domeoclient:uuid:7BC4C9B0-0C06-469D-A30C-A9E128E5C0B3"/>
    <pav:lastSavedOn>2014-07-07 09:44:18 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotationset:F37BE993-E972-47AE-896D-FF4D33157ECF</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-07 09:41:42 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A5E637EF-5CA5-4AAC-BD8B-C136A86E17B7</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:78216FA4-1765-4715-BE1A-5FC1289557F9">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>Fluconazole </ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:78216FA4-1765-4715-BE1A-5FC1289557F9"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-21.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-07 20:00:59 -0400</pav:createdOn>
    <ao:prefix>increased by 24% (95% C.I. range 18 to 31%) and 13% (95% C.I. range 8 to 18%), respectively relative to placebo. </ao:prefix>
    <ao:suffix>treatment did not cause a decrease in the ethinyl estradiol AUC of any individual subject in this study compared to placebo dosing. The individual AUC values of norethindrone decreased very slightly (&lt;5%) in 3 of the 21 subjects after fluconazole treatme</ao:suffix>
    <domeo:uuid>78216FA4-1765-4715-BE1A-5FC1289557F9</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:195820D4-650C-4B61-BC8B-E3BE7F0E7D16">
    <pav:createdOn>2014-07-07 19:58:10 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:195820D4-650C-4B61-BC8B-E3BE7F0E7D16"/>
    <ao:exact> 9-hydroxyrisperidon</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>195820D4-650C-4B61-BC8B-E3BE7F0E7D16</domeo:uuid>
    <ao:prefix>and</ao:prefix>
    <ao:suffix>e combined, after single and multiple doses, were similar in extensive and poor metabolizers, with an overall mean elimination half-life of about 20 hours.</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:BB588D9C-5799-46AB-97CC-B0462C5184CA">
    <domeo:belongsToSet>urn:domeoserver:annotationset:A5E637EF-5CA5-4AAC-BD8B-C136A86E17B7</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotationset:F37BE993-E972-47AE-896D-FF4D33157ECF</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2014-07-07 09:37:30 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-07-07 09:44:18 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:623EC985-5556-44FA-806B-B79E427BC8C2"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/113E77B6-9715-44B7-984E-57FBA75BFE4C">
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/236474</dailymed:activeMoietyRxCUI>
    <rdfs:label>fexofenadine hydrochloride</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:67F3B4FB-2639-40F2-86FB-C5E280F33F53">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:67F3B4FB-2639-40F2-86FB-C5E280F33F53"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-07 19:53:46 -0400</pav:createdOn>
    <ao:exact>co-administration of known enzyme inducers (e.g., carbamazepine, phenytoin, rifampin, and phenobarbital) with risperidone may cause a decrease in the combined plasma concentrations of risperidone and 9-hydroxyrisperidone</ao:exact>
    <domeo:uuid>67F3B4FB-2639-40F2-86FB-C5E280F33F53</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>xsd:String</ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:8D2365AB-E6ED-4F38-8690-7EB2E8B7E934">
    <pav:lineageUri>urn:domeoserver:annotation:37A09DAE-3B1B-4BBC-BC86-D0F4A6DF9CB0</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <ao:body rdf:nodeID="N6a56285be17a4d8cb4229cdaa23e4d91"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:40BDF605-2878-474E-A0F5-2447B35A08D4"/>
    <pav:createdOn>2014-07-08 12:25:28 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:lastSavedOn>2014-07-08 12:25:30 -0400</pav:lastSavedOn>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <domeo:belongsToSet>urn:domeoclient:uuid:D9F8F6A3-1C3D-4E25-9870-A403388D2394</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/0B8AC197-76BF-4BB8-8634-3373C3593E83">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/11289</dailymed:activeMoietyRxCUI>
    <rdfs:label>warfarin</rdfs:label>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/5B52DB41-9FC1-480F-B670-4A3A38F25AA7">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/8754</dailymed:activeMoietyRxCUI>
    <rdfs:label>propafenone</rdfs:label>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/6F1D13EC-A669-48BE-8EF0-63DE747D3CA0">
    <rdfs:label>cimetidine</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/2541</dailymed:activeMoietyRxCUI>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:839D16FA-BCC2-4042-B5A5-DD0504556C7B">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotation:E30F1BF8-9FB8-4779-961D-FAD5EEAD0FDB</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7E49EB7A-DE0E-4720-82D1-8460BA0C770D</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-07-08 14:10:48 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <ao:body rdf:nodeID="Nc5102505fa9440049b6ae99afdbe23ef"/>
    <pav:createdOn>2014-07-08 14:03:24 -0400</pav:createdOn>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:8F1F77E8-8F5C-4350-8372-B2695D0D5BBD"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:4BC34D35-17F6-49DA-A8BA-DBBFD0BD7819">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:body rdf:nodeID="N823c0b92522444f5aadce02d6826112a"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A5E637EF-5CA5-4AAC-BD8B-C136A86E17B7</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:4A5E94F2-5DDE-4570-9865-B005964BD549"/>
    <pav:createdOn>2014-07-07 11:08:44 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-07-07 11:12:49 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotation:4D880435-EC81-42F2-85E5-9A02620CB100</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:B347B2AD-0733-4185-B22B-451999C06E33">
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:AE16633D-EF6A-47C6-8285-531ADE811704"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:21E841BD-3C8C-4B00-91E2-9B17A343BCCE">
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:34FB6161-E70B-4EFD-88C8-11B1476807BA"/>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:183B860F-535B-409C-92E2-DF860F681774">
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:64AE0C86-D69D-4D65-8411-5263170107F4"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:854BFBC4-B40D-4A6D-BBB1-81136F88D29A">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-07-08 08:46:38 -0400</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:23515E27-98AC-4DC9-A4B7-EBFE2991219F</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:ECD4407D-6AC1-4231-916E-89F94396BAA6"/>
    <pav:createdOn>2014-07-08 08:44:16 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotationset:57174A7C-3100-4C8F-9C4A-2991CEE124D5</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A29E5506-73C2-4E2C-ACEF-1D382A41B4BB">
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:506AE58E-EAC3-40CC-B55A-1659A3D9B3AE"/>
    <pav:lineageUri>urn:domeoserver:annotation:51D2635F-A1C3-46B9-BFCF-7F6A988DBD33</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:createdOn>2014-07-08 09:32:01 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-07-08 09:35:29 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:423352B3-8ABA-48B7-98CF-B191A7BFC955</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:7D04978B-320A-4D53-A6B2-08DC794B8519">
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:F2754BF3-A5A7-4D97-B57E-DDEC6DECC483"/>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/2C1D2B84-97A0-4C19-BACC-6C81E6872394">
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/2556</dailymed:activeMoietyRxCUI>
    <rdfs:label>citalopram</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:11597B1E-1AFD-4BE9-925C-9ED0B5B23660">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/889BAEE2-9096-493C-9B50-EAC043F91362"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/010E9851-9F86-43D8-96D9-0D99B06DB471"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B411E156-24DB-46BD-9C1B-18AB6DA0B23C">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:B411E156-24DB-46BD-9C1B-18AB6DA0B23C"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix>(300 mg four times a day for 12 days).</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-57.txt.html</ao:hasSource>
    <ao:exact>cimetidine </ao:exact>
    <pav:createdOn>2014-07-07 20:35:31 -0400</pav:createdOn>
    <ao:prefix>single dose pharmacokinetic parameters were not affected by </ao:prefix>
    <domeo:uuid>B411E156-24DB-46BD-9C1B-18AB6DA0B23C</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:75B65B95-22F0-4F1E-AC57-6DC0251ACD56">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:8A79FFFF-6F81-4C50-9759-0264E92AFDCF"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:23515E27-98AC-4DC9-A4B7-EBFE2991219F</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdOn>2014-07-08 08:43:46 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotationset:57174A7C-3100-4C8F-9C4A-2991CEE124D5</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2014-07-08 08:46:38 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:930DBDA4-D11A-4E4F-9F43-FA805766DC7B">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-08 08:39:30 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:930DBDA4-D11A-4E4F-9F43-FA805766DC7B"/>
    <ao:prefix>Patients with lipid abnormalities were not excluded from clinical trials of </ao:prefix>
    <domeo:uuid>930DBDA4-D11A-4E4F-9F43-FA805766DC7B</domeo:uuid>
    <ao:suffix>. In all 26-week controlled trials, across the recommended dose range, AVANDIA as monotherapy was associated with increases in total cholesterol, LDL, and HDL and decreases in free fatty acids. These changes were statistically significantly different fro</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <ao:exact>AVANDIA</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:10639A96-D771-47D0-86DF-20C30EA39041">
    <ao:exact>AVANDIA </ao:exact>
    <ao:prefix>with food resulted in no change in overall exposure (AUC), but there was an approximately 28% decrease in Cmax and a delay in Tmax (1.75 hours). These changes are not likely to be clinically significant; therefore, </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-08 08:40:31 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:10639A96-D771-47D0-86DF-20C30EA39041"/>
    <domeo:uuid>10639A96-D771-47D0-86DF-20C30EA39041</domeo:uuid>
    <ao:suffix>may be administered with or without food.</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:6FC0C902-E54B-498F-B495-27FA5ED605B0">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/8014FF26-CC26-4854-BC1F-33D05D62D1F1"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/DE864991-F77F-45BB-ACCE-ED7313AE49A6"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:BD210F23-FBA8-4D41-8E53-C9778F7E185F">
    <ao:suffix>is contraindicated in patients with renal impairment, coadministration of metformin with AVANDIA is contraindicated in these patients.</ao:suffix>
    <domeo:uuid>BD210F23-FBA8-4D41-8E53-C9778F7E185F</domeo:uuid>
    <pav:createdOn>2014-07-08 08:43:43 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:BD210F23-FBA8-4D41-8E53-C9778F7E185F"/>
    <ao:prefix>. Since </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <ao:exact>metformin </ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F4DE1F6C-EDE4-459B-80B3-75FA8BB2375D">
    <ao:suffix> [see Warnings and Precautions (5.4)]</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-104.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:F4DE1F6C-EDE4-459B-80B3-75FA8BB2375D"/>
    <ao:prefix>xsd:String</ao:prefix>
    <domeo:uuid>F4DE1F6C-EDE4-459B-80B3-75FA8BB2375D</domeo:uuid>
    <pav:createdOn>2014-07-08 16:25:36 -0400</pav:createdOn>
    <ao:exact>Coadministration of a 0.5 mg dose of digoxin, a P-glycoprotein substrate, with oral conivaptan hydrochloride 40 mg twice daily resulted in a 30% reduction in clearance and 79% and 43% increases in digoxin Cmax and AUC values, respectively</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:CC592906-E5A9-448E-9A27-2732D1D3BC1D">
    <ao:suffix>xsd:String</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:CC592906-E5A9-448E-9A27-2732D1D3BC1D"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-38.txt.html</ao:hasSource>
    <domeo:uuid>CC592906-E5A9-448E-9A27-2732D1D3BC1D</domeo:uuid>
    <ao:exact>The effect of fluvoxamine (25 mg b.i.d. for one week) on thioridazine steady-state concentration was evaluated in ten male inpatients with schizophrenia. Concentrations of thioridazine and its two active metabolites, mesoridazine and sulforidazine, increased 3-fold following coadministration of fluvoxamine. Fluvoxamine and thioridazine should not be coadministered.</ao:exact>
    <pav:createdOn>2014-07-08 19:42:52 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:BFF64705-B133-4000-BF04-DB0A786F2F80">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:BFF64705-B133-4000-BF04-DB0A786F2F80"/>
    <ao:prefix>or </ao:prefix>
    <domeo:uuid>BFF64705-B133-4000-BF04-DB0A786F2F80</domeo:uuid>
    <pav:createdOn>2014-07-08 12:21:41 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>have been used to treat severe reactions, with the addition of intravenous chlorpromazine in those cases exhibiting hypertension and hyperpyrexia. The usefulness and safety of narcotic antagonists in the treatment of these reactions is unknown.)</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-165.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>prednisolone </ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:AACAFE61-5CFB-400D-A0F1-B532D1F173B0">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:AACAFE61-5CFB-400D-A0F1-B532D1F173B0"/>
    <ao:exact>co-administration of known enzyme inducers (e.g., carbamazepine, phenytoin, rifampin, and phenobarbital) with risperidone may cause a decrease in the combined plasma concentrations of risperidone and 9-hydroxyrisperidone</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>xsd:String</ao:prefix>
    <domeo:uuid>AACAFE61-5CFB-400D-A0F1-B532D1F173B0</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <ao:suffix>xsd:String</ao:suffix>
    <pav:createdOn>2014-07-07 19:54:03 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/4521D8AB-E3B2-4AA4-AAF8-8066D097EA09">
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>magnesium</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/</dailymed:activeMoietyRxCUI>
    <dct:description>Referred to the drug in the interaction.</dct:description>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/D5CB839E-1DAE-4310-B399-4E9A6E0D57DD">
    <rdfs:label>propafenone</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/8754</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C4E71265-3AF4-4030-9B11-ECB9EB88730C">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:C4E71265-3AF4-4030-9B11-ECB9EB88730C"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-139.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-08 09:33:04 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>C4E71265-3AF4-4030-9B11-ECB9EB88730C</domeo:uuid>
    <ao:prefix>was reduced by 36%. Therefore, to maximize the effects of </ao:prefix>
    <ao:exact>fexofenadine</ao:exact>
    <ao:suffix>, it is recommended that fexofenadine hydrochloride tablets should be taken with water [see Clinical Pharmacology (12.3) and Dosage and Administration (2.1)].</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:15A2900B-9AAF-45A2-A032-E281FA828CB4">
    <pav:lineageUri>urn:domeoserver:annotation:095CB7FC-6A43-46C5-89CE-7B0895688B5D</pav:lineageUri>
    <ao:body rdf:nodeID="Ndaf5f6e0cf36416f865d97b2f8fc5248"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-07-08 19:52:52 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-08 19:52:51 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:6452DB33-D852-46C0-ADE8-10740D1A89C7"/>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:CF899881-76E1-4005-BE12-FE1112B9CEF9</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:4FFCA2F9-0603-44F9-B812-904155A17612">
    <domeo:belongsToSet>urn:domeoserver:annotationset:A5E637EF-5CA5-4AAC-BD8B-C136A86E17B7</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2014-07-07 09:37:33 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotationset:F37BE993-E972-47AE-896D-FF4D33157ECF</pav:lineageUri>
    <pav:lastSavedOn>2014-07-07 09:44:18 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:A7796091-F0E5-4878-9E07-52946F884221"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:98A2BCCE-B7AD-4A10-801B-78478D087BC4">
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:0ED7471A-86C1-4E44-9D4B-8B976265F8F5"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7F22C687-6FD6-4EEF-AAAF-B34C373B75DC">
    <pav:createdOn>2014-07-07 20:38:07 -0400</pav:createdOn>
    <ao:prefix>with </ao:prefix>
    <domeo:uuid>7F22C687-6FD6-4EEF-AAAF-B34C373B75DC</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:7F22C687-6FD6-4EEF-AAAF-B34C373B75DC"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>is contraindicated (see CONTRAINDICATIONS).</ao:suffix>
    <ao:exact>nefazodone </ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-59.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:5C0759EF-E008-4093-B19D-5A077456D59D">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:lineageUri>urn:domeoserver:annotation:301488A9-8F3C-4ACE-BB8D-3BCA2163EE54</pav:lineageUri>
    <ao:body rdf:nodeID="N64dc3819eef8430db8f6f2141002cbfb"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-08 09:26:20 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:6AFA671B-2945-478E-BB17-6F29A0395344"/>
    <pav:lastSavedOn>2014-07-08 09:27:36 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <domeo:belongsToSet>urn:domeoclient:uuid:7E425E73-12D2-4B08-9D70-75410DE87447</domeo:belongsToSet>
    <rdfs:label>expertstudy Annotation</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:064b871d-11d6-4ea6-b332-4272f2aa3b2f">
    <ao:body rdf:nodeID="N443a6170f739437487479bea75f6389a"/>
    <pav:lastSavedOn>2014-07-21 10:07:27 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:F8604E94-3C93-45CC-9E01-EAAC73FDF0B2</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:5a05bdca-91a8-491a-8d34-ea9f6e9c8f95</pav:lineageUri>
    <pav:createdOn>2014-07-07 08:02:31 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:BFFF1F0E-F6D8-4F2E-A1D1-0D32D6539775"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:5918AB1D-B782-46BF-A2C6-DE53FAAEB382">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-56.txt.html</ao:hasSource>
    <domeo:uuid>5918AB1D-B782-46BF-A2C6-DE53FAAEB382</domeo:uuid>
    <ao:prefix>, or </ao:prefix>
    <ao:suffix>during clinical trials. Zonisamide did not inhibit mixed-function liver oxidase enzymes (cytochrome P450), as measured in human liver microsomal preparations, in vitro. Zonisamide is not expected to interfere with the metabolism of other drugs that are m</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:5918AB1D-B782-46BF-A2C6-DE53FAAEB382"/>
    <ao:exact>valproate </ao:exact>
    <pav:createdOn>2014-07-07 20:32:12 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:02C166B8-5A74-4505-97D6-FF5E4E01C52A">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2014-07-07 20:21:40 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoclient:uuid:CE45A5D4-BD84-4E02-AC7B-C9E12233EC3A</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-07-07 20:18:59 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotation:270AA52D-9D53-499B-8A73-84FB33A12E8D</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:B10D9255-1757-4789-B2A6-45B024A9EA97"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:81021877-5153-4A5C-A823-BBBEE218D949">
    <ao:suffix>xsd:String</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:81021877-5153-4A5C-A823-BBBEE218D949"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-80.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>81021877-5153-4A5C-A823-BBBEE218D949</domeo:uuid>
    <ao:exact>Combined administration of citalopram (40 mg) and ketoconazole (200 mg) decreased the Cmax and AUC of ketoconazole by 21% and 10%, respectively, and did not significantly affect the pharmacokinetics of citalopram.</ao:exact>
    <ao:prefix>xsd:String</ao:prefix>
    <pav:createdOn>2014-07-08 15:04:44 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:C8C5D393-94AF-4F68-A575-13441FB9958D">
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:C3EEDFB7-7EBA-4DBF-9156-59FEF4FDBC91"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:D6771709-0553-4727-90E6-A4C95E584D01">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/5E9503EF-2AD5-454F-AEED-6D410C618627"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/EDB20E1F-6517-47D2-99B9-047ED9C2AEF5"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:59B5D954-E73B-4EFF-B597-82FE1AFA9882">
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdOn>2014-07-07 19:42:57 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:22E2B3A5-0F25-44F0-9BD1-962C23CAF0E8"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2014-07-07 19:50:36 -0400</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotationset:1DED06A6-8562-4CCF-A58C-CA25748FBD31</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5ABD9862-F044-4404-AD04-73DA04ADDA8B</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:6B178133-9B11-445F-A5BB-EF967EA53386">
    <ao:item rdf:resource="urn:domeoclient:uuid:5372C985-BD8B-48DC-919B-78E26F288022"/>
    <pav:lastSavedOn>2014-07-08 12:29:01 -0400</pav:lastSavedOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:D5D0F893-0B95-42AE-8D93-3B2DFD7E8FB4"/>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <ao:item rdf:resource="urn:domeoclient:uuid:A58B1992-5F7F-4BE1-8F71-3FA87F036371"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:75AEB076-CA02-4666-9445-2A03EF492650"/>
    <rdfs:label>Default Set</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:item rdf:resource="urn:domeoclient:uuid:1B57B86A-EAE9-49CA-AEDA-7E5105FF05CF"/>
    <domeo:deleted>false</domeo:deleted>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-201.txt.html</ao:annotatesResource>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <ao:item rdf:resource="urn:domeoclient:uuid:CEFE9AD2-4EDB-439A-9934-38F95F4E811E"/>
    <pav:lineageUri>urn:domeoserver:annotationset:62AE7BBB-9F32-4583-BBF5-79A1CF80D476</pav:lineageUri>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812e52b20002"/>
    <permissions:permissions rdf:nodeID="Nf7c56abb05dc47cdbc2b0a4df3e330d2"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:2C652B3B-EC12-46BC-9363-CD63A2499ACD"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:A2159D1F-D853-4F39-A0D3-C9E13586F4A6"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdOn>2014-07-08 12:28:16 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:72F9AAF8-555C-4C03-9E68-B916924DFF3C">
    <ao:prefix> elimination half-life was prolonged by about 30%, and clearance decreased by about 50% in cirrhotic subjects compared to normal subjects. </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:72F9AAF8-555C-4C03-9E68-B916924DFF3C"/>
    <pav:createdOn>2014-07-21 10:01:38 -0400</pav:createdOn>
    <ao:suffix> elimination half-life was prolonged by about 60%, and clearance decreased by about 30% in cirrhotic subjects compared to normal subjects. A large degree of intersubject variability was noted. Three patients with more severe cirrhosis had a more substant</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>72F9AAF8-555C-4C03-9E68-B916924DFF3C</domeo:uuid>
    <ao:exact>ODV</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-6.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A8872B26-D49E-47E8-8F7B-7E0AC440B47C">
    <ao:suffix>-sensitive sigma site, and no affinity (when tested at concentrations &gt;10-5 M) for cholinergic muscarinic or β1 and β2 adrenergic receptors.</ao:suffix>
    <domeo:uuid>A8872B26-D49E-47E8-8F7B-7E0AC440B47C</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:A8872B26-D49E-47E8-8F7B-7E0AC440B47C"/>
    <ao:prefix>has low to moderate affinity (Ki of 47 to 253 nM) for the serotonin 5HT1C, 5HT1D, and 5HT1A receptors, weak affinity (Ki of 620 to 800 nM) for the dopamine D1 and </ao:prefix>
    <pav:createdOn>2014-07-07 19:42:49 -0400</pav:createdOn>
    <ao:exact>haloperidol</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:0101CEE0-FF8F-4DA5-90C1-2C4D9B03752E">
    <ao:prefix> alone or in combination with either </ao:prefix>
    <domeo:uuid>0101CEE0-FF8F-4DA5-90C1-2C4D9B03752E</domeo:uuid>
    <pav:createdOn>2014-07-08 09:32:20 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:0101CEE0-FF8F-4DA5-90C1-2C4D9B03752E"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-139.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix>or ketoconazole. The findings of these studies are summarized in the following table:</ao:suffix>
    <ao:exact>erythromycin </ao:exact>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N16e1603e5e8c48688af2d465bf6ab686">
    <permissions:isLocked>false</permissions:isLocked>
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E61B013F-126F-4D29-868B-25BA354A7E0F">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5ABD9862-F044-4404-AD04-73DA04ADDA8B</domeo:belongsToSet>
    <pav:createdOn>2014-07-07 19:49:15 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:FF6F3F97-EB6E-4A65-BFA0-F2ADD403812F"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:lastSavedOn>2014-07-07 19:50:36 -0400</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotationset:1DED06A6-8562-4CCF-A58C-CA25748FBD31</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:96252AD4-F350-44FE-8566-9310568DFCC6">
    <pav:createdOn>2014-07-07 19:51:24 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:96252AD4-F350-44FE-8566-9310568DFCC6"/>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:prefix>do not suggest important differences between poor and extensive metabolizers. Second, </ao:prefix>
    <domeo:uuid>96252AD4-F350-44FE-8566-9310568DFCC6</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>co-administration of known enzyme inducers (e.g., carbamazepine, phenytoin, rifampin, and phenobarbital) with risperidone may cause a decrease in the combined plasma concentrations of risperidone and 9-hydroxyrisperidone</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:AAF31B6C-0415-4C04-8A0D-1C29CC4F28EB">
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:CF6DE8C8-AA17-46FD-BA47-DC0793234B56"/>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/7B3B1F2E-BD39-48C7-B984-8445094740C6">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>sildenafil</rdfs:label>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/136411</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A34C5CD3-6C19-4D77-B8BE-838A8FE67CB5">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotation:8B7D16C2-E326-4E63-ADE3-B62153FA79B4</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:F7DE20BC-6042-49BF-84F2-D1173B6F4291"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdOn>2014-07-08 08:53:29 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:23515E27-98AC-4DC9-A4B7-EBFE2991219F</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-08 08:54:46 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:e930d840-61cc-44a8-8146-cc1926d57f47">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:e930d840-61cc-44a8-8146-cc1926d57f47"/>
    <ao:suffix> or ODV were unaltered by age </ao:suffix>
    <pav:createdOn>2014-07-07 08:06:47 -0400</pav:createdOn>
    <ao:prefix>ough plasma levels of either </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-6.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>venlafaxine</ao:exact>
    <domeo:uuid></domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:D0392BAB-2D44-4B7F-9061-4D8C13FA38C5">
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:3309A2DD-1B4E-4FDD-99E4-1EEDFF150A24"/>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A9132970-66F0-427D-8062-6BF37F06BF1C">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:5C44531F-5F11-4CD5-A5A5-ADF80319AED7"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <domeo:belongsToSet>urn:domeoclient:uuid:423352B3-8ABA-48B7-98CF-B191A7BFC955</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdOn>2014-07-08 09:32:09 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2014-07-08 09:35:29 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotation:7F8D8D92-A9BF-4009-8766-7A09F26B439A</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:5DD06FE0-B2B0-47AC-8F74-A165F8D5FF94">
    <ao:exact>Co-administration with aluminum hydroxide gel (1200 mg) may result in a decrease in propranolol concentrations.</ao:exact>
    <ao:suffix>xsd:String</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-129.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:5DD06FE0-B2B0-47AC-8F74-A165F8D5FF94"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-08 09:11:16 -0400</pav:createdOn>
    <ao:prefix> </ao:prefix>
    <domeo:uuid>5DD06FE0-B2B0-47AC-8F74-A165F8D5FF94</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:254EBF3B-2982-4364-95A9-D0B679894EC5">
    <domeo:uuid>254EBF3B-2982-4364-95A9-D0B679894EC5</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-08 15:50:51 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-7.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:254EBF3B-2982-4364-95A9-D0B679894EC5"/>
    <ao:exact> Paroxetine lowered the concentration of 9-hydroxyrisperidone by about 10%.</ao:exact>
    <ao:suffix> When either concomitant</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>xsd:String</ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D1D6A188-FAA5-4A52-93C7-35D7CB74E48A">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-206.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-08 15:33:31 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:D1D6A188-FAA5-4A52-93C7-35D7CB74E48A"/>
    <domeo:uuid>D1D6A188-FAA5-4A52-93C7-35D7CB74E48A</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix> are also present in plasma, along with much smaller amounts of</ao:prefix>
    <ao:exact> 3α, 5α-tetrahydrolevonorgestrel</ao:exact>
    <ao:suffix> and 16βhydroxylevonorgestrel. </ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:040BF857-F51E-4826-A84B-513FC081772B">
    <ao:prefix>did not inhibit mixed-function liver oxidase enzymes (cytochrome P450), as measured in human liver microsomal preparations, in vitro. </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:040BF857-F51E-4826-A84B-513FC081772B"/>
    <ao:suffix>is not expected to interfere with the metabolism of other drugs that are metabolized by cytochrome P450 isozymes.</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-56.txt.html</ao:hasSource>
    <ao:exact>Zonisamide </ao:exact>
    <domeo:uuid>040BF857-F51E-4826-A84B-513FC081772B</domeo:uuid>
    <pav:createdOn>2014-07-07 20:32:25 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B7E3A840-6FAE-4775-9068-98BD07D35A26">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:34E4ED58-41A8-4A59-AC41-E9419344BB30"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-08 09:08:00 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotation:917BBF02-396A-4CE8-8ECE-677566147899</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <domeo:belongsToSet>urn:domeoclient:uuid:4E43D844-2E5A-46D2-8797-09878034F22F</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-08 09:08:48 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:81EB6128-9B59-429F-93DC-F824E1C1731E">
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:93363706-45F5-45F5-8137-37B08C2D8C5C"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:FF4D892F-0BD2-4FD8-9160-6124946DB29D</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:5CF4BE3A-B84D-4A20-B95E-9B396D05847C</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdOn>2014-07-08 09:23:56 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2014-07-08 09:24:20 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:9D7F86CC-36BD-44E4-B672-4E3A28FD3416">
    <ao:suffix>single dose pharmacokinetic parameters were not affected by cimetidine (300 mg four times a day for 12 days).</ao:suffix>
    <ao:exact>Zonisamide </ao:exact>
    <pav:createdOn>2014-07-07 20:35:28 -0400</pav:createdOn>
    <domeo:uuid>9D7F86CC-36BD-44E4-B672-4E3A28FD3416</domeo:uuid>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:9D7F86CC-36BD-44E4-B672-4E3A28FD3416"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-57.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/AF4A44AC-088B-403C-A018-7956CFE466A1">
    <rdfs:label>amitriptyline</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/704</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B2A822AE-953B-494E-B6C8-999D70A6CF0A">
    <pav:lineageUri>urn:domeoserver:annotationset:F37BE993-E972-47AE-896D-FF4D33157ECF</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2014-07-07 09:37:44 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:5F50411D-9AD4-457D-9768-41551FEF44ED"/>
    <pav:lastSavedOn>2014-07-07 09:44:18 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A5E637EF-5CA5-4AAC-BD8B-C136A86E17B7</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:FA39732E-D1AD-4544-9A39-20503C4846DA">
    <ao:suffix> gastrointestinal absorption. This observed increase in the bioavailability of fexofenadine may be due to transport-related effects, such as p-glycoprotein. In vivo animal studies also suggest that in addition to enhancing absorption, ketoconazole decrea</ao:suffix>
    <ao:exact>fexofenadine</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-139.txt.html</ao:hasSource>
    <ao:prefix>coadministration enhances </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:FA39732E-D1AD-4544-9A39-20503C4846DA"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>FA39732E-D1AD-4544-9A39-20503C4846DA</domeo:uuid>
    <pav:createdOn>2014-07-08 09:32:30 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B41CE612-345D-4E17-94DB-98BD2C6B5559">
    <ao:item rdf:resource="urn:domeoclient:uuid:E1C1DEA3-B3B4-40C4-948B-B14CF3F67706"/>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <pav:lineageUri>urn:domeoserver:annotationset:C6E1E0A9-4FE2-4FD1-B7C7-703144BC1236</pav:lineageUri>
    <domeo:deleted>false</domeo:deleted>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812e52b20002"/>
    <rdfs:label>Default Set</rdfs:label>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <ao:item rdf:resource="urn:domeoclient:uuid:EABDABCD-2741-4D6E-B3C5-7532FA912DE0"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:97CC6474-CC25-4439-899B-C8A0633D4912"/>
    <pav:createdOn>2014-07-07 20:13:21 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <pav:lastSavedOn>2014-07-07 20:14:34 -0400</pav:lastSavedOn>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-25.txt.html</ao:annotatesResource>
    <ao:item rdf:resource="urn:domeoclient:uuid:0BB35202-8DFA-4B2E-A72C-E1C0C685AD3E"/>
    <permissions:permissions rdf:nodeID="N51d6e9f16d264d62b4989f375c2424a9"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:4F696F90-D2D9-4E90-9300-C785BC0C7708"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:item rdf:resource="urn:domeoclient:uuid:19E2719A-8D07-4CBD-A8D8-E312B8066467"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:item rdf:resource="urn:domeoclient:uuid:0C2E2974-A103-4F0D-BF11-202AAD2FA481"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:A47B89A3-D4D6-4CD2-AC86-7BC33FD80307"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:0BDA3A7E-9BE5-4D2A-A94D-DDFD1CB62EA0">
    <ao:prefix> (</ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:0BDA3A7E-9BE5-4D2A-A94D-DDFD1CB62EA0"/>
    <domeo:uuid>0BDA3A7E-9BE5-4D2A-A94D-DDFD1CB62EA0</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>). Studies which measured cytotoxicity of </ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-190.txt.html</ao:hasSource>
    <ao:exact>ZDV</ao:exact>
    <pav:createdOn>2014-07-08 14:39:51 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:BC8DFC77-19FE-42F8-93A9-FBB9DEE32C41">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-08 15:57:35 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:9415067E-1AD4-4CC2-B7A1-9C64B0E76DA7"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:930FE356-9730-4335-9929-D854A7CE2092</domeo:belongsToSet>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <ao:body rdf:nodeID="N040de4ca7bc14bf8824bccb2cc5aac79"/>
    <pav:lastSavedOn>2014-07-08 15:58:01 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotation:0D30C6DF-D7A6-48C8-92B0-6E81E846B7A4</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:D4CAF849-C000-48CE-8BC4-66D7356A298E">
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:CF3EFDCD-3D2A-46B8-AEEB-85C8D06AAE1F"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:24FCFD9B-9FA2-4392-BA4F-FE3C1E676D24">
    <ao:suffix> and fluvoxethanol were tested in an in vitro assay of</ao:suffix>
    <ao:prefix>xsd:String</ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:24FCFD9B-9FA2-4392-BA4F-FE3C1E676D24"/>
    <ao:exact>Fluvoxamine acid</ao:exact>
    <domeo:uuid>24FCFD9B-9FA2-4392-BA4F-FE3C1E676D24</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-10.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-21 10:05:07 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:4D2891B5-4DB4-4FF6-9EA1-7A40EAA266F6">
    <pav:lastSavedOn>2014-07-08 08:51:47 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:23515E27-98AC-4DC9-A4B7-EBFE2991219F</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:createdOn>2014-07-08 08:47:59 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotationset:57174A7C-3100-4C8F-9C4A-2991CEE124D5</pav:lineageUri>
    <pav:previousVersion>urn:domeoclient:uuid:5BCE2FDB-C586-44CD-88F7-6EE2BDB6B929</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:177964F2-CE45-4E9B-BC10-A132995F6ACA"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:808A8F1C-57F2-429D-8219-EFE26579913D">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/DC5917AD-D3D2-44C0-BD0B-254C700B3EA3"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/3EBAEE26-C8E7-474B-9535-CF86CA923CAF"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B5CA50CB-8AAD-42D1-ADB9-A524369D214B">
    <ao:context rdf:resource="urn:domeoclient:uuid:5AB1DF7C-39DF-48CE-98A7-046FE021C7D9"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotation:DEE2FF87-63FF-4A37-AD32-3CA8F6DCAAD3</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:lastSavedOn>2014-07-08 15:56:00 -0400</pav:lastSavedOn>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:createdOn>2014-07-08 15:48:28 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5B2167F6-4E63-4A7B-85C1-ACA56DDE7073</domeo:belongsToSet>
    <ao:body rdf:nodeID="N4c1b9847c7e942e88684807f9f6f18fc"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:FF0CAD74-6572-4208-9681-F420B73A83E2">
    <domeo:uuid>FF0CAD74-6572-4208-9681-F420B73A83E2</domeo:uuid>
    <ao:exact>Fexofenadine hydrochloride</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:FF0CAD74-6572-4208-9681-F420B73A83E2"/>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:suffix> should not be taken closely in time with aluminum and magnesium containing antacids. In healthy adult subjects, administration of 120 mg of fexofenadine hydrochloride (2 × 60 mg capsule) within 15 minutes of an aluminum and magnesium containing antacid </ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-139.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-08 09:30:30 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/B21336C3-A4D6-44DE-9019-53E01D8FDD6F">
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>stavudine</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/59763</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:419480B6-68DE-4067-BC3C-11AEAAC9FE41">
    <pav:lastSavedOn>2014-07-21 10:02:11 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-21 10:00:34 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotationset:cf593dca-fe93-451b-8f37-2a96e065da13</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:32944008-A6C6-4D66-8C43-EE4CF2256965</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:7B6CF133-0072-4D53-ADBD-3D64C4899B86"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">3</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:previousVersion>urn:domeoclient:uuid:21a2d27a-13b1-4797-ba7a-c0517e32bb06</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:EB7F039A-9B7C-4CAD-8970-E914E6233F44">
    <ao:context rdf:resource="urn:domeoclient:uuid:E9FE1AE2-0879-4FF7-B956-F5B2318E7E9F"/>
    <pav:lastSavedOn>2014-07-08 09:15:28 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotation:7054E911-F301-4E6A-96FA-4069C71C765D</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdOn>2014-07-08 09:14:50 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoclient:uuid:54F09193-5CC7-4ED3-9261-88C7428E0572</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:EF6F1C63-9235-49B6-82C9-7715B4FD68D7">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5ABD9862-F044-4404-AD04-73DA04ADDA8B</domeo:belongsToSet>
    <pav:createdOn>2014-07-07 19:48:32 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:lastSavedOn>2014-07-07 19:50:36 -0400</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotationset:1DED06A6-8562-4CCF-A58C-CA25748FBD31</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:6E381413-6B32-4BC6-8100-25D31DDB398F"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:1A4D607F-E80D-4B26-A5F5-3912A297D942">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:lastSavedOn>2014-07-07 09:44:18 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:BF8E6EF1-0912-4AAE-8C56-D4EF1439CE2A"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A5E637EF-5CA5-4AAC-BD8B-C136A86E17B7</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdOn>2014-07-07 09:38:40 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotationset:F37BE993-E972-47AE-896D-FF4D33157ECF</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N745d8187e32e4f258999e722ea19bbfc">
    <domeo:sets rdf:resource="urn:pddi:uuid:BDB01C77-508F-48F5-99B7-1196E16FF47F"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:32FCB542-392C-4F5D-83DD-53EC7815F41E">
    <domeo:uuid>32FCB542-392C-4F5D-83DD-53EC7815F41E</domeo:uuid>
    <pav:createdOn>2014-07-07 09:44:06 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>is not considered clinically relevant. The effect of </ao:prefix>
    <ao:suffix>on </ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:32FCB542-392C-4F5D-83DD-53EC7815F41E"/>
    <ao:exact>sildenafil </ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:43759441-9A46-4950-973A-341B063071C7">
    <pav:createdOn>2014-07-08 09:08:47 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:43759441-9A46-4950-973A-341B063071C7"/>
    <ao:exact>Diazepam does not alter the pharmacokinetics of propranolol</ao:exact>
    <ao:suffix>xsd:String</ao:suffix>
    <domeo:uuid>43759441-9A46-4950-973A-341B063071C7</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-128.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:811D400C-B1C8-4FC0-8B9A-57ED7D3B3F18">
    <ao:exact>Zonisamide </ao:exact>
    <pav:createdOn>2014-07-07 20:32:19 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:811D400C-B1C8-4FC0-8B9A-57ED7D3B3F18"/>
    <ao:prefix>during clinical trials. </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-56.txt.html</ao:hasSource>
    <ao:suffix>did not inhibit mixed-function liver oxidase enzymes (cytochrome P450), as measured in human liver microsomal preparations, in vitro. Zonisamide is not expected to interfere with the metabolism of other drugs that are metabolized by cytochrome P450 isozy</ao:suffix>
    <domeo:uuid>811D400C-B1C8-4FC0-8B9A-57ED7D3B3F18</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/2c5e4473-045b-4993-8f47-357c8a48a1ae">
    <ao:context rdf:resource="urn:domeoclient:uuid:de37c2f8-5802-4c55-8257-2f95332a49c0"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:C524950D-FEC8-4563-9BFB-C816C764385C</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2014-07-07 08:07:00 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotationset:fdad2024-fe2f-47d6-b26b-7fda5c8669d1</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-07-07 08:07:00 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/B3F833CF-9D63-412F-830F-1800F4DCFDA5">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>propafenone</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/8754</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:6C2F9CC6-9435-47F5-9EFD-DCFBD6F053CC">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:6C2F9CC6-9435-47F5-9EFD-DCFBD6F053CC"/>
    <ao:suffix> concentrations than poor metabolizers, the pharmacokinetics of risperidone and 9-hydroxyrisperidone combined, after single and multiple doses, are similar in extensive and poor metabolizers.</ao:suffix>
    <domeo:uuid>6C2F9CC6-9435-47F5-9EFD-DCFBD6F053CC</domeo:uuid>
    <ao:exact> 9-hydroxyrisperidone</ao:exact>
    <pav:createdOn>2014-07-07 19:48:43 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>and higher</ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7F5224B1-C1D6-41EE-8832-301040B84271">
    <ao:context rdf:resource="urn:domeoclient:uuid:FB775B66-BA10-4024-BDD0-5CE62758B779"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotationset:1DED06A6-8562-4CCF-A58C-CA25748FBD31</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdOn>2014-07-07 19:47:09 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-07-07 19:50:36 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5ABD9862-F044-4404-AD04-73DA04ADDA8B</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:3F0B4B58-5C9C-4E04-AE2B-42F38AB95BC3">
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:C959A7D5-46C1-4667-9A6D-BECABEF64D72"/>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoclient:uuid:E08D4CED-BE06-4A5F-A2AF-BFBC25BA8AE4</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-07-07 20:46:25 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotation:9B83B3F8-C943-4813-B9B4-F6974106C121</pav:lineageUri>
    <pav:createdOn>2014-07-07 20:45:56 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A44B41B9-1491-478F-A1F2-B5977950A14F">
    <domeo:uuid>A44B41B9-1491-478F-A1F2-B5977950A14F</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:A44B41B9-1491-478F-A1F2-B5977950A14F"/>
    <ao:suffix>500 mg every 8 hours or ketoconazole 400 mg once daily under steady-state conditions to healthy adult subjects (n = 24, each study). No differences in adverse events or QTc interval were observed when subjects were administered fexofenadine hydrochloride</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>erythromycin </ao:exact>
    <pav:createdOn>2014-07-08 09:32:11 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-139.txt.html</ao:hasSource>
    <ao:prefix> 120 mg twice daily (240 mg total daily dose) was coadministered with either </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:4DCD9188-5435-4F57-BE59-468F7DDE8272">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-07 19:49:00 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:4DCD9188-5435-4F57-BE59-468F7DDE8272"/>
    <ao:suffix>, giving essentially all recipients a risperidone pharmacokinetic profile typical of poor metabolizers. The therapeutic benefits and adverse effects of risperidone in patients receiving quinidine have not been evaluated, but observations in a modest numb</ao:suffix>
    <ao:prefix> [see 7 DRUG INTERACTIONS]. This occurs with </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <ao:exact>quinidine</ao:exact>
    <domeo:uuid>4DCD9188-5435-4F57-BE59-468F7DDE8272</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:63ADCA1A-4987-41CC-9143-0CC08C9EA4FB">
    <domeo:uuid>63ADCA1A-4987-41CC-9143-0CC08C9EA4FB</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:63ADCA1A-4987-41CC-9143-0CC08C9EA4FB"/>
    <ao:exact>Ranitidine</ao:exact>
    <pav:createdOn>2014-07-08 08:54:08 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <ao:suffix>xsd:String</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>xsd:String</ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:5312764C-8342-437B-90CA-DDB3491161DB">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2014-07-08 12:05:20 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:9B7DDCE4-9D55-4D85-BBD1-44E13751C35E"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotation:2194C45C-E378-4B54-9527-9517B16481FE</pav:lineageUri>
    <pav:createdOn>2014-07-08 12:02:58 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoclient:uuid:D74AEF81-5B9A-431F-9F0D-1822391A7E30</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:AF427565-AADD-446A-B9E5-7FDBEF322BAD">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:AF427565-AADD-446A-B9E5-7FDBEF322BAD"/>
    <pav:createdOn>2014-07-07 19:58:20 -0400</pav:createdOn>
    <ao:exact>risperidone </ao:exact>
    <domeo:uuid>AF427565-AADD-446A-B9E5-7FDBEF322BAD</domeo:uuid>
    <ao:prefix>Renal Impairment: In patients with moderate to severe renal disease, clearance of the sum of </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix>and its active metabolite decreased by 60% compared to young healthy subjects. Risperidone doses should be reduced in patients with renal disease [see 2 DOSAGE AND ADMINISTRATION and 5 WARNINGS AND PRECAUTIONS]</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D60C171F-5691-4457-A14E-20D46B82B988">
    <ao:prefix>xsd:String</ao:prefix>
    <ao:exact>An open-label, randomized, three-way crossover study in 18 healthy subjects assessed the effect of a single 800 mg oral dose of fluconazole on the pharmacokinetics of a single 1200 mg oral dose of azithromycin as well as the effects of azithromycin on the pharmacokinetics of fluconazole. There was no significant pharmacokinetic interaction between fluconazole and azithromycin.</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-33.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:D60C171F-5691-4457-A14E-20D46B82B988"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>D60C171F-5691-4457-A14E-20D46B82B988</domeo:uuid>
    <ao:suffix>xsd:String</ao:suffix>
    <pav:createdOn>2014-07-08 19:44:57 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoserver:annotationset:8B73FE17-4C95-404F-8029-1D158127FC25">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">3</pav:versionNumber>
    <pav:createdOn>2014-07-07 08:06:28 -0400</pav:createdOn>
    <dct:description>The NER set is created automatically by NER annotation loading program.</dct:description>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <ao:item rdf:resource="file:///home/yin2/python-SPL-connector/ebf238b2-f44e-4602-994d-3bcda968d729"/>
    <permissions:permissions rdf:nodeID="N859724a8c958428ca83084f14c9540ef"/>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <pav:lastSavedOn>2014-07-08 15:05:01 -0400</pav:lastSavedOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:D895BF59-A109-46AB-82C8-77658F9BA940"/>
    <pav:lineageUri>urn:domeoserver:annotationset:ed930db8-ad18-4bde-b1f4-9b5198df60b8</pav:lineageUri>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-80.txt.html</ao:annotatesResource>
    <rdfs:label>NER Sets</rdfs:label>
    <pav:previousVersion>urn:domeoclient:uuid:2b1a6d93-209f-486f-a299-40a1d9e6010c</pav:previousVersion>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812e52b20002"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:item rdf:resource="urn:domeoclient:uuid:7B86D6B5-8B50-4756-92C6-5C423800ACBE"/>
    <domeo:deleted>false</domeo:deleted>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/F60D7750-7ADE-4E90-B609-33B84E864A42">
    <rdfs:label>sertraline</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/36437</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A65792BF-C7C3-4053-BF81-2EC6DC37218A">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:A65792BF-C7C3-4053-BF81-2EC6DC37218A"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-51.txt.html</ao:hasSource>
    <ao:suffix>.</ao:suffix>
    <domeo:uuid>A65792BF-C7C3-4053-BF81-2EC6DC37218A</domeo:uuid>
    <ao:exact>Co-administration of fosamprenavir/ritonavir with paroxetine significantly decreased plasma levels of paroxetine. Any dose adjustment should be guided by clinical effect (tolerability and efficacy)</ao:exact>
    <pav:createdOn>2014-07-07 20:26:24 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>xsd:String</ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:9DC2DB77-A9C1-4AD6-9A3F-B01C7D52043B">
    <ao:exact>ketoconazole</ao:exact>
    <ao:suffix>, ritonavir, and indinavir. The effect of short-term administration of ritonavir (200 mg twice daily, 4 doses) on the pharmacokinetics of a single dose of trazodone (50 mg) has been studied in 10 healthy subjects. The Cmax of trazodone increased by 34%, </ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:9DC2DB77-A9C1-4AD6-9A3F-B01C7D52043B"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-08 09:25:22 -0400</pav:createdOn>
    <domeo:uuid>9DC2DB77-A9C1-4AD6-9A3F-B01C7D52043B</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-136.txt.html</ao:hasSource>
    <ao:prefix>metabolism can be inhibited by the CYP3A4 inhibitors </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:6B3AD3F8-D6B9-4940-A837-44D3CD17F1E7">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:6B3AD3F8-D6B9-4940-A837-44D3CD17F1E7"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix>significantly decreased plasma levels of paroxetine. Any dose adjustment should be guided by clinical effect (tolerability and efficacy). </ao:suffix>
    <pav:createdOn>2014-07-07 20:25:53 -0400</pav:createdOn>
    <ao:exact>paroxetine </ao:exact>
    <domeo:uuid>6B3AD3F8-D6B9-4940-A837-44D3CD17F1E7</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>with </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-51.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:CA0432B1-CF34-4B94-AD8A-04978AE68C3A">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-08 08:40:51 -0400</pav:createdOn>
    <ao:prefix>e N-demethylation and hydroxylation, followed by conjugation with sulfate and glucuronic acid. All the circulating metabolites are considerably less potent than parent and, therefore, are not expected to contribute to the insulin-sensitizing activity of </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:CA0432B1-CF34-4B94-AD8A-04978AE68C3A"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <ao:suffix>.</ao:suffix>
    <ao:exact>rosiglitazone</ao:exact>
    <domeo:uuid>CA0432B1-CF34-4B94-AD8A-04978AE68C3A</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7F08BE75-59EE-45B8-84C3-FFD853167892">
    <ao:exact>Concomitant administration of propafenone and amiodarone can affect conduction and repolarization and is not recommended.</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:7F08BE75-59EE-45B8-84C3-FFD853167892"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-194.txt.html</ao:hasSource>
    <ao:suffix>xsd:String</ao:suffix>
    <domeo:uuid>7F08BE75-59EE-45B8-84C3-FFD853167892</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>xsd:String</ao:prefix>
    <pav:createdOn>2014-07-08 14:01:21 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N4d81a1b090a2402dbc56023f0aa4466e">
    <permissions:isLocked>false</permissions:isLocked>
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:25F5D9E1-9601-4792-859E-BF2A3F33C9AF">
    <domeo:belongsToSet>urn:domeoserver:annotationset:A5E637EF-5CA5-4AAC-BD8B-C136A86E17B7</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2014-07-07 09:42:11 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:B26E2EC2-BEB4-4630-BD21-DB8A5CD00827"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:lastSavedOn>2014-07-07 09:44:18 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotationset:F37BE993-E972-47AE-896D-FF4D33157ECF</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C0CC88E7-DAE2-4FEE-B0C4-B320E566491F">
    <ao:suffix>may cause a decrease in the combined plasma concentrations of risperidone and 9-hydroxyrisperidone [see 7 DRUG INTERACTIONS]. It would also be possible for risperidone to interfere with metabolism of other drugs metabolized by CYP 2D6. Relatively weak bi</ao:suffix>
    <pav:createdOn>2014-07-07 19:49:18 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <ao:exact>risperidone </ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:C0CC88E7-DAE2-4FEE-B0C4-B320E566491F"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>C0CC88E7-DAE2-4FEE-B0C4-B320E566491F</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>) with </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:75DEEBFA-AAD0-4B3A-B058-3C5B9D9240CF">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/311921C4-8A10-4B82-9D46-2C471CC888FE"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/B3F833CF-9D63-412F-830F-1800F4DCFDA5"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:9F19E8E3-8FDC-4D25-A5FF-A7B57F0174A3">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:16DA9B7E-81BE-4385-8EE9-DCF2B93209EF"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2014-07-08 13:50:24 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdOn>2014-07-08 13:49:39 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotation:29BE6A0A-97B2-442B-9A08-F020BEEA05C6</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:F9AE7343-DFD7-456E-804F-77E7D6A72935</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B0EE7D24-D38E-447F-BDE5-EB9118B102E2">
    <ao:context rdf:resource="urn:domeoclient:uuid:40BD8465-AF56-4B52-BBD3-F43CC99AA884"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotationset:1DED06A6-8562-4CCF-A58C-CA25748FBD31</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2014-07-07 19:43:33 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-07-07 19:50:36 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5ABD9862-F044-4404-AD04-73DA04ADDA8B</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoserver:annotationset:841E9565-FA63-4F5B-B42F-81A2A5F8AC58">
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812e52b20002"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:deleted>false</domeo:deleted>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-12.txt.html</ao:annotatesResource>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <pav:lineageUri>urn:domeoclient:uuid:26d5b4d9-0bfb-494c-aa84-15acd5660846</pav:lineageUri>
    <pav:createdOn>2014-07-07 08:02:55 -0400</pav:createdOn>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <rdfs:label>NLP Set</rdfs:label>
    <ao:item rdf:resource="urn:domeoclient:uuid:e926fa75-b7de-4d6e-844f-e3a3322c355e"/>
    <permissions:permissions rdf:nodeID="N7d5383f11eb74d49b08aa991afe59917"/>
    <pav:previousVersion>urn:domeoclient:uuid:c855b2f4-3f80-4338-9a73-318b8cbf1d58</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <pav:lastSavedOn>2014-07-21 10:09:44 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:66DDCA2D-3428-4A4B-8DC4-D7A7A3B39715">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:66DDCA2D-3428-4A4B-8DC4-D7A7A3B39715"/>
    <ao:exact>dalfopristin</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-114.txt.html</ao:hasSource>
    <ao:prefix>/</ao:prefix>
    <pav:createdOn>2014-07-08 14:50:15 -0400</pav:createdOn>
    <ao:suffix> with </ao:suffix>
    <domeo:uuid>66DDCA2D-3428-4A4B-8DC4-D7A7A3B39715</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C1B9032F-3327-47BD-86C2-0CFC399B1808">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix> whose metabolism is mediated by the CYP2D6 isozyme. In these patients, the </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:C1B9032F-3327-47BD-86C2-0CFC399B1808"/>
    <ao:exact>N-depropylpropafenone</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-195.txt.html</ao:hasSource>
    <domeo:uuid>C1B9032F-3327-47BD-86C2-0CFC399B1808</domeo:uuid>
    <pav:createdOn>2014-07-08 13:54:32 -0400</pav:createdOn>
    <ao:suffix> metabolite occurs in quantities comparable to the levels occurring in extensive metabolizers.</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:30D239C1-7EB5-4678-A47E-A0171774A349">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:23515E27-98AC-4DC9-A4B7-EBFE2991219F</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-08 08:46:38 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdOn>2014-07-08 08:42:41 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotationset:57174A7C-3100-4C8F-9C4A-2991CEE124D5</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:48099A33-8250-4530-925A-76809DBF9B83"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:B817495A-8751-415B-A471-6A1B127573EB">
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:72FEB0B8-530B-43D2-9A4B-35D0B59F6FF9"/>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:8126EEBF-25D2-48D6-A8EB-D15CF571A623">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:E8E319B5-4A40-4E2F-B20B-3D3FA11DA16E"/>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoclient:uuid:B44CD6F1-18F6-4252-9E79-5D5107E7044D</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotation:D84DB4BC-D142-4FB5-8F08-3F81DF0FCCBE</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-07-07 20:16:04 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-07 20:15:08 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:221357BB-2689-41F8-AE3D-DC5DC5DA859C">
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:426A845D-1FF1-4463-B663-6D6F1040B1E8"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:81086009-3EF9-4BBC-98D0-68FBC83686B3">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:81086009-3EF9-4BBC-98D0-68FBC83686B3"/>
    <domeo:uuid>81086009-3EF9-4BBC-98D0-68FBC83686B3</domeo:uuid>
    <ao:prefix>Increases in LDL occurred primarily during the first 1 to 2 months of therapy with </ao:prefix>
    <pav:createdOn>2014-07-08 08:39:36 -0400</pav:createdOn>
    <ao:exact>AVANDIA </ao:exact>
    <ao:suffix>and LDL levels remained elevated above baseline throughout the trials. In contrast, HDL continued to rise over time. As a result, the LDL/HDL ratio peaked after 2 months of therapy and then appeared to decrease over time. Because of the temporal nature o</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:4AB59393-C915-4F69-8E8B-26089C4E3598">
    <domeo:belongsToSet>urn:domeoclient:uuid:8D643EAC-88DF-4484-A479-D1E798544DF5</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:lastSavedOn>2014-07-07 20:38:37 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-07 20:38:06 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotation:E17280EC-D02C-4151-98CA-E74C4D261EEB</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:E7498DAA-0A48-4221-AF3C-86C236CB2025"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:BBC079C9-773A-469F-9E70-7E00113653C4">
    <ao:prefix>Pharmacokinetic parameters of </ao:prefix>
    <ao:suffix>in pediatric patients were established using a population pharmacokinetic analysis with sparse data from 96 pediatric patients in a single pediatric clinical trial including 33 males and 63 females with ages ranging from 10 to 17 years (weights ranging f</ao:suffix>
    <domeo:uuid>BBC079C9-773A-469F-9E70-7E00113653C4</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:BBC079C9-773A-469F-9E70-7E00113653C4"/>
    <ao:exact>rosiglitazone </ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-08 08:43:21 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7BAA9796-5131-4A84-B043-5720DE0A59C7">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:7BAA9796-5131-4A84-B043-5720DE0A59C7"/>
    <ao:suffix>xsd:String</ao:suffix>
    <domeo:uuid>7BAA9796-5131-4A84-B043-5720DE0A59C7</domeo:uuid>
    <pav:createdOn>2014-07-08 15:51:35 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-7.txt.html</ao:hasSource>
    <ao:exact>Erythromycin:There were no significant interactions between risperidone and erythromycin.</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:1506CBBE-CBA9-4F6A-BC58-57285B451EC3">
    <pav:previousVersion>urn:domeoclient:uuid:21a2d27a-13b1-4797-ba7a-c0517e32bb06</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">3</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2014-07-21 09:59:50 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:6CD68BE2-BB72-4BBC-8CA7-85C894173C78"/>
    <pav:lineageUri>urn:domeoserver:annotationset:cf593dca-fe93-451b-8f37-2a96e065da13</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-21 10:02:11 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:32944008-A6C6-4D66-8C43-EE4CF2256965</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:88371A6C-1368-436F-988B-CC0B30903A9A">
    <ao:prefix>Coadministration of </ao:prefix>
    <ao:suffix>with nefazodone results in insufficient plasma concentrations of nefazodone and its active metabolite to achieve a therapeutic effect. Coadministration of carbamazepine with nefazodone is contraindicated (see CONTRAINDICATIONS).</ao:suffix>
    <domeo:uuid>88371A6C-1368-436F-988B-CC0B30903A9A</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-59.txt.html</ao:hasSource>
    <ao:exact>carbamazepine </ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:88371A6C-1368-436F-988B-CC0B30903A9A"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-07 20:38:00 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:5F57F497-8A0D-4979-90F5-BA7BFF86F211">
    <pav:createdOn>2014-07-07 10:02:36 -0400</pav:createdOn>
    <pav:previousVersion>urn:domeoclient:uuid:53FAA6D0-9A40-44F9-8FE0-3166137CEF10</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotationset:F37BE993-E972-47AE-896D-FF4D33157ECF</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A5E637EF-5CA5-4AAC-BD8B-C136A86E17B7</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:CD7729B9-CDC5-4A9A-AB6E-ABAAC0B546B1"/>
    <pav:lastSavedOn>2014-07-07 10:03:14 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/40617CEE-F38C-43AD-9163-82281743D868">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>fexofenadine hydrochloride</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/236474</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoserver:annotationset:11406278-E817-40C1-94F2-0DAE4C5FB656">
    <ao:item rdf:resource="urn:domeoclient:uuid:FB77F85C-78C3-42B3-BBE8-77FA8FC73110"/>
    <permissions:permissions rdf:nodeID="N4c155d40d11a44fbb962ddfc7d3b3af9"/>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <dct:description>The NER set is created automatically by NER annotation loading program.</dct:description>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <ao:item rdf:resource="file:///home/yin2/python-SPL-connector/c90d2641-876a-46e3-b02a-68609e62b80f"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotationset:f7a0302d-e389-49f3-ab14-c59c2040b7bc</pav:lineageUri>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812e52b20002"/>
    <pav:lastSavedOn>2014-07-08 15:22:42 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-07 08:06:58 -0400</pav:createdOn>
    <domeo:deleted>false</domeo:deleted>
    <rdfs:label>NER Sets</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">3</pav:versionNumber>
    <pav:previousVersion>urn:domeoclient:uuid:2fa2a796-7d6c-4da3-9fdd-1347bf3854ec</pav:previousVersion>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-84.txt.html</ao:annotatesResource>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/257C0398-A47C-408D-AC7D-3E0CC32D933B">
    <rdfs:label>chlorpromazine</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/2403</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:9E97EA57-E235-4D98-B7F9-E5DD90C91D57">
    <ao:prefix>after 15 days of </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:9E97EA57-E235-4D98-B7F9-E5DD90C91D57"/>
    <ao:exact>rifampin </ao:exact>
    <pav:createdOn>2014-07-07 20:10:19 -0400</pav:createdOn>
    <domeo:uuid>9E97EA57-E235-4D98-B7F9-E5DD90C91D57</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-24.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>administered as 600 mg daily in eight healthy male volunteers resulted in a significant decrease in fluconazole AUC and a significant increase in apparent oral clearance of fluconazole. There was a mean ± SD reduction in fluconazole AUC of 23% ± 9% (rang</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B5492D58-02A9-4548-B4B3-82DC9DEB1410">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>B5492D58-02A9-4548-B4B3-82DC9DEB1410</domeo:uuid>
    <ao:prefix> tablets and the </ao:prefix>
    <ao:exact>Yuzpe</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:B5492D58-02A9-4548-B4B3-82DC9DEB1410"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-206.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-08 15:34:08 -0400</pav:createdOn>
    <ao:suffix> regimen (another form of emergency contraception). The reason for this apparent increase in the pregnancy rate with emergency contraceptives in Chinese women is unknown [see USE IN SPECIFIC POPULATIONS (8.6)].</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:88317D5F-43A1-48DA-B434-36912C36BECD">
    <pav:createdOn>2014-07-07 09:43:46 -0400</pav:createdOn>
    <domeo:uuid>88317D5F-43A1-48DA-B434-36912C36BECD</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>tion of epoprostenol was 28%, resulting in about 22% lower mean average steady state concentrations. Therefore, the slight decrease of sildenafil exposure in the presence of epoprostenol is not considered clinically relevant. The effect of sildenafil on </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:88317D5F-43A1-48DA-B434-36912C36BECD"/>
    <ao:suffix> is not known.</ao:suffix>
    <ao:exact>epoprostenol pharmacokinetics</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:DA6752A8-C0A9-43A0-B592-1639618860DA">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:6DDD95C8-AF2D-4439-9E24-0F6D2346A962"/>
    <pav:lineageUri>urn:domeoserver:annotationset:57174A7C-3100-4C8F-9C4A-2991CEE124D5</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdOn>2014-07-08 08:40:08 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:23515E27-98AC-4DC9-A4B7-EBFE2991219F</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-08 08:46:38 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:333616EE-C90C-4719-8ED0-B37C4E0A592B">
    <ao:prefix> and </ao:prefix>
    <pav:createdOn>2014-07-21 10:01:34 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-6.txt.html</ao:hasSource>
    <ao:suffix> was significantly altered after oral administration of </ao:suffix>
    <domeo:uuid>333616EE-C90C-4719-8ED0-B37C4E0A592B</domeo:uuid>
    <ao:exact>ODV</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:333616EE-C90C-4719-8ED0-B37C4E0A592B"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:6A85F321-84DD-45D0-A71C-412271B1A04E">
    <ao:context rdf:resource="urn:domeoclient:uuid:8555D07E-8DC5-4EC6-8E56-E7326761C338"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:23515E27-98AC-4DC9-A4B7-EBFE2991219F</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdOn>2014-07-08 08:43:36 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-07-08 08:46:38 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotationset:57174A7C-3100-4C8F-9C4A-2991CEE124D5</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:50178458-9F79-4448-9148-D42F665C707C">
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:5B0FC440-8DCE-44BA-BCBE-5196F06A748A"/>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoserver:annotationset:2CD5EC60-6C64-4F1C-8293-A4D163CC9362">
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-191.txt.html</ao:annotatesResource>
    <dct:description>The NER set is created automatically by NER annotation loading program.</dct:description>
    <ao:item rdf:resource="urn:domeoclient:uuid:1AB37877-FF60-406C-B294-16B8DA972E2F"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:lastSavedOn>2014-07-08 14:31:51 -0400</pav:lastSavedOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:1D5A6D41-E5BF-4905-9702-7DA17F74482A"/>
    <pav:previousVersion>urn:domeoclient:uuid:7dccda65-f90e-496a-a377-ca55f309c7fa</pav:previousVersion>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812e52b20002"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">3</pav:versionNumber>
    <ao:item rdf:resource="file:///home/yin2/python-SPL-connector/83bea31c-3d59-49fb-a576-f7ec00da9c05"/>
    <rdfs:label>NER Sets</rdfs:label>
    <pav:createdOn>2014-07-07 08:06:45 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotationset:9585bd87-bb79-42b2-932f-d6b8a0043a90</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <permissions:permissions rdf:nodeID="N74ba8303b08d45508e6b2a4579f94d94"/>
    <domeo:deleted>false</domeo:deleted>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:8973650B-5704-4E3B-B6FD-B8F9AD0B1EA1">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/9718CEAE-6C8C-4A20-8B9F-56FA2D1CA6CB"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/A4581FDC-1E74-44A2-8B80-9192C98CBA5D"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:61AA5AEA-7ED1-4831-8A8A-1150577A32F2">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:23515E27-98AC-4DC9-A4B7-EBFE2991219F</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-08 08:46:38 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-08 08:40:16 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:80D626B6-9F56-4E5F-BE82-765A7A7AED16"/>
    <pav:lineageUri>urn:domeoserver:annotationset:57174A7C-3100-4C8F-9C4A-2991CEE124D5</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nf59180be493e462abd29f051a1ee24a9">
    <domeo:sets rdf:resource="urn:pddi:uuid:7B59FD7B-40C7-4BD1-8519-C2393E0808A0"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/23846A83-E4E2-463A-A164-7C8E7A504557">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/9384</dailymed:activeMoietyRxCUI>
    <rdfs:label>rifampin</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:FAE07F96-AE12-4A34-8AE5-01478E6FC677">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/45CBDB06-7587-4F83-A091-DD5AA73DC829"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/7A9AF895-05ED-4808-9CA2-1A4AEE57AE62"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/E71FB55B-248D-40A1-8652-0359FD90DB04">
    <rdfs:label>9-hydroxyrisperidone</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/679314</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:2F6B7F42-AFC6-41B9-9986-AC2F4CB50C3D">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/D02B5306-AE97-46DE-8D5C-ACE5DD1F4920"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/B0DA37E2-3D95-4E9E-BA4E-7061067AC507"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:756C08BB-1427-4C5A-A11E-DCE1339428E0">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotationset:F37BE993-E972-47AE-896D-FF4D33157ECF</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:createdOn>2014-07-07 09:36:41 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:1E974747-8416-47F3-9D47-C57EEF1AED1D"/>
    <pav:lastSavedOn>2014-07-07 09:44:18 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A5E637EF-5CA5-4AAC-BD8B-C136A86E17B7</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:9A08728A-0366-405A-AA48-2BD8B1D0020A">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotation:38494B83-E909-491F-B8A4-F2C1A4AD37ED</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoclient:uuid:F2EFEF06-B779-484C-B854-043086EB0C5C</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdOn>2014-07-07 20:39:51 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:E454987A-BDD5-4CA4-A48D-D2934210F971"/>
    <pav:lastSavedOn>2014-07-07 20:44:32 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:95E29C43-46EF-4653-ADDE-5360EBC04F9E">
    <ao:prefix>(</ao:prefix>
    <ao:suffix>) is prescribed for patients on this type of anticoagulant therapy.</ao:suffix>
    <pav:createdOn>2014-07-07 20:47:04 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:95E29C43-46EF-4653-ADDE-5360EBC04F9E"/>
    <ao:exact>metronidazole</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-120.txt.html</ao:hasSource>
    <domeo:uuid>95E29C43-46EF-4653-ADDE-5360EBC04F9E</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:0BB459C5-5005-45E8-A601-3A8BE0582675">
    <ao:context rdf:resource="urn:domeoclient:uuid:A52945FE-9967-4CFD-B2D9-8505FDDB41ED"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotationset:F37BE993-E972-47AE-896D-FF4D33157ECF</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdOn>2014-07-07 09:40:26 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A5E637EF-5CA5-4AAC-BD8B-C136A86E17B7</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-07-07 09:44:18 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:03B34860-4FD6-4D21-8F9E-8345C222E7CB">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/82149602-CB19-488F-AB4D-5DB7465DFE9C"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/59874DF3-9C24-4918-99F5-722807F259D3"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/B98077A0-5481-4FAA-9B75-819F4DB9B81D">
    <rdfs:label>fluconazole</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/4450</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:CD4292A0-45D4-4667-BB35-1F3A52D4DE87">
    <domeo:belongsToSet>urn:domeoserver:annotationset:A5E637EF-5CA5-4AAC-BD8B-C136A86E17B7</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:23FA430E-D94F-4E0A-B792-4598E29FCFD1"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:lastSavedOn>2014-07-07 09:44:18 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-07 09:37:45 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotationset:F37BE993-E972-47AE-896D-FF4D33157ECF</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoserver:annotationset:F308746E-1B09-48A9-A699-A66CF195F2F7">
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <permissions:permissions rdf:nodeID="N74e0ad6fab4748fa95109ae74ded6405"/>
    <rdfs:label>NER Sets</rdfs:label>
    <pav:createdOn>2014-07-07 08:06:39 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">3</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotationset:1f6fbb82-e3e5-4fe2-ad47-276697cc9639</pav:lineageUri>
    <dct:description>The NER set is created automatically by NER annotation loading program.</dct:description>
    <ao:item rdf:resource="file:///home/yin2/python-SPL-connector/17e2150b-5f83-45e7-b92d-dfd68bcfe510"/>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <domeo:deleted>false</domeo:deleted>
    <ao:item rdf:resource="urn:domeoclient:uuid:502B7512-035A-4DD5-8452-73F76F70C976"/>
    <pav:previousVersion>urn:domeoclient:uuid:6bbacadc-2e04-4894-aca5-ecf1ecd143a0</pav:previousVersion>
    <pav:lastSavedOn>2014-07-08 14:58:34 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812e52b20002"/>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-110.txt.html</ao:annotatesResource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:99EE304F-3479-4C41-9EA2-2ACE78EA72CB">
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotation:AA2D22B1-098D-4364-96F6-6C05A0015CED</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2014-07-07 19:58:20 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5ABD9862-F044-4404-AD04-73DA04ADDA8B</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:AF427565-AADD-446A-B9E5-7FDBEF322BAD"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2014-07-07 19:59:12 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7CF29B35-95C9-4BFC-A386-5B0C0FFD2800">
    <ao:exact>In a study of healthy volunteers, sildenafil (100 mg) did not affect the steady-state pharmacokinetics of the HIV protease inhibitors saquinavir and ritonavir, both of which are CYP3A substrates.</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:7CF29B35-95C9-4BFC-A386-5B0C0FFD2800"/>
    <ao:suffix>xsd:String</ao:suffix>
    <pav:createdOn>2014-07-07 11:11:02 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <domeo:uuid>7CF29B35-95C9-4BFC-A386-5B0C0FFD2800</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A7EEADA2-34CA-40F2-9B7C-ED43FDDCB9DB">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:A7EEADA2-34CA-40F2-9B7C-ED43FDDCB9DB"/>
    <pav:createdOn>2014-07-08 15:46:27 -0400</pav:createdOn>
    <ao:prefix>xsd:String</ao:prefix>
    <domeo:uuid>A7EEADA2-34CA-40F2-9B7C-ED43FDDCB9DB</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:exact>Chronic administration of clozapine with risperidone may decrease the clearance of risperidone</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-7.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoserver:annotationset:AD5B6A0D-35F7-45B4-AEC9-1F259D4615D1">
    <dct:description>The NER set is created automatically by NER annotation loading program.</dct:description>
    <pav:previousVersion>urn:domeoclient:uuid:5f556b63-d579-42b0-8071-b1836149fca3</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <permissions:permissions rdf:nodeID="N3b4115f8431549d8b293b217d8dbabf3"/>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-31.txt.html</ao:annotatesResource>
    <domeo:deleted>false</domeo:deleted>
    <pav:lineageUri>urn:domeoserver:annotationset:41d7f6e8-3fa7-48a8-9998-4cfd15bd6e30</pav:lineageUri>
    <ao:item rdf:resource="file:///home/yin2/python-SPL-connector/83d92ddf-0c6f-4444-ad86-bc86f32fc6f7"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">3</pav:versionNumber>
    <pav:lastSavedOn>2014-07-08 19:47:49 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:item rdf:resource="urn:domeoclient:uuid:489AEDFE-F9B4-46D2-A1D5-CE787D9B9F27"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:0BDF881C-B03D-4ACA-80BA-F2714EA0074F"/>
    <rdfs:label>NER Sets</rdfs:label>
    <pav:createdOn>2014-07-07 08:06:37 -0400</pav:createdOn>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812e52b20002"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C2002171-DEDA-4096-AF22-F840F116027E">
    <domeo:belongsToSet>urn:domeoserver:annotationset:32944008-A6C6-4D66-8C43-EE4CF2256965</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-21 10:02:11 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:createdOn>2014-07-21 10:01:23 -0400</pav:createdOn>
    <pav:previousVersion>urn:domeoclient:uuid:21a2d27a-13b1-4797-ba7a-c0517e32bb06</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:2F2B075B-7F85-4E5F-A15D-EBBCF050E6D6"/>
    <pav:lineageUri>urn:domeoserver:annotationset:cf593dca-fe93-451b-8f37-2a96e065da13</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">3</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N1558d9582ab6405480a5633c303119bb">
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
    <permissions:isLocked>false</permissions:isLocked>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:CB4CEEF7-3324-4A8B-A2FD-A9BD8B9C3884">
    <domeo:uuid>CB4CEEF7-3324-4A8B-A2FD-A9BD8B9C3884</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix> elimination half-life was prolonged by about 40% although clearance was unchanged in patients with renal impairment (GFR=10 to 70 mL/min) compared to normal subjects. In dialysis patients, </ao:prefix>
    <ao:suffix> elimination half-life was prolonged by about 142% and clearance was reduced by about 56% compared to normal subjects. A large degree of intersubject variability was noted. Dosage adjustment is necessary in these patients [see Dosage and Administration (</ao:suffix>
    <ao:exact>ODV</ao:exact>
    <pav:createdOn>2014-07-21 10:02:07 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:CB4CEEF7-3324-4A8B-A2FD-A9BD8B9C3884"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-6.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/83d92ddf-0c6f-4444-ad86-bc86f32fc6f7">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:AD5B6A0D-35F7-45B4-AEC9-1F259D4615D1</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdOn>2014-07-07 08:06:37 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:491244b8-b76d-4c26-aebc-f36ec916a46f"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotationset:41d7f6e8-3fa7-48a8-9998-4cfd15bd6e30</pav:lineageUri>
    <pav:lastSavedOn>2014-07-07 08:06:37 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:BEB715D4-D4B4-4ED1-8977-BCC5A263E9A6">
    <ao:exact>Digitalis glycosides</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:BEB715D4-D4B4-4ED1-8977-BCC5A263E9A6"/>
    <ao:suffix>, </ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-08 16:16:47 -0400</pav:createdOn>
    <domeo:uuid>BEB715D4-D4B4-4ED1-8977-BCC5A263E9A6</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-106.txt.html</ao:hasSource>
    <ao:prefix>xsd:String</ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:28BE4EBE-BA7D-4FBE-AB55-3A92D8AFFBF3">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:28BE4EBE-BA7D-4FBE-AB55-3A92D8AFFBF3"/>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:suffix>metabolism is principally mediated by the CYP3A (major route) and CYP2C9 (minor route) cytochrome P450 isoforms. Therefore, inhibitors of these isoenzymes may reduce sildenafil clearance and inducers of these isoenzymes may increase sildenafil clearance.</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-07 09:39:37 -0400</pav:createdOn>
    <ao:exact>Sildenafil </ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>28BE4EBE-BA7D-4FBE-AB55-3A92D8AFFBF3</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:4B46BFE1-7618-4E58-B344-CE46CF415C6F">
    <ao:exact>glyburide </ao:exact>
    <domeo:uuid>4B46BFE1-7618-4E58-B344-CE46CF415C6F</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:4B46BFE1-7618-4E58-B344-CE46CF415C6F"/>
    <ao:suffix>at week 52 were statistically significant.</ao:suffix>
    <pav:createdOn>2014-07-08 08:40:05 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <ao:prefix>and </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:291F5C9B-106B-46C8-9617-F191BBB2F751">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:291F5C9B-106B-46C8-9617-F191BBB2F751"/>
    <domeo:uuid>291F5C9B-106B-46C8-9617-F191BBB2F751</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix> elimination half-life was prolonged by about 40% although clearance was unchanged in patients with renal impairment (GFR=10 to 70 mL/min) compared to normal subjects. In dialysis patients, ODV elimination half-life was prolonged by about 142% and cleara</ao:suffix>
    <ao:prefix> elimination half-life was prolonged by about 180% and clearance was reduced by about 57% compared to normal subjects. Similarly, </ao:prefix>
    <ao:exact>ODV</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-6.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-21 10:02:02 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E3CCD1DD-6135-4FC9-96D3-8EE39DBD3A70">
    <pav:createdOn>2014-07-08 09:32:32 -0400</pav:createdOn>
    <ao:exact>fexofenadine </ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>may be due to transport-related effects, such as p-glycoprotein. In vivo animal studies also suggest that in addition to enhancing absorption, ketoconazole decreases fexofenadine gastrointestinal secretion, while erythromycin may also decrease biliary ex</ao:suffix>
    <domeo:uuid>E3CCD1DD-6135-4FC9-96D3-8EE39DBD3A70</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:E3CCD1DD-6135-4FC9-96D3-8EE39DBD3A70"/>
    <ao:prefix> gastrointestinal absorption. This observed increase in the bioavailability of </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-139.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:38DA5B2B-8935-46B8-B188-C98F6F82CBF4">
    <ao:suffix>concentrations.</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:38DA5B2B-8935-46B8-B188-C98F6F82CBF4"/>
    <ao:exact>propranolol </ao:exact>
    <pav:createdOn>2014-07-08 09:14:51 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-131.txt.html</ao:hasSource>
    <ao:prefix>resulted in up to 50% decrease in </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>38DA5B2B-8935-46B8-B188-C98F6F82CBF4</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:0C4287F4-02E3-419A-8EAB-4582BAABB3A2">
    <ao:context rdf:resource="urn:domeoclient:uuid:F5726C15-2670-4EC9-A123-CC04284FE8BB"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotation:715203E6-40B9-423B-B758-2C55F3F2429F</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoclient:uuid:738231FC-4090-4D56-90FB-4FBFF166BD23</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdOn>2014-07-07 20:08:09 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-07-07 20:10:00 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:DE9A23B8-8079-4596-9CC4-6E5E11BBFB8C">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:createdOn>2014-07-07 19:46:38 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:EF9C08F2-1B30-49C0-831D-4BC4BFD6AE48"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5ABD9862-F044-4404-AD04-73DA04ADDA8B</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotationset:1DED06A6-8562-4CCF-A58C-CA25748FBD31</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-07-07 19:50:36 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:1EAC6678-5CA0-4BBC-B006-CFBABC607E33">
    <domeo:uuid>1EAC6678-5CA0-4BBC-B006-CFBABC607E33</domeo:uuid>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:exact>Co-administration of propranolol with lovastatin or pravastatin, decreased 18% to 23% the AUC of both, but did not alter their pharmacodynamics.</ao:exact>
    <ao:suffix>xsd:String</ao:suffix>
    <pav:createdOn>2014-07-08 09:19:45 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:1EAC6678-5CA0-4BBC-B006-CFBABC607E33"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-132.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:AC8C9B28-6185-4FA3-A82C-194F809A60A8">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/64B75E1D-444B-46D0-B066-B6098DBEBFDB"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/AC6C7749-8349-40F9-8362-48F5BB5EA166"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:9AB19197-4B2E-41F0-BA4C-D09863CEB4A9">
    <pav:createdOn>2014-07-08 08:48:00 -0400</pav:createdOn>
    <ao:exact>AVANDIA </ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:9AB19197-4B2E-41F0-BA4C-D09863CEB4A9"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <ao:prefix>xsd:String</ao:prefix>
    <domeo:uuid>9AB19197-4B2E-41F0-BA4C-D09863CEB4A9</domeo:uuid>
    <ao:suffix>(2 mg twice daily) taken concomitantly with glyburide (3.75 to 10 mg/day) for 7 days did not alter the mean steady-state 24-hour plasma glucose concentrations in diabetic patients stabilized on glyburide therapy. Repeat doses of AVANDIA (8 mg once daily)</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:20C3E750-EA09-4B64-8810-7C43F42F8F50">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-08 14:38:04 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:20C3E750-EA09-4B64-8810-7C43F42F8F50"/>
    <ao:suffix>) is the major metabolite and has antiviral activity similar to that of parent drug; however, the concentrations of this metabolite in plasma are low. In vitro studies utilizing human liver microsomes have demonstrated that cytochrome P450 3A (CYP3A) is </ao:suffix>
    <domeo:uuid>20C3E750-EA09-4B64-8810-7C43F42F8F50</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>M-2</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-190.txt.html</ao:hasSource>
    <ao:prefix>(</ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:68210666-C6C1-4B81-A69F-1AD82FD19CA0">
    <pav:lastSavedOn>2014-07-07 20:12:43 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotation:E309E10F-7031-485B-905A-D9496EE6DF55</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoclient:uuid:21FE87BA-B7AA-4926-95E7-7E20EA2E4643</domeo:belongsToSet>
    <pav:createdOn>2014-07-07 20:10:18 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:06584C7A-C7E2-443E-953B-8AC0D9B83FEF"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:684009B0-C0FC-4BBB-823A-4D648E4262EA">
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-07-08 09:35:29 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoclient:uuid:423352B3-8ABA-48B7-98CF-B191A7BFC955</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:A45ED04F-CBB1-4F65-9950-02E6B9519A72</pav:lineageUri>
    <pav:createdOn>2014-07-08 09:33:02 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:3233FF23-797B-4719-814E-5983784E20B1"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N08dfa93142b64b39954e01cd5e5be37f">
    <permissions:isLocked>false</permissions:isLocked>
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:292c05d3-4b2a-4786-8b3b-33cd47ab03d9">
    <ao:prefix>icipating in a multiple dose </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:292c05d3-4b2a-4786-8b3b-33cd47ab03d9"/>
    <ao:exact>doxazosin</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-111.txt.html</ao:hasSource>
    <ao:suffix>-nifedipine interaction study </ao:suffix>
    <domeo:uuid></domeo:uuid>
    <pav:createdOn>2014-07-07 08:06:43 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:AD666251-9AD6-46C2-BA11-161BB5591AD3">
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:0C5EAB8A-A5D7-4D32-83AB-D39CF883B0E8"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N763d82b7c17348188c745d909298c124">
    <permissions:isLocked>false</permissions:isLocked>
    <permissions:accessType>urn:person:uuid:080e143046812afe0146812e52b20002</permissions:accessType>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E24CE0A1-88CD-43C6-8075-A618667EE0F9">
    <ao:prefix>and</ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:E24CE0A1-88CD-43C6-8075-A618667EE0F9"/>
    <pav:createdOn>2014-07-07 19:58:38 -0400</pav:createdOn>
    <domeo:uuid>E24CE0A1-88CD-43C6-8075-A618667EE0F9</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix> was decreased, and elimination half-lives were prolonged compared to young healthy subjects. Dosing should be modified accordingly in the elderly patients [see 2 DOSAGE AND ADMINISTRATION].</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact> 9-hydroxyrisperidone</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:FE387E18-F5F4-49B6-A636-E4FB043C8E04">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-201.txt.html</ao:hasSource>
    <ao:suffix>, the incidence of withdrawal symptoms decreased and methadone exposure increased to a level comparable to that prior to phenytoin administration.</ao:suffix>
    <pav:createdOn>2014-07-08 12:28:24 -0400</pav:createdOn>
    <ao:exact>phenytoin</ao:exact>
    <domeo:uuid>FE387E18-F5F4-49B6-A636-E4FB043C8E04</domeo:uuid>
    <ao:prefix>exposure and withdrawal symptoms occurred concurrently. Upon discontinuation of </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:FE387E18-F5F4-49B6-A636-E4FB043C8E04"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:4137748B-0B0D-43C0-A9BC-2FF22C298165">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/D6093AA4-0972-4663-8527-6B9FFED2C4E4"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/1F621EE5-360A-47E0-881E-AE68E761BBB5"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/ebf238b2-f44e-4602-994d-3bcda968d729">
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-07-07 08:06:28 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:3c78b515-2f1c-4754-b9b5-d7fb2bc7a24f"/>
    <pav:lastSavedOn>2014-07-07 08:06:28 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotationset:ed930db8-ad18-4bde-b1f4-9b5198df60b8</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:8B73FE17-4C95-404F-8029-1D158127FC25</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nd4148062424f41cfa4d8a3a42ab552d5">
    <domeo:sets rdf:resource="urn:pddi:uuid:850BCCCD-2F22-4F0E-8FB6-6648E690DCB1"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A81CDF4E-B534-40E7-AB46-5DB589762ADB">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-08 09:00:25 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <ao:body rdf:nodeID="N43c8ee0a1bec4df3abe7af123c707dac"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:createdOn>2014-07-08 09:00:24 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:7E72F842-35CE-4CEB-A2D4-8D5B03DB4C8A"/>
    <pav:lineageUri>urn:domeoserver:annotation:00EB0262-B351-468D-B85F-BED62489B548</pav:lineageUri>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <domeo:belongsToSet>urn:domeoclient:uuid:86E1DCE1-FFC6-4513-AEF9-EF158A019E6B</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7f5d1295-03df-474d-8a26-28174d887804">
    <pav:createdOn>2014-07-07 08:06:55 -0400</pav:createdOn>
    <ao:suffix>, 20 mg t.i.d., increased Cmax</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix> sulfate, 200 mg t.i.d., and </ao:prefix>
    <domeo:uuid></domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:7f5d1295-03df-474d-8a26-28174d887804"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-108.txt.html</ao:hasSource>
    <ao:exact>nifedipine</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N9df1cef55e5345c7950cc3e2f43f41f7">
    <domeo:sets rdf:resource="urn:pddi:uuid:6F359A75-470A-42B0-BD23-907799D053C4"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:DFAAB2F1-188D-4D4B-8AEC-6A3AF9A0725E">
    <ao:suffix>xsd:String</ao:suffix>
    <ao:prefix>xsd:String</ao:prefix>
    <pav:createdOn>2014-07-08 13:59:58 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:DFAAB2F1-188D-4D4B-8AEC-6A3AF9A0725E"/>
    <ao:exact>Drugs that inhibit CYP2D6 (such as desipramine, paroxetine, ritonavir, sertraline) and CYP3A4 (such as ketoconazole, ritonavir, saquinavir, erythromycin, and grapefruit juice) can be expected to cause increased plasma levels of propafenone. The combination of CYP3A4 inhibition and either CYP2D6 deficiency or CYP2D6 inhibition with administration of propafenone may increase the risk of adverse reactions, including proarrhythmia. Therefore, simultaneous use of RYTHMOL SR with both a CYP2D6 inhibitor and a CYP3A4 inhibitor should be avoided</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-194.txt.html</ao:hasSource>
    <domeo:uuid>DFAAB2F1-188D-4D4B-8AEC-6A3AF9A0725E</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:6FD503C3-5967-4368-998D-CD62C6625AA1">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:6FD503C3-5967-4368-998D-CD62C6625AA1"/>
    <domeo:uuid>6FD503C3-5967-4368-998D-CD62C6625AA1</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-6.txt.html</ao:hasSource>
    <ao:suffix> (ODV) in plasma are attained within 3 days of oral multiple dose therapy. </ao:suffix>
    <ao:exact>O-desmethylvenlafaxine</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-21 09:58:51 -0400</pav:createdOn>
    <ao:prefix> and </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:8AC00FB9-AD4A-47D8-98ED-1285434A85EC">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <ao:suffix> was about 21 hours (CV=20%) in extensive metabolizers and 30 hours (CV=25%) in poor metabolizers. The pharmacokinetics of risperidone and 9-hydroxyrisperidone combined, after single and multiple doses, were similar in extensive and poor metabolizers, wi</ao:suffix>
    <pav:createdOn>2014-07-07 19:58:03 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:8AC00FB9-AD4A-47D8-98ED-1285434A85EC"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>was 3 hours (CV=30%) in extensive metabolizers and 20 hours (CV=40%) in poor metabolizers. The apparent half-life of </ao:prefix>
    <domeo:uuid>8AC00FB9-AD4A-47D8-98ED-1285434A85EC</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>9-hydroxyrisperidone</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Na0b4a45d87bb44e7828d02a48aeb9a33">
    <domeo:sets rdf:resource="urn:pddi:uuid:E58C7387-8AE7-4492-A62F-4391AE4A1C2C"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:81905BDC-D3EE-4998-8837-50782592281E">
    <domeo:belongsToSet>urn:domeoclient:uuid:423352B3-8ABA-48B7-98CF-B191A7BFC955</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:04AA4052-1F92-4C89-B2F0-46529989DBBF"/>
    <pav:createdOn>2014-07-08 09:32:21 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotation:AECC0A31-974F-4E24-884A-A8D19B659967</pav:lineageUri>
    <pav:lastSavedOn>2014-07-08 09:35:29 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:D0E1198D-B467-4D09-86F6-59C3F2F15BCD">
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:99739ED3-5B36-4BE1-82DE-49B2D1703C5A"/>
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:2D30A04F-52B9-41D6-80B3-E687377067CA">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:2D30A04F-52B9-41D6-80B3-E687377067CA"/>
    <ao:suffix>in patients receiving quinidine have not been evaluated, but observations in a modest number (N≅70) of poor metabolizers given risperidone do not suggest important differences between poor and extensive metabolizers. Second, co-administration of known en</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>2D30A04F-52B9-41D6-80B3-E687377067CA</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <ao:exact>risperidone </ao:exact>
    <pav:createdOn>2014-07-07 19:49:05 -0400</pav:createdOn>
    <ao:prefix>pharmacokinetic profile typical of poor metabolizers. The therapeutic benefits and adverse effects of </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:1979CA28-E9EF-4A66-A53F-53E29B63A7A7">
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-07-07 20:34:18 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2014-07-07 20:32:19 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotation:A9AA682B-1E42-49C7-930F-8BDBC2FDB599</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoclient:uuid:51AE28A6-A4F5-4551-AD8B-8ADDDCA82257</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:811D400C-B1C8-4FC0-8B9A-57ED7D3B3F18"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F9AC1D61-58E8-40AA-B5A7-651E0D5145BA">
    <pav:createdOn>2014-07-07 19:58:38 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotation:BF58013E-16E0-4A4D-8D5F-221D2F5F83BE</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:E24CE0A1-88CD-43C6-8075-A618667EE0F9"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2014-07-07 19:59:12 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5ABD9862-F044-4404-AD04-73DA04ADDA8B</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A98A2D6C-5168-4E16-8726-BB2F3BF90FDC">
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:previousVersion>urn:domeoclient:uuid:53FAA6D0-9A40-44F9-8FE0-3166137CEF10</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotationset:F37BE993-E972-47AE-896D-FF4D33157ECF</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:9FAD049C-4CA3-464A-A5A9-9626EA2E4617"/>
    <pav:lastSavedOn>2014-07-07 10:03:14 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-07 10:03:08 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A5E637EF-5CA5-4AAC-BD8B-C136A86E17B7</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:87B81289-98D7-49FE-9CDF-213F4BF3D91D">
    <pav:createdOn>2014-07-07 09:38:32 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:87B81289-98D7-49FE-9CDF-213F4BF3D91D"/>
    <domeo:uuid>87B81289-98D7-49FE-9CDF-213F4BF3D91D</domeo:uuid>
    <ao:exact>sildenafil </ao:exact>
    <ao:prefix>average steady-state concentrations were 20–50% higher when compared to those of healthy volunteers. There was also a doubling of Cmin levels compared to healthy volunteers. Both findings suggest a lower clearance and/or a higher oral bioavailability of </ao:prefix>
    <ao:suffix>in patients with pulmonary hypertension compared to healthy volunteers.</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:854A5EDE-6356-45B0-BCB9-BE45DA770390">
    <ao:body rdf:nodeID="N99b47ea908b14204bebdb7872f6bf9a1"/>
    <pav:lineageUri>urn:domeoserver:annotation:B159B7D5-9BF7-4E05-9C43-FD1F659360DC</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoclient:uuid:F62BD12C-2E69-42FB-A04C-B6D7C7FBB29C</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:774A9347-D89F-48D7-8DED-5584C9494543"/>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:lastSavedOn>2014-07-08 08:56:08 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:createdOn>2014-07-08 08:56:08 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:4A7D60B8-C389-4412-96A0-A073BCDBADBC">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix> (</ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:4A7D60B8-C389-4412-96A0-A073BCDBADBC"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-08 14:25:18 -0400</pav:createdOn>
    <ao:exact>ZDV-TP</ao:exact>
    <domeo:uuid>4A7D60B8-C389-4412-96A0-A073BCDBADBC</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-197.txt.html</ao:hasSource>
    <ao:suffix>). The principal mode of action of ZDV-TP is inhibition of reverse transcriptase (RT) via DNA chain termination after incorporation of the nucleotide analogue. ZDV-TP is a weak inhibitor of the cellular DNA polymerases α and γ and has been reported to be</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/C04F0392-C448-444F-AAA2-57501549FCCB">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/8754</dailymed:activeMoietyRxCUI>
    <rdfs:label>propafenone</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:F6B33A60-A21A-4168-9980-03D3A06B0252">
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:05E013A5-0A04-4AA9-A902-B63CC2AB44A1"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:68A2783E-4A88-456C-AE77-4C384F154759">
    <pav:lineageUri>urn:domeoserver:annotationset:57174A7C-3100-4C8F-9C4A-2991CEE124D5</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:D7BA4EF5-2D70-4B7B-A774-E3ADF8397E7D"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:23515E27-98AC-4DC9-A4B7-EBFE2991219F</domeo:belongsToSet>
    <pav:previousVersion>urn:domeoclient:uuid:5BCE2FDB-C586-44CD-88F7-6EE2BDB6B929</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:createdOn>2014-07-08 08:48:06 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2014-07-08 08:51:47 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:0C3B04D1-EA76-42E1-9C85-0D52A0AA9F4D">
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-07-07 19:49:17 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2014-07-07 19:50:36 -0400</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:D3FC01A7-CA51-4CBF-AD2B-28D403119A0A"/>
    <pav:lineageUri>urn:domeoserver:annotationset:1DED06A6-8562-4CCF-A58C-CA25748FBD31</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5ABD9862-F044-4404-AD04-73DA04ADDA8B</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:06661B74-00AE-4DF7-A9CC-742273A11E94">
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <ao:item rdf:resource="urn:domeoclient:uuid:EDCDCFE8-C8C9-46C5-9B41-E5151A46DE38"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:49BB1687-760C-4132-803F-8929B3CEA2D8"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:677DCD4D-7FD4-4EE7-AF77-0C09D142FF98"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:item rdf:resource="urn:domeoclient:uuid:B6AAAF28-5676-44E1-8BFD-81077C83CD8C"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:709ADA7F-2CEF-4136-B746-E33B1F161FEB"/>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <domeo:deleted>false</domeo:deleted>
    <pav:createdOn>2014-07-07 20:29:17 -0400</pav:createdOn>
    <permissions:permissions rdf:nodeID="N4ed58351f9c44e039be63bf0e09af817"/>
    <pav:lineageUri>urn:domeoserver:annotationset:AB714533-6AE1-4EC1-90ED-FDC53EF4EB3D</pav:lineageUri>
    <ao:item rdf:resource="urn:domeoclient:uuid:FFD6E9D1-D589-4A5D-B1CC-D746B73EFDA8"/>
    <rdfs:label>Default Set</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-07-07 20:30:15 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812e52b20002"/>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-54.txt.html</ao:annotatesResource>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:8A08C851-9953-4E36-9386-3031662BF511">
    <pav:createdOn>2014-07-07 09:35:03 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotationset:F37BE993-E972-47AE-896D-FF4D33157ECF</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-07 09:44:18 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A5E637EF-5CA5-4AAC-BD8B-C136A86E17B7</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:6B6E16AF-4BB6-4379-93DA-F5E3F37A8E6A"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:5df97e45-34d1-4996-b04d-0bd1a3577070">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:5df97e45-34d1-4996-b04d-0bd1a3577070"/>
    <ao:suffix> and a reduction of the dose o</ao:suffix>
    <pav:createdOn>2014-07-07 08:07:05 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-109.txt.html</ao:hasSource>
    <ao:exact>nifedipine</ao:exact>
    <ao:prefix>oadministering diltiazem and </ao:prefix>
    <domeo:uuid></domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/E082272F-163E-44C5-8D3F-DB00EBD18FC6">
    <rdfs:label>carbamazepine</rdfs:label>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/2002</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:9D895D4C-742C-45D3-A2A4-1F667FAC5019">
    <domeo:belongsToSet>urn:domeoserver:annotationset:23515E27-98AC-4DC9-A4B7-EBFE2991219F</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotationset:57174A7C-3100-4C8F-9C4A-2991CEE124D5</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:5C775FDE-7B0E-4E69-BEAA-3DDE26FBB962"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:createdOn>2014-07-08 08:39:49 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-07-08 08:46:38 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7BD07360-3C6E-4CEF-9BC7-C8FD2A61F0B1">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>7BD07360-3C6E-4CEF-9BC7-C8FD2A61F0B1</domeo:uuid>
    <ao:suffix>, naphthyloxylactic acid and glucuronic acid, and sulfate conjugates of 4-hydroxy propranolol.</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:7BD07360-3C6E-4CEF-9BC7-C8FD2A61F0B1"/>
    <ao:exact> propranolol glucuronide</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-135.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>n oxidation, and direct glucuronidation. It has been estimated that the percentage contributions of these routes to total metabolism are 42%, 41% and 17%, respectively, but with considerable variability between individuals. The four major metabolites are</ao:prefix>
    <pav:createdOn>2014-07-08 09:24:09 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:BF8E6EF1-0912-4AAE-8C56-D4EF1439CE2A">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-07 09:38:40 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:BF8E6EF1-0912-4AAE-8C56-D4EF1439CE2A"/>
    <ao:suffix>and its active N-desmethyl metabolite, respectively, compared to those seen in healthy younger volunteers (18–45 years). Due to age-differences in plasma protein binding, the corresponding increase in the AUC of free (unbound) sildenafil and its active N</ao:suffix>
    <ao:prefix>, resulting in approximately 84% and 107% higher plasma concentrations of </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <domeo:uuid>BF8E6EF1-0912-4AAE-8C56-D4EF1439CE2A</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>sildenafil </ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/D75AE2D3-176E-449F-9DC2-2024B57D72BD">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>amitriptyline</rdfs:label>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/704</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:ED1C7034-2357-44D2-91BE-813CD7E3DA2B">
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:B72301C6-9B10-4EDB-BB00-4AC1971A82DC"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:06097890-DF39-4D30-9C17-EEF19190B2D7">
    <ao:item rdf:resource="urn:domeoclient:uuid:A8E93BE5-3F12-47E6-8B5E-3AC5C1255745"/>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812e52b20002"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-07-08 12:26:22 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-07-08 12:26:35 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <permissions:permissions rdf:nodeID="Na8e37c2a3b764547b282291c3bcac06f"/>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-167.txt.html</ao:annotatesResource>
    <domeo:deleted>false</domeo:deleted>
    <rdfs:label>Default Set</rdfs:label>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:item rdf:resource="urn:domeoclient:uuid:7C698764-20DE-4E53-85C8-AA7B6EB906A3"/>
    <pav:lineageUri>urn:domeoserver:annotationset:105B0CB5-356C-4A06-9D12-CE743ECF3CD8</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D5E714D9-FDCD-42A5-8E78-87DE7206FFDB">
    <domeo:uuid>D5E714D9-FDCD-42A5-8E78-87DE7206FFDB</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-22.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:D5E714D9-FDCD-42A5-8E78-87DE7206FFDB"/>
    <ao:prefix> or </ao:prefix>
    <ao:suffix>AUC after the administration of 50 mg of fluconazole. The mean increase in ethinyl estradiol AUC was 6% (range: -47 to 108%) and levonorgestrel AUC increased 17% (range: -33 to 141%).</ao:suffix>
    <pav:createdOn>2014-07-07 20:05:56 -0400</pav:createdOn>
    <ao:exact>levonorgestrel </ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N74e0ad6fab4748fa95109ae74ded6405">
    <permissions:accessType>urn:person:uuid:080e143046812afe0146812e52b20002</permissions:accessType>
    <permissions:isLocked>false</permissions:isLocked>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E8E319B5-4A40-4E2F-B20B-3D3FA11DA16E">
    <pav:createdOn>2014-07-07 20:15:08 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:E8E319B5-4A40-4E2F-B20B-3D3FA11DA16E"/>
    <domeo:uuid>E8E319B5-4A40-4E2F-B20B-3D3FA11DA16E</domeo:uuid>
    <ao:prefix>AUC, Cmax, Cmin (24-hour concentration), and a significant reduction in apparent oral clearance following the administration of </ao:prefix>
    <ao:suffix>. The mean ± SD increase in AUC was 92% ± 43% (range: 18 to 147%). The Cmax increased 60% ± 48% (range: -5 to 133%). The Cmin increased 157% ± 96% (range: 33 to 360%). The apparent oral clearance decreased 45% ± 15% (range: -15 to -60%). (See PRECAUTIONS</ao:suffix>
    <ao:exact>fluconazole</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-26.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:B7AF10B7-52EF-47EE-9448-9BACD4DCAA75">
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:5D36B789-B525-41AE-B057-384504C41940"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:FAE98F89-D4F8-4983-B42C-00D341030245">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:createdOn>2014-07-08 09:33:58 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:body rdf:nodeID="N01d480fec8e040a98f4faace02701e00"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:423352B3-8ABA-48B7-98CF-B191A7BFC955</domeo:belongsToSet>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:FAF680C3-6E84-4E8E-916D-DF5819D3EB75"/>
    <pav:lineageUri>urn:domeoserver:annotation:5A2E5DF5-5089-4CD0-A3FF-56F94A574247</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-07-08 09:35:29 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:4388EE9C-D8AA-4371-A246-D92D12E328A6">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A5E637EF-5CA5-4AAC-BD8B-C136A86E17B7</domeo:belongsToSet>
    <pav:createdOn>2014-07-07 09:37:06 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:6174B8AE-19C6-4BA4-B986-FE9A169F8C43"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotationset:F37BE993-E972-47AE-896D-FF4D33157ECF</pav:lineageUri>
    <pav:lastSavedOn>2014-07-07 09:44:18 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:99739ED3-5B36-4BE1-82DE-49B2D1703C5A">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/EAAF223B-3DAD-4A1B-8640-D67514B27778"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/291B64A8-2FA8-4102-AB70-90580BB3A04D"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:2194D376-E23D-4032-9E14-B41C862D51B2">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoclient:uuid:21FE87BA-B7AA-4926-95E7-7E20EA2E4643</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotation:28A96AF9-EE09-4E67-8EF0-F6D438CA725F</pav:lineageUri>
    <pav:createdOn>2014-07-07 20:10:25 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:51B5C904-6027-4CA8-B4DA-1DF2AAB2ACF4"/>
    <pav:lastSavedOn>2014-07-07 20:12:43 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A985AB9E-D0F3-4E9A-A4A5-D4C311D56DBC">
    <pav:lineageUri>urn:domeoserver:annotationset:F37BE993-E972-47AE-896D-FF4D33157ECF</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2014-07-07 09:44:18 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:8E3D9621-F584-43BA-8EFA-739CAF26EEAC"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A5E637EF-5CA5-4AAC-BD8B-C136A86E17B7</domeo:belongsToSet>
    <pav:createdOn>2014-07-07 09:41:49 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B81F7A57-C2F3-4C53-9A14-2E1BA72D7B7F">
    <pav:createdOn>2014-07-08 09:32:39 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:B81F7A57-C2F3-4C53-9A14-2E1BA72D7B7F"/>
    <ao:suffix> may also decrease biliary excretion.</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-139.txt.html</ao:hasSource>
    <ao:prefix>gastrointestinal secretion, while </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>B81F7A57-C2F3-4C53-9A14-2E1BA72D7B7F</domeo:uuid>
    <ao:exact>erythromycin </ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/D177823B-9EAD-487B-94D2-6DF517A17AF9">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/8787</dailymed:activeMoietyRxCUI>
    <rdfs:label>propranolol</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7F129B4B-B024-45DF-AF73-131C4BA12EAB">
    <domeo:uuid>7F129B4B-B024-45DF-AF73-131C4BA12EAB</domeo:uuid>
    <ao:exact>sildenafil </ao:exact>
    <ao:suffix>levels.</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:7F129B4B-B024-45DF-AF73-131C4BA12EAB"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-07 09:41:29 -0400</pav:createdOn>
    <ao:prefix>has not been studied, their concomitant use is expected to increase </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:A4F34B68-466F-4AE7-8538-3E71001B2E14">
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:EB409F3B-D8A2-4371-AD5C-91EF79AF791A"/>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:CD7729B9-CDC5-4A9A-AB6E-ABAAC0B546B1">
    <ao:exact>sildenafil</ao:exact>
    <pav:createdOn>2014-07-07 10:02:36 -0400</pav:createdOn>
    <domeo:uuid>CD7729B9-CDC5-4A9A-AB6E-ABAAC0B546B1</domeo:uuid>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:CD7729B9-CDC5-4A9A-AB6E-ABAAC0B546B1"/>
    <ao:prefix>xsd:String</ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:23272370-6EDA-4C06-9199-D13977C538E5">
    <pav:createdOn>2014-07-07 20:40:00 -0400</pav:createdOn>
    <domeo:uuid>23272370-6EDA-4C06-9199-D13977C538E5</domeo:uuid>
    <ao:prefix>and </ao:prefix>
    <ao:suffix>, respectively.</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:23272370-6EDA-4C06-9199-D13977C538E5"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-118.txt.html</ao:hasSource>
    <ao:exact>midazolam</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B8024119-B326-4A20-9801-460A2876BCEE">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:9D030CDB-566E-4D88-8D74-12A6DF8F84AB"/>
    <pav:createdOn>2014-07-08 15:44:35 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5B2167F6-4E63-4A7B-85C1-ACA56DDE7073</domeo:belongsToSet>
    <ao:body rdf:nodeID="N1f1b0d7c80364a3e90f1995f9cb44a87"/>
    <pav:previousVersion>urn:domeoserver:annotationset:6C113438-07CB-4840-A14B-360CDF3BD22A</pav:previousVersion>
    <pav:lastSavedOn>2014-07-08 15:45:42 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">4</pav:versionNumber>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotationset:061a21f6-0ef7-497f-bd03-574c24bc0d7c</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:415010FA-44FA-419C-8964-E89BA87BBF93">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>415010FA-44FA-419C-8964-E89BA87BBF93</domeo:uuid>
    <ao:exact>fluconazole </ao:exact>
    <ao:suffix>200 mg daily for 15 days) in 13 volunteers with AIDS or ARC who were on a stable zidovudine dose for at least two weeks. There was a significant increase in zidovudine AUC following the administration of fluconazole. The mean ± SD increase in AUC was 20%</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-27.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:415010FA-44FA-419C-8964-E89BA87BBF93"/>
    <pav:createdOn>2014-07-07 20:16:37 -0400</pav:createdOn>
    <ao:prefix>concentrations were determined on two occasions (before and following </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B46C4987-02D9-4559-B8A5-B281F9E9250B">
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5ABD9862-F044-4404-AD04-73DA04ADDA8B</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotationset:1DED06A6-8562-4CCF-A58C-CA25748FBD31</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:CF30A1F4-6674-47FC-BF71-4AD23FFA7D6A"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-07-07 19:50:36 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-07 19:46:05 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:635A8912-2E77-4AD2-81FB-45E1C9894AD9">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <ao:body rdf:nodeID="Nf61e8b8468014341ba411787e0c1ec2f"/>
    <pav:previousVersion>urn:domeoclient:uuid:e75c9d7b-f906-4c66-8a84-e6eef34d0954</pav:previousVersion>
    <pav:createdOn>2014-07-08 14:24:43 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotationset:0f67c012-7596-4b02-a927-63c0ccbc3afa</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:9C40151B-89FE-439C-8660-16B7812A9785"/>
    <pav:lastSavedOn>2014-07-08 14:24:44 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">3</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:42258B16-6749-4B39-B28D-88C8B63F7A43</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:8061F928-43C7-4E80-9544-E961A1F30C1D">
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:createdOn>2014-07-07 20:25:53 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2014-07-07 20:26:26 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoclient:uuid:25536997-8B2D-4FC8-A79B-A98E343D3101</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:6B3AD3F8-D6B9-4940-A837-44D3CD17F1E7"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotation:3609F343-5402-4BC6-B075-C5300AE33FC1</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:43EDED30-FAB5-4F26-8585-2ED0B4C7D300">
    <ao:suffix>in plasma was increased by about 35% because of the diminished concentration of both albumin and α1-acid glycoprotein. Risperidone doses should be reduced in patients with liver disease [see 2 DOSAGE AND ADMINISTRATION and 5 WARNINGS AND PRECAUTIONS].</ao:suffix>
    <ao:exact>risperidone </ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:43EDED30-FAB5-4F26-8585-2ED0B4C7D300"/>
    <ao:prefix>in subjects with liver disease were comparable to those in young healthy subjects, the mean free fraction of </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-07 19:58:29 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <domeo:uuid>43EDED30-FAB5-4F26-8585-2ED0B4C7D300</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C76F01B7-B793-4BB1-9ACF-8CC577A3F9BF">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>xsd:String</ao:prefix>
    <domeo:uuid>C76F01B7-B793-4BB1-9ACF-8CC577A3F9BF</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:C76F01B7-B793-4BB1-9ACF-8CC577A3F9BF"/>
    <ao:suffix> displaces each other from plasma binding sites. High therapeutic concentrations of sulfamethazine (100 mcg/mL), warfarin (10 mcg/mL), and carbamazepine (10 mcg/mL) caused only a slight increase in the free fraction of risperidone at 10 ng/mL and 9-hydro</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-07 19:46:56 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <ao:exact>e</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/0E4C3039-A561-44D2-B2B5-14FE50280C0E">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/83395</dailymed:activeMoietyRxCUI>
    <rdfs:label>saquinavir</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:20339A30-6028-423D-87E1-5386E60BEAB9">
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:110DB62E-8987-43E3-8C7D-E1BEF7CB0ACF"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotation:C6B5F10D-DF56-4C1D-B52D-2A8E9F5E7123</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-08 13:54:59 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-07-08 13:56:02 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:DD05DE56-7B60-4C06-8552-D1DD652D8A79</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/CFDB108F-E2D7-4178-84D2-7ABD3C4E2E83">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/2447</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>cholestyramine</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoserver:annotationset:A7033EE8-62A2-4AAF-AD21-7D4F7611919F">
    <ao:item rdf:resource="urn:domeoclient:uuid:58BF3512-922E-41A4-AFD3-021EAD6B68E2"/>
    <domeo:deleted>false</domeo:deleted>
    <dct:description>The NER set is created automatically by NER annotation loading program.</dct:description>
    <ao:item rdf:resource="urn:domeoclient:uuid:6ADA22D4-36CE-4212-8A7D-8F44DE2131D9"/>
    <permissions:permissions rdf:nodeID="N480229c169e14edf9197d4832a9c01ec"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-08 15:41:14 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-07 08:06:39 -0400</pav:createdOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:A7A1044A-5798-4AC3-8C4C-D73C3DB57AF5"/>
    <rdfs:label>NER Sets</rdfs:label>
    <ao:item rdf:resource="urn:domeoclient:uuid:FE1A477B-EB1A-420B-AD02-C547D6535DE1"/>
    <pav:previousVersion>urn:domeoclient:uuid:d898bb33-64f8-4fa7-95bf-c3fd1f82b220</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">3</pav:versionNumber>
    <ao:item rdf:resource="urn:domeoclient:uuid:DE560C91-21D6-4968-95FA-224203CA8EF9"/>
    <pav:lineageUri>urn:domeoserver:annotationset:9dbc20ea-3552-4427-930a-52eb84c9e230</pav:lineageUri>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-177.txt.html</ao:annotatesResource>
    <ao:item rdf:resource="file:///home/yin2/python-SPL-connector/f93b2d38-4cf2-4c3d-9dd6-6a79b9a8d884"/>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812e52b20002"/>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:2CF24E02-253A-47F5-8A8B-D610852D912D">
    <pav:createdOn>2014-07-08 08:43:44 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <domeo:uuid>2CF24E02-253A-47F5-8A8B-D610852D912D</domeo:uuid>
    <ao:exact>metformin </ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:2CF24E02-253A-47F5-8A8B-D610852D912D"/>
    <ao:suffix>with AVANDIA is contraindicated in these patients.</ao:suffix>
    <ao:prefix>is contraindicated in patients with renal impairment, coadministration of </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C91AB158-FD90-483E-AE34-00AABE4346B0">
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotation:DFC1B68E-95D0-4EA8-A1BB-E5FB0DFC73C2</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:DD05DE56-7B60-4C06-8552-D1DD652D8A79</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-08 13:56:02 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-07-08 13:54:57 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:79337B16-22ED-4E24-8E1B-97AAA870A411"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:3BC8DEA6-A36F-49F1-87EA-75EBD682F9D2">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/AB0A1481-FD34-441F-844A-402263A4D0F6"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/932AB148-37D7-4E0A-87A8-C43AA4F6E7B7"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:470EC20A-1CAB-484C-BCAC-85674D6119F7">
    <ao:suffix>. GZDV AUC is about 3-fold greater than the </ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:470EC20A-1CAB-484C-BCAC-85674D6119F7"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>470EC20A-1CAB-484C-BCAC-85674D6119F7</domeo:uuid>
    <pav:createdOn>2014-07-08 14:20:00 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-197.txt.html</ao:hasSource>
    <ao:exact>GZDV</ao:exact>
    <ao:prefix> is </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C316D717-8120-4EB8-9B24-36447358217A">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2014-07-08 12:05:20 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotation:81DA58E5-65C1-455D-991B-CB0F20958AD1</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:F0DC88F4-861D-406C-B0AC-5C984835B925"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoclient:uuid:D74AEF81-5B9A-431F-9F0D-1822391A7E30</domeo:belongsToSet>
    <pav:createdOn>2014-07-08 12:02:51 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D9ABDF09-DEE9-4F4A-AF7E-5E45D8F68A4C">
    <ao:suffix>have occasionally precipitated unpredictable, severe, and occasionally fatal reactions in patients who have received such agents within 14 days. The mechanism of these reactions is unclear, but may be related to a preexisting hyperphenylalaninemia. Some </ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-165.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:D9ABDF09-DEE9-4F4A-AF7E-5E45D8F68A4C"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-08 12:21:20 -0400</pav:createdOn>
    <ao:exact>meperidine </ao:exact>
    <domeo:uuid>D9ABDF09-DEE9-4F4A-AF7E-5E45D8F68A4C</domeo:uuid>
    <ao:prefix>is contraindicated in patients who are receiving monoamine oxidase (MAO) inhibitors or those who have recently received such agents. Therapeutic doses of </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/e7e622e7-cc91-4ca6-b2fb-f9679f5cf2ce">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-07 08:07:05 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotationset:9d42d74c-ef20-420f-a0c6-3e880a864174</pav:lineageUri>
    <pav:createdOn>2014-07-07 08:07:05 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:0E266770-6575-4561-B418-59E9FFE8BEE7</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:5df97e45-34d1-4996-b04d-0bd1a3577070"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:06AC0B3A-23F1-4DC7-B6F7-4E99505ADB88">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:06AC0B3A-23F1-4DC7-B6F7-4E99505ADB88"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <ao:suffix>is taken with a high-fat meal, the rate of absorption is reduced, with a mean delay in Tmax of 60 minutes and a mean reduction in Cmax of 29%. The mean steady state volume of distribution (Vss) for sildenafil is 105 L, indicating distribution into the ti</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>REVATIO </ao:exact>
    <domeo:uuid>06AC0B3A-23F1-4DC7-B6F7-4E99505ADB88</domeo:uuid>
    <ao:prefix>is rapidly absorbed after oral administration, with a mean absolute bioavailability of 41% (25–63%). Maximum observed plasma concentrations are reached within 30 to 120 minutes (median 60 minutes) of oral dosing in the fasted state. When </ao:prefix>
    <pav:createdOn>2014-07-07 09:36:50 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoserver:annotationset:4C025723-BCF8-41B1-92B5-614AF1C7050A">
    <ao:item rdf:resource="file:///home/yin2/python-SPL-connector/5144d78f-fe1c-414e-a884-683adc4b9578"/>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">3</pav:versionNumber>
    <ao:item rdf:resource="urn:domeoclient:uuid:F3EDD32E-0A29-4402-89FA-A89B8957004D"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:createdOn>2014-07-07 08:06:43 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotationset:9009c33d-cb3e-4603-bf7c-6e303bab4e6b</pav:lineageUri>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812e52b20002"/>
    <permissions:permissions rdf:nodeID="Nb6c1c4213e2a4e4e8e1a9c21c52587db"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:deleted>false</domeo:deleted>
    <rdfs:label>NER Sets</rdfs:label>
    <pav:lastSavedOn>2014-07-08 14:48:47 -0400</pav:lastSavedOn>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-115.txt.html</ao:annotatesResource>
    <dct:description>The NER set is created automatically by NER annotation loading program.</dct:description>
    <pav:previousVersion>urn:domeoclient:uuid:260ed524-8e24-4546-b8bb-aa04c8b3c9af</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E0C7F5D3-3AB4-4981-99E9-08634670F1AF">
    <pav:lineageUri>urn:domeoserver:annotationset:061a21f6-0ef7-497f-bd03-574c24bc0d7c</pav:lineageUri>
    <ao:body rdf:nodeID="Nd4da246e7c914f53a64e4390773bbe41"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">4</pav:versionNumber>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:BBBC91BF-B93F-4383-9FE6-082D358AB9CB"/>
    <pav:createdOn>2014-07-08 15:45:21 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5B2167F6-4E63-4A7B-85C1-ACA56DDE7073</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-08 15:45:42 -0400</pav:lastSavedOn>
    <pav:previousVersion>urn:domeoserver:annotationset:6C113438-07CB-4840-A14B-360CDF3BD22A</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:6E8909DB-5487-49E2-9EE7-5D60FB6ED6D1">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:createdOn>2014-07-07 20:49:58 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoclient:uuid:29AAB777-4FBF-49C4-ACFD-F2FC169A463D</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotation:5EA5572E-53FD-4C3D-A3C4-D8FE3F666F22</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-07-07 20:51:02 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:7EE21BFF-9BDF-4EF9-BC7C-3814AD40BC5B"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:06A3DDC8-332E-4E54-A5C8-C5EE4826BC46">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/61F96D9A-FC5F-43A2-8933-84144095EC09"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/57E332C5-7223-42D1-9C68-7D90FBAC4378"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:00294AD3-D060-4A30-81CC-B07BEDF6204C">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:4B88F9C8-DB60-4F0F-978B-CCAC83124AAA"/>
    <pav:lastSavedOn>2014-07-08 08:54:46 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:23515E27-98AC-4DC9-A4B7-EBFE2991219F</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdOn>2014-07-08 08:54:05 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotation:8979746D-9CD6-4F10-ADBE-7A89FFAF1CE5</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:DF532E3B-F77C-41C1-ACD1-91EC4B5F075D">
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:ADA6D6F5-D3D0-4351-A7BF-B27CA3D78AAB"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:0A2041A1-9C79-4A4F-91BA-2A9370192C5F">
    <ao:prefix>marked effects on a broad range of P450 substrates. Although the interaction between other protease inhibitors (except </ao:prefix>
    <ao:suffix>) and REVATIO has not been studied, their concomitant use is expected to increase sildenafil levels.</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>saquinavir</ao:exact>
    <domeo:uuid>0A2041A1-9C79-4A4F-91BA-2A9370192C5F</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:0A2041A1-9C79-4A4F-91BA-2A9370192C5F"/>
    <pav:createdOn>2014-07-07 09:40:33 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:057548E3-0455-4B58-B8B0-694BE77B83C5">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/AB7AECF0-86D9-4965-9866-6C295CBB3524"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/40BCF403-E878-446A-AF32-F720DCA5BA74"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/1a7389ee-ad09-4dc4-8ded-7feb1a054a1e">
    <pav:lineageUri>urn:domeoserver:annotationset:32fd2552-646d-4ca2-9689-48223920e52e</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:20BEA201-2787-43B1-AE0E-43BE9F4DA8AA</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdOn>2014-07-07 08:07:00 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-07-07 08:07:00 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:8f8d748e-69b8-427e-98ce-8ad83e6339df"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:330E3EDD-7BBE-4A51-8E64-7A9BB36833A3">
    <ao:context rdf:resource="urn:domeoclient:uuid:5400C9BE-1E8F-4890-B33D-D6F64B94D117"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotation:340677CF-9ACA-40E0-B488-F84A25FE1305</pav:lineageUri>
    <pav:createdOn>2014-07-07 19:57:59 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5ABD9862-F044-4404-AD04-73DA04ADDA8B</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-07 19:59:12 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:5C66B984-0CCA-4D6A-A33E-79218FAC8139">
    <ao:exact>Doxazosin: Healthy volunteers participating in a multiple dose doxazosin-nifedipine interaction study received 2 mg doxazosin q.d. alone or combined with 20 mg nifedipine ER b.i.d. Coadministration of nifedipine resulted in a decrease in AUC and Cmax of doxazosin to 83% and 86% of the values in the absence of nifedipine, respectively. In the presence of doxazosin, AUC and Cmax of nifedipine were increased by factors of 1.13 and 1.23, respectively. Compared to nifedipine monotherapy, blood pressure was lower in the presence of doxazosin. Blood pressure should be monitored when doxazosin is coadministered with nifedipine and dose reduction of nifedipine considered.</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:5C66B984-0CCA-4D6A-A33E-79218FAC8139"/>
    <ao:prefix>xsd:String</ao:prefix>
    <domeo:uuid>5C66B984-0CCA-4D6A-A33E-79218FAC8139</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-08 14:57:00 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-111.txt.html</ao:hasSource>
    <ao:suffix>xsd:String</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:40D7C070-F1A5-4DA0-A500-0A309BCF13C4">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:lineageUri>urn:domeoserver:annotation:908398DD-04DF-4B8C-94FC-53E413954F03</pav:lineageUri>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:A96CC8A1-3686-4F4F-94B5-15C6698415FB"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7E49EB7A-DE0E-4720-82D1-8460BA0C770D</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-08 14:10:48 -0400</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdOn>2014-07-08 14:06:28 -0400</pav:createdOn>
    <ao:body rdf:nodeID="N16d3e9136431471c8f058300bf22c30e"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:233DEF12-16AD-43C4-940B-0565AAC507BE">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/C6339ABC-4E8C-4716-A4FA-BEB9FA971BE2"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/E55352EE-F7EE-43F6-BE34-FA39D87863C0"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:67290D43-D034-4ECB-BD38-A08DD2769327">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:67290D43-D034-4ECB-BD38-A08DD2769327"/>
    <pav:createdOn>2014-07-07 20:21:37 -0400</pav:createdOn>
    <domeo:uuid>67290D43-D034-4ECB-BD38-A08DD2769327</domeo:uuid>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-28.txt.html</ao:hasSource>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:exact>The pharmacokinetics of theophylline were determined from a single intravenous dose of aminophylline (6 mg/kg) before and after the oral administration of fluconazole 200 mg daily for 14 days in 16 normal male volunteers. There were significant increases in theophylline AUC, Cmax, and half-life with a corresponding decrease in clearance. The mean ± SD theophylline AUC increased 21% ± 16% (range: -5 to 48%). The Cmax increased 13% ± 17% (range: -13 to 40%). Theophylline clearance decreased 16% ± 11 % (range: -32 to 5%). The half-life of theophylline increased from 6.6 ± 1.7 hours to 7.9 ± 1.5 hours.</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D0216212-AE15-4734-9E3C-6AE7C23DFC17">
    <domeo:uuid>D0216212-AE15-4734-9E3C-6AE7C23DFC17</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:D0216212-AE15-4734-9E3C-6AE7C23DFC17"/>
    <ao:exact>Risperidone </ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <ao:prefix>and its active metabolite decreased by 60% compared to young healthy subjects. </ao:prefix>
    <ao:suffix>doses should be reduced in patients with renal disease [see 2 DOSAGE AND ADMINISTRATION and 5 WARNINGS AND PRECAUTIONS].</ao:suffix>
    <pav:createdOn>2014-07-07 19:58:22 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/D71116AE-874A-486E-BAA8-DA34611292B9">
    <rdfs:label>azithromycin</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/18631</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/8EC4E370-16FC-443A-A51C-4B4CB8E665B0">
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/10318</dailymed:activeMoietyRxCUI>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>tacrine</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:BED6541B-23EB-4390-89E7-171E1D6FA12C">
    <pav:lastSavedOn>2014-07-21 10:02:11 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdOn>2014-07-21 09:58:38 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">3</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotationset:cf593dca-fe93-451b-8f37-2a96e065da13</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:94CF1E50-CE22-4887-8A21-56B8371A6159"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:previousVersion>urn:domeoclient:uuid:21a2d27a-13b1-4797-ba7a-c0517e32bb06</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:32944008-A6C6-4D66-8C43-EE4CF2256965</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E500AE5C-576C-4FEA-A581-9991EA21002F">
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812e52b20002"/>
    <pav:lastSavedOn>2014-07-07 20:27:05 -0400</pav:lastSavedOn>
    <rdfs:label>Default Set</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <pav:lineageUri>urn:domeoserver:annotationset:06553A8C-D047-48F4-BE56-1D4E372CC3D5</pav:lineageUri>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <permissions:permissions rdf:nodeID="N0c2dfd9445a24e8a99085bfe93bfb0ed"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:deleted>false</domeo:deleted>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-52.txt.html</ao:annotatesResource>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:item rdf:resource="urn:domeoclient:uuid:0963BBC0-6F08-48D9-9F8F-441EE46FB229"/>
    <pav:createdOn>2014-07-07 20:26:54 -0400</pav:createdOn>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D19B9A2C-9CC4-4AE1-BB61-F344D5904F19">
    <ao:body rdf:nodeID="N17bb8f6554134309a67a06abf5b3ce2d"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoclient:uuid:51AE28A6-A4F5-4551-AD8B-8ADDDCA82257</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:E6009B7B-24AB-4057-BA51-3B053974036C</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-07-07 20:34:18 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-07 20:33:43 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:B46A4A55-C807-49A7-A9A2-D2F68349C0C3"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/a5a18d09-0e59-4447-a190-529690005daf">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:lastSavedOn>2014-07-07 08:06:41 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-07 08:06:41 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotationset:24447e81-62a4-42fa-b645-98c0bd027e72</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:327f8345-cd13-4713-a184-3fa1b9e4e31e"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:B3C0E972-7A26-4B8D-88E8-D7C3C96B8C1E</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoserver:annotationset:B3C0E972-7A26-4B8D-88E8-D7C3C96B8C1E">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <ao:item rdf:resource="file:///home/yin2/python-SPL-connector/a5a18d09-0e59-4447-a190-529690005daf"/>
    <domeo:deleted>false</domeo:deleted>
    <dct:description>The NER set is created automatically by NER annotation loading program.</dct:description>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">3</pav:versionNumber>
    <pav:lastSavedOn>2014-07-08 19:45:15 -0400</pav:lastSavedOn>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-33.txt.html</ao:annotatesResource>
    <pav:createdOn>2014-07-07 08:06:41 -0400</pav:createdOn>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812e52b20002"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <permissions:permissions rdf:nodeID="Ncdcd42a396524892bf6ba4b6281c36ff"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:9A39B986-4679-4FD8-A2EF-330D6AC97D86"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:D730927A-7A5C-4283-B110-CA21BC2EF052"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotationset:24447e81-62a4-42fa-b645-98c0bd027e72</pav:lineageUri>
    <rdfs:label>NER Sets</rdfs:label>
    <pav:previousVersion>urn:domeoclient:uuid:4f6ba46d-40db-45d3-be6c-ca49eb5bf881</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:100A0CCD-71E9-4396-9B64-DD8E5ACB7174">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotationset:57174A7C-3100-4C8F-9C4A-2991CEE124D5</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2014-07-08 08:46:38 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:10639A96-D771-47D0-86DF-20C30EA39041"/>
    <pav:createdOn>2014-07-08 08:40:31 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:23515E27-98AC-4DC9-A4B7-EBFE2991219F</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/4FB71BCC-E881-4E33-A764-DA9F00827C8E">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>mesoridazine</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/6779</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:BF1C2089-16A5-414D-8315-E92E584307A0">
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:B60C56F2-1471-4A8A-9B6E-B7BF44526095"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A7166004-450A-4B74-9142-1D57955CF692">
    <ao:exact>lithium</ao:exact>
    <ao:prefix> (3 mg twice daily) did not affect the exposure (AUC) or peak plasma concentrations (Cmax) of </ao:prefix>
    <domeo:uuid>A7166004-450A-4B74-9142-1D57955CF692</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix> (N=13).</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-7.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:A7166004-450A-4B74-9142-1D57955CF692"/>
    <pav:createdOn>2014-07-08 15:46:45 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:1C306C1B-1C06-45C3-9856-1CA3A21437C6">
    <pav:createdOn>2014-07-07 09:36:27 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotationset:F37BE993-E972-47AE-896D-FF4D33157ECF</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:76B7E831-7285-452A-B2B3-79467B745E86"/>
    <pav:lastSavedOn>2014-07-07 09:44:18 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A5E637EF-5CA5-4AAC-BD8B-C136A86E17B7</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A1A9EF24-D8A1-45AE-81E7-25DD7BF04427">
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:createdOn>2014-07-08 13:54:14 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-07-08 13:56:02 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:DD05DE56-7B60-4C06-8552-D1DD652D8A79</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:95BA977E-F5B1-4787-9C77-BE9DDE62AA57</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:2F6D2C5C-D30B-4B33-978E-38E53C1A1168"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:6F359A75-470A-42B0-BD23-907799D053C4">
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:C2C7A88C-89AD-46F7-9603-EE3AB9B12E91"/>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:AC961730-8EF7-4E27-A1B2-BA2D4CA6B161">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoclient:uuid:423352B3-8ABA-48B7-98CF-B191A7BFC955</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-08 09:35:29 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotation:7E1E167B-8186-45FD-88A0-1E91C3A4E13C</pav:lineageUri>
    <pav:createdOn>2014-07-08 09:33:04 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:C4E71265-3AF4-4030-9B11-ECB9EB88730C"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:FC101F04-BB16-40BC-8350-A803BEF007F2">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <pav:createdOn>2014-07-08 08:48:04 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:previousVersion>urn:domeoclient:uuid:5BCE2FDB-C586-44CD-88F7-6EE2BDB6B929</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:23515E27-98AC-4DC9-A4B7-EBFE2991219F</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-08 08:51:47 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:F0A31D46-263C-4433-B1ED-DF6F1406E547"/>
    <pav:lineageUri>urn:domeoserver:annotationset:57174A7C-3100-4C8F-9C4A-2991CEE124D5</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:91C6CD27-CC1A-4F81-B1DB-C1F416895390">
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdOn>2014-07-08 09:31:58 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotation:5B92A536-6786-4E89-A038-B13536B82C62</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:F8BBB30D-F0CB-417D-9159-5C527A334E06"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:423352B3-8ABA-48B7-98CF-B191A7BFC955</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-08 09:35:29 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:2C899ABB-BA3D-4B6D-A232-E2DC49EE1B42">
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-07-07 20:44:32 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-07 20:44:30 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:7509829A-B936-4161-BBE6-69B2DEAE95B2"/>
    <ao:body rdf:nodeID="N12245f2d43ce4619a7cdac0555359cb2"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotation:FFD6209B-0E34-499E-AD31-84A17D9AA0D1</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoclient:uuid:F2EFEF06-B779-484C-B854-043086EB0C5C</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:FD5A3A9B-A753-4539-978E-E4D0CE4EBA04">
    <ao:prefix>xsd:String</ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:FD5A3A9B-A753-4539-978E-E4D0CE4EBA04"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-08 14:31:50 -0400</pav:createdOn>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:exact>Concomitant administration of fluvastatin (40 mg) and itraconazole (100 mg daily x 4 days) does not affect plasma itraconazole or fluvastatin levels.</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-191.txt.html</ao:hasSource>
    <domeo:uuid>FD5A3A9B-A753-4539-978E-E4D0CE4EBA04</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/169CB49D-0198-4EA2-AD6D-62C7C27F83FD">
    <rdfs:label>ribavirin</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/9344</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dct:description>Referred to the drug in the interaction.</dct:description>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:983D2637-CECD-4BE0-A42A-DC5E9E0A15C7">
    <pav:createdOn>2014-07-08 12:24:40 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-166.txt.html</ao:hasSource>
    <ao:suffix>may reduce the renal clearance of methotrexate; increased serum concentrations of methotrexate with concomitant hematologic and gastrointestinal toxicity have been observed with methotrexate. Use of methotrexate with penicillins should be carefully monit</ao:suffix>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:983D2637-CECD-4BE0-A42A-DC5E9E0A15C7"/>
    <ao:exact>Penicillins </ao:exact>
    <domeo:uuid>983D2637-CECD-4BE0-A42A-DC5E9E0A15C7</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/9718CEAE-6C8C-4A20-8B9F-56FA2D1CA6CB">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>acyclovir</rdfs:label>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/281</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:16BBE342-3A77-41E6-8363-68C4C9153AC1">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:16BBE342-3A77-41E6-8363-68C4C9153AC1"/>
    <pav:createdOn>2014-07-07 09:34:25 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <ao:prefix>Studies in vitro have shown that </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>sildenafil </ao:exact>
    <ao:suffix>is selective for PDE5. Its effect is more potent on PDE5 than on other known phosphodiesterases (10-fold for PDE6, &gt; 80-fold for PDE1, &gt; 700-fold for PDE2, PDE3, PDE4, PDE7, PDE8, PDE9, PDE10, and PDE11). The approximately 4,000-fold selectivity for PDE5</ao:suffix>
    <domeo:uuid>16BBE342-3A77-41E6-8363-68C4C9153AC1</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:FD81958B-6AF6-4FD6-AAA0-0B848C953DF2">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:FD81958B-6AF6-4FD6-AAA0-0B848C953DF2"/>
    <ao:exact>3'-amino-3'-deoxythymidine</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-197.txt.html</ao:hasSource>
    <ao:suffix> (AMT), has been identified in the plasma following single-dose intravenous (IV) administration of </ao:suffix>
    <pav:createdOn>2014-07-08 14:20:08 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix> accounts for 14% and 74%, respectively, of the dose following oral administration. A second metabolite, </ao:prefix>
    <domeo:uuid>FD81958B-6AF6-4FD6-AAA0-0B848C953DF2</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:EED1D7DF-CF12-4B75-88EB-142933594019">
    <ao:body rdf:nodeID="N2fe4376784044a85aeb5a0dcd70da54f"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotation:75FFAAB7-5D1F-45A7-AD50-089E710D3DF8</pav:lineageUri>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:createdOn>2014-07-08 09:08:47 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:43759441-9A46-4950-973A-341B063071C7"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:4E43D844-2E5A-46D2-8797-09878034F22F</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-08 09:08:48 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:246FED77-69AE-4605-9175-2C196767388D">
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-07-08 16:27:01 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:FC706AFD-18B6-480C-8EAA-2B16C3212C10</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:765DDF5B-8EE7-4632-A2D8-2C1B9627084C</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-07-08 16:26:44 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:body rdf:nodeID="N5ad2459d384b4b65bd1ab531879638cd"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:67B29DB0-E945-4071-B204-BABBDE330A9C"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:142CCD33-941A-42D7-92F5-348698C3FDEC">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:142CCD33-941A-42D7-92F5-348698C3FDEC"/>
    <ao:exact>quinidine </ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>142CCD33-941A-42D7-92F5-348698C3FDEC</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-53.txt.html</ao:hasSource>
    <ao:prefix>Perhaps because of competition for the P450 3A4metabolic pathway, </ao:prefix>
    <pav:createdOn>2014-07-07 20:27:44 -0400</pav:createdOn>
    <ao:suffix>levels rise when ketoconazole is coadministered.</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/04854F6E-8EE0-4FAD-B060-699C66E8C211">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>nifedipine</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/7417</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:5139B7E4-E320-4D9B-9F60-96E60BBB9B53">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-6.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-21 10:02:16 -0400</pav:createdOn>
    <ao:suffix>are pharmacologically approximately equiactive and equipotent.</ao:suffix>
    <ao:prefix> and </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:5139B7E4-E320-4D9B-9F60-96E60BBB9B53"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>ODV </ao:exact>
    <domeo:uuid>5139B7E4-E320-4D9B-9F60-96E60BBB9B53</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A425A546-8265-4937-89D6-C752CFE5EC29">
    <ao:suffix>has been reported to potentiate the anticoagulant effect of warfarin and other oral coumarin anticoagulants, resulting in a prolongation of prothrombin time. This possible drug interaction should be considered when FLAGYL (metronidazole) is prescribed fo</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:A425A546-8265-4937-89D6-C752CFE5EC29"/>
    <domeo:uuid>A425A546-8265-4937-89D6-C752CFE5EC29</domeo:uuid>
    <ao:exact>Metronidazole </ao:exact>
    <pav:createdOn>2014-07-07 20:46:54 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-120.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:AD5C1981-E550-4092-A3D8-AA534BCAEC42">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:AD5C1981-E550-4092-A3D8-AA534BCAEC42"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>AD5C1981-E550-4092-A3D8-AA534BCAEC42</domeo:uuid>
    <ao:prefix>xsd:String</ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-08 08:53:58 -0400</pav:createdOn>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <ao:exact>Repeat dosing with AVANDIA had no clinically relevant effect on the steady-state pharmacokinetics of warfarin enantiomers.</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/16BC5365-0702-41A5-9913-13721E61A9F2">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>citalopram</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/2556</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:4D6663BD-2805-46B5-BCAF-8863DFD12AEB">
    <ao:context rdf:resource="urn:domeoclient:uuid:AACAFE61-5CFB-400D-A0F1-B532D1F173B0"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5ABD9862-F044-4404-AD04-73DA04ADDA8B</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:lastSavedOn>2014-07-07 19:59:12 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:body rdf:nodeID="N20b39f09f5254a1d9904d9348ef8e40b"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotation:35356BFA-9E65-4289-AF5A-34C47C0A6D1A</pav:lineageUri>
    <pav:createdOn>2014-07-07 19:54:03 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/4FCA88F7-AF88-4AC7-8DE8-1C60E8274EC5">
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>phenytoin</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/8183</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/53A0CE99-22B9-49CA-894F-C6CF81B1FE68">
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/229369</dailymed:activeMoietyRxCUI>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>dalfopristin</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:71D6BAC6-DC3A-4C58-B200-6867338DA2E2">
    <ao:suffix>xsd:String</ao:suffix>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:71D6BAC6-DC3A-4C58-B200-6867338DA2E2"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-08 08:50:50 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>71D6BAC6-DC3A-4C58-B200-6867338DA2E2</domeo:uuid>
    <ao:exact>Concurrent administration of AVANDIA (2 mg twice daily) and metformin (500 mg twice daily) in healthy volunteers for 4 days had no effect on the steady-state pharmacokinetics of either metformin or rosiglitazone</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:26B99496-2759-493D-88DA-2CE5CD5A6F58">
    <pav:lineageUri>urn:domeoserver:annotationset:57174A7C-3100-4C8F-9C4A-2991CEE124D5</pav:lineageUri>
    <pav:lastSavedOn>2014-07-08 08:51:47 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:previousVersion>urn:domeoclient:uuid:5BCE2FDB-C586-44CD-88F7-6EE2BDB6B929</pav:previousVersion>
    <pav:createdOn>2014-07-08 08:46:44 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:0EA140F6-E6A7-459C-BD6F-2848A9DDACC5"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:23515E27-98AC-4DC9-A4B7-EBFE2991219F</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:0DB2814A-76A7-4557-B7FB-171C5A845E17">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/BCF87F07-1002-4D09-9C67-0FC1C19D5FB6"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/35388E97-5248-4CD8-8E7E-5B3D580B692C"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:0B919FC0-1274-4FFB-8B24-778F703E2012">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:0B919FC0-1274-4FFB-8B24-778F703E2012"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>0B919FC0-1274-4FFB-8B24-778F703E2012</domeo:uuid>
    <ao:prefix>can inhibit the metabolism of </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-128.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-08 09:07:59 -0400</pav:createdOn>
    <ao:suffix>, resulting in increased concentrations of diazepam and its metabolites. Diazepam does not alter the pharmacokinetics of propranolol.</ao:suffix>
    <ao:exact>diazepam</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:0366BEB6-FA24-4F5A-932F-9F16FA62E889">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:10B70FF9-9A5E-489B-9AB0-BC7BE3191369"/>
    <pav:lastSavedOn>2014-07-08 09:27:36 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoclient:uuid:7E425E73-12D2-4B08-9D70-75410DE87447</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:1BA31124-0B5F-4491-8197-7FC66DC5A343</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:createdOn>2014-07-08 09:25:36 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:AD84FE45-DF82-45A5-87B4-392E47C82B60">
    <pav:lastSavedOn>2014-07-08 14:52:51 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:273F6AE3-D2A7-42AC-81E3-9FAFA73F834E"/>
    <pav:lineageUri>urn:domeoserver:annotation:61BF78F9-CFA4-44E2-844A-9331911C612B</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-08 14:50:00 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:41C6B392-F8A7-4DBA-AFEF-0BE07588FACF</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:0B3B5126-B681-4D78-BC07-6E2D7ED0A3DF">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <pav:previousVersion>urn:domeoclient:uuid:5BCE2FDB-C586-44CD-88F7-6EE2BDB6B929</pav:previousVersion>
    <pav:lastSavedOn>2014-07-08 08:51:47 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:23515E27-98AC-4DC9-A4B7-EBFE2991219F</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:4D69EC02-5E8E-422F-98CE-657A87F2AAB4"/>
    <pav:createdOn>2014-07-08 08:49:00 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotationset:57174A7C-3100-4C8F-9C4A-2991CEE124D5</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:968978BF-13DD-4F90-AF23-8A7C26298327">
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:0BC292F8-BB45-4653-AD72-195515EA1BDE"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:7E902A46-3539-41A8-90FD-F243C13CF1A3">
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:866CCC7A-93D2-4F06-9190-18051A3FBDA0"/>
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:9C4340B2-9EC2-4322-AE35-B6353B6A145F">
    <ao:prefix>AUC after the administration of 50 mg of </ao:prefix>
    <ao:suffix>. The mean increase in ethinyl estradiol AUC was 6% (range: -47 to 108%) and levonorgestrel AUC increased 17% (range: -33 to 141%).</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>fluconazole</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-22.txt.html</ao:hasSource>
    <domeo:uuid>9C4340B2-9EC2-4322-AE35-B6353B6A145F</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:9C4340B2-9EC2-4322-AE35-B6353B6A145F"/>
    <pav:createdOn>2014-07-07 20:05:58 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:182B9D0A-8D41-4C8C-B599-7C8DB2DEDD2C">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/B02CC646-6745-421D-93E2-2AD1BFF8B511"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/BBB5CAFB-7825-4BC7-9F6E-BD80C1476D81"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:1D5A6D41-E5BF-4905-9702-7DA17F74482A">
    <ao:body rdf:nodeID="Nffd15c55810f47a386d4175447fea002"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:createdOn>2014-07-08 14:31:50 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-07-08 14:31:52 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:2CD5EC60-6C64-4F1C-8293-A4D163CC9362</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:E1E5AC58-BC4E-4477-8F1D-4F244987D956</pav:lineageUri>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:FD5A3A9B-A753-4539-978E-E4D0CE4EBA04"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D57CA9DE-D321-4D8D-8ABA-4B63CB3D44B7">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotationset:F37BE993-E972-47AE-896D-FF4D33157ECF</pav:lineageUri>
    <pav:createdOn>2014-07-07 09:35:53 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A5E637EF-5CA5-4AAC-BD8B-C136A86E17B7</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-07-07 09:44:18 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:57D44181-7978-45E4-B041-BB7F7B4A2A95"/>
    <rdfs:label>Highlight</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:072CF40C-F19A-4344-87A7-437C42B6F310">
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:10CD6BA1-D45A-4A46-BBBD-D2AA7F0304A9"/>
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:EE9A106F-D61D-431B-9AF5-24759392428B">
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotation:8CF2CCB8-B7C7-4A9D-80A8-D17E7CEBB1E7</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-07-08 09:35:29 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:32FB6318-B011-402B-AA12-D80ECA69CF0A"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:createdOn>2014-07-08 09:32:04 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoclient:uuid:423352B3-8ABA-48B7-98CF-B191A7BFC955</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:23B6EFF2-B809-40DE-AD18-61F5912D0D6C">
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:FA018F15-0A29-41F7-A55E-3881C503B8C3"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:21CFAE08-6A9C-4582-9FB0-44FCE6B9D0B8">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-21.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-07 20:00:55 -0400</pav:createdOn>
    <ao:prefix> compared to similar placebo dosing. The mean AUCs of</ao:prefix>
    <ao:exact> ethinyl estradiol</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:21CFAE08-6A9C-4582-9FB0-44FCE6B9D0B8"/>
    <domeo:uuid>21CFAE08-6A9C-4582-9FB0-44FCE6B9D0B8</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix> and norethindrone increased by 24% (95% C.I. range 18 to 31%) and 13% (95% C.I. range 8 to 18%), respectively relative to placebo. Fluconazole treatment did not cause a decrease in the ethinyl estradiol AUC of any individual subject in this study compar</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:2B28BF73-0F68-4B78-8463-1B7C442CDAD9">
    <ao:body rdf:nodeID="N1ddd87dba3834a5883930242554aafc7"/>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:1EAC6678-5CA0-4BBC-B006-CFBABC607E33"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:6FFD9FFA-5CED-4EE2-B68F-77212B4C447D</domeo:belongsToSet>
    <pav:createdOn>2014-07-08 09:19:45 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotation:7AB799D9-310B-4AF9-B368-D9D8CC997819</pav:lineageUri>
    <pav:lastSavedOn>2014-07-08 09:20:18 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N816ffd2194374767bf66e283e2865241">
    <domeo:sets rdf:resource="urn:pddi:uuid:8A385BA7-BCB7-4DBB-BFF5-2D8878861A76"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C85411D9-2A99-483A-972C-7598B110F9E0">
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdOn>2014-07-07 20:16:39 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-07 20:18:07 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotation:84192951-3F62-49F3-BC76-809A00CB29E5</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:98038435-9EF8-454F-93AA-0900F0475D30"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:3857B7A8-EDF2-4956-9CF4-A1B13773E162</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:8F2E3E6E-B3EE-4173-A296-DA4AFECA8AF5">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-08 08:46:45 -0400</pav:createdOn>
    <ao:prefix>xsd:String</ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:8F2E3E6E-B3EE-4173-A296-DA4AFECA8AF5"/>
    <ao:suffix>administration (600 mg once a day), an inducer of CYP2C8, for 6 days is reported to decrease rosiglitazone AUC by 66%, compared to the administration of rosiglitazone (8 mg) alone [see Drug Interactions (7.1)].4</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <domeo:uuid>8F2E3E6E-B3EE-4173-A296-DA4AFECA8AF5</domeo:uuid>
    <ao:exact>Rifampin </ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:ABB567E4-CD8B-462F-AE86-1C88DE059343">
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:D7146058-6910-4D28-A5FB-0A1C90CF9229"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/C09E7B36-CF7E-46CC-BE7A-E390BF765B53">
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>fluvoxamine</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/42355</dailymed:activeMoietyRxCUI>
    <dct:description>Referred to the drug in the interaction.</dct:description>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:1AC43FBA-3486-4890-9F9D-B9404887370D">
    <pav:createdOn>2014-07-08 12:24:46 -0400</pav:createdOn>
    <domeo:uuid>1AC43FBA-3486-4890-9F9D-B9404887370D</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-166.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:1AC43FBA-3486-4890-9F9D-B9404887370D"/>
    <ao:exact>methotrexate </ao:exact>
    <ao:suffix>with penicillins should be carefully monitored.</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>. Use of </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:9DDE1701-45F4-4E13-B434-DCE97580922B">
    <pav:lastSavedOn>2014-07-08 08:46:38 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-08 08:40:36 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotationset:57174A7C-3100-4C8F-9C4A-2991CEE124D5</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:021A107C-3FCC-4855-BA60-5783E9898ED4"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:23515E27-98AC-4DC9-A4B7-EBFE2991219F</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoserver:annotationset:20BEA201-2787-43B1-AE0E-43BE9F4DA8AA">
    <pav:createdOn>2014-07-07 08:07:00 -0400</pav:createdOn>
    <rdfs:label>NER Sets</rdfs:label>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-81.txt.html</ao:annotatesResource>
    <pav:lineageUri>urn:domeoserver:annotationset:32fd2552-646d-4ca2-9689-48223920e52e</pav:lineageUri>
    <ao:item rdf:resource="file:///home/yin2/python-SPL-connector/1a7389ee-ad09-4dc4-8ded-7feb1a054a1e"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812e52b20002"/>
    <pav:previousVersion>urn:domeoclient:uuid:7efcdb8b-a674-42e0-9b55-6e5146be7d37</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <dct:description>The NER set is created automatically by NER annotation loading program.</dct:description>
    <domeo:deleted>false</domeo:deleted>
    <permissions:permissions rdf:nodeID="N35045957b08d4f5791951bc05e522c7e"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">3</pav:versionNumber>
    <pav:lastSavedOn>2014-07-08 15:09:57 -0400</pav:lastSavedOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:0830A501-4DB1-4340-9883-9941C11215DA"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/E7718C56-205F-479E-B8CA-67AB9D3FF18E">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>propafenone</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/8754</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:4F73F61E-E52A-4179-B2CF-7673C04CE37D">
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2014-07-08 08:51:47 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotationset:57174A7C-3100-4C8F-9C4A-2991CEE124D5</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-08 08:50:23 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:23515E27-98AC-4DC9-A4B7-EBFE2991219F</domeo:belongsToSet>
    <pav:previousVersion>urn:domeoclient:uuid:5BCE2FDB-C586-44CD-88F7-6EE2BDB6B929</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:CD88686C-2177-4B29-9DB1-376688CC99AD"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:985C3750-A9C3-40C6-9DED-5084685455B3">
    <ao:prefix> half-life and AUC in patients with impaired renal function (n = 14) following a single 200 mg oral dose (Table 7). Plasma concentrations of </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:985C3750-A9C3-40C6-9DED-5084685455B3"/>
    <ao:suffix> were not determined. A dose adjustment should not be necessary for patients with </ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-197.txt.html</ao:hasSource>
    <ao:exact>AMT</ao:exact>
    <pav:createdOn>2014-07-08 14:20:30 -0400</pav:createdOn>
    <domeo:uuid>985C3750-A9C3-40C6-9DED-5084685455B3</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:08FAE140-9EFB-466F-87F2-3C4FB308BC6F">
    <ao:context rdf:resource="urn:domeoclient:uuid:9A8346F2-5096-4CD8-B9C7-95E9FEE6CA55"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotation:18A09D5F-4542-4F4E-8F46-AC1E5A1BA972</pav:lineageUri>
    <pav:createdOn>2014-07-07 20:16:35 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-07 20:18:07 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:3857B7A8-EDF2-4956-9CF4-A1B13773E162</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:4FA6CAEB-8998-48FA-963C-B5E8B5813755">
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:8874DAF5-8FBD-4442-9EBC-110E9D81AE31"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:9BCF217D-125A-4CCD-8BB9-E8D797EB4954">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotationset:F37BE993-E972-47AE-896D-FF4D33157ECF</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:DC5686B5-C58C-428D-9031-BE2DF553F563"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A5E637EF-5CA5-4AAC-BD8B-C136A86E17B7</domeo:belongsToSet>
    <pav:createdOn>2014-07-07 09:42:06 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-07-07 09:44:18 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:0A6FE314-257F-49FF-80A5-583F34F05A22">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/A325A5F6-908B-4158-9D68-0AFC3F95C7D8"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/82061165-DB05-4BB4-A173-343F5807E5A9"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:2CC8A112-0992-4F8B-A5D7-F7F36716E952">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/212E804D-EDFC-4F51-AB5F-18AAD19DFC62"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/72FC672E-E807-4C48-A10D-F40CD0181765"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:33082633-99C5-45DE-9FC0-FE3A70B22A1A">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/9AB050DC-B5A0-4118-B232-CD9F387B7376"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/9C5399E6-39AF-4792-8CA8-BC4AD95CAD35"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:736E8702-7E07-4AA1-B52A-E135ED1049B3">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotation:A57F808D-9EA6-45A2-A3B8-696A56D3D463</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:98851836-9069-4A89-8A59-0D6CBB2433E5"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:3857B7A8-EDF2-4956-9CF4-A1B13773E162</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2014-07-07 20:16:43 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:lastSavedOn>2014-07-07 20:18:07 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:5F9DB5F2-4005-4062-B633-29BB2F5B94EC">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix> [see 7 DRUG INTERACTIONS]. It would also be possible for </ao:prefix>
    <ao:suffix>to interfere with metabolism of other drugs metabolized by CYP 2D6. Relatively weak binding of risperidone to the enzyme suggests this is unlikely [see 7 DRUG INTERACTIONS].</ao:suffix>
    <ao:exact>risperidone </ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:5F9DB5F2-4005-4062-B633-29BB2F5B94EC"/>
    <pav:createdOn>2014-07-07 19:49:26 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>5F9DB5F2-4005-4062-B633-29BB2F5B94EC</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:A3C91603-68F9-4C23-A55E-41C206B23CFB">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/E5187A7F-0119-4BF1-A74F-8CABF696DAB3"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/00C15DAE-759C-4B42-ABD0-2C1FDB5AAD8D"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:006C2B92-F981-4BFE-BBBA-3EF597F9C02F">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/B8C03BBA-FE59-4DA0-BC00-C39F46BA0681"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/D71116AE-874A-486E-BAA8-DA34611292B9"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:3B7D5A7F-3A18-4BFE-AB7F-3A729CB36D82">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>(200 mg twice daily, 4 doses) on the pharmacokinetics of a single dose of </ao:prefix>
    <domeo:uuid>3B7D5A7F-3A18-4BFE-AB7F-3A729CB36D82</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>trazodone </ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:3B7D5A7F-3A18-4BFE-AB7F-3A729CB36D82"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-136.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-08 09:25:28 -0400</pav:createdOn>
    <ao:suffix>(50 mg) has been studied in 10 healthy subjects. The Cmax of trazodone increased by 34%, the AUC increased 2.4 fold, the half-life increased by 2.2 fold, and the clearance decreased by 52%. Adverse effects including nausea, hypotension, and syncope were </ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A02B1A5E-2703-4702-BEE8-179076130E88">
    <pav:createdOn>2014-07-08 09:25:28 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:3B7D5A7F-3A18-4BFE-AB7F-3A729CB36D82"/>
    <pav:lineageUri>urn:domeoserver:annotation:E937B077-7AD3-4BD5-928E-40A7228048B0</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <domeo:belongsToSet>urn:domeoclient:uuid:7E425E73-12D2-4B08-9D70-75410DE87447</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-08 09:27:36 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:DFAB1A9B-478A-4576-BB50-288C0F93B87F">
    <domeo:uuid>DFAB1A9B-478A-4576-BB50-288C0F93B87F</domeo:uuid>
    <ao:suffix>treatment.</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>ted reports of drowsiness, nystagmus, ataxia, dyspepsia, hypersensitivity reaction, and exacerbation of congestive heart failure in patients with pre-existing compromised ventricular function. There have been rare reports of pancreatitis associated with </ao:prefix>
    <ao:exact>mexiletine </ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:DFAB1A9B-478A-4576-BB50-288C0F93B87F"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-08 12:02:05 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-160.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:08C502D4-52C2-4EA2-ACCF-536F3EE7524E">
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotation:27396121-6192-468D-BFE9-1908F73E8C74</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:B2384FAD-44E7-4FC2-B56E-C1E021B49A36"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:lastSavedOn>2014-07-08 09:20:18 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-08 09:19:02 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoclient:uuid:6FFD9FFA-5CED-4EE2-B68F-77212B4C447D</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:474719AA-7597-40C0-BF57-1E518CB8BEAA">
    <ao:suffix>xsd:String</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-200.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:474719AA-7597-40C0-BF57-1E518CB8BEAA"/>
    <domeo:uuid>474719AA-7597-40C0-BF57-1E518CB8BEAA</domeo:uuid>
    <ao:exact>In patients well-stabilized on methadone, concomitant administration of rifampin resulted in a marked reduction in serum methadone levels and a concurrent appearance of withdrawal symptoms.</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>xsd:String</ao:prefix>
    <pav:createdOn>2014-07-08 13:51:14 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:177964F2-CE45-4E9B-BC10-A132995F6ACA">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:177964F2-CE45-4E9B-BC10-A132995F6ACA"/>
    <ao:suffix>xsd:String</ao:suffix>
    <domeo:uuid>177964F2-CE45-4E9B-BC10-A132995F6ACA</domeo:uuid>
    <ao:exact>Glyburide</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>xsd:String</ao:prefix>
    <pav:createdOn>2014-07-08 08:47:59 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Na22d2403452f4ffe9928c9d5800d7b44">
    <domeo:sets rdf:resource="urn:pddi:uuid:AA0D602A-60C9-4B16-B677-4C07A52E71DF"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:69655336-349D-4D66-93ED-E23E6CCB9AAB">
    <pav:lineageUri>urn:domeoserver:annotationset:cf593dca-fe93-451b-8f37-2a96e065da13</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:7A5C7579-E699-4E87-9C3D-F6E23DE1616B"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">3</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-21 09:58:46 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:32944008-A6C6-4D66-8C43-EE4CF2256965</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-21 10:02:11 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:previousVersion>urn:domeoclient:uuid:21a2d27a-13b1-4797-ba7a-c0517e32bb06</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:846C37C4-BB89-4924-862B-839C0CD40333">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/7F4AF0FC-C024-4D2F-BBED-D534227D90D4"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/F60D7750-7ADE-4E90-B609-33B84E864A42"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:EA167485-6E91-4D6C-A288-E53574EB0CB4">
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:7A821685-58FE-4383-A858-1238080C4D91"/>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/821B63F7-7F62-4655-A95C-79DFBC4EA53E">
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>methadone</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/6813</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:1D3DBFBE-9585-4079-87E5-D1EE0A05CCDC">
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:03B34860-4FD6-4D21-8F9E-8345C222E7CB"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D5B78B84-5FB5-4745-9B1D-7BD8993BCAC9">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:D5B78B84-5FB5-4745-9B1D-7BD8993BCAC9"/>
    <ao:exact>ODV</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-21 09:59:19 -0400</pav:createdOn>
    <domeo:uuid>D5B78B84-5FB5-4745-9B1D-7BD8993BCAC9</domeo:uuid>
    <ao:prefix> is well absorbed and extensively metabolized in the liver. </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-6.txt.html</ao:hasSource>
    <ao:suffix> is the only major active metabolite. On the </ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:11CB835D-E153-42CD-B292-F57F07E59A01">
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:CC0CF3E2-96EB-4CF2-AB3E-74D28222CAFB"/>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:47DFDC03-2D75-49D7-AD77-3276E1D32EC8">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotation:9F0C2C73-F046-48A9-8210-2A8A44145C70</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoclient:uuid:698327F3-D853-41CB-ADF0-60C4BFEB24F4</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:27755963-0AD3-46C8-A60E-34C4AFFDA890"/>
    <pav:lastSavedOn>2014-07-08 09:13:23 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-08 09:12:45 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A7796091-F0E5-4878-9E07-52946F884221">
    <ao:suffix>and the active metabolite have terminal half-lives of about 4 hours.</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-07 09:37:33 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:A7796091-F0E5-4878-9E07-52946F884221"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>is higher. Both </ao:prefix>
    <domeo:uuid>A7796091-F0E5-4878-9E07-52946F884221</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>sildenafil </ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/bbedd82f-ca32-40a5-879c-88175b047f72">
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:F8B6985A-9E31-47A9-A3BD-27C4204B5532</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdOn>2014-07-07 08:07:02 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-07-07 08:07:02 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:fd66d354-8021-4eea-9952-dff9f05f6a15"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotationset:bdca43f8-d464-44b4-963c-ef9b9ef75392</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:858D4B61-9F77-4036-B8A9-80C568ABA660">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/CC55E1F0-319D-4047-B49B-96BD7B80EB24"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/E0C8A2CE-A978-4272-A1E3-AAF778CF075F"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:16709F26-EAC7-479F-B3B4-CAE1A027C7EF">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>16709F26-EAC7-479F-B3B4-CAE1A027C7EF</domeo:uuid>
    <ao:prefix>) and </ao:prefix>
    <pav:createdOn>2014-07-07 09:40:35 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:16709F26-EAC7-479F-B3B4-CAE1A027C7EF"/>
    <ao:suffix>has not been studied, their concomitant use is expected to increase sildenafil levels.</ao:suffix>
    <ao:exact>REVATIO </ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F2709D47-1FC8-4669-BC79-3CEEAA38A81E">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>F2709D47-1FC8-4669-BC79-3CEEAA38A81E</domeo:uuid>
    <ao:suffix> AUC</ao:suffix>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:exact>N-desmethyl metabolite</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-07 09:58:12 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:F2709D47-1FC8-4669-BC79-3CEEAA38A81E"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:251D57FC-2969-4213-92D9-AC40BD390F67">
    <domeo:uuid>251D57FC-2969-4213-92D9-AC40BD390F67</domeo:uuid>
    <ao:suffix> [see Warnings and Precautions (5.6) and Use in Specific Populations (8.7)]. </ao:suffix>
    <ao:exact>conivaptan</ao:exact>
    <pav:createdOn>2014-07-08 19:40:11 -0400</pav:createdOn>
    <ao:prefix> resulted in higher conivaptan exposure than did oral </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-105.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:251D57FC-2969-4213-92D9-AC40BD390F67"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:C0038DAC-B2E3-4A49-A234-356CE629F16E">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/6AE47C65-EA05-4F3D-B809-C3FD66E1DDE5"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/D8D2DC59-6B17-4B98-889B-A5CEF158DDC1"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:808D82BB-EA92-41E7-A49E-919E3DC14991">
    <pav:createdOn>2014-07-07 20:33:16 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoclient:uuid:51AE28A6-A4F5-4551-AD8B-8ADDDCA82257</domeo:belongsToSet>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <ao:body rdf:nodeID="N187fe32e3bfe4e808e6a5b959c65a66b"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotation:D6FE63F6-C53E-4CEA-9ED5-86CA8894AB64</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:3BD2D894-01EB-4131-83A5-9238F4B95521"/>
    <pav:lastSavedOn>2014-07-07 20:34:18 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:EF251D91-3A73-43BC-9A2B-D62E5A26B616">
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotation:0C8E7BBC-E0AD-4CEC-8BC7-9672B9A6909A</pav:lineageUri>
    <ao:body rdf:nodeID="Nae4a1e051b46407786fb7bfae17076d5"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-07-08 16:16:08 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-07-08 16:17:10 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:D5FE9F58-EB3F-4295-9090-E3B773EBD671</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:FB9E50B3-3BA9-4033-BB8D-53071BA97002"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:02E081CF-FE9B-48C0-BB6D-062C578358AA">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>xsd:String</ao:prefix>
    <domeo:uuid>02E081CF-FE9B-48C0-BB6D-062C578358AA</domeo:uuid>
    <ao:exact>Repeat oral dosing of AVANDIA (8 mg once daily) for 14 days did not alter the steady-state pharmacokinetics of digoxin (0.375 mg once daily) in healthy volunteers</ao:exact>
    <pav:createdOn>2014-07-08 08:53:11 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:02E081CF-FE9B-48C0-BB6D-062C578358AA"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <ao:suffix>xsd:String</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A47B89A3-D4D6-4CD2-AC86-7BC33FD80307">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2014-07-07 20:13:29 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:1B8E43F4-D9E1-4A26-A24D-CAC3616BA2C6"/>
    <pav:lineageUri>urn:domeoserver:annotation:FA71646D-E014-48A6-8F7D-82E40639C319</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoclient:uuid:B41CE612-345D-4E17-94DB-98BD2C6B5559</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-07 20:14:34 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B491D9E4-8A78-41ED-AF07-786E84BB79D0">
    <domeo:uuid>B491D9E4-8A78-41ED-AF07-786E84BB79D0</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-55.txt.html</ao:hasSource>
    <ao:prefix>Each </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:B491D9E4-8A78-41ED-AF07-786E84BB79D0"/>
    <pav:createdOn>2014-07-07 20:31:04 -0400</pav:createdOn>
    <ao:suffix> Extended-release Tablet contains 300 mg of quinidine sulfate (249 mg of quinidine base) in a formulation to provide extended release; the inactive ingredients are: fumaric acid, hypromellose, lactose monohydrate, magnesium stearate, polydextrose, polyet</ao:suffix>
    <ao:exact>Quinidine Sulfate</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:1762A543-B637-49B5-A4ED-4B9311ED36D1">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdOn>2014-07-07 20:10:29 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotation:AEF4E5FB-7E34-4F68-90DB-6EF118906EEE</pav:lineageUri>
    <pav:lastSavedOn>2014-07-07 20:12:43 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoclient:uuid:21FE87BA-B7AA-4926-95E7-7E20EA2E4643</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:891C5D04-C5C8-47AF-8B66-E66C5F25FF01"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:67362A51-C044-4566-BDF1-FEC50141A265">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:item rdf:resource="urn:domeoclient:uuid:3EFC02B2-B26D-4288-ADAB-FC22A1452B4C"/>
    <pav:createdOn>2014-07-07 19:41:53 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotationset:95E5A9C5-5772-4BDE-B725-85AA5D74AF50</pav:lineageUri>
    <domeo:deleted>false</domeo:deleted>
    <rdfs:label>Default Set</rdfs:label>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <permissions:permissions rdf:nodeID="N39e55a9b308f4deda0397c1d3244bce0"/>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812e52b20002"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-4.txt.html</ao:annotatesResource>
    <pav:lastSavedOn>2014-07-07 19:42:15 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nf61e8b8468014341ba411787e0c1ec2f">
    <domeo:sets rdf:resource="urn:pddi:uuid:030120D1-FE7F-428F-A259-475CD49BC5B7"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/f2056576-10b4-4525-b819-b988fc2931c4">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:8d6e0f83-0b0d-48af-bcc5-2b7d241d6ad1"/>
    <pav:lineageUri>urn:domeoserver:annotationset:a9cc5584-e837-4dad-beba-c452ba45f3c1</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2014-07-07 08:07:06 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-07-07 08:07:06 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7C1C282A-E938-4B71-A30D-A7B67DB129EE</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:201C251D-D3C3-4CB8-A932-55045D0F92E2">
    <domeo:uuid>201C251D-D3C3-4CB8-A932-55045D0F92E2</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-08 14:01:51 -0400</pav:createdOn>
    <ao:exact>Concomitant administration of propafenone and amiodarone can affect conduction and repolarization and is not recommended.</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:201C251D-D3C3-4CB8-A932-55045D0F92E2"/>
    <ao:prefix>xsd:String</ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-194.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:9A8346F2-5096-4CD8-B9C7-95E9FEE6CA55">
    <ao:exact>zidovudine </ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-27.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:9A8346F2-5096-4CD8-B9C7-95E9FEE6CA55"/>
    <ao:suffix>concentrations were determined on two occasions (before and following fluconazole 200 mg daily for 15 days) in 13 volunteers with AIDS or ARC who were on a stable zidovudine dose for at least two weeks. There was a significant increase in zidovudine AUC </ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-07 20:16:35 -0400</pav:createdOn>
    <ao:prefix>Plasma </ao:prefix>
    <domeo:uuid>9A8346F2-5096-4CD8-B9C7-95E9FEE6CA55</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:3C57C6E7-9704-4071-B9FC-7900D9A7C2F2">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/9799F9EF-3260-40A5-B3D4-0F0DBCE80D07"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/D615845B-266A-47AB-860F-91DB6A6DB3E8"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:4192F65E-0A2A-4144-B614-A7AD53168063">
    <domeo:uuid>4192F65E-0A2A-4144-B614-A7AD53168063</domeo:uuid>
    <ao:exact>paroxetine </ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>(30 mg once daily) increased steady-state AUC0-24, Cmax, and Cmin values of procyclidine (5 mg oral once daily) by 35%, 37%, and 67%, respectively, compared to procyclidine alone at steady state. If anticholinergic effects are seen, the dose of procyclid</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-50.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-07 20:23:14 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:4192F65E-0A2A-4144-B614-A7AD53168063"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>Daily oral dosing of immediate-release </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:EABDABCD-2741-4D6E-B3C5-7532FA912DE0">
    <pav:createdOn>2014-07-07 20:13:26 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotation:27FDCFC3-4B55-4625-80F0-9407ADFD5003</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoclient:uuid:B41CE612-345D-4E17-94DB-98BD2C6B5559</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:A9B1E87D-AEAD-4C83-91D0-47B64B244A03"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:lastSavedOn>2014-07-07 20:14:34 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:4CDF0976-3AF5-46C7-BEA7-E60977C50827">
    <ao:exact>propranolol </ao:exact>
    <ao:prefix>resulted in a 70% increase in </ao:prefix>
    <pav:createdOn>2014-07-08 09:22:38 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-134.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:4CDF0976-3AF5-46C7-BEA7-E60977C50827"/>
    <domeo:uuid>4CDF0976-3AF5-46C7-BEA7-E60977C50827</domeo:uuid>
    <ao:suffix>plasma level.</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/17e2150b-5f83-45e7-b92d-dfd68bcfe510">
    <pav:lineageUri>urn:domeoserver:annotationset:1f6fbb82-e3e5-4fe2-ad47-276697cc9639</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2014-07-07 08:06:39 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:F308746E-1B09-48A9-A699-A66CF195F2F7</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:92b5f083-f97c-4445-8f21-6b9f6e7fc3f9"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-07 08:06:39 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F2DC0496-DA9C-41B6-8A47-26244C1FD0ED">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-08 09:34:37 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:E18E17FF-6251-4263-84EA-46817EE9BCB9"/>
    <ao:body rdf:nodeID="Na6ef47645d6a4438bf102879d20cfe8e"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:423352B3-8ABA-48B7-98CF-B191A7BFC955</domeo:belongsToSet>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotation:C95050E1-1E17-4F81-A8D4-0FA0F7574674</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-07-08 09:35:29 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/555F64D6-85E8-4103-B25B-81DE0BC5656A">
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>glimepiride</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/25789</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:46E97609-7E4C-4EA4-A0E1-1EC7D6C392DE">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix>decreased very slightly (&lt;5%) in 3 of the 21 subjects after fluconazole treatment.</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:46E97609-7E4C-4EA4-A0E1-1EC7D6C392DE"/>
    <pav:createdOn>2014-07-07 20:01:05 -0400</pav:createdOn>
    <ao:prefix> AUC of any individual subject in this study compared to placebo dosing. The individual AUC values of </ao:prefix>
    <ao:exact>norethindrone </ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-21.txt.html</ao:hasSource>
    <domeo:uuid>46E97609-7E4C-4EA4-A0E1-1EC7D6C392DE</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A74F6F6D-8509-4EE5-9A08-B6B745242744">
    <pav:createdOn>2014-07-08 09:20:02 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:A74F6F6D-8509-4EE5-9A08-B6B745242744"/>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:exact>Co-administration of propranolol with lovastatin or pravastatin, decreased 18% to 23% the AUC of both, but did not alter their pharmacodynamics.</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-132.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>xsd:String</ao:prefix>
    <domeo:uuid>A74F6F6D-8509-4EE5-9A08-B6B745242744</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:12B10864-82D4-4C50-973A-65EA156311BB">
    <pav:lineageUri>urn:domeoserver:annotationset:57174A7C-3100-4C8F-9C4A-2991CEE124D5</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdOn>2014-07-08 08:44:18 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2014-07-08 08:46:38 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:23515E27-98AC-4DC9-A4B7-EBFE2991219F</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:1E1CDA40-88A4-4918-BA32-5F6D653CF308"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:8A385BA7-BCB7-4DBB-BFF5-2D8878861A76">
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:E02E5030-656A-4E01-AF54-2CB9DBE69F4A"/>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:CC59C294-5F2A-4672-9802-3F1A7163DDC1">
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:072A08CF-6C01-41CC-AA90-79A70D351815"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/4E6D8555-BF32-4266-8131-8BCA528F84B1">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>risperidone</rdfs:label>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/35636</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:6C63DD1E-3B4D-4549-95F4-FEBCF87CFCEA">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotation:F37FBEFC-6827-4847-8F89-D1646D73AFC0</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2014-07-07 20:10:00 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:4E3F834F-950A-4AA9-84D2-89C939A0167A"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:738231FC-4090-4D56-90FB-4FBFF166BD23</domeo:belongsToSet>
    <pav:createdOn>2014-07-07 20:08:07 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:3FA5BB25-CEBA-4007-911C-2781BAE80D1B">
    <pav:createdOn>2014-07-08 14:20:20 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix> and </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:3FA5BB25-CEBA-4007-911C-2781BAE80D1B"/>
    <domeo:uuid>3FA5BB25-CEBA-4007-911C-2781BAE80D1B</domeo:uuid>
    <ao:suffix> half-life and AUC in patients with impaired renal function (n = 14) following a single 200 mg oral dose (Table 7). Plasma concentrations of AMT were not determined. A dose adjustment should not be necessary for patients with </ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-197.txt.html</ao:hasSource>
    <ao:exact>GZDV</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:907976C5-54D9-472C-8460-A17DCCF26925">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-6.txt.html</ao:hasSource>
    <ao:prefix> and 290 ng/mL for </ao:prefix>
    <ao:suffix>; Tmax's were 2 hours for </ao:suffix>
    <domeo:uuid>907976C5-54D9-472C-8460-A17DCCF26925</domeo:uuid>
    <ao:exact>ODV</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-21 09:59:55 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:907976C5-54D9-472C-8460-A17DCCF26925"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:AD989DCC-D79F-4B84-A75C-5D12A5840929">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:F0F6F527-9A8C-4E31-AA18-E9567E23FF05"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:86E1DCE1-FFC6-4513-AEF9-EF158A019E6B</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotation:6A68740D-E891-4687-9476-67B24E76395E</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:createdOn>2014-07-08 08:59:05 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2014-07-08 09:00:25 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E18E17FF-6251-4263-84EA-46817EE9BCB9">
    <ao:exact>Fexofenadine had no effect on the pharmacokinetics of either erythromycin or ketoconazole.</ao:exact>
    <pav:createdOn>2014-07-08 09:34:37 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-139.txt.html</ao:hasSource>
    <domeo:uuid>E18E17FF-6251-4263-84EA-46817EE9BCB9</domeo:uuid>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:E18E17FF-6251-4263-84EA-46817EE9BCB9"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix> In two separate studies in healthy adult subjects</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:426A845D-1FF1-4463-B663-6D6F1040B1E8">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/4C5F8827-9FFD-4247-B213-97551D74CE55"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/E6B1176F-0D33-46DC-8F64-B31BCA0CA119"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:0F14E241-486F-4C71-B402-4B8875FC3ED0">
    <ao:context rdf:resource="urn:domeoclient:uuid:E6063F3F-E14E-4F7A-BE6B-DBB1A0CC4BA2"/>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:previousVersion>urn:domeoclient:uuid:e75c9d7b-f906-4c66-8a84-e6eef34d0954</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <ao:body rdf:nodeID="N2cd98276db2f44599221ac8ec3f5c967"/>
    <pav:lastSavedOn>2014-07-08 14:24:44 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotationset:0f67c012-7596-4b02-a927-63c0ccbc3afa</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:42258B16-6749-4B39-B28D-88C8B63F7A43</domeo:belongsToSet>
    <pav:createdOn>2014-07-08 14:22:48 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">3</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:9BAD0014-638A-4361-B334-C6268BF4BA0E">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:9BAD0014-638A-4361-B334-C6268BF4BA0E"/>
    <pav:createdOn>2014-07-08 08:56:41 -0400</pav:createdOn>
    <ao:prefix>The metabolism of </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-125.txt.html</ao:hasSource>
    <domeo:uuid>9BAD0014-638A-4361-B334-C6268BF4BA0E</domeo:uuid>
    <ao:exact>propranolol </ao:exact>
    <ao:suffix>is reduced by co-administration of quinidine, leading to a two-three fold increased blood concentration and greater degrees of clinical beta-blockade.</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:9804C8C5-3201-4A0F-9FA1-C6E8E1B1E28D">
    <pav:lineageUri>urn:domeoserver:annotation:2682A733-30B9-40AD-A306-9C79F4447A78</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:body rdf:nodeID="N049d816cb38b414094ebfda7541b09b8"/>
    <pav:createdOn>2014-07-08 09:11:16 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoclient:uuid:1D51EEDF-FCC9-44E1-A13B-BCE69023F944</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:5DD06FE0-B2B0-47AC-8F74-A165F8D5FF94"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-08 09:11:17 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:9DA84262-6A4D-43C9-8EBF-32649516E683">
    <pav:lineageUri>urn:domeoserver:annotation:B1F55D6B-670F-4AD8-AF6D-352B627CF10C</pav:lineageUri>
    <pav:lastSavedOn>2014-07-07 20:28:50 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:createdOn>2014-07-07 20:27:44 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:6922A1EC-C9EF-43D2-BB4F-88A72AC0485C"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:CB4806A3-01B7-46D7-A04A-F22C0AA913DE</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:6A1539CE-1E4A-4CA1-B7D8-50C0E9D4DE13">
    <ao:prefix>xsd:String</ao:prefix>
    <pav:createdOn>2014-07-07 11:04:00 -0400</pav:createdOn>
    <domeo:uuid>6A1539CE-1E4A-4CA1-B7D8-50C0E9D4DE13</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:6A1539CE-1E4A-4CA1-B7D8-50C0E9D4DE13"/>
    <ao:exact>In study in healthy volunteers, co-administration with ritonavir, a potent CYP3A inhibitor, at steady state (500 mg BID) with sildenafil (100 mg single dose) resulted in a 300% (4-fold) increase in sildenafil Cmax and a 1000% (11-fold) increase in sildenafil plasma AUC. At 24 hours, the plasma levels of sildenafil were still approximately 200 ng/mL, compared to approximately 5 ng/mL when sildenafil was dosed alone. This is consistent with ritonavir's marked effects on a broad range of P450 substrates. </ao:exact>
    <ao:suffix> Although the interaction between other protease inhibitors (except</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:4E7EA884-B898-4032-8586-82F4A062BB59">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>There is a potentially relevant interaction between diazepam and compounds which inhibit certain hepatic enzymes (particularly cytochrome P450 3A and 2C19). Data indicate that these compounds influence the pharmacokinetics of diazepam and may lead to increased and prolonged sedation. At present, this reaction is known to occur with cimetidine, ketoconazole, fluvoxamine, fluoxetine, and omeprazole</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-177.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:4E7EA884-B898-4032-8586-82F4A062BB59"/>
    <ao:suffix>xsd:String</ao:suffix>
    <domeo:uuid>4E7EA884-B898-4032-8586-82F4A062BB59</domeo:uuid>
    <pav:createdOn>2014-07-08 15:39:24 -0400</pav:createdOn>
    <ao:prefix>xsd:String</ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/7E36180E-9E78-4C9F-B250-179E9BCBA02D">
    <rdfs:label>ketoconazole</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/6135</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:30C086A4-11FE-457B-8508-99D6F941BC90">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>ritonavir </ao:exact>
    <ao:suffix>(200 mg twice daily, 4 doses) on the pharmacokinetics of a single dose of trazodone (50 mg) has been studied in 10 healthy subjects. The Cmax of trazodone increased by 34%, the AUC increased 2.4 fold, the half-life increased by 2.2 fold, and the clearanc</ao:suffix>
    <domeo:uuid>30C086A4-11FE-457B-8508-99D6F941BC90</domeo:uuid>
    <ao:prefix>. The effect of short-term administration of </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:30C086A4-11FE-457B-8508-99D6F941BC90"/>
    <pav:createdOn>2014-07-08 09:25:26 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-136.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:DF7F2528-C179-470A-BB1B-211F608C52F9">
    <ao:prefix>at doses greater than or equal to 160 mg/day resulted in increased </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>thioridazine </ao:exact>
    <ao:suffix>plasma concentrations ranging from 55% to 369% and increased thioridazine metabolite (mesoridazine) concentrations ranging from 33% to 209%.</ao:suffix>
    <pav:createdOn>2014-07-08 09:21:19 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:DF7F2528-C179-470A-BB1B-211F608C52F9"/>
    <domeo:uuid>DF7F2528-C179-470A-BB1B-211F608C52F9</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-133.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B001789D-324B-4820-98D2-8258B4154F10">
    <ao:prefix> by 65%. The concentrations of </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix> increased by 30%. In poor metabolizers, there was a 50% decrease in </ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:B001789D-324B-4820-98D2-8258B4154F10"/>
    <domeo:uuid>B001789D-324B-4820-98D2-8258B4154F10</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-194.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-08 14:03:45 -0400</pav:createdOn>
    <ao:exact>norpropafenone </ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:4F012F36-22C1-4326-8AFD-9DBB3F0F3993">
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:lastSavedOn>2014-07-07 19:50:36 -0400</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotationset:1DED06A6-8562-4CCF-A58C-CA25748FBD31</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:A5AA5770-ACE2-4D41-8BF7-D13CCD43A5BF"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdOn>2014-07-07 19:47:32 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5ABD9862-F044-4404-AD04-73DA04ADDA8B</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:EECF550C-56E3-4B87-A6AD-C99E211745F2">
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:11E7A483-A6AB-4163-9077-B99D00B57343"/>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:4B728EE1-5EA7-4CEB-BF4E-D5A0FFD21B2C">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:4B728EE1-5EA7-4CEB-BF4E-D5A0FFD21B2C"/>
    <ao:suffix>had no clinically relevant effect on the steady-state pharmacokinetics of warfarin enantiomers.</ao:suffix>
    <pav:createdOn>2014-07-08 08:53:27 -0400</pav:createdOn>
    <domeo:uuid>4B728EE1-5EA7-4CEB-BF4E-D5A0FFD21B2C</domeo:uuid>
    <ao:exact>AVANDIA </ao:exact>
    <ao:prefix>Repeat dosing with </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:3033A046-FC95-44E4-BDBD-5185E9AE5A27">
    <domeo:uuid>3033A046-FC95-44E4-BDBD-5185E9AE5A27</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:3033A046-FC95-44E4-BDBD-5185E9AE5A27"/>
    <ao:exact>Concomitant use of propafenone and digoxin increased steady-state serum digoxin exposure (AUC) in patients by 60 to 270%, and decreased the clearance of digoxin by 31 to 67%. Monitor plasma digoxin levels of patients receiving propafenone and adjust digoxin dosage as needed.</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:suffix>xsd:String</ao:suffix>
    <pav:createdOn>2014-07-08 14:05:39 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-194.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:AFF59558-2512-492E-837B-8B00C119B223">
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:C7464E88-A023-4DF0-9F65-40825A35F919"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:0313DB5F-EB99-4442-991D-8B993A0F2EE3">
    <ao:body rdf:nodeID="Nd4148062424f41cfa4d8a3a42ab552d5"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:createdOn>2014-07-08 14:04:38 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotation:500E77D3-D45F-48FF-AC03-3215863E14D7</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7E49EB7A-DE0E-4720-82D1-8460BA0C770D</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-08 14:10:48 -0400</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:1C22DD7A-B548-4CEF-8D7A-5FDFB7B5EFA8"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/2CBC9504-B160-4CFC-881E-E3FC5D568D1F">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>paroxetine</rdfs:label>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/32937</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C93B2C33-8805-49A5-85A4-1E72F0142400">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:previousVersion>urn:domeoclient:uuid:5BCE2FDB-C586-44CD-88F7-6EE2BDB6B929</pav:previousVersion>
    <pav:lastSavedOn>2014-07-08 08:51:47 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotationset:57174A7C-3100-4C8F-9C4A-2991CEE124D5</pav:lineageUri>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <ao:body rdf:nodeID="Ne376e438bc0c409f8b063d448397d0a5"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:3E776E26-0F50-415F-B2DE-9AB3D6DE0870"/>
    <pav:createdOn>2014-07-08 08:48:53 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:23515E27-98AC-4DC9-A4B7-EBFE2991219F</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B5431951-FA35-4BD7-9027-C69F56975D5D">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:B5431951-FA35-4BD7-9027-C69F56975D5D"/>
    <ao:suffix> by the enzyme, CYP 2D6. A minor metabolic pathway is through N-dealkylation. The main metabolite, 9-hydroxyrisperidone, has similar pharmacological activity as risperidone. Consequently, the clinical effect of the drug results from the combined concentr</ao:suffix>
    <ao:exact> 9-hydroxyrisperidone</ao:exact>
    <pav:createdOn>2014-07-07 19:47:21 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>to</ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <domeo:uuid>B5431951-FA35-4BD7-9027-C69F56975D5D</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:8A841157-24AA-49C8-BACD-FFE74788C959">
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoclient:uuid:921213C5-987C-46D2-9095-A8DDC2B714AB</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:1A4D086F-1574-4DC6-B552-09874AAC413C</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-07-07 20:01:02 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:D43FCBC1-59D3-4B63-8504-A7883192F3A3"/>
    <pav:lastSavedOn>2014-07-07 20:04:45 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:759582FD-ED8F-49B1-93B0-E61DA9EE4C4D">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5ABD9862-F044-4404-AD04-73DA04ADDA8B</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:lastSavedOn>2014-07-07 19:50:36 -0400</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:B5C57D15-B8BA-46C5-A554-0CBBB810E45A"/>
    <pav:lineageUri>urn:domeoserver:annotationset:1DED06A6-8562-4CCF-A58C-CA25748FBD31</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-07-07 19:47:35 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:E916ECEF-4C0F-4B7B-A449-3352F6283E12">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/DF6DB1F3-D74D-4611-A45A-BEA8D3FD6220"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/D155F075-CA4F-461E-B05B-EC89329567C8"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:489511C5-BDE6-405C-A125-B8745F0FBA19">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:exact>Results of a placebo-controlled trial in normal volunteers suggest that chronic administration of sertraline 200 mg/day does not produce clinically important inhibition of phenytoin metabolism. </ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:489511C5-BDE6-405C-A125-B8745F0FBA19"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-15.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>Nonetheless, at this time, it </ao:suffix>
    <pav:createdOn>2014-07-21 10:11:47 -0400</pav:createdOn>
    <domeo:uuid>489511C5-BDE6-405C-A125-B8745F0FBA19</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:0CFD7E69-9F40-4910-8BF8-37AFA7004208">
    <ao:body rdf:nodeID="Nf9d2e9059a7a4ff887aaba2dadbd80e7"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:FC706AFD-18B6-480C-8EAA-2B16C3212C10</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:B357B7CE-D3BD-4F1D-9BC9-22CDEFC21C06"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:createdOn>2014-07-08 16:24:21 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-08 16:27:01 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotation:F8AF811A-36D5-4756-88E5-247E5283CDEB</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:98E0775B-36F4-4979-AB5D-9C93AFBE7986">
    <ao:prefix>xsd:String</ao:prefix>
    <domeo:uuid>98E0775B-36F4-4979-AB5D-9C93AFBE7986</domeo:uuid>
    <ao:exact>Administration of 40 mg/day citalopram for 22 days resulted in a two-fold increase in the plasma levels of the beta-adrenergic blocker metoprolol. Increased metoprolol plasma levels have been associated with decreased cardioselectivity.</ao:exact>
    <ao:suffix> Coadministration of</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-08 15:09:55 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:98E0775B-36F4-4979-AB5D-9C93AFBE7986"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-81.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:EDE2E9FD-1628-41DB-91FD-06502074DA39">
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:057548E3-0455-4B58-B8B0-694BE77B83C5"/>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:49BD4B70-AFF1-4952-A6B1-201F15A44B42">
    <pav:createdOn>2014-07-07 20:32:11 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:51AE28A6-A4F5-4551-AD8B-8ADDDCA82257</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-07 20:34:18 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:3525D7AB-D2C1-4B90-80CF-24C9DC5CB1A4"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotation:F2DB33FF-1644-46D0-8592-2C2CE053AD1F</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:B094B497-00AD-4DA1-ADB6-C553F2EC6219">
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:1D0BFD9C-8A6F-425E-AECA-0BC3FD6D4114"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:DE892FFE-05EE-445E-A1E5-DB329798F0E9">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>inant manifestations have been hyper-excitability, convulsions, tachycardia, hyperpyrexia, and hypertension. Although it is not known that other narcotics are free of the risk of such reactions, virtually all of the reported reactions have occurred with </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:DE892FFE-05EE-445E-A1E5-DB329798F0E9"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-165.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-08 12:21:33 -0400</pav:createdOn>
    <ao:suffix>. If a narcotic is needed in such patients, a sensitivity test should be performed in which repeated, small, incremental doses of morphine are administered over the course of several hours while the patient's condition and vital signs are under careful o</ao:suffix>
    <ao:exact>meperidine</ao:exact>
    <domeo:uuid>DE892FFE-05EE-445E-A1E5-DB329798F0E9</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:CF30A1F4-6674-47FC-BF71-4AD23FFA7D6A">
    <ao:exact>9-hydroxyrisperidone</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-07 19:46:05 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:CF30A1F4-6674-47FC-BF71-4AD23FFA7D6A"/>
    <domeo:uuid>CF30A1F4-6674-47FC-BF71-4AD23FFA7D6A</domeo:uuid>
    <ao:prefix>, its major metabolite, </ao:prefix>
    <ao:suffix>, and risperidone plus 9-hydroxyrisperidone are dose proportional over the dosing range of 1 to 16 mg daily (0.5 to 8 mg twice daily). Following oral administration of solution or tablet, mean peak plasma concentrations of risperidone occurred at about 1</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:EFBB8C05-50BC-42AC-990B-1894DF82D8A0">
    <pav:createdOn>2014-07-08 13:48:38 -0400</pav:createdOn>
    <domeo:uuid>EFBB8C05-50BC-42AC-990B-1894DF82D8A0</domeo:uuid>
    <ao:exact>Experimental evidence demonstrated that methadone increased the area under the concentration-time curve (AUC) of zidovudine which could result in toxic effects.</ao:exact>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:EFBB8C05-50BC-42AC-990B-1894DF82D8A0"/>
    <ao:suffix>xsd:String</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-199.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A3F1FD13-4CD2-4567-893C-0AFE467D43DA">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-08 14:51:45 -0400</pav:createdOn>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-114.txt.html</ao:hasSource>
    <ao:exact>Quinupristin/Dalfopristin:In vitro drug interaction studies have demonstrated that quinupristin/dalfopristin significantly inhibits the CYP3A metabolism of nifedipine. Concomitant administration of quinupristin/dalfopristin and nifedipine (repeated oral dose) in healthy volunteers increased AUC and Cmax for nifedipine by factors of 1.44 and 1.18, respectively, compared to nifedipine monotherapy. Upon coadministration of quinupristin/dalfopristin with nifedipine, blood pressure should be monitored and a reduction of the dose of nifedipine considered.</ao:exact>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:A3F1FD13-4CD2-4567-893C-0AFE467D43DA"/>
    <domeo:uuid>A3F1FD13-4CD2-4567-893C-0AFE467D43DA</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:76CF4898-7375-498D-B5C6-754888833FC6">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:63759ED3-5523-4017-96A7-C1AF471A4463"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-07-08 09:35:29 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotation:85A9831F-A316-4617-88F3-CA2F3BE20C75</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoclient:uuid:423352B3-8ABA-48B7-98CF-B191A7BFC955</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdOn>2014-07-08 09:33:10 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B3F9B5CE-6271-4933-ADD4-3F4B12457E4F">
    <pav:createdOn>2014-07-08 16:27:00 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-104.txt.html</ao:hasSource>
    <domeo:uuid>B3F9B5CE-6271-4933-ADD4-3F4B12457E4F</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:B3F9B5CE-6271-4933-ADD4-3F4B12457E4F"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>The pharmacokinetics of oral conivaptan (20 - 40 mg/day) were unchanged with coadministration of either captopril 25 mg or furosemide up to 80 mg/day.</ao:exact>
    <ao:suffix>xsd:String</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>xsd:String</ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:67B29DB0-E945-4071-B204-BABBDE330A9C">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>67B29DB0-E945-4071-B204-BABBDE330A9C</domeo:uuid>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:67B29DB0-E945-4071-B204-BABBDE330A9C"/>
    <ao:exact>The pharmacokinetics of oral conivaptan (20 - 40 mg/day) were unchanged with coadministration of either captopril 25 mg or furosemide up to 80 mg/day.</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-08 16:26:44 -0400</pav:createdOn>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-104.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/1B7DFF9A-8B7A-4F5D-9A36-1A18501F264E">
    <rdfs:label>aluminum</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C9ACBCB7-738B-47D3-9E81-7BC584E142D6">
    <domeo:belongsToSet>urn:domeoserver:annotationset:A5E637EF-5CA5-4AAC-BD8B-C136A86E17B7</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotation:DFD9D6D5-0030-4AA1-A0FB-2445A0A67C45</pav:lineageUri>
    <pav:lastSavedOn>2014-07-07 11:12:49 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:A68363CC-89C4-4421-AF09-72F49EC3E620"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:body rdf:nodeID="N2e8aad01f50844f79d251802f421c112"/>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:createdOn>2014-07-07 11:10:01 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:002956E9-3141-4AE1-AF90-7B1829FC8783">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>002956E9-3141-4AE1-AF90-7B1829FC8783</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:002956E9-3141-4AE1-AF90-7B1829FC8783"/>
    <ao:exact>ritonavir </ao:exact>
    <pav:createdOn>2014-07-07 20:25:52 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-51.txt.html</ao:hasSource>
    <ao:suffix>with paroxetine significantly decreased plasma levels of paroxetine. Any dose adjustment should be guided by clinical effect (tolerability and efficacy). </ao:suffix>
    <ao:prefix>/</ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:8D643EAC-88DF-4484-A479-D1E798544DF5">
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-07-07 20:38:37 -0400</pav:lastSavedOn>
    <permissions:permissions rdf:nodeID="Nc086d59ad7484121a75b52671002bfec"/>
    <domeo:deleted>false</domeo:deleted>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:item rdf:resource="urn:domeoclient:uuid:E2B32452-94CE-429F-9E26-4DD8ED692BAA"/>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812e52b20002"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:014825DB-33FE-4C88-8EBE-8618F90BB82F"/>
    <rdfs:label>Default Set</rdfs:label>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-59.txt.html</ao:annotatesResource>
    <pav:createdOn>2014-07-07 20:38:00 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <ao:item rdf:resource="urn:domeoclient:uuid:4AB59393-C915-4F69-8E8B-26089C4E3598"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:1042BEE0-D02D-4D4B-90A7-BDFF93CE2721"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:7667302E-8FB4-4133-9AA5-8A110A10EBC4"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotationset:68C4E0BA-A3EF-4ACF-925D-FF9E01314A6B</pav:lineageUri>
    <ao:item rdf:resource="urn:domeoclient:uuid:B7A5894E-24AE-458F-B71F-942381442E70"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:9EFE3B77-625E-4E43-9E5A-F8C4EC580340">
    <ao:prefix>In post-marketing experience, there have been isolated, spontaneous reports of pulmonary changes including pulmonary infiltration and pulmonary fibrosis during </ao:prefix>
    <domeo:uuid>9EFE3B77-625E-4E43-9E5A-F8C4EC580340</domeo:uuid>
    <ao:exact>mexiletine </ao:exact>
    <pav:createdOn>2014-07-08 12:01:52 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix>therapy with or without other drugs or diseases that are known to produce pulmonary toxicity. A causal relationship to mexiletine therapy has not been established. In addition, there have been isolated reports of drowsiness, nystagmus, ataxia, dyspepsia,</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-160.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:9EFE3B77-625E-4E43-9E5A-F8C4EC580340"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A2159D1F-D853-4F39-A0D3-C9E13586F4A6">
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoclient:uuid:6B178133-9B11-445F-A5BB-EF967EA53386</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-08 12:29:01 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-08 12:28:24 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotation:60270894-103B-4B09-AC11-18EADE1E3276</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:FE387E18-F5F4-49B6-A636-E4FB043C8E04"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:3BD2D894-01EB-4131-83A5-9238F4B95521">
    <ao:exact>Zonisamide had no appreciable effect on the steady-state plasma concentrations of phenytoin, carbamazepine, or valproate during clinical trials. Zonisamide did not inhibit mixed-function liver oxidase enzymes (cytochrome P450), as measured in human liver microsomal preparations, in vitro. Zonisamide is not expected to interfere with the metabolism of other drugs that are metabolized by cytochrome P450 isozymes</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-56.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:3BD2D894-01EB-4131-83A5-9238F4B95521"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-07 20:33:16 -0400</pav:createdOn>
    <ao:suffix>xsd:String</ao:suffix>
    <domeo:uuid>3BD2D894-01EB-4131-83A5-9238F4B95521</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>xsd:String</ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/9D29611B-85E1-4F7D-A43F-CBF76D27A884">
    <rdfs:label>lamivudine</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/68244</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:5C41F5FD-EFAB-4A38-9898-1CE8DD82FA04">
    <ao:context rdf:resource="urn:domeoclient:uuid:A4B747AB-66DF-46F5-AD34-DC8247F1C83C"/>
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotationset:1DED06A6-8562-4CCF-A58C-CA25748FBD31</pav:lineageUri>
    <pav:lastSavedOn>2014-07-07 19:50:36 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdOn>2014-07-07 19:43:30 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5ABD9862-F044-4404-AD04-73DA04ADDA8B</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:8413376C-C4CA-44D9-8317-8E5709B90DCB">
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:885F403E-C357-4B40-9CD3-954956D19A4A"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D543C3F1-DA54-4DBF-A2A2-25D79FA02724">
    <ao:item rdf:resource="urn:domeoclient:uuid:38D25A1F-8E25-4571-9547-3CA72D3D56A7"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:E26D6177-D8B1-4F96-9181-786D41BF0F0E"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:0BE3DE02-72E6-4599-9DF2-42F5F2C5B771"/>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812e52b20002"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-134.txt.html</ao:annotatesResource>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:deleted>false</domeo:deleted>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotationset:7C8C3029-B0B9-4D06-BF5D-C828E3418F3A</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <rdfs:label>Default Set</rdfs:label>
    <permissions:permissions rdf:nodeID="Nf78fbc90883c4be89012dc0318e769eb"/>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <pav:createdOn>2014-07-08 09:22:36 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-07-08 09:22:59 -0400</pav:lastSavedOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:1DCD5B8E-9FFE-4C5C-8D9D-00777470B236"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:29AAB777-4FBF-49C4-ACFD-F2FC169A463D">
    <pav:lineageUri>urn:domeoserver:annotationset:64562729-51FC-41D7-95DD-C5BDAA86CC40</pav:lineageUri>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812e52b20002"/>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <ao:item rdf:resource="urn:domeoclient:uuid:A783503F-D134-4BA3-811E-99FCE28F6D1F"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:CD5613AC-945E-4FC7-A565-D7E9BE8DEF19"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:A5666665-429A-40E8-930C-06F3AC6B57C1"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:68B1ECAD-98F7-48B9-B1A7-85401F8AE404"/>
    <rdfs:label>Default Set</rdfs:label>
    <pav:lastSavedOn>2014-07-07 20:51:01 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-07 20:49:58 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <permissions:permissions rdf:nodeID="N4d81a1b090a2402dbc56023f0aa4466e"/>
    <domeo:deleted>false</domeo:deleted>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-122.txt.html</ao:annotatesResource>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:item rdf:resource="urn:domeoclient:uuid:2382E309-E3E2-4D56-8CFB-6B8B214C41E1"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:6E8909DB-5487-49E2-9EE7-5D60FB6ED6D1"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:12BD4746-33B5-4A1A-BBB2-DAED545318FA"/>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/d759aa74-17a7-4350-a348-8a76f5c19cd2">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9432C436-030D-4F96-AC0D-73DA640746E2</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdOn>2014-07-07 08:06:50 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-07-07 08:06:50 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotationset:40d1f7ac-a4d3-4319-971a-f582165db20e</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:367d682d-4fbb-49e0-94c6-e015fac80bab"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:40520150-B72F-4AAE-822F-F3A56B8EC9EB">
    <ao:body rdf:nodeID="N14092d8ccdbd436f868bd19ffde57112"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-07-07 19:59:12 -0400</pav:lastSavedOn>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:createdOn>2014-07-07 19:53:04 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5ABD9862-F044-4404-AD04-73DA04ADDA8B</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:E4F73D48-6A10-4A06-BFBC-DEBAA86412DF"/>
    <pav:lineageUri>urn:domeoserver:annotation:1F1B967E-68BA-449D-BCD8-30BE0042CA38</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:08D9C061-174E-46EF-AF78-C90119DC56DF">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-07-08 08:52:43 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-08 08:54:46 -0400</pav:lastSavedOn>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:23515E27-98AC-4DC9-A4B7-EBFE2991219F</domeo:belongsToSet>
    <ao:body rdf:nodeID="Na4abaf9ffc6b4fd4abee4c3d571458a3"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:95A575B7-D25D-4077-8C94-5A2FF84DB82C"/>
    <pav:lineageUri>urn:domeoserver:annotation:6710A821-F6B9-4C09-B9CB-F518689D127A</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoserver:annotationset:C9868B04-3F07-42FC-8F5C-D0B3D0DA54B1">
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:2B6220CC-057A-44B0-856A-829A9EE325F9"/>
    <pav:lineageUri>urn:domeoserver:annotationset:ecd845f9-401b-446c-8abd-920f97670010</pav:lineageUri>
    <permissions:permissions rdf:nodeID="Nf6f2fdb3e24b42d1830787a2573aca38"/>
    <pav:lastSavedOn>2014-07-08 19:43:50 -0400</pav:lastSavedOn>
    <rdfs:label>NER Sets</rdfs:label>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-38.txt.html</ao:annotatesResource>
    <ao:item rdf:resource="file:///home/yin2/python-SPL-connector/a00b6a0b-5870-4218-bd0e-1a999185f12b"/>
    <pav:previousVersion>urn:domeoclient:uuid:7abf027b-4357-4954-8607-522a297d6530</pav:previousVersion>
    <ao:item rdf:resource="urn:domeoclient:uuid:DF75E64A-4D45-4393-A03E-A3D34A40FC13"/>
    <pav:createdOn>2014-07-07 08:06:29 -0400</pav:createdOn>
    <dct:description>The NER set is created automatically by NER annotation loading program.</dct:description>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">3</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:item rdf:resource="urn:domeoclient:uuid:A59461AD-50B9-4CEB-AE18-C0F87F411CF3"/>
    <domeo:deleted>false</domeo:deleted>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812e52b20002"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:1B8E43F4-D9E1-4A26-A24D-CAC3616BA2C6">
    <domeo:uuid>1B8E43F4-D9E1-4A26-A24D-CAC3616BA2C6</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix>AUC. The mean ± SD increase in phenytoin AUC was 88% ± 68% (range: 16 to 247%). The absolute magnitude of this interaction is unknown because of the intrinsically nonlinear disposition of phenytoin. (See PRECAUTIONS.)</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:1B8E43F4-D9E1-4A26-A24D-CAC3616BA2C6"/>
    <ao:prefix>200 mg daily for 16 days) in 10 normal male volunteers. There was a significant increase in </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-25.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-07 20:13:29 -0400</pav:createdOn>
    <ao:exact>phenytoin </ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D24C42FB-BDF9-4C29-B4A3-83C19B89B73F">
    <pav:createdOn>2014-07-07 20:46:09 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:41602C88-4D14-4A90-A022-DE93CDD7B096"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotation:902570BF-7187-4324-8E07-8000F078A616</pav:lineageUri>
    <pav:lastSavedOn>2014-07-07 20:46:25 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoclient:uuid:E08D4CED-BE06-4A5F-A2AF-BFBC25BA8AE4</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:96CB6F69-5967-473C-9B9E-B9F188F09023">
    <ao:prefix>is increased by more than 200% by co-administration of </ao:prefix>
    <domeo:uuid>96CB6F69-5967-473C-9B9E-B9F188F09023</domeo:uuid>
    <ao:exact>propranolol</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:96CB6F69-5967-473C-9B9E-B9F188F09023"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-08 08:55:50 -0400</pav:createdOn>
    <ao:suffix>.</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-124.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:75BA01BB-6505-483D-8D05-31105AB1D4BF">
    <ao:exact>colestipol </ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-131.txt.html</ao:hasSource>
    <domeo:uuid>75BA01BB-6505-483D-8D05-31105AB1D4BF</domeo:uuid>
    <pav:createdOn>2014-07-08 09:14:49 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>or </ao:prefix>
    <ao:suffix>with propranolol resulted in up to 50% decrease in propranolol concentrations.</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:75BA01BB-6505-483D-8D05-31105AB1D4BF"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:81D18ECD-60AA-44D8-99E7-C390ADFDD89D">
    <pav:lineageUri>urn:domeoserver:annotation:94F51F1B-5031-4FE1-87FC-62EBA41F75CF</pav:lineageUri>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <ao:body rdf:nodeID="N11ab702490384ba5ae4a09d73e94a52e"/>
    <pav:createdOn>2014-07-07 20:04:12 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-07-07 20:04:45 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoclient:uuid:921213C5-987C-46D2-9095-A8DDC2B714AB</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:8A953E90-C2D0-4352-ABDF-7BE4E11F229A"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:825E94D7-A56C-4804-AACC-D6EB9189DE40">
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:2C0E39A3-C26E-46D5-B5D9-060D5C02B896"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:body rdf:nodeID="N5d459dfadf5347dda8e0d8049510a297"/>
    <pav:createdOn>2014-07-08 14:10:46 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-07-08 14:10:48 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotation:61AD45C9-1EC5-426D-9A5D-CA14AE072E40</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7E49EB7A-DE0E-4720-82D1-8460BA0C770D</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:71A47C83-384A-4077-8084-BBFDB9A5EBC2">
    <domeo:uuid>71A47C83-384A-4077-8084-BBFDB9A5EBC2</domeo:uuid>
    <ao:exact>sildenafil Cmax</ao:exact>
    <ao:prefix> and a 55% decrease in </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix>. Co-administration resulted in a 50% increase in AUC of bosentan. The combination of both drugs did not lead to clinically significant changes in blood pressure (supine or standing). Concomitant administration of potent CYP3A inducers is expected to cau</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-07 09:42:50 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:71A47C83-384A-4077-8084-BBFDB9A5EBC2"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:EDA4D145-47CC-4A95-B0DA-36D349F1451A">
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:06A3DDC8-332E-4E54-A5C8-C5EE4826BC46"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C27C38CA-1604-4FDC-B80E-A5F7086C56BB">
    <pav:lastSavedOn>2014-07-07 19:50:36 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotationset:1DED06A6-8562-4CCF-A58C-CA25748FBD31</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5ABD9862-F044-4404-AD04-73DA04ADDA8B</domeo:belongsToSet>
    <pav:createdOn>2014-07-07 19:43:21 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:064399E9-B524-4FE1-8D5C-3FDE4F9BDAE1"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A6119BEE-21EC-4D17-A8B5-EA1E30152F02">
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:983B2BBE-243E-4F7D-8D3E-2998CAF31599"/>
    <pav:createdOn>2014-07-08 14:20:09 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">3</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:42258B16-6749-4B39-B28D-88C8B63F7A43</domeo:belongsToSet>
    <pav:previousVersion>urn:domeoclient:uuid:e75c9d7b-f906-4c66-8a84-e6eef34d0954</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotationset:0f67c012-7596-4b02-a927-63c0ccbc3afa</pav:lineageUri>
    <pav:lastSavedOn>2014-07-08 14:24:44 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:5E82EA3B-FCBE-4273-A007-E3672C43D525">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:BCC9EB2F-25E7-44FF-83F2-904B4F4819EC</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:createdOn>2014-07-08 09:28:17 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:70A87BF4-C82E-4FBC-AE3B-7D16BFF92FB7"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotation:78577111-FCB8-4173-BAE2-C59F37C73BCE</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2014-07-08 09:28:41 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:2B7A79EA-546C-4BB9-9E76-51AA78FB3451">
    <pav:lineageUri>urn:domeoserver:annotationset:1DED06A6-8562-4CCF-A58C-CA25748FBD31</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-07 19:50:36 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdOn>2014-07-07 19:49:07 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5ABD9862-F044-4404-AD04-73DA04ADDA8B</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:A6F2702F-9127-4851-8993-25C4F8A959BD"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:87745CB9-8FA7-464F-8951-65523296C788">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/821B63F7-7F62-4655-A95C-79DFBC4EA53E"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/B21336C3-A4D6-44DE-9019-53E01D8FDD6F"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:4C2701B1-6391-4B52-9FAA-57695F47BF9B">
    <ao:suffix>or erythromycin coadministration enhances fexofenadine gastrointestinal absorption. This observed increase in the bioavailability of fexofenadine may be due to transport-related effects, such as p-glycoprotein. In vivo animal studies also suggest that in</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-139.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:4C2701B1-6391-4B52-9FAA-57695F47BF9B"/>
    <ao:exact>ketoconazole </ao:exact>
    <pav:createdOn>2014-07-08 09:32:27 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>The mechanism of these interactions has been evaluated in in vitro, in situ, and in vivo animal models. These studies indicate that </ao:prefix>
    <domeo:uuid>4C2701B1-6391-4B52-9FAA-57695F47BF9B</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/4307A329-598A-4D48-AA8E-4B439BB5E1F2">
    <rdfs:label>nifedipine</rdfs:label>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/7417</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:84B48D1F-30B7-47C9-A879-646C36614703">
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-07-08 08:57:14 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:C673D49F-D791-4325-A924-0B57680A3527</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-08 08:56:41 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:9BAD0014-638A-4361-B334-C6268BF4BA0E"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotation:3B76DF18-7847-40E7-B2D5-24E7512807ED</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/E079F00F-69EB-4F85-BF7E-B89E4393D276">
    <rdfs:label>phenytoin</rdfs:label>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/8183</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:964D229E-7742-4278-8030-45571F6470DC">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-07-08 15:55:47 -0400</pav:createdOn>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:body rdf:nodeID="N0aa00e4ac26c49c89f8e5f542eb105bc"/>
    <pav:lastSavedOn>2014-07-08 15:56:00 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5B2167F6-4E63-4A7B-85C1-ACA56DDE7073</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:AF2C79DB-879F-48ED-AAFE-58E59F95753A"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:lineageUri>urn:domeoserver:annotation:74E15BD2-6A1A-49E5-AC22-3AF9870407E8</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:297EB28E-F930-4764-85C7-ED2F52B1F6EB">
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:6FC0C902-E54B-498F-B495-27FA5ED605B0"/>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:0C47D7EE-6686-4B42-B21C-DE2132583AF4">
    <ao:suffix>xsd:String</ao:suffix>
    <pav:createdOn>2014-07-08 12:06:38 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:0C47D7EE-6686-4B42-B21C-DE2132583AF4"/>
    <domeo:uuid>0C47D7EE-6686-4B42-B21C-DE2132583AF4</domeo:uuid>
    <ao:prefix>xsd:String</ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-163.txt.html</ao:hasSource>
    <ao:exact>Plasma concentrations of meperidine and its metabolite, normeperidine, may be increased by acyclovir, thus caution should be used with concomitant administration</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:60212a27-d4be-4876-9a87-d94e2c0d74a6">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:60212a27-d4be-4876-9a87-d94e2c0d74a6"/>
    <ao:prefix>eased the bioavailability of </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>risperidone</ao:exact>
    <domeo:uuid></domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-7.txt.html</ao:hasSource>
    <ao:suffix> by 64% and 26%, respectively.</ao:suffix>
    <pav:createdOn>2014-07-07 08:07:04 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:CE9CDAC4-3C9D-4E89-95A8-A53185AACF8B">
    <domeo:belongsToSet>urn:domeoserver:annotationset:A5E637EF-5CA5-4AAC-BD8B-C136A86E17B7</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotationset:F37BE993-E972-47AE-896D-FF4D33157ECF</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-07-07 09:44:18 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-07 09:42:50 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:71A47C83-384A-4077-8084-BBFDB9A5EBC2"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:8B476D0C-9B27-4B08-A7C5-2F86AC7912F3">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>methotrexate</ao:exact>
    <pav:createdOn>2014-07-08 12:24:41 -0400</pav:createdOn>
    <ao:suffix>; increased serum concentrations of methotrexate with concomitant hematologic and gastrointestinal toxicity have been observed with methotrexate. Use of methotrexate with penicillins should be carefully monitored.</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:8B476D0C-9B27-4B08-A7C5-2F86AC7912F3"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-166.txt.html</ao:hasSource>
    <domeo:uuid>8B476D0C-9B27-4B08-A7C5-2F86AC7912F3</domeo:uuid>
    <ao:prefix>may reduce the renal clearance of </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:1C021AB0-72D6-4EB8-B9DB-38B652CD3E1D">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:1C021AB0-72D6-4EB8-B9DB-38B652CD3E1D"/>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <ao:exact>AVANDIA (4 mg twice daily) was shown to have no clinically relevant effect on the pharmacokinetics of nifedipine and oral contraceptives (ethinyl estradiol and norethindrone), which are predominantly metabolized by CYP3A4.</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-08 08:45:25 -0400</pav:createdOn>
    <domeo:uuid>1C021AB0-72D6-4EB8-B9DB-38B652CD3E1D</domeo:uuid>
    <ao:prefix>xsd:String</ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:FFF82639-F04C-408F-8A11-01A3070D4E29">
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:858D4B61-9F77-4036-B8A9-80C568ABA660"/>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:41EC1F70-B919-4563-BA6C-23B2DE0ACFF8">
    <pav:createdOn>2014-07-08 15:51:21 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:3BC1B93B-7350-4A55-AC66-9076AAF802BA"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5B2167F6-4E63-4A7B-85C1-ACA56DDE7073</domeo:belongsToSet>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <ao:body rdf:nodeID="N476ce95e3fca4c40abc8e53fef05fb5a"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotation:000C4645-6176-48BA-B52E-29F109B0F351</pav:lineageUri>
    <pav:lastSavedOn>2014-07-08 15:56:00 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7A1C9B36-806F-4044-8F68-5A318498BC6C">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-31.txt.html</ao:hasSource>
    <domeo:uuid>7A1C9B36-806F-4044-8F68-5A318498BC6C</domeo:uuid>
    <ao:prefix> in 20 normal male volunteers. There was a mean ± SD increase in AUC of 44% ± 29% (range: -13 to 115%) and Cmax increased 19% ± 19% (range: -23 to 62%). Five subjects required oral </ao:prefix>
    <ao:exact>glucose</ao:exact>
    <ao:suffix> following the ingestion of </ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:7A1C9B36-806F-4044-8F68-5A318498BC6C"/>
    <pav:createdOn>2014-07-08 19:47:25 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:0770C0E2-F30E-4577-B7BD-ECBD88172920">
    <ao:suffix>administered as solution to three healthy male volunteers, total recovery of radioactivity at 1 week was 84%, including 70% in the urine and 14% in the feces.</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <ao:exact>risperidone </ao:exact>
    <ao:prefix>and its metabolites are eliminated via the urine and, to a much lesser extent, via the feces. As illustrated by a mass balance study of a single 1 mg oral dose of 14C-</ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:0770C0E2-F30E-4577-B7BD-ECBD88172920"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-07 19:57:55 -0400</pav:createdOn>
    <domeo:uuid>0770C0E2-F30E-4577-B7BD-ECBD88172920</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:506062D5-8533-4516-863B-C94A942F4B96">
    <ao:suffix> inhibits the activity of HIV-1 reverse transcriptase both by competing with the natural substrate, deoxyadenosine 5’-triphosphate, and by its incorporation into viral DNA causing termination of viral DNA chain elongation</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-2.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:506062D5-8533-4516-863B-C94A942F4B96"/>
    <ao:prefix>.</ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact> Dideoxyadenosine 5’-triphosphate</ao:exact>
    <domeo:uuid>506062D5-8533-4516-863B-C94A942F4B96</domeo:uuid>
    <pav:createdOn>2014-07-21 09:43:45 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D7023550-028F-4956-B8CA-87F1AF29A164">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotation:52C8690D-E324-43D7-9AEA-7355B9FBB1C7</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:4A7D60B8-C389-4412-96A0-A073BCDBADBC"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdOn>2014-07-08 14:25:18 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:42258B16-6749-4B39-B28D-88C8B63F7A43</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-08 14:26:16 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:137ED6B6-D58E-4B3D-919B-4BF77268CD53">
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:body rdf:nodeID="Naa8eccd5fad345a6a8a0bb7d17a26d3a"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:14126FF0-58E7-4C3F-854A-32C0BA20B0B0"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5ABD9862-F044-4404-AD04-73DA04ADDA8B</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-07-07 19:59:12 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-07 19:52:07 -0400</pav:createdOn>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:lineageUri>urn:domeoserver:annotation:EC9244D7-233E-4F7E-BA7D-1E7321EEECA8</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:3BC1B93B-7350-4A55-AC66-9076AAF802BA">
    <ao:suffix>xsd:String</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-7.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:3BC1B93B-7350-4A55-AC66-9076AAF802BA"/>
    <ao:exact>Erythromycin:There were no significant interactions between risperidone and erythromycin</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>3BC1B93B-7350-4A55-AC66-9076AAF802BA</domeo:uuid>
    <pav:createdOn>2014-07-08 15:51:21 -0400</pav:createdOn>
    <ao:prefix>xsd:String</ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/6461087D-9BBA-4596-BE97-3EFFC7C9732C">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/8787</dailymed:activeMoietyRxCUI>
    <rdfs:label>propranolol</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/70B62EC4-4ADA-4112-8636-FF088E74D00D">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/7514</dailymed:activeMoietyRxCUI>
    <rdfs:label>norethindrone</rdfs:label>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B3FD7844-E20B-4D1C-95F6-19F94B514146">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:B3FD7844-E20B-4D1C-95F6-19F94B514146"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-139.txt.html</ao:hasSource>
    <ao:prefix>400 mg once daily under steady-state conditions to healthy adult subjects (n = 24, each study). No differences in adverse events or QTc interval were observed when subjects were administered </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix> alone or in combination with either erythromycin or ketoconazole. The findings of these studies are summarized in the following table:</ao:suffix>
    <pav:createdOn>2014-07-08 09:32:19 -0400</pav:createdOn>
    <ao:exact>fexofenadine hydrochloride</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>B3FD7844-E20B-4D1C-95F6-19F94B514146</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:88A53C37-C91D-4321-972E-215E698B9BF3">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoclient:uuid:86E1DCE1-FFC6-4513-AEF9-EF158A019E6B</domeo:belongsToSet>
    <ao:body rdf:nodeID="N4da183e02f9f49778e958c7e659d4b20"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotation:5A1FEB7D-585A-4452-A1AA-976C22B99DE6</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:FADB1D60-DCB2-40A1-A37B-321DD9EB3027"/>
    <pav:lastSavedOn>2014-07-08 09:00:25 -0400</pav:lastSavedOn>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:createdOn>2014-07-08 08:59:57 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:18D8786F-1216-4DDA-8591-252576279D62">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:18D8786F-1216-4DDA-8591-252576279D62"/>
    <pav:createdOn>2014-07-08 09:10:45 -0400</pav:createdOn>
    <ao:suffix> Co-administration wit</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-129.txt.html</ao:hasSource>
    <domeo:uuid>18D8786F-1216-4DDA-8591-252576279D62</domeo:uuid>
    <ao:exact>Co-administration of propranolol with cimetidine, a non-specific CYP450 inhibitor, increased propranolol AUC and Cmax by 46% and 35%, respectively.</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C8E7398B-A687-4370-874E-68C2EFFD0F5C">
    <pav:createdOn>2014-07-07 09:37:15 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A5E637EF-5CA5-4AAC-BD8B-C136A86E17B7</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:413E8823-E641-4B6C-8233-7C509C86A346"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:lastSavedOn>2014-07-07 09:44:18 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotationset:F37BE993-E972-47AE-896D-FF4D33157ECF</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/0F8794D3-EE9E-46A8-AF6A-5DA06883035F">
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>phenobarbital</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/8134</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nc086d59ad7484121a75b52671002bfec">
    <permissions:isLocked>false</permissions:isLocked>
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E7498DAA-0A48-4221-AF3C-86C236CB2025">
    <domeo:uuid>E7498DAA-0A48-4221-AF3C-86C236CB2025</domeo:uuid>
    <ao:suffix>with nefazodone is contraindicated (see CONTRAINDICATIONS).</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:E7498DAA-0A48-4221-AF3C-86C236CB2025"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>and its active metabolite to achieve a therapeutic effect. Coadministration of </ao:prefix>
    <ao:exact>carbamazepine </ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-59.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-07 20:38:06 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:B72301C6-9B10-4EDB-BB00-4AC1971A82DC">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/FDC0BABD-576B-4151-A4D2-06BA005D1319"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/C8BE8E8A-7852-4E83-BE10-6699E45131C2"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:3EDAD445-40E3-4EB0-BF26-CA562642BAB0">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>Amitriptyline did not affect the pharmacokinetics of risperidone or risperidone and 9-hydroxyrisperidone combined</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:3EDAD445-40E3-4EB0-BF26-CA562642BAB0"/>
    <ao:prefix>xsd:String</ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-7.txt.html</ao:hasSource>
    <domeo:uuid>3EDAD445-40E3-4EB0-BF26-CA562642BAB0</domeo:uuid>
    <pav:createdOn>2014-07-08 15:43:16 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:1BE3533C-2291-4EF4-97BB-137F285EE3EB">
    <ao:exact> ethinyl estradiol</ao:exact>
    <domeo:uuid>1BE3533C-2291-4EF4-97BB-137F285EE3EB</domeo:uuid>
    <pav:createdOn>2014-07-07 20:06:02 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-22.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:1BE3533C-2291-4EF4-97BB-137F285EE3EB"/>
    <ao:suffix> AUC was 6% (range: -47 to 108%) and levonorgestrel AUC increased 17% (range: -33 to 141%).</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>. The mean increase in</ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:921213C5-987C-46D2-9095-A8DDC2B714AB">
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <pav:createdOn>2014-07-07 20:00:33 -0400</pav:createdOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:20C2F32A-1370-4EF2-BDF5-977B27436701"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:item rdf:resource="urn:domeoclient:uuid:8A841157-24AA-49C8-BACD-FFE74788C959"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-07-07 20:04:45 -0400</pav:lastSavedOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:03E0AB5B-5F5B-4DF0-9D97-01607B82D9CB"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:4A9EEEEB-A8B2-4979-A187-0B3336654D7A"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:81D18ECD-60AA-44D8-99E7-C390ADFDD89D"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:6819E238-7679-4EEF-827E-2E642C80664C"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:E62AB53D-EE03-48A2-8134-3BC40C9F7830"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:EB32DF82-19F1-4506-BA93-CF38DE05C68A"/>
    <pav:lineageUri>urn:domeoserver:annotationset:FBD878A5-52B7-4348-B726-AFD3C73DD514</pav:lineageUri>
    <permissions:permissions rdf:nodeID="N9b2fa83d5903490389f398a98231c54c"/>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-21.txt.html</ao:annotatesResource>
    <domeo:deleted>false</domeo:deleted>
    <ao:item rdf:resource="urn:domeoclient:uuid:53451EFA-435E-4280-9EBF-96B72E35525B"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812e52b20002"/>
    <rdfs:label>Default Set</rdfs:label>
    <ao:item rdf:resource="urn:domeoclient:uuid:46113E93-8644-4468-916F-0232D35E311B"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:0D5EBC4C-8790-476B-81E6-9049B7366310"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <ao:item rdf:resource="urn:domeoclient:uuid:8C8566AB-DEEC-49B5-AB41-B5CC8114ADE7"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:81F0B14E-0B17-458B-B8DA-5733BFA54466"/>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <ao:item rdf:resource="urn:domeoclient:uuid:AE273420-DDF8-4C9E-B8ED-6379C6714633"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/454E08CE-230F-4257-8E40-56C4E52A3761">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>zidovudine</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/11413</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:5E43E412-CC11-44B9-BCF8-EE8A3F78D619">
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:F913AD73-2825-4550-B9B9-C8F20585B6C1"/>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:0F97BB98-A4A8-4794-9B98-50ED646AB72D">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:DFEC07A0-0254-4C07-AEA9-201F0354FEAF"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:F8266BC9-0FBE-4F89-99BF-28181281C00F</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-07-07 19:59:52 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotation:BFCF2C12-E932-4255-9476-D593D2D02F8F</pav:lineageUri>
    <pav:lastSavedOn>2014-07-07 20:00:02 -0400</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:3729EE77-B980-41A7-B3A7-1160C8DCBDB0">
    <ao:suffix>, its major metabolite, 9-hydroxyrisperidone, and risperidone plus 9-hydroxyrisperidone are dose proportional over the dosing range of 1 to 16 mg daily (0.5 to 8 mg twice daily). Following oral administration of solution or tablet, mean peak plasma conce</ao:suffix>
    <ao:prefix>Plasma concentrations of </ao:prefix>
    <ao:exact>risperidone</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <domeo:uuid>3729EE77-B980-41A7-B3A7-1160C8DCBDB0</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:3729EE77-B980-41A7-B3A7-1160C8DCBDB0"/>
    <pav:createdOn>2014-07-07 19:46:00 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:64EE0DE1-0041-4599-B2F7-B51C3F0990FE">
    <ao:suffix>TM is believed to act as an emergency contraceptive principally by preventing ovulation or fertilization (by altering tubal transport of sperm and/or ova). In addition, they may inhibit implantation (by altering the endometrium). It is not effective once</ao:suffix>
    <domeo:uuid>64EE0DE1-0041-4599-B2F7-B51C3F0990FE</domeo:uuid>
    <pav:createdOn>2014-07-08 15:32:11 -0400</pav:createdOn>
    <ao:prefix>Emergency contraceptive pills are not effective if a woman is already pregnant. </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:64EE0DE1-0041-4599-B2F7-B51C3F0990FE"/>
    <ao:exact>Next Choice</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-206.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:C3EEDFB7-7EBA-4DBF-9156-59FEF4FDBC91">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/8DA51822-E520-4CD7-B9E6-5C34841D70B7"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/EAF2CAF5-255C-4273-A771-20F4AF61E6A5"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:43CCC5CC-8859-4834-A955-A002353E5EC1">
    <ao:suffix>xsd:String</ao:suffix>
    <pav:createdOn>2014-07-08 12:10:56 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:43CCC5CC-8859-4834-A955-A002353E5EC1"/>
    <domeo:uuid>43CCC5CC-8859-4834-A955-A002353E5EC1</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-164.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:exact>Cimetidine reduced the clearance and volume of distribution of meperidine and also the formation of the metabolite, normeperidine, in healthy subjects and thus, caution should be used with concomitant administration</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F5E4B1A3-C7BF-4842-AED6-20FD0118DE74">
    <pav:createdOn>2014-07-07 19:59:04 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>F5E4B1A3-C7BF-4842-AED6-20FD0118DE74</domeo:uuid>
    <ao:exact>risperidone </ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:F5E4B1A3-C7BF-4842-AED6-20FD0118DE74"/>
    <ao:prefix>Race and Gender Effects: No specific pharmacokinetic study was conducted to investigate race and gender effects, but a population pharmacokinetic analysis did not identify important differences in the disposition of </ao:prefix>
    <ao:suffix>due to gender (whether corrected for body weight or not) or race.</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:6C352172-64DF-4EE5-8AE0-B0F86B8E4F0B">
    <pav:lineageUri>urn:domeoserver:annotationset:57174A7C-3100-4C8F-9C4A-2991CEE124D5</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:23515E27-98AC-4DC9-A4B7-EBFE2991219F</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-08 08:46:38 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:D2035610-1F9A-4358-A464-068664EB4D73"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdOn>2014-07-08 08:40:34 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E6063F3F-E14E-4F7A-BE6B-DBB1A0CC4BA2">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>xsd:String</ao:prefix>
    <domeo:uuid>E6063F3F-E14E-4F7A-BE6B-DBB1A0CC4BA2</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-197.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:E6063F3F-E14E-4F7A-BE6B-DBB1A0CC4BA2"/>
    <ao:exact>Phenytoin: Phenytoin plasma levels have been reported to be low in some patients receiving zidovudine, while in one case a high level was documented. However, in a pharmacokinetic interaction study in which 12 HIV-1-positive volunteers received a single 300 mg phenytoin dose alone and during steady-state zidovudine conditions (200 mg every 4 hours), no change in phenytoin kinetics was observed. Although not designed to optimally assess the effect of phenytoin on zidovudine kinetics, a 30% decrease in oral zidovudine clearance was observed with phenytoin.</ao:exact>
    <pav:createdOn>2014-07-08 14:22:48 -0400</pav:createdOn>
    <ao:suffix>xsd:String</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:34FB6161-E70B-4EFD-88C8-11B1476807BA">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/B7C31221-04F8-4CEE-AAAC-778C9169ACCD"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/FC58BA69-9FE6-4D4E-BEEF-272817554373"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:9A6BA5E0-3F05-4309-BE07-2C1C74223C40">
    <domeo:belongsToSet>urn:domeoserver:annotationset:23515E27-98AC-4DC9-A4B7-EBFE2991219F</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-08 08:46:38 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:A38EEBF0-E48A-401A-8476-8FDBD696DDFD"/>
    <pav:createdOn>2014-07-08 08:39:52 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotationset:57174A7C-3100-4C8F-9C4A-2991CEE124D5</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E473FFA3-3057-44B1-81C6-97BACFE87878">
    <ao:context rdf:resource="urn:domeoclient:uuid:66DDCA2D-3428-4A4B-8DC4-D7A7A3B39715"/>
    <pav:lineageUri>urn:domeoserver:annotation:B7B818B1-98E9-4A76-A094-EB59D256C61A</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2014-07-08 14:52:51 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-08 14:50:15 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:41C6B392-F8A7-4DBA-AFEF-0BE07588FACF</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F13B25C3-3520-42DE-85EF-21881CB9A279">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotationset:F37BE993-E972-47AE-896D-FF4D33157ECF</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdOn>2014-07-07 09:40:35 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-07-07 09:44:18 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A5E637EF-5CA5-4AAC-BD8B-C136A86E17B7</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:16709F26-EAC7-479F-B3B4-CAE1A027C7EF"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A751B0FE-9015-43D2-AA1E-AF456C1C9527">
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdOn>2014-07-08 09:24:19 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoclient:uuid:FF4D892F-0BD2-4FD8-9160-6124946DB29D</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:518AD2AC-4AF1-4A5C-9EBC-A0A09E2F4BCE"/>
    <pav:lastSavedOn>2014-07-08 09:24:21 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotation:5980DF5D-4C5B-4480-A5FD-D790BA9748C1</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:BA759022-B015-4D11-8039-A1577FD96049">
    <pav:createdOn>2014-07-07 09:37:37 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:BA759022-B015-4D11-8039-A1577FD96049"/>
    <ao:suffix>is excreted as metabolites predominantly in the feces (approximately 80% of the administered oral dose) and to a lesser extent in the urine (approximately 13% of the administered oral dose).</ao:suffix>
    <domeo:uuid>BA759022-B015-4D11-8039-A1577FD96049</domeo:uuid>
    <ao:exact>sildenafil </ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>After either oral or intravenous administration, </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:DA42D122-3010-429C-B980-DB548D699AE1">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:423352B3-8ABA-48B7-98CF-B191A7BFC955</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-08 09:35:29 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-08 09:31:51 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotation:8C78C8D6-72DA-423A-AB5E-66CA734A6935</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:82CB26E9-3B23-40F5-9BC7-449481FF0D92"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:AF9BBA5D-B17E-4B8C-BD7E-9F298BD9EC7C">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/9351F136-D702-454C-8A37-CCEEB19628AC"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/9C08BFE1-3C39-43F6-A44F-C1258C7BC980"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:EF2016C0-0435-461F-B46F-5F2F183C369E">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-07-08 08:39:23 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:23515E27-98AC-4DC9-A4B7-EBFE2991219F</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotationset:57174A7C-3100-4C8F-9C4A-2991CEE124D5</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:7A79C46E-A15F-428F-A1D0-9FC0AD09BDCC"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2014-07-08 08:46:38 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B3F29EBC-4966-40C6-A05A-1B0A92E2985C">
    <domeo:uuid>B3F29EBC-4966-40C6-A05A-1B0A92E2985C</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:B3F29EBC-4966-40C6-A05A-1B0A92E2985C"/>
    <ao:exact>azithromycin </ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>resulted in increased </ao:prefix>
    <pav:createdOn>2014-07-08 12:02:53 -0400</pav:createdOn>
    <ao:suffix>serum concentrations. Although a dose adjustment of azithromycin is not recommended when administered in combination with nelfinavir, close monitoring for known side effects of azithromycin, such as liver enzyme abnormalities and hearing impairment, is w</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-161.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:483F76E5-1D7F-4A20-81C1-51BE0194127E">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">3</pav:versionNumber>
    <pav:createdOn>2014-07-21 10:00:02 -0400</pav:createdOn>
    <pav:previousVersion>urn:domeoclient:uuid:21a2d27a-13b1-4797-ba7a-c0517e32bb06</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:AE61EF6D-C59F-430B-8D31-9555FF011B63"/>
    <pav:lineageUri>urn:domeoserver:annotationset:cf593dca-fe93-451b-8f37-2a96e065da13</pav:lineageUri>
    <pav:lastSavedOn>2014-07-21 10:02:11 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:32944008-A6C6-4D66-8C43-EE4CF2256965</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:2382E309-E3E2-4D56-8CFB-6B8B214C41E1">
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdOn>2014-07-07 20:50:05 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-07-07 20:51:02 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotation:E2E10EEE-E504-4983-B614-6A60E3094060</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:5117E723-600D-43FA-A0F5-3B0D6AB776ED"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:29AAB777-4FBF-49C4-ACFD-F2FC169A463D</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:63667359-9BDD-4D22-A604-47C4E1FA2996">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-08 16:16:47 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-07-08 16:17:10 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:D5FE9F58-EB3F-4295-9090-E3B773EBD671</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotation:C3294636-5D8F-4879-890C-E1CF0D6ADB5D</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:BEB715D4-D4B4-4ED1-8977-BCC5A263E9A6"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:46A53F25-C7A3-4D90-8A60-29F0AF4E0BB9">
    <ao:body rdf:nodeID="N4258cac2f3e6468686acf01469c403b6"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-08 08:53:11 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotation:DCB9A9A0-2596-4079-B70D-0E4122B4704A</pav:lineageUri>
    <pav:lastSavedOn>2014-07-08 08:54:46 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:23515E27-98AC-4DC9-A4B7-EBFE2991219F</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:02E081CF-FE9B-48C0-BB6D-062C578358AA"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>expertstudy Annotation</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/DC5D26F9-8AA7-4A81-9E15-A57BFEABEBA9">
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>zonisamide</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/39998</dailymed:activeMoietyRxCUI>
    <dct:description>Referred to the drug in the interaction.</dct:description>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N92a252c1a6c142dfaf16e84884bb7063">
    <domeo:sets rdf:resource="urn:pddi:uuid:BF1C2089-16A5-414D-8315-E92E584307A0"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/01C26E45-CF08-4563-A5B1-557526382E74">
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/10438</dailymed:activeMoietyRxCUI>
    <rdfs:label>theophylline</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:6AFA671B-2945-478E-BB17-6F29A0395344">
    <pav:createdOn>2014-07-08 09:26:20 -0400</pav:createdOn>
    <ao:exact>In vitro drug metabolism studies reveal that trazodone is a substrate of the cytochrome P450 3A4 (CYP3A4) enzyme and trazodone metabolism can be inhibited by the CYP3A4 inhibitors ketoconazole, ritonavir, and indinavir</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>6AFA671B-2945-478E-BB17-6F29A0395344</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:6AFA671B-2945-478E-BB17-6F29A0395344"/>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-136.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/baa8fbbb-84d5-4f92-aa86-b07ad5bda767">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:6b7f671d-70f8-46be-9a8f-ed31f277e60f"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdOn>2014-07-07 08:06:41 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:4813B8AA-0B59-46E2-A60D-4C599BDB18F2</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotationset:71ef9d96-69ba-4693-8517-f0b0ec28acf8</pav:lineageUri>
    <pav:lastSavedOn>2014-07-07 08:06:41 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:DCE4E80E-B2DD-4A92-854A-C154970AB4EA">
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <domeo:belongsToSet>urn:domeoclient:uuid:BCC9EB2F-25E7-44FF-83F2-904B4F4819EC</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2014-07-08 09:28:41 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-08 09:28:20 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:2F772F9A-A059-49D1-8FD1-A685F5D44261"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotation:88112AC0-80BE-4132-AB4C-B4534CC2F844</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:577B7F0B-0576-4755-9243-C37BEFE35128">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-139.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:577B7F0B-0576-4755-9243-C37BEFE35128"/>
    <ao:exact> fexofenadine hydrochloride</ao:exact>
    <ao:prefix>has been shown to exhibit minimal (ca. 5%) metabolism. However, coadministration of</ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix> with either ketoconazole or erythromycin led to increased plasma concentrations of fexofenadine in healthy adult subjects. Fexofenadine had no effect on the pharmacokinetics of either erythromycin or ketoconazole. In two separate studies in healthy adul</ao:suffix>
    <pav:createdOn>2014-07-08 09:31:57 -0400</pav:createdOn>
    <domeo:uuid>577B7F0B-0576-4755-9243-C37BEFE35128</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E29379BB-3B42-46F1-AAD5-9403BAF6750F">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-08 13:51:14 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-08 13:51:14 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <ao:body rdf:nodeID="Na0b4a45d87bb44e7828d02a48aeb9a33"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:lineageUri>urn:domeoserver:annotation:CF941F59-693F-4513-9033-D0046362B262</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:0FEEAD08-987A-4FB4-A1A5-C8AB4B60CF6C</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:474719AA-7597-40C0-BF57-1E518CB8BEAA"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:B0057C60-E1DF-4175-8D6C-02632B09207F">
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:1C8F355C-9736-48FE-90F1-529FF2A3C2D6"/>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:4e77548e-dbfe-4049-b41b-230bed4c58ce">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:4e77548e-dbfe-4049-b41b-230bed4c58ce"/>
    <domeo:uuid></domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-07 08:06:55 -0400</pav:createdOn>
    <ao:suffix> concentrations were observed </ao:suffix>
    <ao:exact>zidovudine</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-197.txt.html</ao:hasSource>
    <ao:prefix>ortional increases in plasma </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:486F1875-BE96-445A-B94C-56B972E73163">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:486F1875-BE96-445A-B94C-56B972E73163"/>
    <domeo:uuid>486F1875-BE96-445A-B94C-56B972E73163</domeo:uuid>
    <ao:suffix>, whereas poor CYP 2D6 metabolizers convert it much more slowly. Although extensive metabolizers have lower risperidone and higher 9-hydroxyrisperidone concentrations than poor metabolizers, the pharmacokinetics of risperidone and 9-hydroxyrisperidone co</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <ao:exact>9-hydroxyrisperidone</ao:exact>
    <ao:prefix>rapidly into </ao:prefix>
    <pav:createdOn>2014-07-07 19:48:36 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:83DB2E5E-A3FD-4CD4-8D24-9B7AC9DD3DA0">
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:8B6EB8FD-0A13-4C94-ACDC-67E123749800"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/E55CFD5B-9512-4ADF-8EA7-57764E3ECA86">
    <rdfs:label>sertraline</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/36437</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:1D6456DE-2785-4888-87AC-4EFB4B133035">
    <domeo:belongsToSet>urn:domeoserver:annotationset:5B2167F6-4E63-4A7B-85C1-ACA56DDE7073</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotation:C44095F9-911F-4BE1-9119-2AEA82371D27</pav:lineageUri>
    <ao:body rdf:nodeID="N98f654b426294075a96d6db9fb42868b"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:30946630-56C3-41E1-B676-2074DA88BD79"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:createdOn>2014-07-08 15:53:01 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-07-08 15:56:00 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:5550D10C-1548-447C-BE34-823232268511">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/4521D8AB-E3B2-4AA4-AAF8-8066D097EA09"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/113E77B6-9715-44B7-984E-57FBA75BFE4C"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E4AB0974-9669-4DE7-9384-60B4037F205C">
    <domeo:uuid>E4AB0974-9669-4DE7-9384-60B4037F205C</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:E4AB0974-9669-4DE7-9384-60B4037F205C"/>
    <ao:exact>sildenafil </ao:exact>
    <pav:createdOn>2014-07-07 09:39:03 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <ao:suffix>clearance was reduced, resulting in approximately doubling of AUC and Cmax compared to age-matched volunteers with no renal impairment. In addition, N-desmethyl metabolite AUC and Cmax values were significantly increased 200 % and 79 %, respectively, in </ao:suffix>
    <ao:prefix>(50 mg) was not altered. In volunteers with severe (CLcr &lt; 30 mL/min) renal impairment, </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:EB409F3B-D8A2-4371-AD5C-91EF79AF791A">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/0AF6C0E5-D0AD-4395-9B6E-E2D8EA190503"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/635890C4-55D3-4AB0-B86F-8D50D190FDB3"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:1D0BFD9C-8A6F-425E-AECA-0BC3FD6D4114">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/5770B439-9C56-4747-891A-E4CE950D918B"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/4FB71BCC-E881-4E33-A764-DA9F00827C8E"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:20D893AB-9EDF-4151-BDFE-9E866F3EA66E">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-08 08:43:05 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:20D893AB-9EDF-4151-BDFE-9E866F3EA66E"/>
    <ao:suffix>was significantly lower in patients with moderate to severe liver disease (Child-Pugh Class B/C) compared to healthy subjects. As a result, unbound Cmax and AUC0-inf were increased 2- and 3-fold, respectively. Elimination half-life for rosiglitazone was </ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>20D893AB-9EDF-4151-BDFE-9E866F3EA66E</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <ao:exact>rosiglitazone </ao:exact>
    <ao:prefix>Unbound oral clearance of </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7171DE37-9D8F-4F93-87FA-0142C406E31D">
    <ao:prefix>could be subject to two kinds of drug-drug interactions. First, inhibitors of CYP 2D6 interfere with conversion of </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:7171DE37-9D8F-4F93-87FA-0142C406E31D"/>
    <pav:createdOn>2014-07-07 19:48:55 -0400</pav:createdOn>
    <ao:suffix>to 9-hydroxyrisperidone [see 7 DRUG INTERACTIONS]. This occurs with quinidine, giving essentially all recipients a risperidone pharmacokinetic profile typical of poor metabolizers. The therapeutic benefits and adverse effects of risperidone in patients r</ao:suffix>
    <domeo:uuid>7171DE37-9D8F-4F93-87FA-0142C406E31D</domeo:uuid>
    <ao:exact>risperidone </ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:8FC5EF9F-EB1B-43BF-850E-AF5E195EFC5C">
    <ao:exact>risperidone</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>. Thus, risperidone can be given with or without meals.</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:8FC5EF9F-EB1B-43BF-850E-AF5E195EFC5C"/>
    <domeo:uuid>8FC5EF9F-EB1B-43BF-850E-AF5E195EFC5C</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <ao:prefix>Food Effect: Food does not affect either the rate or extent of absorption of </ao:prefix>
    <pav:createdOn>2014-07-07 19:46:33 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:CF082F25-5A3B-47A4-B556-A95EB5E8F6ED">
    <domeo:belongsToSet>urn:domeoserver:annotationset:5ABD9862-F044-4404-AD04-73DA04ADDA8B</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:8E0CE684-2FCB-4277-B658-E94214F3A298"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotationset:1DED06A6-8562-4CCF-A58C-CA25748FBD31</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-07 19:50:36 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:createdOn>2014-07-07 19:43:25 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B238DEAE-5735-47B7-B2B9-C89091DFDDAA">
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-07-08 09:28:41 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotation:3B377150-45C6-4CD8-B90F-81125EC91B8E</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:67EA985C-B122-4F30-AFC2-CCB43D5D83A8"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:BCC9EB2F-25E7-44FF-83F2-904B4F4819EC</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:createdOn>2014-07-08 09:28:14 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:20F2D3B8-1AF0-434F-8139-53E035F90C2A">
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:FC706AFD-18B6-480C-8EAA-2B16C3212C10</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <ao:body rdf:nodeID="N39ec460835d84ba39e765e464445dfce"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-07-08 16:27:00 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotation:062F0D10-D3EF-4C75-98A1-CDB34C9ABF7C</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:B3F9B5CE-6271-4933-ADD4-3F4B12457E4F"/>
    <pav:lastSavedOn>2014-07-08 16:27:01 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F4CDB8C6-ED4F-4A7C-9BBA-6BBC6817B743">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <ao:exact>rosiglitazone </ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:F4CDB8C6-ED4F-4A7C-9BBA-6BBC6817B743"/>
    <ao:suffix>is 99%. Peak plasma concentrations are observed about 1 hour after dosing. Administration of rosiglitazone with food resulted in no change in overall exposure (AUC), but there was an approximately 28% decrease in Cmax and a delay in Tmax (1.75 hours). Th</ao:suffix>
    <domeo:uuid>F4CDB8C6-ED4F-4A7C-9BBA-6BBC6817B743</domeo:uuid>
    <pav:createdOn>2014-07-08 08:40:25 -0400</pav:createdOn>
    <ao:prefix>The absolute bioavailability of </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D5E8779C-83A0-4F43-8C63-95B2C4B0BE18">
    <pav:lineageUri>urn:domeoserver:annotationset:cf593dca-fe93-451b-8f37-2a96e065da13</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:333616EE-C90C-4719-8ED0-B37C4E0A592B"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:32944008-A6C6-4D66-8C43-EE4CF2256965</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-21 10:02:11 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:createdOn>2014-07-21 10:01:34 -0400</pav:createdOn>
    <pav:previousVersion>urn:domeoclient:uuid:21a2d27a-13b1-4797-ba7a-c0517e32bb06</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">3</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C7FBB110-7C8D-4BAE-9B98-22638C9B3686">
    <pav:lineageUri>urn:domeoserver:annotationset:F37BE993-E972-47AE-896D-FF4D33157ECF</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A5E637EF-5CA5-4AAC-BD8B-C136A86E17B7</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <pav:previousVersion>urn:domeoclient:uuid:53FAA6D0-9A40-44F9-8FE0-3166137CEF10</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-07 10:03:14 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:37A38B64-B8DE-4261-A02E-126661A1A141"/>
    <pav:createdOn>2014-07-07 09:49:48 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:68B1ECAD-98F7-48B9-B1A7-85401F8AE404">
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:29AAB777-4FBF-49C4-ACFD-F2FC169A463D</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:A413330D-2AA0-42F9-AD8F-DA7BBCBD4BCC"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotation:FD6F0698-7F9F-4BDC-B249-98EA1FD826F2</pav:lineageUri>
    <pav:createdOn>2014-07-07 20:49:59 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-07-07 20:51:02 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/3EBAEE26-C8E7-474B-9535-CF86CA923CAF">
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>levonorgestrel</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/6373</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:4CBC8554-5F6F-4DB5-82A4-30C03AA012CD">
    <pav:lineageUri>urn:domeoserver:annotationset:def720a3-9364-4d0d-a156-423274fb2386</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:createdOn>2014-07-08 13:58:12 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-07-08 13:59:58 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7E49EB7A-DE0E-4720-82D1-8460BA0C770D</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:297398A4-DB9A-4685-8F5A-232BC8FD4BAE"/>
    <ao:body rdf:nodeID="N94d266d26d5d422abf1d96b374969007"/>
    <pav:previousVersion>urn:domeoclient:uuid:203110ef-d319-4c8c-8da1-19d68e91f895</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">3</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/B0136BFA-3999-4CC3-972B-A93AF566760D">
    <rdfs:label>orlistat</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/37925</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C152A582-9934-4BB0-B266-57744AF622AB">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-07-08 08:55:50 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:lastSavedOn>2014-07-08 08:56:08 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:96CB6F69-5967-473C-9B9E-B9F188F09023"/>
    <pav:lineageUri>urn:domeoserver:annotation:870B2AC7-8795-4A95-B625-F1F1A05E5A72</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoclient:uuid:F62BD12C-2E69-42FB-A04C-B6D7C7FBB29C</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:BA98E64D-53F6-4BC4-9626-26A09B240057">
    <domeo:uuid>BA98E64D-53F6-4BC4-9626-26A09B240057</domeo:uuid>
    <pav:createdOn>2014-07-07 09:39:59 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix>is a weak inhibitor of the cytochrome P450 isoforms 1A2, 2C9, 2C19, 2D6, 2E1 and 3A (IC50 &gt;150 µM).</ao:suffix>
    <ao:exact>Sildenafil </ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:BA98E64D-53F6-4BC4-9626-26A09B240057"/>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:FF0495DC-B940-41F7-B322-700005CB46DB">
    <domeo:uuid>FF0495DC-B940-41F7-B322-700005CB46DB</domeo:uuid>
    <ao:suffix>Injection: Predictions based on a pharmacokinetic model suggest that drug-drug interactions with CYP3A inhibitors will be less than those observed after oral sildenafil administration.</ao:suffix>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:FF0495DC-B940-41F7-B322-700005CB46DB"/>
    <pav:createdOn>2014-07-07 09:42:23 -0400</pav:createdOn>
    <ao:exact>REVATIO </ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:67193145-3d5c-4a7d-9f58-b2ca2ec5382b">
    <domeo:uuid></domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:67193145-3d5c-4a7d-9f58-b2ca2ec5382b"/>
    <ao:suffix> SR. However, in the multiple </ao:suffix>
    <pav:createdOn>2014-07-07 08:06:59 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix> administration of 425 mg of </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>RYTHMOL</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-195.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E3560C9E-9D75-4969-8C76-9E09CBC067AE">
    <domeo:uuid>E3560C9E-9D75-4969-8C76-9E09CBC067AE</domeo:uuid>
    <pav:createdOn>2014-07-08 14:47:41 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:E3560C9E-9D75-4969-8C76-9E09CBC067AE"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-192.txt.html</ao:hasSource>
    <ao:exact>Erythromycin (500 mg, single dose) did not affect steady-state plasma levels of fluvastatin (40 mg daily).</ao:exact>
    <ao:suffix>xsd:String</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:90FDAF68-043B-4B5A-A508-DF827D98A2B1">
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:D9E289F1-718B-4AC7-9185-0A6C369D0C71"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/311921C4-8A10-4B82-9D46-2C471CC888FE">
    <rdfs:label>erythromycin</rdfs:label>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/4053</dailymed:activeMoietyRxCUI>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:86052697-6C0F-4E2F-9991-D28255AC0B0E">
    <pav:createdOn>2014-07-08 12:03:01 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-161.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:86052697-6C0F-4E2F-9991-D28255AC0B0E"/>
    <ao:prefix>, close monitoring for known side effects of </ao:prefix>
    <domeo:uuid>86052697-6C0F-4E2F-9991-D28255AC0B0E</domeo:uuid>
    <ao:exact>azithromycin</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>, such as liver enzyme abnormalities and hearing impairment, is warranted (see ADVERSE REACTIONS).</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/537C490B-617D-4E96-BFCD-14F22A73ED08">
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/4053</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>erythromycin</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:34EF3EBF-8EEC-484A-BE29-FA1A508BCD46">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-07 20:50:58 -0400</pav:createdOn>
    <ao:exact>An inhibitor of CYP2C8 (e.g., gemfibrozil) may increase the AUC of rosiglitazone and an inducer of CYP2C8 (e.g., rifampin) may decrease the AUC of rosiglitazone. Therefore, if an inhibitor or an inducer of CYP2C8 is started or stopped during treatment with rosiglitazone, changes in diabetes treatment may be needed based upon clinical response.</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:34EF3EBF-8EEC-484A-BE29-FA1A508BCD46"/>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-122.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>34EF3EBF-8EEC-484A-BE29-FA1A508BCD46</domeo:uuid>
    <ao:suffix>xsd:String</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:179EC496-B79D-4BB5-9503-8E3A9D0133FB">
    <domeo:uuid>179EC496-B79D-4BB5-9503-8E3A9D0133FB</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <ao:exact>AVANDIA (4 mg twice daily) was shown to have no clinically relevant effect on the pharmacokinetics of nifedipine and oral contraceptives (ethinyl estradiol and norethindrone), which are predominantly metabolized by CYP3A4.</ao:exact>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:179EC496-B79D-4BB5-9503-8E3A9D0133FB"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-08 08:45:09 -0400</pav:createdOn>
    <ao:prefix>xsd:String</ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/9EA5D626-46B7-4466-AC62-473998053FD1">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>methotrexate</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/6851</dailymed:activeMoietyRxCUI>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:EFC836FC-2F4B-4D37-88E1-1FE17E222A9F">
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:9D3720FD-9395-447F-8A75-437833292F26"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:54022FB0-AA7C-455C-A000-B3052D915530">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdOn>2014-07-07 19:58:03 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:8AC00FB9-AD4A-47D8-98ED-1285434A85EC"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2014-07-07 19:59:12 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5ABD9862-F044-4404-AD04-73DA04ADDA8B</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotation:68E6A934-D199-44CB-8D85-E21E4F21D455</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:6477EB37-EE85-453E-8948-66FFF50EE9F0">
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:ED7D7CD7-54C7-4657-8B88-65D1C1D8BA33"/>
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:AD703DCB-F0EC-4F79-9C36-E0FBB495DE86">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/2C20D8EA-4843-42D3-9576-6832132BCB43"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/DCC6BEF8-EAC0-4911-9DFC-B36D0D3B586D"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:2CD1333E-DD8C-41F8-8B2C-A24926A13D02">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:suffix>xsd:String</ao:suffix>
    <pav:createdOn>2014-07-08 14:56:44 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:2CD1333E-DD8C-41F8-8B2C-A24926A13D02"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-111.txt.html</ao:hasSource>
    <domeo:uuid>2CD1333E-DD8C-41F8-8B2C-A24926A13D02</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>Doxazosin: Healthy volunteers participating in a multiple dose doxazosin-nifedipine interaction study received 2 mg doxazosin q.d. alone or combined with 20 mg nifedipine ER b.i.d. Coadministration of nifedipine resulted in a decrease in AUC and Cmax of doxazosin to 83% and 86% of the values in the absence of nifedipine, respectively. In the presence of doxazosin, AUC and Cmax of nifedipine were increased by factors of 1.13 and 1.23, respectively. Compared to nifedipine monotherapy, blood pressure was lower in the presence of doxazosin. Blood pressure should be monitored when doxazosin is coadministered with nifedipine and dose reduction of nifedipine considered.</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/59874DF3-9C24-4918-99F5-722807F259D3">
    <rdfs:label>warfarin</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/11289</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:6174B8AE-19C6-4BA4-B986-FE9A169F8C43">
    <ao:prefix>xsd:String</ao:prefix>
    <pav:createdOn>2014-07-07 09:37:06 -0400</pav:createdOn>
    <domeo:uuid>6174B8AE-19C6-4BA4-B986-FE9A169F8C43</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:6174B8AE-19C6-4BA4-B986-FE9A169F8C43"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>Sildenafil </ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix>is cleared predominantly by the CYP3A (major route) and cytochrome P450 2C9 (CYP2C9, minor route) hepatic microsomal isoenzymes. The major circulating metabolite results from N-desmethylation of sildenafil, and is, itself, further metabolized. This metab</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C37D52C1-1EBE-483A-850E-8073748F07C5">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-08 09:28:18 -0400</pav:createdOn>
    <ao:exact>trazodone </ao:exact>
    <ao:suffix>(as well as mCPP) by 76 and 60%, respectively, compared to pre-carbamazepine values.</ao:suffix>
    <domeo:uuid>C37D52C1-1EBE-483A-850E-8073748F07C5</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-137.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:C37D52C1-1EBE-483A-850E-8073748F07C5"/>
    <ao:prefix>reduced plasma concentrations of </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:81F0B14E-0B17-458B-B8DA-5733BFA54466">
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotation:D64B3227-47B2-4936-A7CB-2798F600FBC4</pav:lineageUri>
    <pav:lastSavedOn>2014-07-07 20:04:45 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoclient:uuid:921213C5-987C-46D2-9095-A8DDC2B714AB</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:24EB8C16-A12C-49AC-B1E7-F9FCBFD265DC"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-07 20:00:39 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/419612D9-028A-4427-B768-B6BAB067A5B0">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>9-hydroxyrisperidone</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/679314</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:58BB1A0F-45CF-4007-9F0B-174F2D0ECB7A">
    <ao:prefix>and its metabolite, </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:58BB1A0F-45CF-4007-9F0B-174F2D0ECB7A"/>
    <ao:suffix>, may be increased by acyclovir, thus caution should be used with concomitant administration.</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-08 12:06:17 -0400</pav:createdOn>
    <ao:exact>normeperidine</ao:exact>
    <domeo:uuid>58BB1A0F-45CF-4007-9F0B-174F2D0ECB7A</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-163.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:593C4E07-8641-4432-8F40-A2A764150D7C">
    <pav:createdOn>2014-07-07 20:18:57 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotation:789CAEF7-415B-4EE9-9189-4B905163637B</pav:lineageUri>
    <pav:lastSavedOn>2014-07-07 20:21:40 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoclient:uuid:CE45A5D4-BD84-4E02-AC7B-C9E12233EC3A</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:FC4FF959-6C60-4B14-86FE-4FB2A5D97DD0"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C7FE8482-AABD-45DD-A614-B05E7CB13A04">
    <ao:suffix>should be carefully monitored.</ao:suffix>
    <ao:exact>penicillins </ao:exact>
    <ao:prefix>with </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:C7FE8482-AABD-45DD-A614-B05E7CB13A04"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>C7FE8482-AABD-45DD-A614-B05E7CB13A04</domeo:uuid>
    <pav:createdOn>2014-07-08 12:24:47 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-166.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:845B21DC-E1C4-4BD7-97B1-E8B17C1D446E">
    <domeo:uuid>845B21DC-E1C4-4BD7-97B1-E8B17C1D446E</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-07 09:41:53 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:845B21DC-E1C4-4BD7-97B1-E8B17C1D446E"/>
    <ao:exact>sildenafil </ao:exact>
    <ao:suffix>was co-administered with erythromycin, a CYP3A inhibitor, at steady state (500 mg BID for 5 days), there was a 182% increase in sildenafil systemic exposure (AUC).</ao:suffix>
    <ao:prefix>When a single 100 mg dose of </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:82716E9E-8396-4935-B77D-E0FFECFEC71F">
    <pav:createdOn>2014-07-08 08:49:43 -0400</pav:createdOn>
    <domeo:uuid>82716E9E-8396-4935-B77D-E0FFECFEC71F</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:82716E9E-8396-4935-B77D-E0FFECFEC71F"/>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:exact>Single oral doses of glimepiride in 14 healthy adult subjects had no clinically significant effect on the steady-state pharmacokinetics of AVANDIA. No clinically significant reductions in glimepiride AUC and Cmax were observed after repeat doses of AVANDIA (8 mg once daily) for 8 days in healthy adult subjects</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <ao:prefix>xsd:String</ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/3CC40A8E-3D6F-4DA1-B812-DEFC672BD00E">
    <rdfs:label>conivaptan</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/302285</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:4DDB8C1A-18B8-4AE2-823E-A4C0817C7FFE">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-07 20:32:10 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-56.txt.html</ao:hasSource>
    <ao:suffix>, carbamazepine, or valproate during clinical trials. Zonisamide did not inhibit mixed-function liver oxidase enzymes (cytochrome P450), as measured in human liver microsomal preparations, in vitro. Zonisamide is not expected to interfere with the metabo</ao:suffix>
    <ao:exact>phenytoin</ao:exact>
    <domeo:uuid>4DDB8C1A-18B8-4AE2-823E-A4C0817C7FFE</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:4DDB8C1A-18B8-4AE2-823E-A4C0817C7FFE"/>
    <ao:prefix>had no appreciable effect on the steady-state plasma concentrations of </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:CA969ACC-523C-4D38-BD0F-F71CD3AEB48F">
    <domeo:belongsToSet>urn:domeoserver:annotationset:A5E637EF-5CA5-4AAC-BD8B-C136A86E17B7</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:015F557A-02A3-4D42-B273-E16B5158D869"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdOn>2014-07-07 09:41:44 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotationset:F37BE993-E972-47AE-896D-FF4D33157ECF</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2014-07-07 09:44:18 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:030120D1-FE7F-428F-A259-475CD49BC5B7">
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:754BED3A-2AFD-4639-985C-597BEC2FF280"/>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/3aae0f3a-9f40-4ba8-a000-4aec379d9be4">
    <pav:createdOn>2014-07-07 08:06:47 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:e930d840-61cc-44a8-8146-cc1926d57f47"/>
    <pav:lineageUri>urn:domeoserver:annotationset:cf593dca-fe93-451b-8f37-2a96e065da13</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:32944008-A6C6-4D66-8C43-EE4CF2256965</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-07 08:06:47 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:9E3A4D83-9BFB-4908-B71A-17D759012341">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/4FCA88F7-AF88-4AC7-8DE8-1C60E8274EC5"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/136A3F0E-A044-4BEE-AE7D-57707845EA15"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:CA19C0B4-A6AA-4D2A-961B-91E4F3C1E4CB">
    <pav:createdOn>2014-07-08 08:43:51 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:23515E27-98AC-4DC9-A4B7-EBFE2991219F</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotationset:57174A7C-3100-4C8F-9C4A-2991CEE124D5</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:4FA9DC31-8CE9-46AD-8B7E-3F40917F1993"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:lastSavedOn>2014-07-08 08:46:38 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:EB1D6CB2-B734-4DE7-B630-05FF0D70D1DF">
    <ao:context rdf:resource="urn:domeoclient:uuid:318A6930-88A3-4F19-9405-FD9AD055008D"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdOn>2014-07-07 10:03:44 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-07-07 10:54:10 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotationset:F37BE993-E972-47AE-896D-FF4D33157ECF</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>urn:domeoserver:annotationset:E0912BFE-3C9A-4C5D-81F4-9D862F25D230</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">3</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A5E637EF-5CA5-4AAC-BD8B-C136A86E17B7</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:EC4DCAFE-CA86-476E-8005-98C657C55AFD">
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdOn>2014-07-08 09:24:13 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotation:A6AF6E1D-F949-4925-8DAD-85144D2134DC</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:E1F292D3-D7D0-4351-BFCC-3AFCF3B73226"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:FF4D892F-0BD2-4FD8-9160-6124946DB29D</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-08 09:24:21 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:73C13A6E-1AA6-404D-ACA7-3543294F7C0E">
    <ao:context rdf:resource="urn:domeoclient:uuid:2D3C474B-0547-4FC1-91FE-9AE5EFAE0DA6"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:423352B3-8ABA-48B7-98CF-B191A7BFC955</domeo:belongsToSet>
    <pav:createdOn>2014-07-08 09:32:36 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-08 09:35:29 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotation:00983609-87E4-4BDA-BD21-9C99134AA1EB</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:3EF89173-73C9-47C8-BC8E-167E787388EE">
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:7FF4AC6B-3611-40E7-8A46-6935871B9CA4"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotation:0065C946-F281-406B-ABE8-E0E6F1B662AD</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoclient:uuid:921CCEB9-21F5-4162-854B-F60FC028BC15</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-08 12:02:05 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-08 12:01:58 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:7F578098-5612-4E2A-92D1-A379DB25B905">
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:F002FE31-A0C4-45E0-AD94-B77840FF2BE3"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:20C2F32A-1370-4EF2-BDF5-977B27436701">
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdOn>2014-07-07 20:01:07 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:54923395-7267-4B53-A7BA-CD3F8B5B4E2C"/>
    <pav:lastSavedOn>2014-07-07 20:04:45 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoclient:uuid:921213C5-987C-46D2-9095-A8DDC2B714AB</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotation:70DFC809-2AB9-4795-AF0B-A78BF1ABEC41</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:AB22A180-DD58-40D6-9FC7-E65A1AFC9D85">
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdOn>2014-07-08 19:40:11 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:251D57FC-2969-4213-92D9-AC40BD390F67"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:AFA31957-0959-46DF-B640-AD0687F186D6</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:lastSavedOn>2014-07-08 19:40:31 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotation:3206141D-F474-46DE-9317-009CE8376039</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:21F405B7-4F22-4193-BD1F-3752F9723002">
    <domeo:belongsToSet>urn:domeoserver:annotationset:5B2167F6-4E63-4A7B-85C1-ACA56DDE7073</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:lastSavedOn>2014-07-08 15:56:00 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotation:7F9074EB-6B74-43EB-88BD-832B607BF08D</pav:lineageUri>
    <ao:body rdf:nodeID="Nad77ead57e074971b2b3e314f02c6b5b"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:createdOn>2014-07-08 15:50:32 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:022238E3-0C81-4435-98B6-076F649717A3"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:1569F388-68F2-4105-9806-F73C9D7B1FA0">
    <ao:exact>fexofenadine </ao:exact>
    <pav:createdOn>2014-07-08 09:32:37 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-139.txt.html</ao:hasSource>
    <ao:prefix> decreases </ao:prefix>
    <ao:suffix>gastrointestinal secretion, while erythromycin may also decrease biliary excretion.</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:1569F388-68F2-4105-9806-F73C9D7B1FA0"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>1569F388-68F2-4105-9806-F73C9D7B1FA0</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/1551B4FA-E530-41EB-BBEB-493FC7DF9D95">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>9-hydroxyrisperidone</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/679314</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/metabolite"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:AB07B422-A2C8-4EFF-AB73-7F294EB50835">
    <domeo:uuid>AB07B422-A2C8-4EFF-AB73-7F294EB50835</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-131.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-08 09:15:27 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:AB07B422-A2C8-4EFF-AB73-7F294EB50835"/>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:exact>Co-administration of cholestyramine or colestipol with propranolol resulted in up to 50% decrease in propranolol concentrations</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>xsd:String</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B33CECFD-3CA7-447A-8B97-83947DDADD1B">
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:body rdf:nodeID="N745648abdf974ae6bb16b1028ab988fe"/>
    <pav:lastSavedOn>2014-07-08 13:50:24 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:createdOn>2014-07-08 13:50:24 -0400</pav:createdOn>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:9E15E869-50C5-4886-94F6-4670553A8F87"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotation:5A2EABF6-99BD-4BB2-A7A1-C8A15F85DCA6</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:F9AE7343-DFD7-456E-804F-77E7D6A72935</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:4D69EC02-5E8E-422F-98CE-657A87F2AAB4">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>4D69EC02-5E8E-422F-98CE-657A87F2AAB4</domeo:uuid>
    <pav:createdOn>2014-07-08 08:49:00 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:4D69EC02-5E8E-422F-98CE-657A87F2AAB4"/>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:exact>Glimepiride</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <ao:prefix>xsd:String</ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:9B5297FD-0CCC-46CB-B3D6-051A21EC4A28">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-08 08:45:45 -0400</pav:createdOn>
    <ao:exact>AVANDIA (4 mg twice daily) was shown to have no clinically relevant effect on the pharmacokinetics of nifedipine and oral contraceptives (ethinyl estradiol and norethindrone), which are predominantly metabolized by CYP3A4.</ao:exact>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:9B5297FD-0CCC-46CB-B3D6-051A21EC4A28"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>9B5297FD-0CCC-46CB-B3D6-051A21EC4A28</domeo:uuid>
    <ao:prefix>xsd:String</ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:6A33E692-FE6C-4ED9-BB29-3C4EAA599090">
    <ao:context rdf:resource="urn:domeoclient:uuid:58BB1A0F-45CF-4007-9F0B-174F2D0ECB7A"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-08 12:06:17 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2014-07-08 12:08:36 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoclient:uuid:15A8BD5A-D46C-4E84-8B70-5066D260486D</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:43DD3913-B11B-49E0-9575-68DC1AC8F93D</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:098066AF-1EFC-46DD-B0DF-59694396B58B">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/385EB5E0-1B0B-45AA-8E02-9A80114BBC16"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/0B8AC197-76BF-4BB8-8634-3373C3593E83"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:FDE5759F-C43D-4692-875D-23DB15AAFE13">
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:F7E90859-FC99-4915-A03B-569143B3043B"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/B67FCB11-23CA-469A-8D02-EAB2019D489E">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>fluvoxamine</rdfs:label>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/42355</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/5CC7D46B-007F-44E6-AF8E-62F7C28E3054">
    <rdfs:label>propafenone</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/8754</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:5CEE5BD7-E5C5-478E-B803-2CBD5D4A8DE5">
    <pav:lastSavedOn>2014-07-08 08:54:46 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdOn>2014-07-08 08:53:27 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:4B728EE1-5EA7-4CEB-BF4E-D5A0FFD21B2C"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:23515E27-98AC-4DC9-A4B7-EBFE2991219F</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotation:F9F4B32A-42BB-48D0-A1D2-31F9AADCE29D</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:2C8B0EDA-9F75-41C8-96B8-03A4F8A850C7">
    <pav:createdOn>2014-07-07 20:06:03 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoclient:uuid:4A49ACB6-4B71-452F-80EE-8A84DEF45C29</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:1276F76D-C47E-46B4-91BB-8A4065E62D84</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2014-07-07 20:07:11 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:E9862CD5-0A72-430D-AFB1-BF93E2D4E3B1"/>
    <rdfs:label>Highlight</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C22A1B89-EC18-484C-B641-2F1ED7A00D4F">
    <ao:prefix>xsd:String</ao:prefix>
    <ao:suffix>. At 24 hours, the plasma levels of sildenafil were still approximately 200 ng/mL, compared to approximately 5 ng/mL when sildenafil was dosed alone. This is consistent with ritonavir's marked effects on a broad range of P450 substrates. Although the int</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:C22A1B89-EC18-484C-B641-2F1ED7A00D4F"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-07 09:40:21 -0400</pav:createdOn>
    <ao:exact>sildenafil plasma AUC</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>C22A1B89-EC18-484C-B641-2F1ED7A00D4F</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/AB7AECF0-86D9-4965-9866-6C295CBB3524">
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/136411</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>sildenafil</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:AA0D602A-60C9-4B16-B677-4C07A52E71DF">
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:253AFE47-A2D2-48FA-8046-A75BAD32D2F2"/>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D7695313-EC5E-4B88-A948-EC49D5337698">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:D7695313-EC5E-4B88-A948-EC49D5337698"/>
    <ao:exact>sildenafil </ao:exact>
    <ao:suffix>(100 mg single dose) resulted in a 300% (4-fold) increase in sildenafil Cmax and a 1000% (11-fold) increase in sildenafil plasma AUC. At 24 hours, the plasma levels of sildenafil were still approximately 200 ng/mL, compared to approximately 5 ng/mL when </ao:suffix>
    <pav:createdOn>2014-07-07 09:40:06 -0400</pav:createdOn>
    <domeo:uuid>D7695313-EC5E-4B88-A948-EC49D5337698</domeo:uuid>
    <ao:prefix>, a potent CYP3A inhibitor, at steady state (500 mg BID) with </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:BE406CB6-FC66-444E-B750-7B5BCA81DC08">
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:DC615822-3032-426F-B92E-5680D53CCDC8"/>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:BBBC91BF-B93F-4383-9FE6-082D358AB9CB">
    <domeo:uuid>BBBC91BF-B93F-4383-9FE6-082D358AB9CB</domeo:uuid>
    <ao:exact>ranitidine increased the AUC of risperidone and 9-hydroxyrisperidone combined by 20%</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:BBBC91BF-B93F-4383-9FE6-082D358AB9CB"/>
    <ao:suffix>xsd:String</ao:suffix>
    <pav:createdOn>2014-07-08 15:45:21 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-7.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:AA9C22DF-5C95-4367-BE71-B2810297B2A7">
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:425F3947-F42E-4A5B-87EC-655A7930AEC9"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N58b12e254ec94d90bc0dd6a417f95197">
    <domeo:sets rdf:resource="urn:pddi:uuid:98C467B9-B912-42D8-87FF-A9575405F201"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/16D343DF-2D5F-4267-B97E-81BB056B2EB1">
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/6809</dailymed:activeMoietyRxCUI>
    <rdfs:label>metformin</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:B38FF6AA-748B-4206-B206-DD37D92D16C5">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/DC971235-170B-4071-BD69-B8DDDFBF7FCF"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/1ACD03EB-70E5-4D00-B677-83904E36D981"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:1c6446b3-fba1-46a2-96b8-6f03a8c2dde7">
    <ao:prefix>uinupristin/dalfopristin and </ao:prefix>
    <ao:suffix> (repeated oral dose) in healt</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid></domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-114.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:1c6446b3-fba1-46a2-96b8-6f03a8c2dde7"/>
    <pav:createdOn>2014-07-07 08:07:02 -0400</pav:createdOn>
    <ao:exact>nifedipine</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/0C543B99-2957-4B98-97A0-7FEEF1ED30EC">
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/35636</dailymed:activeMoietyRxCUI>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>risperidone</rdfs:label>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:468ed9c4-680e-43d2-9069-0c9655c0f7e2">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:457516BA-A108-484A-A95F-27847AC4C3A6"/>
    <ao:body rdf:nodeID="Nf09764332e694e18a8934269ad26902f"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:F77928E0-81FC-4E23-A4AE-843EFB9044A3</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-21 10:10:56 -0400</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotation:5df1593d-51f9-4cea-93be-697ceaa4f8aa</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:createdOn>2014-07-07 08:02:52 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:2706CEF8-2F29-4169-9FE6-1B02D268167E">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:2706CEF8-2F29-4169-9FE6-1B02D268167E"/>
    <pav:createdOn>2014-07-07 09:42:08 -0400</pav:createdOn>
    <ao:prefix>Cmax and a 210% increase in </ao:prefix>
    <ao:suffix>AUC.</ao:suffix>
    <domeo:uuid>2706CEF8-2F29-4169-9FE6-1B02D268167E</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>sildenafil </ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:49FBB7FA-A7AD-41E5-8022-357F6957DAC6">
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:A7F51E53-793A-4CD7-A0F3-81F882156AF4"/>
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/16D6DA8B-381F-4C63-B0B8-BAEFC5009B4B">
    <rdfs:label>warfarin</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/11289</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:98A01E90-AA25-4D94-ACD9-71A554BFFFA6">
    <ao:prefix>and an in vitro potency for PDE5 approximately 50% of the parent drug. In healthy volunteers, plasma concentrations of this metabolite are approximately 40% of those seen for </ao:prefix>
    <pav:createdOn>2014-07-07 09:37:24 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:98A01E90-AA25-4D94-ACD9-71A554BFFFA6"/>
    <domeo:uuid>98A01E90-AA25-4D94-ACD9-71A554BFFFA6</domeo:uuid>
    <ao:exact>sildenafil</ao:exact>
    <ao:suffix>, so that the metabolite accounts for about 20% of sildenafil's pharmacologic effects. In patients with pulmonary arterial hypertension, however, the ratio of the metabolite to sildenafil is higher. Both sildenafil and the active metabolite have terminal</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Ned8f28ce8f4e4f0ab4240c20b5ef649a">
    <domeo:sets rdf:resource="urn:pddi:uuid:49EC311A-D3CF-4712-9F56-1DAC3870D7FC"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:3BF30024-BAFB-47A6-BC6D-3656B7A0EBD6">
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:lastSavedOn>2014-07-08 09:20:18 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoclient:uuid:6FFD9FFA-5CED-4EE2-B68F-77212B4C447D</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:F5561C43-6248-48AC-91C8-4C5E6ECD1BA9"/>
    <pav:createdOn>2014-07-08 09:19:00 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotation:02B6515F-AE66-4D38-BE9B-2D5021858B74</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:FDC1B86E-9081-4995-AC9B-E0F371F56E0E">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:FDC1B86E-9081-4995-AC9B-E0F371F56E0E"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-08 09:25:30 -0400</pav:createdOn>
    <ao:prefix>(50 mg) has been studied in 10 healthy subjects. The Cmax of </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-136.txt.html</ao:hasSource>
    <domeo:uuid>FDC1B86E-9081-4995-AC9B-E0F371F56E0E</domeo:uuid>
    <ao:suffix>increased by 34%, the AUC increased 2.4 fold, the half-life increased by 2.2 fold, and the clearance decreased by 52%. Adverse effects including nausea, hypotension, and syncope were observed when ritonavir and trazodone were coadministered.</ao:suffix>
    <ao:exact>trazodone </ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:CCFB939C-0A41-4B05-B1AF-F1FAF1080E01">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotationset:F37BE993-E972-47AE-896D-FF4D33157ECF</pav:lineageUri>
    <pav:lastSavedOn>2014-07-07 09:44:18 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdOn>2014-07-07 09:39:00 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:CACB74BB-5A35-40B2-8307-9910FB41E5E9"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A5E637EF-5CA5-4AAC-BD8B-C136A86E17B7</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:1269AD96-8843-4C29-B650-67CFC82561F7">
    <domeo:uuid>1269AD96-8843-4C29-B650-67CFC82561F7</domeo:uuid>
    <ao:prefix>AUC of 26% ± 9% (range: 12 to 39%). </ao:prefix>
    <ao:exact>Tolbutamide </ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-29.txt.html</ao:hasSource>
    <ao:suffix>Cmax increased 11% ± 9% (range: -6 to 27%). (See PRECAUTIONS.)</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:1269AD96-8843-4C29-B650-67CFC82561F7"/>
    <pav:createdOn>2014-07-07 20:22:09 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:E60A06EA-9B09-4209-978B-BA42D2A6E6F6">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/65457ABE-BAE3-4005-A13F-A2834CBD9EF7"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/701E4503-2478-4933-8D3F-3D55C26232A1"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/6AE47C65-EA05-4F3D-B809-C3FD66E1DDE5">
    <rdfs:label>paroxetine</rdfs:label>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/32937</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:2398E0CD-A6FA-4F99-8926-12FF03473A60">
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:AB99AD03-9381-485E-9E73-C5953E8CFFF6"/>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/1F621EE5-360A-47E0-881E-AE68E761BBB5">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/84108</dailymed:activeMoietyRxCUI>
    <rdfs:label>rosiglitazone</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/BCB2FCB7-4E9C-4255-B15D-A495E09E0F93">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/9384</dailymed:activeMoietyRxCUI>
    <rdfs:label>rifampin</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:1153D11D-21AA-4E03-9C4A-C4185B5F0487">
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-07-08 15:34:18 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-08 15:33:25 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:7A39E70C-7BEF-4D74-AEC3-73FD2C720B0D"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:0F235438-66A4-4847-A5E7-8A71C3802072</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:76BFF24F-3E1E-424F-B077-68F45025E094</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:5B0FC440-8DCE-44BA-BCBE-5196F06A748A">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/C44D64A4-30A2-4E97-807F-C827A96CD0A2"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/1458E8AA-7250-46B1-BD2D-576F73653E4E"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B070D36A-6F20-4184-BF24-12B662F31AE0">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5ABD9862-F044-4404-AD04-73DA04ADDA8B</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:276B1B42-AC40-49BB-AA5C-52AF3D8570FD"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:lastSavedOn>2014-07-07 19:50:36 -0400</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotationset:1DED06A6-8562-4CCF-A58C-CA25748FBD31</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-07-07 19:49:30 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E0E36EFF-8146-4DA0-B2B8-2F6338680E87">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:E0E36EFF-8146-4DA0-B2B8-2F6338680E87"/>
    <ao:suffix> by 74 and 20%, respectively. Urinary excretion of </ao:suffix>
    <domeo:uuid>E0E36EFF-8146-4DA0-B2B8-2F6338680E87</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-194.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-08 14:03:44 -0400</pav:createdOn>
    <ao:exact>norpropafenone</ao:exact>
    <ao:prefix> plasma concentrations and increased the AUC and Cmax of </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:9BF00F9A-B1AE-4C45-BC7F-84B9C55BD6DB">
    <pav:lineageUri>urn:domeoserver:annotationset:1DED06A6-8562-4CCF-A58C-CA25748FBD31</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-07 19:50:36 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:7171DE37-9D8F-4F93-87FA-0142C406E31D"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdOn>2014-07-07 19:48:55 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5ABD9862-F044-4404-AD04-73DA04ADDA8B</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:1ADD4C68-4EF4-4E45-953D-1EE552C70A7D">
    <domeo:belongsToSet>urn:domeoserver:annotationset:FC706AFD-18B6-480C-8EAA-2B16C3212C10</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:BE60B9D6-BE48-45DC-9591-7A2516FD0A6D"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotation:C26F7B49-3619-49FD-84F1-155419F09726</pav:lineageUri>
    <pav:lastSavedOn>2014-07-08 16:27:01 -0400</pav:lastSavedOn>
    <ao:body rdf:nodeID="Ne41a7d74c2f74093a83676cafe63ede3"/>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:createdOn>2014-07-08 16:25:08 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:BB14D7C1-A7C7-4F32-9504-B26D88BB695B">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:A614DE59-7AF1-43EC-82E1-263324794024"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotationset:1DED06A6-8562-4CCF-A58C-CA25748FBD31</pav:lineageUri>
    <pav:createdOn>2014-07-07 19:49:29 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-07-07 19:50:36 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5ABD9862-F044-4404-AD04-73DA04ADDA8B</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E236639E-7D4F-4C38-A396-CBBC20E12C95">
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:B411E156-24DB-46BD-9C1B-18AB6DA0B23C"/>
    <pav:lineageUri>urn:domeoserver:annotation:F6C66570-BB86-43D6-9166-5B25C8470629</pav:lineageUri>
    <pav:lastSavedOn>2014-07-07 20:36:25 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-07-07 20:35:31 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoclient:uuid:C56FAF33-D751-43EF-B31E-95E23B8E733A</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:EDFA8C04-287E-4E02-A34E-9FAF2A0DB09D">
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">3</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2014-07-21 10:02:11 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotationset:cf593dca-fe93-451b-8f37-2a96e065da13</pav:lineageUri>
    <pav:createdOn>2014-07-21 09:59:07 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:32944008-A6C6-4D66-8C43-EE4CF2256965</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:D386F873-0ADA-4CA7-BF06-CA1FF9673B34"/>
    <pav:previousVersion>urn:domeoclient:uuid:21a2d27a-13b1-4797-ba7a-c0517e32bb06</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F9F0536F-1818-4273-B244-A651525D47DD">
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:24593F85-D497-4965-9F0A-FFE8CA65E40C"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-07-07 19:46:48 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2014-07-07 19:50:36 -0400</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotationset:1DED06A6-8562-4CCF-A58C-CA25748FBD31</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5ABD9862-F044-4404-AD04-73DA04ADDA8B</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:ECE13C32-CF6F-45B3-88CA-0A913EAE55D3">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdOn>2014-07-07 20:16:50 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:ECC47BFB-74A2-4ACF-B43B-D8E36122A57C"/>
    <pav:lineageUri>urn:domeoserver:annotation:A8B65733-9DE1-4267-BA4C-5CA301229D8D</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoclient:uuid:3857B7A8-EDF2-4956-9CF4-A1B13773E162</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:lastSavedOn>2014-07-07 20:18:07 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:8B9E1BD5-B077-42D2-81BD-F76692A03855">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotation:A6815FBD-7D5D-4E0D-B202-736C05FD1638</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoclient:uuid:423352B3-8ABA-48B7-98CF-B191A7BFC955</domeo:belongsToSet>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:body rdf:nodeID="N58004a0d8b43493ea143e39b1a2ca2a4"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:DCAA0D82-9C8F-4404-997E-223F52082CBB"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:lastSavedOn>2014-07-08 09:35:29 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-08 09:34:19 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:2896EAD9-998E-417F-90ED-17FBDF536C79">
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:233DEF12-16AD-43C4-940B-0565AAC507BE"/>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F386BE12-0116-489D-AD53-AFB673B02FE7">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-12.txt.html</ao:hasSource>
    <domeo:uuid>F386BE12-0116-489D-AD53-AFB673B02FE7</domeo:uuid>
    <ao:suffix>The clinical significance of t</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:F386BE12-0116-489D-AD53-AFB673B02FE7"/>
    <pav:createdOn>2014-07-21 10:09:40 -0400</pav:createdOn>
    <ao:exact>In a study comparing the disposition of intravenously administered diazepam before and after 21 days of dosing with either sertraline (50 to 200 mg/day escalating dose) or placebo, there was a 32% decrease relative to baseline in diazepam clearance for the sertraline group compared to a 19% decrease relative to baseline for the placebo group (p &lt; 0.03). There was a 23% increase in T max for desmethyldiazepam in the sertraline group compared to a 20% decrease in the placebo group (p &lt; 0.03). </ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:6FD7B9B1-ABD3-457C-AFF2-4807BF097EA4">
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotation:F60FC486-2760-4D9A-A6CD-071FF9846A08</pav:lineageUri>
    <pav:createdOn>2014-07-08 09:10:20 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:4C4AF543-4FAA-46CE-AD88-E8E065564D97"/>
    <pav:lastSavedOn>2014-07-08 09:11:17 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoclient:uuid:1D51EEDF-FCC9-44E1-A13B-BCE69023F944</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:53444DA6-EFD4-42C1-9FCB-6AD24BB84832">
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotationset:1DED06A6-8562-4CCF-A58C-CA25748FBD31</pav:lineageUri>
    <pav:createdOn>2014-07-07 19:46:54 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-07-07 19:50:36 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5ABD9862-F044-4404-AD04-73DA04ADDA8B</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:AD68EA56-80D0-40F0-8AAD-E711ED29F200"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:D65A7DF1-CB44-4281-9DED-B7378D1ACD1B">
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:6F5B8347-2FB2-4DAE-A033-930841BF5F41"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/20819184-D02D-4038-A0A8-12D067501F6C">
    <rdfs:label>propafenone</rdfs:label>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/8754</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/F0968EE0-6683-48D8-A598-CDF0A5A4A102">
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>ketoconazole</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/6135</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C8BAD97F-1713-4E27-9DBA-BBEE72BF7B39">
    <ao:prefix>xsd:String</ao:prefix>
    <pav:createdOn>2014-07-08 13:58:47 -0400</pav:createdOn>
    <ao:exact>Drugs that inhibit CYP2D6 (such as desipramine, paroxetine, ritonavir, sertraline) and CYP3A4 (such as ketoconazole, ritonavir, saquinavir, erythromycin, and grapefruit juice) can be expected to cause increased plasma levels of propafenone. The combination of CYP3A4 inhibition and either CYP2D6 deficiency or CYP2D6 inhibition with administration of propafenone may increase the risk of adverse reactions, including proarrhythmia. Therefore, simultaneous use of RYTHMOL SR with both a CYP2D6 inhibitor and a CYP3A4 inhibitor should be avoided</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:C8BAD97F-1713-4E27-9DBA-BBEE72BF7B39"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-194.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>xsd:String</ao:suffix>
    <domeo:uuid>C8BAD97F-1713-4E27-9DBA-BBEE72BF7B39</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:DB57EF22-CD62-4A86-80A0-79B1F2AD9319">
    <pav:createdOn>2014-07-08 09:28:18 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:C37D52C1-1EBE-483A-850E-8073748F07C5"/>
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotation:7FF95FC8-5590-4273-B7CD-01F22846BA5C</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:lastSavedOn>2014-07-08 09:28:41 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoclient:uuid:BCC9EB2F-25E7-44FF-83F2-904B4F4819EC</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nbc8823dfedf44df38ce609d805fb6da9">
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
    <permissions:isLocked>false</permissions:isLocked>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:BE60B9D6-BE48-45DC-9591-7A2516FD0A6D">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-104.txt.html</ao:hasSource>
    <ao:exact>Oral conivaptan hydrochloride 40 mg twice daily resulted in a 2-fold increase in the AUC and half-life of amlodipine</ao:exact>
    <ao:suffix>xsd:String</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>BE60B9D6-BE48-45DC-9591-7A2516FD0A6D</domeo:uuid>
    <ao:prefix> </ao:prefix>
    <pav:createdOn>2014-07-08 16:25:08 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:BE60B9D6-BE48-45DC-9591-7A2516FD0A6D"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:0DC71C86-09AB-4E4E-9691-791E19A0DB21">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:0DC71C86-09AB-4E4E-9691-791E19A0DB21"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix>, and sulfate conjugates of 4-hydroxy propranolol.</ao:suffix>
    <ao:prefix> and</ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-135.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact> glucuronic acid</ao:exact>
    <pav:createdOn>2014-07-08 09:24:15 -0400</pav:createdOn>
    <domeo:uuid>0DC71C86-09AB-4E4E-9691-791E19A0DB21</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C2517233-6850-4D46-BB46-D725F456F94C">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-08 19:45:15 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-33.txt.html</ao:hasSource>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:C2517233-6850-4D46-BB46-D725F456F94C"/>
    <ao:exact>An open-label, randomized, three-way crossover study in 18 healthy subjects assessed the effect of a single 800 mg oral dose of fluconazole on the pharmacokinetics of a single 1200 mg oral dose of azithromycin as well as the effects of azithromycin on the pharmacokinetics of fluconazole. There was no significant pharmacokinetic interaction between fluconazole and azithromycin</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>C2517233-6850-4D46-BB46-D725F456F94C</domeo:uuid>
    <ao:prefix>xsd:String</ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/1ACD03EB-70E5-4D00-B677-83904E36D981">
    <rdfs:label>trazodone</rdfs:label>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/10737</dailymed:activeMoietyRxCUI>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:3DEE2593-CF46-4671-BDFE-E99A43F1EA44">
    <pav:lineageUri>urn:domeoserver:annotation:8A8B3E7C-50E9-4D8A-94F7-9E36D1BFF7FB</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdOn>2014-07-08 09:07:59 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-07-08 09:08:48 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:0B919FC0-1274-4FFB-8B24-778F703E2012"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:4E43D844-2E5A-46D2-8797-09878034F22F</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7C8C6B1F-D237-479B-A410-1A3EC5D1D274">
    <ao:exact>Drugs that inhibit CYP2D6 (such as desipramine, paroxetine, ritonavir, sertraline) and CYP3A4 (such as ketoconazole, ritonavir, saquinavir, erythromycin, and grapefruit juice) can be expected to cause increased plasma levels of propafenone. The combination of CYP3A4 inhibition and either CYP2D6 deficiency or CYP2D6 inhibition with administration of propafenone may increase the risk of adverse reactions, including proarrhythmia. Therefore, simultaneous use of RYTHMOL SR with both a CYP2D6 inhibitor and a CYP3A4 inhibitor should be avoided</ao:exact>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:prefix>xsd:String</ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-08 13:59:41 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-194.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:7C8C6B1F-D237-479B-A410-1A3EC5D1D274"/>
    <domeo:uuid>7C8C6B1F-D237-479B-A410-1A3EC5D1D274</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:9E4A4036-68BA-48EF-91F4-FD104E60538D">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:9E4A4036-68BA-48EF-91F4-FD104E60538D"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-6.txt.html</ao:hasSource>
    <domeo:uuid>9E4A4036-68BA-48EF-91F4-FD104E60538D</domeo:uuid>
    <ao:exact>ODV</ao:exact>
    <ao:prefix> and </ao:prefix>
    <pav:createdOn>2014-07-21 10:01:30 -0400</pav:createdOn>
    <ao:suffix> was similar in poor and extensive metabolizer groups, however, there is no need for different </ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:CA0F8B4D-5EF3-4FE9-A834-82FFC2B34383">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:CA0F8B4D-5EF3-4FE9-A834-82FFC2B34383"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>ODV</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-6.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-21 10:00:45 -0400</pav:createdOn>
    <domeo:uuid>CA0F8B4D-5EF3-4FE9-A834-82FFC2B34383</domeo:uuid>
    <ao:prefix> undergoes extensive presystemic metabolism in the liver, primarily to </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix>, but also to N-desmethylvenlafaxine, N,O-didesmethylvenlafaxine, and other minor metabolites. In vitro studies indicate that the formation of ODV is catalyzed by CYP2D6; this has been confirmed in a clinical study showing that patients with low CYP2D6 l</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:0FC9A1FC-0D72-4871-82DC-81A8C658E5A8">
    <pav:lastSavedOn>2014-07-08 14:10:48 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:CDC5329A-F9D8-40D0-9126-03010EC40DB9"/>
    <pav:createdOn>2014-07-08 14:07:35 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <ao:body rdf:nodeID="N8ab6b98e52fb4b5aa398bffb047d35ea"/>
    <pav:lineageUri>urn:domeoserver:annotation:D26B9823-3081-4C72-B2E6-DB6DBF2E13F3</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7E49EB7A-DE0E-4720-82D1-8460BA0C770D</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C4CDC7AA-D0B3-4BE7-9804-2D3ECDA935DA">
    <ao:exact>rosiglitazone </ao:exact>
    <ao:prefix>Insulin resistance is a common feature characterizing the pathogenesis of type 2 diabetes. The antidiabetic activity of </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:C4CDC7AA-D0B3-4BE7-9804-2D3ECDA935DA"/>
    <ao:suffix>has been demonstrated in animal models of type 2 diabetes in which hyperglycemia and/or impaired glucose tolerance is a consequence of insulin resistance in target tissues. Rosiglitazone reduces blood glucose concentrations and reduces hyperinsulinemia i</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-08 08:38:45 -0400</pav:createdOn>
    <domeo:uuid>C4CDC7AA-D0B3-4BE7-9804-2D3ECDA935DA</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7844EA3E-1BD1-4F53-BBF2-97F005CEF6CE">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:7844EA3E-1BD1-4F53-BBF2-97F005CEF6CE"/>
    <pav:createdOn>2014-07-07 09:41:50 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <ao:exact>sildenafil </ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>7844EA3E-1BD1-4F53-BBF2-97F005CEF6CE</domeo:uuid>
    <ao:prefix>concentrations when co-administered with </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix>(50 mg) to healthy volunteers.</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:ACD33836-557A-490B-8596-AAF387EB5EBB">
    <ao:prefix>Pretreatment with </ao:prefix>
    <ao:suffix>(150 mg twice daily for 4 days) did not alter the pharmacokinetics of either single oral or intravenous doses of rosiglitazone in healthy volunteers. These results suggest that the absorption of oral rosiglitazone is not altered in conditions accompanied</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:ACD33836-557A-490B-8596-AAF387EB5EBB"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>ranitidine </ao:exact>
    <domeo:uuid>ACD33836-557A-490B-8596-AAF387EB5EBB</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-08 08:54:09 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:7A821685-58FE-4383-A858-1238080C4D91">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/7C4B1784-1430-407F-9FAA-88E97F36C9EB"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/BF968EF9-C4E9-4782-8751-6FE8B1C0AC19"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:74382DD9-DC18-4CB3-BC5D-36E8D1786DF0">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-07-08 15:15:12 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:B5848078-B8B2-4608-8ADE-6713D8FF58D8"/>
    <pav:createdOn>2014-07-08 15:15:00 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A3F3FCF5-5359-4741-877D-D2B185DE2072</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotation:ADD4F3F4-B886-479C-A9AD-9BDEB29A69C7</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/D155F075-CA4F-461E-B05B-EC89329567C8">
    <rdfs:label>bosentan</rdfs:label>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/75207</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:102525F0-3A81-481E-ABF7-39F13AF8C42F">
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotation:1F6E6F05-84CC-4D01-9250-65BFD1AEB239</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:40DF0243-E4B1-4FCF-9A78-C1F8BC78BF21"/>
    <pav:createdOn>2014-07-08 13:52:56 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-07-08 13:56:02 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:DD05DE56-7B60-4C06-8552-D1DD652D8A79</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:3525D7AB-D2C1-4B90-80CF-24C9DC5CB1A4">
    <ao:suffix>, or valproate during clinical trials. Zonisamide did not inhibit mixed-function liver oxidase enzymes (cytochrome P450), as measured in human liver microsomal preparations, in vitro. Zonisamide is not expected to interfere with the metabolism of other d</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>3525D7AB-D2C1-4B90-80CF-24C9DC5CB1A4</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:3525D7AB-D2C1-4B90-80CF-24C9DC5CB1A4"/>
    <ao:exact>carbamazepine</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-56.txt.html</ao:hasSource>
    <ao:prefix>, </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-07 20:32:11 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N51d6e9f16d264d62b4989f375c2424a9">
    <permissions:isLocked>false</permissions:isLocked>
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nafa2cbda1bac4f44bb4e6052698bd456">
    <permissions:isLocked>false</permissions:isLocked>
    <permissions:accessType>urn:person:uuid:080e143046812afe0146812e52b20002</permissions:accessType>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:2A5F3F7C-44F3-47B7-A81B-5FA80E3062EB">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:2A5F3F7C-44F3-47B7-A81B-5FA80E3062EB"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-163.txt.html</ao:hasSource>
    <domeo:uuid>2A5F3F7C-44F3-47B7-A81B-5FA80E3062EB</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-08 12:08:35 -0400</pav:createdOn>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:exact>Plasma concentrations of meperidine and its metabolite, normeperidine, may be increased by acyclovir, thus caution should be used with concomitant administration</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/FB696F7E-A0E1-4A9F-A31F-A6D4E833586C">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>stavudine</rdfs:label>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/59763</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7A82298A-C721-4D5E-8E8D-DF02586C8C9D">
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:7B5A7AF9-19A2-412F-B6C7-42B4A6C76C1C"/>
    <pav:lineageUri>urn:domeoserver:annotation:35574156-0543-4535-BDC4-031294C79EB8</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoclient:uuid:7E425E73-12D2-4B08-9D70-75410DE87447</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-08 09:25:20 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:lastSavedOn>2014-07-08 09:27:36 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/7A9AF895-05ED-4808-9CA2-1A4AEE57AE62">
    <rdfs:label>cimetidine</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/2541</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:93F4CA25-B4EB-4AA8-8B3E-263A35D74809">
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotation:0E445237-79B8-4BD9-9D58-4FEEC155174B</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2014-07-07 20:10:00 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoclient:uuid:738231FC-4090-4D56-90FB-4FBFF166BD23</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:7FB803D3-6B1E-475E-9879-D98ABDFF0FC5"/>
    <pav:createdOn>2014-07-07 20:08:15 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:AACB148D-E63A-4610-A835-D766ED240017">
    <domeo:uuid>AACB148D-E63A-4610-A835-D766ED240017</domeo:uuid>
    <ao:exact>metformin</ao:exact>
    <ao:prefix>As monotherapy and in combination with </ao:prefix>
    <pav:createdOn>2014-07-08 08:42:46 -0400</pav:createdOn>
    <ao:suffix>, </ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:AACB148D-E63A-4610-A835-D766ED240017"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:BC5C33FE-36D7-48F5-869B-96146A06BE2D">
    <pav:lineageUri>urn:domeoserver:annotation:84CDACF3-62B7-4154-A2DB-2F8C4FDE297C</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdOn>2014-07-07 20:06:02 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:1BE3533C-2291-4EF4-97BB-137F285EE3EB"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoclient:uuid:4A49ACB6-4B71-452F-80EE-8A84DEF45C29</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2014-07-07 20:07:11 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:EE6E27DD-8804-42E9-AD77-30D0F8243B04">
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:B857E3A2-5ED6-4E48-BDCF-81276B042A8E"/>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:57025C5D-977A-46F5-ADF5-8441A9FC0693">
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:4A38099F-C63F-4568-8A69-C675EF12DC53"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:009F8C96-1AEA-4B59-B278-1C6873AA45B5</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:852388F2-37F6-4606-AEDC-7B3D56DC2AC1</pav:lineageUri>
    <pav:createdOn>2014-07-07 20:49:27 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-07-07 20:49:30 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:68E15F64-3CE8-4FAB-A79C-2379BBEB9C23">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/332B872F-F6F9-4A13-B97B-1BE5AAA74964"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/D75AE2D3-176E-449F-9DC2-2024B57D72BD"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/BCC87BA0-688A-457E-94EF-F246894837D0">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>risperidone</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/35636</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/EAF2CAF5-255C-4273-A771-20F4AF61E6A5">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>methadone</rdfs:label>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/6813</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:D9FF5205-23B6-4D07-9F7B-61A78AA14B73">
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:9E9F03AB-A2A6-46C9-BCA7-02C82341907C"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/40BCF403-E878-446A-AF32-F720DCA5BA74">
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>bosentan</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/75207</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:DFEC07A0-0254-4C07-AEA9-201F0354FEAF">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>DFEC07A0-0254-4C07-AEA9-201F0354FEAF</domeo:uuid>
    <ao:exact> sertraline hydrochloride</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:DFEC07A0-0254-4C07-AEA9-201F0354FEAF"/>
    <pav:createdOn>2014-07-07 19:59:52 -0400</pav:createdOn>
    <ao:suffix> equivalent to 25, 50, 100, 150 and 200 mg of sertraline and the following inactive ingredients: dibasic calcium phosphate dihydrate, hydroxypropyl cellulose, hypromellose, magnesium stearate, microcrystalline cellulose, polyethylene glycol, sodium starc</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-20.txt.html</ao:hasSource>
    <ao:prefix> is supplied for oral administration as scored tablets containing</ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/5EDD6A69-3882-4211-8040-2744F687D40F">
    <rdfs:label>rifampin</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/9384</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:26EF607E-0816-4DEB-BD3B-5D52CE89A4F2">
    <pav:lastSavedOn>2014-07-08 12:02:05 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoclient:uuid:921CCEB9-21F5-4162-854B-F60FC028BC15</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotation:93525863-41C3-4187-9FD1-C9F123694EE4</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:4F2A8991-53A7-4DF5-8084-52158EDD3F0F"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2014-07-08 12:01:59 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:82CB26E9-3B23-40F5-9BC7-449481FF0D92">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-08 09:31:51 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:82CB26E9-3B23-40F5-9BC7-449481FF0D92"/>
    <ao:prefix>7.2 </ao:prefix>
    <domeo:uuid>82CB26E9-3B23-40F5-9BC7-449481FF0D92</domeo:uuid>
    <ao:suffix> and Ketoconazole</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-139.txt.html</ao:hasSource>
    <ao:exact>Erythromycin</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:81BC7624-9543-45D0-A22E-FE1DD45A07BE">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/3AAA5683-00B9-4493-AF86-26FF9DEFA0BF"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/16BC5365-0702-41A5-9913-13721E61A9F2"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/CCEE52EA-EDD1-4655-8203-DF4101ABDED4">
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/8183</dailymed:activeMoietyRxCUI>
    <rdfs:label>phenytoin</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:D9E289F1-718B-4AC7-9185-0A6C369D0C71">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/4A5DB76A-8F7C-4CBE-BBAF-8808097EC9BB"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/035E7A1C-90DC-4659-8B21-212B516B5025"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:5C803E1E-D69A-40B2-9B06-AC9770FF4DFF">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>5C803E1E-D69A-40B2-9B06-AC9770FF4DFF</domeo:uuid>
    <ao:prefix>have been used to treat severe reactions, with the addition of intravenous </ao:prefix>
    <ao:suffix>in those cases exhibiting hypertension and hyperpyrexia. The usefulness and safety of narcotic antagonists in the treatment of these reactions is unknown.)</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:5C803E1E-D69A-40B2-9B06-AC9770FF4DFF"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-165.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>chlorpromazine </ao:exact>
    <pav:createdOn>2014-07-08 12:21:43 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:BD2C5DEC-48C9-42AD-BA70-1E222E156673">
    <pav:createdOn>2014-07-21 10:01:54 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-6.txt.html</ao:hasSource>
    <domeo:uuid>BD2C5DEC-48C9-42AD-BA70-1E222E156673</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:BD2C5DEC-48C9-42AD-BA70-1E222E156673"/>
    <ao:exact>ODV </ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix> oral elimination half-life was prolonged by about 40%, while oral clearance for </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix>was similar to that for normal subjects. A large degree of intersubject variability was noted.</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:2E2A04B6-D35B-4539-A6D7-FDA17AD8C196">
    <domeo:belongsToSet>urn:domeoclient:uuid:BCC9EB2F-25E7-44FF-83F2-904B4F4819EC</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:createdOn>2014-07-08 09:28:39 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:FCF20AEC-F7C8-470C-A47C-D84769733981"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-07-08 09:28:41 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotation:60B5928E-6B7B-4AF6-80A1-BE163F890E60</pav:lineageUri>
    <ao:body rdf:nodeID="Nf59180be493e462abd29f051a1ee24a9"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:CBA9257A-6BFA-4C8D-A8DA-49FF788B2ABB">
    <ao:exact>nefazodone </ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-59.txt.html</ao:hasSource>
    <ao:suffix>and its active metabolite to achieve a therapeutic effect. Coadministration of carbamazepine with nefazodone is contraindicated (see CONTRAINDICATIONS).</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:CBA9257A-6BFA-4C8D-A8DA-49FF788B2ABB"/>
    <domeo:uuid>CBA9257A-6BFA-4C8D-A8DA-49FF788B2ABB</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>results in insufficient plasma concentrations of </ao:prefix>
    <pav:createdOn>2014-07-07 20:38:03 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/B1D5C3E6-1C69-4520-A396-98360C72654E">
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/4124</dailymed:activeMoietyRxCUI>
    <rdfs:label>ethinyl estradiol</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F30C724A-EBE5-4CD7-B5BE-2399F7E6F1FC">
    <ao:suffix>is rapidly absorbed after oral administration, with a mean absolute bioavailability of 41% (25–63%). Maximum observed plasma concentrations are reached within 30 to 120 minutes (median 60 minutes) of oral dosing in the fasted state. When REVATIO is taken</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:F30C724A-EBE5-4CD7-B5BE-2399F7E6F1FC"/>
    <domeo:uuid>F30C724A-EBE5-4CD7-B5BE-2399F7E6F1FC</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>REVATIO </ao:exact>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-07 09:36:44 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:BACA32E9-C346-4CFC-84F0-69F0173195F5">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">3</pav:versionNumber>
    <pav:previousVersion>urn:domeoclient:uuid:21a2d27a-13b1-4797-ba7a-c0517e32bb06</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:lastSavedOn>2014-07-21 10:02:11 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:32944008-A6C6-4D66-8C43-EE4CF2256965</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-21 09:58:16 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotationset:cf593dca-fe93-451b-8f37-2a96e065da13</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:042FD13F-4820-41DF-9E7F-B53A0D5AD8ED"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:9DCC526E-8763-49C5-98FB-B1613386AA3D">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoclient:uuid:3857B7A8-EDF2-4956-9CF4-A1B13773E162</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <ao:body rdf:nodeID="Na8b9b00515f742e8a10d284c873f3a36"/>
    <pav:createdOn>2014-07-07 20:17:32 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-07-07 20:18:07 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotation:4C61BAD9-E72A-413A-BE40-46DA7C459D9C</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:BD24CFC4-ABB3-434E-9897-CD48A4D2ADA5"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:8296C0C0-1C3C-44C8-9B26-378BE7A2167B">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:32944008-A6C6-4D66-8C43-EE4CF2256965</domeo:belongsToSet>
    <pav:previousVersion>urn:domeoclient:uuid:21a2d27a-13b1-4797-ba7a-c0517e32bb06</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">3</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotationset:cf593dca-fe93-451b-8f37-2a96e065da13</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2014-07-21 10:01:09 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2014-07-21 10:02:11 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:5CFA2EBB-041F-42ED-B805-74B3976B05B2"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:62DB213B-D0D2-4AAE-8061-DE7A3FACC0A3">
    <ao:exact>ddI</ao:exact>
    <ao:suffix>)</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:62DB213B-D0D2-4AAE-8061-DE7A3FACC0A3"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-190.txt.html</ao:hasSource>
    <ao:prefix>xsd:String</ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>62DB213B-D0D2-4AAE-8061-DE7A3FACC0A3</domeo:uuid>
    <pav:createdOn>2014-07-08 14:40:01 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:0D5EBC4C-8790-476B-81E6-9049B7366310">
    <domeo:belongsToSet>urn:domeoclient:uuid:921213C5-987C-46D2-9095-A8DDC2B714AB</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:16071B8A-0D01-4246-AF6D-001BAAD999EC"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotation:DA1D3A2A-D65A-4A24-9EB7-3C953C89D17A</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-07-07 20:04:45 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-07 20:00:56 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:BDE1F912-643A-43B6-9AF4-9B44C866F37D">
    <ao:context rdf:resource="urn:domeoclient:uuid:D0524BB4-91EE-451E-BCCA-7E02735CA128"/>
    <pav:lastSavedOn>2014-07-08 08:58:29 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-08 08:58:10 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotation:9D191506-FC1C-41FE-9C66-854D0A2F2A30</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoclient:uuid:A927CF27-CC1C-4BE1-9435-0875A6356C3E</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:3EFC02B2-B26D-4288-ADAB-FC22A1452B4C">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:A518666B-94DF-4BFF-ACE1-1F6BB97200EB"/>
    <pav:lastSavedOn>2014-07-07 19:42:16 -0400</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoclient:uuid:67362A51-C044-4566-BDF1-FEC50141A265</domeo:belongsToSet>
    <pav:createdOn>2014-07-07 19:41:53 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotation:300BE828-6841-454E-B56F-D77783E3C406</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/2E948120-9C8C-416C-B96B-017E148E7A69">
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/679314</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>9-hydroxyrisperidone</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:3EBF74E0-8A42-48E9-9F4D-5D7E21FFD4B3">
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:B456BE0F-C7EE-45C3-A8C4-FD0EAFA2EA56"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:607C6F6D-1F88-482B-89CC-3B1CE45A2E73">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>urn:domeoclient:uuid:5BCE2FDB-C586-44CD-88F7-6EE2BDB6B929</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotationset:57174A7C-3100-4C8F-9C4A-2991CEE124D5</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2014-07-08 08:51:47 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-08 08:50:18 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:BC031B07-0984-4C88-9A32-7B2B0C2A80FC"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:23515E27-98AC-4DC9-A4B7-EBFE2991219F</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:BE5BBB91-BFBC-4A97-A6BF-09DF9AD3ACB7">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:BE5BBB91-BFBC-4A97-A6BF-09DF9AD3ACB7"/>
    <domeo:uuid>BE5BBB91-BFBC-4A97-A6BF-09DF9AD3ACB7</domeo:uuid>
    <ao:suffix>exposure and withdrawal symptoms occurred concurrently. Upon discontinuation of phenytoin, the incidence of withdrawal symptoms decreased and methadone exposure increased to a level comparable to that prior to phenytoin administration.</ao:suffix>
    <ao:prefix>administration (250 mg b.i.d. initially for 1 day followed by 300 mg QD for 3 to 4 days) resulted in an approximately 50% reduction in </ao:prefix>
    <ao:exact>methadone </ao:exact>
    <pav:createdOn>2014-07-08 12:28:22 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-201.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:FE578436-DEA3-4835-8703-49F739FC71ED">
    <pav:createdOn>2014-07-07 20:46:11 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:E08D4CED-BE06-4A5F-A2AF-BFBC25BA8AE4</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:D36055F2-4A13-4201-86B3-31BB43715538"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-07-07 20:46:25 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotation:6162469F-B102-42C7-9168-E8798488EAE9</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:234802F1-72E6-403E-AB88-E5B255950B39">
    <ao:suffix>xsd:String</ao:suffix>
    <ao:exact>The mean Cmax and AUC of nifedipine are increased by 64% and 79%, respectively, by co-administration of propranolol.</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:234802F1-72E6-403E-AB88-E5B255950B39"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-126.txt.html</ao:hasSource>
    <domeo:uuid>234802F1-72E6-403E-AB88-E5B255950B39</domeo:uuid>
    <pav:createdOn>2014-07-08 08:58:29 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:D7146058-6910-4D28-A5FB-0A1C90CF9229">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/7DA5AFC9-2884-4C0C-926E-B1CA3F86107B"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/0402ABD7-DCC7-4E46-820F-F8370F53E288"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A702B53A-0DB9-41E0-A53E-EB4ECB7132EB">
    <pav:previousVersion>urn:domeoclient:uuid:5BCE2FDB-C586-44CD-88F7-6EE2BDB6B929</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2014-07-08 08:51:47 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:81D862BF-6755-45B3-8EAE-F922FD9F4239"/>
    <pav:createdOn>2014-07-08 08:50:22 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotationset:57174A7C-3100-4C8F-9C4A-2991CEE124D5</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:23515E27-98AC-4DC9-A4B7-EBFE2991219F</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:6924A8BB-D094-4B99-8CC6-4C1C52D1971C">
    <pav:createdOn>2014-07-07 09:41:26 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A5E637EF-5CA5-4AAC-BD8B-C136A86E17B7</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:CA2A6108-D730-43DF-9BCF-AD1DE31C2743"/>
    <pav:lastSavedOn>2014-07-07 09:44:18 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotationset:F37BE993-E972-47AE-896D-FF4D33157ECF</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:10CD6BA1-D45A-4A46-BBBD-D2AA7F0304A9">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/3BE703A9-954B-4CD3-A7C4-BAA1FE159825"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/7795CCEF-74BF-4E32-9312-8D63BE1D340B"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:66CDEBD7-A3E0-4107-B811-3798E8B44C9A">
    <pav:createdOn>2014-07-07 19:46:34 -0400</pav:createdOn>
    <domeo:uuid>66CDEBD7-A3E0-4107-B811-3798E8B44C9A</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:66CDEBD7-A3E0-4107-B811-3798E8B44C9A"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>. Thus, </ao:prefix>
    <ao:suffix>can be given with or without meals.</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>risperidone </ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N9b212d98657842029f425b2b4bcf4e22">
    <permissions:isLocked>false</permissions:isLocked>
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:4FBE52B1-7369-4C72-B088-9FD2E6AF2E35">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:4FBE52B1-7369-4C72-B088-9FD2E6AF2E35"/>
    <ao:suffix>clearance</ao:suffix>
    <domeo:uuid>4FBE52B1-7369-4C72-B088-9FD2E6AF2E35</domeo:uuid>
    <ao:exact>sildenafil </ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-07 09:59:25 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/7DA5AFC9-2884-4C0C-926E-B1CA3F86107B">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>carbamazepine</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/2002</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:16F384F2-6BA5-4604-ADEC-3707AB4DACDF">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:2A5F3F7C-44F3-47B7-A81B-5FA80E3062EB"/>
    <pav:lastSavedOn>2014-07-08 12:08:36 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotation:2BF2043C-88D9-4D25-954D-AC06622C0E09</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:createdOn>2014-07-08 12:08:35 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:body rdf:nodeID="N17ebfbdd1c8b491b8a0221195789d134"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:15A8BD5A-D46C-4E84-8B70-5066D260486D</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:8609552E-F73C-43EE-BE60-46F60869DC13">
    <pav:lineageUri>urn:domeoserver:annotation:BBE397E3-2DB4-4DD5-981F-72B52BAB4578</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:D35135EF-F047-4064-990E-F10BA4BF8634"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-08 14:26:16 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-08 14:25:26 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:42258B16-6749-4B39-B28D-88C8B63F7A43</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B115457B-6573-489E-97A1-794F562EF7E2">
    <pav:createdOn>2014-07-08 13:58:47 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7E49EB7A-DE0E-4720-82D1-8460BA0C770D</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-08 13:59:58 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotationset:def720a3-9364-4d0d-a156-423274fb2386</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:previousVersion>urn:domeoclient:uuid:203110ef-d319-4c8c-8da1-19d68e91f895</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:C8BAD97F-1713-4E27-9DBA-BBEE72BF7B39"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">3</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <ao:body rdf:nodeID="N9f5d44e0fda24e41a08b78a2c94a0e17"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:0522CC55-078E-405F-9A7C-F3B2B4298A87">
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:E7CA2C0E-E8F6-4E24-AD53-4E4D701715AD"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A26943A6-0973-45A0-9E75-B6D2CDDB08C5">
    <domeo:uuid>A26943A6-0973-45A0-9E75-B6D2CDDB08C5</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <ao:prefix>has been demonstrated in animal models of type 2 diabetes in which hyperglycemia and/or impaired glucose tolerance is a consequence of insulin resistance in target tissues. </ao:prefix>
    <pav:createdOn>2014-07-08 08:38:50 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:A26943A6-0973-45A0-9E75-B6D2CDDB08C5"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>Rosiglitazone </ao:exact>
    <ao:suffix>reduces blood glucose concentrations and reduces hyperinsulinemia in the ob/ob obese mouse, db/db diabetic mouse, and fa/fa fatty Zucker rat.</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:FAF680C3-6E84-4E8E-916D-DF5819D3EB75">
    <ao:prefix> </ao:prefix>
    <pav:createdOn>2014-07-08 09:33:58 -0400</pav:createdOn>
    <domeo:uuid>FAF680C3-6E84-4E8E-916D-DF5819D3EB75</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:FAF680C3-6E84-4E8E-916D-DF5819D3EB75"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>coadministration of fexofenadine hydrochloride with either ketoconazole or erythromycin led to increased plasma concentrations of fexofenadine in healthy adult subjects.</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-139.txt.html</ao:hasSource>
    <ao:suffix>xsd:String</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:315E84B1-D1AA-45C2-B6CA-88D16B9BF064">
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdOn>2014-07-07 09:43:53 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A5E637EF-5CA5-4AAC-BD8B-C136A86E17B7</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2014-07-07 09:44:18 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotationset:F37BE993-E972-47AE-896D-FF4D33157ECF</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:2D515E32-15EF-4D9F-A77C-90EEB262FE6A"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A6E4CE45-BCB0-440E-8EE0-970472A2D684">
    <pav:lastSavedOn>2014-07-08 09:22:07 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoclient:uuid:C0CE4AC7-F72D-4A94-BD3E-4720F127B810</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:lineageUri>urn:domeoserver:annotation:68EDBC1C-E24F-4F02-A4F6-35CDBEC3B982</pav:lineageUri>
    <pav:createdOn>2014-07-08 09:21:49 -0400</pav:createdOn>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <ao:body rdf:nodeID="N58b12e254ec94d90bc0dd6a417f95197"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:02D1A810-D529-4164-B732-BD1045B92C6F"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C5008EE9-521F-4EEA-93D7-45CB50B81E97">
    <ao:prefix>, rit</ao:prefix>
    <ao:suffix>navir, and indinavir. The effect of short-term administration of ritonavir (200 mg twice daily, 4 doses) on the pharmacokinetics of a single dose of trazodone (50 mg) has been studied in 10 healthy subjects. The Cmax of trazodone increased by 34%, the AU</ao:suffix>
    <ao:exact>o</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:C5008EE9-521F-4EEA-93D7-45CB50B81E97"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-136.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-08 09:25:23 -0400</pav:createdOn>
    <domeo:uuid>C5008EE9-521F-4EEA-93D7-45CB50B81E97</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7077B078-BE1D-4254-B06C-784D3164483E">
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-07-07 19:46:34 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:66CDEBD7-A3E0-4107-B811-3798E8B44C9A"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5ABD9862-F044-4404-AD04-73DA04ADDA8B</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:lastSavedOn>2014-07-07 19:50:36 -0400</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotationset:1DED06A6-8562-4CCF-A58C-CA25748FBD31</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:CD065A10-794D-48E3-B791-B6EA38BFF459">
    <pav:createdOn>2014-07-07 19:58:18 -0400</pav:createdOn>
    <ao:suffix>speridone and its active metabolite decreased by 60% compared to young healthy subjects. Risperidone doses should be reduced in patients with renal disease [see 2 DOSAGE AND ADMINISTRATION and 5 WARNINGS AND PRECAUTIONS].</ao:suffix>
    <domeo:uuid>CD065A10-794D-48E3-B791-B6EA38BFF459</domeo:uuid>
    <ao:exact>i</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <ao:prefix>Renal Impairment: In patients with moderate to severe renal disease, clearance of the sum of r</ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:CD065A10-794D-48E3-B791-B6EA38BFF459"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:390AE58E-C470-422B-8044-D7F163F66800">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <ao:exact>rosiglitazone </ao:exact>
    <domeo:uuid>390AE58E-C470-422B-8044-D7F163F66800</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:390AE58E-C470-422B-8044-D7F163F66800"/>
    <ao:prefix>AUC by 66%, compared to the administration of </ao:prefix>
    <ao:suffix>(8 mg) alone [see Drug Interactions (7.1)].4</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-08 08:46:48 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D9EED41A-E6F7-4E30-82A2-EFCE4D840C64">
    <pav:lineageUri>urn:domeoserver:annotationset:cf593dca-fe93-451b-8f37-2a96e065da13</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:32944008-A6C6-4D66-8C43-EE4CF2256965</domeo:belongsToSet>
    <pav:previousVersion>urn:domeoclient:uuid:21a2d27a-13b1-4797-ba7a-c0517e32bb06</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:7801AA43-244B-4455-BC62-B1BED0BCE6DA"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-21 10:02:11 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdOn>2014-07-21 09:58:18 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">3</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:D2489EE0-7C3D-4370-B631-E17D1D3EE5F3">
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:079736F9-4C55-4D4F-BE5E-A1152FAB146A"/>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:F384E0B8-1F36-4347-BCD2-B507489DD605">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/63CC8424-0167-4DD3-BFB3-56A9E60548FF"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/DFC77010-ACAE-46CC-A0AF-4594577A8729"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B7A5894E-24AE-458F-B71F-942381442E70">
    <pav:createdOn>2014-07-07 20:38:07 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoclient:uuid:8D643EAC-88DF-4484-A479-D1E798544DF5</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:7F22C687-6FD6-4EEF-AAAF-B34C373B75DC"/>
    <pav:lastSavedOn>2014-07-07 20:38:37 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotation:BDA7272D-CFD3-480D-B519-4586230C1F30</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:83E50C5D-510D-47CE-AA37-898B57D1C9B1">
    <ao:context rdf:resource="urn:domeoclient:uuid:20EFF2EE-AAF5-4EDA-917C-21E2A880209F"/>
    <pav:lineageUri>urn:domeoserver:annotationset:57174A7C-3100-4C8F-9C4A-2991CEE124D5</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdOn>2014-07-08 08:50:20 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:23515E27-98AC-4DC9-A4B7-EBFE2991219F</domeo:belongsToSet>
    <pav:previousVersion>urn:domeoclient:uuid:5BCE2FDB-C586-44CD-88F7-6EE2BDB6B929</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2014-07-08 08:51:47 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:15989C9D-F8F5-4B7E-89A2-5024DE28F437">
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:39C7490C-F7EF-4E93-A34E-42899C09A8EE"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A113E100-0D7F-48FA-9485-DF4B79B6D3C4">
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2014-07-07 19:59:12 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-07 19:58:18 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:CD065A10-794D-48E3-B791-B6EA38BFF459"/>
    <pav:lineageUri>urn:domeoserver:annotation:B01B11E2-E9C4-4546-887D-3ED7535D6500</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5ABD9862-F044-4404-AD04-73DA04ADDA8B</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B1510031-6C56-42CA-8590-3A1B5ADD6A7D">
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdOn>2014-07-07 09:39:59 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotationset:F37BE993-E972-47AE-896D-FF4D33157ECF</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-07 09:44:18 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A5E637EF-5CA5-4AAC-BD8B-C136A86E17B7</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:BA98E64D-53F6-4BC4-9626-26A09B240057"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:46113E93-8644-4468-916F-0232D35E311B">
    <pav:lastSavedOn>2014-07-07 20:04:45 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoclient:uuid:921213C5-987C-46D2-9095-A8DDC2B714AB</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:78216FA4-1765-4715-BE1A-5FC1289557F9"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotation:990411F3-7D62-42A9-B78E-10A5E9D85245</pav:lineageUri>
    <pav:createdOn>2014-07-07 20:00:59 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/9C5399E6-39AF-4792-8CA8-BC4AD95CAD35">
    <rdfs:label>fluvastatin</rdfs:label>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/41127</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:86633E71-C3F0-42BD-ABC5-16ADACA99690">
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:3EF641E1-18D0-4BB8-809D-CF2D2FA89BB3"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/b964f0b6-1110-4a58-aa44-a490eabead47">
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:3ce99a54-4f9e-442c-946c-e89d6ef85612"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:CEC2E6BB-4A0E-4F14-B024-B1C9027CF3AE</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2014-07-07 08:06:49 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-07-07 08:06:49 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotationset:a54cadb3-7650-4db0-b96f-ce26cf3a1ef6</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:7E2E158E-902A-4662-B0F0-04D80631F810">
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:6EF82B31-3A34-4275-A117-F44BB02FE863"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F18CDAEB-614F-4670-B2F1-093666B82181">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2014-07-08 09:08:03 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoclient:uuid:4E43D844-2E5A-46D2-8797-09878034F22F</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-08 09:08:48 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:AD9E0654-93ED-4495-91C0-4216D6585844"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotation:1BAB3A61-A1E5-4B13-90F4-B99174C65875</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D83F7899-4FE7-41D8-9B1D-F0858AB1EA1F">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:F533733D-05CF-40C9-9FAA-8FAFB5EFC64E"/>
    <pav:createdOn>2014-07-08 14:50:09 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotation:E226F4FE-9404-4648-AC8D-AAA48DBB082A</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:41C6B392-F8A7-4DBA-AFEF-0BE07588FACF</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2014-07-08 14:52:51 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:5F2EAB8E-988F-446A-A2CD-BACEBB26F805">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-08 14:25:21 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:5F2EAB8E-988F-446A-A2CD-BACEBB26F805"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>). The principal mode of action of </ao:prefix>
    <ao:exact>ZDV-TP</ao:exact>
    <ao:suffix> is inhibition of reverse transcriptase (RT) via DNA chain termination after incorporation of the nucleotide analogue. ZDV-TP is a weak inhibitor of the cellular DNA polymerases α and γ and has been reported to be incorporated into the DNA of cells in cu</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-197.txt.html</ao:hasSource>
    <domeo:uuid>5F2EAB8E-988F-446A-A2CD-BACEBB26F805</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F1E73FC8-A1AF-4584-97F4-1342666BD5FA">
    <pav:createdOn>2014-07-07 20:15:05 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotation:3A8E67CE-7C49-4FFF-8FCB-4DFCC779FBB5</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:FDB4919D-6446-4981-9689-7E91247A2B9C"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:B44CD6F1-18F6-4252-9E79-5D5107E7044D</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-07-07 20:16:04 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:4F696F90-D2D9-4E90-9300-C785BC0C7708">
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotation:D8D9CE5C-85F2-47BF-B108-697EF05E27F1</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2014-07-07 20:13:21 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-07-07 20:14:34 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoclient:uuid:B41CE612-345D-4E17-94DB-98BD2C6B5559</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:ED201F07-D8A3-4A66-A1AD-5C521E57A143"/>
    <rdfs:label>Highlight</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/4DB0A1E7-E228-49D0-8188-72F996564E53">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>propranolol</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/8787</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:8AE6F604-2CDB-4CCB-9934-F0021BE9F5DD">
    <ao:suffix>.</ao:suffix>
    <domeo:uuid>8AE6F604-2CDB-4CCB-9934-F0021BE9F5DD</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:8AE6F604-2CDB-4CCB-9934-F0021BE9F5DD"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-2.txt.html</ao:hasSource>
    <ao:prefix>xsd:String</ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>dideoxyadenosine 5’-triphosphate</ao:exact>
    <pav:createdOn>2014-07-21 09:43:42 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F3EDD32E-0A29-4402-89FA-A89B8957004D">
    <ao:body rdf:nodeID="N00ca8f501bb348909ae7e48e8f780ad4"/>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:lastSavedOn>2014-07-08 14:48:48 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-08 14:48:48 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotation:5648DB7D-6D66-4B4F-AC36-31BE241F7600</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:8A876274-D553-4BE5-8E65-126846D61286"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:4C025723-BCF8-41B1-92B5-614AF1C7050A</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/291B64A8-2FA8-4102-AB70-90580BB3A04D">
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>lidocaine</rdfs:label>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E62AB53D-EE03-48A2-8134-3BC40C9F7830">
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdOn>2014-07-07 20:00:33 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoclient:uuid:921213C5-987C-46D2-9095-A8DDC2B714AB</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-07 20:04:45 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:7579EDB7-667C-4606-9F8F-BE3B39EAB203"/>
    <pav:lineageUri>urn:domeoserver:annotation:FDD9A39E-3525-42F7-8998-B2CD82B29B7A</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:1B57B86A-EAE9-49CA-AEDA-7E5105FF05CF">
    <domeo:belongsToSet>urn:domeoclient:uuid:6B178133-9B11-445F-A5BB-EF967EA53386</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-08 12:29:01 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotation:6FD6A2ED-A99A-4342-BE77-3A6AA79A35FA</pav:lineageUri>
    <pav:createdOn>2014-07-08 12:28:26 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:B4E6B43A-C912-4D44-8848-19C5654AB69F"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B26E2EC2-BEB4-4630-BD21-DB8A5CD00827">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact> AUC</ao:exact>
    <ao:suffix>xsd:String</ao:suffix>
    <domeo:uuid>B26E2EC2-BEB4-4630-BD21-DB8A5CD00827</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:B26E2EC2-BEB4-4630-BD21-DB8A5CD00827"/>
    <pav:createdOn>2014-07-07 09:42:11 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>sildenafil</ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D4E0E92E-4021-4F3E-AF8B-C653EECCD3B4">
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">3</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-21 10:02:07 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:CB4CEEF7-3324-4A8B-A2FD-A9BD8B9C3884"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotationset:cf593dca-fe93-451b-8f37-2a96e065da13</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:previousVersion>urn:domeoclient:uuid:21a2d27a-13b1-4797-ba7a-c0517e32bb06</pav:previousVersion>
    <pav:lastSavedOn>2014-07-21 10:02:11 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:32944008-A6C6-4D66-8C43-EE4CF2256965</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:064399E9-B524-4FE1-8D5C-3FDE4F9BDAE1">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix> [see 12 CLINICAL PHARMACOLOGY]. Antagonism at receptors other than D2 and 5HT2 [see 12 CLINICAL PHARMACOLOGY] may explain some of the other effects of risperidone.</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:064399E9-B524-4FE1-8D5C-3FDE4F9BDAE1"/>
    <ao:prefix>and its major metabolite,</ao:prefix>
    <pav:createdOn>2014-07-07 19:43:21 -0400</pav:createdOn>
    <ao:exact> 9-hydroxyrisperidone</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>064399E9-B524-4FE1-8D5C-3FDE4F9BDAE1</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:4E164FAD-B09D-4789-9CE9-9C3256D72F7D">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:4E164FAD-B09D-4789-9CE9-9C3256D72F7D"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>epoprostenol </ao:exact>
    <ao:prefix> in the presence of </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix>is not considered clinically relevant. The effect of sildenafil on </ao:suffix>
    <pav:createdOn>2014-07-07 09:44:04 -0400</pav:createdOn>
    <domeo:uuid>4E164FAD-B09D-4789-9CE9-9C3256D72F7D</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:54400419-BC05-429A-AC24-786E53EBBC07">
    <pav:createdOn>2014-07-07 09:37:24 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotationset:F37BE993-E972-47AE-896D-FF4D33157ECF</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A5E637EF-5CA5-4AAC-BD8B-C136A86E17B7</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:lastSavedOn>2014-07-07 09:44:18 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:98A01E90-AA25-4D94-ACD9-71A554BFFFA6"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:B60C56F2-1471-4A8A-9B6E-B7BF44526095">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/E082272F-163E-44C5-8D3F-DB00EBD18FC6"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/BCC87BA0-688A-457E-94EF-F246894837D0"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:560A42E5-FE10-4D20-A7E1-B57AD34849F4">
    <pav:createdOn>2014-07-07 09:42:38 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2014-07-07 09:44:18 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:306D66E1-EEA7-47C1-B74F-BDAB19758905"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A5E637EF-5CA5-4AAC-BD8B-C136A86E17B7</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotationset:F37BE993-E972-47AE-896D-FF4D33157ECF</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:5771D074-1193-4EB7-997B-31710E663873">
    <ao:body rdf:nodeID="N81cbf2f6985b46a0ad29459d6aeca554"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A5E637EF-5CA5-4AAC-BD8B-C136A86E17B7</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-07 11:12:49 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotation:0E894A5A-DC04-4D81-9A11-48A02CD4351C</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdOn>2014-07-07 11:04:00 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:6A1539CE-1E4A-4CA1-B7D8-50C0E9D4DE13"/>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:59CDDEDF-00A5-4DF8-A2C0-E36773BF2D0E">
    <ao:exact>ODV</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-6.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:59CDDEDF-00A5-4DF8-A2C0-E36773BF2D0E"/>
    <domeo:uuid>59CDDEDF-00A5-4DF8-A2C0-E36773BF2D0E</domeo:uuid>
    <pav:createdOn>2014-07-21 10:01:51 -0400</pav:createdOn>
    <ao:prefix> oral bioavailability was increased 2 to 3 fold, oral elimination half-life was approximately twice as long and oral clearance was reduced by more than half, compared to normal subjects. In hepatically impaired subjects, </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix> oral elimination half-life was prolonged by about 40%, while oral clearance for ODV was similar to that for normal subjects. A large degree of intersubject variability was noted.</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:1E974747-8416-47F3-9D47-C57EEF1AED1D">
    <ao:prefix>-hue test, with peak effects near the time of peak plasma levels. This finding is consistent with the inhibition of PDE6, which is involved in phototransduction in the retina. An evaluation of visual function at doses up to 200 mg revealed no effects of </ao:prefix>
    <ao:exact>REVATIO </ao:exact>
    <pav:createdOn>2014-07-07 09:36:41 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <ao:suffix>on visual acuity, intraocular pressure, or pupillometry.</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:1E974747-8416-47F3-9D47-C57EEF1AED1D"/>
    <domeo:uuid>1E974747-8416-47F3-9D47-C57EEF1AED1D</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:97B076E9-5A06-41B3-A7E3-7DFE6F39C69A">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:97B076E9-5A06-41B3-A7E3-7DFE6F39C69A"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-08 14:20:44 -0400</pav:createdOn>
    <ao:suffix> plasma concentrations. Apparent </ao:suffix>
    <ao:prefix>uated in a multiple-dose study in patients undergoing hemodialysis (n = 5) or peritoneal dialysis (n = 6) receiving escalating doses up to 200 mg 5 times daily for 8 weeks. Daily doses of 500 mg or less were well tolerated despite significantly elevated </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-197.txt.html</ao:hasSource>
    <ao:exact>GZDV</ao:exact>
    <domeo:uuid>97B076E9-5A06-41B3-A7E3-7DFE6F39C69A</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:51546F2E-82E2-467D-9134-5220E7AAC16A">
    <ao:prefix> and an inducer of CYP2C8 (e.g., </ao:prefix>
    <ao:suffix>) may decrease the AUC of rosiglitazone. Therefore, if an inhibitor or an inducer of CYP2C8 is started or stopped during treatment with rosiglitazone, changes in diabetes treatment may be needed based upon clinical response. [See Clinical Pharmacology (1</ao:suffix>
    <ao:exact>rifampin</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-122.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:51546F2E-82E2-467D-9134-5220E7AAC16A"/>
    <pav:createdOn>2014-07-07 20:50:01 -0400</pav:createdOn>
    <domeo:uuid>51546F2E-82E2-467D-9134-5220E7AAC16A</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F090DBDF-A110-4DE9-80B1-119A6E43488A">
    <ao:prefix>xsd:String</ao:prefix>
    <domeo:uuid>F090DBDF-A110-4DE9-80B1-119A6E43488A</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:F090DBDF-A110-4DE9-80B1-119A6E43488A"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-07 11:09:19 -0400</pav:createdOn>
    <ao:exact>In a study of healthy male volunteers, co-administration of sildenafil at steady state (80 mg TID) with bosentan (a moderate inducer of CYP3A, CYP2C9 and possibly of cytochrome P450 2C19) at steady state (125 mg BID) resulted in a 63% decrease of sildenafil AUC and a 55% decrease in sildenafil Cmax. Co-administration resulted in a 50% increase in AUC of bosentan. The combination of both drugs did not lead to clinically significant changes in blood pressure (supine or standing). Concomitant administration of potent CYP3A inducers is expected to cause greater decreases in plasma levels of sildenafil.</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:328D21B5-4D95-45E2-B811-1DDDD22421D8">
    <ao:suffix>(oral fluconazole 200 mg daily for 16 days) in 10 normal male volunteers. There was a significant increase in phenytoin AUC. The mean ± SD increase in phenytoin AUC was 88% ± 68% (range: 16 to 247%). The absolute magnitude of this interaction is unknown </ao:suffix>
    <ao:prefix>dosing (200 mg daily, orally for 3 days followed by 250 mg intravenously for one dose) both with and without the administration of </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-25.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-07 20:13:25 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:328D21B5-4D95-45E2-B811-1DDDD22421D8"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>fluconazole </ao:exact>
    <domeo:uuid>328D21B5-4D95-45E2-B811-1DDDD22421D8</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:097B1A34-716D-4A0E-95FE-A452BE7F5D92">
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:12EBC24C-8600-4D85-A9A7-1C62410457FF"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:364772D1-CC5B-4386-AE66-69C622A604AE">
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:EA1E63D4-5825-43E9-BE29-4D1EBE7D64D0"/>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:2EB5E47F-B66E-44F8-9384-DC066F6C5771">
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotation:A7A4835C-9E08-4988-8031-E1856C023A8A</pav:lineageUri>
    <pav:createdOn>2014-07-08 14:03:44 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:E0E36EFF-8146-4DA0-B2B8-2F6338680E87"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7E49EB7A-DE0E-4720-82D1-8460BA0C770D</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-08 14:10:48 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:FE9AADB1-C722-4760-8125-5860CC27B488">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-54.txt.html</ao:hasSource>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:FE9AADB1-C722-4760-8125-5860CC27B488"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-07 20:29:17 -0400</pav:createdOn>
    <domeo:uuid>FE9AADB1-C722-4760-8125-5860CC27B488</domeo:uuid>
    <ao:suffix>significantly decreases the clearance and increases the t1/2 of quinidine, but quinidine does not alter the kinetics of diltiazem.</ao:suffix>
    <ao:exact>Diltiazem </ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/5452E1F8-900D-4E76-ACDF-715CE5F0D54A">
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/3322</dailymed:activeMoietyRxCUI>
    <rdfs:label>diazepam</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:61AFB096-D032-4484-98D0-1E1435D6BA6C">
    <ao:exact>methadone </ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-201.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:61AFB096-D032-4484-98D0-1E1435D6BA6C"/>
    <ao:suffix>maintenance therapy, phenytoin administration (250 mg b.i.d. initially for 1 day followed by 300 mg QD for 3 to 4 days) resulted in an approximately 50% reduction in methadone exposure and withdrawal symptoms occurred concurrently. Upon discontinuation o</ao:suffix>
    <ao:prefix>In a pharmacokinetic study with patients on </ao:prefix>
    <pav:createdOn>2014-07-08 12:28:18 -0400</pav:createdOn>
    <domeo:uuid>61AFB096-D032-4484-98D0-1E1435D6BA6C</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:2F47F565-35EA-4A4D-BBF3-08BB71607252">
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:006C2B92-F981-4BFE-BBBA-3EF597F9C02F"/>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:F002FE31-A0C4-45E0-AD94-B77840FF2BE3">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/E4934FAF-B157-4C6B-B6A1-21AE3A7D4360"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/38F65DE7-565F-4D13-BD4E-F21C558A1FAD"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:21BB89F3-A6EB-41F3-A8A0-3EDF64C57EBE">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:21BB89F3-A6EB-41F3-A8A0-3EDF64C57EBE"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix>(10 mcg/mL) caused only a slight increase in the free fraction of risperidone at 10 ng/mL and 9-hydroxyrisperidone at 50 ng/mL, changes of unknown clinical significance.</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-07 19:47:04 -0400</pav:createdOn>
    <ao:exact>carbamazepine </ao:exact>
    <domeo:uuid>21BB89F3-A6EB-41F3-A8A0-3EDF64C57EBE</domeo:uuid>
    <ao:prefix>(10 mcg/mL), and </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:8F31A6C4-0092-4AC8-862A-2F69A4C04CAC">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>8F31A6C4-0092-4AC8-862A-2F69A4C04CAC</domeo:uuid>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:8F31A6C4-0092-4AC8-862A-2F69A4C04CAC"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <ao:exact>Acarbose</ao:exact>
    <pav:createdOn>2014-07-08 08:52:22 -0400</pav:createdOn>
    <ao:prefix>xsd:String</ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:06584C7A-C7E2-443E-953B-8AC0D9B83FEF">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix>after 15 days of rifampin administered as 600 mg daily in eight healthy male volunteers resulted in a significant decrease in fluconazole AUC and a significant increase in apparent oral clearance of fluconazole. There was a mean ± SD reduction in flucona</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:06584C7A-C7E2-443E-953B-8AC0D9B83FEF"/>
    <ao:exact>fluconazole </ao:exact>
    <domeo:uuid>06584C7A-C7E2-443E-953B-8AC0D9B83FEF</domeo:uuid>
    <pav:createdOn>2014-07-07 20:10:18 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-24.txt.html</ao:hasSource>
    <ao:prefix>Administration of a single oral 200 mg dose of </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E606D7B6-14FA-4E2D-BCC8-D22226EA970D">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-07 19:46:24 -0400</pav:createdOn>
    <ao:prefix> occurred at about 3 hours in extensive metabolizers, and 17 hours in poor metabolizers. Steady-state concentrations of </ao:prefix>
    <ao:suffix>are reached in 1 day in extensive metabolizers and would be expected to reach steady-state in about 5 days in poor metabolizers. Steady-state concentrations of 9-hydroxyrisperidone are reached in 5 to 6 days (measured in extensive metabolizers).</ao:suffix>
    <ao:exact>risperidone </ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:E606D7B6-14FA-4E2D-BCC8-D22226EA970D"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <domeo:uuid>E606D7B6-14FA-4E2D-BCC8-D22226EA970D</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:034EA61C-9BDA-4E57-9796-F89476A46606">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/E55CFD5B-9512-4ADF-8EA7-57764E3ECA86"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/FB5D8B58-E9B0-4F9F-B0F6-C2F3C5C50455"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/058E562F-0D13-44AF-BADD-367FA54B0E7B">
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>propranolol</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/8787</dailymed:activeMoietyRxCUI>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:FF6F3F97-EB6E-4A65-BFA0-F2ADD403812F">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>, </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:FF6F3F97-EB6E-4A65-BFA0-F2ADD403812F"/>
    <ao:exact>phenytoin</ao:exact>
    <pav:createdOn>2014-07-07 19:49:15 -0400</pav:createdOn>
    <ao:suffix>, rifampin, and phenobarbital) with risperidone may cause a decrease in the combined plasma concentrations of risperidone and 9-hydroxyrisperidone [see 7 DRUG INTERACTIONS]. It would also be possible for risperidone to interfere with metabolism of other </ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <domeo:uuid>FF6F3F97-EB6E-4A65-BFA0-F2ADD403812F</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:539A2287-0EAA-4035-9DF6-020FD4CB0F55">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/DC5D26F9-8AA7-4A81-9E15-A57BFEABEBA9"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/591B3511-CF63-4182-98CA-4CCD27664BDA"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D7507B01-F0B9-43AE-9F16-A33790165DAB">
    <pav:lineageUri>urn:domeoserver:annotation:C383B103-3D74-4501-BB13-DD8CB5240CC0</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:lastSavedOn>2014-07-08 14:26:16 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:61840257-052E-47A8-838A-0584C7CBEDAB"/>
    <pav:createdOn>2014-07-08 14:25:15 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:42258B16-6749-4B39-B28D-88C8B63F7A43</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/546815C0-01DB-45B5-B13E-96321735ABBF">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>risperidone</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/35636</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:BF5B9586-8B87-4545-B4AB-36CD8A6842A6">
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:F8B6985A-9E31-47A9-A3BD-27C4204B5532</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:body rdf:nodeID="Nf670f69d68634395b9127b879f41bcb2"/>
    <pav:lineageUri>urn:domeoserver:annotation:B55CE710-6309-444C-A47B-0B3E1B52F5C4</pav:lineageUri>
    <pav:createdOn>2014-07-08 15:27:47 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-08 15:27:47 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:33BE73AD-3707-4143-B6D0-BA5C84ABC402"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/0A2105BA-161C-46C3-8F75-2B8D19459A6D">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>phenytoin</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/8183</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/CE418736-DE0D-4D38-A56E-BBFA9F574C20">
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>itraconazole</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/28031</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:664A8EC3-6EA0-47D2-B994-117AE852D15B">
    <domeo:uuid>664A8EC3-6EA0-47D2-B994-117AE852D15B</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>Hepatic Impairment: While the pharmacokinetics of </ao:prefix>
    <pav:createdOn>2014-07-07 19:58:26 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:664A8EC3-6EA0-47D2-B994-117AE852D15B"/>
    <ao:suffix>in subjects with liver disease were comparable to those in young healthy subjects, the mean free fraction of risperidone in plasma was increased by about 35% because of the diminished concentration of both albumin and α1-acid glycoprotein. Risperidone do</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>risperidone </ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:51C71B58-C391-4F1C-932F-ABA9EBDD073F">
    <pav:lineageUri>urn:domeoserver:annotation:BB8398BC-258E-4CDA-8E43-F7BBDF3290FE</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdOn>2014-07-08 09:18:58 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoclient:uuid:6FFD9FFA-5CED-4EE2-B68F-77212B4C447D</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-08 09:20:18 -0400</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:C88C2278-7541-4D02-8B06-2BA03A19B570"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:A0C6E460-DD04-4F20-80C1-0A461A44A2B0">
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:A7CFF507-F3EB-4AF0-84F3-89A814F6D884"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D36055F2-4A13-4201-86B3-31BB43715538">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-119.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:D36055F2-4A13-4201-86B3-31BB43715538"/>
    <pav:createdOn>2014-07-07 20:46:11 -0400</pav:createdOn>
    <ao:suffix>. Study JRV 304 enrolled 450 patients (n = 229 Synercid; n= 221 Comparator) and Study JRV 305 enrolled 443 patients (n = 221 Synercid; n = 222 Comparator). </ao:suffix>
    <domeo:uuid>D36055F2-4A13-4201-86B3-31BB43715538</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>or </ao:prefix>
    <ao:exact>carbapenems</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/1DBFD671-A5D4-40AA-9487-73BC18A11692">
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/8787</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>propranolol</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dct:description>Referred to the drug in the interaction.</dct:description>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:18C81208-4F0B-4465-A81D-C8ABBAE695A3">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-198.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:18C81208-4F0B-4465-A81D-C8ABBAE695A3"/>
    <pav:createdOn>2014-07-08 15:29:46 -0400</pav:createdOn>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:exact>Experimental evidence demonstrated that methadone decreased the AUC and peak levels for didanosine and stavudine, with a more significant decrease for didanosine. Methadone disposition was not substantially altered.</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>xsd:String</ao:prefix>
    <domeo:uuid>18C81208-4F0B-4465-A81D-C8ABBAE695A3</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:CF406020-588D-4EBE-B4C3-7CE73DC72A94">
    <ao:suffix>. In two separate studies in healthy adult subjects, fexofenadine hydrochloride 120 mg twice daily (240 mg total daily dose) was coadministered with either erythromycin 500 mg every 8 hours or ketoconazole 400 mg once daily under steady-state conditions </ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:CF406020-588D-4EBE-B4C3-7CE73DC72A94"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-139.txt.html</ao:hasSource>
    <domeo:uuid>CF406020-588D-4EBE-B4C3-7CE73DC72A94</domeo:uuid>
    <ao:exact>ketoconazole</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>or </ao:prefix>
    <pav:createdOn>2014-07-08 09:32:05 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:60F6E6D9-123E-48EC-9080-2A64EE9B0316">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-21 10:00:38 -0400</pav:createdOn>
    <ao:prefix> and </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:60F6E6D9-123E-48EC-9080-2A64EE9B0316"/>
    <ao:suffix>.</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-6.txt.html</ao:hasSource>
    <domeo:uuid>60F6E6D9-123E-48EC-9080-2A64EE9B0316</domeo:uuid>
    <ao:exact>ODV</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/B0DA37E2-3D95-4E9E-BA4E-7061067AC507">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/8754</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>propafenone</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:1EC9DEFA-A53D-41B6-AFEB-8FF1AF1315F9">
    <ao:exact>ne</ao:exact>
    <ao:suffix> combined, after single and multiple doses, were similar in extensive and poor metabolizers, with an overall mean elimination half-life of about 20 hours</ao:suffix>
    <domeo:uuid>1EC9DEFA-A53D-41B6-AFEB-8FF1AF1315F9</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-07 19:58:12 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:1EC9DEFA-A53D-41B6-AFEB-8FF1AF1315F9"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix> 9-hydroxyrisperido</ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:76B7E831-7285-452A-B2B3-79467B745E86">
    <pav:createdOn>2014-07-07 09:36:27 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>REVATIO </ao:exact>
    <ao:suffix>on Vision</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:76B7E831-7285-452A-B2B3-79467B745E86"/>
    <domeo:uuid>76B7E831-7285-452A-B2B3-79467B745E86</domeo:uuid>
    <ao:prefix>Effects of </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Na64f360dc46e4c31b282926e36c72195">
    <domeo:sets rdf:resource="urn:pddi:uuid:2C3E8695-7874-4E52-8D3F-836455A22787"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F6088F1B-4F14-4BBC-AC65-20541EBE4ACE">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:F6088F1B-4F14-4BBC-AC65-20541EBE4ACE"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact> sildenafil exposure</ao:exact>
    <domeo:uuid>F6088F1B-4F14-4BBC-AC65-20541EBE4ACE</domeo:uuid>
    <pav:createdOn>2014-07-07 09:44:02 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>was 28%, resulting in about 22% lower mean average steady state concentrations. Therefore, the slight decrease of</ao:prefix>
    <ao:suffix> in the presence of epoprostenol is not considered clinically relevant. The effect of sildenafil on </ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A8568E50-8A2B-4FA8-8EDF-E66544486BE7">
    <ao:exact>Rosiglitazone </ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:A8568E50-8A2B-4FA8-8EDF-E66544486BE7"/>
    <pav:createdOn>2014-07-08 08:38:26 -0400</pav:createdOn>
    <ao:suffix>is a highly selective and potent agonist for the peroxisome proliferator-activated receptor-gamma (PPARγ). In humans, PPAR receptors are found in key target tissues for insulin action such as adipose tissue, skeletal muscle, and liver. Activation of PPAR</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <domeo:uuid>A8568E50-8A2B-4FA8-8EDF-E66544486BE7</domeo:uuid>
    <ao:prefix>, a member of the thiazolidinedione class of antidiabetic agents, improves glycemic control by improving insulin sensitivity. </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Naee197a63b1b4151877ffb88086ca19e">
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
    <permissions:isLocked>false</permissions:isLocked>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C88C2278-7541-4D02-8B06-2BA03A19B570">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-132.txt.html</ao:hasSource>
    <ao:prefix>or </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:C88C2278-7541-4D02-8B06-2BA03A19B570"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>, decreased 18% to 23% the AUC of both, but did not alter their pharmacodynamics. Propranolol did not have an effect on the pharmacokinetics of fluvastatin.</ao:suffix>
    <domeo:uuid>C88C2278-7541-4D02-8B06-2BA03A19B570</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>pravastatin</ao:exact>
    <pav:createdOn>2014-07-08 09:18:58 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:8d6e0f83-0b0d-48af-bcc5-2b7d241d6ad1">
    <ao:prefix>it the hepatic metabolism of </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-88.txt.html</ao:hasSource>
    <domeo:uuid></domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:8d6e0f83-0b0d-48af-bcc5-2b7d241d6ad1"/>
    <ao:exact>phenytoin</ao:exact>
    <ao:suffix>. SEPTRA, given at a common cl</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-07 08:07:06 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/213EABC8-6CEA-4750-9D74-37FF92DB0C44">
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/9068</dailymed:activeMoietyRxCUI>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>quinidine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N4297ae45353f4051a15762a953c5670f">
    <permissions:isLocked>false</permissions:isLocked>
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N5ffd5c60eede4161863c9b4f1987a13a">
    <domeo:sets rdf:resource="urn:pddi:uuid:07E3EE16-E126-4A79-BA88-FC9476641A66"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F2AC25E9-648C-455E-B53B-3BEC0E388961">
    <domeo:belongsToSet>urn:domeoclient:uuid:F2EFEF06-B779-484C-B854-043086EB0C5C</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotation:6674562B-30F0-42BC-97E9-77860A42A111</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:5A0AED5D-2E08-4D62-B0A9-40B016E82D27"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:createdOn>2014-07-07 20:39:58 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-07-07 20:44:32 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:4C9C4BAA-DD71-4F08-86F7-7FE9A2EF8CF0">
    <ao:context rdf:resource="urn:domeoclient:uuid:977F575F-4B3E-4EAC-BFEA-5E0193ADAED2"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2014-07-07 20:12:43 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdOn>2014-07-07 20:10:24 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotation:99E90B5C-628D-4658-990A-48CDF901AC53</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoclient:uuid:21FE87BA-B7AA-4926-95E7-7E20EA2E4643</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/0b953413-5ff5-40c0-8b69-e7687ef3bd6f">
    <pav:lineageUri>urn:domeoserver:annotationset:7bc2bb03-2737-42c9-8874-80f8ab9161ef</pav:lineageUri>
    <pav:createdOn>2014-07-07 08:07:06 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:063A7209-93BB-42E1-A05D-D45CEF402ED2</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:lastSavedOn>2014-07-07 08:07:06 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:d3bcbf90-f98c-4c6e-8d1b-a9affec5cf82"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/533B93F7-F71C-42ED-86A4-1CD4112CACDB">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>quinidine</rdfs:label>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/9068</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:DC912587-7435-4123-A04D-00971BD8B7A9">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-07-07 09:44:18 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotationset:F37BE993-E972-47AE-896D-FF4D33157ECF</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdOn>2014-07-07 09:42:46 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:21797E6A-7A79-4039-B057-F569BB109D0A"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A5E637EF-5CA5-4AAC-BD8B-C136A86E17B7</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7B6CF133-0072-4D53-ADBD-3D64C4899B86">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:7B6CF133-0072-4D53-ADBD-3D64C4899B86"/>
    <pav:createdOn>2014-07-21 10:00:34 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-6.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>ODV</ao:exact>
    <domeo:uuid>7B6CF133-0072-4D53-ADBD-3D64C4899B86</domeo:uuid>
    <ao:suffix>, after administration of </ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix> or its active metabolite, </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:FA10B71B-CEE2-400B-8D1A-0151B5F4CD95">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix>(600 mg twice daily), an inhibitor of CYP2C8, and rosiglitazone (4 mg once daily) for 7 days increased rosiglitazone AUC by 127%, compared to the administration of rosiglitazone (4 mg once daily) alone. Given the potential for dose-related adverse events</ao:suffix>
    <ao:prefix>Concomitant administration of </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:FA10B71B-CEE2-400B-8D1A-0151B5F4CD95"/>
    <ao:exact>gemfibrozil </ao:exact>
    <pav:createdOn>2014-07-08 08:45:51 -0400</pav:createdOn>
    <domeo:uuid>FA10B71B-CEE2-400B-8D1A-0151B5F4CD95</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:982DE6D2-1536-4AF3-8090-72E0C7BD0D53">
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotationset:57174A7C-3100-4C8F-9C4A-2991CEE124D5</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-08 08:40:05 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:23515E27-98AC-4DC9-A4B7-EBFE2991219F</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:4B46BFE1-7618-4E58-B344-CE46CF415C6F"/>
    <pav:lastSavedOn>2014-07-08 08:46:38 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:F5812029-F895-4B75-8E03-F1F15EBFBF14">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/F7427BDA-5185-4463-8457-C5F62A27D2CF"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/E36D20BF-A00A-4402-8BB3-1E415197F08D"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D1E2CD3F-B149-4606-932A-7ABF131FC2DE">
    <ao:prefix> have not been evaluated, but observations in a modest number (N≅70) of poor metabolizers given </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:D1E2CD3F-B149-4606-932A-7ABF131FC2DE"/>
    <domeo:uuid>D1E2CD3F-B149-4606-932A-7ABF131FC2DE</domeo:uuid>
    <pav:createdOn>2014-07-07 19:49:10 -0400</pav:createdOn>
    <ao:suffix>do not suggest important differences between poor and extensive metabolizers. Second, co-administration of known enzyme inducers (e.g., carbamazepine, phenytoin, rifampin, and phenobarbital) with risperidone may cause a decrease in the combined plasma co</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>risperidone </ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:2F6D2C5C-D30B-4B33-978E-38E53C1A1168">
    <ao:prefix> which is formed by CYP2D6 and </ao:prefix>
    <ao:suffix> (norpropafenone) which is formed by both CYP3A4 and CYP1A2. In less than 10% of patients, metabolism of </ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-08 13:54:14 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-195.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>2F6D2C5C-D30B-4B33-978E-38E53C1A1168</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:2F6D2C5C-D30B-4B33-978E-38E53C1A1168"/>
    <ao:exact>N-depropylpropafenone</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:AE273420-DDF8-4C9E-B8ED-6379C6714633">
    <pav:lastSavedOn>2014-07-07 20:04:45 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotation:D734EE1D-150E-45C6-B009-7C26BD042C40</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdOn>2014-07-07 20:00:38 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:DFFE09AB-3270-45A4-925E-D7EC0F15E1D5"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:921213C5-987C-46D2-9095-A8DDC2B714AB</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C52EEE5D-519C-4CE5-BD28-6C0C2DFCF52A">
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:lastSavedOn>2014-07-08 09:27:36 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoclient:uuid:7E425E73-12D2-4B08-9D70-75410DE87447</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:82C30C3D-B4DB-4D33-98E2-40A5A667E03F"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-08 09:25:24 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotation:D55B98C5-3743-4710-8226-4A5AABE1FB12</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:DA4E7EF4-590C-4EAD-9A7F-FF98FC7AD5ED">
    <ao:suffix>dose for at least 6 weeks. There was a significant increase in cyclosporine AUC, Cmax, Cmin (24-hour concentration), and a significant reduction in apparent oral clearance following the administration of fluconazole. The mean ± SD increase in AUC was 92%</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>DA4E7EF4-590C-4EAD-9A7F-FF98FC7AD5ED</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:DA4E7EF4-590C-4EAD-9A7F-FF98FC7AD5ED"/>
    <ao:exact>cyclosporine </ao:exact>
    <ao:prefix>therapy for at least 6 months and on a stable </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-26.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-07 20:15:03 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:CE0DB488-E5B8-43F0-ADE4-EB39B88A60FA">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-08 12:21:50 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:84BC69AA-E94C-4A46-B55A-44D7D84F953C"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:7821C64B-A0CD-480C-9DC8-F790FC33069A</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2014-07-08 12:21:37 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotation:DEE80B53-9F40-42B8-80ED-077D6AA8B011</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:3C176CE0-79F8-4208-98CF-913AC15E6C5D">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/57C3952B-3E4F-45C6-A803-6EF548827610"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/537C490B-617D-4E96-BFCD-14F22A73ED08"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:04CD5AFF-A9E0-42FF-B3F8-82385101DD14">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5B2167F6-4E63-4A7B-85C1-ACA56DDE7073</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:body rdf:nodeID="N216a3fb3c7564de4b4cbfa5003028267"/>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:lastSavedOn>2014-07-08 15:56:00 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-08 15:49:40 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:936C739F-ED1E-458D-BFDD-37FDEC3CCED2"/>
    <pav:lineageUri>urn:domeoserver:annotation:89AE5031-FEB4-4ECF-9AF7-26F7825FB605</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:3F40DD6E-04E6-4CE5-AE6D-15E564491E4F">
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:3C57C6E7-9704-4071-B9FC-7900D9A7C2F2"/>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/BCF2904D-F2EE-4E1A-93C8-2A8DB8975E85">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>quinidine</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/9068</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:0963BBC0-6F08-48D9-9F8F-441EE46FB229">
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:lastSavedOn>2014-07-07 20:27:05 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotation:8F997A6D-5030-40B9-8FC5-867A416ED363</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoclient:uuid:E500AE5C-576C-4FEA-A581-9991EA21002F</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:E18DA2C3-E819-4D64-9CE5-59644A017B3F"/>
    <pav:createdOn>2014-07-07 20:26:54 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:A08A88A9-81EE-48F0-8E02-4BBE38B2E99A">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/31E47F1F-5904-4B00-9DA4-4330017DDA59"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/5EDD6A69-3882-4211-8040-2744F687D40F"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:2848E1E3-47B6-4C73-8AA5-0AC3E1913232">
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:DBCA122B-BC4C-436B-B180-3AB768003708"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:30838343-4298-4505-9B6F-82717973AFDF">
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:7094BA23-6692-4F7B-93E9-551DC9D56FA3"/>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:D33F324B-7D3C-451C-A261-4745E71B2BB2">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/50A6DB6C-33B0-4D08-B4E1-2895C9381964"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/BD9CA01A-55E5-4356-AD8A-5527CC3559FF"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/57613F17-B9E0-4DDD-A332-6D5DE9EEA74F">
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/9143</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>ranitidine</rdfs:label>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:0D5DA780-13BE-454F-8F2A-50EEBFA54789">
    <domeo:belongsToSet>urn:domeoclient:uuid:423352B3-8ABA-48B7-98CF-B191A7BFC955</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:C71EBA4C-AB92-4094-AB7C-2AE0FD34CF7A"/>
    <pav:lineageUri>urn:domeoserver:annotation:61D6BB3E-9493-4D52-BCD9-1F93D6489803</pav:lineageUri>
    <pav:lastSavedOn>2014-07-08 09:35:29 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2014-07-08 09:32:13 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:425F3947-F42E-4A5B-87EC-655A7930AEC9">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/31425B5E-0A6D-44B4-9AA4-883674DD71EB"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/16D6DA8B-381F-4C63-B0B8-BAEFC5009B4B"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:DC5F64F1-A5A8-49DE-B3E5-A21D3CDA467A">
    <ao:prefix>xsd:String</ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-165.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:DC5F64F1-A5A8-49DE-B3E5-A21D3CDA467A"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-08 12:21:14 -0400</pav:createdOn>
    <ao:suffix>is contraindicated in patients who are receiving monoamine oxidase (MAO) inhibitors or those who have recently received such agents. Therapeutic doses of meperidine have occasionally precipitated unpredictable, severe, and occasionally fatal reactions in</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>Meperidine </ao:exact>
    <domeo:uuid>DC5F64F1-A5A8-49DE-B3E5-A21D3CDA467A</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:853DC411-0B9B-49E4-8EDB-8B5761358DE8">
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:D33F324B-7D3C-451C-A261-4745E71B2BB2"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/6B307E5B-3667-4F5E-A3B3-944545D190BF">
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>ketoconazole</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/6135</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Na8528f1314f5446082f1d2f49910d3e6">
    <permissions:isLocked>false</permissions:isLocked>
    <permissions:accessType>urn:person:uuid:080e143046812afe0146812e52b20002</permissions:accessType>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:1ADEF082-C8D1-4819-BAF7-F900CA73882C">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/9D29611B-85E1-4F7D-A43F-CBF76D27A884"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/85DB35C4-60E1-4AC9-BC21-3BB30DE241E4"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:95A575B7-D25D-4077-8C94-5A2FF84DB82C">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-08 08:52:43 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <ao:exact>Coadministration of acarbose (100 mg three times daily) for 7 days in healthy volunteers had no clinically relevant effect on the pharmacokinetics of a single oral dose of AVANDIA</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:95A575B7-D25D-4077-8C94-5A2FF84DB82C"/>
    <ao:suffix>xsd:String</ao:suffix>
    <domeo:uuid>95A575B7-D25D-4077-8C94-5A2FF84DB82C</domeo:uuid>
    <ao:prefix>xsd:String</ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:4C95EFBB-D305-46B6-B43B-65EBD8A79E89">
    <pav:createdOn>2014-07-08 13:55:08 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-195.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:4C95EFBB-D305-46B6-B43B-65EBD8A79E89"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>4C95EFBB-D305-46B6-B43B-65EBD8A79E89</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix> metabolite is usually present in concentrations less than 10% of </ao:suffix>
    <ao:prefix>. The </ao:prefix>
    <ao:exact>norpropafenone</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:F7E90859-FC99-4915-A03B-569143B3043B">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/3CC40A8E-3D6F-4DA1-B812-DEFC672BD00E"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/53D6639B-4B87-48ED-8EAE-141236471F28"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:F3A34621-4324-4719-8256-47B8ABF30D7D">
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:46F66B6A-550C-4B02-A9FC-43E0C6C80309"/>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:35CB69EC-6BE2-45B8-88CA-A6C6CB1E94E7">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/23846A83-E4E2-463A-A164-7C8E7A504557"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/E9386BA8-0C34-4C3D-A902-605E9575CD22"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/8ef630a1-4580-4c84-b0a2-dd063e91b594">
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-07-07 08:06:34 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:62b33602-2d04-4259-80a8-85ea50c8d83e"/>
    <pav:lineageUri>urn:domeoserver:annotationset:ec7c35b0-89da-4e71-92ef-3c6ed6456c23</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdOn>2014-07-07 08:06:34 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:31BF5260-976E-4243-A257-4879A500F1C6</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:4CC2ED68-5F57-44BC-8831-AC44D49F2EDA">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/150DE25D-3B69-4F2F-A3A7-E11046556BF9"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/3B256923-9EB0-4646-A9CF-69CC04808464"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/A0A76A9B-9342-4FF7-9356-72AEACE106D4">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/drug-product"/>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>septra</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/202807</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:8A8C178E-AD9A-4972-8142-599E34A9DF0E">
    <ao:exact>risperidone</ao:exact>
    <pav:createdOn>2014-07-07 19:42:28 -0400</pav:createdOn>
    <ao:prefix>The mechanism of action of </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:8A8C178E-AD9A-4972-8142-599E34A9DF0E"/>
    <ao:suffix>, as with other drugs used to treat schizophrenia, is unknown. However, it has been proposed that the drug’s therapeutic activity in schizophrenia is mediated through a combination of dopamine Type 2 (D2) and serotonin Type 2 (5HT2) receptor antagonism.</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>8A8C178E-AD9A-4972-8142-599E34A9DF0E</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:0151A8DE-1840-4184-A1AD-7C1D14FC1ADF">
    <pav:createdOn>2014-07-07 09:57:49 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A5E637EF-5CA5-4AAC-BD8B-C136A86E17B7</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotationset:F37BE993-E972-47AE-896D-FF4D33157ECF</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <pav:previousVersion>urn:domeoclient:uuid:53FAA6D0-9A40-44F9-8FE0-3166137CEF10</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-07 10:03:14 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:359FE0D1-F23A-437F-9FB6-775E88D87C91"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:3A5A80F9-DC68-4C7C-A655-65EE08B07140">
    <ao:prefix>50 mg once daily for 10 days in 10 healthy women. There was no significant difference in </ao:prefix>
    <pav:createdOn>2014-07-07 20:05:55 -0400</pav:createdOn>
    <ao:exact>ethinyl estradiol</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix> or levonorgestrel AUC after the administration of 50 mg of fluconazole. The mean increase in ethinyl estradiol AUC was 6% (range: -47 to 108%) and levonorgestrel AUC increased 17% (range: -33 to 141%).</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:3A5A80F9-DC68-4C7C-A655-65EE08B07140"/>
    <domeo:uuid>3A5A80F9-DC68-4C7C-A655-65EE08B07140</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-22.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B03D187E-821B-460F-B68E-A349CCC50FE7">
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:AF2D7E22-ECE6-4B27-AB7C-5654B17AD443"/>
    <pav:createdOn>2014-07-07 09:36:55 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotationset:F37BE993-E972-47AE-896D-FF4D33157ECF</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A5E637EF-5CA5-4AAC-BD8B-C136A86E17B7</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2014-07-07 09:44:18 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A4A391DA-E5AB-48C9-9A15-DD1F4CCBB417">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>xsd:String</ao:prefix>
    <pav:createdOn>2014-07-07 20:29:43 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-54.txt.html</ao:hasSource>
    <domeo:uuid>A4A391DA-E5AB-48C9-9A15-DD1F4CCBB417</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:A4A391DA-E5AB-48C9-9A15-DD1F4CCBB417"/>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:exact>Diltiazem significantly decreases the clearance and increases the t1/2 of quinidine, but quinidine does not alter the kinetics of diltiazem.</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:AE61EF6D-C59F-430B-8D31-9555FF011B63">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:AE61EF6D-C59F-430B-8D31-9555FF011B63"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>AE61EF6D-C59F-430B-8D31-9555FF011B63</domeo:uuid>
    <ao:exact> ODV</ao:exact>
    <ao:suffix>). </ao:suffix>
    <pav:createdOn>2014-07-21 10:00:02 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-6.txt.html</ao:hasSource>
    <ao:prefix> and 3 hours for</ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:f714af22-9495-418f-aca9-54a2066b10f0">
    <pav:createdOn>2014-07-07 08:06:48 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:f714af22-9495-418f-aca9-54a2066b10f0"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>fluconazole</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-30.txt.html</ao:hasSource>
    <ao:prefix>lowing the administration of </ao:prefix>
    <domeo:uuid></domeo:uuid>
    <ao:suffix> in 13 normal male volunteers.</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/72FC672E-E807-4C48-A10D-F40CD0181765">
    <rdfs:label>fluvoxamine</rdfs:label>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/42355</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dct:description>Referred to the drug in the interaction.</dct:description>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/3AAA5683-00B9-4493-AF86-26FF9DEFA0BF">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/6135</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>ketoconazole</rdfs:label>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:D62B514A-BF31-403E-B6EB-BB4003236AA5">
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:D6771709-0553-4727-90E6-A4C95E584D01"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:12534F44-8FD4-4F21-9E61-2A4EA1AF6718">
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:0DFFB663-C168-46F5-B757-996F83D2D6EB"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <domeo:belongsToSet>urn:domeoclient:uuid:4E43D844-2E5A-46D2-8797-09878034F22F</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:body rdf:nodeID="Na64f360dc46e4c31b282926e36c72195"/>
    <pav:createdOn>2014-07-08 09:08:32 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotation:9347751A-6D49-46C5-A094-4784E1B71310</pav:lineageUri>
    <pav:lastSavedOn>2014-07-08 09:08:48 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/4719F3B4-9AC7-46DA-99CD-B3B7A79B1942">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/85762</dailymed:activeMoietyRxCUI>
    <rdfs:label>ritonavir</rdfs:label>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/4E2F7D81-8F11-4303-8EA8-E69554DD9059">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/9384</dailymed:activeMoietyRxCUI>
    <rdfs:label>rifampin</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N39e55a9b308f4deda0397c1d3244bce0">
    <permissions:isLocked>false</permissions:isLocked>
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/48B02570-2E21-4F96-8E16-C280E379D64C">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/7417</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>nifedipine</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:4E2557F1-AB97-476F-A2D3-386033B0FBDD">
    <pav:lineageUri>urn:domeoserver:annotationset:cf593dca-fe93-451b-8f37-2a96e065da13</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:7D8FE54F-1E53-443D-916E-FD703C9204A6"/>
    <pav:previousVersion>urn:domeoclient:uuid:21a2d27a-13b1-4797-ba7a-c0517e32bb06</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:32944008-A6C6-4D66-8C43-EE4CF2256965</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-21 09:58:53 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-07-21 10:02:11 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">3</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:8DD7480D-E4F1-4530-9B61-A05EAB8A0A7B">
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A5E637EF-5CA5-4AAC-BD8B-C136A86E17B7</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2014-07-07 09:44:18 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:EBCEFF15-A1C3-44C0-84A0-D1F85342D030"/>
    <pav:createdOn>2014-07-07 09:38:01 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotationset:F37BE993-E972-47AE-896D-FF4D33157ECF</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:CCBEC9F5-7E23-4A91-AAFB-F31A5F1B3C47">
    <domeo:uuid>CCBEC9F5-7E23-4A91-AAFB-F31A5F1B3C47</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:CCBEC9F5-7E23-4A91-AAFB-F31A5F1B3C47"/>
    <pav:createdOn>2014-07-07 09:40:12 -0400</pav:createdOn>
    <ao:prefix> and a 1000% (11-fold) increase in </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <ao:suffix> plasma AUC. At 24 hours, the plasma levels of sildenafil were still approximately 200 ng/mL, compared to approximately 5 ng/mL when sildenafil was dosed alone. This is consistent with ritonavir's marked effects on a broad range of P450 substrates. Altho</ao:suffix>
    <ao:exact>sildenafil </ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:960DF358-FF78-4C37-91FE-21CF19E22817">
    <pav:lineageUri>urn:domeoserver:annotationset:def720a3-9364-4d0d-a156-423274fb2386</pav:lineageUri>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:body rdf:nodeID="Ne4977c5e45e446f183ccb2af28ca6f58"/>
    <pav:createdOn>2014-07-08 13:58:33 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:D7B3EBC0-5C8D-4ED2-BA17-F32776FBE7E3"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7E49EB7A-DE0E-4720-82D1-8460BA0C770D</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">3</pav:versionNumber>
    <pav:previousVersion>urn:domeoclient:uuid:203110ef-d319-4c8c-8da1-19d68e91f895</pav:previousVersion>
    <pav:lastSavedOn>2014-07-08 13:59:58 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B47A1CB6-870C-4FBF-A075-53C17B33C855">
    <ao:exact>Cimetidine </ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-08 12:10:18 -0400</pav:createdOn>
    <domeo:uuid>B47A1CB6-870C-4FBF-A075-53C17B33C855</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:B47A1CB6-870C-4FBF-A075-53C17B33C855"/>
    <ao:suffix>reduced the clearance and volume of distribution of meperidine and also the formation of the metabolite, normeperidine, in healthy subjects and thus, caution should be used with concomitant administration.</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-164.txt.html</ao:hasSource>
    <ao:prefix>xsd:String</ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7C4BF249-DC7E-484D-B5CB-8DE807B5C07D">
    <pav:lastSavedOn>2014-07-21 10:02:11 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotationset:cf593dca-fe93-451b-8f37-2a96e065da13</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:32944008-A6C6-4D66-8C43-EE4CF2256965</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:9E4A4036-68BA-48EF-91F4-FD104E60538D"/>
    <pav:previousVersion>urn:domeoclient:uuid:21a2d27a-13b1-4797-ba7a-c0517e32bb06</pav:previousVersion>
    <pav:createdOn>2014-07-21 10:01:30 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">3</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/7E67FBD1-1884-411C-8CBD-31822D4DFA45">
    <rdfs:label>carbamazepine</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/2002</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:AD9E0654-93ED-4495-91C0-4216D6585844">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:AD9E0654-93ED-4495-91C0-4216D6585844"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-128.txt.html</ao:hasSource>
    <domeo:uuid>AD9E0654-93ED-4495-91C0-4216D6585844</domeo:uuid>
    <ao:suffix>.</ao:suffix>
    <pav:createdOn>2014-07-08 09:08:03 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>does not alter the pharmacokinetics of </ao:prefix>
    <ao:exact>propranolol</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:5F50411D-9AD4-457D-9768-41551FEF44ED">
    <domeo:uuid>5F50411D-9AD4-457D-9768-41551FEF44ED</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:5F50411D-9AD4-457D-9768-41551FEF44ED"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <ao:suffix>Injection: The pharmacokinetic profile of REVATIO has been characterized following intravenous administration. A 10 mg dose of REVATIO Injection is predicted to provide a pharmacological effect of sildenafil and its N-desmethyl metabolite equivalent to t</ao:suffix>
    <pav:createdOn>2014-07-07 09:37:44 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>REVATIO </ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:FCB599A7-C7CF-4E31-AAD2-7226E2C20D8B">
    <pav:createdOn>2014-07-08 14:08:46 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotation:D61433B6-501A-4D14-BEDA-9ED4B7548738</pav:lineageUri>
    <pav:lastSavedOn>2014-07-08 14:10:48 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:25067F56-C3A3-47C2-8051-3511E78A30F1"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7E49EB7A-DE0E-4720-82D1-8460BA0C770D</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <ao:body rdf:nodeID="Na9692d2d4cba41a3ba7d241b1a01b9ed"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:61840257-052E-47A8-838A-0584C7CBEDAB">
    <pav:createdOn>2014-07-08 14:25:15 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:61840257-052E-47A8-838A-0584C7CBEDAB"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-197.txt.html</ao:hasSource>
    <ao:suffix> (ZDV-TP). The principal mode of action of ZDV-TP is inhibition of reverse transcriptase (RT) via DNA chain termination after incorporation of the nucleotide analogue. ZDV-TP is a weak inhibitor of the cellular DNA polymerases α and γ and has been report</ao:suffix>
    <ao:exact>zidovudine triphosphate</ao:exact>
    <ao:prefix>, </ao:prefix>
    <domeo:uuid>61840257-052E-47A8-838A-0584C7CBEDAB</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N1e76db275f2e49279b7412eadc62e985">
    <domeo:sets rdf:resource="urn:pddi:uuid:26E852FF-9AB5-41CB-82A3-AB96066621EA"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:491244b8-b76d-4c26-aebc-f36ec916a46f">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>glyburide</ao:exact>
    <ao:suffix> (5 mg single dose) were signi</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-31.txt.html</ao:hasSource>
    <ao:prefix>The AUC and Cmax of </ao:prefix>
    <pav:createdOn>2014-07-07 08:06:37 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:491244b8-b76d-4c26-aebc-f36ec916a46f"/>
    <domeo:uuid></domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:3F7AD7B4-6D3B-4D15-A88B-43F72DC9BB6F">
    <domeo:uuid>3F7AD7B4-6D3B-4D15-A88B-43F72DC9BB6F</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:3F7AD7B4-6D3B-4D15-A88B-43F72DC9BB6F"/>
    <pav:createdOn>2014-07-08 12:21:40 -0400</pav:createdOn>
    <ao:prefix>are administered over the course of several hours while the patient's condition and vital signs are under careful observation. (Intravenous </ao:prefix>
    <ao:exact>hydrocortisone </ao:exact>
    <ao:suffix>or prednisolone have been used to treat severe reactions, with the addition of intravenous chlorpromazine in those cases exhibiting hypertension and hyperpyrexia. The usefulness and safety of narcotic antagonists in the treatment of these reactions is un</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-165.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:cd87917e-4b7b-4df1-8946-26a2b89c3123">
    <pav:createdOn>2014-07-07 08:06:29 -0400</pav:createdOn>
    <ao:prefix> its two active metabolites, </ao:prefix>
    <domeo:uuid></domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:cd87917e-4b7b-4df1-8946-26a2b89c3123"/>
    <ao:suffix> and sulforidazine, increased </ao:suffix>
    <ao:exact>mesoridazine</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-38.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:25067F56-C3A3-47C2-8051-3511E78A30F1">
    <pav:createdOn>2014-07-08 14:08:46 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:25067F56-C3A3-47C2-8051-3511E78A30F1"/>
    <domeo:uuid>25067F56-C3A3-47C2-8051-3511E78A30F1</domeo:uuid>
    <ao:suffix> The pharmacokinetics of</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-194.txt.html</ao:hasSource>
    <ao:exact>Concomitant use of propafenone and propranolol in healthy subjects increased propranolol plasma concentrations at steady state by 113%. In 4 patients, administration of metoprolol with propafenone increased the metoprolol plasma concentrations at steady state by 100-400%.</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/C8BE8E8A-7852-4E83-BE10-6699E45131C2">
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>risperidone</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/35636</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:CC7CA38D-AE4E-485A-90AF-2EBDAA671ED6">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:CC7CA38D-AE4E-485A-90AF-2EBDAA671ED6"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>tolbutamide </ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <ao:prefix>No significant interactions were shown with </ao:prefix>
    <pav:createdOn>2014-07-07 11:11:50 -0400</pav:createdOn>
    <ao:suffix>(250 mg) or warfarin (40 mg), both of which are metabolized by CYP2C9.</ao:suffix>
    <domeo:uuid>CC7CA38D-AE4E-485A-90AF-2EBDAA671ED6</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:16DA9B7E-81BE-4385-8EE9-DCF2B93209EF">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-179.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-08 13:49:39 -0400</pav:createdOn>
    <domeo:uuid>16DA9B7E-81BE-4385-8EE9-DCF2B93209EF</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact> isonia-\n\nzid</ao:exact>
    <ao:prefix> levels should be determined prior to concurrent administration with</ao:prefix>
    <ao:suffix>, signs and symptoms of</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:16DA9B7E-81BE-4385-8EE9-DCF2B93209EF"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:6E381413-6B32-4BC6-8100-25D31DDB398F">
    <ao:prefix>r drugs. CYP 2D6 is subject to genetic polymorphism (about 6% to 8% of Caucasians, and a very low percentage of Asians, have little or no activity and are “poor metabolizers”) and to inhibition by a variety of substrates and some non-substrates, notably </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:6E381413-6B32-4BC6-8100-25D31DDB398F"/>
    <pav:createdOn>2014-07-07 19:48:32 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <ao:suffix>. Extensive CYP 2D6 metabolizers convert risperidone rapidly into 9-hydroxyrisperidone, whereas poor CYP 2D6 metabolizers convert it much more slowly. Although extensive metabolizers have lower risperidone and higher 9-hydroxyrisperidone concentrations t</ao:suffix>
    <ao:exact>quinidine</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>6E381413-6B32-4BC6-8100-25D31DDB398F</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Na08af156a1d944e6956d8cbb92973526">
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
    <permissions:isLocked>false</permissions:isLocked>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:936C739F-ED1E-458D-BFDD-37FDEC3CCED2">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>Fluoxetine and Paroxetine: Fluoxetine (20 mg once daily) and paroxetine (20 mg once daily) have been shown to increase the plasma concentration of risperidone 2.5 to 2.8 fold and 3 to 9 fold, respectively. Fluoxetine did not affect the plasma concentration of 9-hydroxyrisperidone. Paroxetine lowered the concentration of 9-hydroxyrisperidone by about 10%. When either concomitant fluoxetine or paroxetine is initiated or discontinued, the physician should re-evaluate the dosing of risperidone. The effects of discontinuation of concomitant fluoxetine or paroxetine therapy on the pharmacokinetics of risperidone and 9-hydroxyrisperidone have not been studied.</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:936C739F-ED1E-458D-BFDD-37FDEC3CCED2"/>
    <ao:prefix>xsd:String</ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>936C739F-ED1E-458D-BFDD-37FDEC3CCED2</domeo:uuid>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-7.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-08 15:49:40 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/BE83D8F0-D6BC-4B2D-B219-233DAB7AAC59">
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/8787</dailymed:activeMoietyRxCUI>
    <rdfs:label>propranolol</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:14f6e0d2-d451-479b-a9c4-2bee3b2c2021">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:14f6e0d2-d451-479b-a9c4-2bee3b2c2021"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-83.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>theophylline</ao:exact>
    <ao:suffix> dose are recommended in patie</ao:suffix>
    <pav:createdOn>2014-07-07 08:06:27 -0400</pav:createdOn>
    <ao:prefix>and appropriate reduction of </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid></domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F940A75F-56E5-47F9-A053-09C49A2E4491">
    <ao:exact> 9-hydroxyrisperidone</ao:exact>
    <ao:prefix>and</ao:prefix>
    <pav:createdOn>2014-07-07 19:48:50 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:F940A75F-56E5-47F9-A053-09C49A2E4491"/>
    <ao:suffix> combined, after single and multiple doses, are similar in extensive and poor metabolizers.</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>F940A75F-56E5-47F9-A053-09C49A2E4491</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:5C206F8A-9D72-4001-935D-5EE38FAACF77">
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:5EA4C0F8-EA6B-4BE6-A3B9-DC86052DB26F"/>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E18DA2C3-E819-4D64-9CE5-59644A017B3F">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:E18DA2C3-E819-4D64-9CE5-59644A017B3F"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-52.txt.html</ao:hasSource>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:exact>Paroxetine </ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-07 20:26:54 -0400</pav:createdOn>
    <ao:suffix>produced no genotoxic effects in a battery of 5 in vitro and 2 in vivo assays that included the following: Bacterial mutation assay, mouse lymphoma mutation assay, unscheduled DNA synthesis assay, and tests for cytogenetic aberrations in vivo in mouse bo</ao:suffix>
    <domeo:uuid>E18DA2C3-E819-4D64-9CE5-59644A017B3F</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D35135EF-F047-4064-990E-F10BA4BF8634">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-197.txt.html</ao:hasSource>
    <domeo:uuid>D35135EF-F047-4064-990E-F10BA4BF8634</domeo:uuid>
    <ao:exact>ZDV-TP</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:D35135EF-F047-4064-990E-F10BA4BF8634"/>
    <ao:prefix> is inhibition of reverse transcriptase (RT) via DNA chain termination after incorporation of the nucleotide analogue. </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-08 14:25:26 -0400</pav:createdOn>
    <ao:suffix> is a weak inhibitor of the cellular DNA polymerases α and γ and has been reported to be incorporated into the DNA of cells in culture.</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:64010148-6206-423A-B586-75B62D61CE15">
    <ao:suffix>to patients with pulmonary arterial hypertension, lesser reductions than above in systolic and diastolic blood pressures were observed (a decrease in both of 2 mmHg).</ao:suffix>
    <ao:exact>sildenafil </ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:64010148-6206-423A-B586-75B62D61CE15"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>After chronic dosing of 80 mg TID </ao:prefix>
    <domeo:uuid>64010148-6206-423A-B586-75B62D61CE15</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-07 09:36:24 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/CDF068B7-D2FE-4238-B7BE-F36222B0C2D5">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>metoprolol</rdfs:label>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/6918</dailymed:activeMoietyRxCUI>
    <dct:description>Referred to the drug in the interaction.</dct:description>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:43057692-88dd-423b-a1d4-0b7bb3aeba77">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:43057692-88dd-423b-a1d4-0b7bb3aeba77"/>
    <ao:exact>Digoxin</ao:exact>
    <domeo:uuid></domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-104.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix> Coadministration of a 0.5 mg</ao:suffix>
    <pav:createdOn>2014-07-07 08:06:39 -0400</pav:createdOn>
    <ao:prefix>and Precautions (5.3)]. 7.2 </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:BFFF1F0E-F6D8-4F2E-A1D1-0D32D6539775">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:BFFF1F0E-F6D8-4F2E-A1D1-0D32D6539775"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>xsd:String</ao:prefix>
    <pav:createdOn>2014-07-21 10:07:27 -0400</pav:createdOn>
    <ao:exact>In a study assessing disposition of sertraline (100 mg) on the second of 8 days of cimetidine administration (800 mg daily), there were significant increases in sertraline mean AUC (50%), C max (24%) and half-life (26%) compared to the placebo group. </ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-11.txt.html</ao:hasSource>
    <domeo:uuid>BFFF1F0E-F6D8-4F2E-A1D1-0D32D6539775</domeo:uuid>
    <ao:suffix>The clinical significance of t</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:4CE342AF-CFF4-436C-8AE9-F334ED3D9C32">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdOn>2014-07-08 12:24:46 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-07-08 12:25:30 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:1AC43FBA-3486-4890-9F9D-B9404887370D"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotation:7CA59721-8D88-4B5B-AEE9-068715957071</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoclient:uuid:D9F8F6A3-1C3D-4E25-9870-A403388D2394</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:3E3130FC-0907-4E19-8842-732E612964EE">
    <pav:createdOn>2014-07-21 10:02:16 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotation:C24178C5-B723-42B7-958E-702C9BF47496</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:32944008-A6C6-4D66-8C43-EE4CF2256965</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:5139B7E4-E320-4D9B-9F60-96E60BBB9B53"/>
    <pav:lastSavedOn>2014-07-21 10:02:25 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/104E3B41-690C-4D81-925B-B26A1F620F05">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/7646</dailymed:activeMoietyRxCUI>
    <rdfs:label>omeprazole</rdfs:label>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/FED356F3-23B5-4F53-9570-A1096F15C824">
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/42355</dailymed:activeMoietyRxCUI>
    <rdfs:label>fluvoxamine</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/D4EA4B34-7DD7-4A86-868F-2C363572C2BE">
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/41127</dailymed:activeMoietyRxCUI>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>fluvastatin</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:AA3A993C-272A-4746-BB5C-A4D6A8B03411">
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-07-08 14:10:48 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotation:02FC0B13-D74B-4EE8-B187-9A7953D7146C</pav:lineageUri>
    <pav:createdOn>2014-07-08 14:03:45 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:B001789D-324B-4820-98D2-8258B4154F10"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7E49EB7A-DE0E-4720-82D1-8460BA0C770D</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N98f654b426294075a96d6db9fb42868b">
    <domeo:sets rdf:resource="urn:pddi:uuid:C0F5E09B-989A-4423-BBF2-BDACC0B7A49E"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:E06449FF-27AB-409D-ACCE-6989F9003648">
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:54F6DEFC-18B2-4047-98BF-0D0048E3E48B"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:19FCD5A4-DAD1-4385-92A4-C97DA109A39A">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-07-08 08:39:31 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:23515E27-98AC-4DC9-A4B7-EBFE2991219F</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotationset:57174A7C-3100-4C8F-9C4A-2991CEE124D5</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:47A49213-4781-4A5D-998D-28DB4593DAE8"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2014-07-08 08:46:38 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:4FA9DC31-8CE9-46AD-8B7E-3F40917F1993">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>Results of a population pharmacokinetic analysis including subjects of Caucasian, black, and other ethnic origins indicate that race has no influence on the pharmacokinetics of </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:4FA9DC31-8CE9-46AD-8B7E-3F40917F1993"/>
    <domeo:uuid>4FA9DC31-8CE9-46AD-8B7E-3F40917F1993</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <ao:suffix>.</ao:suffix>
    <pav:createdOn>2014-07-08 08:43:51 -0400</pav:createdOn>
    <ao:exact>rosiglitazone</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/5144d78f-fe1c-414e-a884-683adc4b9578">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-07-07 08:06:43 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotationset:9009c33d-cb3e-4603-bf7c-6e303bab4e6b</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:65faa5b1-21d0-4ddb-b606-3a4b995a94ef"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:4C025723-BCF8-41B1-92B5-614AF1C7050A</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2014-07-07 08:06:43 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:FA018F15-0A29-41F7-A55E-3881C503B8C3">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/F30BF7BE-D789-4923-B724-563AB39A2B2F"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/C0825640-E0E2-4D2F-B013-A6305C0932F0"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:438F0D23-6DA9-4F72-B481-939F5E080E4D">
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:F5E53238-CF11-42DE-A096-289EB80BA1EA"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/C7A7E069-0951-4C27-ADE5-B290103902BF">
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/2002</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>carbamazepine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:48F1AED5-61EA-4859-A9DA-74D16F93CA0C">
    <domeo:belongsToSet>urn:domeoclient:uuid:25536997-8B2D-4FC8-A79B-A98E343D3101</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotation:8483B8D9-3534-4492-9C36-B9CA7268758F</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:002956E9-3141-4AE1-AF90-7B1829FC8783"/>
    <pav:lastSavedOn>2014-07-07 20:26:26 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-07 20:25:52 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:EBCEFF15-A1C3-44C0-84A0-D1F85342D030">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:EBCEFF15-A1C3-44C0-84A0-D1F85342D030"/>
    <pav:createdOn>2014-07-07 09:38:01 -0400</pav:createdOn>
    <domeo:uuid>EBCEFF15-A1C3-44C0-84A0-D1F85342D030</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>Age, gender, race, and renal and hepatic function were included as factors assessed in the population pharmacokinetic model to evaluate </ao:prefix>
    <ao:exact>sildenafil </ao:exact>
    <ao:suffix>pharmacokinetics in patients with PAH. The dataset available for the population pharmacokinetic evaluation contained a wide range of demographic data and laboratory parameters associated with hepatic and renal function. None of these factors had a signif</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nfb1f791c4e1f4a0b8bbd85454357c951">
    <domeo:sets rdf:resource="urn:pddi:uuid:B347B2AD-0733-4185-B22B-451999C06E33"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoserver:annotationset:D5FE9F58-EB3F-4295-9090-E3B773EBD671">
    <ao:item rdf:resource="urn:domeoclient:uuid:51450C97-6C41-4FBD-8342-15BE45A2DDE8"/>
    <pav:lineageUri>urn:domeoserver:annotationset:89f9f7ee-5cce-4dda-8df8-7ac97b746603</pav:lineageUri>
    <ao:item rdf:resource="file:///home/yin2/python-SPL-connector/650db048-e16a-4f92-83d3-99d83bfd216f"/>
    <rdfs:label>NER Sets</rdfs:label>
    <ao:item rdf:resource="urn:domeoclient:uuid:EF251D91-3A73-43BC-9A2B-D62E5A26B616"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812e52b20002"/>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:63667359-9BDD-4D22-A604-47C4E1FA2996"/>
    <permissions:permissions rdf:nodeID="N7285abf0aa0b4e46bc93d6ef995d27af"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:createdOn>2014-07-07 08:07:06 -0400</pav:createdOn>
    <dct:description>The NER set is created automatically by NER annotation loading program.</dct:description>
    <domeo:deleted>false</domeo:deleted>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-106.txt.html</ao:annotatesResource>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">3</pav:versionNumber>
    <pav:previousVersion>urn:domeoclient:uuid:dc76beb6-7283-4574-a618-d18bd2fdb7bf</pav:previousVersion>
    <pav:lastSavedOn>2014-07-08 16:17:09 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:D2097D36-94DF-4060-86D3-20EBBA772832">
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:312F878C-8DBF-4403-8209-A5AC17F01EB8"/>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/0AF6C0E5-D0AD-4395-9B6E-E2D8EA190503">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>phenobarbital</rdfs:label>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/8134</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:0BC292F8-BB45-4653-AD72-195515EA1BDE">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/4307A329-598A-4D48-AA8E-4B439BB5E1F2"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/BE83D8F0-D6BC-4B2D-B219-233DAB7AAC59"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:85eae2de-4b9b-41a8-844e-715bfa847610">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:85eae2de-4b9b-41a8-844e-715bfa847610"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-179.txt.html</ao:hasSource>
    <ao:suffix> is known to slow the metaboli</ao:suffix>
    <ao:exact>Isoniazid</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>Carbamazepine </ao:prefix>
    <domeo:uuid></domeo:uuid>
    <pav:createdOn>2014-07-07 08:06:34 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:6F8497C4-E271-4453-9F18-EB2A7ED370E8">
    <ao:suffix>plus 9-hydroxyrisperidone are dose proportional over the dosing range of 1 to 16 mg daily (0.5 to 8 mg twice daily). Following oral administration of solution or tablet, mean peak plasma concentrations of risperidone occurred at about 1 hour. Peak concen</ao:suffix>
    <ao:exact>risperidone </ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:6F8497C4-E271-4453-9F18-EB2A7ED370E8"/>
    <pav:createdOn>2014-07-07 19:46:06 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <domeo:uuid>6F8497C4-E271-4453-9F18-EB2A7ED370E8</domeo:uuid>
    <ao:prefix>, and </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/1458E8AA-7250-46B1-BD2D-576F73653E4E">
    <rdfs:label>nifedipine</rdfs:label>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/7417</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7AA77C36-4C02-464C-B6F2-DF542FF996A9">
    <ao:context rdf:resource="urn:domeoclient:uuid:81A3A3E1-22A9-4374-92CF-BCB6D0B5025C"/>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:23515E27-98AC-4DC9-A4B7-EBFE2991219F</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotationset:57174A7C-3100-4C8F-9C4A-2991CEE124D5</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <pav:createdOn>2014-07-08 08:49:05 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:previousVersion>urn:domeoclient:uuid:5BCE2FDB-C586-44CD-88F7-6EE2BDB6B929</pav:previousVersion>
    <pav:lastSavedOn>2014-07-08 08:51:47 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:12A75B96-2A4B-477D-9FA3-394A35EC16A3">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>Coadministration of tacrine with theophylline increased theophylline elimination half-life and average plasma theophylline concentrations by approximately 2-fold. Therefore, monitoring of plasma theophylline concentrations and appropriate reduction of theophylline dose are recommended in patients receiving tacrine and theophylline concurrently.</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-83.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:12A75B96-2A4B-477D-9FA3-394A35EC16A3"/>
    <domeo:uuid>12A75B96-2A4B-477D-9FA3-394A35EC16A3</domeo:uuid>
    <pav:createdOn>2014-07-08 15:03:21 -0400</pav:createdOn>
    <ao:suffix> The effect of</ao:suffix>
    <ao:prefix>xsd:String</ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:5DA41851-B1C4-4333-976C-F8C3B63A82E8">
    <ao:prefix> resulted in higher </ao:prefix>
    <ao:exact>conivaptan</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:5DA41851-B1C4-4333-976C-F8C3B63A82E8"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix> exposure than did oral </ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-105.txt.html</ao:hasSource>
    <domeo:uuid>5DA41851-B1C4-4333-976C-F8C3B63A82E8</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-08 19:40:15 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:3407A3F0-5CF5-40EC-AD36-0C1F5658770B">
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:createdOn>2014-07-07 20:18:05 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-07-07 20:18:07 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:body rdf:nodeID="Ned8f28ce8f4e4f0ab4240c20b5ef649a"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:3857B7A8-EDF2-4956-9CF4-A1B13773E162</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:174A3F67-12FA-4C56-B389-705CE878C8CA</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:49704B7D-496E-47CD-AD8F-92CA4B51CEE3"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:2B74AE9D-C80C-4DC2-A338-FD5823416713">
    <pav:createdOn>2014-07-07 20:34:01 -0400</pav:createdOn>
    <ao:exact>Zonisamide had no appreciable effect on the steady-state plasma concentrations of phenytoin, carbamazepine, or valproate during clinical trials. Zonisamide did not inhibit mixed-function liver oxidase enzymes (cytochrome P450), as measured in human liver microsomal preparations, in vitro. Zonisamide is not expected to interfere with the metabolism of other drugs that are metabolized by cytochrome P450 isozymes.</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-56.txt.html</ao:hasSource>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:2B74AE9D-C80C-4DC2-A338-FD5823416713"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>xsd:String</ao:prefix>
    <domeo:uuid>2B74AE9D-C80C-4DC2-A338-FD5823416713</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:122513B4-2721-41E9-AC85-6EB95C153974">
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:lastSavedOn>2014-07-08 08:51:47 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2014-07-08 08:50:19 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotationset:57174A7C-3100-4C8F-9C4A-2991CEE124D5</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:4C0C8D77-8AC0-4C62-A21D-65190C72A23A"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:23515E27-98AC-4DC9-A4B7-EBFE2991219F</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>urn:domeoclient:uuid:5BCE2FDB-C586-44CD-88F7-6EE2BDB6B929</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:be3a0971-7e05-4fc6-b8bd-a2a56d82b51a">
    <ao:exact>omeprazole</ao:exact>
    <pav:createdOn>2014-07-07 08:06:39 -0400</pav:createdOn>
    <ao:suffix>.</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:be3a0971-7e05-4fc6-b8bd-a2a56d82b51a"/>
    <domeo:uuid></domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>fluvoxamine, fluoxetine, and </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-177.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:24EB8C16-A12C-49AC-B1E7-F9FCBFD265DC">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-07 20:00:39 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:24EB8C16-A12C-49AC-B1E7-F9FCBFD265DC"/>
    <ao:prefix> and </ao:prefix>
    <ao:suffix>. In this placebo-controlled, double-blind, randomized, two-way crossover study carried out over three cycles of oral contraceptive treatment, fluconazole dosing resulted in small increases in the mean AUCs of ethinyl estradiol and norethindrone compared</ao:suffix>
    <ao:exact>norethindrone</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>24EB8C16-A12C-49AC-B1E7-F9FCBFD265DC</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-21.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/9F2C382B-34F4-4C1F-95FD-7D67E69F62DD">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>carbamazepine</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/2002</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D0524BB4-91EE-451E-BCCA-7E02735CA128">
    <domeo:uuid>D0524BB4-91EE-451E-BCCA-7E02735CA128</domeo:uuid>
    <ao:prefix>The mean Cmax and AUC of </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-126.txt.html</ao:hasSource>
    <ao:suffix>are increased by 64% and 79%, respectively, by co-administration of propranolol.</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:D0524BB4-91EE-451E-BCCA-7E02735CA128"/>
    <pav:createdOn>2014-07-08 08:58:10 -0400</pav:createdOn>
    <ao:exact>nifedipine </ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:85BC7B1F-9961-47FC-9A7E-0A309C19F4CA">
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdOn>2014-07-07 20:47:53 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <domeo:belongsToSet>urn:domeoclient:uuid:5741C3AA-07D0-4BB3-9A9F-55B13B957620</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:CEFEAC9B-2F87-4A0C-818F-348955395F23"/>
    <pav:lastSavedOn>2014-07-07 20:48:02 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotation:BC2EB85A-2A48-4375-96CC-AFD3DD03385A</pav:lineageUri>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <ao:body rdf:nodeID="N79a4fb7592f247a0bb623a70501d0d00"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/E4934FAF-B157-4C6B-B6A1-21AE3A7D4360">
    <rdfs:label>aminophylline</rdfs:label>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/689</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/metabolite"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:2735C95B-2AB7-40E5-936D-BF99AE7B09F8">
    <pav:createdOn>2014-07-08 09:22:05 -0400</pav:createdOn>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-133.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:2735C95B-2AB7-40E5-936D-BF99AE7B09F8"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:exact>Co-administration of long-acting propranolol at doses greater than or equal to 160 mg/day resulted in increased thioridazine plasma concentrations ranging from 55% to 369% and increased thioridazine metabolite (mesoridazine) concentrations ranging from 33% to 209%.</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>2735C95B-2AB7-40E5-936D-BF99AE7B09F8</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:75AEB076-CA02-4666-9445-2A03EF492650">
    <pav:lastSavedOn>2014-07-08 12:29:01 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdOn>2014-07-08 12:28:16 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoclient:uuid:6B178133-9B11-445F-A5BB-EF967EA53386</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:A07432B5-9DFD-4087-A2C6-D1D6D66A1E03</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:ACDFA635-44FF-495A-9275-7BD45253B01E"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:998F06C5-9B75-4437-A300-774242E78229">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/EA48A47B-C2BF-4775-966C-E7FD9981D298"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/D6840DC4-C792-42AB-A34D-D3E3FA29F035"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N3d572e04019f442d8697cc830d7fad5a">
    <domeo:sets rdf:resource="urn:pddi:uuid:07942BD0-56D4-4AFD-A94E-19C5FFA2451E"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:6D24ADA6-A839-4786-990A-09504C69DDC8">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/7ACF8347-8F3F-47DE-913B-8929BD2810B0"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/C27FA43E-4E7E-43AF-80A0-13FFCAFABACA"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B6DBFC52-0B8E-43ED-8D86-68D172CF514C">
    <pav:createdOn>2014-07-07 19:42:44 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotationset:1DED06A6-8562-4CCF-A58C-CA25748FBD31</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5ABD9862-F044-4404-AD04-73DA04ADDA8B</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:0E223290-8363-415F-9D4D-EE3BB5F3F7C6"/>
    <pav:lastSavedOn>2014-07-07 19:50:36 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:AFED3911-9323-4C42-AC39-E1CB44107AE7">
    <domeo:uuid>AFED3911-9323-4C42-AC39-E1CB44107AE7</domeo:uuid>
    <ao:suffix>containing antacids. In healthy adult subjects, administration of 120 mg of fexofenadine hydrochloride (2 × 60 mg capsule) within 15 minutes of an aluminum and magnesium containing antacid (Maalox®1) decreased fexofenadine AUC by 41% and Cmax by 43%.</ao:suffix>
    <pav:createdOn>2014-07-08 09:30:36 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>magnesium </ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-139.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:AFED3911-9323-4C42-AC39-E1CB44107AE7"/>
    <ao:prefix>and </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/8B32E833-0D72-42BA-834D-546A60FEFC4D">
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/drug-product"/>
    <rdfs:label>avandia</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/261455</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/31E47F1F-5904-4B00-9DA4-4330017DDA59">
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/8754</dailymed:activeMoietyRxCUI>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>propafenone</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F230EC89-2EB5-41D2-BFB4-DB595A0CAD0C">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-139.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:F230EC89-2EB5-41D2-BFB4-DB595A0CAD0C"/>
    <ao:exact>erythromycin </ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>coadministration enhances fexofenadine gastrointestinal absorption. This observed increase in the bioavailability of fexofenadine may be due to transport-related effects, such as p-glycoprotein. In vivo animal studies also suggest that in addition to enh</ao:suffix>
    <ao:prefix>or </ao:prefix>
    <pav:createdOn>2014-07-08 09:32:28 -0400</pav:createdOn>
    <domeo:uuid>F230EC89-2EB5-41D2-BFB4-DB595A0CAD0C</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:04BC8504-1898-4FC8-9B56-82F1A6E4C52D">
    <domeo:uuid>04BC8504-1898-4FC8-9B56-82F1A6E4C52D</domeo:uuid>
    <ao:prefix>AUC and Cmax slightly increased following coadministration of </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:04BC8504-1898-4FC8-9B56-82F1A6E4C52D"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>AVANDIA</ao:exact>
    <pav:createdOn>2014-07-08 08:48:12 -0400</pav:createdOn>
    <ao:suffix>.</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:DC615822-3032-426F-B92E-5680D53CCDC8">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/B68D0CDC-632E-4907-A731-70041A95EBBA"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/FE843A57-1C85-4A34-9967-7859486CFF70"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:DDA91BB7-5333-423E-AA15-01C0E39F278D">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>AVANDIA </ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:DDA91BB7-5333-423E-AA15-01C0E39F278D"/>
    <ao:suffix>improved glycemic control in both males and females. In metformin combination studies, efficacy was demonstrated with no gender differences in glycemic response.</ao:suffix>
    <pav:createdOn>2014-07-08 08:42:44 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <ao:prefix>As monotherapy and in combination with metformin, </ao:prefix>
    <domeo:uuid>DDA91BB7-5333-423E-AA15-01C0E39F278D</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:0A2563FC-7297-4A00-9A4F-79E2815D869C">
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:40E59130-9EA1-45C0-B6FE-2A93C522117C"/>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:1274CFBF-641E-46E7-9B1E-4CDDA91198ED">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>chlorpromazine </ao:exact>
    <pav:createdOn>2014-07-08 09:22:36 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-134.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:1274CFBF-641E-46E7-9B1E-4CDDA91198ED"/>
    <ao:suffix>with propranolol resulted in a 70% increase in propranolol plasma level.</ao:suffix>
    <domeo:uuid>1274CFBF-641E-46E7-9B1E-4CDDA91198ED</domeo:uuid>
    <ao:prefix>Co-administration of </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:8A953E90-C2D0-4352-ABDF-7BE4E11F229A">
    <pav:createdOn>2014-07-07 20:04:12 -0400</pav:createdOn>
    <ao:suffix>xsd:String</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:8A953E90-C2D0-4352-ABDF-7BE4E11F229A"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-21.txt.html</ao:hasSource>
    <ao:exact>A third study evaluated the potential interaction of once weekly dosing of fluconazole 300 mg to 21 normal females taking an oral contraceptive containing ethinyl estradiol and norethindrone. In this placebo-controlled, double-blind, randomized, two-way crossover study carried out over three cycles of oral contraceptive treatment, fluconazole dosing resulted in small increases in the mean AUCs of ethinyl estradiol and norethindrone compared to similar placebo dosing. The mean AUCs of ethinyl estradiol and norethindrone increased by 24% (95% C.I. range 18 to 31%) and 13% (95% C.I. range 8 to 18%), respectively relative to placebo. Fluconazole treatment did not cause a decrease in the ethinyl estradiol AUC of any individual subject in this study compared to placebo dosing. The individual AUC values of norethindrone decreased very slightly (&lt;5%) in 3 of the 21 subjects after fluconazole treatment.</ao:exact>
    <domeo:uuid>8A953E90-C2D0-4352-ABDF-7BE4E11F229A</domeo:uuid>
    <ao:prefix>xsd:String</ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/C44D64A4-30A2-4E97-807F-C827A96CD0A2">
    <rdfs:label>irbesartan</rdfs:label>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:57D44181-7978-45E4-B041-BB7F7B4A2A95">
    <pav:createdOn>2014-07-07 09:35:53 -0400</pav:createdOn>
    <ao:suffix>up to 100 mg in healthy volunteers produced no clinically relevant effects on ECG. After chronic dosing of 80 mg TID to patients with pulmonary arterial hypertension, no clinically relevant effects on ECG were reported.</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:57D44181-7978-45E4-B041-BB7F7B4A2A95"/>
    <domeo:uuid>57D44181-7978-45E4-B041-BB7F7B4A2A95</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <ao:exact>sildenafil </ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>Single oral doses of </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:84DFA5A2-ACDE-4ECD-8DEB-0CF25A36BACD">
    <domeo:uuid>84DFA5A2-ACDE-4ECD-8DEB-0CF25A36BACD</domeo:uuid>
    <ao:exact>warfarin </ao:exact>
    <ao:suffix>(10 mcg/mL), and carbamazepine (10 mcg/mL) caused only a slight increase in the free fraction of risperidone at 10 ng/mL and 9-hydroxyrisperidone at 50 ng/mL, changes of unknown clinical significance.</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <ao:prefix>(100 mcg/mL), </ao:prefix>
    <pav:createdOn>2014-07-07 19:47:02 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:84DFA5A2-ACDE-4ECD-8DEB-0CF25A36BACD"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/889BAEE2-9096-493C-9B50-EAC043F91362">
    <rdfs:label>vaprisol</rdfs:label>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/drug-product"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N1f1b0d7c80364a3e90f1995f9cb44a87">
    <domeo:sets rdf:resource="urn:pddi:uuid:D65A7DF1-CB44-4281-9DED-B7378D1ACD1B"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:62CA95E4-68D2-44F1-804E-2C9864131893">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/058E562F-0D13-44AF-BADD-367FA54B0E7B"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/257C0398-A47C-408D-AC7D-3E0CC32D933B"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:35854C63-4A4D-4E2A-A517-034C635FEDEA">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/35947A3C-4AA6-4324-963E-A1060E9A91B8"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/E23B4D2D-34FE-4CDD-A2D4-AB290C2DEFCA"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F0E086BE-BE55-423E-8698-BE529EBD322E">
    <pav:createdOn>2014-07-08 12:26:22 -0400</pav:createdOn>
    <ao:suffix>therapy should be closely monitored so that toxic effects are detected promptly. Baseline assessment should include a complete blood count with differential and platelet counts, hepatic enzymes, renal function tests, and a chest X-ray. During therapy of </ao:suffix>
    <ao:exact>methotrexate </ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:F0E086BE-BE55-423E-8698-BE529EBD322E"/>
    <ao:prefix>Patients undergoing </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>F0E086BE-BE55-423E-8698-BE529EBD322E</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-167.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B1A54878-F086-483F-BB56-18237215082B">
    <ao:prefix>xsd:String</ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:B1A54878-F086-483F-BB56-18237215082B"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-139.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>Fexofenadine hydrochloride should not be taken closely in time with aluminum and magnesium containing antacids. In healthy adult subjects, administration of 120 mg of fexofenadine hydrochloride (2 × 60 mg capsule) within 15 minutes of an aluminum and magnesium containing antacid (Maalox®1) decreased fexofenadine AUC by 41% and Cmax by 43%</ao:exact>
    <pav:createdOn>2014-07-08 09:31:42 -0400</pav:createdOn>
    <domeo:uuid>B1A54878-F086-483F-BB56-18237215082B</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:69BAF58F-968A-4C0A-A53D-74650194B697">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotationset:F37BE993-E972-47AE-896D-FF4D33157ECF</pav:lineageUri>
    <pav:lastSavedOn>2014-07-07 09:44:18 -0400</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdOn>2014-07-07 09:42:36 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:09FA0E94-1FC3-4C97-8B13-295C5963F698"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A5E637EF-5CA5-4AAC-BD8B-C136A86E17B7</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/2C20D8EA-4843-42D3-9576-6832132BCB43">
    <rdfs:label>erythromycin</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/4053</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:5A07D976-5651-4E28-A92F-4FCF50FD08E6">
    <pav:createdOn>2014-07-07 09:35:44 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-07-07 09:44:18 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:5C535A92-DF0B-4451-A43C-DC545710848D"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotationset:F37BE993-E972-47AE-896D-FF4D33157ECF</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A5E637EF-5CA5-4AAC-BD8B-C136A86E17B7</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:491654FF-D757-49BB-ADF3-AADC51B4BB4A">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotation:12D96EF2-DE1A-4BE1-BE71-BA582E5A9581</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdOn>2014-07-07 20:32:08 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-07-07 20:34:18 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoclient:uuid:51AE28A6-A4F5-4551-AD8B-8ADDDCA82257</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:40487319-2D7C-4141-BDF6-2DD339521BBE"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/212E804D-EDFC-4F51-AB5F-18AAD19DFC62">
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/6779</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>mesoridazine</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/metabolite"/>
    <dct:description>Referred to the drug in the interaction.</dct:description>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/9799F9EF-3260-40A5-B3D4-0F0DBCE80D07">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/35636</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>risperidone</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/c90d2641-876a-46e3-b02a-68609e62b80f">
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdOn>2014-07-07 08:06:58 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-07 08:06:58 -0400</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotationset:f7a0302d-e389-49f3-ab14-c59c2040b7bc</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:11406278-E817-40C1-94F2-0DAE4C5FB656</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:befcd494-a98b-4f55-ab9f-59ef8bb5e4de"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoserver:annotationset:F77928E0-81FC-4E23-A4AE-843EFB9044A3">
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812e52b20002"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:item rdf:resource="urn:domeoclient:uuid:468ed9c4-680e-43d2-9069-0c9655c0f7e2"/>
    <domeo:deleted>false</domeo:deleted>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-14.txt.html</ao:annotatesResource>
    <pav:lineageUri>urn:domeoclient:uuid:2ef7b34e-4523-4ed1-a472-656fa9732814</pav:lineageUri>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <pav:lastSavedOn>2014-07-21 10:10:56 -0400</pav:lastSavedOn>
    <rdfs:label>NLP Set</rdfs:label>
    <permissions:permissions rdf:nodeID="Ndf247b9d910f492b94b7d476b2e26e30"/>
    <pav:previousVersion>urn:domeoclient:uuid:8b27b6f8-809f-4c0c-8c7f-7bd8393985b9</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <pav:createdOn>2014-07-07 08:02:52 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7D8FE54F-1E53-443D-916E-FD703C9204A6">
    <ao:prefix> (</ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-6.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:7D8FE54F-1E53-443D-916E-FD703C9204A6"/>
    <ao:suffix>) in plasma are attained within 3 days of oral multiple dose therapy. </ao:suffix>
    <pav:createdOn>2014-07-21 09:58:53 -0400</pav:createdOn>
    <domeo:uuid>7D8FE54F-1E53-443D-916E-FD703C9204A6</domeo:uuid>
    <ao:exact>ODV</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D3826C1D-60FD-4571-B1BE-8626E7C83AEA">
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2014-07-08 08:51:47 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotationset:57174A7C-3100-4C8F-9C4A-2991CEE124D5</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-08 08:48:12 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:04BC8504-1898-4FC8-9B56-82F1A6E4C52D"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:23515E27-98AC-4DC9-A4B7-EBFE2991219F</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:previousVersion>urn:domeoclient:uuid:5BCE2FDB-C586-44CD-88F7-6EE2BDB6B929</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7FB803D3-6B1E-475E-9879-D98ABDFF0FC5">
    <pav:createdOn>2014-07-07 20:08:15 -0400</pav:createdOn>
    <ao:suffix>600 mg to 900 mg intravenously over a four-hour period (from one hour before to 3 hours after a single oral dose of fluconazole 200 mg) did not affect the bioavailability or pharmacokinetics of fluconazole in 24 healthy male volunteers.</ao:suffix>
    <domeo:uuid>7FB803D3-6B1E-475E-9879-D98ABDFF0FC5</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:7FB803D3-6B1E-475E-9879-D98ABDFF0FC5"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-23.txt.html</ao:hasSource>
    <ao:exact>cimetidine </ao:exact>
    <ao:prefix>AUC of 13% ± 11% (range: -3.4 to -31%) and Cmax decreased 19% ± 14% (range: -5 to -40%). However, the administration of </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:4A9EEEEB-A8B2-4979-A187-0B3336654D7A">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:4760224B-BA51-444B-B6B5-33CB08955766"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoclient:uuid:921213C5-987C-46D2-9095-A8DDC2B714AB</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2014-07-07 20:04:45 -0400</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdOn>2014-07-07 20:00:43 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotation:DD31D2F6-55CF-4B41-9F95-76EF39194F59</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Na96265415b00433898977a6b3de62259">
    <permissions:accessType>urn:person:uuid:080e143046812afe0146812e52b20002</permissions:accessType>
    <permissions:isLocked>false</permissions:isLocked>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:698327F3-D853-41CB-ADF0-60C4BFEB24F4">
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-130.txt.html</ao:annotatesResource>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:item rdf:resource="urn:domeoclient:uuid:0505C3FD-D949-47BA-8DA3-BF23A9FEA75A"/>
    <domeo:deleted>false</domeo:deleted>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <rdfs:label>Default Set</rdfs:label>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <permissions:permissions rdf:nodeID="N8237b5f1e9e348deba3b6fd4bbec3ed3"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:47DFDC03-2D75-49D7-AD77-3276E1D32EC8"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotationset:D046C0CF-9AD5-4FB1-B5F0-822AEB669E68</pav:lineageUri>
    <pav:lastSavedOn>2014-07-08 09:13:23 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812e52b20002"/>
    <pav:createdOn>2014-07-08 09:12:44 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:569DC956-53BD-4E43-849C-88221ACE29B1"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:C3C39F76-C9B9-48EB-A990-C0E86CC638AB"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F646572E-B969-438E-A7F9-F78708BEB651">
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdOn>2014-07-08 09:30:40 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:A10DDC7F-3198-42E3-82DB-01779514C248"/>
    <pav:lastSavedOn>2014-07-08 09:35:29 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotation:4758FB1F-2117-4A56-8F1F-1300089CC4F6</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <domeo:belongsToSet>urn:domeoclient:uuid:423352B3-8ABA-48B7-98CF-B191A7BFC955</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/85DB35C4-60E1-4AC9-BC21-3BB30DE241E4">
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>ribavirin</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/9344</dailymed:activeMoietyRxCUI>
    <dct:description>Referred to the drug in the interaction.</dct:description>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:4A90EC65-D119-4C69-9F09-14B07DEC6E87">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-08 09:18:57 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:4A90EC65-D119-4C69-9F09-14B07DEC6E87"/>
    <ao:exact>lovastatin </ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-132.txt.html</ao:hasSource>
    <domeo:uuid>4A90EC65-D119-4C69-9F09-14B07DEC6E87</domeo:uuid>
    <ao:suffix>or pravastatin, decreased 18% to 23% the AUC of both, but did not alter their pharmacodynamics. Propranolol did not have an effect on the pharmacokinetics of fluvastatin.</ao:suffix>
    <ao:prefix>with </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:4B9AE825-7422-4188-A7F7-45AEA39061D5">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:4B9AE825-7422-4188-A7F7-45AEA39061D5"/>
    <ao:exact>Oral contraceptives were administered as a single dose both before and after the oral administration of fluconazole 50 mg once daily for 10 days in 10 healthy women. There was no significant difference in ethinyl estradiol or levonorgestrel AUC after the administration of 50 mg of fluconazole. The mean increase in ethinyl estradiol AUC was 6% (range: -47 to 108%) and levonorgestrel AUC increased 17% (range: -33 to 141%).</ao:exact>
    <domeo:uuid>4B9AE825-7422-4188-A7F7-45AEA39061D5</domeo:uuid>
    <pav:createdOn>2014-07-07 20:07:04 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-22.txt.html</ao:hasSource>
    <ao:suffix>xsd:String</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:2684C92B-90DE-4D9B-BA75-B78634E161FD">
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:E916ECEF-4C0F-4B7B-A449-3352F6283E12"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:7F55385D-7971-4B91-8841-7E619722B72E">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/23EE4D9C-404A-4D73-B39A-6237CB849495"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/05F43156-9499-468D-886D-43E1E6B18F9F"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:D1191553-94A9-4539-9050-69E35BDD13E0">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/B1C80378-05AF-4F54-B108-29F0FCF2815B"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/D6690764-EECE-40AB-892E-50BBA7F581D0"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C19232C5-C67F-4BDB-B93E-0D5C690AD368">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-08 09:00:25 -0400</pav:lastSavedOn>
    <ao:body rdf:nodeID="N4b8ae6092e904d52804f772208226631"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:09E5CBBF-225B-47F1-A546-8C855C0B0ACC"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:createdOn>2014-07-08 08:59:29 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotation:9A745045-16A2-4DA6-BEC9-0566A546FA45</pav:lineageUri>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <domeo:belongsToSet>urn:domeoclient:uuid:86E1DCE1-FFC6-4513-AEF9-EF158A019E6B</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:CB472DE5-7133-4590-9307-2238BFC2555D">
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:734E53B9-AB5D-4B89-A9E2-092C2AF4B18D"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:7094BA23-6692-4F7B-93E9-551DC9D56FA3">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/326D235D-181F-4247-8092-418CD17F5B15"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/4E2F7D81-8F11-4303-8EA8-E69554DD9059"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A92286D9-3B1F-4493-AFE3-77FB27A6005F">
    <ao:suffix>blood levels (eg, dehydration), more frequent monitoring may also be indicated.</ao:suffix>
    <ao:exact>methotrexate </ao:exact>
    <pav:createdOn>2014-07-08 12:26:32 -0400</pav:createdOn>
    <domeo:uuid>A92286D9-3B1F-4493-AFE3-77FB27A6005F</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:A92286D9-3B1F-4493-AFE3-77FB27A6005F"/>
    <ao:prefix>commended: hematology at least monthly, renal function and liver function every 1 to 2 months. More frequent monitoring is usually indicated during antineoplastic therapy. During initial or changing doses, or during periods of increased risk of elevated </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-167.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:3A568E85-0F74-41C8-9FBD-C2915444AED0">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>. </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:3A568E85-0F74-41C8-9FBD-C2915444AED0"/>
    <domeo:uuid>3A568E85-0F74-41C8-9FBD-C2915444AED0</domeo:uuid>
    <pav:createdOn>2014-07-08 08:59:08 -0400</pav:createdOn>
    <ao:suffix>does not affect the pharmacokinetics of propranolol.</ao:suffix>
    <ao:exact>Verapamil </ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-127.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:843FC03C-9B2F-41DA-AC2E-992179D1B23C">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>propranolol </ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix>resulted in a 70% increase in propranolol plasma level.</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:843FC03C-9B2F-41DA-AC2E-992179D1B23C"/>
    <domeo:uuid>843FC03C-9B2F-41DA-AC2E-992179D1B23C</domeo:uuid>
    <ao:prefix>with </ao:prefix>
    <pav:createdOn>2014-07-08 09:22:37 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-134.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:AE1B6FFA-E968-4ABC-9E50-DB1A83132DE8">
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:5385CB5D-503D-45A4-8152-D9264772EA7C"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/DB710ECA-3146-4E5C-B892-0DFBAF26E8AE">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>quinidine</rdfs:label>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/9068</dailymed:activeMoietyRxCUI>
    <dct:description>Referred to the drug in the interaction.</dct:description>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:39BBA246-6636-4708-986A-236B349DBC5A">
    <domeo:belongsToSet>urn:domeoclient:uuid:FF4D892F-0BD2-4FD8-9160-6124946DB29D</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:E18A76D4-19FB-496D-8162-8C60CAD2D009"/>
    <pav:lastSavedOn>2014-07-08 09:24:21 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotation:A7B8848D-8D36-4967-996A-97100E364F04</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:createdOn>2014-07-08 09:23:58 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:34DDD2AA-0C18-4F6D-BFC5-FECA040CBB7C">
    <domeo:belongsToSet>urn:domeoclient:uuid:54F09193-5CC7-4ED3-9261-88C7428E0572</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:6B4F3A01-D743-4479-A678-8FB1A8C9FC61</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdOn>2014-07-08 09:14:49 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:75BA01BB-6505-483D-8D05-31105AB1D4BF"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2014-07-08 09:15:28 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:0BE3DE02-72E6-4599-9DF2-42F5F2C5B771">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-07-08 09:22:59 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoclient:uuid:D543C3F1-DA54-4DBF-A2A2-25D79FA02724</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotation:813C1486-2B42-469C-A854-1079CE8D45ED</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:4CDF0976-3AF5-46C7-BEA7-E60977C50827"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:createdOn>2014-07-08 09:22:38 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N7c0e682c0fe541a4a85f6301b6423698">
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
    <permissions:isLocked>false</permissions:isLocked>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nf94d0350f8ba45b6a70b297c83e6598c">
    <domeo:sets rdf:resource="urn:pddi:uuid:CB472DE5-7133-4590-9307-2238BFC2555D"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:67735738-FC3C-42FD-BFD7-D8C8D19F702E">
    <pav:createdOn>2014-07-07 19:49:00 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-07-07 19:50:36 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotationset:1DED06A6-8562-4CCF-A58C-CA25748FBD31</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:4DCD9188-5435-4F57-BE59-468F7DDE8272"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5ABD9862-F044-4404-AD04-73DA04ADDA8B</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:9D3720FD-9395-447F-8A75-437833292F26">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/4719F3B4-9AC7-46DA-99CD-B3B7A79B1942"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/D5CB839E-1DAE-4310-B399-4E9A6E0D57DD"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:921CCEB9-21F5-4162-854B-F60FC028BC15">
    <ao:item rdf:resource="urn:domeoclient:uuid:3EF89173-73C9-47C8-BC8E-167E787388EE"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:472196F7-4FC8-4182-A979-F3EA2A6B03E6"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:1224BD42-425D-416C-86A8-AAEA31EEA238"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotationset:CDCF5602-12FB-4507-8971-A51CB8D6B606</pav:lineageUri>
    <pav:lastSavedOn>2014-07-08 12:02:05 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-08 12:01:52 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <permissions:permissions rdf:nodeID="N5b52c2c68dfc4fada9a6c0bb36e8f666"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:26EF607E-0816-4DEB-BD3B-5D52CE89A4F2"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812e52b20002"/>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-160.txt.html</ao:annotatesResource>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:deleted>false</domeo:deleted>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <rdfs:label>Default Set</rdfs:label>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A7D225EF-5C27-4DC2-8F2F-673A67EBA563">
    <pav:createdOn>2014-07-08 08:42:48 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:A7D225EF-5C27-4DC2-8F2F-673A67EBA563"/>
    <ao:suffix>combination studies, efficacy was demonstrated with no gender differences in glycemic response.</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>A7D225EF-5C27-4DC2-8F2F-673A67EBA563</domeo:uuid>
    <ao:exact>metformin </ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>improved glycemic control in both males and females. In </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:6D30D040-0C0B-4B18-9202-85E9BC0808EB">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/DE8413F2-03D2-4A31-BFA6-A6A9333B0A2D"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/53A0CE99-22B9-49CA-894F-C6CF81B1FE68"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/34ED9A58-0FFA-4618-A4E3-C0DDE772538F">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>fluoxetine</rdfs:label>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/4493</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/E55352EE-F7EE-43F6-BE34-FA39D87863C0">
    <rdfs:label>ritonavir</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/85762</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N9cea969ea75e4d8ea6810dec10deb6d3">
    <domeo:sets rdf:resource="urn:pddi:uuid:BE406CB6-FC66-444E-B750-7B5BCA81DC08"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:388D8AC2-947B-41E8-A79A-82BB3937BC8D">
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:95E29C43-46EF-4653-ADDE-5360EBC04F9E"/>
    <pav:createdOn>2014-07-07 20:47:04 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-07-07 20:48:02 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotation:7C6A3221-B2DE-4871-968C-D6876E546E31</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoclient:uuid:5741C3AA-07D0-4BB3-9A9F-55B13B957620</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/A10D2735-6C1C-471A-BAA3-E82218F7D177">
    <rdfs:label>cimetidine</rdfs:label>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/2541</dailymed:activeMoietyRxCUI>
    <dct:description>Referred to the drug in the interaction.</dct:description>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N5b52c2c68dfc4fada9a6c0bb36e8f666">
    <permissions:isLocked>false</permissions:isLocked>
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:F2754BF3-A5A7-4D97-B57E-DDEC6DECC483">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/8655CFA8-7A82-44B7-B3AA-CD0D5FD18BBA"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/D8A1D49C-D373-412D-91FB-8141DB5F9226"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:8AAF0037-89BE-4D47-8BBF-0D3D1A3A3D91">
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:846C37C4-BB89-4924-862B-839C0CD40333"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:26444E6B-4F7D-4B82-823E-8448D975E2A7">
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:C3CE169C-F943-430B-8542-3ECB65A617D0"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:E92F7BC2-8BCB-4661-A965-804023FE2DB0">
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:1D290924-DB5E-41E2-8AAF-8EE3C253F8DC"/>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:43E8F576-741A-42DD-B286-791DFAFFBBF3">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-07 19:49:14 -0400</pav:createdOn>
    <ao:exact>carbamazepine</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:43E8F576-741A-42DD-B286-791DFAFFBBF3"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>do not suggest important differences between poor and extensive metabolizers. Second, co-administration of known enzyme inducers (e.g., </ao:prefix>
    <ao:suffix>, phenytoin, rifampin, and phenobarbital) with risperidone may cause a decrease in the combined plasma concentrations of risperidone and 9-hydroxyrisperidone [see 7 DRUG INTERACTIONS]. It would also be possible for risperidone to interfere with metabolis</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <domeo:uuid>43E8F576-741A-42DD-B286-791DFAFFBBF3</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:4AE53870-0F9C-4B76-81EF-43A19DE4BE7C">
    <ao:suffix>doses should be reduced in patients with liver disease [see 2 DOSAGE AND ADMINISTRATION and 5 WARNINGS AND PRECAUTIONS].</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>in plasma was increased by about 35% because of the diminished concentration of both albumin and α1-acid glycoprotein. </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:4AE53870-0F9C-4B76-81EF-43A19DE4BE7C"/>
    <pav:createdOn>2014-07-07 19:58:32 -0400</pav:createdOn>
    <domeo:uuid>4AE53870-0F9C-4B76-81EF-43A19DE4BE7C</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>Risperidone </ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:EEA8974C-14B9-4871-9A82-DA731C3D9E38">
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2014-07-08 09:35:29 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-08 09:30:42 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotation:6834A28D-C53F-430C-AF83-2D2908274BC9</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:6834076A-FAEB-482A-9DB7-C25772BDB3DC"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoclient:uuid:423352B3-8ABA-48B7-98CF-B191A7BFC955</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/E3A695D5-C612-44CB-BF54-67E1C8FC49CF">
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>nifedipine</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/7417</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:311056FB-C736-4832-AA31-5105D423B0C2">
    <ao:exact>rosiglitazone </ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:311056FB-C736-4832-AA31-5105D423B0C2"/>
    <pav:createdOn>2014-07-08 08:54:14 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>311056FB-C736-4832-AA31-5105D423B0C2</domeo:uuid>
    <ao:suffix>is not altered in conditions accompanied by increases in gastrointestinal pH.</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <ao:prefix>in healthy volunteers. These results suggest that the absorption of oral </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:60FB0B7C-2294-4527-B2F8-DA2CBC7F5354">
    <ao:suffix>200 mg daily for 14 days in eight renal transplant patients who had been on cyclosporine therapy for at least 6 months and on a stable cyclosporine dose for at least 6 weeks. There was a significant increase in cyclosporine AUC, Cmax, Cmin (24-hour conce</ao:suffix>
    <domeo:uuid>60FB0B7C-2294-4527-B2F8-DA2CBC7F5354</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>fluconazole </ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-26.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-07 20:14:59 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:60FB0B7C-2294-4527-B2F8-DA2CBC7F5354"/>
    <ao:prefix>AUC and Cmax were determined before and after the administration of </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:CA3FC337-1E48-443B-B3B8-481C893B954A">
    <ao:prefix>, </ao:prefix>
    <ao:exact>rifampin</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-07 19:49:16 -0400</pav:createdOn>
    <domeo:uuid>CA3FC337-1E48-443B-B3B8-481C893B954A</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:CA3FC337-1E48-443B-B3B8-481C893B954A"/>
    <ao:suffix>, and phenobarbital) with risperidone may cause a decrease in the combined plasma concentrations of risperidone and 9-hydroxyrisperidone [see 7 DRUG INTERACTIONS]. It would also be possible for risperidone to interfere with metabolism of other drugs meta</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:14FCA0B3-FAC3-4B43-8315-2DC7FE7E5AD6">
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:75B44BA0-D816-46A5-99A6-457021B00223"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/AA9634F6-D250-4C4D-AA41-989959E66D94">
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/16681</dailymed:activeMoietyRxCUI>
    <rdfs:label>acarbose</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/E2BDB371-63C8-454A-AD68-EB53444E8AC6">
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/9069</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>quinidine sulfate</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:FCE1BB80-1EF1-4DF7-92C7-EBCD8FE195D9">
    <pav:createdOn>2014-07-07 19:43:12 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotationset:1DED06A6-8562-4CCF-A58C-CA25748FBD31</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:93699E01-A44B-40BD-A675-E1DF78CB3A81"/>
    <pav:lastSavedOn>2014-07-07 19:50:36 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5ABD9862-F044-4404-AD04-73DA04ADDA8B</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A928CC89-1353-4933-B9B7-D9F19B446555">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotationset:57174A7C-3100-4C8F-9C4A-2991CEE124D5</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:23515E27-98AC-4DC9-A4B7-EBFE2991219F</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:0C86AF8B-7C1E-401A-A291-D7EE4238C804"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:createdOn>2014-07-08 08:45:53 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-07-08 08:46:38 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:9AC3A15C-32E3-4412-9825-AB5FBC4D13EE">
    <domeo:uuid>9AC3A15C-32E3-4412-9825-AB5FBC4D13EE</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:9AC3A15C-32E3-4412-9825-AB5FBC4D13EE"/>
    <ao:prefix>may cause a decrease in the combined plasma concentrations of </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <ao:suffix>and 9-hydroxyrisperidone [see 7 DRUG INTERACTIONS]. It would also be possible for risperidone to interfere with metabolism of other drugs metabolized by CYP 2D6. Relatively weak binding of risperidone to the enzyme suggests this is unlikely [see 7 DRUG I</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-07 19:49:21 -0400</pav:createdOn>
    <ao:exact>risperidone </ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:C0F5E09B-989A-4423-BBF2-BDACC0B7A49E">
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:0A4EAF63-CC18-4B64-866C-110E5C3A514A"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:5C353245-0082-48BE-BC73-23D94862A8F2">
    <ao:prefix>xsd:String</ao:prefix>
    <ao:exact>There is a potentially relevant interaction between diazepam and compounds which inhibit certain hepatic enzymes (particularly cytochrome P450 3A and 2C19). Data indicate that these compounds influence the pharmacokinetics of diazepam and may lead to increased and prolonged sedation. At present, this reaction is known to occur with cimetidine, ketoconazole, fluvoxamine, fluoxetine, and omeprazole.</ao:exact>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-177.txt.html</ao:hasSource>
    <domeo:uuid>5C353245-0082-48BE-BC73-23D94862A8F2</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:5C353245-0082-48BE-BC73-23D94862A8F2"/>
    <pav:createdOn>2014-07-08 15:38:45 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:947CB97B-D444-436B-ADED-04B03318AEFC">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/904DB7CC-73CB-4BBB-8AAD-C8F50A8C78A1"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/624F4EBB-99A6-45BE-AFCE-8DEAA8027CD9"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Na211c39f95804379ab6f944d89a1359e">
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
    <permissions:isLocked>false</permissions:isLocked>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B1A1E1B5-B433-4F1E-9163-D3CA4290CAE8">
    <ao:context rdf:resource="urn:domeoclient:uuid:0BDA3A7E-9BE5-4D2A-A94D-DDFD1CB62EA0"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:C2CFDC7A-D407-48FD-81AA-DFCEA656C0BE</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:51C5097D-5D82-4BC6-88CD-6771EE987B5F</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdOn>2014-07-08 14:39:51 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2014-07-08 14:40:40 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:983B2BBE-243E-4F7D-8D3E-2998CAF31599">
    <ao:prefix> (</ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:983B2BBE-243E-4F7D-8D3E-2998CAF31599"/>
    <pav:createdOn>2014-07-08 14:20:09 -0400</pav:createdOn>
    <ao:suffix>), has been identified in the plasma following single-dose intravenous (IV) administration of </ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>AMT</ao:exact>
    <domeo:uuid>983B2BBE-243E-4F7D-8D3E-2998CAF31599</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-197.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/212DE14C-F6F2-442C-9261-2FCF8A64585C">
    <rdfs:label>thioridazine</rdfs:label>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/10502</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/FB42240B-C361-448A-BEE4-E705D0525538">
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>magnesium trisilicate</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/29170</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:0B3B636D-FBE7-43AC-A231-753D133FC763">
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:63257A98-DB0C-475E-8995-EF0D01E81320"/>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:4C4AF543-4FAA-46CE-AD88-E8E065564D97">
    <ao:suffix> concentrations.</ao:suffix>
    <ao:prefix> (1200 mg) may result in a decrease in </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:4C4AF543-4FAA-46CE-AD88-E8E065564D97"/>
    <domeo:uuid>4C4AF543-4FAA-46CE-AD88-E8E065564D97</domeo:uuid>
    <ao:exact>propranolol </ao:exact>
    <pav:createdOn>2014-07-08 09:10:20 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-129.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N2e9abfea72284e44b683e499606d2826">
    <permissions:isLocked>false</permissions:isLocked>
    <permissions:accessType>urn:person:uuid:080e143046812afe0146812e52b20002</permissions:accessType>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E78B48BE-9D1F-4F71-93E3-934B0E1BA43D">
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:31BF5260-976E-4243-A257-4879A500F1C6</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:body rdf:nodeID="N264d40e444ea4895a3b1fcda0db469b0"/>
    <pav:lastSavedOn>2014-07-08 19:57:02 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-08 19:57:01 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotation:C2A8C3BA-42FF-438C-8CD4-A94E79AE8F07</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:534E4891-ED83-41A7-A95F-9D41BF14A274"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:0F98760D-1183-41B4-9BFC-7410F6D25503">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:C3C90736-8577-44AC-A28B-2C4F3547DF63"/>
    <pav:createdOn>2014-07-08 15:58:02 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:lastSavedOn>2014-07-08 15:58:01 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotation:90EA7748-7C2C-4403-9BBE-663DC5C457BE</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:930FE356-9730-4335-9929-D854A7CE2092</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:body rdf:nodeID="N6159ca4759f0451a80ebecb56ce5e9d5"/>
    <rdfs:label>expertstudy Annotation</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B682A853-E31E-4B00-ADD5-E614528CF156">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdOn>2014-07-07 19:47:01 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:72D22D36-D0B1-4EDA-A452-24416E0EFAF1"/>
    <pav:lineageUri>urn:domeoserver:annotationset:1DED06A6-8562-4CCF-A58C-CA25748FBD31</pav:lineageUri>
    <pav:lastSavedOn>2014-07-07 19:50:36 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5ABD9862-F044-4404-AD04-73DA04ADDA8B</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/D6093AA4-0972-4663-8527-6B9FFED2C4E4">
    <rdfs:label>ranitidine</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/9143</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:8D2BD98C-D72E-4268-8341-658939384183">
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:1AEBA1F8-7388-4240-AD4F-BB2A2C16FADC"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A3AF9C3D-E78E-4973-B274-664C01EDAC39">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotationset:57174A7C-3100-4C8F-9C4A-2991CEE124D5</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2014-07-08 08:42:06 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:01CE3AEB-76EE-4C9B-B5BC-DD09469BE1C6"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:lastSavedOn>2014-07-08 08:46:38 -0400</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:23515E27-98AC-4DC9-A4B7-EBFE2991219F</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:FFD6E9D1-D589-4A5D-B1CC-D746B73EFDA8">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-07-07 20:29:22 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotation:F74AB5DF-2DA9-4CCF-AFB2-0C551D712F74</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoclient:uuid:06661B74-00AE-4DF7-A9CC-742273A11E94</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:72260FA8-0B73-4A65-A3CB-995662149BAB"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2014-07-07 20:30:15 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/ACF97FAB-AB8F-4F1A-ABC3-3AB98B72889E">
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>ritonavir</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/85762</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:3D67FCFB-8ABA-41EB-AA10-7BC258CFCAD5">
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:7E49AB8E-8817-45B4-8E16-558BDA21606A"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:273F6AE3-D2A7-42AC-81E3-9FAFA73F834E">
    <pav:createdOn>2014-07-08 14:50:00 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:suffix>:In</ao:suffix>
    <domeo:uuid>273F6AE3-D2A7-42AC-81E3-9FAFA73F834E</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:273F6AE3-D2A7-42AC-81E3-9FAFA73F834E"/>
    <ao:exact>Dalfopristin</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-114.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:327BB2AE-CC56-4759-9D3F-CDAD46111F6C">
    <ao:context rdf:resource="urn:domeoclient:uuid:15855941-9FDC-41F8-9C9C-27A5F2113767"/>
    <pav:lastSavedOn>2014-07-08 15:56:00 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5B2167F6-4E63-4A7B-85C1-ACA56DDE7073</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-07-08 15:50:07 -0400</pav:createdOn>
    <ao:body rdf:nodeID="Nc49aed790c7643d3889bcbb34b78f1b1"/>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotation:CEC2D54F-AFFD-4E9B-8DE9-9B5992C7DE9E</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/B02CC646-6745-421D-93E2-2AD1BFF8B511">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/10502</dailymed:activeMoietyRxCUI>
    <rdfs:label>thioridazine</rdfs:label>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:5C535A92-DF0B-4451-A43C-DC545710848D">
    <ao:exact>sildenafil</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:5C535A92-DF0B-4451-A43C-DC545710848D"/>
    <pav:createdOn>2014-07-07 09:35:44 -0400</pav:createdOn>
    <ao:suffix>, therefore the effects are not related to dose or plasma levels within this dosage range. Larger effects were recorded among patients receiving concomitant nitrates [see Contraindications (4)].</ao:suffix>
    <ao:prefix>iastolic blood pressure of 8/5 mmHg). The decrease in blood pressure was most notable approximately 1–2 hours after dosing, and was not different from placebo at 8 hours. Similar effects on blood pressure were noted with 25 mg, 50 mg and 100 mg doses of </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>5C535A92-DF0B-4451-A43C-DC545710848D</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:103D889B-187C-4462-956F-FE724BC7FF0B">
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:D510B1DE-D0F4-412E-93BD-FCC4D13BAB1B"/>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:39C356F9-335F-4E0C-A1CD-9C873D70F463">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotation:B9CC40C3-19F3-4B60-9A71-1958323F42C3</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-07-07 20:37:13 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:0AE5EBB3-4BC0-4820-A3BB-8BB34491757D"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoclient:uuid:7E6B38CA-10F3-41E5-9A31-80E5F9447237</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-07 20:37:16 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/F4FB4230-0BD0-43E1-A876-B462C9AD90A5">
    <rdfs:label>cimetidine</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/2541</dailymed:activeMoietyRxCUI>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:50A07CC8-B02F-4746-8B09-F09F638E2254">
    <ao:context rdf:resource="urn:domeoclient:uuid:5181BC1D-3286-4894-A565-A9FFC27DE47D"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A5E637EF-5CA5-4AAC-BD8B-C136A86E17B7</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdOn>2014-07-07 09:34:15 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-07-07 09:44:18 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotationset:F37BE993-E972-47AE-896D-FF4D33157ECF</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:130562BB-40D3-499C-B72D-0AE05B41F0FF">
    <ao:context rdf:resource="urn:domeoclient:uuid:EA91700D-D73A-43DE-A1B4-8B33328FE90E"/>
    <pav:lineageUri>urn:domeoserver:annotationset:1DED06A6-8562-4CCF-A58C-CA25748FBD31</pav:lineageUri>
    <pav:lastSavedOn>2014-07-07 19:50:36 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:createdOn>2014-07-07 19:47:28 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5ABD9862-F044-4404-AD04-73DA04ADDA8B</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:5A6C89B0-919C-4970-B2AE-E66C2282C770">
    <ao:prefix> was about 21 hours (CV=20%) in extensive metabolizers and 30 hours (CV=25%) in poor metabolizers. The pharmacokinetics of </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-07 19:58:07 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:5A6C89B0-919C-4970-B2AE-E66C2282C770"/>
    <ao:suffix>and 9-hydroxyrisperidone combined, after single and multiple doses, were similar in extensive and poor metabolizers, with an overall mean elimination half-life of about 20 hours.</ao:suffix>
    <domeo:uuid>5A6C89B0-919C-4970-B2AE-E66C2282C770</domeo:uuid>
    <ao:exact>risperidone </ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/DC78EBFC-1228-41D5-AFE9-3F54A9457DAB">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>penicillins</rdfs:label>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/0</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:82E011D1-3D6C-4BEA-8CAD-519E0D372E99">
    <domeo:uuid>82E011D1-3D6C-4BEA-8CAD-519E0D372E99</domeo:uuid>
    <ao:suffix> [see 7 DRUG INTERACTIONS]. This occurs with quinidine, giving essentially all recipients a risperidone pharmacokinetic profile typical of poor metabolizers. The therapeutic benefits and adverse effects of risperidone in patients receiving quinidine have</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:82E011D1-3D6C-4BEA-8CAD-519E0D372E99"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>to</ao:prefix>
    <pav:createdOn>2014-07-07 19:48:58 -0400</pav:createdOn>
    <ao:exact> 9-hydroxyrisperidone</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7BC4C9B0-0C06-469D-A30C-A9E128E5C0B3">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:7BC4C9B0-0C06-469D-A30C-A9E128E5C0B3"/>
    <ao:suffix>, itraconazole, and ritonavir).</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <ao:exact>ketoconazole</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-07 09:41:42 -0400</pav:createdOn>
    <domeo:uuid>7BC4C9B0-0C06-469D-A30C-A9E128E5C0B3</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>exposure observed in specifically-designed drug interaction studies with CYP3A inhibitors (except for potent inhibitors such as </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:2E87D888-9C78-4226-B0BD-E5E0E67003BD">
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:4A112A7B-0BD7-4310-8FBA-D12983EDEE55"/>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E27A16CE-6580-45E8-8355-59330E7DE10B">
    <ao:exact>glimepiride </ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:E27A16CE-6580-45E8-8355-59330E7DE10B"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix>in 14 healthy adult subjects had no clinically significant effect on the steady-state pharmacokinetics of AVANDIA. No clinically significant reductions in glimepiride AUC and Cmax were observed after repeat doses of AVANDIA (8 mg once daily) for 8 days i</ao:suffix>
    <pav:createdOn>2014-07-08 08:49:01 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <domeo:uuid>E27A16CE-6580-45E8-8355-59330E7DE10B</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>Single oral doses of </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:BA20E396-75C5-4827-9982-C1702AC94E69">
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:9E3A4D83-9BFB-4908-B71A-17D759012341"/>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:67CFF9B5-80F5-47C2-9CC2-3643ED8CFC60">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/0FBD86F2-13B9-4547-99B1-38FEA6044EAD"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/6461087D-9BBA-4596-BE97-3EFFC7C9732C"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:9BC311BC-A0C1-4FAE-9E74-D9C420B6A90A">
    <ao:exact>quinidine</ao:exact>
    <ao:prefix>is reduced by co-administration of </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:9BC311BC-A0C1-4FAE-9E74-D9C420B6A90A"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>9BC311BC-A0C1-4FAE-9E74-D9C420B6A90A</domeo:uuid>
    <pav:createdOn>2014-07-08 08:56:43 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix>, leading to a two-three fold increased blood concentration and greater degrees of clinical beta-blockade.</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-125.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:DB554CE5-0CDD-4795-87C2-02BE9BAD787B">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/15579BF0-688E-4BD6-A314-9E23151F9DD3"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/A45E5283-1A87-4DDA-B789-CEA168E699ED"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N11ab702490384ba5ae4a09d73e94a52e">
    <domeo:sets rdf:resource="urn:pddi:uuid:2398E0CD-A6FA-4F99-8926-12FF03473A60"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:CCD9BDE6-F8A6-4C7F-944E-A90E670A790B">
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:E5F0B80A-96B4-4BA7-AAF2-FE0504723103"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:0DFFB663-C168-46F5-B757-996F83D2D6EB">
    <pav:createdOn>2014-07-08 09:08:32 -0400</pav:createdOn>
    <ao:suffix>xsd:String</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:0DFFB663-C168-46F5-B757-996F83D2D6EB"/>
    <ao:exact>Propranolol can inhibit the metabolism of diazepam, resulting in increased concentrations of diazepam and its metabolites.</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>0DFFB663-C168-46F5-B757-996F83D2D6EB</domeo:uuid>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-128.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:ADA6D6F5-D3D0-4351-A7BF-B27CA3D78AAB">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/F561A4CA-25B4-4436-94B2-027E1D99C26D"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/B98077A0-5481-4FAA-9B75-819F4DB9B81D"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B886CBC4-6B52-4262-B1B8-616044D4371E">
    <pav:previousVersion>urn:domeoclient:uuid:53FAA6D0-9A40-44F9-8FE0-3166137CEF10</pav:previousVersion>
    <pav:createdOn>2014-07-07 10:02:48 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotationset:F37BE993-E972-47AE-896D-FF4D33157ECF</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A5E637EF-5CA5-4AAC-BD8B-C136A86E17B7</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:lastSavedOn>2014-07-07 10:03:14 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:9E934103-8948-4317-83F6-3946F62BD7A5"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N2e8aad01f50844f79d251802f421c112">
    <domeo:sets rdf:resource="urn:pddi:uuid:B901A23A-2D92-4B95-A7E7-00DFB949D801"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/C9BA828B-CAAC-4396-BA76-584A34D7A18A">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/6135</dailymed:activeMoietyRxCUI>
    <rdfs:label>ketoconazole</rdfs:label>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/3BE703A9-954B-4CD3-A7C4-BAA1FE159825">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/8787</dailymed:activeMoietyRxCUI>
    <rdfs:label>propranolol</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:2967BEAF-4FBA-4182-BDBF-1E12F3816AC2">
    <ao:prefix> and its active metabolite, </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:2967BEAF-4FBA-4182-BDBF-1E12F3816AC2"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-6.txt.html</ao:hasSource>
    <domeo:uuid>2967BEAF-4FBA-4182-BDBF-1E12F3816AC2</domeo:uuid>
    <pav:createdOn>2014-07-21 09:58:37 -0400</pav:createdOn>
    <ao:suffix> (ODV) have no significant affinity for muscarinic cholinergic, H1-histaminergic, or α1-adrenergic receptors in vitro. Pharmacologic activity at these receptors is hypothesized to be associated with the various anticholinergic, sedative, and cardiovascul</ao:suffix>
    <ao:exact>O-desmethylvenlafaxine</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:A63BDBB5-15F1-4DEB-B8BD-C390C13121EE">
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:75DEEBFA-AAD0-4B3A-B058-3C5B9D9240CF"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:509296DF-B123-4BF0-83A9-60329DB03E04">
    <ao:prefix>, is 77%. Neither </ao:prefix>
    <ao:suffix> nor 9-hydroxyrisperidone displaces each other from plasma binding sites. High therapeutic concentrations of sulfamethazine (100 mcg/mL), warfarin (10 mcg/mL), and carbamazepine (10 mcg/mL) caused only a slight increase in the free fraction of risperidon</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:509296DF-B123-4BF0-83A9-60329DB03E04"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <domeo:uuid>509296DF-B123-4BF0-83A9-60329DB03E04</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-07 19:46:50 -0400</pav:createdOn>
    <ao:exact>risperidone</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/E5187A7F-0119-4BF1-A74F-8CABF696DAB3">
    <rdfs:label>cimetidine</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/2541</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:4579EAFF-E003-4408-A2BE-920C104981EA">
    <pav:lineageUri>urn:domeoserver:annotationset:0f67c012-7596-4b02-a927-63c0ccbc3afa</pav:lineageUri>
    <pav:createdOn>2014-07-08 14:20:30 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:42258B16-6749-4B39-B28D-88C8B63F7A43</domeo:belongsToSet>
    <pav:previousVersion>urn:domeoclient:uuid:e75c9d7b-f906-4c66-8a84-e6eef34d0954</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">3</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:985C3750-A9C3-40C6-9DED-5084685455B3"/>
    <pav:lastSavedOn>2014-07-08 14:24:44 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:49EC311A-D3CF-4712-9F56-1DAC3870D7FC">
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:D1191553-94A9-4539-9050-69E35BDD13E0"/>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/FDC0BABD-576B-4151-A4D2-06BA005D1319">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>donepezil</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7A5C7579-E699-4E87-9C3D-F6E23DE1616B">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:7A5C7579-E699-4E87-9C3D-F6E23DE1616B"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix> and </ao:prefix>
    <ao:exact>ODV</ao:exact>
    <ao:suffix> do not possess monoamine oxidase (MAO) inhibitory activity.</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-6.txt.html</ao:hasSource>
    <domeo:uuid>7A5C7579-E699-4E87-9C3D-F6E23DE1616B</domeo:uuid>
    <pav:createdOn>2014-07-21 09:58:46 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:7B59FD7B-40C7-4BD1-8519-C2393E0808A0">
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:998F06C5-9B75-4437-A300-774242E78229"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:380CAFAB-F13E-4844-9A26-B9BADAEE53FF">
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdOn>2014-07-07 19:47:18 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5ABD9862-F044-4404-AD04-73DA04ADDA8B</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:54D20BC4-F36E-4EA2-B59F-954DEB519409"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotationset:1DED06A6-8562-4CCF-A58C-CA25748FBD31</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-07 19:50:36 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/0f80bca5-6085-4482-b1db-5a8aabde8d34">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-07 08:06:34 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotationset:893c800d-6a5b-496c-8182-1911e321d300</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:85eae2de-4b9b-41a8-844e-715bfa847610"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:F9AE7343-DFD7-456E-804F-77E7D6A72935</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-07 08:06:34 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:8203300B-7D6E-4809-A3FF-16CDA16CDF40">
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:D3BEFEBB-9211-43B5-A0FB-019C489569E0"/>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:4AF8E204-1E57-411D-9013-3CA029E06DB7">
    <domeo:belongsToSet>urn:domeoserver:annotationset:A5E637EF-5CA5-4AAC-BD8B-C136A86E17B7</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-07 10:54:10 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-07 10:54:03 -0400</pav:createdOn>
    <ao:body rdf:nodeID="N45fcaba63136437a91f9219a1a563b03"/>
    <pav:previousVersion>urn:domeoserver:annotationset:E0912BFE-3C9A-4C5D-81F4-9D862F25D230</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">3</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotationset:F37BE993-E972-47AE-896D-FF4D33157ECF</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:5738340B-DE0D-4110-95FC-8E23D9AA4DF8"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:20EFF2EE-AAF5-4EDA-917C-21E2A880209F">
    <pav:createdOn>2014-07-08 08:50:20 -0400</pav:createdOn>
    <ao:suffix>(500 mg twice daily) in healthy volunteers for 4 days had no effect on the steady-state pharmacokinetics of either metformin or rosiglitazone.</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <ao:prefix>(2 mg twice daily) and </ao:prefix>
    <domeo:uuid>20EFF2EE-AAF5-4EDA-917C-21E2A880209F</domeo:uuid>
    <ao:exact>metformin </ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:20EFF2EE-AAF5-4EDA-917C-21E2A880209F"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E96D33F6-142B-4A53-83BD-A17107D024E4">
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdOn>2014-07-07 09:37:47 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A5E637EF-5CA5-4AAC-BD8B-C136A86E17B7</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-07 09:44:18 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:0D8FAF03-60C1-4EE4-B17A-F31AEF7068A8"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotationset:F37BE993-E972-47AE-896D-FF4D33157ECF</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:8555D07E-8DC5-4EC6-8E56-E7326761C338">
    <ao:suffix>in patients with mild to severe renal impairment or in hemodialysis-dependent patients compared to subjects with normal renal function. No dosage adjustment is therefore required in such patients receiving AVANDIA. Since metformin is contraindicated in p</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:8555D07E-8DC5-4EC6-8E56-E7326761C338"/>
    <pav:createdOn>2014-07-08 08:43:36 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <ao:exact>rosiglitazone </ao:exact>
    <ao:prefix>There are no clinically relevant differences in the pharmacokinetics of </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>8555D07E-8DC5-4EC6-8E56-E7326761C338</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F3CA35E9-AEA1-406C-BAD1-E54E69EB5BC5">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A5E637EF-5CA5-4AAC-BD8B-C136A86E17B7</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:4FBE52B1-7369-4C72-B088-9FD2E6AF2E35"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotationset:F37BE993-E972-47AE-896D-FF4D33157ECF</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:previousVersion>urn:domeoclient:uuid:53FAA6D0-9A40-44F9-8FE0-3166137CEF10</pav:previousVersion>
    <pav:createdOn>2014-07-07 09:59:25 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <pav:lastSavedOn>2014-07-07 10:03:14 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N1ddd87dba3834a5883930242554aafc7">
    <domeo:sets rdf:resource="urn:pddi:uuid:E2432E61-6381-481B-A3AB-D8427E3230EC"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:CF7A802A-A584-4317-9FE0-3694CBF9A54D">
    <domeo:uuid>CF7A802A-A584-4317-9FE0-3694CBF9A54D</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:CF7A802A-A584-4317-9FE0-3694CBF9A54D"/>
    <ao:exact>Ribavirin: In vitro data indicate ribavirin reduces phosphorylation of lamivudine, stavudine, and zidovudine. However, no pharmacokinetic (e.g., plasma concentrations or intracellular triphosphorylated active metabolite concentrations) or pharmacodynamic (e.g., loss of HIV-1/HCV virologic suppression) interaction was observed when ribavirin and lamivudine (n = 18), stavudine (n = 10), or zidovudine (n = 6) were coadministered as part of a multi-drug regimen to HIV-1/HCV co-infected patients [see Warnings and Precautions (5.4)].</ao:exact>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-197.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-08 14:24:00 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:EF978B29-00A9-40C7-BDE7-946DD69D71FC">
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:33B59D6A-E02C-4A07-A4B9-71E121EBF442"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:EF68C576-A9B2-4B74-B4C1-3DF5E1B3A6C1">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/2CBC9504-B160-4CFC-881E-E3FC5D568D1F"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/E71FB55B-248D-40A1-8652-0359FD90DB04"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:59BCB49F-3C4C-4535-8F02-274F903E1D23">
    <pav:lineageUri>urn:domeoserver:annotationset:F37BE993-E972-47AE-896D-FF4D33157ECF</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2014-07-07 09:44:18 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A5E637EF-5CA5-4AAC-BD8B-C136A86E17B7</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdOn>2014-07-07 09:36:50 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:06AC0B3A-23F1-4DC7-B6F7-4E99505ADB88"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:5FF7629F-F304-4A86-BE42-01786FB50EDA">
    <pav:createdOn>2014-07-08 09:34:54 -0400</pav:createdOn>
    <ao:body rdf:nodeID="N310490f36c194f878c4417c981f7fdd4"/>
    <pav:lastSavedOn>2014-07-08 09:35:29 -0400</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotation:18B1F322-B50A-4DEC-9052-E670F4C29134</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:DA0BDD7D-CA94-49A6-984F-9B740BC66A4D"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoclient:uuid:423352B3-8ABA-48B7-98CF-B191A7BFC955</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:4C4D70A4-7E29-4CD9-A33B-0C238E448F70">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:51AE28A6-A4F5-4551-AD8B-8ADDDCA82257</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-07 20:34:18 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-07 20:32:12 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:5918AB1D-B782-46BF-A2C6-DE53FAAEB382"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotation:650C2FA3-DBEE-4E7F-B0AB-9C25A8FC4492</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:60BB8E86-2F9F-497F-BB60-44B1ED83874E">
    <domeo:uuid>60BB8E86-2F9F-497F-BB60-44B1ED83874E</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>glyburide</ao:exact>
    <pav:createdOn>2014-07-08 08:40:03 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:60BB8E86-2F9F-497F-BB60-44B1ED83874E"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <ao:suffix>-controlled study is most pertinent to assess long-term effects on lipids. At baseline, week 26, and week 52, mean LDL/HDL ratios were 3.1, 3.2, and 3.0, respectively, for </ao:suffix>
    <ao:prefix>ted above baseline throughout the trials. In contrast, HDL continued to rise over time. As a result, the LDL/HDL ratio peaked after 2 months of therapy and then appeared to decrease over time. Because of the temporal nature of lipid changes, the 52-week </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B0351284-4078-469B-9852-85337F49883D">
    <pav:lastSavedOn>2014-07-07 09:44:18 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotationset:F37BE993-E972-47AE-896D-FF4D33157ECF</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:06B0EE80-4CF0-4C8C-9834-50D1BE1F6B19"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-07-07 09:43:50 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A5E637EF-5CA5-4AAC-BD8B-C136A86E17B7</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/70E14994-95FA-477A-950C-6D4BDACBA860">
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/35636</dailymed:activeMoietyRxCUI>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>risperidone</rdfs:label>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:DEF403A7-A195-4A96-8530-9C1D07D3A545">
    <domeo:belongsToSet>urn:domeoclient:uuid:15A8BD5A-D46C-4E84-8B70-5066D260486D</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:createdOn>2014-07-08 12:06:18 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotation:9BF5E9DB-E5EA-4FD1-9ABD-6EE1FA89BAF5</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:ABBCEFA8-F816-416D-87B3-F8BB5696B8F3"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-07-08 12:08:36 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/2EFEC6C2-03E2-4C62-B4F2-7F08370D57F3">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/drug-product"/>
    <rdfs:label>avandia</rdfs:label>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/261455</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:EAEE7E8B-FF76-4E91-ACE4-5F9CDED0BE04">
    <domeo:belongsToSet>urn:domeoserver:annotationset:C2CFDC7A-D407-48FD-81AA-DFCEA656C0BE</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-07-08 14:40:01 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:62DB213B-D0D2-4AAE-8061-DE7A3FACC0A3"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2014-07-08 14:40:40 -0400</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotation:C2B91ADD-4343-41C1-8C34-130F82F9B371</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:FF1C6068-2FFE-4633-8A8C-DC8BF089155B">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/A08A1833-AC3A-48ED-9E14-C0222DE73198"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/3BBAEE26-B09E-403A-A3F1-D75446BB25C5"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7A79C46E-A15F-428F-A1D0-9FC0AD09BDCC">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:7A79C46E-A15F-428F-A1D0-9FC0AD09BDCC"/>
    <ao:prefix>inhibits hepatic gluconeogenesis. The expression of the insulin-regulated glucose transporter GLUT-4 was increased in adipose tissue. </ao:prefix>
    <ao:suffix>did not induce hypoglycemia in animal models of type 2 diabetes and/or impaired glucose tolerance.</ao:suffix>
    <domeo:uuid>7A79C46E-A15F-428F-A1D0-9FC0AD09BDCC</domeo:uuid>
    <ao:exact>Rosiglitazone </ao:exact>
    <pav:createdOn>2014-07-08 08:39:23 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:11460EEB-C89E-451E-BE57-28F4DDA84CD0">
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:62CA95E4-68D2-44F1-804E-2C9864131893"/>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N040de4ca7bc14bf8824bccb2cc5aac79">
    <domeo:sets rdf:resource="urn:pddi:uuid:3D67FCFB-8ABA-41EB-AA10-7BC258CFCAD5"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:0503C423-2E86-4B5E-AD19-E054650EBD1D">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/CFDB108F-E2D7-4178-84D2-7ABD3C4E2E83"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/1D2BA564-4D1D-4BAF-98C0-C9BEF56EA87A"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:E469C1E6-5FEF-4979-A372-CABE985684AE">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/57813A66-7835-4757-A474-8796049D5B9B"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/9FF2C3C3-B69C-43B4-B33D-08E0833F429A"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:9A1171A2-A76D-4CA2-B04D-A83316D5759E">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5ABD9862-F044-4404-AD04-73DA04ADDA8B</domeo:belongsToSet>
    <pav:createdOn>2014-07-07 19:43:28 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:5C6CE9E5-AE81-4BEB-B698-F027E2D10804"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotationset:1DED06A6-8562-4CCF-A58C-CA25748FBD31</pav:lineageUri>
    <pav:lastSavedOn>2014-07-07 19:50:36 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nf78fbc90883c4be89012dc0318e769eb">
    <permissions:isLocked>false</permissions:isLocked>
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:8FB241FE-F32C-4D8C-8E1B-082F499034C4">
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:F9B040DB-5C26-4D30-AFB9-675193FE3E06"/>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A5AA5770-ACE2-4D41-8BF7-D13CCD43A5BF">
    <pav:createdOn>2014-07-07 19:47:32 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:A5AA5770-ACE2-4D41-8BF7-D13CCD43A5BF"/>
    <domeo:uuid>A5AA5770-ACE2-4D41-8BF7-D13CCD43A5BF</domeo:uuid>
    <ao:suffix>plus 9-hydroxyrisperidone.</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>risperidone </ao:exact>
    <ao:prefix>. Consequently, the clinical effect of the drug results from the combined concentrations of </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F5561C43-6248-48AC-91C8-4C5E6ECD1BA9">
    <ao:prefix>, decreased 18% to 23% the AUC of both, but did not alter their pharmacodynamics. </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>Propranolol </ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-132.txt.html</ao:hasSource>
    <domeo:uuid>F5561C43-6248-48AC-91C8-4C5E6ECD1BA9</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:F5561C43-6248-48AC-91C8-4C5E6ECD1BA9"/>
    <pav:createdOn>2014-07-08 09:19:00 -0400</pav:createdOn>
    <ao:suffix>did not have an effect on the pharmacokinetics of fluvastatin.</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B51EB7EF-7461-4184-98B0-3424937CD1FA">
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A5E637EF-5CA5-4AAC-BD8B-C136A86E17B7</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-07-07 09:42:08 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotationset:F37BE993-E972-47AE-896D-FF4D33157ECF</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:2706CEF8-2F29-4169-9FE6-1B02D268167E"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-07-07 09:44:18 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:E5E01AF0-C5DD-4644-87A7-A8B9B417DE5A">
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:A5315A64-8E04-4F6D-9568-15785741BAE7"/>
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/780BF305-B0DE-4AB1-AA49-E1BF6C54B7D9">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/2685</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>colestipol</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:799D80AA-0C08-46BD-B79B-45AEEB971F79">
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A5E637EF-5CA5-4AAC-BD8B-C136A86E17B7</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-07-07 09:44:18 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:EF3AEA47-BC2D-46E8-8DEF-D15CEE83AC74"/>
    <pav:lineageUri>urn:domeoserver:annotationset:F37BE993-E972-47AE-896D-FF4D33157ECF</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-07 09:41:54 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/53D6639B-4B87-48ED-8EAE-141236471F28">
    <rdfs:label>furosemide</rdfs:label>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/4603</dailymed:activeMoietyRxCUI>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:89FA163B-E81A-4575-957E-AB4A89C9439A">
    <ao:prefix>Co-administration of </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:89FA163B-E81A-4575-957E-AB4A89C9439A"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-51.txt.html</ao:hasSource>
    <ao:exact>fosamprenavir</ao:exact>
    <ao:suffix>/ritonavir with paroxetine significantly decreased plasma levels of paroxetine. Any dose adjustment should be guided by clinical effect (tolerability and efficacy). </ao:suffix>
    <domeo:uuid>89FA163B-E81A-4575-957E-AB4A89C9439A</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-07 20:25:50 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N5146d17280124665abd670546ed1680a">
    <permissions:isLocked>false</permissions:isLocked>
    <permissions:accessType>urn:person:uuid:080e143046812afe0146812e52b20002</permissions:accessType>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/099D3005-17B5-4D7E-9FCD-3988CF551CF0">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>galantamine</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:9DEEB774-8BA5-4C4D-92D6-53CB1639FECD">
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:EF68C576-A9B2-4B74-B4C1-3DF5E1B3A6C1"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/C0196136-3C84-442C-B200-A6303F71A2D0">
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>nifedipine</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/7417</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N82e0e62c52c74da8962365b26018a4ec">
    <domeo:sets rdf:resource="urn:pddi:uuid:5C206F8A-9D72-4001-935D-5EE38FAACF77"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:411EFF57-BDB0-4ADE-9CA0-6A141E246E64">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>After chronic dosing of 80 mg TID </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:411EFF57-BDB0-4ADE-9CA0-6A141E246E64"/>
    <ao:exact>sildenafil </ao:exact>
    <pav:createdOn>2014-07-07 09:36:17 -0400</pav:createdOn>
    <domeo:uuid>411EFF57-BDB0-4ADE-9CA0-6A141E246E64</domeo:uuid>
    <ao:suffix>to healthy volunteers, the largest mean change from baseline in supine systolic and supine diastolic blood pressures was a decrease of 9.0 mmHg and 8.4 mmHg, respectively.</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:F4E891D3-BA8C-4980-935F-8169415B3261">
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:F5812029-F895-4B75-8E03-F1F15EBFBF14"/>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/BB8C069D-1C36-4E96-B9E9-E0E159690B6D">
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/3443</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>diltiazem</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/14DFE55C-BB47-4B58-A7E8-FC46364B8315">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>acyclovir</rdfs:label>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/281</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B751918C-EA39-4A8A-A1C0-EAD51F1DC933">
    <ao:prefix>Co-administration of </ao:prefix>
    <domeo:uuid>B751918C-EA39-4A8A-A1C0-EAD51F1DC933</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:B751918C-EA39-4A8A-A1C0-EAD51F1DC933"/>
    <pav:createdOn>2014-07-08 09:18:55 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-132.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>propranolol </ao:exact>
    <ao:suffix>with lovastatin or pravastatin, decreased 18% to 23% the AUC of both, but did not alter their pharmacodynamics. Propranolol did not have an effect on the pharmacokinetics of fluvastatin.</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:40501BB8-EF48-40F1-AFFD-CE5741575FFF">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:40501BB8-EF48-40F1-AFFD-CE5741575FFF"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-21.txt.html</ao:hasSource>
    <domeo:uuid>40501BB8-EF48-40F1-AFFD-CE5741575FFF</domeo:uuid>
    <pav:createdOn>2014-07-07 20:04:28 -0400</pav:createdOn>
    <ao:exact>A third study evaluated the potential interaction of once weekly dosing of fluconazole 300 mg to 21 normal females taking an oral contraceptive containing ethinyl estradiol and norethindrone. In this placebo-controlled, double-blind, randomized, two-way crossover study carried out over three cycles of oral contraceptive treatment, fluconazole dosing resulted in small increases in the mean AUCs of ethinyl estradiol and norethindrone compared to similar placebo dosing. The mean AUCs of ethinyl estradiol and norethindrone increased by 24% (95% C.I. range 18 to 31%) and 13% (95% C.I. range 8 to 18%), respectively relative to placebo. Fluconazole treatment did not cause a decrease in the ethinyl estradiol AUC of any individual subject in this study compared to placebo dosing. The individual AUC values of norethindrone decreased very slightly (&lt;5%) in 3 of the 21 subjects after fluconazole treatment.</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/701E4503-2478-4933-8D3F-3D55C26232A1">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/6813</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>methadone</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E737183E-644F-428E-8509-B0ACD6712B9E">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2014-07-08 13:56:02 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:DD05DE56-7B60-4C06-8552-D1DD652D8A79</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:createdOn>2014-07-08 13:52:49 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotation:FA115D20-7971-47D8-B72D-236DC4D331F2</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:9701169E-B533-44C4-8108-EE3B9D4FC032"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nf7c56abb05dc47cdbc2b0a4df3e330d2">
    <permissions:isLocked>false</permissions:isLocked>
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/66FF8966-1521-4CF1-AA71-E2698D1361EB">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>quinupristin</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/229367</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:28FECF39-4562-444A-9C77-7BBF262CC5E2">
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:6D30D040-0C0B-4B18-9202-85E9BC0808EB"/>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/64AE7B4D-E1D0-409C-9F66-90128E8CF907">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>sildenafil</rdfs:label>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/136411</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:64EB2603-4A87-4E9E-AB5D-A9C2CBF4406A">
    <pav:lastSavedOn>2014-07-07 20:12:43 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotation:659C612B-8106-4976-B01E-6782D733FE3D</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:9E97EA57-E235-4D98-B7F9-E5DD90C91D57"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoclient:uuid:21FE87BA-B7AA-4926-95E7-7E20EA2E4643</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:createdOn>2014-07-07 20:10:19 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:806814E2-6819-43DF-A823-97F018FEE863">
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:C0038DAC-B2E3-4A49-A234-356CE629F16E"/>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:94CF1E50-CE22-4887-8A21-56B8371A6159">
    <ao:exact>ODV</ao:exact>
    <domeo:uuid>94CF1E50-CE22-4887-8A21-56B8371A6159</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:94CF1E50-CE22-4887-8A21-56B8371A6159"/>
    <ao:suffix>) have no significant affinity for muscarinic cholinergic, H1-histaminergic, or α1-adrenergic receptors in vitro. Pharmacologic activity at these receptors is hypothesized to be associated with the various anticholinergic, sedative, and cardiovascular ef</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-21 09:58:38 -0400</pav:createdOn>
    <ao:prefix> (</ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-6.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:9E15E869-50C5-4886-94F6-4670553A8F87">
    <domeo:uuid>9E15E869-50C5-4886-94F6-4670553A8F87</domeo:uuid>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:9E15E869-50C5-4886-94F6-4670553A8F87"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:exact>Isoniazid is known to slow the metabolism of carbamazepine and increase its serum levels. Carbamazepine levels should be determined prior to concurrent administration with isonia-\n\nzid, signs and symptoms of carbamazepine toxicity should be monitored closely, and ap- propriate dosage adjustment of the anticonvulsant should be made3.</ao:exact>
    <pav:createdOn>2014-07-08 13:50:24 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-179.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:CD4AA3A0-B633-44B5-94F3-36F11CB4BF31">
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:8AA97147-AF03-4B01-B629-3C1F5AA55B8E"/>
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:2590A94C-B94E-43C0-9310-7F6EEAF8C072">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/31809C64-5016-4FAC-B2FF-A4F084885AB4"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/C04F0392-C448-444F-AAA2-57501549FCCB"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:CF6DE8C8-AA17-46FD-BA47-DC0793234B56">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/8AE291B8-ECE2-46D1-AD69-E23C7E415BCC"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/FD45A94A-DBBD-4A14-8FF0-071717BF6599"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:6088A1D3-834D-4614-BEC7-94E6DE5B99D1">
    <ao:exact>ritonavir</ao:exact>
    <ao:prefix>, and </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:6088A1D3-834D-4614-BEC7-94E6DE5B99D1"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-07 09:41:45 -0400</pav:createdOn>
    <ao:suffix>).</ao:suffix>
    <domeo:uuid>6088A1D3-834D-4614-BEC7-94E6DE5B99D1</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:2A953CC4-23F6-4525-849F-0A5A2C32E759">
    <pav:createdOn>2014-07-08 15:53:19 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5B2167F6-4E63-4A7B-85C1-ACA56DDE7073</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:64F121B4-4817-4C72-973E-55226B522A0D</pav:lineageUri>
    <ao:body rdf:nodeID="N6c9ccf05bc504ffab744f29f638a369a"/>
    <pav:lastSavedOn>2014-07-08 15:56:00 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:79EF1544-DE9E-4DAB-B25D-7FE39CCD711D"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:866B9D61-E16F-4706-BECB-2F73AB4474F2">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/C4D64223-F9F7-4D70-BA26-E9CED330DEC2"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/3E293358-D96E-49E3-8DF6-F99C2AE5F414"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B8F5CDC4-B4BB-4203-A5A9-BB01E739D22D">
    <ao:context rdf:resource="urn:domeoclient:uuid:5B6DD925-BCA7-4CD2-A767-823689EF5780"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:createdOn>2014-07-07 20:10:21 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:21FE87BA-B7AA-4926-95E7-7E20EA2E4643</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotation:A84DE199-3A1F-4AF6-BA2D-332520184C62</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-07 20:12:43 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/DB75092B-C73B-4848-9086-92F4260E2407">
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/4124</dailymed:activeMoietyRxCUI>
    <rdfs:label>ethinyl estradiol</rdfs:label>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/03FE4D2F-0B60-460B-845F-C8447542D4E8">
    <rdfs:label>9-hydroxyrisperidone</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/679314</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/metabolite"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:1761CE3B-543E-4D8E-BC57-62759E6DF137">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:1761CE3B-543E-4D8E-BC57-62759E6DF137"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-139.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-08 09:32:42 -0400</pav:createdOn>
    <ao:exact>fexofenadine</ao:exact>
    <ao:prefix>Fruit juices such as grapefruit, orange and apple may reduce the bioavailability and exposure of </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>1761CE3B-543E-4D8E-BC57-62759E6DF137</domeo:uuid>
    <ao:suffix>. This is based on the results from three clinical studies using histamine induced skin wheals and flares coupled with population pharmacokinetic analysis. The size of wheal and flare were significantly larger when fexofenadine hydrochloride was administ</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:69E0609F-6686-461A-8738-BCD370887AFD">
    <domeo:belongsToSet>urn:domeoclient:uuid:D74AEF81-5B9A-431F-9F0D-1822391A7E30</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-08 12:05:20 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-08 12:02:53 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotation:98D10311-6B7A-4E74-A4A2-F48D41407625</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:B3F29EBC-4966-40C6-A05A-1B0A92E2985C"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:5D36B789-B525-41AE-B057-384504C41940">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/ACF97FAB-AB8F-4F1A-ABC3-3AB98B72889E"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/EB04F09B-EFA9-412A-91A8-D56E330C3863"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/7795CCEF-74BF-4E32-9312-8D63BE1D340B">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>verapamil</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/11170</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:32D7C002-D1F7-45DE-93C0-E75EC19F9E0C">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:32D7C002-D1F7-45DE-93C0-E75EC19F9E0C"/>
    <ao:exact>rosiglitazone </ao:exact>
    <ao:prefix>AUC by 127%, compared to the administration of </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-08 08:45:56 -0400</pav:createdOn>
    <domeo:uuid>32D7C002-D1F7-45DE-93C0-E75EC19F9E0C</domeo:uuid>
    <ao:suffix>(4 mg once daily) alone. Given the potential for dose-related adverse events with rosiglitazone, a decrease in the dose of rosiglitazone may be needed when gemfibrozil is introduced [see Drug Interactions (7.1)].</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N3a5d4b4e632847ebb420010ff2a67651">
    <domeo:sets rdf:resource="urn:pddi:uuid:50178458-9F79-4448-9148-D42F665C707C"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7022DAEA-7889-4B04-9A51-29FE6F0BE4B2">
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdOn>2014-07-08 08:38:26 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotationset:57174A7C-3100-4C8F-9C4A-2991CEE124D5</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:23515E27-98AC-4DC9-A4B7-EBFE2991219F</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-08 08:46:38 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:A8568E50-8A2B-4FA8-8EDF-E66544486BE7"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:92082388-F929-4C36-B23F-1BDE3DD1144F">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-6.txt.html</ao:hasSource>
    <domeo:uuid>92082388-F929-4C36-B23F-1BDE3DD1144F</domeo:uuid>
    <ao:exact>N,O-didesmethylvenlafaxine</ao:exact>
    <ao:prefix>, </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:92082388-F929-4C36-B23F-1BDE3DD1144F"/>
    <ao:suffix>, and other minor metabolites. In vitro studies indicate that the formation of ODV is catalyzed by CYP2D6; this has been confirmed in a clinical study showing that patients with low CYP2D6 levels ("poor metabolizers") had increased levels of </ao:suffix>
    <pav:createdOn>2014-07-21 10:00:52 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/035E7A1C-90DC-4659-8B21-212B516B5025">
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>trazodone</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/10737</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N95348413915c4fffbd74d962a08d6d3a">
    <domeo:sets rdf:resource="urn:pddi:uuid:FF239867-DDAA-4EE1-BD31-B9FE9F8EE013"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:3C979E76-9208-4356-A3EF-AB2C09EAFBFC">
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:11597B1E-1AFD-4BE9-925C-9ED0B5B23660"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/08A790EF-B177-41C4-A7D3-441F3A73EB04">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>nitrofurantoin</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/7454</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:992E7A10-4A9E-4A7A-AF1A-AD11F9C38A11">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-50.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>(30 mg once daily) increased steady-state AUC0-24, Cmax, and Cmin values of </ao:prefix>
    <domeo:uuid>992E7A10-4A9E-4A7A-AF1A-AD11F9C38A11</domeo:uuid>
    <pav:createdOn>2014-07-07 20:23:16 -0400</pav:createdOn>
    <ao:exact>procyclidine </ao:exact>
    <ao:suffix>(5 mg oral once daily) by 35%, 37%, and 67%, respectively, compared to procyclidine alone at steady state. If anticholinergic effects are seen, the dose of procyclidine should be reduced.</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:992E7A10-4A9E-4A7A-AF1A-AD11F9C38A11"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:006C0ED2-D661-42AD-8D59-EF2EF2C640AA">
    <domeo:uuid>006C0ED2-D661-42AD-8D59-EF2EF2C640AA</domeo:uuid>
    <ao:exact>Diltiazem significantly decreases the clearance and increases the t1/2 of quinidine, but quinidine does not alter the kinetics of diltiazem.</ao:exact>
    <pav:createdOn>2014-07-07 20:30:12 -0400</pav:createdOn>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:006C0ED2-D661-42AD-8D59-EF2EF2C640AA"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-54.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>xsd:String</ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C959A7D5-46C1-4667-9A6D-BECABEF64D72">
    <domeo:uuid>C959A7D5-46C1-4667-9A6D-BECABEF64D72</domeo:uuid>
    <ao:suffix>(1g q8h iv) in the second study (JRV 305); however, in both studies vancomycin (1g q12h iv) could be substituted for the specified comparator if the causative pathogen was suspected or confirmed methicillin-resistant staphylococcus or if the patient was </ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:C959A7D5-46C1-4667-9A6D-BECABEF64D72"/>
    <pav:createdOn>2014-07-07 20:45:56 -0400</pav:createdOn>
    <ao:prefix>(2g q6h iv) in the first study (JRV 304) and </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>cefazolin </ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-119.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/AC6C7749-8349-40F9-8362-48F5BB5EA166">
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/42355</dailymed:activeMoietyRxCUI>
    <rdfs:label>fluvoxamine</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:53451EFA-435E-4280-9EBF-96B72E35525B">
    <pav:lineageUri>urn:domeoserver:annotation:B86E7BAC-43FD-458A-89F9-F5333E36BF6C</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoclient:uuid:921213C5-987C-46D2-9095-A8DDC2B714AB</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:46E97609-7E4C-4EA4-A0E1-1EC7D6C392DE"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2014-07-07 20:01:05 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-07 20:04:45 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:3EF641E1-18D0-4BB8-809D-CF2D2FA89BB3">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/25F2A428-2819-436D-9BE5-515C97BCB896"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/AA9634F6-D250-4C4D-AA41-989959E66D94"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:DA801614-F554-4AFC-848A-FFA649DAB1A6">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/64AE7B4D-E1D0-409C-9F66-90128E8CF907"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/476A3272-8A58-4131-A754-84A3669B925F"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:909C62AA-B9E7-4A5C-9F41-3AE350579069">
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:91EDAA42-79D3-4D95-A202-95002BE782A6"/>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:18EC125D-0EC4-460B-B28A-2212E22F82E9">
    <pav:lineageUri>urn:domeoserver:annotationset:0f67c012-7596-4b02-a927-63c0ccbc3afa</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:42258B16-6749-4B39-B28D-88C8B63F7A43</domeo:belongsToSet>
    <pav:previousVersion>urn:domeoclient:uuid:e75c9d7b-f906-4c66-8a84-e6eef34d0954</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">3</pav:versionNumber>
    <pav:createdOn>2014-07-08 14:20:03 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:9CCAF920-9EFC-4521-9D3F-42FDD3027A7B"/>
    <pav:lastSavedOn>2014-07-08 14:24:44 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/332B872F-F6F9-4A13-B97B-1BE5AAA74964">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>risperidone</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/35636</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/EA608D09-B1FC-4430-8CE3-0E74299DFDB3">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/8754</dailymed:activeMoietyRxCUI>
    <rdfs:label>propafenone</rdfs:label>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A518666B-94DF-4BFF-ACE1-1F6BB97200EB">
    <domeo:uuid>A518666B-94DF-4BFF-ACE1-1F6BB97200EB</domeo:uuid>
    <ao:prefix>The usual initial dosage of </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:A518666B-94DF-4BFF-ACE1-1F6BB97200EB"/>
    <ao:exact>acebutolol </ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-4.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-07 19:41:53 -0400</pav:createdOn>
    <ao:suffix>is 400 mg daily given as 200 mg b.i.d. Dosage should be increased gradually until an optimal clinical response is obtained, generally at 600 to 1200 mg per day. If treatment is to be discontinued, the dosage should be reduced gradually over a period of a</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:1FAA43A7-B3D9-40CC-BFEF-F1012A394ACA">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/C1226775-5083-4A9F-9222-7AF1243FB256"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/7B3B1F2E-BD39-48C7-B984-8445094740C6"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/ABE75BCD-13B4-4B31-BF5F-12D04B91FA6B">
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>propafenone</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/8754</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:49DFB722-44E6-452F-AEF7-2184C3580181">
    <pav:createdOn>2014-07-08 12:10:21 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:49DFB722-44E6-452F-AEF7-2184C3580181"/>
    <ao:prefix>and also the formation of the metabolite, </ao:prefix>
    <domeo:uuid>49DFB722-44E6-452F-AEF7-2184C3580181</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-164.txt.html</ao:hasSource>
    <ao:suffix>, in healthy subjects and thus, caution should be used with concomitant administration.</ao:suffix>
    <ao:exact>normeperidine</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C9FCC72A-F1EC-478F-B94F-5EFF2CA1E33B">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <ao:prefix>is bound to albumin and α1-acid glycoprotein. The plasma protein binding of </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:C9FCC72A-F1EC-478F-B94F-5EFF2CA1E33B"/>
    <domeo:uuid>C9FCC72A-F1EC-478F-B94F-5EFF2CA1E33B</domeo:uuid>
    <ao:exact>risperidone </ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-07 19:46:42 -0400</pav:createdOn>
    <ao:suffix>is 90%, and that of its major metabolite, 9-hydroxyrisperidone, is 77%. Neither risperidone nor 9-hydroxyrisperidone displaces each other from plasma binding sites. High therapeutic concentrations of sulfamethazine (100 mcg/mL), warfarin (10 mcg/mL), and</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:AC56289B-E372-495E-88D3-3D4C45D79ACF">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotationset:F37BE993-E972-47AE-896D-FF4D33157ECF</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2014-07-07 09:40:24 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A5E637EF-5CA5-4AAC-BD8B-C136A86E17B7</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2014-07-07 09:44:18 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:C02F267C-77D9-453C-840C-8AB33EDB7019"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:F5E53238-CF11-42DE-A096-289EB80BA1EA">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/C4BFA302-F317-46ED-815E-B1D71FEB5BB0"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/5AB20F80-BC18-4891-A9B4-168721105167"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D83571AE-9C61-456B-896B-1D4E29645B31">
    <domeo:uuid>D83571AE-9C61-456B-896B-1D4E29645B31</domeo:uuid>
    <ao:exact>ranitidine increased the AUC of risperidone and 9-hydroxyrisperidone combined by 20%</ao:exact>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:D83571AE-9C61-456B-896B-1D4E29645B31"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-7.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>xsd:String</ao:prefix>
    <pav:createdOn>2014-07-08 15:45:42 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/85456BAF-DEC7-4A06-8E92-CC7FA11F98C0">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/metabolite"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/</dailymed:activeMoietyRxCUI>
    <rdfs:label>sulforidazine</rdfs:label>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/0E4C87E8-886C-4557-A4DA-D648516CDD37">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>nifedipine</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/7417</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/4A8BE959-FCBB-4145-9ACC-9103097BBE9E">
    <rdfs:label>fluconazole</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/4450</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:E4B983E4-C5EE-4550-8111-73443B99C14D">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/03FE4D2F-0B60-460B-845F-C8447542D4E8"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/DF5E80C8-3983-4AF3-A772-2CAA4BEAB7F2"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:063DDD2E-07DC-41EA-83C3-DC7D055BB450">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:063DDD2E-07DC-41EA-83C3-DC7D055BB450"/>
    <ao:suffix>CL/F was shown to be influenced by both weight and gender, being lower (about 15%) in female patients.</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <ao:prefix>me of distribution (Vss/F) were shown to increase with increases in body weight. Over the weight range observed in these analyses (50 to 150 kg), the range of predicted CL/F and Vss/F values varied by &lt;1.7-fold and &lt;2.3-fold, respectively. Additionally, </ao:prefix>
    <pav:createdOn>2014-07-08 08:42:27 -0400</pav:createdOn>
    <ao:exact>rosiglitazone </ao:exact>
    <domeo:uuid>063DDD2E-07DC-41EA-83C3-DC7D055BB450</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A614DE59-7AF1-43EC-82E1-263324794024">
    <ao:prefix>to interfere with metabolism of other drugs metabolized by CYP 2D6. Relatively weak binding of </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:A614DE59-7AF1-43EC-82E1-263324794024"/>
    <pav:createdOn>2014-07-07 19:49:29 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <domeo:uuid>A614DE59-7AF1-43EC-82E1-263324794024</domeo:uuid>
    <ao:exact>risperidone </ao:exact>
    <ao:suffix>to the enzyme suggests this is unlikely [see 7 DRUG INTERACTIONS].</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/7F992173-E32B-4C8E-B733-5E741ADFAD47">
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>risperidone</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/35636</dailymed:activeMoietyRxCUI>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:24593F85-D497-4965-9F0A-FFE8CA65E40C">
    <ao:prefix>is 90%, and that of its major metabolite, </ao:prefix>
    <ao:suffix>, is 77%. Neither risperidone nor 9-hydroxyrisperidone displaces each other from plasma binding sites. High therapeutic concentrations of sulfamethazine (100 mcg/mL), warfarin (10 mcg/mL), and carbamazepine (10 mcg/mL) caused only a slight increase in th</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <ao:exact>9-hydroxyrisperidone</ao:exact>
    <pav:createdOn>2014-07-07 19:46:48 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:24593F85-D497-4965-9F0A-FFE8CA65E40C"/>
    <domeo:uuid>24593F85-D497-4965-9F0A-FFE8CA65E40C</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F665F26F-89E0-4E5A-BF79-1108D829C70A">
    <domeo:uuid>F665F26F-89E0-4E5A-BF79-1108D829C70A</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>therapy for at least 6 months and on a stable cyclosporine dose for at least 6 weeks. There was a significant increase in cyclosporine AUC, Cmax, Cmin (24-hour concentration), and a significant reduction in apparent oral clearance following the administr</ao:suffix>
    <ao:exact>cyclosporine </ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:F665F26F-89E0-4E5A-BF79-1108D829C70A"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>200 mg daily for 14 days in eight renal transplant patients who had been on </ao:prefix>
    <pav:createdOn>2014-07-07 20:15:01 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-26.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:072A08CF-6C01-41CC-AA90-79A70D351815">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/2330B94A-D045-489D-A83C-36DF1292A974"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/375A46D7-7759-41D5-9E8F-E7870641FDAB"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/624F4EBB-99A6-45BE-AFCE-8DEAA8027CD9">
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/18631</dailymed:activeMoietyRxCUI>
    <rdfs:label>azithromycin</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:46F66B6A-550C-4B02-A9FC-43E0C6C80309">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/B10807E1-FC12-4534-8AE2-885FC006F07A"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/2C500AE3-4892-4662-8FFB-CE45555EA3AE"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/f4612399-d05c-4616-80ca-a71b1b7ca43e">
    <ao:context rdf:resource="urn:domeoclient:uuid:7f5d1295-03df-474d-8a26-28174d887804"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:createdOn>2014-07-07 08:06:55 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotationset:ae7139a4-efa1-41da-97f5-562a9e551f1d</pav:lineageUri>
    <pav:lastSavedOn>2014-07-07 08:06:55 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:930FE356-9730-4335-9929-D854A7CE2092</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:95CCB727-C04A-42A4-87E0-858322F5C26C">
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:81BC7624-9543-45D0-A22E-FE1DD45A07BE"/>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N0dd4c58eaaa6421da49977ab5f3c4a58">
    <domeo:sets rdf:resource="urn:pddi:uuid:A0C6E460-DD04-4F20-80C1-0A461A44A2B0"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/476A3272-8A58-4131-A754-84A3669B925F">
    <rdfs:label>ritonavir</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/85762</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:6b7f671d-70f8-46be-9a8f-ed31f277e60f">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid></domeo:uuid>
    <ao:prefix>ntration-time curve (AUC) of </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>zidovudine</ao:exact>
    <pav:createdOn>2014-07-07 08:06:41 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:6b7f671d-70f8-46be-9a8f-ed31f277e60f"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-199.txt.html</ao:hasSource>
    <ao:suffix> which could result in toxic e</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nae4a1e051b46407786fb7bfae17076d5">
    <domeo:sets rdf:resource="urn:pddi:uuid:B0057C60-E1DF-4175-8D6C-02632B09207F"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:5AE76B76-C14D-4ADE-8F12-C92F7868F83E">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:5AE76B76-C14D-4ADE-8F12-C92F7868F83E"/>
    <pav:createdOn>2014-07-07 09:43:54 -0400</pav:createdOn>
    <ao:exact>sildenafil </ao:exact>
    <ao:suffix>(80 mg tid) bioavailability due to co-administration of epoprostenol was 28%, resulting in about 22% lower mean average steady state concentrations. Therefore, the slight decrease of sildenafil exposure in the presence of epoprostenol is not considered c</ao:suffix>
    <domeo:uuid>5AE76B76-C14D-4ADE-8F12-C92F7868F83E</domeo:uuid>
    <ao:prefix>The mean reduction of </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:669CA41E-0BFF-4BE0-9F75-CCEB7B793D71">
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:createdOn>2014-07-08 08:45:56 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:23515E27-98AC-4DC9-A4B7-EBFE2991219F</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-08 08:46:38 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:32D7C002-D1F7-45DE-93C0-E75EC19F9E0C"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotationset:57174A7C-3100-4C8F-9C4A-2991CEE124D5</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:5DA3E7EC-AAFD-413F-8CBA-43DD92E2FB7C">
    <ao:prefix>is predominantly metabolized by CYP2C8, and to a lesser extent, 2C9. </ao:prefix>
    <ao:suffix>(4 mg twice daily) was shown to have no clinically relevant effect on the pharmacokinetics of nifedipine and oral contraceptives (ethinyl estradiol and norethindrone), which are predominantly metabolized by CYP3A4.</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-08 08:44:20 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>5DA3E7EC-AAFD-413F-8CBA-43DD92E2FB7C</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:5DA3E7EC-AAFD-413F-8CBA-43DD92E2FB7C"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>AVANDIA </ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:88277212-693D-4F60-BB36-52271F5C953B">
    <ao:prefix>xsd:String</ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-08 15:22:43 -0400</pav:createdOn>
    <domeo:uuid>88277212-693D-4F60-BB36-52271F5C953B</domeo:uuid>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:exact>Cimetidine increased the Cmax and AUC of tacrine by approximately 54% and 64%, respectively.</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:88277212-693D-4F60-BB36-52271F5C953B"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-84.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:7AD90DF1-436B-401A-98CC-DE8342562E62">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/C7A7E069-0951-4C27-ADE5-B290103902BF"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/15D10FDA-BFFF-4DCD-8DC9-80786849F110"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:FEE758AF-9694-4E13-8586-E5A05D6D8C08">
    <ao:prefix>Population pharmacokinetic analyses from 3 large clinical trials including 642 men and 405 women with type 2 diabetes (aged 35 to 80 years) showed that the pharmacokinetics of </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>rosiglitazone </ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:FEE758AF-9694-4E13-8586-E5A05D6D8C08"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <ao:suffix>are not influenced by age, race, smoking, or alcohol consumption. Both oral clearance (CL/F) and oral steady-state volume of distribution (Vss/F) were shown to increase with increases in body weight. Over the weight range observed in these analyses (50 t</ao:suffix>
    <domeo:uuid>FEE758AF-9694-4E13-8586-E5A05D6D8C08</domeo:uuid>
    <pav:createdOn>2014-07-08 08:42:16 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nca36b37233f844bcb0147ecec44858fa">
    <permissions:accessType>urn:person:uuid:080e143046812afe0146812e52b20002</permissions:accessType>
    <permissions:isLocked>false</permissions:isLocked>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:FB06B874-B4FF-4D62-8B98-AF71219A34FD">
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:7CF29B35-95C9-4BFC-A386-5B0C0FFD2800"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A5E637EF-5CA5-4AAC-BD8B-C136A86E17B7</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <ao:body rdf:nodeID="N1c82f3c5b27847e5bf4a69f4586ec9f2"/>
    <pav:lineageUri>urn:domeoserver:annotation:65809AED-1B4A-41AE-A38E-DC8BF1D151F8</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-07-07 11:11:02 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-07 11:12:49 -0400</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N594fecdc7ef54e7d9e2ed87d5086d47d">
    <permissions:accessType>urn:person:uuid:080e143046812afe0146812e52b20002</permissions:accessType>
    <permissions:isLocked>false</permissions:isLocked>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A96CC8A1-3686-4F4F-94B5-15C6698415FB">
    <ao:prefix>xsd:String</ao:prefix>
    <domeo:uuid>A96CC8A1-3686-4F4F-94B5-15C6698415FB</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:A96CC8A1-3686-4F4F-94B5-15C6698415FB"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-194.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:exact>The concomitant administration of propafenone and warfarin increased warfarin plasma concentrations at steady state by 39% in healthy volunteers and prolonged the prothrombin time (PT) in patients taking warfarin. Adjust the warfarin dose as needed by monitoring INR (international normalized ratio)</ao:exact>
    <pav:createdOn>2014-07-08 14:06:28 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N0dc06b8b944b478dbea28a617a7c8fb4">
    <domeo:sets rdf:resource="urn:pddi:uuid:E06449FF-27AB-409D-ACCE-6989F9003648"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/CC7958A8-EF8C-497D-80BC-EC5B5BB91BA7">
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/136411</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>sildenafil</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:0C897DE4-8371-4AB8-8304-233D75C3D5C4">
    <pav:createdOn>2014-07-07 09:37:19 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:834C81A5-0020-416F-9B77-7242D8278517"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A5E637EF-5CA5-4AAC-BD8B-C136A86E17B7</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:lastSavedOn>2014-07-07 09:44:18 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotationset:F37BE993-E972-47AE-896D-FF4D33157ECF</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N8c191c2b128345c3a10b3506d993a868">
    <domeo:sets rdf:resource="urn:pddi:uuid:D2489EE0-7C3D-4370-B631-E17D1D3EE5F3"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:EC52E3BA-595C-4898-AB8A-72864AC3BB2A">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:23515E27-98AC-4DC9-A4B7-EBFE2991219F</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2014-07-08 08:54:46 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotation:2FEA36C9-B3DE-4FD8-9841-430DA0A2575E</pav:lineageUri>
    <pav:createdOn>2014-07-08 08:53:35 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:5FB8459E-CDD4-48C4-9193-B435F97D88AE"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N0c2dfd9445a24e8a99085bfe93bfb0ed">
    <permissions:isLocked>false</permissions:isLocked>
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:9E9F03AB-A2A6-46C9-BCA7-02C82341907C">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/DB710ECA-3146-4E5C-B892-0DFBAF26E8AE"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/C0196136-3C84-442C-B200-A6303F71A2D0"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B246ADC4-BE56-4B04-B17C-94F12339D19A">
    <pav:createdOn>2014-07-07 19:59:54 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>B246ADC4-BE56-4B04-B17C-94F12339D19A</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>sertraline </ao:exact>
    <ao:prefix> equivalent to 25, 50, 100, 150 and 200 mg of </ao:prefix>
    <ao:suffix>and the following inactive ingredients: dibasic calcium phosphate dihydrate, hydroxypropyl cellulose, hypromellose, magnesium stearate, microcrystalline cellulose, polyethylene glycol, sodium starch glycolate, talc, and titanium dioxide.</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-20.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:B246ADC4-BE56-4B04-B17C-94F12339D19A"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:C2C7A88C-89AD-46F7-9603-EE3AB9B12E91">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/C09E7B36-CF7E-46CC-BE7A-E390BF765B53"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/85456BAF-DEC7-4A06-8E92-CC7FA11F98C0"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N80fa97d4ea264918a086f6ad7c01e86c">
    <domeo:sets rdf:resource="urn:pddi:uuid:9D29B1FE-8301-4A0B-AD3B-AB30761382BF"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nb9996d9958824481aee1fbc979222b47">
    <domeo:sets rdf:resource="urn:pddi:uuid:AD666251-9AD6-46C2-BA11-161BB5591AD3"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:0830A501-4DB1-4340-9883-9941C11215DA">
    <domeo:belongsToSet>urn:domeoserver:annotationset:20BEA201-2787-43B1-AE0E-43BE9F4DA8AA</domeo:belongsToSet>
    <pav:createdOn>2014-07-08 15:09:55 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotation:49462E3D-87A2-47F2-B137-7D6272678EF9</pav:lineageUri>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <ao:body rdf:nodeID="Nf559bef8175e41c4867ccb22673fc473"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:98E0775B-36F4-4979-AB5D-9C93AFBE7986"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:lastSavedOn>2014-07-08 15:09:57 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A619E03D-B353-436C-B34F-AA16F0D5282C">
    <ao:context rdf:resource="urn:domeoclient:uuid:21787F97-E99B-41EF-B77B-AB0F5528C723"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:CE45A5D4-BD84-4E02-AC7B-C9E12233EC3A</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotation:0D3E7D7F-7038-4934-BA4F-6B5363904EA9</pav:lineageUri>
    <pav:lastSavedOn>2014-07-07 20:21:40 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-07 20:18:55 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:3F955BFA-EB21-4D9D-A158-F8EF51127ABC">
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-07-07 20:48:02 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:5741C3AA-07D0-4BB3-9A9F-55B13B957620</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:4EBBC32F-0A6D-4C7D-A6E8-705144460C2D"/>
    <pav:lineageUri>urn:domeoserver:annotation:1BA5AC4D-9521-4B36-8387-98B7E5016CB6</pav:lineageUri>
    <pav:createdOn>2014-07-07 20:46:55 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/98A8D343-C135-435E-83F6-1A8ECDB2D8FF">
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/8754</dailymed:activeMoietyRxCUI>
    <rdfs:label>propafenone</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Na46495a1a31840e0ac5ff1904bca3fa0">
    <permissions:isLocked>false</permissions:isLocked>
    <permissions:accessType>urn:person:uuid:080e143046812afe0146812e52b20002</permissions:accessType>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:8C6194A4-8368-4656-9E3C-7E4284F1F9AA">
    <ao:suffix>xsd:String</ao:suffix>
    <pav:createdOn>2014-07-08 15:48:09 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:8C6194A4-8368-4656-9E3C-7E4284F1F9AA"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-7.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>xsd:String</ao:prefix>
    <domeo:uuid>8C6194A4-8368-4656-9E3C-7E4284F1F9AA</domeo:uuid>
    <ao:exact>Repeated oral doses of risperidone (4 mg once daily) did not affect the pre-dose or average plasma concentrations and exposure (AUC) of valproate (1000 mg/day in three divided doses) compared to placebo (N=21). However, there was a 20% increase in valproate peak plasma concentration (Cmax) after concomitant administration of risperidone</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7001DCC7-6265-46EB-A6C2-9C6B3E296409">
    <ao:prefix>Therapy with </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>should not be initiated if the patient exhibits clinical evidence of active liver disease or increased serum transaminase levels (ALT &gt;2.5X upper limit of normal) at baseline [see Warnings and Precautions (5.6)].</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:7001DCC7-6265-46EB-A6C2-9C6B3E296409"/>
    <ao:exact>AVANDIA </ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <domeo:uuid>7001DCC7-6265-46EB-A6C2-9C6B3E296409</domeo:uuid>
    <pav:createdOn>2014-07-08 08:43:14 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:A7CFF507-F3EB-4AF0-84F3-89A814F6D884">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/273C8C06-1913-476F-AB03-E93F984B1A43"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/48B02570-2E21-4F96-8E16-C280E379D64C"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:9F30A64D-EE5B-4F2B-8A69-7ECE39EA536B">
    <domeo:belongsToSet>urn:domeoclient:uuid:423352B3-8ABA-48B7-98CF-B191A7BFC955</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotation:3EEA9DEA-F358-4946-B7A2-72B659E553A5</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2014-07-08 09:35:29 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:createdOn>2014-07-08 09:32:19 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:B3FD7844-E20B-4D1C-95F6-19F94B514146"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nd4aa9a77b49149b09c07e1eada5e953b">
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
    <permissions:isLocked>false</permissions:isLocked>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:79753D21-4644-4E68-92CD-EFE8375D06D1">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/5452E1F8-900D-4E76-ACDF-715CE5F0D54A"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/A10D2735-6C1C-471A-BAA3-E82218F7D177"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:022238E3-0C81-4435-98B6-076F649717A3">
    <ao:suffix>xsd:String</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-7.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:022238E3-0C81-4435-98B6-076F649717A3"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>022238E3-0C81-4435-98B6-076F649717A3</domeo:uuid>
    <ao:prefix> 2.5 to 2.8 fold and 3 to 9 fold, respectively.</ao:prefix>
    <pav:createdOn>2014-07-08 15:50:32 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact> Fluoxetine did not affect the plasma concentration of 9-hydroxyrisperidone.</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:902AF6DE-7CF7-4B84-AC6F-B07989802523">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-07-07 20:14:59 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-07-07 20:16:04 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotation:A6880569-C936-4E7E-8F9F-E25F85CC3653</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <domeo:belongsToSet>urn:domeoclient:uuid:B44CD6F1-18F6-4252-9E79-5D5107E7044D</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:60FB0B7C-2294-4527-B2F8-DA2CBC7F5354"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:BFB71C54-4802-4C93-ABB0-37D1A60425FB">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:23515E27-98AC-4DC9-A4B7-EBFE2991219F</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:lastSavedOn>2014-07-08 08:46:38 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdOn>2014-07-08 08:42:33 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:509F6E6E-9A2D-47D4-9790-C21E0B41EEC3"/>
    <pav:lineageUri>urn:domeoserver:annotationset:57174A7C-3100-4C8F-9C4A-2991CEE124D5</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/326D235D-181F-4247-8092-418CD17F5B15">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/metabolite"/>
    <rdfs:label>norpropafenone</rdfs:label>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/327F567C-19B8-4219-9D9F-0D7F48BD60E9">
    <rdfs:label>fluconazole</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/4450</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/57813A66-7835-4757-A474-8796049D5B9B">
    <rdfs:label>paroxetine</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/32937</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nfb03440ea9f24e0694ce7337bff52953">
    <domeo:sets rdf:resource="urn:pddi:uuid:438F0D23-6DA9-4F72-B481-939F5E080E4D"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:259BE027-3543-490B-ADFA-0EAA9F6709FE">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-21 09:59:01 -0400</pav:createdOn>
    <ao:prefix> and </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:259BE027-3543-490B-ADFA-0EAA9F6709FE"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-6.txt.html</ao:hasSource>
    <domeo:uuid>259BE027-3543-490B-ADFA-0EAA9F6709FE</domeo:uuid>
    <ao:exact>ODV</ao:exact>
    <ao:suffix> after administration of 75 mg </ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:6F5B8347-2FB2-4DAE-A033-930841BF5F41">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/5B2AFCE3-904C-4C03-865C-A3CA1AC1EA68"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/4E6D8555-BF32-4266-8131-8BCA528F84B1"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nf670f69d68634395b9127b879f41bcb2">
    <domeo:sets rdf:resource="urn:pddi:uuid:909C62AA-B9E7-4A5C-9F41-3AE350579069"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/586B177C-B407-4D17-9929-5037CBEF34AA">
    <rdfs:label>ranitidine</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/9143</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:28E91BAE-A9E3-4E24-BA99-95331522F49E">
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:0503C423-2E86-4B5E-AD19-E054650EBD1D"/>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A49E799F-F9F2-49F3-97FB-7B01C8E2B837">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:A49E799F-F9F2-49F3-97FB-7B01C8E2B837"/>
    <domeo:uuid>A49E799F-F9F2-49F3-97FB-7B01C8E2B837</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-07 19:47:14 -0400</pav:createdOn>
    <ao:prefix>Metabolism and Drug Interactions: </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>Risperidone </ao:exact>
    <ao:suffix>is extensively metabolized in the liver. The main metabolic pathway is through hydroxylation of risperidone to 9-hydroxyrisperidone by the enzyme, CYP 2D6. A minor metabolic pathway is through N-dealkylation. The main metabolite, 9-hydroxyrisperidone, ha</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/02ac44a8-840f-4804-a492-bd318355c376">
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:42258B16-6749-4B39-B28D-88C8B63F7A43</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:4e77548e-dbfe-4049-b41b-230bed4c58ce"/>
    <pav:lineageUri>urn:domeoserver:annotationset:0f67c012-7596-4b02-a927-63c0ccbc3afa</pav:lineageUri>
    <pav:lastSavedOn>2014-07-07 08:06:55 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-07 08:06:55 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/09710064-E598-46D4-AE2F-21EEBC2859B0">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>9-hydroxyrisperidone</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/679314</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:8724ee1c-ce76-41b0-b020-ddbf101fa416">
    <pav:createdOn>2014-07-07 08:06:28 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-200.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:8724ee1c-ce76-41b0-b020-ddbf101fa416"/>
    <ao:suffix> resulted in a marked reductio</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>oncomitant administration of </ao:prefix>
    <domeo:uuid></domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>rifampin</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/23EE4D9C-404A-4D73-B39A-6237CB849495">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>9-hydroxyrisperidone</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/679314</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/metabolite"/>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:A540168D-5909-4E6B-9619-215C806B5B22">
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:33082633-99C5-45DE-9FC0-FE3A70B22A1A"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nf559bef8175e41c4867ccb22673fc473">
    <domeo:sets rdf:resource="urn:pddi:uuid:3EBF74E0-8A42-48E9-9F4D-5D7E21FFD4B3"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/6F932F0B-7816-45CF-B148-22F02B5B7B6C">
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/10318</dailymed:activeMoietyRxCUI>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>tacrine</rdfs:label>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:4C0C8D77-8AC0-4C62-A21D-65190C72A23A">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:4C0C8D77-8AC0-4C62-A21D-65190C72A23A"/>
    <ao:prefix>Concurrent administration of </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix>(2 mg twice daily) and metformin (500 mg twice daily) in healthy volunteers for 4 days had no effect on the steady-state pharmacokinetics of either metformin or rosiglitazone.</ao:suffix>
    <ao:exact>AVANDIA </ao:exact>
    <pav:createdOn>2014-07-08 08:50:19 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <domeo:uuid>4C0C8D77-8AC0-4C62-A21D-65190C72A23A</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:CF3EFDCD-3D2A-46B8-AEEB-85C8D06AAE1F">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/86490AFC-CD00-42BB-8142-F90AFDBD9AD3"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/2B3A939E-28BE-4343-95DE-7D1343FA7300"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:0D6D5C14-8BCC-4BA3-9883-54BDC79B61E5">
    <pav:createdOn>2014-07-07 09:41:38 -0400</pav:createdOn>
    <ao:suffix>exposure observed in specifically-designed drug interaction studies with CYP3A inhibitors (except for potent inhibitors such as ketoconazole, itraconazole, and ritonavir).</ao:suffix>
    <domeo:uuid>0D6D5C14-8BCC-4BA3-9883-54BDC79B61E5</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:0D6D5C14-8BCC-4BA3-9883-54BDC79B61E5"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>sildenafil </ao:exact>
    <ao:prefix>exposure without concomitant medication is shown to be 5-fold higher at a dose of 80 mg TID compared to its exposure at a dose of 20 mg TID. This concentration range covers the same increased </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:8FC38083-ECBA-4875-8517-ADB6E4075689">
    <pav:createdOn>2014-07-08 09:30:35 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:B723CBE3-00ED-4773-B4C9-85758048822D"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoclient:uuid:423352B3-8ABA-48B7-98CF-B191A7BFC955</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-08 09:35:29 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotation:13170BF1-3559-4656-A01C-FF6DA84C792F</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:9524D5E6-725D-4392-B518-A9F156431770">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:9524D5E6-725D-4392-B518-A9F156431770"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-194.txt.html</ao:hasSource>
    <domeo:uuid>9524D5E6-725D-4392-B518-A9F156431770</domeo:uuid>
    <pav:createdOn>2014-07-08 14:02:11 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:exact>Concomitant administration of propafenone immediate release tablets and cimetidine in 12 healthy subjects resulted in a 20% increase in steady-state plasma concentrations of propafenone.</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Ne376e438bc0c409f8b063d448397d0a5">
    <domeo:sets rdf:resource="urn:pddi:uuid:EDA4D145-47CC-4A95-B0DA-36D349F1451A"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:CB9CB80C-C629-4453-B307-7061BD797F36">
    <ao:prefix>xsd:String</ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:CB9CB80C-C629-4453-B307-7061BD797F36"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-08 08:47:38 -0400</pav:createdOn>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:exact>Rifampin administration (600 mg once a day), an inducer of CYP2C8, for 6 days is reported to decrease rosiglitazone AUC by 66%, compared to the administration of rosiglitazone</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>CB9CB80C-C629-4453-B307-7061BD797F36</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N0ab0e7c43977446cbd449d045f25a4c1">
    <domeo:sets rdf:resource="urn:pddi:uuid:2A841B9C-D1B0-4F20-A19F-377F63105F6F"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N05bd096ab162492c94b5d0a16acd3a7d">
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
    <permissions:isLocked>false</permissions:isLocked>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/B8452916-45CA-4FB2-BC6D-33F06AF4ECE8">
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>propranolol</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/8787</dailymed:activeMoietyRxCUI>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E9FE1AE2-0879-4FF7-B956-F5B2318E7E9F">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:E9FE1AE2-0879-4FF7-B956-F5B2318E7E9F"/>
    <pav:createdOn>2014-07-08 09:14:50 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>with </ao:prefix>
    <ao:exact>propranolol </ao:exact>
    <ao:suffix>resulted in up to 50% decrease in propranolol concentrations.</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>E9FE1AE2-0879-4FF7-B956-F5B2318E7E9F</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-131.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:A9EAC357-CD11-473D-A57C-5A4721E2CA4F">
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:FAE07F96-AE12-4A34-8AE5-01478E6FC677"/>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:A5315A64-8E04-4F6D-9568-15785741BAE7">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/F0968EE0-6683-48D8-A598-CDF0A5A4A102"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/8D351DCF-757B-4036-9D77-B788A5C7F1B1"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/307C8A7B-C281-4B0C-A5D6-85C576184EEC">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>quinidine</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/9068</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Ne38c3e54b3d2457da7aa506ad1f94598">
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
    <permissions:isLocked>false</permissions:isLocked>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:5B0BA3D0-BE5E-4C18-9751-42A24A039F70">
    <pav:createdOn>2014-07-07 19:52:32 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:DB592E95-99A7-412C-9278-470ED93BE6C1"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <ao:body rdf:nodeID="Na92af93b98874a0ab91747fe80c131a5"/>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:lastSavedOn>2014-07-07 19:59:12 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5ABD9862-F044-4404-AD04-73DA04ADDA8B</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotation:40C6BA61-8917-4A0F-B467-2AA64EFB7164</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:2C0E39A3-C26E-46D5-B5D9-060D5C02B896">
    <pav:createdOn>2014-07-08 14:10:46 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:exact>No significant effects on the pharmacokinetics of propafenone or lidocaine have been seen following their concomitant use in patients.</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-194.txt.html</ao:hasSource>
    <domeo:uuid>2C0E39A3-C26E-46D5-B5D9-060D5C02B896</domeo:uuid>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:2C0E39A3-C26E-46D5-B5D9-060D5C02B896"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nb91e8c7c9d9944178ac0fb5fda3339d9">
    <permissions:accessType>urn:person:uuid:080e143046812afe0146812e52b20002</permissions:accessType>
    <permissions:isLocked>false</permissions:isLocked>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:5039F630-8691-4EE0-B107-894A04362AD6">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/B2341A2E-8D14-49D7-A1C5-3AE702B50889"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/6B307E5B-3667-4F5E-A3B3-944545D190BF"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:3ce99a54-4f9e-442c-946c-e89d6ef85612">
    <ao:exact>didanosine</ao:exact>
    <ao:prefix>nts: The pharmacokinetics of </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:3ce99a54-4f9e-442c-946c-e89d6ef85612"/>
    <pav:createdOn>2014-07-07 08:06:49 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-2.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix> have been evaluated in HIV-ex</ao:suffix>
    <domeo:uuid></domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:4990DB56-73F8-45D3-8251-28D66DAA4A08">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/8B32E833-0D72-42BA-834D-546A60FEFC4D"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/B1D5C3E6-1C69-4520-A396-98360C72654E"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:4A38099F-C63F-4568-8A69-C675EF12DC53">
    <ao:exact>FLAGYL</ao:exact>
    <ao:prefix>at high doses for extended periods of time. A cause and effect relationship has not been established. Crohn's disease is not an approved indication for </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:4A38099F-C63F-4568-8A69-C675EF12DC53"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>.</ao:suffix>
    <pav:createdOn>2014-07-07 20:49:27 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-121.txt.html</ao:hasSource>
    <domeo:uuid>4A38099F-C63F-4568-8A69-C675EF12DC53</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:89DD9489-0036-44B2-9633-543661408072">
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:1412C159-DED8-4D9D-8155-79A5C84AFDCF"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:2C3E8695-7874-4E52-8D3F-836455A22787">
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:ECF50F48-1702-488B-83D2-B0931A1B95D9"/>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:139D415F-8F6D-49CD-B44F-E015C847C5CC">
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:2F6B7F42-AFC6-41B9-9986-AC2F4CB50C3D"/>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:0E94D58B-540F-4528-9F95-4F7176AA19B4">
    <pav:lineageUri>urn:domeoserver:annotation:67F9B33B-8FA1-4A51-99E5-DF5A041271E8</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:D9F8F6A3-1C3D-4E25-9870-A403388D2394</domeo:belongsToSet>
    <pav:createdOn>2014-07-08 12:24:44 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-07-08 12:25:30 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:6FCD0EEA-F2CD-4F0C-807C-1511D1B0FDF5"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/DF6DB1F3-D74D-4611-A45A-BEA8D3FD6220">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/136411</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>sildenafil</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C616CA3F-D5BA-4A06-8DEC-31C84D750966">
    <pav:lineageUri>urn:domeoserver:annotation:0AD28226-93F5-4E50-9A40-4252027FBDC2</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:FC706AFD-18B6-480C-8EAA-2B16C3212C10</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-08 16:24:47 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-07-08 16:27:01 -0400</pav:lastSavedOn>
    <ao:body rdf:nodeID="N8de2a9aea70d4965af0d70cd027b7478"/>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:777C9E4C-1B03-4921-9AE5-9EE6928B3C02"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Ne41a7d74c2f74093a83676cafe63ede3">
    <domeo:sets rdf:resource="urn:pddi:uuid:103D889B-187C-4462-956F-FE724BC7FF0B"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:72FEB0B8-530B-43D2-9A4B-35D0B59F6FF9">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/22298611-16FE-4E59-B553-21245942BFC3"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/8D44C172-C6F0-4671-9756-C4F28A2B2863"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:1E224B43-906A-4906-BCC8-73BE83836DA5">
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:AD703DCB-F0EC-4F79-9C36-E0FBB495DE86"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:0A6ECB26-7E88-457C-9908-8D6F2BD3CFE9">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>Fluconazole 100 mg was administered as a single oral dose alone and two hours after a single dose of cimetidine 400 mg to six healthy male volunteers. After the administration of cimetidine, there was a significant decrease in fluconazole AUC and Cmax. There was a mean ± SD decrease in fluconazole AUC of 13% ± 11% (range: -3.4 to -31%) and Cmax decreased 19% ± 14% (range: -5 to -40%). However, the administration of cimetidine 600 mg to 900 mg intravenously over a four-hour period (from one hour before to 3 hours after a single oral dose of fluconazole 200 mg) did not affect the bioavailability or pharmacokinetics of fluconazole in 24 healthy male volunteers.</ao:exact>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-23.txt.html</ao:hasSource>
    <domeo:uuid>0A6ECB26-7E88-457C-9908-8D6F2BD3CFE9</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:0A6ECB26-7E88-457C-9908-8D6F2BD3CFE9"/>
    <ao:suffix>xsd:String</ao:suffix>
    <pav:createdOn>2014-07-07 20:09:35 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E9CDCB47-0AFD-42FA-A005-046710AA7DA9">
    <ao:body rdf:nodeID="Nb49098238eac4ee0af9597e50e756108"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:FB87340E-70BC-45FD-9049-CFF3CB56C885"/>
    <pav:lastSavedOn>2014-07-08 16:27:01 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:FC706AFD-18B6-480C-8EAA-2B16C3212C10</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotation:BF681788-36A0-423C-9D3F-C53ABDA382BF</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:createdOn>2014-07-08 16:23:13 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/2C500AE3-4892-4662-8FFB-CE45555EA3AE">
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>synercid</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/drug-product"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/135097</dailymed:activeMoietyRxCUI>
    <dct:description>Referred to the drug in the interaction.</dct:description>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:391F9F2D-B990-4A7F-AB0A-29238C621196">
    <domeo:uuid>391F9F2D-B990-4A7F-AB0A-29238C621196</domeo:uuid>
    <pav:createdOn>2014-07-07 09:38:43 -0400</pav:createdOn>
    <ao:exact>N-desmethyl</ao:exact>
    <ao:suffix> metabolite, respectively, compared to those seen in healthy younger volunteers (18–45 years). Due to age-differences in plasma protein binding, the corresponding increase in the AUC of free (unbound) sildenafil and its active N-desmethyl metabolite were</ao:suffix>
    <ao:prefix>and its active </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:391F9F2D-B990-4A7F-AB0A-29238C621196"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/1D3FDE5B-24D7-456E-8010-9792EF8845A5">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>metformin</rdfs:label>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/6809</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7055BC1F-17EA-44CF-878C-8B64C98F7D1E">
    <pav:createdOn>2014-07-08 08:39:16 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>was shown to be mediated by increased sensitivity to insulin’s action in the liver, muscle, and adipose tissues. Pharmacological studies in animal models indicate that rosiglitazone inhibits hepatic gluconeogenesis. The expression of the insulin-regulate</ao:suffix>
    <ao:exact>rosiglitazone </ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:7055BC1F-17EA-44CF-878C-8B64C98F7D1E"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <ao:prefix>In animal models, the antidiabetic activity of </ao:prefix>
    <domeo:uuid>7055BC1F-17EA-44CF-878C-8B64C98F7D1E</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:49704B7D-496E-47CD-AD8F-92CA4B51CEE3">
    <ao:exact>Plasma zidovudine concentrations were determined on two occasions (before and following fluconazole 200 mg daily for 15 days) in 13 volunteers with AIDS or ARC who were on a stable zidovudine dose for at least two weeks. There was a significant increase in zidovudine AUC following the administration of fluconazole. The mean ± SD increase in AUC was 20% ± 32% (range: -27 to 104%). The metabolite, GZDV, to parent drug ratio significantly decreased after the administration of fluconazole, from 7.6 ± 3.6 to 5.7 ± 2.2.</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-27.txt.html</ao:hasSource>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:49704B7D-496E-47CD-AD8F-92CA4B51CEE3"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-07 20:18:05 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>xsd:String</ao:prefix>
    <domeo:uuid>49704B7D-496E-47CD-AD8F-92CA4B51CEE3</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:9E35FC3E-1628-48F1-8A0E-34D3D804CA99">
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:4990DB56-73F8-45D3-8251-28D66DAA4A08"/>
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:ECD4407D-6AC1-4231-916E-89F94396BAA6">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:ECD4407D-6AC1-4231-916E-89F94396BAA6"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-08 08:44:16 -0400</pav:createdOn>
    <domeo:uuid>ECD4407D-6AC1-4231-916E-89F94396BAA6</domeo:uuid>
    <ao:suffix>does not inhibit any of the major P450 enzymes at clinically relevant concentrations. In vitro data demonstrate that rosiglitazone is predominantly metabolized by CYP2C8, and to a lesser extent, 2C9. AVANDIA (4 mg twice daily) was shown to have no clinic</ao:suffix>
    <ao:prefix>In vitro drug metabolism studies suggest that </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <ao:exact>rosiglitazone </ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:C755BB2A-5541-440B-AEE6-51B8F4C9E01D">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/1E4E8F6A-3A48-4092-AAF6-AC5D3FAF61DE"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/7F638D5E-20F1-4197-85B5-3382FBAE9B3F"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/8BAF963A-578A-4CDA-B28C-2B0C856CC916">
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>ribavirin</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/9344</dailymed:activeMoietyRxCUI>
    <dct:description>Referred to the drug in the interaction.</dct:description>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/C1226775-5083-4A9F-9222-7AF1243FB256">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>cimetidine</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/2541</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/4F4DAAF9-DAE5-455A-8F29-B2B127598365">
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/10438</dailymed:activeMoietyRxCUI>
    <rdfs:label>theophylline</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A44FCBB3-9EDC-4EFA-A3BD-7C8E0304D317">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">3</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:32944008-A6C6-4D66-8C43-EE4CF2256965</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-21 10:02:11 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotationset:cf593dca-fe93-451b-8f37-2a96e065da13</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:createdOn>2014-07-21 10:00:45 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:previousVersion>urn:domeoclient:uuid:21a2d27a-13b1-4797-ba7a-c0517e32bb06</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:CA0F8B4D-5EF3-4FE9-A834-82FFC2B34383"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nff20b33c196a4a36862fcfbc543e21ff">
    <domeo:sets rdf:resource="urn:pddi:uuid:2F47F565-35EA-4A4D-BBF3-08BB71607252"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/904DB7CC-73CB-4BBB-8AAD-C8F50A8C78A1">
    <rdfs:label>fluconazole</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/4450</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N6159ca4759f0451a80ebecb56ce5e9d5">
    <domeo:sets rdf:resource="urn:pddi:uuid:D9FF5205-23B6-4D07-9F7B-61A78AA14B73"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/913A2B29-87B1-46E4-AD36-9F679285636D">
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/35636</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>risperidone</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D64630DF-4F6D-414D-AEED-E6781F4A963F">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:D64630DF-4F6D-414D-AEED-E6781F4A963F"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-201.txt.html</ao:hasSource>
    <ao:exact>In a pharmacokinetic study with patients on methadone maintenance therapy, phenytoin administration (250 mg b.i.d. initially for 1 day followed by 300 mg QD for 3 to 4 days) resulted in an approximately 50% reduction in methadone exposure and withdrawal symptoms occurred concurrently. Upon discontinuation of phenytoin, the incidence of withdrawal symptoms decreased and methadone exposure increased to a level comparable to that prior to phenytoin administration.</ao:exact>
    <ao:suffix>xsd:String</ao:suffix>
    <pav:createdOn>2014-07-08 12:29:01 -0400</pav:createdOn>
    <domeo:uuid>D64630DF-4F6D-414D-AEED-E6781F4A963F</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/36bf1ceb-9ee3-475a-9565-323ce4c6e4c6">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:AFA31957-0959-46DF-B640-AD0687F186D6</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:lastSavedOn>2014-07-07 08:06:56 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:b90c038c-fd66-4f1e-9b69-1afb329a449b"/>
    <pav:createdOn>2014-07-07 08:06:56 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotationset:e2189d4e-f5e1-4d47-aaf1-f7ab8dd8e62f</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/C4BFA302-F317-46ED-815E-B1D71FEB5BB0">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/7514</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>norethindrone</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoserver:annotationset:4813B8AA-0B59-46E2-A60D-4C599BDB18F2">
    <dct:description>The NER set is created automatically by NER annotation loading program.</dct:description>
    <pav:previousVersion>urn:domeoclient:uuid:94d83f17-f79a-4c8d-8cd3-39498bf0d4b3</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">3</pav:versionNumber>
    <permissions:permissions rdf:nodeID="N5146d17280124665abd670546ed1680a"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotationset:71ef9d96-69ba-4693-8517-f0b0ec28acf8</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812e52b20002"/>
    <rdfs:label>NER Sets</rdfs:label>
    <pav:lastSavedOn>2014-07-08 13:48:39 -0400</pav:lastSavedOn>
    <domeo:deleted>false</domeo:deleted>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:33F47466-2571-42C4-A381-03919A7C6041"/>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-199.txt.html</ao:annotatesResource>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <pav:createdOn>2014-07-07 08:06:41 -0400</pav:createdOn>
    <ao:item rdf:resource="file:///home/yin2/python-SPL-connector/baa8fbbb-84d5-4f92-aa86-b07ad5bda767"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:0D8FAF03-60C1-4EE4-B17A-F31AEF7068A8">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>REVATIO </ao:exact>
    <ao:prefix>has been characterized following intravenous administration. A 10 mg dose of </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:0D8FAF03-60C1-4EE4-B17A-F31AEF7068A8"/>
    <ao:suffix>Injection is predicted to provide a pharmacological effect of sildenafil and its N-desmethyl metabolite equivalent to that of a 20 mg oral dose.</ao:suffix>
    <pav:createdOn>2014-07-07 09:37:47 -0400</pav:createdOn>
    <domeo:uuid>0D8FAF03-60C1-4EE4-B17A-F31AEF7068A8</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:4C98BC55-C073-4B2D-A1EF-169277F2920F">
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotation:3FD27975-8838-4CFE-B8EF-0941E9C6E471</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:664A8EC3-6EA0-47D2-B994-117AE852D15B"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5ABD9862-F044-4404-AD04-73DA04ADDA8B</domeo:belongsToSet>
    <pav:createdOn>2014-07-07 19:58:26 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-07-07 19:59:12 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N0861eaedbdab40f1b5b4de99c9e07070">
    <domeo:sets rdf:resource="urn:pddi:uuid:39AFBC32-AA3F-440F-AF92-CA97278CFD93"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/FC58BA69-9FE6-4D4E-BEEF-272817554373">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>fluconazole</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/4450</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N7f31acf777024b738b59aecba5d3b02a">
    <domeo:sets rdf:resource="urn:pddi:uuid:28E91BAE-A9E3-4E24-BA99-95331522F49E"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/0402ABD7-DCC7-4E46-820F-F8370F53E288">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/31565</dailymed:activeMoietyRxCUI>
    <rdfs:label>nefazodone</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:754BED3A-2AFD-4639-985C-597BEC2FF280">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/169CB49D-0198-4EA2-AD6D-62C7C27F83FD"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/39FD41C7-82A3-43B9-8C95-EDB6013A5402"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B5C57D15-B8BA-46C5-A554-0CBBB810E45A">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:B5C57D15-B8BA-46C5-A554-0CBBB810E45A"/>
    <ao:suffix>.</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>B5C57D15-B8BA-46C5-A554-0CBBB810E45A</domeo:uuid>
    <ao:prefix>plus </ao:prefix>
    <pav:createdOn>2014-07-07 19:47:35 -0400</pav:createdOn>
    <ao:exact>9-hydroxyrisperidone</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:AFFE5BB1-A40C-4E7F-8B02-439CA1FD04C1">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/FB42240B-C361-448A-BEE4-E705D0525538"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/08A790EF-B177-41C4-A7D3-441F3A73EB04"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C1A84858-737F-4A61-A1F1-F52D60DE0638">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>C1A84858-737F-4A61-A1F1-F52D60DE0638</domeo:uuid>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:C1A84858-737F-4A61-A1F1-F52D60DE0638"/>
    <ao:suffix>clearance</ao:suffix>
    <ao:exact>sildenafil </ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-07 09:59:42 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/6BB530E4-371C-4611-9227-183E9C959EC6">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>propranolol</rdfs:label>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/8787</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:10ACC947-F6D8-49C9-8281-3FDD803F2175">
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:C0FBEBCF-3474-4EF0-82C4-429CF3F5D004"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:464BFA2C-135D-42E7-BAF8-E1621BE503F2">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotation:62743313-025A-4635-9B48-220EE892F812</pav:lineageUri>
    <pav:createdOn>2014-07-08 15:47:13 -0400</pav:createdOn>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5B2167F6-4E63-4A7B-85C1-ACA56DDE7073</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:9B0E5A58-4948-43CE-8D14-EEFE932458AA"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:body rdf:nodeID="N56d3905d335640a18f55fecd2496e498"/>
    <pav:lastSavedOn>2014-07-08 15:56:00 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:ED201F07-D8A3-4A66-A1AD-5C521E57A143">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:suffix>AUC was determined after 4 days of phenytoin dosing (200 mg daily, orally for 3 days followed by 250 mg intravenously for one dose) both with and without the administration of fluconazole (oral fluconazole 200 mg daily for 16 days) in 10 normal male volu</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-25.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-07 20:13:21 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:ED201F07-D8A3-4A66-A1AD-5C521E57A143"/>
    <ao:exact>Phenytoin </ao:exact>
    <domeo:uuid>ED201F07-D8A3-4A66-A1AD-5C521E57A143</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:35C5E273-FFFA-4DC2-98FD-912FDF2383BB">
    <ao:exact>sildenafil</ao:exact>
    <pav:createdOn>2014-07-07 09:38:38 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:35C5E273-FFFA-4DC2-98FD-912FDF2383BB"/>
    <ao:prefix>Healthy elderly volunteers (65 years or over) had a reduced clearance of </ao:prefix>
    <ao:suffix>, resulting in approximately 84% and 107% higher plasma concentrations of sildenafil and its active N-desmethyl metabolite, respectively, compared to those seen in healthy younger volunteers (18–45 years). Due to age-differences in plasma protein binding</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>35C5E273-FFFA-4DC2-98FD-912FDF2383BB</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:8393BD4D-8CD7-4806-9E0A-35FDD4A60FC0">
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:D15E7653-CB57-4569-A367-133D3E4E0D38"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:CDFD2463-4A00-4BEF-AEE9-ED3BF98C439C">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:CDFD2463-4A00-4BEF-AEE9-ED3BF98C439C"/>
    <ao:exact>ODV</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix> and </ao:prefix>
    <pav:createdOn>2014-07-21 09:58:56 -0400</pav:createdOn>
    <domeo:uuid>CDFD2463-4A00-4BEF-AEE9-ED3BF98C439C</domeo:uuid>
    <ao:suffix> exhibited linear kinetics over the dose range of 75 to 450 mg/day. The mean ± SD apparent elimination half-life for </ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-6.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:80283BB4-29B5-4452-8CDF-A0101F68A693">
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:0A6FE314-257F-49FF-80A5-583F34F05A22"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/31425B5E-0A6D-44B4-9AA4-883674DD71EB">
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/6922</dailymed:activeMoietyRxCUI>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>metronidazole</rdfs:label>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/DFFD245D-5941-4C8E-8A49-EEDBEF09FE21">
    <rdfs:label>metoprolol</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/6918</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/4DA8DAF4-7FC4-40C0-B72B-9E5949E0AAF9">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>carbamazepine</rdfs:label>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/2002</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:866CCC7A-93D2-4F06-9190-18051A3FBDA0">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/D177823B-9EAD-487B-94D2-6DF517A17AF9"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/2A400422-D42A-409F-B8B5-C371F4009186"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N2ac19a41de314c75ab1bc855f11a23c4">
    <domeo:sets rdf:resource="urn:pddi:uuid:57682BEC-A9C6-4874-9392-76F313AC2B89"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/8014FF26-CC26-4854-BC1F-33D05D62D1F1">
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/4450</dailymed:activeMoietyRxCUI>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>fluconazole</rdfs:label>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:5C44531F-5F11-4CD5-A5A5-ADF80319AED7">
    <ao:prefix>. In two separate studies in healthy adult subjects,</ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:5C44531F-5F11-4CD5-A5A5-ADF80319AED7"/>
    <ao:suffix> 120 mg twice daily (240 mg total daily dose) was coadministered with either erythromycin 500 mg every 8 hours or ketoconazole 400 mg once daily under steady-state conditions to healthy adult subjects (n = 24, each study). No differences in adverse event</ao:suffix>
    <domeo:uuid>5C44531F-5F11-4CD5-A5A5-ADF80319AED7</domeo:uuid>
    <pav:createdOn>2014-07-08 09:32:09 -0400</pav:createdOn>
    <ao:exact> fexofenadine hydrochloride</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-139.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N117049124655432bafe7633d805b02da">
    <domeo:sets rdf:resource="urn:pddi:uuid:806814E2-6819-43DF-A823-97F018FEE863"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/22298611-16FE-4E59-B553-21245942BFC3">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/2541</dailymed:activeMoietyRxCUI>
    <rdfs:label>cimetidine</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:FFE06586-CA64-4D14-9906-87BF1D474D89">
    <ao:prefix>Repeat oral dosing of </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:FFE06586-CA64-4D14-9906-87BF1D474D89"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>FFE06586-CA64-4D14-9906-87BF1D474D89</domeo:uuid>
    <ao:suffix>(8 mg once daily) for 14 days did not alter the steady-state pharmacokinetics of digoxin (0.375 mg once daily) in healthy volunteers.</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-08 08:52:49 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>AVANDIA </ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:DCF51EA4-ED9F-4B02-9629-083F4CF8C4B9">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/F4FB4230-0BD0-43E1-A876-B462C9AD90A5"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/5B52DB41-9FC1-480F-B670-4A3A38F25AA7"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/BBB5CAFB-7825-4BC7-9F6E-BD80C1476D81">
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>propranolol</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/8787</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/D8D2DC59-6B17-4B98-889B-A5CEF158DDC1">
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/358262</dailymed:activeMoietyRxCUI>
    <rdfs:label>fosamprenavir</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/91508FEF-0959-4477-AE90-C239D7B3B3D5">
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/9384</dailymed:activeMoietyRxCUI>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>rifampin</rdfs:label>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/9351F136-D702-454C-8A37-CCEEB19628AC">
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/10318</dailymed:activeMoietyRxCUI>
    <rdfs:label>tacrine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:344A5D2F-014C-4385-9EFC-D45AA24FD6AB">
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:07B006D3-C156-4713-8F3B-12933069FD58"/>
    <pav:lastSavedOn>2014-07-21 10:02:11 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:32944008-A6C6-4D66-8C43-EE4CF2256965</domeo:belongsToSet>
    <pav:previousVersion>urn:domeoclient:uuid:21a2d27a-13b1-4797-ba7a-c0517e32bb06</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:createdOn>2014-07-21 10:00:06 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">3</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotationset:cf593dca-fe93-451b-8f37-2a96e065da13</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/579F25EF-46DB-40E8-A6EE-8D523F3C8E7B">
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>gemfibrozil</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/4719</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:E623C8BF-4B60-46A2-ABC4-B069E31D8178">
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:034EA61C-9BDA-4E57-9796-F89476A46606"/>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:56A35079-EF48-414A-B9BF-0DB91C8DFB1C">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">3</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:previousVersion>urn:domeoclient:uuid:21a2d27a-13b1-4797-ba7a-c0517e32bb06</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:lastSavedOn>2014-07-21 10:02:11 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-21 09:59:55 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotationset:cf593dca-fe93-451b-8f37-2a96e065da13</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:907976C5-54D9-472C-8460-A17DCCF26925"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:32944008-A6C6-4D66-8C43-EE4CF2256965</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/A2CAB863-5774-4FA6-B534-E9C0B853023A">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/7417</dailymed:activeMoietyRxCUI>
    <rdfs:label>nifedipine</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7509829A-B936-4161-BBE6-69B2DEAE95B2">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:7509829A-B936-4161-BBE6-69B2DEAE95B2"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-118.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:suffix>xsd:String</ao:suffix>
    <pav:createdOn>2014-07-07 20:44:30 -0400</pav:createdOn>
    <domeo:uuid>7509829A-B936-4161-BBE6-69B2DEAE95B2</domeo:uuid>
    <ao:exact>Concomitant administration of Synercid and nifedipine (repeated oral doses) and midazolam (intravenous bolus dose) in healthy volunteers led to elevated plasma concentrations of these drugs. The Cmax increased by 18% and 14% (median values) and the AUC increased by 44% and 33% for nifedipine and midazolam, respectively</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/3FB7D59A-2FF4-483E-85DA-F584C275EB6A">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>risperidone</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/35636</dailymed:activeMoietyRxCUI>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/854A3D13-94BA-4398-986C-292EFE511072">
    <rdfs:label>conivaptan</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/302285</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:25B2E67D-ACC9-4BF4-BD21-6D415CC88B22">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/5EA05A06-BCD5-4338-8FF9-7C01CFDC9D99"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/B0136BFA-3999-4CC3-972B-A93AF566760D"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N065d126d033442f58138d3eee5b0857d">
    <domeo:sets rdf:resource="urn:pddi:uuid:23B6EFF2-B809-40DE-AD18-61F5912D0D6C"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N32e2767b22964219bbe06d9a60e77f00">
    <permissions:accessType>urn:person:uuid:080e143046812afe0146812e52b20002</permissions:accessType>
    <permissions:isLocked>false</permissions:isLocked>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/B7C31221-04F8-4CEE-AAAC-778C9169ACCD">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>cimetidine</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/2541</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D8B7217A-0E2A-4A58-9940-24D039448A5A">
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:4192F65E-0A2A-4144-B614-A7AD53168063"/>
    <pav:createdOn>2014-07-07 20:23:14 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoclient:uuid:5F40D6FC-BF07-4E5A-BB51-EB521FF63890</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:992B50A0-FD7B-402B-A2C4-284F15A69A5F</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:lastSavedOn>2014-07-07 20:25:19 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N16d3e9136431471c8f058300bf22c30e">
    <domeo:sets rdf:resource="urn:pddi:uuid:1D3DBFBE-9585-4079-87E5-D1EE0A05CCDC"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:2A841B9C-D1B0-4F20-A19F-377F63105F6F">
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:88BF56BF-3895-498E-A799-0899022AB075"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/AC839FA9-6493-45F4-A616-B24C258ADE3D">
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>norverapamil</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/0</dailymed:activeMoietyRxCUI>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:5C775FDE-7B0E-4E69-BEAA-3DDE26FBB962">
    <ao:exact>AVANDIA </ao:exact>
    <ao:suffix>4 mg twice daily. The corresponding values for glyburide were 3.2, 3.1, and 2.9. The differences in change from baseline between AVANDIA and glyburide at week 52 were statistically significant.</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:5C775FDE-7B0E-4E69-BEAA-3DDE26FBB962"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <ao:prefix> over time. Because of the temporal nature of lipid changes, the 52-week glyburide-controlled study is most pertinent to assess long-term effects on lipids. At baseline, week 26, and week 52, mean LDL/HDL ratios were 3.1, 3.2, and 3.0, respectively, for </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-08 08:39:49 -0400</pav:createdOn>
    <domeo:uuid>5C775FDE-7B0E-4E69-BEAA-3DDE26FBB962</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:2298466A-2D08-484D-9B2F-8BD46B755ED5">
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:9DE423B5-ABCD-4F5E-9946-38D40B8FFA92"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N6ea66fc4ceb2412fa021dfb41d134ba4">
    <domeo:sets rdf:resource="urn:pddi:uuid:99B66051-05C5-4A5C-9CC4-9F934D30E681"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:5385CB5D-503D-45A4-8152-D9264772EA7C">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/913A2B29-87B1-46E4-AD36-9F679285636D"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/76B37439-260F-48CE-B23E-0D570EF0A919"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/650db048-e16a-4f92-83d3-99d83bfd216f">
    <pav:lineageUri>urn:domeoserver:annotationset:89f9f7ee-5cce-4dda-8df8-7ac97b746603</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:D5FE9F58-EB3F-4295-9090-E3B773EBD671</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2014-07-07 08:07:06 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-07 08:07:06 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:de0a7789-8d6c-49a1-95fc-556021933023"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/57E332C5-7223-42D1-9C68-7D90FBAC4378">
    <rdfs:label>glyburide</rdfs:label>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/drug-product"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/4815</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Na637fbd890c44dc69385c0af620e7597">
    <permissions:isLocked>false</permissions:isLocked>
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N92c6456254d145ed9b16f64beebcd6e1">
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
    <permissions:isLocked>false</permissions:isLocked>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:224CE40F-FA7D-412A-991C-46B58835C734">
    <ao:exact>zonisamide </ao:exact>
    <ao:suffix>who experienced an event on at least one occasion. All events are included except those already listed in the previous table or discussed in WARNINGS or PRECAUTIONS, trivial events, those too general to be informative, and those not reasonably associated</ao:suffix>
    <ao:prefix>e of the proportion of individuals having adverse events, similar events have been grouped into a smaller number of standardized categories using a modified COSTART dictionary. The frequencies represent the proportion of the 1,598 individuals exposed to </ao:prefix>
    <domeo:uuid>224CE40F-FA7D-412A-991C-46B58835C734</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:224CE40F-FA7D-412A-991C-46B58835C734"/>
    <pav:createdOn>2014-07-07 20:37:07 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-58.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N94d266d26d5d422abf1d96b374969007">
    <domeo:sets rdf:resource="urn:pddi:uuid:07F30C2A-43FD-4CEE-AA13-00183CE2740B"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/82061165-DB05-4BB4-A173-343F5807E5A9">
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/261455</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/drug-product"/>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>avandia</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:3741A47A-7BB2-4E44-9D97-AA1C2F61C8E0">
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:E469C1E6-5FEF-4979-A372-CABE985684AE"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:BCF0BF4F-A014-4C3F-B48D-43FE6F97E692">
    <ao:context rdf:resource="urn:domeoclient:uuid:FFE06586-CA64-4D14-9906-87BF1D474D89"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:lastSavedOn>2014-07-08 08:54:46 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-08 08:52:49 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:23515E27-98AC-4DC9-A4B7-EBFE2991219F</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotation:C3DD3B8B-2692-49F3-806A-0E65E84965CD</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeo:software:id:Domeo-2.1alpha-050">
    <foafx:name>Domeo Annotation Toolkit</foafx:name>
    <rdf:type rdf:resource="http://xmlns.com/foaf/0.1/Software"/>
    <foafx:version>2.1alpha</foafx:version>
    <foafx:homepage></foafx:homepage>
    <foafx:build>050</foafx:build>
    <rdfs:label>Domeo Annotation Toolkit</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:5181BC1D-3286-4894-A565-A9FFC27DE47D">
    <ao:exact>Sildenafil</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:5181BC1D-3286-4894-A565-A9FFC27DE47D"/>
    <ao:prefix>is an inhibitor of cGMP specific phosphodiesterase type-5 (PDE5) in the smooth muscle of the pulmonary vasculature, where PDE5 is responsible for degradation of cGMP. </ao:prefix>
    <domeo:uuid>5181BC1D-3286-4894-A565-A9FFC27DE47D</domeo:uuid>
    <pav:createdOn>2014-07-07 09:34:15 -0400</pav:createdOn>
    <ao:suffix>, therefore, increases cGMP within pulmonary vascular smooth muscle cells resulting in relaxation. In patients with pulmonary hypertension, this can lead to vasodilation of the pulmonary vascular bed and, to a lesser degree, vasodilatation in the systemi</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:39C7490C-F7EF-4E93-A34E-42899C09A8EE">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/9F2C382B-34F4-4C1F-95FD-7D67E69F62DD"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/06C43F74-BFE4-4D12-A90C-CC09F2C57EC0"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:4760224B-BA51-444B-B6B5-33CB08955766">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:4760224B-BA51-444B-B6B5-33CB08955766"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>4760224B-BA51-444B-B6B5-33CB08955766</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-21.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-07 20:00:43 -0400</pav:createdOn>
    <ao:suffix>dosing resulted in small increases in the mean AUCs of ethinyl estradiol and norethindrone compared to similar placebo dosing. The mean AUCs of ethinyl estradiol and norethindrone increased by 24% (95% C.I. range 18 to 31%) and 13% (95% C.I. range 8 to 1</ao:suffix>
    <ao:prefix>. In this placebo-controlled, double-blind, randomized, two-way crossover study carried out over three cycles of oral contraceptive treatment, </ao:prefix>
    <ao:exact>fluconazole </ao:exact>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N8a93165935c74feab832de0da8225b33">
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
    <permissions:isLocked>false</permissions:isLocked>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:C089E1CC-2282-47A7-9CD8-1A8CDE44E4CF">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/0F8794D3-EE9E-46A8-AF6A-5DA06883035F"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/2A15FE31-8FA9-40F5-A760-5DD109DE3566"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/B745E074-30FB-4142-81F6-BD02946EC3D1">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>risperidone</rdfs:label>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/35636</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:8AA97147-AF03-4B01-B629-3C1F5AA55B8E">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/F7CA2B97-C5F9-46D6-BFFF-90E12B0B93D1"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/0DC6D3A9-A74B-4580-A1F6-4B53C8FA2A15"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:EF949635-6901-4CE4-BCD7-44DBD592D1A1">
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:8973650B-5704-4E3B-B6FD-B8F9AD0B1EA1"/>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:3c78b515-2f1c-4754-b9b5-d7fb2bc7a24f">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-80.txt.html</ao:hasSource>
    <ao:exact>citalopram</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>fect the pharmacokinetics of </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:3c78b515-2f1c-4754-b9b5-d7fb2bc7a24f"/>
    <ao:suffix>.</ao:suffix>
    <domeo:uuid></domeo:uuid>
    <pav:createdOn>2014-07-07 08:06:28 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Ndf247b9d910f492b94b7d476b2e26e30">
    <permissions:accessType>urn:person:uuid:080e143046812afe0146812e52b20002</permissions:accessType>
    <permissions:isLocked>false</permissions:isLocked>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:10FC2AE6-3D78-49F7-A50F-BE9A59A3CDC0">
    <pav:createdOn>2014-07-08 09:20:02 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:body rdf:nodeID="Nb583a21519834a7da32d7d79862bd1eb"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotation:B254B027-2A6A-4848-BE02-2C1551B79849</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:A74F6F6D-8509-4EE5-9A08-B6B745242744"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoclient:uuid:6FFD9FFA-5CED-4EE2-B68F-77212B4C447D</domeo:belongsToSet>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-08 09:20:18 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/7C4B1784-1430-407F-9FAA-88E97F36C9EB">
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/49276</dailymed:activeMoietyRxCUI>
    <rdfs:label>doxazosin</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:0040EE85-0BD0-4541-A221-A6208194C8B8">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:0040EE85-0BD0-4541-A221-A6208194C8B8"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-07 09:42:27 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>0040EE85-0BD0-4541-A221-A6208194C8B8</domeo:uuid>
    <ao:exact>sildenafil </ao:exact>
    <ao:prefix>Injection: Predictions based on a pharmacokinetic model suggest that drug-drug interactions with CYP3A inhibitors will be less than those observed after oral </ao:prefix>
    <ao:suffix>administration.</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/38F65DE7-565F-4D13-BD4E-F21C558A1FAD">
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>fluconazole</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/4450</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N87f517a3446042478ba5c2a312374b04">
    <domeo:sets rdf:resource="urn:pddi:uuid:89DD9489-0036-44B2-9633-543661408072"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A783503F-D134-4BA3-811E-99FCE28F6D1F">
    <ao:body rdf:nodeID="N8c191c2b128345c3a10b3506d993a868"/>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotation:F04E8A0C-7170-44F1-8E1E-4998E50A17E9</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoclient:uuid:29AAB777-4FBF-49C4-ACFD-F2FC169A463D</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-07 20:51:02 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:B5CD836A-F310-4CCA-A338-1A237A923AFA"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-07 20:50:29 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:570AE2C8-D6FE-4DBE-9EDE-B410F3051CE4">
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:C089E1CC-2282-47A7-9CD8-1A8CDE44E4CF"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N8de2a9aea70d4965af0d70cd027b7478">
    <domeo:sets rdf:resource="urn:pddi:uuid:3C979E76-9208-4356-A3EF-AB2C09EAFBFC"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/2B3A939E-28BE-4343-95DE-7D1343FA7300">
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>fluconazole</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/4450</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nf9d2e9059a7a4ff887aaba2dadbd80e7">
    <domeo:sets rdf:resource="urn:pddi:uuid:10343BA1-CFD4-4E42-B692-9AE2060A8BC5"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:0C5EAB8A-A5D7-4D32-83AB-D39CF883B0E8">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/0A2105BA-161C-46C3-8F75-2B8D19459A6D"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/87B49C8E-24A1-466A-9FB8-10E9639396E3"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:724E7696-829F-4C35-B420-71C3F76F5576">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/FB757EE1-994D-4CD6-8BB6-BB8D93075EC8"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/8BC4CE43-4877-4129-9C2B-F586677B731A"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N310490f36c194f878c4417c981f7fdd4">
    <domeo:sets rdf:resource="urn:pddi:uuid:5D143EBD-CAED-45DA-B862-537A83975A7D"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:7E49AB8E-8817-45B4-8E16-558BDA21606A">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/A2CAB863-5774-4FA6-B534-E9C0B853023A"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/E2BDB371-63C8-454A-AD68-EB53444E8AC6"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/EB04F09B-EFA9-412A-91A8-D56E330C3863">
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/10737</dailymed:activeMoietyRxCUI>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>trazodone</rdfs:label>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N6d3a3a35d06b43848acc6998e1d606ec">
    <permissions:isLocked>false</permissions:isLocked>
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N5d459dfadf5347dda8e0d8049510a297">
    <domeo:sets rdf:resource="urn:pddi:uuid:AB8171F3-07B9-42F6-9D75-FD10020A5985"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:D399BCC8-CC65-4CC4-B163-F49A409E7F12">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/21E36C1E-B88A-4461-9263-C02A58739F96"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/C721EADB-C42D-4138-BA2B-ACCB482924B1"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:2D03CF26-E207-41FC-9CD7-850A03CDCCD2">
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:1ADEF082-C8D1-4819-BAF7-F900CA73882C"/>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:F406802A-8A0C-434F-AE23-CB449ABB6F23">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/2A2722D8-9183-4738-9882-DF85987C17F1"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/1D3FDE5B-24D7-456E-8010-9792EF8845A5"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:9DE423B5-ABCD-4F5E-9946-38D40B8FFA92">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/454E08CE-230F-4257-8E40-56C4E52A3761"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/C773EABA-6050-40AF-B6A4-222438562519"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nf6f2fdb3e24b42d1830787a2573aca38">
    <permissions:accessType>urn:person:uuid:080e143046812afe0146812e52b20002</permissions:accessType>
    <permissions:isLocked>false</permissions:isLocked>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N9dc55c89f01a4a128eed91f40ae18879">
    <domeo:sets rdf:resource="urn:pddi:uuid:26444E6B-4F7D-4B82-823E-8448D975E2A7"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:AE16633D-EF6A-47C6-8285-531ADE811704">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/70AA207A-68D2-4FD4-9EA8-5885D4F53473"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/5745BEC0-963C-402D-A4E8-FA2EC4385EF6"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N17ebfbdd1c8b491b8a0221195789d134">
    <domeo:sets rdf:resource="urn:pddi:uuid:EF949635-6901-4CE4-BCD7-44DBD592D1A1"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:1BF81E1E-29DF-40E7-AA33-3733E21C84C5">
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:900260F9-4D67-46D8-94CE-466B51D8EFDA"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:1D290924-DB5E-41E2-8AAF-8EE3C253F8DC">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/59D9ECD3-E41B-4231-9AF0-2BDE7B69432D"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/FD95F493-0BAA-45A7-99BF-73C7148B90E0"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:DD3B7CB1-50CE-40F2-9924-420A9DBAC79F">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/30F837D7-0FB7-4976-B0BD-225960FF74DA"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/5CC7D46B-007F-44E6-AF8E-62F7C28E3054"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:A7F51E53-793A-4CD7-A0F3-81F882156AF4">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/F66FD94C-0E21-4E46-B074-8DBC81252C1E"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/7FBEF37B-C286-4C21-880E-2EEC16F03F5E"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/B9C43951-91D7-4A8E-A429-F7C9AF3A67CB">
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>diazepam</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/3322</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:0ED7471A-86C1-4E44-9D4B-8B976265F8F5">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/C9BA828B-CAAC-4396-BA76-584A34D7A18A"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/7D74AB39-C011-4EAC-ABA2-04B165D3B788"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/50A6DB6C-33B0-4D08-B4E1-2895C9381964">
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/11170</dailymed:activeMoietyRxCUI>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>verapamil</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/CECB4775-D4B7-429E-8E14-0456EA8E8052">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/8754</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>propafenone</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/65457ABE-BAE3-4005-A13F-A2834CBD9EF7">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>stavudine</rdfs:label>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/59763</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:54F6DEFC-18B2-4047-98BF-0D0048E3E48B">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/2336CD05-F58E-4A57-BFFA-5855A4F3A62F"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/6EE857E3-B335-4B8B-BDBD-88275DA0B4AB"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:B456BE0F-C7EE-45C3-A8C4-FD0EAFA2EA56">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/DFFD245D-5941-4C8E-8A49-EEDBEF09FE21"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/2C1D2B84-97A0-4C19-BACC-6C81E6872394"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:3309A2DD-1B4E-4FDD-99E4-1EEDFF150A24">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/787A9872-C820-49C3-952B-1F9E77649F9C"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/8BEB2377-350D-4F73-AC83-E152716A168D"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N108ba8f9c86342028a1306cddd46710b">
    <permissions:isLocked>false</permissions:isLocked>
    <permissions:accessType>urn:person:uuid:080e143046812afe0146812e52b20002</permissions:accessType>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:E07E4FF7-42C6-4591-ABCD-0B1AACC8916F">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/327F567C-19B8-4219-9D9F-0D7F48BD60E9"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/70B62EC4-4ADA-4112-8636-FF088E74D00D"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:2C26BC1F-A06D-41FA-A11C-92D12A631B4E">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/3FB7D59A-2FF4-483E-85DA-F584C275EB6A"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/D7A28440-08F4-43AC-9202-1443C29DAA3E"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7872312D-0BC1-4F3D-B41E-15A504540DB2">
    <pav:createdOn>2014-07-07 20:16:47 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-27.txt.html</ao:hasSource>
    <domeo:uuid>7872312D-0BC1-4F3D-B41E-15A504540DB2</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:7872312D-0BC1-4F3D-B41E-15A504540DB2"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>. The mean ± SD increase in AUC was 20% ± 32% (range: -27 to 104%). The metabolite, </ao:prefix>
    <ao:suffix>, to parent drug ratio significantly decreased after the administration of fluconazole, from 7.6 ± 3.6 to 5.7 ± 2.2.</ao:suffix>
    <ao:exact>GZDV</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:CA1B9D41-C7F8-47A4-A4C7-3EABFE91B094">
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:9C7C5039-DD8D-4FE8-BB4A-9936F8D84081"/>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N7d5383f11eb74d49b08aa991afe59917">
    <permissions:isLocked>false</permissions:isLocked>
    <permissions:accessType>urn:person:uuid:080e143046812afe0146812e52b20002</permissions:accessType>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N289f90950b36473cbd19dfd95a06aa50">
    <domeo:sets rdf:resource="urn:pddi:uuid:2FF7AFF6-AC26-446E-BEDB-AAD17733DA7D"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N3b4115f8431549d8b293b217d8dbabf3">
    <permissions:isLocked>false</permissions:isLocked>
    <permissions:accessType>urn:person:uuid:080e143046812afe0146812e52b20002</permissions:accessType>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/591B3511-CF63-4182-98CA-4CCD27664BDA">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>valproate</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/40254</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:1412C159-DED8-4D9D-8155-79A5C84AFDCF">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/B2DBECBC-E519-456B-B6A9-CD187A695253"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/B0E08964-375C-4F20-9B1B-C43DF7C0AF1C"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:9D29B1FE-8301-4A0B-AD3B-AB30761382BF">
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:BF596DE1-89B2-4F17-BEE1-BCD4AB86BEB1"/>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:99B66051-05C5-4A5C-9CC4-9F934D30E681">
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:4137748B-0B0D-43C0-A9BC-2FF22C298165"/>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:05E013A5-0A04-4AA9-A902-B63CC2AB44A1">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/DBE7AE9D-51F6-4790-98F3-E24A4410C8B9"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/DB75092B-C73B-4848-9086-92F4260E2407"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/7F638D5E-20F1-4197-85B5-3382FBAE9B3F">
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>cimetidine</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/2541</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:CEBD26AA-9CF9-41E1-A1B9-84D97923F68D">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/57613F17-B9E0-4DDD-A332-6D5DE9EEA74F"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/F0A44968-9104-4A52-8182-BAD78F48C11F"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:9C7C5039-DD8D-4FE8-BB4A-9936F8D84081">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/35E575CF-A8D9-4836-A122-AEAD931648B0"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/989A4B6C-6497-4A7C-8D4D-80E118AD049A"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:068F30EB-E921-459E-9FA7-715247E2E20D">
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:6086A2AC-2622-4D21-93E3-4827AB9A3275"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:5323E4F3-3BE3-400B-AA93-AB47E8EB9EF5">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:5323E4F3-3BE3-400B-AA93-AB47E8EB9EF5"/>
    <pav:createdOn>2014-07-08 15:00:04 -0400</pav:createdOn>
    <ao:prefix>xsd:String</ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>5323E4F3-3BE3-400B-AA93-AB47E8EB9EF5</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-113.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:exact>Cimetidine: Five studies in healthy volunteers investigated the impact of multiple cimetidine doses on the single or multiple dose pharmacokinetics of nifedipine. Two studies investigated the impact of coadministered cimetidine on blood pressure in hypertensive subjects on nifedipine. In normotensive subjects receiving single doses of 10 mg or multiple doses of up to 20 mg nifedipine t.i.d. alone or together with cimetidine up to 1000 mg/day, the AUC values of nifedipine in the presence of cimetidine were between 1.52 and 2.01 times those in the absence of cimetidine. The Cmax values of nifedipine in the presence of cimetidine were increased by factors ranging between 1.60 and 2.02. The increase in exposure to nifedipine by cimetidine was accompanied by relevant changes in blood pressure or heart rate in normotensive subjects. Hypertensive subjects receiving 10 mg q.d. nifedipine alone or in combination with cimetidine 1000 mg q.d. also experienced relevant changes in blood pressure when cimetidine was added to nifedipine. The interaction between cimetidine and nifedipine is of clinical relevance and blood pressure should be monitored and a reduction of the dose of nifedipine considered.</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N58004a0d8b43493ea143e39b1a2ca2a4">
    <domeo:sets rdf:resource="urn:pddi:uuid:7C4AA39C-93C3-49FA-BD23-FDE9388D7CDF"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A7CD6119-C16D-4C28-A98A-7728036DFE6F">
    <ao:suffix> These increases in plasma concentration would decrease the cardioselectivity of</ao:suffix>
    <domeo:uuid>A7CD6119-C16D-4C28-A98A-7728036DFE6F</domeo:uuid>
    <ao:exact>In four patients with cardiovascular disease, coadministration of propafenone 150 mg t.i.d. with immediate-release metoprolol 50 mg t.i.d. resulted in two- to five-fold increases in the steady-state concentration of metoprolol.</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-106.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:A7CD6119-C16D-4C28-A98A-7728036DFE6F"/>
    <pav:createdOn>2014-07-08 16:16:30 -0400</pav:createdOn>
    <ao:prefix> </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N2b13e9878164449e9a2325a44e3dc0bb">
    <domeo:sets rdf:resource="urn:pddi:uuid:11CB835D-E153-42CD-B292-F57F07E59A01"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N7a37923d86f04459acb1f4f161b242b6">
    <domeo:sets rdf:resource="urn:pddi:uuid:B8FAC4A2-6DD2-4B0B-BB1D-A40E87B33736"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/29C34D0E-2F46-4BA3-9CA0-689762F394CA">
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>carbamazepine</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/2002</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C4DC9582-5EF5-481D-8D20-F00BC67EBF18">
    <ao:suffix>results in insufficient plasma concentrations of nefazodone and its active metabolite to achieve a therapeutic effect. Coadministration of carbamazepine with nefazodone is contraindicated (see CONTRAINDICATIONS).</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:C4DC9582-5EF5-481D-8D20-F00BC67EBF18"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>with </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-59.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-07 20:38:01 -0400</pav:createdOn>
    <ao:exact>nefazodone </ao:exact>
    <domeo:uuid>C4DC9582-5EF5-481D-8D20-F00BC67EBF18</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:55513051-DFF3-4FF6-887C-1DABCEA7A687">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/174851CD-339E-4EB2-9D68-23B44533AF1D"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/EA608D09-B1FC-4430-8CE3-0E74299DFDB3"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N11e31bc86b46416ab06f8a1e2207e3a2">
    <domeo:sets rdf:resource="urn:pddi:uuid:2E87D888-9C78-4226-B0BD-E5E0E67003BD"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:734E53B9-AB5D-4B89-A9E2-092C2AF4B18D">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/66FF8966-1521-4CF1-AA71-E2698D1361EB"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/0E4C87E8-886C-4557-A4DA-D648516CDD37"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:2BFF8E2A-425A-4FC7-A14C-E1B47EEBF558">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/E7718C56-205F-479E-B8CA-67AB9D3FF18E"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/8623D3EF-4558-43BF-81E6-F4E924429C85"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N61ae5f846f6a4f5ebd74741e8362c9bb">
    <domeo:sets rdf:resource="urn:pddi:uuid:91E17503-6125-4400-96AB-ADC20AA1778D"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N74ba8303b08d45508e6b2a4579f94d94">
    <permissions:accessType>urn:person:uuid:080e143046812afe0146812e52b20002</permissions:accessType>
    <permissions:isLocked>false</permissions:isLocked>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N32b773b19e5043a99c729e387641b947">
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
    <permissions:isLocked>false</permissions:isLocked>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:99255C70-041A-42DF-B255-977CABD47162">
    <pav:lineageUri>urn:domeoserver:annotation:112845DC-730E-4866-9943-CD41A9309265</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2014-07-08 12:21:20 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2014-07-08 12:21:50 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:D9ABDF09-DEE9-4F4A-AF7E-5E45D8F68A4C"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:7821C64B-A0CD-480C-9DC8-F790FC33069A</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:CA735731-CC8F-4385-910D-C906B33A428D">
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:DB554CE5-0CDD-4795-87C2-02BE9BAD787B"/>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:9E783620-42AF-4752-A325-B509AFDFFB28">
    <ao:body rdf:nodeID="Nd95638a5abd649eba1af67cfcd1bd4ac"/>
    <pav:createdOn>2014-07-08 12:10:56 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:lastSavedOn>2014-07-08 12:10:57 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:43CCC5CC-8859-4834-A955-A002353E5EC1"/>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotation:06F69744-428C-4A39-B260-2C821ACB0583</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:BA8F9408-39CC-4619-AA2D-75BA5518E56A</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:ED7D7CD7-54C7-4657-8B88-65D1C1D8BA33">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/3950011E-E876-4E30-B0EA-49F04F9A0AAA"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/E079F00F-69EB-4F85-BF7E-B89E4393D276"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N8237b5f1e9e348deba3b6fd4bbec3ed3">
    <permissions:isLocked>false</permissions:isLocked>
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N172c327ab41f458ab288cae0703380b4">
    <permissions:accessType>urn:person:uuid:080e143046812afe0146812e52b20002</permissions:accessType>
    <permissions:isLocked>false</permissions:isLocked>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:2060940A-BAB5-4249-9194-D54B0DB0122C">
    <domeo:uuid>2060940A-BAB5-4249-9194-D54B0DB0122C</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:2060940A-BAB5-4249-9194-D54B0DB0122C"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix>, but quinidine does not alter the kinetics of diltiazem.</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-54.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>significantly decreases the clearance and increases the t1/2 of </ao:prefix>
    <pav:createdOn>2014-07-07 20:29:19 -0400</pav:createdOn>
    <ao:exact>quinidine</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:8A241659-7402-4319-97F5-5963D71DBD57">
    <ao:prefix>Coadministration of </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-161.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:8A241659-7402-4319-97F5-5963D71DBD57"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>at steady-state with a single oral dose of azithromycin resulted in increased azithromycin serum concentrations. Although a dose adjustment of azithromycin is not recommended when administered in combination with nelfinavir, close monitoring for known si</ao:suffix>
    <pav:createdOn>2014-07-08 12:02:49 -0400</pav:createdOn>
    <ao:exact>nelfinavir </ao:exact>
    <domeo:uuid>8A241659-7402-4319-97F5-5963D71DBD57</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/E0C8A2CE-A978-4272-A1E3-AAF778CF075F">
    <rdfs:label>risperidone</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/35636</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:75B44BA0-D816-46A5-99A6-457021B00223">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/213EABC8-6CEA-4750-9D74-37FF92DB0C44"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/C195D96F-1230-45AA-BB89-7D58FDD0E249"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N7b56766e55bf4f4390027e0f5c4c3d4b">
    <domeo:sets rdf:resource="urn:pddi:uuid:E92F7BC2-8BCB-4661-A965-804023FE2DB0"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/D8A1D49C-D373-412D-91FB-8141DB5F9226">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>fluoxetine</rdfs:label>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/4493</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/60987FBE-1EE6-4110-AC7D-451F54CCD3F6">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>propranolol</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/8787</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:E2432E61-6381-481B-A3AB-D8427E3230EC">
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:9ADDA684-1D80-4FB0-AACD-815525325B37"/>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:11E7A483-A6AB-4163-9077-B99D00B57343">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/CE7FEF8E-0597-493A-B9DE-0605AB63DB26"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/73E79438-B92C-497E-BE60-91BD62FF6502"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/E87E97CB-75F7-426C-BC5C-862E55883384">
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>metoprolol</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/6918</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nc5102505fa9440049b6ae99afdbe23ef">
    <domeo:sets rdf:resource="urn:pddi:uuid:14FCA0B3-FAC3-4B43-8315-2DC7FE7E5AD6"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A9B1E87D-AEAD-4C83-91D0-47B64B244A03">
    <ao:exact>fluconazole </ao:exact>
    <ao:prefix>(oral </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-25.txt.html</ao:hasSource>
    <domeo:uuid>A9B1E87D-AEAD-4C83-91D0-47B64B244A03</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:A9B1E87D-AEAD-4C83-91D0-47B64B244A03"/>
    <pav:createdOn>2014-07-07 20:13:26 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix>200 mg daily for 16 days) in 10 normal male volunteers. There was a significant increase in phenytoin AUC. The mean ± SD increase in phenytoin AUC was 88% ± 68% (range: 16 to 247%). The absolute magnitude of this interaction is unknown because of the int</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nc1755b3b0c6c4ca4a74d233019132e17">
    <permissions:accessType>urn:person:uuid:080e143046812afe0146812e52b20002</permissions:accessType>
    <permissions:isLocked>false</permissions:isLocked>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nb5d07bd24c94494b833e86046d9a8ba8">
    <permissions:isLocked>false</permissions:isLocked>
    <permissions:accessType>urn:person:uuid:080e143046812afe0146812e52b20002</permissions:accessType>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/F7427BDA-5185-4463-8457-C5F62A27D2CF">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>propafenone</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/8754</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/B8F23E92-2827-483E-8296-5E8BE85291A6">
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>propranolol</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/8787</dailymed:activeMoietyRxCUI>
    <dct:description>Referred to the drug in the interaction.</dct:description>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:676B923B-76C4-4DC8-A8B1-EB5F0038B6C7">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/B7C8DD30-1B6B-4BD8-89A8-87EDEEE8007E"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/73454139-0B0D-48FA-9133-D060ACC18FC1"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/989A4B6C-6497-4A7C-8D4D-80E118AD049A">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/0</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/metabolite"/>
    <rdfs:label>normeperidine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/16A7EFEF-5084-4E85-BE25-7F496A380249">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>diazepam</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/3322</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/23650622-8463-4D76-A1BD-36175D649F09">
    <rdfs:label>zidovudine</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/11413</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Ne309c6be35c74b0da4df1d44be4fd28b">
    <domeo:sets rdf:resource="urn:pddi:uuid:1086D8AE-9571-4279-BF24-48DE0417DC58"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/E36D20BF-A00A-4402-8BB3-1E415197F08D">
    <rdfs:label>ketoconazole</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/6135</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/2A400422-D42A-409F-B8B5-C371F4009186">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>diazepam</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/3322</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/375A46D7-7759-41D5-9E8F-E7870641FDAB">
    <rdfs:label>glipizide</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/4821</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:5EA4C0F8-EA6B-4BE6-A3B9-DC86052DB26F">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/86E96E12-27C6-4F67-9634-38348E14C402"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/0C543B99-2957-4B98-97A0-7FEEF1ED30EC"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:7AF2CBA9-42F4-4A07-A533-38832949E9CD">
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:FF1C6068-2FFE-4633-8A8C-DC8BF089155B"/>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Ndb65d5051b424394a5571b0f8031cd36">
    <domeo:sets rdf:resource="urn:pddi:uuid:84281820-7E4B-45D0-B3A3-06DFBF19FD17"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N8ab6b98e52fb4b5aa398bffb047d35ea">
    <domeo:sets rdf:resource="urn:pddi:uuid:CAA6775D-8044-4806-8565-503A0E33EE07"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N39ec460835d84ba39e765e464445dfce">
    <domeo:sets rdf:resource="urn:pddi:uuid:FDE5759F-C43D-4692-875D-23DB15AAFE13"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N3d52ae6291a04881970e84d7c3d3b9b0">
    <domeo:sets rdf:resource="urn:pddi:uuid:A0840F01-8503-4B3F-B653-98AB1ED1E2DD"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Na9692d2d4cba41a3ba7d241b1a01b9ed">
    <domeo:sets rdf:resource="urn:pddi:uuid:D2097D36-94DF-4060-86D3-20EBBA772832"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/35388E97-5248-4CD8-8E7E-5B3D580B692C">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>sildenafil</rdfs:label>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/136411</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:53ADDC78-18B4-44AD-ABBF-A30CDF275DCD">
    <domeo:belongsToSet>urn:domeoclient:uuid:6FFD9FFA-5CED-4EE2-B68F-77212B4C447D</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotation:F4C85D93-A0F4-4ECC-8F9B-7947D6B61EF6</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2014-07-08 09:20:18 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-07-08 09:18:55 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:B751918C-EA39-4A8A-A1C0-EAD51F1DC933"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N35045957b08d4f5791951bc05e522c7e">
    <permissions:accessType>urn:person:uuid:080e143046812afe0146812e52b20002</permissions:accessType>
    <permissions:isLocked>false</permissions:isLocked>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N03f8776ca8b942808d07e122df4760a8">
    <permissions:isLocked>false</permissions:isLocked>
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N682aead81e164d5891cb07472a7b7a3d">
    <permissions:accessType>urn:person:uuid:080e143046812afe0146812e52b20002</permissions:accessType>
    <permissions:isLocked>false</permissions:isLocked>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/2D4DEE29-CCF4-4C1F-B9EF-A5ED6DE97483">
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>ketoconazole</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/6135</dailymed:activeMoietyRxCUI>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nd891230a6eaf41d6a0d376f7b2a678c0">
    <permissions:accessType>urn:person:uuid:080e143046812afe0146812e52b20002</permissions:accessType>
    <permissions:isLocked>false</permissions:isLocked>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/8BC4CE43-4877-4129-9C2B-F586677B731A">
    <rdfs:label>vaprisol</rdfs:label>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/drug-product"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:E5F0B80A-96B4-4BA7-AAF2-FE0504723103">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/7011C888-1DBD-407F-BF39-7F15390D0EE1"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/14DFE55C-BB47-4B58-A7E8-FC46364B8315"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/7D74AB39-C011-4EAC-ABA2-04B165D3B788">
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>diazepam</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/3322</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N68cb233e4ef8440f897d557ab3e8db96">
    <permissions:isLocked>false</permissions:isLocked>
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/010E9851-9F86-43D8-96D9-0D99B06DB471">
    <rdfs:label>simvastatin</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/36567</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:1C8F355C-9736-48FE-90F1-529FF2A3C2D6">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/E87E97CB-75F7-426C-BC5C-862E55883384"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/307C8A7B-C281-4B0C-A5D6-85C576184EEC"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/15D10FDA-BFFF-4DCD-8DC9-80786849F110">
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>isoniazid</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/</dailymed:activeMoietyRxCUI>
    <dct:description>Referred to the drug in the interaction.</dct:description>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:5BFAB712-E552-497E-A61F-9D79D928F612">
    <pav:createdOn>2014-07-08 16:25:36 -0400</pav:createdOn>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:FC706AFD-18B6-480C-8EAA-2B16C3212C10</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-07-08 16:27:01 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:F4DE1F6C-EDE4-459B-80B3-75FA8BB2375D"/>
    <pav:lineageUri>urn:domeoserver:annotation:FDD04DCA-4207-4558-AE74-3D18F248A9C9</pav:lineageUri>
    <ao:body rdf:nodeID="Ne2d4b4666157454697f831078df69a14"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nfbd826c802584448b68537059a93a48a">
    <permissions:isLocked>false</permissions:isLocked>
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N12245f2d43ce4619a7cdac0555359cb2">
    <domeo:sets rdf:resource="urn:pddi:uuid:AAF31B6C-0415-4C04-8A0D-1C29CC4F28EB"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N5ad2459d384b4b65bd1ab531879638cd">
    <domeo:sets rdf:resource="urn:pddi:uuid:8393BD4D-8CD7-4806-9E0A-35FDD4A60FC0"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/BF968EF9-C4E9-4782-8751-6FE8B1C0AC19">
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/7417</dailymed:activeMoietyRxCUI>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>nifedipine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:EB75C25A-6C63-4297-9772-CF11D5C04339">
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotation:069468E7-6AC6-473A-AB26-6731132F68FF</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:81F2A979-244B-45F4-8FC4-8C849AAFC0A7"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:23515E27-98AC-4DC9-A4B7-EBFE2991219F</domeo:belongsToSet>
    <pav:createdOn>2014-07-08 08:54:11 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2014-07-08 08:54:46 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D0B7DE32-3D78-4C61-966D-2B5132608A55">
    <ao:prefix>xsd:String</ao:prefix>
    <ao:suffix> and a 210% increase in </ao:suffix>
    <domeo:uuid>D0B7DE32-3D78-4C61-966D-2B5132608A55</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:D0B7DE32-3D78-4C61-966D-2B5132608A55"/>
    <ao:exact>Cmax</ao:exact>
    <pav:createdOn>2014-07-07 09:42:19 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:72260FA8-0B73-4A65-A3CB-995662149BAB">
    <ao:exact>diltiazem</ao:exact>
    <pav:createdOn>2014-07-07 20:29:22 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:72260FA8-0B73-4A65-A3CB-995662149BAB"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-54.txt.html</ao:hasSource>
    <domeo:uuid>72260FA8-0B73-4A65-A3CB-995662149BAB</domeo:uuid>
    <ao:prefix>does not alter the kinetics of </ao:prefix>
    <ao:suffix>.</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:B901A23A-2D92-4B95-A7E7-00DFB949D801">
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:6D24ADA6-A839-4786-990A-09504C69DDC8"/>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N7170e779e71c4c07ad5d26e134ded7e3">
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
    <permissions:isLocked>false</permissions:isLocked>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/C27FA43E-4E7E-43AF-80A0-13FFCAFABACA">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>sildenafil</rdfs:label>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/136411</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/2330B94A-D045-489D-A83C-36DF1292A974">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/4450</dailymed:activeMoietyRxCUI>
    <rdfs:label>fluconazole</rdfs:label>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nd33b787970c3490390b5241899f30ccb">
    <domeo:sets rdf:resource="urn:pddi:uuid:2896EAD9-998E-417F-90ED-17FBDF536C79"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N443a6170f739437487479bea75f6389a">
    <domeo:sets rdf:resource="urn:pddi:uuid:A9EAC357-CD11-473D-A57C-5A4721E2CA4F"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/86E96E12-27C6-4F67-9634-38348E14C402">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>phenytoin</rdfs:label>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/8183</dailymed:activeMoietyRxCUI>
    <dct:description>Referred to the drug in the interaction.</dct:description>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N69359b24f9094664acd5cca01641d85b">
    <domeo:sets rdf:resource="urn:pddi:uuid:49FBB7FA-A7AD-41E5-8022-357F6957DAC6"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N2fe4376784044a85aeb5a0dcd70da54f">
    <domeo:sets rdf:resource="urn:pddi:uuid:7E902A46-3539-41A8-90FD-F243C13CF1A3"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/1948CE05-84FB-406D-BD86-37071A76770B">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/36437</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>sertraline</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:DB0CF638-0598-4B41-A77B-7A38CD787732">
    <pav:createdOn>2014-07-08 15:30:37 -0400</pav:createdOn>
    <ao:exact>Experimental evidence demonstrated that methadone decreased the AUC and peak levels for didanosine and stavudine, with a more significant decrease for didanosine. Methadone disposition was not substantially altered.</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:DB0CF638-0598-4B41-A77B-7A38CD787732"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>xsd:String</ao:prefix>
    <domeo:uuid>DB0CF638-0598-4B41-A77B-7A38CD787732</domeo:uuid>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-198.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:AB99AD03-9381-485E-9E73-C5953E8CFFF6">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/A8F107DC-5781-4268-AC53-71F6114F4523"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/CB34AE0A-F55D-4FD1-8DCA-AFD5309C11F7"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N7338ee47b7884d81aa08b211f62bbe1a">
    <domeo:sets rdf:resource="urn:pddi:uuid:38AA06CF-CFD2-443D-82BE-6543FB9C2898"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:D9D2D21A-F876-40E7-971B-098FE7CBA0D7">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/212DE14C-F6F2-442C-9261-2FCF8A64585C"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/FED356F3-23B5-4F53-9570-A1096F15C824"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:F7E8F731-D07C-40BE-B0AF-196E15B59701">
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:08F1DD6D-5B4C-4E48-AC58-284431A52EA7"/>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:2D934787-5E98-487C-8EC9-10858A122FA8">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/780BF305-B0DE-4AB1-AA49-E1BF6C54B7D9"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/4DB0A1E7-E228-49D0-8188-72F996564E53"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N6f7fb1e00638415193eb32ba67aee72a">
    <domeo:sets rdf:resource="urn:pddi:uuid:D7BCED1A-9822-4118-8E30-EDD14522080A"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/7ACF8347-8F3F-47DE-913B-8929BD2810B0">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/8814</dailymed:activeMoietyRxCUI>
    <rdfs:label>epoprostenol</rdfs:label>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N23e4a5448931432183b93fe3d9c6411a">
    <permissions:isLocked>false</permissions:isLocked>
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nc49aed790c7643d3889bcbb34b78f1b1">
    <domeo:sets rdf:resource="urn:pddi:uuid:3F40DD6E-04E6-4CE5-AE6D-15E564491E4F"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N57e218f459e8455b922477980e35d728">
    <permissions:accessType>urn:person:uuid:080e143046812afe0146812e52b20002</permissions:accessType>
    <permissions:isLocked>false</permissions:isLocked>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N82b56864af014f968b08de96ad4b3c7d">
    <domeo:sets rdf:resource="urn:pddi:uuid:968978BF-13DD-4F90-AF23-8A7C26298327"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Ncdcd42a396524892bf6ba4b6281c36ff">
    <permissions:accessType>urn:person:uuid:080e143046812afe0146812e52b20002</permissions:accessType>
    <permissions:isLocked>false</permissions:isLocked>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:0A4EAF63-CC18-4B64-866C-110E5C3A514A">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/7E67FBD1-1884-411C-8CBD-31822D4DFA45"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/546815C0-01DB-45B5-B13E-96321735ABBF"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:9E42F185-8094-4BFF-A454-C4C8D38C7000">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/CC7958A8-EF8C-497D-80BC-EC5B5BB91BA7"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/0E4C3039-A561-44D2-B2B5-14FE50280C0E"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:70F5B079-3744-487B-86C2-80B6B7EFA7FA">
    <pav:createdOn>2014-07-07 20:05:55 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2014-07-07 20:07:11 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812e52b20002</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotation:704C146B-B84D-46A7-8C0A-AD46E450BDE5</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:3A5A80F9-DC68-4C7C-A655-65EE08B07140"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoclient:uuid:4A49ACB6-4B71-452F-80EE-8A84DEF45C29</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:01B4DFB6-1E6D-448E-8813-3E2BAD66E729">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/6877D20B-179B-4477-8400-4C49D09BBE59"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/98A8D343-C135-435E-83F6-1A8ECDB2D8FF"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/61EDB172-8B70-4F81-A8AF-29810964A17A">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>glyburide</rdfs:label>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/4815</dailymed:activeMoietyRxCUI>
    <dct:description>Referred to the drug in the interaction.</dct:description>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/3BBAEE26-B09E-403A-A3F1-D75446BB25C5">
    <rdfs:label>pimozide</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/8331</dailymed:activeMoietyRxCUI>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/B10807E1-FC12-4534-8AE2-885FC006F07A">
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/7417</dailymed:activeMoietyRxCUI>
    <rdfs:label>nifedipine</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N6c9ccf05bc504ffab744f29f638a369a">
    <domeo:sets rdf:resource="urn:pddi:uuid:8FB241FE-F32C-4D8C-8E1B-082F499034C4"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:64F313A0-19D6-48B5-93D3-2BA905C097F9">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/0BDAF8E9-DD98-4554-9ED9-A766580D5592"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/D9C80643-B2F0-4DC6-9193-A68CBB23B4B2"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:54D20BC4-F36E-4EA2-B59F-954DEB519409">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>54D20BC4-F36E-4EA2-B59F-954DEB519409</domeo:uuid>
    <ao:suffix>to 9-hydroxyrisperidone by the enzyme, CYP 2D6. A minor metabolic pathway is through N-dealkylation. The main metabolite, 9-hydroxyrisperidone, has similar pharmacological activity as risperidone. Consequently, the clinical effect of the drug results fro</ao:suffix>
    <ao:prefix>is extensively metabolized in the liver. The main metabolic pathway is through hydroxylation of </ao:prefix>
    <pav:createdOn>2014-07-07 19:47:18 -0400</pav:createdOn>
    <ao:exact>risperidone </ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:54D20BC4-F36E-4EA2-B59F-954DEB519409"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A73CA70C-594C-4651-8C54-617A39333BF3">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:A73CA70C-594C-4651-8C54-617A39333BF3"/>
    <pav:createdOn>2014-07-07 09:35:34 -0400</pav:createdOn>
    <domeo:uuid>A73CA70C-594C-4651-8C54-617A39333BF3</domeo:uuid>
    <ao:suffix>on Blood Pressure</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>REVATIO </ao:exact>
    <ao:prefix>Effects of </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Naa8eccd5fad345a6a8a0bb7d17a26d3a">
    <domeo:sets rdf:resource="urn:pddi:uuid:5E43E412-CC11-44B9-BCF8-EE8A3F78D619"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nf051d5be4bc04cd7af04840c4db3bd8d">
    <domeo:sets rdf:resource="urn:pddi:uuid:CCD9BDE6-F8A6-4C7F-944E-A90E670A790B"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:1CB611B0-6AD8-4324-B643-42DE5864CFF9">
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:808A8F1C-57F2-429D-8219-EFE26579913D"/>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/6EE857E3-B335-4B8B-BDBD-88275DA0B4AB">
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/4450</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>fluconazole</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/8A186325-8DCE-44DE-812F-F2CE9C6B70AF">
    <rdfs:label>conivaptan</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/302285</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N14a5c68735da4cf88468c47c3cc942be">
    <domeo:sets rdf:resource="urn:pddi:uuid:9D7E7C43-98FA-48B1-A007-559C7E9E16DF"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:91EDAA42-79D3-4D95-A202-95002BE782A6">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/8EC4E370-16FC-443A-A51C-4B4CB8E665B0"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/B67FCB11-23CA-469A-8D02-EAB2019D489E"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N5e900611943e471da25732676f8d4960">
    <domeo:sets rdf:resource="urn:pddi:uuid:30A7C621-CE0B-4F38-9093-2C12DF3A6185"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:64AE0C86-D69D-4D65-8411-5263170107F4">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/0AFFD176-DC9D-49E4-90F6-E40F8DB81C2A"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/60987FBE-1EE6-4110-AC7D-451F54CCD3F6"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N2cd98276db2f44599221ac8ec3f5c967">
    <domeo:sets rdf:resource="urn:pddi:uuid:2298466A-2D08-484D-9B2F-8BD46B755ED5"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N64dc3819eef8430db8f6f2141002cbfb">
    <domeo:sets rdf:resource="urn:pddi:uuid:C7BE795D-5206-40FE-8E16-CE80148D9C23"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:60B2F624-82F3-4850-A07E-C14BE5C50B7D">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/61B86845-4EAE-44DA-90EE-8B8F4954091A"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/CE418736-DE0D-4D38-A56E-BBFA9F574C20"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/FEFF941F-51C6-4218-A0D7-EEE4AF29B30E">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/134527</dailymed:activeMoietyRxCUI>
    <rdfs:label>nelfinavir</rdfs:label>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N4f05bdf122b7424da08d224f9508b605">
    <domeo:sets rdf:resource="urn:pddi:uuid:90FDAF68-043B-4B5A-A508-DF827D98A2B1"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N54751d99a46940dc87d2db2215faef5d">
    <permissions:accessType>urn:person:uuid:080e143046812afe0146812e52b20002</permissions:accessType>
    <permissions:isLocked>false</permissions:isLocked>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:F913AD73-2825-4550-B9B9-C8F20585B6C1">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/7F992173-E32B-4C8E-B733-5E741ADFAD47"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/8CC81AC0-CEFB-4A96-947B-166920995536"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N4258cac2f3e6468686acf01469c403b6">
    <domeo:sets rdf:resource="urn:pddi:uuid:80283BB4-29B5-4452-8CDF-A0101F68A693"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:D3BEFEBB-9211-43B5-A0FB-019C489569E0">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/5A39A9EB-5E3D-48B3-BB2E-313515FFB236"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/1B7DFF9A-8B7A-4F5D-9A36-1A18501F264E"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:36261CBC-4B41-4EC9-867A-6D92A84961B6">
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:5039F630-8691-4EE0-B107-894A04362AD6"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/C721EADB-C42D-4138-BA2B-ACCB482924B1">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>rosiglitazone</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/84108</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N3cf276e60ae94f4da0c9a4d640367fa8">
    <domeo:sets rdf:resource="urn:pddi:uuid:B7AF10B7-52EF-47EE-9448-9BACD4DCAA75"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N95dd15ea8e664c77ae1b4b9d1698a0f7">
    <domeo:sets rdf:resource="urn:pddi:uuid:E623C8BF-4B60-46A2-ABC4-B069E31D8178"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/4A5DB76A-8F7C-4CBE-BBAF-8808097EC9BB">
    <rdfs:label>indinavir</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/114289</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N096a4f82f94e4bc18a85cdcad17de92e">
    <domeo:sets rdf:resource="urn:pddi:uuid:068F30EB-E921-459E-9FA7-715247E2E20D"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:BFBB2077-1A80-4B2E-AEB9-4B0C13D522DC">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:BFBB2077-1A80-4B2E-AEB9-4B0C13D522DC"/>
    <pav:createdOn>2014-07-08 08:59:07 -0400</pav:createdOn>
    <domeo:uuid>BFBB2077-1A80-4B2E-AEB9-4B0C13D522DC</domeo:uuid>
    <ao:exact>norverapamil</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix>. Verapamil does not affect the pharmacokinetics of propranolol.</ao:suffix>
    <ao:prefix>and </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-127.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nf09764332e694e18a8934269ad26902f">
    <domeo:sets rdf:resource="urn:pddi:uuid:7AF2CBA9-42F4-4A07-A533-38832949E9CD"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N04a6c3d47e9043f7b0aa8f48ee8413ae">
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
    <permissions:isLocked>false</permissions:isLocked>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N006a786d97d4430dbd4dceb4aafb2f18">
    <domeo:sets rdf:resource="urn:pddi:uuid:0A2563FC-7297-4A00-9A4F-79E2815D869C"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nc39d15f0d7bd469e9ba089bbed6d34f8">
    <domeo:sets rdf:resource="urn:pddi:uuid:8413376C-C4CA-44D9-8317-8E5709B90DCB"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Ne8fd0c5d20af43d99bce2cf3936dbce7">
    <permissions:isLocked>false</permissions:isLocked>
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:34C79DFC-63F9-4C19-AE17-236F4ABA72C4">
    <ao:suffix>. Consequently, the clinical effect of the drug results from the combined concentrations of risperidone plus 9-hydroxyrisperidone.</ao:suffix>
    <ao:prefix>, has similar pharmacological activity as </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:34C79DFC-63F9-4C19-AE17-236F4ABA72C4"/>
    <ao:exact>risperidone</ao:exact>
    <pav:createdOn>2014-07-07 19:47:30 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>34C79DFC-63F9-4C19-AE17-236F4ABA72C4</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/B7C8DD30-1B6B-4BD8-89A8-87EDEEE8007E">
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/49276</dailymed:activeMoietyRxCUI>
    <rdfs:label>doxazosin</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:EA1E63D4-5825-43E9-BE29-4D1EBE7D64D0">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/BCB2FCB7-4E9C-4255-B15D-A495E09E0F93"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/A37E3538-05E4-4038-A1A4-D26BD899F8A0"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/DF5E80C8-3983-4AF3-A772-2CAA4BEAB7F2">
    <rdfs:label>fluoxetine</rdfs:label>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/4493</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:BE439E61-E001-41B0-B77A-085E37C7491C">
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:79753D21-4644-4E68-92CD-EFE8375D06D1"/>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:44A07F1C-B80C-4F44-B76D-D603846E38E2">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/BD40068E-3501-4592-ABFD-56C81D247946"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/F2AA3C8E-F73D-4C8D-A2A0-7FBB9B1A75A6"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N2c41716d52724e45b5a003f8586ae5d3">
    <domeo:sets rdf:resource="urn:pddi:uuid:B094B497-00AD-4DA1-ADB6-C553F2EC6219"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nc090325e59624d298fb73966ea2c9a3f">
    <domeo:sets rdf:resource="urn:pddi:uuid:EE6E27DD-8804-42E9-AD77-30D0F8243B04"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N11cdabcddb904199af2da1b4763f64ff">
    <domeo:sets rdf:resource="urn:pddi:uuid:E5E01AF0-C5DD-4644-87A7-A8B9B417DE5A"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:6086A2AC-2622-4D21-93E3-4827AB9A3275">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/20819184-D02D-4038-A0A8-12D067501F6C"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/CDF068B7-D2FE-4238-B7BE-F36222B0C2D5"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N662226fb7e55472996a4dfcc368d28a6">
    <permissions:accessType>urn:person:uuid:080e143046812afe0146812e52b20002</permissions:accessType>
    <permissions:isLocked>false</permissions:isLocked>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:88BF56BF-3895-498E-A799-0899022AB075">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/533B93F7-F71C-42ED-86A4-1CD4112CACDB"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/EDCCEBF0-09D9-4240-BEDE-4C60956F8C86"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:D15E7653-CB57-4569-A367-133D3E4E0D38">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/8A186325-8DCE-44DE-812F-F2CE9C6B70AF"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/61820CD5-0B51-4F89-B183-2912AB3E7DAD"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Ne9ec5a3511834ae8be64e5b76ef2201b">
    <domeo:sets rdf:resource="urn:pddi:uuid:69F6D661-D368-4573-82A2-50A2E595A757"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:33B59D6A-E02C-4A07-A4B9-71E121EBF442">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/E3A695D5-C612-44CB-BF54-67E1C8FC49CF"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/7325E7C2-1A5F-458D-A0BA-520A8C606134"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nd95638a5abd649eba1af67cfcd1bd4ac">
    <domeo:sets rdf:resource="urn:pddi:uuid:CA1B9D41-C7F8-47A4-A4C7-3EABFE91B094"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Na00d5847535349b290e0b3610007f938">
    <domeo:sets rdf:resource="urn:pddi:uuid:21E841BD-3C8C-4B00-91E2-9B17A343BCCE"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N50fbdc5ff06b443cbbcfba667c71878c">
    <permissions:accessType>urn:person:uuid:080e143046812afe0146812e52b20002</permissions:accessType>
    <permissions:isLocked>false</permissions:isLocked>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N4c1b9847c7e942e88684807f9f6f18fc">
    <domeo:sets rdf:resource="urn:pddi:uuid:D62B514A-BF31-403E-B6EB-BB4003236AA5"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N11667947c8824a12a94292bb4623d14e">
    <permissions:isLocked>false</permissions:isLocked>
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:114C154E-9AAD-46A3-988D-3FB10EF03E6B">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/C058CF98-3195-48C4-9708-A3B23586DCA0"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/2D4DEE29-CCF4-4C1F-B9EF-A5ED6DE97483"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nad77ead57e074971b2b3e314f02c6b5b">
    <domeo:sets rdf:resource="urn:pddi:uuid:930AAFB6-BA24-4725-8133-8B8E35E9EFDA"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N063a286d52b64f2f9e9200b64c650eaf">
    <domeo:sets rdf:resource="urn:pddi:uuid:70B9F308-2B30-4DA6-BA01-B62ED8CB1A0B"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N99d745f22930446196d0b562f4a9a5a7">
    <domeo:sets rdf:resource="urn:pddi:uuid:D51EDA8E-DA34-47CD-B996-4CFA6AFC27BF"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Ndea8479551704062ac8a93c2e92d827c">
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
    <permissions:isLocked>false</permissions:isLocked>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N5da9653fcb464c529b68189c6f12ece4">
    <domeo:sets rdf:resource="urn:pddi:uuid:AFF59558-2512-492E-837B-8B00C119B223"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N0aa00e4ac26c49c89f8e5f542eb105bc">
    <domeo:sets rdf:resource="urn:pddi:uuid:ED1C7034-2357-44D2-91BE-813CD7E3DA2B"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:E02E5030-656A-4E01-AF54-2CB9DBE69F4A">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/D4EA4B34-7DD7-4A86-868F-2C363572C2BE"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/0A8DF056-7E31-4E84-A5BD-033D5164416E"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:A9A833B1-C047-4B4F-BA2D-EA6659E4D34B">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/23650622-8463-4D76-A1BD-36175D649F09"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/7F244531-ACB3-49A1-9C69-FB96F337AFE1"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nda6e5e534e4f482f9e14e29790f524fb">
    <domeo:sets rdf:resource="urn:pddi:uuid:C8C5D393-94AF-4F68-A575-13441FB9958D"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N6cc9c06eb0d34c728fe8fd14c9bf9d98">
    <domeo:sets rdf:resource="urn:pddi:uuid:EDE2E9FD-1628-41DB-91FD-06502074DA39"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:BF596DE1-89B2-4F17-BEE1-BCD4AB86BEB1">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/42898F9B-5014-43C1-9EC8-8305C2D81B57"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/104E3B41-690C-4D81-925B-B26A1F620F05"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N17bb8f6554134309a67a06abf5b3ce2d">
    <domeo:sets rdf:resource="urn:pddi:uuid:15989C9D-F8F5-4B7E-89A2-5024DE28F437"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/F2AA3C8E-F73D-4C8D-A2A0-7FBB9B1A75A6">
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>aluminum hydroxide gel</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/</dailymed:activeMoietyRxCUI>
    <dct:description>Referred to the drug in the interaction.</dct:description>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N46944551a151472c9e955deaefd346a1">
    <domeo:sets rdf:resource="urn:pddi:uuid:2D03CF26-E207-41FC-9CD7-850A03CDCCD2"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N795282a01bb64101bfccb18a12b33eda">
    <permissions:isLocked>false</permissions:isLocked>
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:07E3EE16-E126-4A79-BA88-FC9476641A66">
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:55513051-DFF3-4FF6-887C-1DABCEA7A687"/>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:C75EF972-9D73-45F3-8C60-EF1D58AF29F9">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/AF4A44AC-088B-403C-A018-7956CFE466A1"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/56B0DEA3-D4B8-4D76-863C-D2C262C4AF2E"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N9f5d44e0fda24e41a08b78a2c94a0e17">
    <domeo:sets rdf:resource="urn:pddi:uuid:EFC836FC-2F4B-4D37-88E1-1FE17E222A9F"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N6137a252339641bda53ea6882b951f12">
    <domeo:sets rdf:resource="urn:pddi:uuid:11460EEB-C89E-451E-BE57-28F4DDA84CD0"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N912f6bbbd244421eb0fb70ae43060232">
    <domeo:sets rdf:resource="urn:pddi:uuid:4D82CCD7-A841-4857-B182-D7EC99071EF0"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nefc5b5ed38e14f519711388dae9a587b">
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
    <permissions:isLocked>false</permissions:isLocked>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nb49098238eac4ee0af9597e50e756108">
    <domeo:sets rdf:resource="urn:pddi:uuid:36261CBC-4B41-4EC9-867A-6D92A84961B6"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/EDCCEBF0-09D9-4240-BEDE-4C60956F8C86">
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/35636</dailymed:activeMoietyRxCUI>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>risperidone</rdfs:label>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N5879bba1c08647faa31197657b25cf1a">
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
    <permissions:isLocked>false</permissions:isLocked>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:63257A98-DB0C-475E-8995-EF0D01E81320">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/CC251E12-645E-4DAF-9284-02CE70210D23"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/FF2BF6A3-274B-4A01-9381-03CE2B964685"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N56d3905d335640a18f55fecd2496e498">
    <domeo:sets rdf:resource="urn:pddi:uuid:CD4AA3A0-B633-44B5-94F3-36F11CB4BF31"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nffd15c55810f47a386d4175447fea002">
    <domeo:sets rdf:resource="urn:pddi:uuid:6BD55200-00BD-42E2-9C53-8DD2867F80DC"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:079736F9-4C55-4D4F-BE5E-A1152FAB146A">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/FADA78F7-F25A-4A0C-ADB8-883B05FCC8C6"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/579F25EF-46DB-40E8-A6EE-8D523F3C8E7B"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N43c8ee0a1bec4df3abe7af123c707dac">
    <domeo:sets rdf:resource="urn:pddi:uuid:072CF40C-F19A-4344-87A7-437C42B6F310"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nb583a21519834a7da32d7d79862bd1eb">
    <domeo:sets rdf:resource="urn:pddi:uuid:F7E8F731-D07C-40BE-B0AF-196E15B59701"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N9b2fa83d5903490389f398a98231c54c">
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
    <permissions:isLocked>false</permissions:isLocked>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N5ebb25ec997a4a8a8e6afbf25750e9c8">
    <domeo:sets rdf:resource="urn:pddi:uuid:3DF1657C-6AB7-4108-81E9-CFE0C2B7C644"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N4787a183562e432fb60deaf74f4ffc74">
    <domeo:sets rdf:resource="urn:pddi:uuid:4FFCD141-5AA2-436C-9117-F0576C0823F5"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/150DE25D-3B69-4F2F-A3A7-E11046556BF9">
    <rdfs:label>rifampin</rdfs:label>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/9384</dailymed:activeMoietyRxCUI>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N1c82f3c5b27847e5bf4a69f4586ec9f2">
    <domeo:sets rdf:resource="urn:pddi:uuid:6C4881EE-692B-43EF-89CA-3564DF645FEE"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nab6d7fbc121a4d21b2c611f3f8cac413">
    <permissions:accessType>urn:person:uuid:080e143046812afe0146812e52b20002</permissions:accessType>
    <permissions:isLocked>false</permissions:isLocked>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/63CC8424-0167-4DD3-BFB3-56A9E60548FF">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>methadone</rdfs:label>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/6813</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N5f766e7bf2a7439eae196604a3f97883">
    <domeo:sets rdf:resource="urn:pddi:uuid:D8C85CA5-4085-4727-9E5E-B29A85F0174D"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N187fe32e3bfe4e808e6a5b959c65a66b">
    <domeo:sets rdf:resource="urn:pddi:uuid:6477EB37-EE85-453E-8948-66FFF50EE9F0"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N21ed88a7066346808e3bdd5f361a5177">
    <domeo:sets rdf:resource="urn:pddi:uuid:7C040413-A39D-43DF-8875-79B15B405CD2"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Ne07b3259b9ca4a47932799da685f3c83">
    <permissions:isLocked>false</permissions:isLocked>
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nc127679f3fa14839921c6a9e996cbcc0">
    <domeo:sets rdf:resource="urn:pddi:uuid:A39CC67D-1901-459D-B0B8-39681A921204"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N470b4faa261f432a935d80ff33e7e586">
    <domeo:sets rdf:resource="urn:pddi:uuid:9E35FC3E-1628-48F1-8A0E-34D3D804CA99"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nac2643dd578d4eb8901fdaf355e735bf">
    <permissions:accessType>urn:person:uuid:080e143046812afe0146812e52b20002</permissions:accessType>
    <permissions:isLocked>false</permissions:isLocked>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:ECF50F48-1702-488B-83D2-B0931A1B95D9">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/1DBFD671-A5D4-40AA-9487-73BC18A11692"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/B9C43951-91D7-4A8E-A429-F7C9AF3A67CB"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N264d40e444ea4895a3b1fcda0db469b0">
    <domeo:sets rdf:resource="urn:pddi:uuid:85080FBE-9D21-4608-A18C-5BB6574C4AAE"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N5fb4fd66869f46b5882e1d2b549a69a3">
    <domeo:sets rdf:resource="urn:pddi:uuid:28FECF39-4562-444A-9C77-7BBF262CC5E2"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N08f94404e59946a8a3bcc0d9b131b56b">
    <domeo:sets rdf:resource="urn:pddi:uuid:ABB567E4-CD8B-462F-AE86-1C88DE059343"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:3E86AA83-E2A8-46C4-BD9A-365D504AF7F8">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/BCF2904D-F2EE-4E1A-93C8-2A8DB8975E85"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/7E36180E-9E78-4C9F-B250-179E9BCBA02D"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Na78067124c114d52bc80faa58848e496">
    <domeo:sets rdf:resource="urn:pddi:uuid:2B0B133F-3636-48C3-B972-A6B55BE02576"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N548a437ae06f444ea92d85e08a3f0745">
    <domeo:sets rdf:resource="urn:pddi:uuid:61E9853F-DC24-40CC-A092-28A53CDA36EC"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N4ecbbff1c01743e58ea623a683bfad04">
    <domeo:sets rdf:resource="urn:pddi:uuid:1CB611B0-6AD8-4324-B643-42DE5864CFF9"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nd4da246e7c914f53a64e4390773bbe41">
    <domeo:sets rdf:resource="urn:pddi:uuid:D0392BAB-2D44-4B7F-9061-4D8C13FA38C5"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/0FBD86F2-13B9-4547-99B1-38FEA6044EAD">
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/9068</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>quinidine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N745648abdf974ae6bb16b1028ab988fe">
    <domeo:sets rdf:resource="urn:pddi:uuid:0CA59AE8-1A92-466F-B216-0940DA19A0C8"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nf63bfafdd677429681ed8054e4c1da6f">
    <domeo:sets rdf:resource="urn:pddi:uuid:20C1B844-001A-4CA9-97FA-D4E6A5AC2069"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Na8e37c2a3b764547b282291c3bcac06f">
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
    <permissions:isLocked>false</permissions:isLocked>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:40E59130-9EA1-45C0-B6FE-2A93C522117C">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/7D1A908A-5C31-4797-9FE9-F3A966262FA3"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/BB8C069D-1C36-4E96-B9E9-E0E159690B6D"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N384a64adbc6c47c3b80afb9001d29be8">
    <domeo:sets rdf:resource="urn:pddi:uuid:7F578098-5612-4E2A-92D1-A379DB25B905"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/61B86845-4EAE-44DA-90EE-8B8F4954091A">
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>fluvastatin</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/41127</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N4b8ae6092e904d52804f772208226631">
    <domeo:sets rdf:resource="urn:pddi:uuid:853DC411-0B9B-49E4-8EDB-8B5761358DE8"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N14092d8ccdbd436f868bd19ffde57112">
    <domeo:sets rdf:resource="urn:pddi:uuid:1BF81E1E-29DF-40E7-AA33-3733E21C84C5"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Na8b9b00515f742e8a10d284c873f3a36">
    <domeo:sets rdf:resource="urn:pddi:uuid:D4CAF849-C000-48CE-8BC4-66D7356A298E"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N389f9389a9e74edb9d373a938d70c8fb">
    <domeo:sets rdf:resource="urn:pddi:uuid:B55091DF-79BD-4E15-9803-8FB9D85822A5"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:4A112A7B-0BD7-4310-8FBA-D12983EDEE55">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/09710064-E598-46D4-AE2F-21EEBC2859B0"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/C49FAE86-1ECA-48BD-99AC-0E69425593E3"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N8b16901010234248975e7a5f368298e9">
    <permissions:isLocked>false</permissions:isLocked>
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Ne4977c5e45e446f183ccb2af28ca6f58">
    <domeo:sets rdf:resource="urn:pddi:uuid:3741A47A-7BB2-4E44-9D97-AA1C2F61C8E0"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:6EF82B31-3A34-4275-A117-F44BB02FE863">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/70E14994-95FA-477A-950C-6D4BDACBA860"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/02AD7A69-B306-4B61-A307-74F9427F8412"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nbed970982c9d49de9796d3319d6b1dbd">
    <permissions:accessType>urn:person:uuid:080e143046812afe0146812e52b20002</permissions:accessType>
    <permissions:isLocked>false</permissions:isLocked>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N823c0b92522444f5aadce02d6826112a">
    <domeo:sets rdf:resource="urn:pddi:uuid:2684C92B-90DE-4D9B-BA75-B78634E161FD"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N20b39f09f5254a1d9904d9348ef8e40b">
    <domeo:sets rdf:resource="urn:pddi:uuid:570AE2C8-D6FE-4DBE-9EDE-B410F3051CE4"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N83cf286ecbb049219dc191ee472092ed">
    <domeo:sets rdf:resource="urn:pddi:uuid:F4E891D3-BA8C-4980-935F-8169415B3261"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N49cf6f3468854b8290985bfb8d20a582">
    <domeo:sets rdf:resource="urn:pddi:uuid:139D415F-8F6D-49CD-B44F-E015C847C5CC"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N6a56285be17a4d8cb4229cdaa23e4d91">
    <domeo:sets rdf:resource="urn:pddi:uuid:8D2BD98C-D72E-4268-8341-658939384183"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N859724a8c958428ca83084f14c9540ef">
    <permissions:accessType>urn:person:uuid:080e143046812afe0146812e52b20002</permissions:accessType>
    <permissions:isLocked>false</permissions:isLocked>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nbf54f9e93d694653b290cb1d1a195d4a">
    <domeo:sets rdf:resource="urn:pddi:uuid:27B4044D-BAED-42FB-996A-CEFABBB885A4"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nbd2429a4f70d467cb4c0abbfcfac9130">
    <domeo:sets rdf:resource="urn:pddi:uuid:51166EA0-74CD-429C-AFAE-CE03BDFF84DB"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Ncb2bba057abc426993f6978923e1deef">
    <domeo:sets rdf:resource="urn:pddi:uuid:7D04978B-320A-4D53-A6B2-08DC794B8519"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N45fcaba63136437a91f9219a1a563b03">
    <domeo:sets rdf:resource="urn:pddi:uuid:51A70545-FD58-441C-9E45-815D0E26D0ED"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Na6ef47645d6a4438bf102879d20cfe8e">
    <domeo:sets rdf:resource="urn:pddi:uuid:1E224B43-906A-4906-BCC8-73BE83836DA5"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N4da183e02f9f49778e958c7e659d4b20">
    <domeo:sets rdf:resource="urn:pddi:uuid:180F9EC8-2179-4455-B418-8AAF372AA675"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N2ba9723d055442c0b074f14f3340e99e">
    <domeo:sets rdf:resource="urn:pddi:uuid:8203300B-7D6E-4809-A3FF-16CDA16CDF40"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N67994f49c7d746418505f3d25cd62ae1">
    <domeo:sets rdf:resource="urn:pddi:uuid:0B895EAD-D7C4-4E9B-B382-DEBD787CE8B8"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N3c25829d115a42e6b9f5bf63641d69b4">
    <domeo:sets rdf:resource="urn:pddi:uuid:B817495A-8751-415B-A471-6A1B127573EB"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N41fe3d7adfbf4fe685d30669685be554">
    <domeo:sets rdf:resource="urn:pddi:uuid:4FA6CAEB-8998-48FA-963C-B5E8B5813755"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N6b69cbe6c2804e27b4e4746d7a6582fa">
    <permissions:accessType>urn:person:uuid:080e143046812afe0146812e52b20002</permissions:accessType>
    <permissions:isLocked>false</permissions:isLocked>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nebe2b41b8b9441009e5c13e5f7e10d76">
    <domeo:sets rdf:resource="urn:pddi:uuid:BA20E396-75C5-4827-9982-C1702AC94E69"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nb4ca3880c32e4959be4b65b29e2fb7db">
    <permissions:isLocked>false</permissions:isLocked>
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Ndaf5f6e0cf36416f865d97b2f8fc5248">
    <domeo:sets rdf:resource="urn:pddi:uuid:CC59C294-5F2A-4672-9802-3F1A7163DDC1"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N999fe5bc11d3499bbf629d148915e165">
    <permissions:accessType>urn:person:uuid:080e143046812afe0146812e52b20002</permissions:accessType>
    <permissions:isLocked>false</permissions:isLocked>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Ncaacf543c27a4a41b5c3394a74abba6b">
    <domeo:sets rdf:resource="urn:pddi:uuid:10ACC947-F6D8-49C9-8281-3FDD803F2175"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N6e4675d5fed74a5c9abf89a208f11015">
    <domeo:sets rdf:resource="urn:pddi:uuid:9DEEB774-8BA5-4C4D-92D6-53CB1639FECD"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:F9B040DB-5C26-4D30-AFB9-675193FE3E06">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/1551B4FA-E530-41EB-BBEB-493FC7DF9D95"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/29C34D0E-2F46-4BA3-9CA0-689762F394CA"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N1df69f6e16594e488f576cdbc14ac4c0">
    <domeo:sets rdf:resource="urn:pddi:uuid:98A2BCCE-B7AD-4A10-801B-78478D087BC4"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N1e21821254e04efd966f5a7bda5503f9">
    <domeo:sets rdf:resource="urn:pddi:uuid:8AAF0037-89BE-4D47-8BBF-0D3D1A3A3D91"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N16fbeb976465444d8810c50e32c7d00b">
    <domeo:sets rdf:resource="urn:pddi:uuid:A540168D-5909-4E6B-9619-215C806B5B22"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nbd202d0d3288464696567c39ab317f48">
    <domeo:sets rdf:resource="urn:pddi:uuid:B7E0294C-F193-4CB1-8AB8-83C562AD21DC"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nb5617b7175a84b86937becadf2ebf962">
    <domeo:sets rdf:resource="urn:pddi:uuid:FFF82639-F04C-408F-8A11-01A3070D4E29"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N9f57dd9ba0e8438ea05029499dcf44d8">
    <domeo:sets rdf:resource="urn:pddi:uuid:110012FA-E5E5-4A1B-B382-8E109A7FA4C1"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N81cbf2f6985b46a0ad29459d6aeca554">
    <domeo:sets rdf:resource="urn:pddi:uuid:0546FBBA-CDB2-46D1-830E-2F04F36E980E"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N8b500c41c6904297bab35004945ddea7">
    <domeo:sets rdf:resource="urn:pddi:uuid:F3A34621-4324-4719-8256-47B8ABF30D7D"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N540d12b887df4ca0a0f079360c63f345">
    <domeo:sets rdf:resource="urn:pddi:uuid:DF532E3B-F77C-41C1-ACD1-91EC4B5F075D"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N049d816cb38b414094ebfda7541b09b8">
    <domeo:sets rdf:resource="urn:pddi:uuid:2295CCE9-3A07-4B53-B46F-5AFFD19002AE"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nb48dfab9835b45298ae8f95211e4e4d6">
    <domeo:sets rdf:resource="urn:pddi:uuid:E52729A4-0084-4CFA-BE82-D80D665A77B5"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N7aa7bc8023cd4d8daca2a4b95fef0693">
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
    <permissions:isLocked>false</permissions:isLocked>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Ned89cd995ef740b49180f2b2c4a5d80c">
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
    <permissions:isLocked>false</permissions:isLocked>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Ncc6d28d4009048af8aec31c48af2e81e">
    <domeo:sets rdf:resource="urn:pddi:uuid:2B73BEE2-E8B0-497C-93BD-D085C7A765ED"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N01d480fec8e040a98f4faace02701e00">
    <domeo:sets rdf:resource="urn:pddi:uuid:0522CC55-078E-405F-9A7C-F3B2B4298A87"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N668ac451d16b4fed8559a9ee025c96ea">
    <domeo:sets rdf:resource="urn:pddi:uuid:2848E1E3-47B6-4C73-8AA5-0AC3E1913232"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nd836162d55be400e83a22ec91b2bbcb3">
    <domeo:sets rdf:resource="urn:pddi:uuid:30838343-4298-4505-9B6F-82717973AFDF"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N20f3cb9c829842ab98043ff37e16dfea">
    <domeo:sets rdf:resource="urn:pddi:uuid:641CBD79-D57F-4A7A-B321-274C4D24C748"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N3cec04f2aca144b3b20db2b7e4051512">
    <domeo:sets rdf:resource="urn:pddi:uuid:FC065FBE-922F-4D8C-91CF-496EDE482A39"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Na92af93b98874a0ab91747fe80c131a5">
    <domeo:sets rdf:resource="urn:pddi:uuid:A4F34B68-466F-4AE7-8538-3E71001B2E14"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N1ec64a49af9d48faad35552c5b81cd88">
    <domeo:sets rdf:resource="urn:pddi:uuid:0B3B636D-FBE7-43AC-A231-753D133FC763"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Na4abaf9ffc6b4fd4abee4c3d571458a3">
    <domeo:sets rdf:resource="urn:pddi:uuid:86633E71-C3F0-42BD-ABC5-16ADACA99690"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N923c917ab20e469e85a56d71e9734601">
    <domeo:sets rdf:resource="urn:pddi:uuid:83DB2E5E-A3FD-4CD4-8D24-9B7AC9DD3DA0"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N7285abf0aa0b4e46bc93d6ef995d27af">
    <permissions:isLocked>false</permissions:isLocked>
    <permissions:accessType>urn:person:uuid:080e143046812afe0146812e52b20002</permissions:accessType>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N4d50196103054e1591b4d5f27b38ee07">
    <domeo:sets rdf:resource="urn:pddi:uuid:364772D1-CC5B-4386-AE66-69C622A604AE"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Naf87b445ea904f6f896e380f5f4de31a">
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
    <permissions:isLocked>false</permissions:isLocked>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N3952d26c2dab4d359bc4be576bf66204">
    <domeo:sets rdf:resource="urn:pddi:uuid:BE439E61-E001-41B0-B77A-085E37C7491C"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N6e7a7ce7f1e14afa84f3dd9c66115d6b">
    <domeo:sets rdf:resource="urn:pddi:uuid:B736374E-F0F6-4B93-8883-B0EB4CCF0B24"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Ne2d4b4666157454697f831078df69a14">
    <domeo:sets rdf:resource="urn:pddi:uuid:CA735731-CC8F-4385-910D-C906B33A428D"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nc79f26437c984f0797e66f5f44e7614a">
    <domeo:sets rdf:resource="urn:pddi:uuid:D0E1198D-B467-4D09-86F6-59C3F2F15BCD"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N216a3fb3c7564de4b4cbfa5003028267">
    <domeo:sets rdf:resource="urn:pddi:uuid:AE1B6FFA-E968-4ABC-9E50-DB1A83132DE8"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N4c708d362f1e454e958c94b0ee1a6a4b">
    <domeo:sets rdf:resource="urn:pddi:uuid:EECF550C-56E3-4B87-A6AD-C99E211745F2"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N00ca8f501bb348909ae7e48e8f780ad4">
    <domeo:sets rdf:resource="urn:pddi:uuid:EF978B29-00A9-40C7-BDE7-946DD69D71FC"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nea24a2bb750a42e9be30c4f8813e3dad">
    <domeo:sets rdf:resource="urn:pddi:uuid:221357BB-2689-41F8-AE3D-DC5DC5DA859C"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N476ce95e3fca4c40abc8e53fef05fb5a">
    <domeo:sets rdf:resource="urn:pddi:uuid:7E2E158E-902A-4662-B0F0-04D80631F810"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N23e8a45963d24d60bfbf45b26062bca8">
    <domeo:sets rdf:resource="urn:pddi:uuid:F6B33A60-A21A-4168-9980-03D3A06B0252"/>
  </rdf:Description>
</rdf:RDF>
